Psyllid ID: psy1789
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 499 | 2.2.26 [Sep-21-2011] | |||||||
| Q9V422 | 584 | Tyrosine-protein kinase D | yes | N/A | 0.943 | 0.806 | 0.493 | 1e-126 | |
| Q01887 | 594 | Tyrosine-protein kinase R | yes | N/A | 0.961 | 0.808 | 0.421 | 1e-112 | |
| P34925 | 604 | Tyrosine-protein kinase R | yes | N/A | 0.953 | 0.788 | 0.428 | 1e-111 | |
| Q27324 | 610 | Tyrosine-protein kinase D | no | N/A | 0.599 | 0.490 | 0.520 | 6e-94 | |
| P23049 | 370 | Tyrosine-protein kinase t | N/A | N/A | 0.573 | 0.772 | 0.377 | 2e-55 | |
| Q07E01 | 1382 | Hepatocyte growth factor | no | N/A | 0.631 | 0.227 | 0.345 | 1e-53 | |
| Q09YH7 | 1381 | Hepatocyte growth factor | N/A | N/A | 0.494 | 0.178 | 0.386 | 9e-53 | |
| Q07DV8 | 1381 | Hepatocyte growth factor | N/A | N/A | 0.494 | 0.178 | 0.386 | 1e-52 | |
| Q2QLC0 | 1381 | Hepatocyte growth factor | N/A | N/A | 0.494 | 0.178 | 0.386 | 1e-52 | |
| Q2QLG5 | 1381 | Hepatocyte growth factor | no | N/A | 0.494 | 0.178 | 0.386 | 1e-52 |
| >sp|Q9V422|RYK2_DROME Tyrosine-protein kinase Dnt OS=Drosophila melanogaster GN=dnt PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 452 bits (1162), Expect = e-126, Method: Compositional matrix adjust.
Identities = 242/490 (49%), Positives = 333/490 (67%), Gaps = 19/490 (3%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS 79
LPYSI+V S++++ L P +N+S G IPT+IQT+SI L C+G AEV V +S+ V L+
Sbjct: 104 LPYSINVVSSDQEVLPRPAINVSHSGEIPTTIQTWSIALKCSGLKAAEVDVTVSLEVVLN 163
Query: 80 RNSNNVTSLNFKRKKICLR------VAADLDEPSI--NVLDEPVSRLHLYNILAICAACV 131
R+ NNVT L F+RKKICL ++ D+D+P + V+ P + L +++ V
Sbjct: 164 RSLNNVTHLVFRRKKICLMNDSAEDLSEDVDDPQLLETVMLPPTGLITLVVGVSVAMGSV 223
Query: 132 LITVVVIYSCACFVRNKKLRRHG-EILQNGSNSSTTGHTPFLLPAPVLNCGATSASSNTS 190
+ +++ Y ++ +HG + ++ S H P S +
Sbjct: 224 CLLLMIAYCVKGAANKRQHHQHGGQPMRTSSFQRLNTHPPCQSSMGSAAYMTPSIIAPIH 283
Query: 191 YASFKRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVE 250
+S R+ S ++LH ++SELT++RCRVRL S+ EGTFGRVYRGTY +
Sbjct: 284 GSSLPRKVPVSVEQQHPEELHRRISELTVERCRVRLSSLLQEGTFGRVYRGTYNDT---- 339
Query: 251 EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYT- 309
++VLVKTV +AS +QV LLLQEGM +YG SH IL+VLGVSIEDHT+PF++YP + T
Sbjct: 340 QDVLVKTVAQHASQMQVLLLLQEGMLLYGASHPGILSVLGVSIEDHTTPFVLYPALNNTR 399
Query: 310 NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369
NLK+FL L P A T+TT ++V M Q+ M + +LH ++HKD+ATRNCV+DD+L
Sbjct: 400 NLKQFL----LDP-ACARTVTTIQIVMMASQLSMALDHLHSHGVVHKDIATRNCVIDDQL 454
Query: 370 RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429
R++++D++L+RDLFPSDY+CLGD+ENRPVKW+++E+L HK FS ASD WAFGVL+WEL T
Sbjct: 455 RVKLSDSSLSRDLFPSDYNCLGDSENRPVKWMSLEALQHKQFSEASDSWAFGVLMWELCT 514
Query: 430 LAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489
A+QPYAE+DPFEM L+DGYRL QP NCPDELF++MAYCWA+ P RPTF QL SCL
Sbjct: 515 SAKQPYAEVDPFEMEHYLKDGYRLAQPFNCPDELFTIMAYCWALLPAERPTFAQLQSCLS 574
Query: 490 EFHAQLTRYV 499
EF++Q+TRYV
Sbjct: 575 EFYSQITRYV 584
|
May play an essential role in neuronal pathway recognition and ventral muscle attachment site selection. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1 |
| >sp|Q01887|RYK_MOUSE Tyrosine-protein kinase RYK OS=Mus musculus GN=Ryk PE=1 SV=2 | Back alignment and function description |
|---|
Score = 405 bits (1041), Expect = e-112, Method: Compositional matrix adjust.
Identities = 216/512 (42%), Positives = 313/512 (61%), Gaps = 32/512 (6%)
Query: 10 LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVI 69
L F + Y + + N A+ P +NIS+ G +P ++ F + L CTG +++EV+
Sbjct: 93 LHFTWHAKSKVEYKLGFQVDNFVAMGMPQVNISAQGEVPRTLSVFRVELSCTGKVDSEVM 152
Query: 70 VLISINVTLSRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSR-----LH----- 119
+L+ +N+T++ +S N T LNFKR+K+C + L+E + LD+ SR +H
Sbjct: 153 ILMQLNLTVN-SSKNFTVLNFKRRKMCYK---KLEEVKTSALDKNTSRTIYDPVHAAPTT 208
Query: 120 ----LYNILAICAACVLITVVVIYSCACFVRNKKLR---RHGEILQNGSNSSTTGHTPFL 172
Y + +C A + + V +I + K++ + S + T
Sbjct: 209 STRVFYISVGVCCAVIFL-VAIILAVLHLHSMKRIELDDSISASSSSQGLSQPSTQTTQY 267
Query: 173 LPAPVLNCGATSASSNTSYASFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFSV 229
L A N AT +S++ Y + + + D R+ L E K+ ++ I R R+ L V
Sbjct: 268 LRADTPN-NATPITSSSGYPTLR----IEKNDLRSVTLLEAKAKVKDIAISRERITLKDV 322
Query: 230 NMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EGTFGR++ G +E E++ VKTV D AS VQV+++L E + GL H+N+L
Sbjct: 323 LQEGTFGRIFHGILVDEKDPNKEKQTFVKTVKDQASEVQVTMMLTESCKLRGLHHRNLLP 382
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ V IE+ P ++ PY ++ NLK FL++CKL ++ Q++V M +QI G+ Y
Sbjct: 383 ITHVCIEEGEKPMVVLPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSY 442
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
L +++++H+DLA RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+ESLV
Sbjct: 443 LARREVIHRDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESLV 502
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+VM
Sbjct: 503 NNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVM 562
Query: 468 AYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
A CWA++PE RP F QL CL EFHA L YV
Sbjct: 563 ACCWALDPEERPKFQQLVQCLTEFHAALGAYV 594
|
May be a coreceptor along with FZD8 of Wnt proteins, such as WNT1, WNT3, WNT3A and WNT5A. Involved in neuron differentiation, axon guidance, corpus callosum establishment and neurite outgrowth. In response to WNT3 stimulation, receptor C-terminal cleavage occurs in its transmembrane region and allows the C-terminal intracellular product to translocate from the cytoplasm to the nucleus where it plays a crucial role in neuronal development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P34925|RYK_HUMAN Tyrosine-protein kinase RYK OS=Homo sapiens GN=RYK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 402 bits (1034), Expect = e-111, Method: Compositional matrix adjust.
Identities = 220/513 (42%), Positives = 312/513 (60%), Gaps = 37/513 (7%)
Query: 10 LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVI 69
L F + Y + + N A+ P +NIS G +P ++ F + L CTG +++EV+
Sbjct: 106 LHFTWHAKSKVEYKLGFQVDNVLAMDMPQVNISVQGEVPRTLSVFRVELSCTGKVDSEVM 165
Query: 70 VLISINVTLSRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSR-----LH----- 119
+L+ +N+T++ +S N T LNFKR+K+C + L+E + LD+ SR +H
Sbjct: 166 ILMQLNLTVN-SSKNFTVLNFKRRKMCYK---KLEEVKTSALDKNTSRTIYDPVHAAPTT 221
Query: 120 ----LYNILAICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTG----HTPF 171
Y + +C C +I +V I + N K + + S+S T
Sbjct: 222 STRVFYISVGVC--CAVIFLVAIILAVLHLHNMKRIELDDSISASSSSQGLSQPSTQTTQ 279
Query: 172 LLPAPVLNCGATSASSNTSYASFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFS 228
L A N +A+ TSY + + + D R+ L E K+ ++ I R R+ L
Sbjct: 280 YLRADTPN----NATPITSYPTLR----IEKNDLRSVTLLEAKGKVKDIAISRERITLKD 331
Query: 229 VNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNIL 286
V EGTFGR++ G +E E++ VKTV D AS +QV+++L E + GL H+N+L
Sbjct: 332 VLQEGTFGRIFHGILIDEKDPNKEKQAFVKTVKDQASEIQVTMMLTESCKLRGLHHRNLL 391
Query: 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+ V IE+ P +I PY ++ NLK FL++CKL ++ Q++V M +QI G+
Sbjct: 392 PITHVCIEEGEKPMVILPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMS 451
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESL 406
YL +++++HKDLA RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+ESL
Sbjct: 452 YLARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESL 511
Query: 407 VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSV 466
V+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+V
Sbjct: 512 VNNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAV 571
Query: 467 MAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
MA CWA++PE RP F QL CL EFHA L YV
Sbjct: 572 MACCWALDPEERPKFQQLVQCLTEFHAALGAYV 604
|
May be a coreceptor along with FZD8 of Wnt proteins, such as WNT1, WNT3, WNT3A and WNT5A. Involved in neuron differentiation, axon guidance, corpus callosum establishment and neurite outgrowth. In response to WNT3 stimulation, receptor C-terminal cleavage occurs in its transmembrane region and allows the C-terminal intracellular product to translocate from the cytoplasm to the nucleus where it plays a crucial role in neuronal development. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q27324|RYK1_DROME Tyrosine-protein kinase Drl OS=Drosophila melanogaster GN=drl PE=2 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (884), Expect = 6e-94, Method: Compositional matrix adjust.
Identities = 162/311 (52%), Positives = 221/311 (71%), Gaps = 12/311 (3%)
Query: 190 SYASFKRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGV 249
+YA+ R + + ++ + +L ELT+Q+CRVRL + EG FGR+YRGTY +
Sbjct: 311 TYATLTR--PFREYEHEPEEFNRRLQELTVQKCRVRLSCLVQEGNFGRIYRGTYNDC--- 365
Query: 250 EEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYT 309
+EVLVKTV +AS +QV+LLLQE M +Y SH N+L+VLG+SIED+ +PF++Y
Sbjct: 366 -QEVLVKTVAQHASQLQVNLLLQESMMLYEASHPNVLSVLGISIEDYATPFVLYAATGSV 424
Query: 310 -NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK 368
NLK FLQ A ++TT + V M Q+ M +++LH ++HKD+A RNCV+DD+
Sbjct: 425 RNLKSFLQD-----PSYARSVTTIQTVLMGSQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 479
Query: 369 LRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELT 428
LR+++TD+AL+RDLFP DY+ LGD E RP+KWL++E+L ++ SDVW+FGVL+WE+
Sbjct: 480 LRVKLTDSALSRDLFPGDYNSLGDGEYRPIKWLSLEALQKSHYNEGSDVWSFGVLMWEMC 539
Query: 429 TLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488
TL + PYAEIDP+EM L+DGYRL QP NCPDELF++MAYCWA P RP+F QL CL
Sbjct: 540 TLGKLPYAEIDPYEMEHYLKDGYRLAQPFNCPDELFTIMAYCWASMPAERPSFSQLQICL 599
Query: 489 QEFHAQLTRYV 499
EFH Q+TRYV
Sbjct: 600 SEFHTQITRYV 610
|
Probable coreceptor of Wnt proteins. Involved in neuronal pathway recognition and ventral muscle attachment site selection. Non-vital for development. May be part of a signal transduction cascade involved in learning and possibly memory. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P23049|SEA_AVIET Tyrosine-protein kinase transforming protein SEA OS=Avian erythroblastosis virus (strain S13) GN=V-SEA PE=3 SV=2 | Back alignment and function description |
|---|
Score = 216 bits (551), Expect = 2e-55, Method: Compositional matrix adjust.
Identities = 112/297 (37%), Positives = 172/297 (57%), Gaps = 11/297 (3%)
Query: 203 LDDRNKDLHEKLSELTI--QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTD 260
L+D +L E++ ++ I +R V G FG VY GTY + VK++
Sbjct: 37 LEDLRPELLEEVKDILIPEERLITHRSRVIGRGHFGSVYHGTYMDPLLGNLHCAVKSLHR 96
Query: 261 NASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKL 320
+V L+EG+ M G H +L++LGV + H P ++ PY + +L+ F++ +
Sbjct: 97 ITYLEEVEEFLREGILMKGFHHPQVLSLLGVCLPRHGLPLVVLPYMRHGDLRHFVRAQER 156
Query: 321 CPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
P T +E++ LQ+ +G++YL +KK +H+DLA RNC++D+ L +++ D LAR
Sbjct: 157 SP-------TVKELIGFGLQVALGMEYLAQKKFVHRDLAARNCMLDETLTVKVADFGLAR 209
Query: 381 DLFPSDYHCLGDNENR--PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI 438
D+F +Y+ + + + PV+W+A+ESL + F+T SDVW+FGVL+WEL T PY E+
Sbjct: 210 DVFGKEYYSIRQHRHAKLPVRWMALESLQTQKFTTKSDVWSFGVLMWELLTRGASPYPEV 269
Query: 439 DPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
DP++MA L G RL QP CPD L+ VM CWA PE RP+F L L+ A L
Sbjct: 270 DPYDMARYLLRGRRLPQPQPCPDTLYGVMLSCWAPTPEERPSFSGLVCELERVLASL 326
|
Galliformes (taxid: 8976) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q07E01|MET_ORNAN Hepatocyte growth factor receptor OS=Ornithorhynchus anatinus GN=MET PE=3 SV=1 | Back alignment and function description |
|---|
Score = 211 bits (536), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 115/333 (34%), Positives = 181/333 (54%), Gaps = 18/333 (5%)
Query: 158 QNGSNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFKRRPSYSRLDDRNKDLHEKLSEL 217
QNGS H P +P+L+ G ++ SS ++ + + N DL + + +
Sbjct: 1018 QNGS--CRQAHYPLADLSPILSSGDSNPSSPLLQSNV-----HIDISALNPDLVQAVQHV 1070
Query: 218 TI--QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGM 275
I V + G FG VY GT + D + VK++ +VS L EG+
Sbjct: 1071 VIGPDSLMVHFTEIIGRGHFGCVYHGTLLDNDDKKIHCAVKSLNRITDIEEVSQFLTEGI 1130
Query: 276 AMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVV 335
M SH N+L++LG+ + SP ++ PY + +L+ F++ +H T ++++
Sbjct: 1131 IMKDFSHPNVLSLLGICLRREGSPLVVLPYMKHGDLRNFIRN-------ESHNPTVKDLI 1183
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
LQ+ G++YL KK +H+DLA RNC++D+K +++ D LARD++ +Y+ + +
Sbjct: 1184 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 1243
Query: 396 R--PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
PVKW+A+ESL + F++ SDVW+FGVLLWEL T PY +++ F++ L G RL
Sbjct: 1244 AKLPVKWMALESLQTQKFTSKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 1303
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486
QP CPD LF VM CW N E RP+F +L S
Sbjct: 1304 LQPEYCPDPLFEVMLKCWHPNAEMRPSFSELVS 1336
|
Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. Ornithorhynchus anatinus (taxid: 9258) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q09YH7|MET_SAIBB Hepatocyte growth factor receptor OS=Saimiri boliviensis boliviensis GN=MET PE=3 SV=1 | Back alignment and function description |
|---|
Score = 208 bits (529), Expect = 9e-53, Method: Compositional matrix adjust.
Identities = 99/256 (38%), Positives = 151/256 (58%), Gaps = 9/256 (3%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG VY GT + DG + VK++ +VS L EG+ M SH N+L++LG+
Sbjct: 1087 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 1146
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ SP ++ PY + +L+ F++ H T ++++ LQ+ G++YL KK
Sbjct: 1147 LRSEGSPLVVLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKYLASKK 1199
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--PVKWLAIESLVHKT 410
+H+DLA RNC++D+K +++ D LARD++ +Y+ + + PVKW+A+ESL +
Sbjct: 1200 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 1259
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F+T SDVW+FGVLLWEL T PY +++ F++ L G RL QP CPD L+ VM C
Sbjct: 1260 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 1319
Query: 471 WAMNPEGRPTFPQLHS 486
W E RP+F +L S
Sbjct: 1320 WHPKAEMRPSFSELVS 1335
|
Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. Saimiri boliviensis boliviensis (taxid: 39432) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q07DV8|MET_AOTNA Hepatocyte growth factor receptor OS=Aotus nancymaae GN=MET PE=3 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (528), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 99/256 (38%), Positives = 151/256 (58%), Gaps = 9/256 (3%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG VY GT + DG + VK++ +VS L EG+ M SH N+L++LG+
Sbjct: 1087 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 1146
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ SP ++ PY + +L+ F++ H T ++++ LQ+ G++YL KK
Sbjct: 1147 LRSEGSPLVVLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKYLASKK 1199
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--PVKWLAIESLVHKT 410
+H+DLA RNC++D+K +++ D LARD++ +Y+ + + PVKW+A+ESL +
Sbjct: 1200 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 1259
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F+T SDVW+FGVLLWEL T PY +++ F++ L G RL QP CPD L+ VM C
Sbjct: 1260 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 1319
Query: 471 WAMNPEGRPTFPQLHS 486
W E RP+F +L S
Sbjct: 1320 WHPKAEMRPSFSELVS 1335
|
Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. Aotus nancymaae (taxid: 37293) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q2QLC0|MET_CALMO Hepatocyte growth factor receptor OS=Callicebus moloch GN=MET PE=3 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (528), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 99/256 (38%), Positives = 151/256 (58%), Gaps = 9/256 (3%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG VY GT + DG + VK++ +VS L EG+ M SH N+L++LG+
Sbjct: 1087 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 1146
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ SP ++ PY + +L+ F++ H T ++++ LQ+ G++YL KK
Sbjct: 1147 LRSEGSPLVVLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKYLASKK 1199
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--PVKWLAIESLVHKT 410
+H+DLA RNC++D+K +++ D LARD++ +Y+ + + PVKW+A+ESL +
Sbjct: 1200 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 1259
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F+T SDVW+FGVLLWEL T PY +++ F++ L G RL QP CPD L+ VM C
Sbjct: 1260 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 1319
Query: 471 WAMNPEGRPTFPQLHS 486
W E RP+F +L S
Sbjct: 1320 WHPKAEMRPSFSELVS 1335
|
Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. Callicebus moloch (taxid: 9523) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q2QLG5|MET_CALJA Hepatocyte growth factor receptor OS=Callithrix jacchus GN=MET PE=3 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (528), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 99/256 (38%), Positives = 151/256 (58%), Gaps = 9/256 (3%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG VY GT + DG + VK++ +VS L EG+ M SH N+L++LG+
Sbjct: 1087 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 1146
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ SP ++ PY + +L+ F++ H T ++++ LQ+ G++YL KK
Sbjct: 1147 LRSEGSPLVVLPYMKHGDLRNFIRN-------ETHNPTVKDLIGFGLQVAKGMKYLASKK 1199
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--PVKWLAIESLVHKT 410
+H+DLA RNC++D+K +++ D LARD++ +Y+ + + PVKW+A+ESL +
Sbjct: 1200 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 1259
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F+T SDVW+FGVLLWEL T PY +++ F++ L G RL QP CPD L+ VM C
Sbjct: 1260 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKC 1319
Query: 471 WAMNPEGRPTFPQLHS 486
W E RP+F +L S
Sbjct: 1320 WHPKAEMRPSFSELVS 1335
|
Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. Callithrix jacchus (taxid: 9483) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 499 | ||||||
| 91092648 | 541 | PREDICTED: similar to tyrosine-protein k | 0.951 | 0.878 | 0.599 | 1e-171 | |
| 242025394 | 532 | receptor tyrosine kinase, putative [Pedi | 0.951 | 0.892 | 0.606 | 1e-169 | |
| 380017605 | 553 | PREDICTED: tyrosine-protein kinase Dnt-l | 0.929 | 0.839 | 0.574 | 1e-153 | |
| 340719227 | 553 | PREDICTED: tyrosine-protein kinase Drl-l | 0.929 | 0.839 | 0.574 | 1e-153 | |
| 328786622 | 553 | PREDICTED: tyrosine-protein kinase Dnt [ | 0.929 | 0.839 | 0.574 | 1e-153 | |
| 307181593 | 700 | Tyrosine-protein kinase Dnt [Camponotus | 0.943 | 0.672 | 0.569 | 1e-153 | |
| 322794828 | 478 | hypothetical protein SINV_12024 [Solenop | 0.931 | 0.972 | 0.566 | 1e-152 | |
| 307200186 | 518 | Tyrosine-protein kinase Dnt [Harpegnatho | 0.929 | 0.895 | 0.567 | 1e-152 | |
| 383848159 | 554 | PREDICTED: tyrosine-protein kinase Dnt-l | 0.931 | 0.839 | 0.567 | 1e-151 | |
| 332026344 | 528 | Tyrosine-protein kinase Dnt [Acromyrmex | 0.939 | 0.888 | 0.562 | 1e-150 |
| >gi|91092648|ref|XP_969941.1| PREDICTED: similar to tyrosine-protein kinase drl [Tribolium castaneum] gi|270014831|gb|EFA11279.1| hypothetical protein TcasGA2_TC010814 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1563), Expect = e-171, Method: Compositional matrix adjust.
Identities = 296/494 (59%), Positives = 380/494 (76%), Gaps = 19/494 (3%)
Query: 8 DNLEFGTRPLGHLP--YSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMN 65
++L F L P Y+I V++++ L+ P LNI+S GS+PT++QTFS++L C+G
Sbjct: 65 NSLHFTWESLADRPLLYTIKVDTSDSQILLPPQLNITSRGSVPTTLQTFSLSLLCSGAAT 124
Query: 66 AEVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHLYNILA 125
EV V I+I+VT++ +NVT+L F+RKKIC + + ++ + + ++ A
Sbjct: 125 GEVNVTITISVTIT--PSNVTTLMFRRKKICTKFEMQTNHVLVHTVPTYSNSTSIF-YTA 181
Query: 126 ICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTGHTPFLLPAPVLNCGATSA 185
I +A +LI ++ + A +V+NKK R + S++TG T L N
Sbjct: 182 IVSALILIIILASVTAAYYVKNKKTR--------DTTSASTGPTTTFLTTGPRN------ 227
Query: 186 SSNTSYASFKRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTE 245
+ NTSY+SF+R PSYS +D+R+KDL E+++ELT+QRCRVRL +V MEGTF RVY+G+YT
Sbjct: 228 TVNTSYSSFRRMPSYSLIDERSKDLQERITELTVQRCRVRLSNVIMEGTFARVYQGSYTN 287
Query: 246 EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305
E+GV+E V+VKTVTD+AS +Q+SLLLQEGM+MY L+HKNIL++L VSIEDHT+PFL+Y Y
Sbjct: 288 EEGVDEPVIVKTVTDHASQIQISLLLQEGMSMYSLNHKNILSILRVSIEDHTAPFLLYAY 347
Query: 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV 365
+Y+NLK FLQKCKL PEGV+HTLTTQEVVDM LQII +QYLHKK LLHKDLATRNC+V
Sbjct: 348 NNYSNLKIFLQKCKLSPEGVSHTLTTQEVVDMALQIIQAMQYLHKKNLLHKDLATRNCIV 407
Query: 366 DDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLW 425
DDKL +Q+ DNAL+RDLFPSDYHCLGDNENRP+KW+AIESLVHKTFS +SDVW+FGVLLW
Sbjct: 408 DDKLNVQVADNALSRDLFPSDYHCLGDNENRPIKWMAIESLVHKTFSFSSDVWSFGVLLW 467
Query: 426 ELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLH 485
ELTTLAQQPY EIDPFE+ A L+DGYRL QP+NCPDELF+VMAYCWAM+ E RPTF QLH
Sbjct: 468 ELTTLAQQPYVEIDPFEIVAYLKDGYRLAQPINCPDELFAVMAYCWAMSAEERPTFTQLH 527
Query: 486 SCLQEFHAQLTRYV 499
CLQ+F+ QLTRYV
Sbjct: 528 ICLQDFYTQLTRYV 541
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242025394|ref|XP_002433109.1| receptor tyrosine kinase, putative [Pediculus humanus corporis] gi|212518650|gb|EEB20371.1| receptor tyrosine kinase, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1548), Expect = e-169, Method: Compositional matrix adjust.
Identities = 298/491 (60%), Positives = 383/491 (78%), Gaps = 16/491 (3%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS 79
L Y+I+++ +N LINP LNIS G +P ++QTF++ LPC+G +AE+ + +++ +T++
Sbjct: 47 LKYNIALQLSNSRILINPKLNISHSGFVPITLQTFTVELPCSGLADAEIDIRLNVTITIN 106
Query: 80 RNSNNVTSLNFKRKKICLRVAADL--DEPSINVLDEPVSRLHLYNILAICAACVLITVVV 137
+ +N VT L FKR+KICL+ + D I ++D + Y +A+ AC LI V+V
Sbjct: 107 KANNTVTHLMFKRRKICLKDSKTTSDDSQQIVLIDTTPAPNIFY--IAVGCACALIAVIV 164
Query: 138 IYSCACFVRNKKLRRHGEILQNGSNSST---TGHTPFLLPAPVLN----CGATSASSNTS 190
A +V+ KK+RR +LQ N S GH FL P + N +S S TS
Sbjct: 165 TMIIAYYVKTKKIRRG--MLQESRNESACSGQGHATFL-PVEMANNRTGTSLSSCKSITS 221
Query: 191 YASFKRRPSYSRLDDR--NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDG 248
YASFKR PSYS ++D+ +KDL E+++EL+I +CR+RL S+ +EGTFG+VYRGT+ EEDG
Sbjct: 222 YASFKRMPSYSVIEDKQKDKDLSERIAELSIPKCRIRLKSIILEGTFGKVYRGTFAEEDG 281
Query: 249 VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDY 308
EEE++VKTV ++AS Q+S+LLQEGM++Y L+HKNIL++LGVSIE+H+SPFL+Y YQ Y
Sbjct: 282 GEEEIIVKTVLEHASQTQISVLLQEGMSLYNLNHKNILSILGVSIEEHSSPFLVYHYQGY 341
Query: 309 TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK 368
TNLKRFLQKCK+CPEG+AH LTTQEVVDM LQI+ G+QYLHKKK++HKD+A RNCVVDDK
Sbjct: 342 TNLKRFLQKCKVCPEGIAHALTTQEVVDMALQIVHGLQYLHKKKIIHKDIAARNCVVDDK 401
Query: 369 LRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELT 428
LR+QI DNAL+RDLFP+DYHCLGDNENRP+KWLAIESL KTFSTASDVW+FGVLLWELT
Sbjct: 402 LRVQIWDNALSRDLFPADYHCLGDNENRPIKWLAIESLTLKTFSTASDVWSFGVLLWELT 461
Query: 429 TLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488
TLAQQPY E+DPFEMAA L+DGYRL QP+NCPDELF+VM YCWAM+ + RPTF QL+ CL
Sbjct: 462 TLAQQPYLEVDPFEMAAYLRDGYRLTQPINCPDELFAVMGYCWAMSIDERPTFTQLNICL 521
Query: 489 QEFHAQLTRYV 499
QEF+AQLTRYV
Sbjct: 522 QEFYAQLTRYV 532
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380017605|ref|XP_003692743.1| PREDICTED: tyrosine-protein kinase Dnt-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1414), Expect = e-153, Method: Compositional matrix adjust.
Identities = 283/493 (57%), Positives = 350/493 (70%), Gaps = 29/493 (5%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTS-IQTFSINLPCTGTMNAEVIVLISINVTL 78
LPY++SV+ +N AL + LNIS G IP +QT+++ L C G +AEV + + INV+L
Sbjct: 77 LPYTMSVDISNPSALTS-SLNISQAGEIPVGGLQTWALALHC-GPYDAEVDLSLRINVSL 134
Query: 79 SRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHLYNILAICAACVLITVVVI 138
SR N TSL+F+RKKICL+ +++ + V S AI AC I + +
Sbjct: 135 SRR--NTTSLDFRRKKICLKDKSNVGAEEVLVAASGSSSGGQVFYAAIGCACAFIAAIFV 192
Query: 139 YSCACFVRNKKLRRHGEILQNGSNSST-------TGHTP---FLLPAPVLNCGATSASSN 188
A +VR+KK RRH + LQ S+ TG P FL P ATS S+
Sbjct: 193 LVIAYYVRDKKTRRHRDPLQESRGLSSACSVERGTGVGPAQTFLSPETPPPASATSTST- 251
Query: 189 TSYASFKRRPSYSRLDDR-NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED 247
Y RLDDR +++LHE++ E+T+QRCRVRL S+ MEGTFGRVYRG+Y EE
Sbjct: 252 -----------YRRLDDRPSRELHERIQEITVQRCRVRLLSIEMEGTFGRVYRGSYHEEG 300
Query: 248 GVE-EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306
+VLVKT ++AS QV+LLL+EG+A+YGLSH +L VLGVSIED ++PFL+YP+
Sbjct: 301 ASSPRDVLVKTAAEHASQSQVALLLREGLALYGLSHPALLPVLGVSIEDRSAPFLLYPHT 360
Query: 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366
Y N+KRFL +CKL EG LTTQEVV+M LQ GVQYLH+K+L+H+DLA RNCVVD
Sbjct: 361 GYKNMKRFLVRCKLSSEGPPRALTTQEVVEMALQAAKGVQYLHRKRLVHRDLAARNCVVD 420
Query: 367 DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWE 426
D LR+QITDNALARDLFP DYHCLGDNENRP+KWLAIESL++KTFSTASDVWAFGVLLWE
Sbjct: 421 DDLRVQITDNALARDLFPQDYHCLGDNENRPIKWLAIESLLNKTFSTASDVWAFGVLLWE 480
Query: 427 LTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486
LTTLAQQPY E+D FEMA+ L+DGYRL QP+NCPDELF+VMAYCWAM+ + RPTF QL
Sbjct: 481 LTTLAQQPYVEVDAFEMASYLRDGYRLAQPINCPDELFAVMAYCWAMSADERPTFSQLIV 540
Query: 487 CLQEFHAQLTRYV 499
CLQ+FH QLTRYV
Sbjct: 541 CLQDFHTQLTRYV 553
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340719227|ref|XP_003398057.1| PREDICTED: tyrosine-protein kinase Drl-like [Bombus terrestris] gi|350408793|ref|XP_003488517.1| PREDICTED: tyrosine-protein kinase Drl-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 283/493 (57%), Positives = 349/493 (70%), Gaps = 29/493 (5%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTS-IQTFSINLPCTGTMNAEVIVLISINVTL 78
LPY++SV+ +N AL + LNIS G IP +QT+++ L C G +AEV + + INV+L
Sbjct: 77 LPYTMSVDISNPSAL-SSSLNISQAGEIPVGGLQTWALALHC-GPYDAEVDLSLRINVSL 134
Query: 79 SRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHLYNILAICAACVLITVVVI 138
SR N TSL+FKRKKICL+ +++ + V S AI AC I + +
Sbjct: 135 SRR--NTTSLDFKRKKICLKDKSNIGAEEVLVAASGSSSGGQVFYAAIGCACAFIAAIFV 192
Query: 139 YSCACFVRNKKLRRHGEILQNGSNSST-------TGHTP---FLLPAPVLNCGATSASSN 188
A +VR+KK RRH + LQ S+ TG P FL P ATS S+
Sbjct: 193 LVIAYYVRDKKTRRHRDPLQESRGLSSACSVERGTGVGPAQTFLSPETPPPASATSTST- 251
Query: 189 TSYASFKRRPSYSRLDDR-NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED 247
Y RLDDR +++LHE++ E+T+QRCRVRL S+ MEGTFGRVYRG+Y EE
Sbjct: 252 -----------YRRLDDRPSRELHERIQEITVQRCRVRLLSIEMEGTFGRVYRGSYHEEG 300
Query: 248 GVE-EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306
+VLVKT ++AS QV+LLL+EG+A+YGLSH +L VLGVSIED ++PFL+YP+
Sbjct: 301 ASSPRDVLVKTAAEHASQSQVALLLREGLALYGLSHPALLPVLGVSIEDRSAPFLLYPHT 360
Query: 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366
Y N+KRFL +CKL EG LTTQEVV+M LQ GVQYLH+K+L+H+DLA RNCVVD
Sbjct: 361 GYKNMKRFLLRCKLSSEGPPRALTTQEVVEMALQAAKGVQYLHRKRLVHRDLAARNCVVD 420
Query: 367 DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWE 426
D LR+QITDNALARDLFP DYHCLGDNENRP+KWLAIESL++K FSTASDVWAFGVLLWE
Sbjct: 421 DDLRVQITDNALARDLFPQDYHCLGDNENRPIKWLAIESLLNKAFSTASDVWAFGVLLWE 480
Query: 427 LTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486
LTTLAQQPY E+D FEMA+ L+DGYRL QP+NCPDELF+VMAYCWAM+ + RPTF QL
Sbjct: 481 LTTLAQQPYVEVDAFEMASYLRDGYRLAQPINCPDELFAVMAYCWAMSADERPTFSQLIV 540
Query: 487 CLQEFHAQLTRYV 499
CLQ+FH QLTRYV
Sbjct: 541 CLQDFHTQLTRYV 553
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328786622|ref|XP_393673.3| PREDICTED: tyrosine-protein kinase Dnt [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1411), Expect = e-153, Method: Compositional matrix adjust.
Identities = 283/493 (57%), Positives = 349/493 (70%), Gaps = 29/493 (5%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTS-IQTFSINLPCTGTMNAEVIVLISINVTL 78
LPY++SV+ +N AL + LNIS G IP +QT+++ L C G +AEV + + INV+L
Sbjct: 77 LPYTMSVDISNPSALTS-SLNISQAGEIPVGGLQTWALALHC-GPYDAEVDLSLRINVSL 134
Query: 79 SRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHLYNILAICAACVLITVVVI 138
SR N TSL+F+RKKICL+ ++ + V S AI AC I + +
Sbjct: 135 SRR--NTTSLDFRRKKICLKDKSNAGPEEVLVAASGSSTGGQVFYAAIGCACAFIAAIFV 192
Query: 139 YSCACFVRNKKLRRHGEILQNGSNSST-------TGHTP---FLLPAPVLNCGATSASSN 188
A +VR+KK RRH + LQ S+ TG P FL P ATS S+
Sbjct: 193 LVIAYYVRDKKTRRHRDPLQESRGLSSACSVERGTGVGPAQTFLSPETPPPASATSTST- 251
Query: 189 TSYASFKRRPSYSRLDDR-NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED 247
Y RLDDR +++LHE++ E+T+QRCRVRL S+ MEGTFGRVYRG+Y EE
Sbjct: 252 -----------YRRLDDRPSRELHERIQEITVQRCRVRLLSIEMEGTFGRVYRGSYHEEG 300
Query: 248 GVE-EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306
+VLVKT ++AS QV+LLL+EG+A+YGLSH +L VLGVSIED ++PFL+YP+
Sbjct: 301 ASSPRDVLVKTAAEHASQSQVALLLREGLALYGLSHPALLPVLGVSIEDRSAPFLLYPHT 360
Query: 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366
Y N+KRFL +CKL EG LTTQEVV+M LQ GVQYLH+K+L+H+DLA RNCVVD
Sbjct: 361 GYKNMKRFLVRCKLSSEGPPRALTTQEVVEMALQAAKGVQYLHRKRLVHRDLAARNCVVD 420
Query: 367 DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWE 426
D LR+QITDNALARDLFP DYHCLGDNENRP+KWLAIESL++KTFSTASDVWAFGVLLWE
Sbjct: 421 DDLRVQITDNALARDLFPQDYHCLGDNENRPIKWLAIESLLNKTFSTASDVWAFGVLLWE 480
Query: 427 LTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486
LTTLAQQPY E+D FEMA+ L+DGYRL QP+NCPDELF+VMAYCWAM+ + RPTF QL
Sbjct: 481 LTTLAQQPYVEVDAFEMASYLRDGYRLAQPINCPDELFAVMAYCWAMSADERPTFSQLIV 540
Query: 487 CLQEFHAQLTRYV 499
CLQ+FH QLTRYV
Sbjct: 541 CLQDFHTQLTRYV 553
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307181593|gb|EFN69133.1| Tyrosine-protein kinase Dnt [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 547 bits (1409), Expect = e-153, Method: Compositional matrix adjust.
Identities = 276/485 (56%), Positives = 353/485 (72%), Gaps = 14/485 (2%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIP-TSIQTFSINLPCTGTMNAEVIVLISINVTL 78
LPY++SV+ +N AL + LNIS G IP +QT++++L C G +AE+ + + INV+L
Sbjct: 225 LPYTMSVDISNPTAL-SSSLNISQAGDIPLAGLQTWALSLHC-GPYDAEIDLTLRINVSL 282
Query: 79 SRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHLYNILAICAACVLITVVVI 138
SR N T L F+RKKICL+ + ++ + V + AI AC ++TV+ I
Sbjct: 283 SRR--NTTYLEFRRKKICLKDKSYIEPEEVLVAVSGSTTGGQIFYAAIGCACAVMTVIFI 340
Query: 139 YSCACFVRNKKLRRHGEILQNG---SNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFK 195
+ +VRNKK RH + LQ S++ + + + PA T ++ + S
Sbjct: 341 LAMMYYVRNKKTTRHRDPLQESRGLSSACSMERSAGVGPAQTFLSPETPPPASAASGS-- 398
Query: 196 RRPSYSRLDDR-NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVL 254
SY RLDDR +++LHE++ E+T+QRCRVRL S+ MEGTFGRVYRG+Y EE G+ E VL
Sbjct: 399 ---SYRRLDDRPSRELHERIQEITVQRCRVRLLSIEMEGTFGRVYRGSYHEEGGLCENVL 455
Query: 255 VKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRF 314
VKT ++AS QV+LLL+EG+ +YGL+H +L VLGVSIED ++PFL+YP+ Y N+KRF
Sbjct: 456 VKTAAEHASQSQVALLLREGLVLYGLNHPALLPVLGVSIEDRSAPFLLYPHTGYRNMKRF 515
Query: 315 LQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374
L +CKL EG LTTQEVV+M LQ GVQYLH+K+++H+DLA RNCVVDD LR+QIT
Sbjct: 516 LLRCKLSSEGPPRALTTQEVVEMALQAAKGVQYLHRKRIVHRDLAARNCVVDDDLRVQIT 575
Query: 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP 434
DNALARDLFP DYHCLGDNENRP+KWLAIESL+ KTF+TASDVWAFGVLLWELTTLAQQP
Sbjct: 576 DNALARDLFPQDYHCLGDNENRPIKWLAIESLLSKTFTTASDVWAFGVLLWELTTLAQQP 635
Query: 435 YAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494
Y E+DPFEMA+ L+DGYRL QP+NCPDELF+VMAYCWAM+ E RPTF QL CLQ+FH Q
Sbjct: 636 YVEVDPFEMASYLRDGYRLAQPINCPDELFAVMAYCWAMSAEERPTFSQLIICLQDFHTQ 695
Query: 495 LTRYV 499
LTRYV
Sbjct: 696 LTRYV 700
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322794828|gb|EFZ17775.1| hypothetical protein SINV_12024 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1406), Expect = e-152, Method: Compositional matrix adjust.
Identities = 280/494 (56%), Positives = 352/494 (71%), Gaps = 29/494 (5%)
Query: 19 HLPYSISVESTNKDALINPHLNISSIGSIPTS-IQTFSINLPCTGTMNAEVIVLISINVT 77
LPY++SV+ +N ++++ LNIS G IP +QT++++L C G N EV + + INV+
Sbjct: 1 QLPYTMSVDISNP-SVLSSTLNISQFGEIPVGGLQTWALSLHC-GPYNVEVDLSLRINVS 58
Query: 78 LSRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHLYNILAICAACVLITVVV 137
LSR N TSL FKRKKIC++ + + + V + +AI AC + V
Sbjct: 59 LSRK--NTTSLEFKRKKICMKKESYTEPEEVLVAASDSTSGGQIFYVAIGCACAFMAAVF 116
Query: 138 IYSCACFVRNKKLRRHGEILQNGSNSST-------TGHTP---FLLPAPVLNCGATSASS 187
+ A +VR+KK RRH + LQ S+ TG P FL P A SASS
Sbjct: 117 VLIMAYYVRDKKARRHRDPLQESRGLSSACSMERGTGVGPAQTFLSPETPPPTSAASASS 176
Query: 188 NTSYASFKRRPSYSRLDDR-NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE 246
Y RLD+R N++LHE++ E+T+QRCRVRL S+ +EGTFGRVYRG+Y EE
Sbjct: 177 ------------YRRLDERPNRELHERIQEITVQRCRVRLLSIELEGTFGRVYRGSYHEE 224
Query: 247 DGVE-EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305
+ ++VLVKT ++AS QV+LLL+EG+A+YGLSH +L VLGVSIED ++PFL+YP+
Sbjct: 225 GALSPKDVLVKTAAEHASQSQVALLLREGLALYGLSHPALLPVLGVSIEDRSAPFLLYPH 284
Query: 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV 365
Y N+KRFL +CK EG LTTQEVV+M LQ GVQYLH+K+L+H+DLA RNCVV
Sbjct: 285 TGYKNMKRFLLRCKFSNEGPPRALTTQEVVEMALQAAKGVQYLHRKRLVHRDLAARNCVV 344
Query: 366 DDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLW 425
DD LR+QITDNALARDLFP DYHCLGDNENRP+KWLAIESL++KTFSTASDVWAFGVLLW
Sbjct: 345 DDDLRVQITDNALARDLFPQDYHCLGDNENRPIKWLAIESLLNKTFSTASDVWAFGVLLW 404
Query: 426 ELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLH 485
ELTTLAQQPY E+DPFEMA+ L++GYRL QP+NCPDELF+VMAYCWAM+ E RPTF QL
Sbjct: 405 ELTTLAQQPYGEVDPFEMASYLREGYRLAQPINCPDELFAVMAYCWAMSAEERPTFSQLI 464
Query: 486 SCLQEFHAQLTRYV 499
CLQ+FH QLTRYV
Sbjct: 465 ICLQDFHTQLTRYV 478
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307200186|gb|EFN80484.1| Tyrosine-protein kinase Dnt [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1400), Expect = e-152, Method: Compositional matrix adjust.
Identities = 280/493 (56%), Positives = 347/493 (70%), Gaps = 29/493 (5%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTS-IQTFSINLPCTGTMNAEVIVLISINVTL 78
LPY++SV+ ++ AL + LNIS G +P S +QT++++L C G +AE+ + INV+L
Sbjct: 42 LPYTLSVDISDPTAL-SSSLNISQAGDMPISGLQTWALSLHC-GPYDAEIDFNLRINVSL 99
Query: 79 SRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHLYNILAICAACVLITVVVI 138
SR N TSL FKRKKICL+ + + V + AI AC + + +
Sbjct: 100 SRR--NTTSLQFKRKKICLKDKSYTGPEEVLVAASGTTSGGQVFYAAIGCACAFMAAIFV 157
Query: 139 YSCACFVRNKKLRRHGEILQNGSNSST-------TGHTP---FLLPAPVLNCGATSASSN 188
+VR+KK RRH + LQ S+ TG P FL P ATS SS
Sbjct: 158 LVIVYYVRDKKARRHRDPLQESRGLSSACSVERGTGVGPAQTFLSPETPPPASATSGSS- 216
Query: 189 TSYASFKRRPSYSRLDDR-NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED 247
Y RLDDR +++LHE++ E+T+QRCRVRL S+ MEGTFGRVYRG+Y EE
Sbjct: 217 -----------YRRLDDRPSRELHERIQEITVQRCRVRLLSIEMEGTFGRVYRGSYHEEG 265
Query: 248 GVE-EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306
+VLVKT ++AS QV+LLL+EG+ +YGLSH +L VLGVSIED ++PFL+YP+
Sbjct: 266 ASSSRDVLVKTAAEHASQSQVALLLREGLVLYGLSHPALLPVLGVSIEDRSAPFLLYPHT 325
Query: 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366
Y N+KRFL +CKL EG+ LTTQEVV+M LQ GVQYLH+K+L+H+DLA RNCVVD
Sbjct: 326 GYRNMKRFLLRCKLSSEGLPRALTTQEVVEMALQAAKGVQYLHRKRLVHRDLAARNCVVD 385
Query: 367 DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWE 426
D LR+QITDNALARDLFP DYHCLGDNENRP+KWLAIESL+ KTF+TASDVWAFGVLLWE
Sbjct: 386 DDLRVQITDNALARDLFPQDYHCLGDNENRPIKWLAIESLLSKTFTTASDVWAFGVLLWE 445
Query: 427 LTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486
LTTLAQQPY E+DPFEMA+ L+DGYRL QP+NCPDELF+VMAYCWAM+ E RPTF QL
Sbjct: 446 LTTLAQQPYVEVDPFEMASYLRDGYRLAQPINCPDELFAVMAYCWAMSAEERPTFSQLII 505
Query: 487 CLQEFHAQLTRYV 499
CLQ+FH QLTRYV
Sbjct: 506 CLQDFHTQLTRYV 518
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383848159|ref|XP_003699719.1| PREDICTED: tyrosine-protein kinase Dnt-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-151, Method: Compositional matrix adjust.
Identities = 280/493 (56%), Positives = 349/493 (70%), Gaps = 28/493 (5%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIP-TSIQTFSINLPCTGTMNAEVIVLISINVTL 78
LPY+++V+ +N AL + LNIS G IP +QT+++ L C G +AEV + + INV+
Sbjct: 77 LPYTMTVDISNPSALTS-SLNISQAGEIPFGGLQTWALALHC-GPYDAEVDLSLRINVS- 133
Query: 79 SRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHLYNILAICAACVLITVVVI 138
+ + N TSL+FKRKKICL+ +++ I V + AI AC I + +
Sbjct: 134 TPSRRNTTSLDFKRKKICLKDKSNIGAEEILVAASGSTSGGQVFYAAIGCACAFIAAIFV 193
Query: 139 YSCACFVRNKKLRRHGEILQNGSNSST-------TGHTP---FLLPAPVLNCGATSASSN 188
A +VR+KK RRH + LQ S+ TG P FL P ATS S+
Sbjct: 194 LVIAYYVRDKKTRRHRDPLQESRGLSSACSVERGTGVGPAQTFLSPETPPPTSATSTST- 252
Query: 189 TSYASFKRRPSYSRLDDR-NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED 247
Y RLDDR +++LHE++ E+T+QRCRVRL S+ MEGTFGRVYRG+Y EE
Sbjct: 253 -----------YRRLDDRPSRELHERIQEITVQRCRVRLLSIEMEGTFGRVYRGSYHEEG 301
Query: 248 GVE-EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306
+VLVKT ++AS QV+LLL+EG+A+YGLSH +L VLGVSIED ++PFL+YP+
Sbjct: 302 ASSPRDVLVKTAAEHASQSQVALLLREGLALYGLSHPALLPVLGVSIEDRSAPFLLYPHT 361
Query: 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366
Y N+KRFL +CKL EG LTTQEVV+M LQ GVQYLH+K+L+H+DLA RNCVVD
Sbjct: 362 GYKNMKRFLLRCKLSSEGPPRALTTQEVVEMALQAAKGVQYLHRKRLVHRDLAARNCVVD 421
Query: 367 DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWE 426
D LR+QITDNALARDLFP DYHCLGDNENRP+KWLAIESL++KTFSTASDVWAFGVLLWE
Sbjct: 422 DDLRVQITDNALARDLFPQDYHCLGDNENRPIKWLAIESLLNKTFSTASDVWAFGVLLWE 481
Query: 427 LTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486
LTTLAQQPY E+D FEMA+ L+DGYRL QP+NCPDELF+VMAYCWAM+ + RPTF QL
Sbjct: 482 LTTLAQQPYVEVDAFEMASYLRDGYRLAQPINCPDELFAVMAYCWAMSADERPTFSQLIV 541
Query: 487 CLQEFHAQLTRYV 499
CLQ+FH QLTRYV
Sbjct: 542 CLQDFHTQLTRYV 554
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332026344|gb|EGI66473.1| Tyrosine-protein kinase Dnt [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 275/489 (56%), Positives = 349/489 (71%), Gaps = 20/489 (4%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTS-IQTFSINLPCTGTMNAEVIVLISINVTL 78
LPY++ V+ +N AL + LNIS IG IP +QT++++L C G N EV + + INV++
Sbjct: 51 LPYTMFVDISNPTAL-SSSLNISHIGEIPVGGLQTWALSLHC-GPYNIEVDLSLRINVSV 108
Query: 79 SRNSNNVTSLNFKRKKICLRVAADLDEPS---INVLDEPVSRLHLYNILAICAACVLITV 135
SR N TSL FKRKKIC+ + EP + V D Y +AI AC +
Sbjct: 109 SRK--NTTSLEFKRKKICMNLKETPTEPEEVLVAVPDSTSGGQIFY--VAIGCACAFMAA 164
Query: 136 VVIYSCACFVRNKKLRRHGEILQNG---SNSSTTGHTPFLLPAPVLNCGATSASSNTSYA 192
+ + +VR+KK RRH + LQ S++ + + PA T ++ +
Sbjct: 165 IFVLIIIYYVRDKKTRRHRDPLQESRGLSSACSMERGTGVGPAQTFLSSETPPPASAASG 224
Query: 193 SFKRRPSYSRLDDR-NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVE- 250
S SY RLDDR N++LHE++ E+T+QRCRVRL S+ +EGTFGRVYRG+Y EE +
Sbjct: 225 S-----SYRRLDDRPNRELHERIQEITVQRCRVRLISIELEGTFGRVYRGSYHEEGALSP 279
Query: 251 EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTN 310
++VLVKT ++AS QV+LLL+EG+ +YGLSH +L VLGVSIED ++PFL+YP+ Y N
Sbjct: 280 KDVLVKTAAEHASQSQVALLLREGLVLYGLSHPALLPVLGVSIEDRSAPFLLYPHTGYKN 339
Query: 311 LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370
+KRFL +CK EG LTTQEVV+M LQ GVQYLH+K+L+H+DLA RNCVVDD LR
Sbjct: 340 MKRFLLRCKFSNEGPPRALTTQEVVEMALQAAKGVQYLHRKRLVHRDLAARNCVVDDDLR 399
Query: 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL 430
+QITDNALARDLFP DYHCLGDNENRP+KWLAIESL++KTF+TASDVWAFGV LWELTTL
Sbjct: 400 VQITDNALARDLFPQDYHCLGDNENRPIKWLAIESLLNKTFTTASDVWAFGVFLWELTTL 459
Query: 431 AQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
AQQPY E+DPFEMA+ L++GYRL QP+NCPDELF+VMAYCWAM+ E RPTF QL CLQ+
Sbjct: 460 AQQPYGEVDPFEMASYLREGYRLAQPINCPDELFAVMAYCWAMSAEERPTFSQLLICLQD 519
Query: 491 FHAQLTRYV 499
FH QLTRYV
Sbjct: 520 FHTQLTRYV 528
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 499 | ||||||
| FB|FBgn0024245 | 584 | dnt "doughnut on 2" [Drosophil | 0.941 | 0.804 | 0.484 | 2.4e-115 | |
| FB|FBgn0015380 | 610 | drl "derailed" [Drosophila mel | 0.587 | 0.480 | 0.516 | 2.2e-101 | |
| UNIPROTKB|Q6GLP3 | 599 | MGC84433 "MGC84433 protein" [X | 0.977 | 0.814 | 0.401 | 1.3e-98 | |
| UNIPROTKB|F1LQR5 | 532 | Ryk "Protein Ryk" [Rattus norv | 0.983 | 0.922 | 0.414 | 2.8e-98 | |
| UNIPROTKB|F1LSQ1 | 532 | Ryk "Protein Ryk" [Rattus norv | 0.983 | 0.922 | 0.414 | 2.8e-98 | |
| MGI|MGI:101766 | 594 | Ryk "receptor-like tyrosine ki | 0.983 | 0.826 | 0.410 | 3.5e-98 | |
| UNIPROTKB|F1PKW2 | 574 | RYK "Uncharacterized protein" | 0.977 | 0.850 | 0.412 | 5.8e-98 | |
| UNIPROTKB|P34925 | 604 | RYK "Tyrosine-protein kinase R | 0.975 | 0.806 | 0.413 | 7.4e-98 | |
| UNIPROTKB|H0Y8A4 | 587 | RYK "Tyrosine-protein kinase R | 0.977 | 0.831 | 0.412 | 1.5e-97 | |
| UNIPROTKB|F1MGI6 | 584 | RYK "Uncharacterized protein" | 0.983 | 0.840 | 0.409 | 5.2e-97 |
| FB|FBgn0024245 dnt "doughnut on 2" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1137 (405.3 bits), Expect = 2.4e-115, P = 2.4e-115
Identities = 238/491 (48%), Positives = 323/491 (65%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS 79
LPYSI+V S++++ L P +N+S G IPT+IQT+SI L C+G AEV V +S+ V L+
Sbjct: 104 LPYSINVVSSDQEVLPRPAINVSHSGEIPTTIQTWSIALKCSGLKAAEVDVTVSLEVVLN 163
Query: 80 RNSNNVTSLNFKRKKICLR------VAADLDEPSI--NVLDEPVSRLHLYNILAICAACV 131
R+ NNVT L F+RKKICL ++ D+D+P + V+ P + L +++ V
Sbjct: 164 RSLNNVTHLVFRRKKICLMNDSAEDLSEDVDDPQLLETVMLPPTGLITLVVGVSVAMGSV 223
Query: 132 LITVVVIYSCACFVRNKKLR-RHG-EILQNGSNSSTTGHTPFLLPAPVLNCGXXXXXXXX 189
+ +++ Y C NK+ +HG + ++ S H P
Sbjct: 224 CLLLMIAY-CVKGAANKRQHHQHGGQPMRTSSFQRLNTHPPCQSSMGSAAYMTPSIIAPI 282
Query: 190 XXXXFKRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGV 249
R+ S ++LH ++SELT++RCRVRL S+ EGTFGRVYRGTY +
Sbjct: 283 HGSSLPRKVPVSVEQQHPEELHRRISELTVERCRVRLSSLLQEGTFGRVYRGTYNDT--- 339
Query: 250 EEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYT 309
++VLVKTV +AS +QV LLLQEGM +YG SH IL+VLGVSIEDHT+PF++YP + T
Sbjct: 340 -QDVLVKTVAQHASQMQVLLLLQEGMLLYGASHPGILSVLGVSIEDHTTPFVLYPALNNT 398
Query: 310 -NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYXXXXXXXXXXXATRNCVVDDK 368
NLK+FL L P A T+TT ++V M Q+ M + + ATRNCV+DD+
Sbjct: 399 RNLKQFL----LDP-ACARTVTTIQIVMMASQLSMALDHLHSHGVVHKDIATRNCVIDDQ 453
Query: 369 LRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELT 428
LR++++D++L+RDLFPSDY+CLGD+ENRPVKW+++E+L HK FS ASD WAFGVL+WEL
Sbjct: 454 LRVKLSDSSLSRDLFPSDYNCLGDSENRPVKWMSLEALQHKQFSEASDSWAFGVLMWELC 513
Query: 429 TLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488
T A+QPYAE+DPFEM L+DGYRL QP NCPDELF++MAYCWA+ P RPTF QL SCL
Sbjct: 514 TSAKQPYAEVDPFEMEHYLKDGYRLAQPFNCPDELFTIMAYCWALLPAERPTFAQLQSCL 573
Query: 489 QEFHAQLTRYV 499
EF++Q+TRYV
Sbjct: 574 SEFYSQITRYV 584
|
|
| FB|FBgn0015380 drl "derailed" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 811 (290.5 bits), Expect = 2.2e-101, Sum P(2) = 2.2e-101
Identities = 157/304 (51%), Positives = 211/304 (69%)
Query: 197 RPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVK 256
RP + + ++ + +L ELT+Q+CRVRL + EG FGR+YRGTY + +EVLVK
Sbjct: 317 RP-FREYEHEPEEFNRRLQELTVQKCRVRLSCLVQEGNFGRIYRGTYNDC----QEVLVK 371
Query: 257 TVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ-DYTNLKRFL 315
TV +AS +QV+LLLQE M +Y SH N+L+VLG+SIED+ +PF++Y NLK FL
Sbjct: 372 TVAQHASQLQVNLLLQESMMLYEASHPNVLSVLGISIEDYATPFVLYAATGSVRNLKSFL 431
Query: 316 QKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYXXXXXXXXXXXATRNCVVDDKLRIQITD 375
Q P A ++TT + V M Q+ M +++ A RNCV+DD+LR+++TD
Sbjct: 432 QD----PS-YARSVTTIQTVLMGSQLAMAMEHLHNHGVIHKDIAARNCVIDDQLRVKLTD 486
Query: 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
+AL+RDLFP DY+ LGD E RP+KWL++E+L ++ SDVW+FGVL+WE+ TL + PY
Sbjct: 487 SALSRDLFPGDYNSLGDGEYRPIKWLSLEALQKSHYNEGSDVWSFGVLMWEMCTLGKLPY 546
Query: 436 AEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
AEIDP+EM L+DGYRL QP NCPDELF++MAYCWA P RP+F QL CL EFH Q+
Sbjct: 547 AEIDPYEMEHYLKDGYRLAQPFNCPDELFTIMAYCWASMPAERPSFSQLQICLSEFHTQI 606
Query: 496 TRYV 499
TRYV
Sbjct: 607 TRYV 610
|
|
| UNIPROTKB|Q6GLP3 MGC84433 "MGC84433 protein" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
Identities = 205/510 (40%), Positives = 295/510 (57%)
Query: 7 SDNLEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNA 66
+++L F + Y + + N A+ P NIS G +P+S+ F ++L C+G M++
Sbjct: 95 TNSLHFTWHAKSKVEYKLGFQVDNPMAMTMPQANISMQGEVPSSLTVFRVDLYCSGKMDS 154
Query: 67 EVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAADLDEPSINVLDEPVSRLHL--YNI- 123
EV+ L+ +N+T+S S N+T LNFKR+K+C R D+ P + D+ +R+H N+
Sbjct: 155 EVLFLMQLNITIS--SKNITVLNFKRRKMCYRKLEDIKVPMLQ--DKNNTRIHFDPVNVA 210
Query: 124 ---------LAICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTGHTPFLLP 174
+++ C +I +V I + + K + + + S+S P
Sbjct: 211 PTTSTRVFYISVGVCCAVIFLVAIILAVLHLHSMKRVELDDSMSDSSSSQGLSQ-PSTQT 269
Query: 175 APVLNCGXXXXXXXXXXXXFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFSVNM 231
L + D ++ L E K+ ++ I R RV L V
Sbjct: 270 TQYLRADTPNNATPVTSSSGYPTLRIEKNDLKSVTLQEAKAKVKDIAISRERVTLKDVLQ 329
Query: 232 EGTFGRVYRGTYTEEDGVEEE--VLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EGTFGR++ G +E +E VKTV D AS VQ++++L E + GL H+N+L +
Sbjct: 330 EGTFGRIFHGILVDEKDPSKERAFFVKTVKDQASEVQITMMLTESCKLRGLHHRNLLPIG 389
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYXX 349
V IED P ++ PY ++ NLK FL++CKL ++ Q++V M +QI G+ Y
Sbjct: 390 HVCIEDGEKPMVLLPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSYLA 449
Query: 350 XXXXXXXXXATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409
A RNCV+D+ L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+++ESLV+K
Sbjct: 450 RREVIHKDLAARNCVIDESLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMSLESLVNK 509
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
FS+A DVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+VMA
Sbjct: 510 EFSSAGDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVMAC 569
Query: 470 CWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
CWA++PE RP F QL CL EFH+ L YV
Sbjct: 570 CWALDPEERPKFQQLVQCLTEFHSALGAYV 599
|
|
| UNIPROTKB|F1LQR5 Ryk "Protein Ryk" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 212/512 (41%), Positives = 296/512 (57%)
Query: 5 PCSDN-LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGT 63
P N L F + Y + + N A+ P +NIS+ G +P ++ F + L CTG
Sbjct: 25 PSETNFLHFTWHAKSKVEYKLGFQVDNFVAMGMPQVNISAQGEVPRTLSVFRVELSCTGK 84
Query: 64 MNAEVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAAD-----LDEPSINVLDEPV--- 115
+++EV++L+ +N+T++ +S N T LNFKR+K+C + + LD+ + + +PV
Sbjct: 85 VDSEVMILMQLNLTVN-SSKNFTVLNFKRRKMCYKKLEEVKTSALDKNTSRTIYDPVHAA 143
Query: 116 ---SRLHLYNILAICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTGHTPFL 172
S Y + +C A V+ V +I + K++ I + S+SS P
Sbjct: 144 PTTSTRVFYISVGVCCA-VIFLVAIILAVLHLHSMKRIELDDSI--SASSSSQGLSQPST 200
Query: 173 LPAPVLNCGXXXXXXXXXXXXFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFSV 229
L + D R+ L E K+ ++ I R RV L V
Sbjct: 201 QTTQYLRADTPNNATPVTTSAGYPTLRIEKNDLRSVTLLEAKAKVKDIAISRERVTLKDV 260
Query: 230 NMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EGTFGR++ G +E E++ VKTV D AS VQV+++L E + GL H+N+L
Sbjct: 261 LQEGTFGRIFHGILVDEKDPNKEKQTFVKTVKDQASEVQVTMMLTESCKLRGLHHRNLLP 320
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ V IE+ P +I PY ++ NLK FL++CKL ++ Q++V M +QI G+ Y
Sbjct: 321 ITHVCIEEGEKPMVISPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSY 380
Query: 348 XXXXXXXXXXXATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
A RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+ESLV
Sbjct: 381 LARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESLV 440
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+VM
Sbjct: 441 NNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVM 500
Query: 468 AYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
A CWA++PE RP F QL CL EFHA L YV
Sbjct: 501 ACCWALDPEERPKFQQLVQCLTEFHAALGAYV 532
|
|
| UNIPROTKB|F1LSQ1 Ryk "Protein Ryk" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 212/512 (41%), Positives = 296/512 (57%)
Query: 5 PCSDN-LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGT 63
P N L F + Y + + N A+ P +NIS+ G +P ++ F + L CTG
Sbjct: 25 PSETNFLHFTWHAKSKVEYKLGFQVDNFVAMGMPQVNISAQGEVPRTLSVFRVELSCTGK 84
Query: 64 MNAEVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAAD-----LDEPSINVLDEPV--- 115
+++EV++L+ +N+T++ +S N T LNFKR+K+C + + LD+ + + +PV
Sbjct: 85 VDSEVMILMQLNLTVN-SSKNFTVLNFKRRKMCYKKLEEVKTSALDKNTSRTIYDPVHAA 143
Query: 116 ---SRLHLYNILAICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTGHTPFL 172
S Y + +C A V+ V +I + K++ I + S+SS P
Sbjct: 144 PTTSTRVFYISVGVCCA-VIFLVAIILAVLHLHSMKRIELDDSI--SASSSSQGLSQPST 200
Query: 173 LPAPVLNCGXXXXXXXXXXXXFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFSV 229
L + D R+ L E K+ ++ I R RV L V
Sbjct: 201 QTTQYLRADTPNNATPVTSSSGYPTLRIEKNDLRSVTLLEAKAKVKDIAISRERVTLKDV 260
Query: 230 NMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EGTFGR++ G +E E++ VKTV D AS VQV+++L E + GL H+N+L
Sbjct: 261 LQEGTFGRIFHGILVDEKDPNKEKQTFVKTVKDQASEVQVTMMLTESCKLRGLHHRNLLP 320
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ V IE+ P +I PY ++ NLK FL++CKL ++ Q++V M +QI G+ Y
Sbjct: 321 ITHVCIEEGEKPMVISPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSY 380
Query: 348 XXXXXXXXXXXATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
A RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+ESLV
Sbjct: 381 LARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESLV 440
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+VM
Sbjct: 441 NNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVM 500
Query: 468 AYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
A CWA++PE RP F QL CL EFHA L YV
Sbjct: 501 ACCWALDPEERPKFQQLVQCLTEFHAALGAYV 532
|
|
| MGI|MGI:101766 Ryk "receptor-like tyrosine kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 975 (348.3 bits), Expect = 3.5e-98, P = 3.5e-98
Identities = 210/512 (41%), Positives = 296/512 (57%)
Query: 5 PCSDN-LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGT 63
P N L F + Y + + N A+ P +NIS+ G +P ++ F + L CTG
Sbjct: 87 PSETNFLHFTWHAKSKVEYKLGFQVDNFVAMGMPQVNISAQGEVPRTLSVFRVELSCTGK 146
Query: 64 MNAEVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAAD-----LDEPSINVLDEPV--- 115
+++EV++L+ +N+T++ +S N T LNFKR+K+C + + LD+ + + +PV
Sbjct: 147 VDSEVMILMQLNLTVN-SSKNFTVLNFKRRKMCYKKLEEVKTSALDKNTSRTIYDPVHAA 205
Query: 116 ---SRLHLYNILAICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTGHTPFL 172
S Y + +C A V+ V +I + K++ I + S+SS P
Sbjct: 206 PTTSTRVFYISVGVCCA-VIFLVAIILAVLHLHSMKRIELDDSI--SASSSSQGLSQPST 262
Query: 173 LPAPVLNCGXXXXXXXXXXXXFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFSV 229
L + D R+ L E K+ ++ I R R+ L V
Sbjct: 263 QTTQYLRADTPNNATPITSSSGYPTLRIEKNDLRSVTLLEAKAKVKDIAISRERITLKDV 322
Query: 230 NMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EGTFGR++ G +E E++ VKTV D AS VQV+++L E + GL H+N+L
Sbjct: 323 LQEGTFGRIFHGILVDEKDPNKEKQTFVKTVKDQASEVQVTMMLTESCKLRGLHHRNLLP 382
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ V IE+ P ++ PY ++ NLK FL++CKL ++ Q++V M +QI G+ Y
Sbjct: 383 ITHVCIEEGEKPMVVLPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSY 442
Query: 348 XXXXXXXXXXXATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
A RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+ESLV
Sbjct: 443 LARREVIHRDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESLV 502
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+VM
Sbjct: 503 NNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVM 562
Query: 468 AYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
A CWA++PE RP F QL CL EFHA L YV
Sbjct: 563 ACCWALDPEERPKFQQLVQCLTEFHAALGAYV 594
|
|
| UNIPROTKB|F1PKW2 RYK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
Identities = 211/512 (41%), Positives = 297/512 (58%)
Query: 5 PCSDN-LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGT 63
P N L F + Y + + N A+ P +NIS+ G +P ++ F + L CTG
Sbjct: 70 PSETNFLHFTWHAKSKVEYKLGFQVDNFVAMDMPQVNISAQGEVPRTLSVFRVELSCTGK 129
Query: 64 MNAEVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAAD-----LDEPSINVLDEPV--- 115
+++EV++L+ +N+T++ +S N T LNFKR+K+C + + LD+ + + +PV
Sbjct: 130 VDSEVMILMQLNLTVN-SSKNFTVLNFKRRKMCYKKLEEVKTSALDKNTSRTIYDPVHAA 188
Query: 116 ---SRLHLYNILAICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTGHTPFL 172
S Y + +C A V+ V +I + K++ I + S+SS P
Sbjct: 189 PTTSTRVFYISVGVCCA-VIFLVAIILAVLHLHSMKRIELDDSI--SASSSSQGLSQPST 245
Query: 173 LPAPVLNCGXXXXXXXXXXXXFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFSV 229
L R + D R+ L E K+ ++ I R R+ L V
Sbjct: 246 QTTQYLRADTPNNATPITSYPTLR---IEKNDLRSVTLLEAKAKVKDIAISRERITLKDV 302
Query: 230 NMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EGTFGR++ G +E E++ VKTV D AS +QV+++L E + GL H+N+L
Sbjct: 303 LQEGTFGRIFHGILVDEKDPNKEKQAFVKTVKDQASEIQVTMMLTESCKLRGLHHRNLLP 362
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ V IE+ P +I PY ++ NLK FL++CKL ++ Q++V M +QI G+ Y
Sbjct: 363 ITHVCIEEGEKPMVILPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSY 422
Query: 348 XXXXXXXXXXXATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
A RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+ESLV
Sbjct: 423 LARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESLV 482
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+VM
Sbjct: 483 NNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVM 542
Query: 468 AYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
A CWA++PE RP F QL CL EFHA L YV
Sbjct: 543 ACCWALDPEERPKFQQLVQCLTEFHAALGAYV 574
|
|
| UNIPROTKB|P34925 RYK "Tyrosine-protein kinase RYK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
Identities = 212/513 (41%), Positives = 297/513 (57%)
Query: 5 PCSDN-LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGT 63
P N L F + Y + + N A+ P +NIS G +P ++ F + L CTG
Sbjct: 100 PSETNFLHFTWHAKSKVEYKLGFQVDNVLAMDMPQVNISVQGEVPRTLSVFRVELSCTGK 159
Query: 64 MNAEVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAAD-----LDEPSINVLDEPV--- 115
+++EV++L+ +N+T++ +S N T LNFKR+K+C + + LD+ + + +PV
Sbjct: 160 VDSEVMILMQLNLTVN-SSKNFTVLNFKRRKMCYKKLEEVKTSALDKNTSRTIYDPVHAA 218
Query: 116 ---SRLHLYNILAICAACVLITVVVIYSCACFVRN-KKLRRHGEILQNGSNSSTTGHTPF 171
S Y + +C C +I +V I + N K++ I + S+SS P
Sbjct: 219 PTTSTRVFYISVGVC--CAVIFLVAIILAVLHLHNMKRIELDDSI--SASSSSQGLSQPS 274
Query: 172 LLPAPVLNCGXXXXXXXXXXXXFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFS 228
L R + D R+ L E K+ ++ I R R+ L
Sbjct: 275 TQTTQYLRADTPNNATPITSYPTLR---IEKNDLRSVTLLEAKGKVKDIAISRERITLKD 331
Query: 229 VNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNIL 286
V EGTFGR++ G +E E++ VKTV D AS +QV+++L E + GL H+N+L
Sbjct: 332 VLQEGTFGRIFHGILIDEKDPNKEKQAFVKTVKDQASEIQVTMMLTESCKLRGLHHRNLL 391
Query: 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+ V IE+ P +I PY ++ NLK FL++CKL ++ Q++V M +QI G+
Sbjct: 392 PITHVCIEEGEKPMVILPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMS 451
Query: 347 YXXXXXXXXXXXATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESL 406
Y A RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+ESL
Sbjct: 452 YLARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESL 511
Query: 407 VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSV 466
V+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+V
Sbjct: 512 VNNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAV 571
Query: 467 MAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
MA CWA++PE RP F QL CL EFHA L YV
Sbjct: 572 MACCWALDPEERPKFQQLVQCLTEFHAALGAYV 604
|
|
| UNIPROTKB|H0Y8A4 RYK "Tyrosine-protein kinase RYK" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
Identities = 211/512 (41%), Positives = 296/512 (57%)
Query: 5 PCSDN-LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGT 63
P N L F + Y + + N A+ P +NIS G +P ++ F + L CTG
Sbjct: 83 PSETNFLHFTWHAKSKVEYKLGFQVDNVLAMDMPQVNISVQGEVPRTLSVFRVELSCTGK 142
Query: 64 MNAEVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAAD-----LDEPSINVLDEPV--- 115
+++EV++L+ +N+T++ +S N T LNFKR+K+C + + LD+ + + +PV
Sbjct: 143 VDSEVMILMQLNLTVN-SSKNFTVLNFKRRKMCYKKLEEVKTSALDKNTSRTIYDPVHAA 201
Query: 116 ---SRLHLYNILAICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTGHTPFL 172
S Y + +C A V+ V +I + K++ I + S+SS P
Sbjct: 202 PTTSTRVFYISVGVCCA-VIFLVAIILAVLHLHSMKRIELDDSI--SASSSSQGLSQPST 258
Query: 173 LPAPVLNCGXXXXXXXXXXXXFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFSV 229
L R + D R+ L E K+ ++ I R R+ L V
Sbjct: 259 QTTQYLRADTPNNATPITSYPTLR---IEKNDLRSVTLLEAKGKVKDIAISRERITLKDV 315
Query: 230 NMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EGTFGR++ G +E E++ VKTV D AS +QV+++L E + GL H+N+L
Sbjct: 316 LQEGTFGRIFHGILIDEKDPNKEKQAFVKTVKDQASEIQVTMMLTESCKLRGLHHRNLLP 375
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ V IE+ P +I PY ++ NLK FL++CKL ++ Q++V M +QI G+ Y
Sbjct: 376 ITHVCIEEGEKPMVILPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACGMSY 435
Query: 348 XXXXXXXXXXXATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
A RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+ESLV
Sbjct: 436 LARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALESLV 495
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF+VM
Sbjct: 496 NNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELFAVM 555
Query: 468 AYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
A CWA++PE RP F QL CL EFHA L YV
Sbjct: 556 ACCWALDPEERPKFQQLVQCLTEFHAALGAYV 587
|
|
| UNIPROTKB|F1MGI6 RYK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 5.2e-97, P = 5.2e-97
Identities = 211/515 (40%), Positives = 297/515 (57%)
Query: 5 PCSDN-LEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQT-FSINLPCTG 62
P N L F + Y + + N A+ P +NIS+ G +P ++ F + L CTG
Sbjct: 74 PSETNFLHFTWHAKSKVEYKLGFQVDNFVAMDMPQVNISAQGEVPRTLSAVFRVELSCTG 133
Query: 63 TMNAEVIVLISINVTLSRNSNNVTSLNFKRKKICLRVAAD-----LDEPSINVLDEPV-- 115
+++EV++L+ +N+T++ +S N T LNFKR+K+C + + LD+ + + +PV
Sbjct: 134 KVDSEVMILMQLNLTVN-SSKNFTVLNFKRRKMCYKKLEEVKTSALDKNTSRTIYDPVHA 192
Query: 116 ----SRLHLYNILAICAACVLITVVVIYSCACFVRNKKLRRHGEILQNGSNSSTTGHTPF 171
S Y + +C A V+ V +I + K++ I + S+SS P
Sbjct: 193 APTTSTRVFYISVGVCCA-VIFLVAIILAVLHLHSMKRIELDDSI--SASSSSQGLSQPS 249
Query: 172 LLPAPVLNCGXXXXXXXXXXXXFKRRPSYSRLDDRNKDLHE---KLSELTIQRCRVRLFS 228
L + D R+ L E K+ ++ I R R+ L
Sbjct: 250 TQTTQYLRADTPNNATPITSSSGYPTLRIEKNDLRSVTLLEAKAKVKDIAISRERITLKD 309
Query: 229 VNMEGTFGRVYRGTYTEED--GVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKN 284
V EGTFGR++ G +E E++ VKTV TD AS +QV+++L E + GL H+N
Sbjct: 310 VLQEGTFGRIFHGILVDEKDPNKEKQAFVKTVKDTDQASEIQVTMMLTESCKLRGLHHRN 369
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344
+L + V IE+ P +I PY ++ NLK FL++CKL ++ Q++V M +QI G
Sbjct: 370 LLPITNVCIEEGEKPMVILPYMNWGNLKLFLRQCKLVEANNPQAISQQDLVHMAIQIACG 429
Query: 345 VQYXXXXXXXXXXXATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIE 404
+ Y A RNCV+DD L+++ITDNAL+RDLFP DYHCLGDNENRPV+W+A+E
Sbjct: 430 MSYLARREVIHKDLAARNCVIDDTLQVKITDNALSRDLFPMDYHCLGDNENRPVRWMALE 489
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464
SLV+ FS+ASDVWAFGV LWEL TL Q PY +IDPFEMAA L+DGYR+ QP+NCPDELF
Sbjct: 490 SLVNNEFSSASDVWAFGVTLWELMTLGQTPYVDIDPFEMAAYLKDGYRIAQPINCPDELF 549
Query: 465 SVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
+VMA CWA++PE RP F QL CL EFHA L YV
Sbjct: 550 AVMACCWALDPEERPKFQQLVQCLTEFHAALGAYV 584
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P34925 | RYK_HUMAN | 2, ., 7, ., 1, 0, ., 1 | 0.4288 | 0.9539 | 0.7880 | yes | N/A |
| Q9V422 | RYK2_DROME | 2, ., 7, ., 1, 0, ., 1 | 0.4938 | 0.9438 | 0.8065 | yes | N/A |
| Q01887 | RYK_MOUSE | 2, ., 7, ., 1, 0, ., 1 | 0.4218 | 0.9619 | 0.8080 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.10 | 0.921 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 499 | |||
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-175 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-103 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-99 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-99 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-98 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-72 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-67 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-64 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-63 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-61 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-58 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-57 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-55 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-55 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-55 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-55 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-55 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-54 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-53 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-52 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-52 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-52 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-52 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-50 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-49 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-49 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-49 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-48 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-48 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-48 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-48 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-48 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-47 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-47 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-47 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-46 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-45 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-45 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-45 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-45 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-44 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-44 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-44 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-43 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-43 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-43 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-42 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-42 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-42 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-41 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-41 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-41 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-41 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-40 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-40 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-40 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-40 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-40 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-40 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-40 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-39 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-38 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-38 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-38 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-37 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-37 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-36 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-36 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-36 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-35 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-35 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-34 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-34 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-34 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-34 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-33 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-33 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-33 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-33 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-31 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-31 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-30 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-30 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-29 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-28 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-28 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-25 | |
| smart00469 | 136 | smart00469, WIF, Wnt-inhibitory factor-1 like doma | 5e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-22 | |
| pfam02019 | 132 | pfam02019, WIF, WIF domain | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-15 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-14 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-10 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-08 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-07 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-05 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.001 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.001 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 0.001 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.001 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.002 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.002 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 0.002 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.002 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.002 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 0.002 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.003 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 491 bits (1267), Expect = e-175
Identities = 175/280 (62%), Positives = 221/280 (78%), Gaps = 1/280 (0%)
Query: 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGM 275
+ I R RV L + EGTFGR++ G +E G EEEV VKTV D+AS +QV+LLLQE
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 276 AMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVV 335
+YGLSH+NIL +L V IED PF++YPY ++ NLK FLQ+C+L L+TQ++V
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
M +QI G+ YLHK+ ++HKD+A RNCV+D++L+++ITDNAL+RDLFP DYHCLGDNEN
Sbjct: 121 HMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455
RPVKW+A+ESLV+K +S+ASDVW+FGVLLWEL TL Q PY EIDPFEMAA L+DGYRL Q
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ 240
Query: 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
P+NCPDELF+VMA CWA++PE RP+F QL CL +FHAQL
Sbjct: 241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = e-103
Identities = 102/259 (39%), Positives = 156/259 (60%), Gaps = 2/259 (0%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG FG VY+G +DG EV VKT+ ++AS + L+E M L H N++ +LGV
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGV 64
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLC-PEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
E+ +L+ Y + +L +L+K + P TL+ ++++ +QI G++YL
Sbjct: 65 CTEEE-PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
KK +H+DLA RNC+V + L ++I+D L+RD++ DY+ P++W+A ESL
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F++ SDVW+FGVLLWE+ TL PY + E+ L+ GYRL +P CPDEL+ +M C
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSC 243
Query: 471 WAMNPEGRPTFPQLHSCLQ 489
W ++PE RPTF +L L+
Sbjct: 244 WQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 298 bits (766), Expect = 4e-99
Identities = 103/258 (39%), Positives = 155/258 (60%), Gaps = 10/258 (3%)
Query: 232 EGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EG FG VY+G + G + EV VKT+ ++AS Q+ L+E M L H N++ +LG
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLG 68
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V E+ +++ Y + +L +L+K + L+ +++ LQI G++YL
Sbjct: 69 VCTEEE-PLYIVMEYMEGGDLLSYLRKNR-------PKLSLSDLLSFALQIARGMEYLES 120
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K +H+DLA RNC+V + L ++I+D L+RDL+ DY+ P++W+A ESL
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK-RGGKLPIRWMAPESLKEGK 179
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F++ SDVW+FGVLLWE+ TL +QPY + E+ L++GYRL QP NCP EL+ +M C
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQC 239
Query: 471 WAMNPEGRPTFPQLHSCL 488
WA +PE RPTF +L L
Sbjct: 240 WAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 297 bits (764), Expect = 7e-99
Identities = 108/258 (41%), Positives = 156/258 (60%), Gaps = 9/258 (3%)
Query: 232 EGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EG FG VY+GT + +G E +V VKT+ + AS + L+E M LSH NI+ +LG
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLG 68
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V + +++ Y +L FL+K LT ++++ M LQI G++YL
Sbjct: 69 VCTQGE-PLYIVTEYMPGGDLLDFLRKHG-------EKLTLKDLLQMALQIAKGMEYLES 120
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K +H+DLA RNC+V + L ++I+D L+RD++ DY+ P+KW+A ESL
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F++ SDVW+FGVLLWE+ TL +QPY + E+ L+DGYRL +P NCPDEL+ +M C
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQC 240
Query: 471 WAMNPEGRPTFPQLHSCL 488
WA +PE RPTF +L L
Sbjct: 241 WAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 295 bits (758), Expect = 5e-98
Identities = 103/258 (39%), Positives = 153/258 (59%), Gaps = 9/258 (3%)
Query: 232 EGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EG FG VY+GT + E EV VKT+ ++AS Q+ L+E M L H NI+ +LG
Sbjct: 9 EGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLG 68
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V E+ ++ Y +L +L+K + L+ +++ LQI G++YL
Sbjct: 69 VCTEEE-PLMIVMEYMPGGDLLDYLRKNR------PKELSLSDLLSFALQIARGMEYLES 121
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K +H+DLA RNC+V + L ++I+D L+RDL+ DY+ + P++W+A ESL
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV-KGGKLPIRWMAPESLKEGK 180
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F++ SDVW+FGVLLWE+ TL ++PY + E+ L+ GYRL +P NCP EL+ +M C
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQC 240
Query: 471 WAMNPEGRPTFPQLHSCL 488
WA +PE RPTF +L L
Sbjct: 241 WAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 228 bits (584), Expect = 7e-72
Identities = 100/256 (39%), Positives = 152/256 (59%), Gaps = 9/256 (3%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG VY GT + DG + VK++ +V L+EG+ M SH N+L++LG+
Sbjct: 6 GHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGIC 65
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ SP ++ PY + +L+ F++ H T ++++ LQ+ G++YL KK
Sbjct: 66 LPSEGSPLVVLPYMKHGDLRNFIRSET-------HNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--PVKWLAIESLVHKT 410
+H+DLA RNC++D+ +++ D LARD++ +Y+ + ++ PVKW+A+ESL +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
F+T SDVW+FGVLLWEL T PY ++D F++ L G RL QP CPD L+ VM C
Sbjct: 179 FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238
Query: 471 WAMNPEGRPTFPQLHS 486
W PE RPTF +L S
Sbjct: 239 WHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 2e-67
Identities = 91/265 (34%), Positives = 149/265 (56%), Gaps = 8/265 (3%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EG FG V G +++DG + +V VKT+ D + ++ L E M H N++ ++G
Sbjct: 9 EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIG 68
Query: 291 VSIEDHT-----SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
V E + P +I P+ + +L FL +L G+ L Q ++ + I +G+
Sbjct: 69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRL--GGLPEKLPLQTLLKFMVDIALGM 126
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
+YL + +H+DLA RNC++ + + + + D L++ ++ DY+ G PVKW+AIES
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES 186
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465
L + +++ SDVWAFGV +WE+ T Q PY ++ E+ L+ G RL QP +C DEL+
Sbjct: 187 LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYD 246
Query: 466 VMAYCWAMNPEGRPTFPQLHSCLQE 490
+M CW +P+ RPTF +L L+
Sbjct: 247 LMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 2e-64
Identities = 99/266 (37%), Positives = 151/266 (56%), Gaps = 10/266 (3%)
Query: 233 GTFGRVYRGTYTEEDGVEEE---VLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
G FG VY GT T+ G V VKT+ A+ + L+E M +H NI+ +L
Sbjct: 6 GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLL 65
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
GV + + ++I + +L +L+ ++ G LT +E++D+CL + G YL
Sbjct: 66 GVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPP-LLTLKELLDICLDVAKGCVYLE 123
Query: 350 KKKLLHKDLATRNCVVDDKLR-----IQITDNALARDLFPSDYHCLGDNENRPVKWLAIE 404
+ +H+DLA RNC+V +K ++I D LARD++ SDY+ PV+W+A E
Sbjct: 124 QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE 183
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464
SL+ F+T SDVW+FGVL+WE+ TL QQPY ++ E+ + G RL +P NCPD+++
Sbjct: 184 SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIY 243
Query: 465 SVMAYCWAMNPEGRPTFPQLHSCLQE 490
+M CWA +P RPTF ++ LQ
Sbjct: 244 QLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 2e-63
Identities = 102/278 (36%), Positives = 150/278 (53%), Gaps = 14/278 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE--VLVKTVTDNASAVQVSLLLQE--G 274
+ R R+ L EG FG+V + D E V VK + D+A+ +S L+ E
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM 68
Query: 275 MAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFL-------QKCKL-CPEGVA 326
M M G HKNI+ +LGV ++ +++ Y + NL+ FL + P
Sbjct: 69 MKMIG-KHKNIINLLGVCTQE-GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 327 HTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386
TLT +++V Q+ G+++L KK +H+DLA RN +V + ++I D LARD+ D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 387 YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446
Y+ N PVKW+A E+L + ++ SDVW+FGVLLWE+ TL PY I E+
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 447 LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L++GYR+ +P NC EL+ +M CW P RPTF QL
Sbjct: 247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 2e-61
Identities = 96/265 (36%), Positives = 147/265 (55%), Gaps = 9/265 (3%)
Query: 232 EGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G+FG VY G + E V +KTV +NAS + L E M + +++ +L
Sbjct: 16 QGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLL 75
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE----GVAHTLTTQEVVDMCLQIIMGV 345
GV + ++ +LK +L+ + PE T Q+ + M +I G+
Sbjct: 76 GV-VSTGQPTLVVMELMAKGDLKSYLRSRR--PEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
YL KK +H+DLA RNC+V + L ++I D + RD++ +DY+ G PV+W+A ES
Sbjct: 133 AYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465
L F+T SDVW+FGV+LWE+ TLA+QPY + E+ + DG L+ P NCPD+L
Sbjct: 193 LKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLE 252
Query: 466 VMAYCWAMNPEGRPTFPQLHSCLQE 490
+M CW NP+ RPTF ++ S L++
Sbjct: 253 LMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 9e-58
Identities = 95/277 (34%), Positives = 151/277 (54%), Gaps = 19/277 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVE--EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EG FG+V + T G V VK + +NAS+ ++ LL E + ++H +++ +
Sbjct: 10 EGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLY 69
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKC-KLCPEGVA---------------HTLTTQE 333
G +D LI Y Y +L+ FL++ K+ P + LT +
Sbjct: 70 GACSQDG-PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD 128
Query: 334 VVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN 393
++ QI G+QYL + KL+H+DLA RN +V + +++I+D L+RD++ D +
Sbjct: 129 LISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSK 188
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
PVKW+AIESL ++T SDVW+FGVLLWE+ TL PY I P + L+ GYR+
Sbjct: 189 GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM 248
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
+P NC +E++++M CW P+ RPTF + L++
Sbjct: 249 ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 3e-57
Identities = 87/258 (33%), Positives = 135/258 (52%), Gaps = 13/258 (5%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V +G Y + G E EV VKT+ A L+E M L H I+ ++GV
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65
Query: 293 IEDHTSPF-LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ P L+ L ++L+K + + ++ ++ Q+ MG+ YL K
Sbjct: 66 KGE---PLMLVMELAPLGPLLKYLKKRR--------EIPVSDLKELAHQVAMGMAYLESK 114
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYHCLGDNENRPVKWLAIESLVHKT 410
+H+DLA RN ++ ++ + +I+D ++R L SDY+ P+KW A E + +
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
FS+ SDVW++GV LWE + +PY E+ E+ A L+ G RL +P CP E++S+M C
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234
Query: 471 WAMNPEGRPTFPQLHSCL 488
W PE RPTF +L S
Sbjct: 235 WKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 3e-55
Identities = 95/283 (33%), Positives = 147/283 (51%), Gaps = 25/283 (8%)
Query: 232 EGTFGRVYRGT------YTEEDGVEEE-------VLVKTVTDNASAVQVSLLLQEGMAMY 278
EG FG V+ ++E+ E + V VK + +AS L+E +
Sbjct: 15 EGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILS 74
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAH---TLTTQEVV 335
LS NI +LGV D +I Y + +L +FLQK G+A +L+ ++
Sbjct: 75 RLSDPNIARLLGVCTVDP-PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
M QI G++YL +H+DLATRNC+V I+I D ++R+L+ SDY+ +
Sbjct: 134 YMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP 193
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQ-QPYAEIDPFEMAASLQDGYR-- 452
P++W+A ES++ F+T SDVWAFGV LWE+ TL + QPY + ++ + +R
Sbjct: 194 LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDD 253
Query: 453 -----LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
L +P NCP +++ +M CW + E RPTF ++H LQ
Sbjct: 254 GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 3e-55
Identities = 88/279 (31%), Positives = 148/279 (53%), Gaps = 27/279 (9%)
Query: 232 EGTFGRVYRGTY-----TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNIL 286
+G FGRV++ E + V VK + + ASA + +E M H NI+
Sbjct: 15 QGAFGRVFQARAPGLLPYEPFTM---VAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 287 TVLGVSIEDHTSPF-LIYPYQDYTNLKRFLQ---------------KCKLCPEGVAHTLT 330
+LGV P L++ Y Y +L FL+ + C L+
Sbjct: 72 KLLGVCAVG--KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL-PLS 128
Query: 331 TQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCL 390
E + + Q+ G+ YL ++K +H+DLATRNC+V + + ++I D L+R+++ +DY+
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 391 GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450
+N+ P++W+ ES+ + ++T SDVWA+GV+LWE+ + QPY + E+ ++DG
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248
Query: 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489
L+ P NCP EL+++M CW+ P RP+F ++ LQ
Sbjct: 249 NVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 4e-55
Identities = 88/281 (31%), Positives = 152/281 (54%), Gaps = 9/281 (3%)
Query: 218 TIQRCRVRLFSVNMEGTFGRVYRGT--YTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGM 275
+QR + L EG FG+V+ G + E + +E V VKT+ + AS +E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 276 AMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFL-----QKCKLCPEGVAHT-L 329
+ H+NI+ GV E P +++ Y ++ +L +FL L L
Sbjct: 61 LLTNFQHENIVKFYGVCTEG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 330 TTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC 389
T +++ + +QI G+ YL + +H+DLATRNC+V L ++I D ++RD++ +DY+
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 390 LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449
+G + P++W+ ES++++ F+T SDVW+FGV+LWE+ T +QP+ + E+ +
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239
Query: 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
G L +P CP E++ +M CW +P+ R +H LQ+
Sbjct: 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 185 bits (470), Expect = 6e-55
Identities = 90/264 (34%), Positives = 144/264 (54%), Gaps = 8/264 (3%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G FG V EDG ++V VK + D S+ + L+E M H N++ ++G
Sbjct: 9 KGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIG 68
Query: 291 VSIEDHTS-----PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
VS+ P +I P+ + +L FL ++ E TL Q +V + I G+
Sbjct: 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF--TLPLQTLVRFMIDIASGM 126
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
+YL K +H+DLA RNC++++ + + + D L++ ++ DY+ G PVKWLA+ES
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465
L ++T SDVWAFGV +WE+ T Q PYA ++ E+ L G RL QP +C ++++
Sbjct: 187 LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYE 246
Query: 466 VMAYCWAMNPEGRPTFPQLHSCLQ 489
+M CW+ P+ RP+F L L+
Sbjct: 247 LMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 8e-55
Identities = 88/261 (33%), Positives = 137/261 (52%), Gaps = 21/261 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG V G Y + +V VK + D+++A Q L E M L H N++ +LGV
Sbjct: 16 KGEFGDVMLGDYRGQ-----KVAVKCLKDDSTAAQA--FLAEASVMTTLRHPNLVQLLGV 68
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ +++ Y +L +L+ G A +T + + L + G++YL +K
Sbjct: 69 VL-QGNPLYIVTEYMAKGSLVDYLRS-----RGRAV-ITLAQQLGFALDVCEGMEYLEEK 121
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLG-DNENRPVKWLAIESLVHKT 410
+H+DLA RN +V + L +++D LA++ G D+ PVKW A E+L K
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKE------ASQGQDSGKLPVKWTAPEALREKK 175
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
FST SDVW+FG+LLWE+ + + PY I ++ ++ GYR+ P CP E++ VM C
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235
Query: 471 WAMNPEGRPTFPQLHSCLQEF 491
W ++P RPTF QL L
Sbjct: 236 WELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 2e-54
Identities = 94/267 (35%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EG FG V G ++D + + V VKT+ + ++ L E + M H N++ ++G
Sbjct: 9 EGEFGSVMEGQLNQDDSILK-VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIG 67
Query: 291 VSI-----EDHTSPFLIYPYQDYTNLKRFLQKCKL--CPEGVAHTLTTQEVVDMCLQIIM 343
V + E + SP +I P+ + +L FL +L CP+ L TQ +V I
Sbjct: 68 VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ----YLPTQMLVKFMTDIAS 123
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAI 403
G++YL K +H+DLA RNC++++ + + + D L++ ++ DY+ G PVKW+AI
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 404 ESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDEL 463
ESL + ++T SDVW+FGV +WE+ T Q PY ++ E+ L+ G RL QP +C D L
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGL 243
Query: 464 FSVMAYCWAMNPEGRPTFPQLHSCLQE 490
+S+M+ CW +NP+ RP+F L L++
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-53
Identities = 87/271 (32%), Positives = 144/271 (53%), Gaps = 19/271 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVE--EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EG FG+VY+G T + V +KT+ +NA QE M L H NI+ +L
Sbjct: 15 EGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLL 74
Query: 290 GVSIEDHTSPF-LIYPYQDYTNLKRFL--------QKCKLCPEGVAHTLTTQEVVDMCLQ 340
GV ++ P +++ Y + +L FL + E V +L + + + +Q
Sbjct: 75 GVCTKE--QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
I G++YL +H+DLA RNC+V + L ++I+D L+RD++ +DY+ + PV+W
Sbjct: 133 IAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192
Query: 401 LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY---AEIDPFEMAASLQDGYRLNQPV 457
+ E++++ F+T SD+W+FGV+LWE+ + QPY + + EM S Q L P
Sbjct: 193 MPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ---LLPCPE 249
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488
+CP ++++M CW P RP F +H+ L
Sbjct: 250 DCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 2e-52
Identities = 96/263 (36%), Positives = 149/263 (56%), Gaps = 8/263 (3%)
Query: 233 GTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G FG V+ EE+G E VLVK + S +E LSHKN++ +LG
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLG 75
Query: 291 VSIEDHTSPF-LIYPYQDYTNLKRFLQKCKLCPEGVA-HTLTTQEVVDMCLQIIMGVQYL 348
+ E P +I Y D +LK+FL+ K E + L+T++ V +C QI +G+ +L
Sbjct: 76 LCRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL 133
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH 408
+ +H+DLA RNC+V + ++++ +L++D++ S+Y+ L N P++WLA E++
Sbjct: 134 SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL-RNALIPLRWLAPEAVQE 192
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRLNQPVNCPDELFSVM 467
FST SDVW+FGVL+WE+ T + P+ + E+ LQ G L P CP L+ +M
Sbjct: 193 DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLM 252
Query: 468 AYCWAMNPEGRPTFPQLHSCLQE 490
CWA+NP+ RP+F +L S L E
Sbjct: 253 TRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 94/276 (34%), Positives = 156/276 (56%), Gaps = 5/276 (1%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTE--EDGVEEEVLVKTVTDNASAVQVSLLLQEGMA 276
+ R ++ L +G+FG VY G + + E V VKTV ++AS + L E
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTL--TTQEV 334
M G + +++ +LGV + ++ + +LK +L+ + E T QE+
Sbjct: 63 MKGFTCHHVVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 335 VDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394
+ M +I G+ YL+ KK +H+DLA RNC+V ++I D + RD++ +DY+ G
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 395 NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454
PV+W+A ESL F+T+SD+W+FGV+LWE+T+LA+QPY + ++ + DG L+
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241
Query: 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
QP NCP+ + +M CW NP+ RPTF ++ + L++
Sbjct: 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 3e-52
Identities = 82/268 (30%), Positives = 141/268 (52%), Gaps = 10/268 (3%)
Query: 233 GTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG VY+G + E + V+ V +K + + S +L E M + H +++ +LG+
Sbjct: 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI 77
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ LI L +++ K + +Q +++ C+QI G+ YL +K
Sbjct: 78 CLSSQVQ--LITQLMPLGCLLDYVRNHK-------DNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+L+H+DLA RN +V ++ITD LA+ L + + P+KW+A+ES++H+ +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
+ SDVW++GV +WEL T +PY I E+ L+ G RL QP C +++ V+ CW
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCW 248
Query: 472 AMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
++ E RPTF +L + + RY+
Sbjct: 249 MIDAESRPTFKELINEFSKMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 5e-52
Identities = 88/258 (34%), Positives = 135/258 (52%), Gaps = 15/258 (5%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G +G VY G + + V VKT+ ++ V+ L+E M + H N++ +LGV
Sbjct: 17 GQYGEVYEGVWKKYSLT---VAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVC 71
Query: 293 IEDHTSPF-LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
PF +I + Y NL +L++C + ++ M QI ++YL KK
Sbjct: 72 T--REPPFYIITEFMTYGNLLDYLRECN------RQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+H+DLA RNC+V + +++ D L+R L D + P+KW A ESL + F
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
S SDVWAFGVLLWE+ T PY ID ++ L+ GYR+ +P CP +++ +M CW
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACW 242
Query: 472 AMNPEGRPTFPQLHSCLQ 489
NP RP+F ++H +
Sbjct: 243 QWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 4e-50
Identities = 84/277 (30%), Positives = 138/277 (49%), Gaps = 10/277 (3%)
Query: 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277
IQR + L EG FG VY+G Y + + V VKT + S LQE M
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 278 YGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
H +I+ ++GV E+ +++ L+ +LQ K ++L ++
Sbjct: 62 RQFDHPHIVKLIGVITENPV--WIVMELAPLGELRSYLQVNK-------YSLDLASLILY 112
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
Q+ + YL K+ +H+D+A RN +V +++ D L+R L Y+ P
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLP 171
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
+KW+A ES+ + F++ASDVW FGV +WE+ L +P+ + ++ +++G RL P
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP 231
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494
NCP L+S+M CWA +P RP F +L + L + +
Sbjct: 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 89/268 (33%), Positives = 143/268 (53%), Gaps = 7/268 (2%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDG--VEEEVLVKTVTDNASAVQVSLLLQEGMA 276
+ R + L G FG VY G Y DG VE +V VKT+ ++ S S L E +
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
M +H+NI+ ++GVS E F++ +LK FL++ + PE +LT ++++
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPER-PSSLTMKDLLF 120
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK--LRI-QITDNALARDLFPSDYHCLGDN 393
+ G +YL + +H+D+A RNC++ K R+ +I D +ARD++ + Y+ G
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
P+KW+ E+ + F++ +DVW+FGVLLWE+ +L PY E+ + G RL
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTF 481
+ P CP ++ +M CW PE RP F
Sbjct: 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNF 268
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 91/263 (34%), Positives = 134/263 (50%), Gaps = 20/263 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ GT+ +V VKT+ + LQE M L H ++ + V
Sbjct: 16 AGQFGEVWMGTWNGT----TKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 292 SIEDHTSPFLIYPYQDYT---NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
E P IY +Y +L FL+ EG L ++VDM QI G+ YL
Sbjct: 70 CSE--EEP--IYIVTEYMSKGSLLDFLKS----GEG--KKLRLPQLVDMAAQIAEGMAYL 119
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH 408
+ +H+DLA RN +V + L +I D LAR L D + + P+KW A E+ +
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANY 178
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMA 468
F+ SDVW+FG+LL E+ T + PY + E+ ++ GYR+ +P NCP+EL+ +M
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLML 238
Query: 469 YCWAMNPEGRPTFPQLHSCLQEF 491
CW +PE RPTF L S L+++
Sbjct: 239 QCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 9e-49
Identities = 96/273 (35%), Positives = 151/273 (55%), Gaps = 28/273 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEE-------VLVKTVTDNASAVQVSLLLQEGMAMYGL--SH 282
EG FG+V R E G+++ V VK + DNA+ ++ L+ E M + L H
Sbjct: 22 EGCFGQVVRA---EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE-MELMKLIGKH 77
Query: 283 KNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHT----------LTT 331
KNI+ +LGV ++ P ++I Y NL+ FL+ + P G +T L+
Sbjct: 78 KNIINLLGVCTQE--GPLYVIVEYAAKGNLREFLRARR--PPGPDYTFDITKVPEEQLSF 133
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLG 391
+++V Q+ G++YL ++ +H+DLA RN +V + ++I D LAR + DY+
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 392 DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451
N PVKW+A E+L + ++ SDVW+FG+L+WE+ TL PY I E+ L++G+
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH 253
Query: 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
R+++P NC EL+ +M CW P RPTF QL
Sbjct: 254 RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 86/271 (31%), Positives = 146/271 (53%), Gaps = 14/271 (5%)
Query: 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHK 283
V + V G FG V RG E +V +KT+ +S Q L E M H
Sbjct: 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHP 65
Query: 284 NILTVLGVSIEDHTSPFLIY-PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQII 342
NI+ + GV + + P +I Y + +L +FL++ +G T ++V M I
Sbjct: 66 NIIRLEGVVTK--SRPVMIITEYMENGSLDKFLRE----NDG---KFTVGQLVGMLRGIA 116
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD--YHCLGDNENRPVKW 400
G++YL + +H+DLA RN +V+ L +++D L+R L S+ Y G P++W
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRW 174
Query: 401 LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460
A E++ ++ F++ASDVW+FG+++WE+ + ++PY ++ ++ +++DGYRL P++CP
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCP 234
Query: 461 DELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
L+ +M CW + RPTF Q+ S L +
Sbjct: 235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 1e-48
Identities = 90/263 (34%), Positives = 148/263 (56%), Gaps = 5/263 (1%)
Query: 232 EGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G+FG VY G +D E V +KTV + AS + L E M + +++ +L
Sbjct: 16 QGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 75
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG--VAHTLTTQEVVDMCLQIIMGVQY 347
GV + +I +LK +L+ + E V + ++++ M +I G+ Y
Sbjct: 76 GV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAY 134
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
L+ K +H+DLA RNC+V + ++I D + RD++ +DY+ G PV+W++ ESL
Sbjct: 135 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
F+T SDVW+FGV+LWE+ TLA+QPY + ++ + +G L++P NCPD LF +M
Sbjct: 195 DGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELM 254
Query: 468 AYCWAMNPEGRPTFPQLHSCLQE 490
CW NP+ RP+F ++ S ++E
Sbjct: 255 RMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 84/261 (32%), Positives = 131/261 (50%), Gaps = 16/261 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ G + V +K + + ++ +E A+ L HK+++++ V
Sbjct: 16 SGYFGEVWEGLWKNR----VRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 292 SIEDHTSPF-LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
P +I + +L FL+ PEG L ++DM Q+ G+ YL +
Sbjct: 71 CSVG--EPVYIITELMEKGSLLAFLRS----PEG--QVLPVASLIDMACQVAEGMAYLEE 122
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
+ +H+DLA RN +V + L ++ D LAR + Y L ++ P KW A E+ H T
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGT 180
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
FST SDVW+FG+LL+E+ T Q PY ++ E+ + GYR+ P CP E++ +M C
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC 240
Query: 471 WAMNPEGRPTFPQLHSCLQEF 491
WA PE RP+F L L
Sbjct: 241 WAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 7e-48
Identities = 96/272 (35%), Positives = 152/272 (55%), Gaps = 26/272 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEE-------VLVKTVTDNASAVQVSLLLQEG--MAMYGLSH 282
EG FG+V E G++++ V VK + D+A+ +S L+ E M M G H
Sbjct: 25 EGCFGQV---VMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG-KH 80
Query: 283 KNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHT----------LTTQ 332
KNI+ +LG +D ++I Y NL+ +L+ + P G+ ++ +T +
Sbjct: 81 KNIINLLGACTQDGPL-YVIVEYASKGNLREYLRARR--PPGMEYSYDIARVPDEQMTFK 137
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
++V Q+ G++YL +K +H+DLA RN +V + ++I D LARD+ DY+
Sbjct: 138 DLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452
N PVKW+A E+L + ++ SDVW+FGVL+WE+ TL PY I E+ L++G+R
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR 257
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+++P NC +EL+ +M CW P RPTF QL
Sbjct: 258 MDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 7e-48
Identities = 104/288 (36%), Positives = 156/288 (54%), Gaps = 32/288 (11%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE-------VLVKTVTDNASAVQVSLLL 271
+ R R+ L EG FG+V E G++++ V VK + D+A+ +S L+
Sbjct: 9 LSRTRLTLGKPLGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 272 QEG--MAMYGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQ------------ 316
E M M G HKNI+ +LG +D P +++ Y NL+ +L+
Sbjct: 66 SEMEMMKMIG-KHKNIINLLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 317 KCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376
CKL PE LT +++V Q+ G++YL +K +H+DLA RN +V + ++I D
Sbjct: 123 TCKL-PE---EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYA 436
LARD+ DY+ N PVKW+A E+L + ++ SDVW+FGVLLWE+ TL PY
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 437 EIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
I E+ L++G+R+++P NC EL+ +M CW P RPTF QL
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-47
Identities = 80/256 (31%), Positives = 129/256 (50%), Gaps = 15/256 (5%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+ G + + +V +K + A+ ++E M LSH N++ + GV
Sbjct: 15 GQFGVVHLGKWRGKI----DVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ F++ Y L +L++ K L T+ ++DMC + ++YL
Sbjct: 69 TK-QRPIFIVTEYMANGCLLNYLRERK-------GKLGTEWLLDMCSDVCEAMEYLESNG 120
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS 412
+H+DLA RNC+V + ++++D LAR + Y + PVKW E + FS
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK-FPVKWAPPEVFDYSRFS 179
Query: 413 TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWA 472
+ SDVW+FGVL+WE+ + + PY E+ S+ GYRL +P P E++++M CW
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWH 239
Query: 473 MNPEGRPTFPQLHSCL 488
PE RP F +L S L
Sbjct: 240 EKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 5e-47
Identities = 101/286 (35%), Positives = 156/286 (54%), Gaps = 28/286 (9%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE-------VLVKTVTDNASAVQVSLLL 271
+ R R+ L EG FG+V E G+++E V VK + +A+ +S L+
Sbjct: 15 VPRDRLVLGKPLGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLI 71
Query: 272 QEG--MAMYGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHT 328
E M M G HKNI+ +LG +D P ++I Y NL+ +L+ + P G+ +
Sbjct: 72 SEMEMMKMIG-KHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARR--PPGMEYC 126
Query: 329 ----------LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378
L+ +++V Q+ G++YL KK +H+DLA RN +V + ++I D L
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 186
Query: 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI 438
ARD+ DY+ N PVKW+A E+L + ++ SDVW+FGVLLWE+ TL PY +
Sbjct: 187 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
Query: 439 DPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
E+ L++G+R+++P NC +EL+ +M CW P RPTF QL
Sbjct: 247 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 6e-47
Identities = 87/283 (30%), Positives = 137/283 (48%), Gaps = 27/283 (9%)
Query: 221 RCRVRLFSVNM--EGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277
R L + EG FG+V Y D E+V VK++ + S +E +
Sbjct: 2 EKRH-LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60
Query: 278 YGLSHKNILTVLGVSIEDH-TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H+NI+ GV + S LI Y +L+ +LQ+ + + + ++
Sbjct: 61 RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-------DQINLKRLLL 113
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYHCLGDNEN 395
QI G+ YL ++ +H+DLA RN +V+ + ++I+D LA+ L DY+ + +
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL---AQQPYAEIDP-----------F 441
P+ W A E L FS+ASDVW+FGV L+EL T +Q P AE
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ L++G RL +P +CPDE++ +M CW P+ RP+F L
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 1e-46
Identities = 89/260 (34%), Positives = 142/260 (54%), Gaps = 23/260 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG FG V +G YT + +V VK + + +A L+E M L HKN++ +LGV
Sbjct: 16 EGEFGAVLQGEYTGQ-----KVAVKNIKCDVTA---QAFLEETAVMTKLHHKNLVRLLGV 67
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ H +++ NL FL+ G A ++ +++ L + G++YL K
Sbjct: 68 IL--HNGLYIVMELMSKGNLVNFLRT-----RGRA-LVSVIQLLQFSLDVAEGMEYLESK 119
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLG-DNENRPVKWLAIESLVHKT 410
KL+H+DLA RN +V + +++D LAR +G DN PVKW A E+L HK
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLAR------VGSMGVDNSKLPVKWTAPEALKHKK 173
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
FS+ SDVW++GVLLWE+ + + PY ++ E+ ++ GYR+ P CP +++ +M C
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC 233
Query: 471 WAMNPEGRPTFPQLHSCLQE 490
W P+ RP+F +L L++
Sbjct: 234 WETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 94/283 (33%), Positives = 147/283 (51%), Gaps = 26/283 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-------AVQVSLLLQEGMAMYGLSHKN 284
EG FG+V R ++DG++ +K + + AS A ++ +L + G H N
Sbjct: 12 EGNFGQVIRAM-IKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG------HHPN 64
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVD 336
I+ +LG + E+ ++ Y Y NL FL+K ++ G A TLT+Q+++
Sbjct: 65 IINLLG-ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
+ G+QYL +K+ +H+DLA RN +V + L +I D L+R + +
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG---EEVYVKKTMGRL 180
Query: 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456
PV+W+AIESL + ++T SDVW+FGVLLWE+ +L PY + E+ L GYR+ +P
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP 240
Query: 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
NC DE++ +M CW P RP F Q+ L YV
Sbjct: 241 RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 2e-45
Identities = 85/270 (31%), Positives = 144/270 (53%), Gaps = 14/270 (5%)
Query: 233 GTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG VY+G + + + V+ V +K + +N S +L E M G+ + +LG+
Sbjct: 18 GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGI 77
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ L+ Y L ++++ K + +Q++++ C+QI G+ YL +
Sbjct: 78 CLTSTVQ--LVTQLMPYGCLLDYVRENK-------DRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALAR--DLFPSDYHCLGDNENRPVKWLAIESLVHK 409
+L+H+DLA RN +V ++ITD LAR D+ ++YH D P+KW+A+ES++H+
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH--ADGGKVPIKWMALESILHR 186
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
F+ SDVW++GV +WEL T +PY I E+ L+ G RL QP C +++ +M
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVK 246
Query: 470 CWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
CW ++ E RP F +L +R+V
Sbjct: 247 CWMIDSECRPRFRELVDEFSRMARDPSRFV 276
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 88/264 (33%), Positives = 137/264 (51%), Gaps = 16/264 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G+FG V RG ++ G V VK + +D S + L +E M+ L H+N++ + G
Sbjct: 5 DGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLIRLYG 63
Query: 291 VSIEDHTSPFLIYPYQDYTNLK--RFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
V L +P T L L ++T + D +QI G++YL
Sbjct: 64 V--------VLTHPLMMVTELAPLGSLLDRLRKDALGHFLIST--LCDYAVQIANGMRYL 113
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYHCLGDNENRPVKWLAIESLV 407
K+ +H+DLA RN ++ +++I D L R L D++ + ++ P W A ESL
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QDGYRLNQPVNCPDELFSV 466
+TFS ASDVW FGV LWE+ T ++P+A + ++ + ++G RL +P CP ++++V
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV 233
Query: 467 MAYCWAMNPEGRPTFPQLHSCLQE 490
M CWA NP RPTF L L E
Sbjct: 234 MLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 82/259 (31%), Positives = 135/259 (52%), Gaps = 14/259 (5%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG VY+G EV VKT LQE + H NI+ ++GV
Sbjct: 5 KGNFGDVYKGVLKGN----TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 292 SIEDHTSPFLI-YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
++ P I +L FL+K K + LT ++++ M L G++YL
Sbjct: 61 CVQ--KQPIYIVMELVPGGSLLTFLRKKK-------NRLTVKKLLQMSLDAAAGMEYLES 111
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K +H+DLA RNC+V + ++I+D ++R+ Y + P+KW A E+L +
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
+++ SDVW++G+LLWE +L PY + + ++ GYR+ P CP+E++ +M C
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQC 231
Query: 471 WAMNPEGRPTFPQLHSCLQ 489
WA +PE RP+F ++++ LQ
Sbjct: 232 WAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-45
Identities = 85/280 (30%), Positives = 133/280 (47%), Gaps = 28/280 (10%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R ++L G FG V+ G + V VKT+ + L E M
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTL--KPGTMDPKDFLAEAQIMK 56
Query: 279 GLSHKNILTVLGV-SIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H ++ + V ++E+ P +++ Y +L +LQ G L +++D
Sbjct: 57 KLRHPKLIQLYAVCTLEE---PIYIVTELMKYGSLLEYLQG------GAGRALKLPQLID 107
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
M Q+ G+ YL + +H+DLA RN +V + ++ D LAR + Y E R
Sbjct: 108 MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY------EAR 161
Query: 397 -----PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451
P+KW A E+ ++ FS SDVW+FG+LL E+ T + PY + E+ + GY
Sbjct: 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY 221
Query: 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
R+ P CP EL+ +M CW +P+ RPTF L L++F
Sbjct: 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 80/267 (29%), Positives = 144/267 (53%), Gaps = 11/267 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLV--KTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EG FG+V+ ++++LV K + + + + + +E + L H++I+
Sbjct: 15 EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ-REAELLTVLQHQHIVRFY 73
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQK----CKLCPEGVAHT---LTTQEVVDMCLQII 342
GV E +++ Y + +L RFL+ K+ G LT +++ + QI
Sbjct: 74 GVCTEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLA 402
G+ YL +H+DLATRNC+V L ++I D ++RD++ +DY+ +G P++W+
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192
Query: 403 IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462
ES++++ F+T SD+W+FGV+LWE+ T +QP+ ++ E + G L +P CP E
Sbjct: 193 PESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPE 252
Query: 463 LFSVMAYCWAMNPEGRPTFPQLHSCLQ 489
++++M CW P+ R +HS LQ
Sbjct: 253 VYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 86/268 (32%), Positives = 142/268 (52%), Gaps = 26/268 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-------AVQVSLLLQEGMAMYGLSHKN 284
EG FG+V + ++DG+ + +K + + AS A ++ +L + G H N
Sbjct: 5 EGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPN 57
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVD 336
I+ +LG + E +L Y + NL FL+K ++ A TL++Q+++
Sbjct: 58 IINLLG-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
+ G+ YL +K+ +H+DLA RN +V + +I D L+R + +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRL 173
Query: 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456
PV+W+AIESL + ++T SDVW++GVLLWE+ +L PY + E+ L GYRL +P
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233
Query: 457 VNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+NC DE++ +M CW P RP+F Q+
Sbjct: 234 LNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-44
Identities = 80/264 (30%), Positives = 135/264 (51%), Gaps = 15/264 (5%)
Query: 233 GTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVL 289
G FG+V T + +V VK + A + + L+ E M L +H+NI+ +L
Sbjct: 46 GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLL 105
Query: 290 GVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHT-LTTQEVVDMCLQIIMGVQY 347
G P +I Y Y +L FL++ + + LT ++++ Q+ G+ +
Sbjct: 106 GACT--IGGPILVITEYCCYGDLLNFLRRKR-------ESFLTLEDLLSFSYQVAKGMAF 156
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
L K +H+DLA RN ++ ++I D LARD+ + + N PVKW+A ES+
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QDGYRLNQPVNCPDELFSV 466
+ ++ SDVW++G+LLWE+ +L PY + L ++GYR+ QP + P E++ +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDI 276
Query: 467 MAYCWAMNPEGRPTFPQLHSCLQE 490
M CW +P RPTF Q+ + +
Sbjct: 277 MKTCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 85/270 (31%), Positives = 148/270 (54%), Gaps = 15/270 (5%)
Query: 232 EGTFGRVYRGTY----TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EG FG+V+ E+D + V VKT+ D + + +E + L H++I+
Sbjct: 15 EGAFGKVFLAECYNLCPEQDKIL--VAVKTLKDASDNARKDFH-REAELLTNLQHEHIVK 71
Query: 288 VLGVSIEDHTSPF-LIYPYQDYTNLKRFLQ----KCKLCPEGVAHT-LTTQEVVDMCLQI 341
GV +E P +++ Y + +L +FL+ L EG LT +++ + QI
Sbjct: 72 FYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL 401
G+ YL + +H+DLATRNC+V + L ++I D ++RD++ +DY+ +G + P++W+
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 402 AIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461
ES++++ F+T SDVW+ GV+LWE+ T +QP+ ++ E+ + G L +P CP
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPK 249
Query: 462 ELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
E++ +M CW P R ++HS LQ
Sbjct: 250 EVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 7e-43
Identities = 90/287 (31%), Positives = 149/287 (51%), Gaps = 33/287 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEE----------------EVLVKTVTDNASAVQVSLLLQEGM 275
EG FG V+ E +G+E+ V VK + ++A+ + L+E
Sbjct: 15 EGQFGEVH---LCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 276 AMYGLSHKNILTVLGVSIEDHTSPF-LIYPYQDYTNLKRFLQKCKLCPEGV---AHTLTT 331
M L NI+ +L V I P +I Y + +L +FL + + T++
Sbjct: 72 IMSRLKDPNIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLG 391
++ M QI G++YL +H+DLATRNC+V I+I D ++R+L+ DY+ +
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 392 DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQ-QPYAEIDPFEMAASLQDG 450
P++W++ ES++ F+TASDVWAFGV LWE+ TL + QPY+++ ++ + +
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEF 249
Query: 451 YR-------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
+R L +P CPD L+ +M CW N + RP+F ++H+ L E
Sbjct: 250 FRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 9e-43
Identities = 85/259 (32%), Positives = 138/259 (53%), Gaps = 15/259 (5%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+ G Y +V +K++ ++ L E M L H ++ + V
Sbjct: 17 GQFGEVWMGYYNGH----TKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
++ ++I Y + +L FL+ PEG LT +++DM QI G+ ++ +K
Sbjct: 71 TQEPI--YIITEYMENGSLVDFLKT----PEG--IKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS 412
+H+DL N +V + L +I D LAR + ++Y + P+KW A E++ + TF+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFT 181
Query: 413 TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWA 472
SDVW+FG+LL E+ T + PY + E+ +L+ GYR+ +P NCP+EL+ +M CW
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWK 241
Query: 473 MNPEGRPTFPQLHSCLQEF 491
PE RPTF L S L++F
Sbjct: 242 EKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 92/297 (30%), Positives = 154/297 (51%), Gaps = 32/297 (10%)
Query: 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEE--------------EVLVKTVTDNASAVQ 266
R ++RL EG FG V+ E +G+ E V VK + + +
Sbjct: 4 RQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 267 VSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF-LIYPYQDYTNLKRFLQK----CKLC 321
+ L+E M L + NI+ +LGV + D P +I Y + +L +FL +
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSD--DPLCMITEYMENGDLNQFLSQREIESTFT 118
Query: 322 PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381
+++ ++ M +QI G++YL +H+DLATRNC+V + I+I D ++R+
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLA-QQPYAEIDP 440
L+ DY+ + P++W+A ES++ F+TASDVWAFGV LWE+ TL +QPY+ +
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238
Query: 441 FEMAASLQDGYR-------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
++ + + +R L+Q CP +F +M CW+ + + RPTF ++H L+E
Sbjct: 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-42
Identities = 78/268 (29%), Positives = 142/268 (52%), Gaps = 10/268 (3%)
Query: 233 GTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG VY+G + E + V+ V +K + + S +L E M + + ++ +LG+
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 77
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ LI + L ++++ K + +Q +++ C+QI G+ YL ++
Sbjct: 78 CLTSTVQ--LITQLMPFGCLLDYVREHK-------DNIGSQYLLNWCVQIAKGMNYLEER 128
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+L+H+DLA RN +V ++ITD LA+ L + + P+KW+A+ES++H+ +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
+ SDVW++GV +WEL T +PY I E+++ L+ G RL QP C +++ +M CW
Sbjct: 189 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCW 248
Query: 472 AMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
++ + RP F +L + RY+
Sbjct: 249 MIDADSRPKFRELIIEFSKMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 89/283 (31%), Positives = 146/283 (51%), Gaps = 26/283 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-------AVQVSLLLQEGMAMYGLSHKN 284
EG FG+V + ++DG+ + +K + + AS A ++ +L + G H N
Sbjct: 17 EGNFGQVLKAR-IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG------HHPN 69
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKL--------CPEGVAHTLTTQEVVD 336
I+ +LG + E +L Y + NL FL+K ++ A TL++Q+++
Sbjct: 70 IINLLG-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
+ G+ YL +K+ +H+DLA RN +V + +I D L+R + +
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRL 185
Query: 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456
PV+W+AIESL + ++T SDVW++GVLLWE+ +L PY + E+ L GYRL +P
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245
Query: 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
+NC DE++ +M CW P RP+F Q+ L + YV
Sbjct: 246 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 288
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 77/267 (28%), Positives = 141/267 (52%), Gaps = 12/267 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLV--KTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EG FG+V+ ++++LV K + D A + +E + L H++I+
Sbjct: 15 EGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ-REAELLTNLQHEHIVKFY 73
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQK--------CKLCPEGVAHTLTTQEVVDMCLQI 341
GV D +++ Y + +L +FL+ P L +++ + QI
Sbjct: 74 GVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL 401
G+ YL + +H+DLATRNC+V L ++I D ++RD++ +DY+ +G + P++W+
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 192
Query: 402 AIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461
ES++++ F+T SDVW+FGV+LWE+ T +QP+ ++ E+ + G L +P CP
Sbjct: 193 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPK 252
Query: 462 ELFSVMAYCWAMNPEGRPTFPQLHSCL 488
E++ +M CW P+ R +++ L
Sbjct: 253 EVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 83/279 (29%), Positives = 145/279 (51%), Gaps = 13/279 (4%)
Query: 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLV--KTVTDNASAVQVSLLLQEGMAMYGLS 281
VR E FG++Y+G + G++ LV KT+ D + Q QE M L
Sbjct: 7 VRFMEELGECAFGKIYKG-HLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH 65
Query: 282 HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFL--------QKCKLCPEG-VAHTLTTQ 332
H NI+ +LGV ++ L + Y + +L FL C +G V +L
Sbjct: 66 HPNIVCLLGVVTQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
+ + + +QI G++YL +HKDLA RN ++ ++L ++I+D L+R+++ +DY+ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452
P++W+ E++++ FS+ SD+W+FGV+LWE+ + QPY E+ ++
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
L +CP ++S+M CW P RP F +H+ L+ +
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 5e-41
Identities = 81/258 (31%), Positives = 131/258 (50%), Gaps = 11/258 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ G ++ V VK+ + + LQE + SH NI+ ++GV
Sbjct: 5 RGNFGEVFSGRLRADNTP---VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ +++ + FL+ EG L +E++ M G++YL K
Sbjct: 62 CTQKQPI-YIVMELVQGGDFLTFLRT-----EGP--RLKVKELIQMVENAAAGMEYLESK 113
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+H+DLA RNC+V +K ++I+D ++R+ Y G + PVKW A E+L + +
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
S+ SDVW+FG+LLWE +L PYA + + +++ G RL P CPD ++ +M CW
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCW 233
Query: 472 AMNPEGRPTFPQLHSCLQ 489
+P RP+F +H LQ
Sbjct: 234 EYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 5e-41
Identities = 87/273 (31%), Positives = 138/273 (50%), Gaps = 14/273 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R ++L G FG V+ G Y +V VKT+ +VQ L+E M
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNS----TKVAVKTLKPGTMSVQA--FLEEANLMK 56
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H ++ + V + ++I Y +L FL+ EG + +++D
Sbjct: 57 TLQHDKLVRLYAV-VTKEEPIYIITEYMAKGSLLDFLKS----DEG--GKVLLPKLIDFS 109
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
QI G+ Y+ +K +H+DL N +V + L +I D LAR + ++Y + P+
Sbjct: 110 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGAKFPI 168
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E++ +F+ SDVW+FG+LL+E+ T + PY + ++ ++LQ GYR+ + N
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CPDEL+ +M CW E RPTF L S L +F
Sbjct: 229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 1e-40
Identities = 77/262 (29%), Positives = 135/262 (51%), Gaps = 13/262 (4%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+RG E V +KT+ + Q L E M SH NI+ + GV
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGV- 74
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ +I Y + L ++L+ +G ++ ++V M I G++YL
Sbjct: 75 VTKFKPAMIITEYMENGALDKYLRD----HDG---EFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDL--FP-SDYHCLGDNENRPVKWLAIESLVHK 409
+H+DLA RN +V+ L +++D L+R L P Y G P++W A E++ ++
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK--IPIRWTAPEAIAYR 185
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
F++ASDVW+FG+++WE+ + ++PY ++ E+ ++ DG+RL P++CP ++ +M
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQ 245
Query: 470 CWAMNPEGRPTFPQLHSCLQEF 491
CW + RP F + + L +
Sbjct: 246 CWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 79/259 (30%), Positives = 131/259 (50%), Gaps = 19/259 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG V G Y G + V VK + ++A+A L E M L H N++ +LGV
Sbjct: 16 KGEFGDVMLGDYR---GNK--VAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+E+ +++ Y +L +L+ G + L ++ L + ++YL
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRS-VLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+H+DLA RN +V + +++D L ++ + D PVKW A E+L K F
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 176
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
ST SDVW+FG+LLWE+ + + PY I ++ ++ GY+++ P CP ++ VM CW
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236
Query: 472 AMNPEGRPTFPQLHSCLQE 490
++ RP+F QL L+
Sbjct: 237 HLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-40
Identities = 68/221 (30%), Positives = 119/221 (53%), Gaps = 11/221 (4%)
Query: 270 LLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTL 329
++E M LSH+ ++ + GV + +++ Y L +L++
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPI-YIVTEYMSNGCLLNYLREHG-------KRF 97
Query: 330 TTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY-H 388
++++MC + G+ YL K+ +H+DLA RNC+VDD+ ++++D L+R + +Y
Sbjct: 98 QPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ 448
+G PV+W E L++ FS+ SDVWAFGVL+WE+ +L + PY + E +
Sbjct: 158 SVG--SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215
Query: 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489
G RL +P ++++++M CW E RPTF QL S ++
Sbjct: 216 QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 2e-40
Identities = 76/255 (29%), Positives = 135/255 (52%), Gaps = 10/255 (3%)
Query: 233 GTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V++G + E D ++ V +KT+ D + + +AM L H I+ +LG+
Sbjct: 18 GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGI 77
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
S L+ +L +++ + +L Q +++ C+QI G+ YL +
Sbjct: 78 C--PGASLQLVTQLSPLGSLLDHVRQHR-------DSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+++H++LA RN ++ +QI D +A L+P D P+KW+A+ES++ +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
+ SDVW++GV +WE+ + +PYA + P E+ L+ G RL QP C +++ VM CW
Sbjct: 189 THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCW 248
Query: 472 AMNPEGRPTFPQLHS 486
++ RPTF +L +
Sbjct: 249 MIDENVRPTFKELAN 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 6e-40
Identities = 91/283 (32%), Positives = 145/283 (51%), Gaps = 21/283 (7%)
Query: 224 VRLFSVNMEGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS 281
VR E FG+VY+G T + V +KT+ D A E M L
Sbjct: 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ 66
Query: 282 HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG----------VAHTLTT 331
H NI+ +LGV ++ +I+ Y +++L FL P V TL
Sbjct: 67 HPNIVCLLGVVTKEQPLS-MIFSYCSHSDLHEFL--VMRSPHSDVGSTDDDKTVKSTLEP 123
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLG 391
+ V + QI G+++L ++HKDLATRN +V DKL ++I+D L R+++ +DY+ L
Sbjct: 124 ADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLM 183
Query: 392 DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP---YAEIDPFEMAASLQ 448
N P++W++ E++++ FS SD+W++GV+LWE+ + QP Y+ D EM + Q
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243
Query: 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
L P +CP ++++M CW P RP F +HS L+ +
Sbjct: 244 ---VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-40
Identities = 81/258 (31%), Positives = 136/258 (52%), Gaps = 22/258 (8%)
Query: 253 VLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF-LIYPYQDYTNL 311
V VK + +A+ + L+E + L NI+ +LGV +++ P +I Y + +L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE--DPLCMITEYMENGDL 106
Query: 312 KRFLQKCKL-----------CPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360
+FL L P ++ ++ + LQI G++YL +H+DLAT
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLAT 166
Query: 361 RNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAF 420
RNC+V + L I+I D ++R+L+ DY+ + P++W+A E ++ F+TASDVWAF
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226
Query: 421 GVLLWELTTLAQ-QPYAEIDPFEMAASLQDGYR-------LNQPVNCPDELFSVMAYCWA 472
GV LWE+ L + QPY E+ ++ + + +R L +P CP L+ +M CW+
Sbjct: 227 GVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWS 286
Query: 473 MNPEGRPTFPQLHSCLQE 490
+ RP+F +H+ L E
Sbjct: 287 RDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 8e-40
Identities = 70/252 (27%), Positives = 129/252 (51%), Gaps = 15/252 (5%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+ G + E+ +V +KT+ + A + + ++E M LSH ++ + GV
Sbjct: 15 GQFGLVWLGYWLEKR----KVAIKTIREGAMSEED--FIEEAQVMMKLSHPKLVQLYGVC 68
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
E + L++ + ++ L +L+ + + + ++ MCL + G+ YL
Sbjct: 69 TE-RSPICLVFEFMEHGCLSDYLRAQR-------GKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS 412
++H+DLA RNC+V + ++++D + R + D + PVKW + E +S
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 413 TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWA 472
+ SDVW+FGVL+WE+ + + PY E+ ++ G+RL +P ++ +M +CW
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWK 239
Query: 473 MNPEGRPTFPQL 484
PE RP+F L
Sbjct: 240 ERPEDRPSFSLL 251
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-39
Identities = 83/287 (28%), Positives = 144/287 (50%), Gaps = 15/287 (5%)
Query: 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQ 272
L E ++R +V G FG VY+G + E + V+ V +K + + +
Sbjct: 4 LKETELKRVKVL-----GSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD 58
Query: 273 EGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQ 332
E + M + H +++ +LGV + L+ + L ++ + K + +Q
Sbjct: 59 EALIMASMDHPHLVRLLGVCLSPTIQ--LVTQLMPHGCLLDYVHEHK-------DNIGSQ 109
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
+++ C+QI G+ YL +++L+H+DLA RN +V ++ITD LAR L + D
Sbjct: 110 LLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452
P+KW+A+E + ++ F+ SDVW++GV +WEL T +PY I E+ L+ G R
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 229
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
L QP C +++ VM CW ++ + RP F +L + RY+
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-38
Identities = 83/270 (30%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG+V G V+VK + +A+ + L LQE L+H N+L LG
Sbjct: 6 GWFGKVLLGEAHRGMSKAR-VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC 64
Query: 293 IEDHTSPFL-IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
IE + P+L + + +LK +L+ + +A Q M ++ G+ +LH+
Sbjct: 65 IE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR---MACEVASGLLWLHQA 119
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIE------- 404
+H DLA RNC + L ++I D LA + +P DY+ D P++WLA E
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL---QDGYRLNQP---VN 458
L+ K + S++W+ GV +WEL T A QPY ++ ++ + QD +L +P +
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-IKLPKPQLDLK 238
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488
D + VM +CW ++PE RPT ++H L
Sbjct: 239 YSDRWYEVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 82/258 (31%), Positives = 130/258 (50%), Gaps = 21/258 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG V++GT ++ V VKT ++ L E + H NI+ ++GV
Sbjct: 5 KGNFGEVFKGTLKDK----TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 292 SIEDHTSPFLI----YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ P I P D+ + FL+K K L T+++V L G+ Y
Sbjct: 61 CTQRQ--PIYIVMELVPGGDFLS---FLRKKK-------DELKTKQLVKFALDAAAGMAY 108
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
L K +H+DLA RNC+V + ++I+D ++R Y G + P+KW A E+L
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ-IPIKWTAPEALN 167
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
+ +S+ SDVW++G+LLWE +L PY + + ++ GYR++ P CPD+++ VM
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227
Query: 468 AYCWAMNPEGRPTFPQLH 485
CW PE RP F +L
Sbjct: 228 QRCWDYKPENRPKFSELQ 245
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 81/259 (31%), Positives = 134/259 (51%), Gaps = 15/259 (5%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+ TY + +V VKT+ ++ V L E M L H ++ + V
Sbjct: 17 GQFGEVWMATYNKH----TKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
++ ++I + +L FL+ EG L +++D QI G+ ++ ++
Sbjct: 71 TKEPI--YIITEFMAKGSLLDFLKS----DEGSKQPLP--KLIDFSAQIAEGMAFIEQRN 122
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS 412
+H+DL N +V L +I D LAR + ++Y + P+KW A E++ +F+
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFT 181
Query: 413 TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWA 472
SDVW+FG+LL E+ T + PY + E+ +L+ GYR+ +P NCP+EL+++M CW
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWK 241
Query: 473 MNPEGRPTFPQLHSCLQEF 491
PE RPTF + S L +F
Sbjct: 242 NRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 81/260 (31%), Positives = 130/260 (50%), Gaps = 15/260 (5%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ GT+ +V VKT+ + + L+E M L H ++ + V
Sbjct: 16 NGQFGEVWMGTWNGN----TKVAVKTLKPGTMSPES--FLEEAQIMKKLRHDKLVQLYAV 69
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
E+ +++ Y +L FL+ +G L +VDM Q+ G+ Y+ +
Sbjct: 70 VSEEPI--YIVTEYMSKGSLLDFLK------DGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+H+DL + N +V D L +I D LAR L + + P+KW A E+ ++ F
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
+ SDVW+FG+LL EL T + PY ++ E+ ++ GYR+ P +CP L +M CW
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCW 240
Query: 472 AMNPEGRPTFPQLHSCLQEF 491
+PE RPTF L S L+++
Sbjct: 241 KKDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 83/281 (29%), Positives = 138/281 (49%), Gaps = 27/281 (9%)
Query: 232 EGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EG FG+V Y E D E+V VK++ + ++ L +E + L H+NI+ G
Sbjct: 14 EGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKG 73
Query: 291 VSIEDHTSPF-LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
+ ED + LI + +LK +L P + ++ + +QI G+ YL
Sbjct: 74 ICTEDGGNGIKLIMEFLPSGSLKEYL------PRNKNK-INLKQQLKYAVQICKGMDYLG 126
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYHCLGDNENRPVKWLAIESLVH 408
++ +H+DLA RN +V+ + +++I D L + + +Y+ + D+ + PV W A E L+
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF--------------EMAASLQDGYRLN 454
F ASDVW+FGV L+EL T + + F + L++G RL
Sbjct: 187 SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLP 246
Query: 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
+P NCP+E++ +M CW P R TF + ++ F A L
Sbjct: 247 RPPNCPEEVYQLMRKCWEFQPSKRTTF---QNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 78/251 (31%), Positives = 129/251 (51%), Gaps = 13/251 (5%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V +G Y + E+ V VK + DN LL+E M L + I+ ++G+
Sbjct: 6 GNFGTVKKGMYKMKKS-EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI 64
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ S L+ + L +FLQK K +T + + ++ Q+ MG++YL +
Sbjct: 65 C--EAESWMLVMELAELGPLNKFLQKNK--------HVTEKNITELVHQVSMGMKYLEET 114
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD-YHCLGDNENRPVKWLAIESLVHKT 410
+H+DLA RN ++ + +I+D L++ L + Y+ + PVKW A E + +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
FS+ SDVW+FGVL+WE + Q+PY + E+ ++ G R+ P CP E++ +M C
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLC 234
Query: 471 WAMNPEGRPTF 481
W + RP F
Sbjct: 235 WTYGVDERPGF 245
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 11/259 (4%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG + RG E V + T+ S Q L E + + H NI+ + GV
Sbjct: 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGV- 74
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
I + ++ Y L FL+K EG L +++ M + G++YL +
Sbjct: 75 ITRGNTMMIVTEYMSNGALDSFLRK----HEG---QLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 353 LLHKDLATRNCVVDDKLRIQITD-NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+HK LA +V+ L +I+ L D + Y + PV W A E++ + F
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKS--PVLWAAPEAIQYHHF 185
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
S+ASDVW+FG+++WE+ + ++PY ++ ++ +++DG+RL P NCP+ L +M CW
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCW 245
Query: 472 AMNPEGRPTFPQLHSCLQE 490
RP F Q+HS L +
Sbjct: 246 QKERGERPRFSQIHSILSK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 2e-36
Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R +RL +G FG V+ GT+ V +KT+ + + LQE M
Sbjct: 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMSPEA--FLQEAQVMK 56
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H+ ++ + V E+ +++ Y +L FL+ + L ++VDM
Sbjct: 57 KLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKG------EMGKYLRLPQLVDMA 108
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
QI G+ Y+ + +H+DL N +V + L ++ D LAR L + + P+
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPI 167
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E+ ++ F+ SDVW+FG+LL ELTT + PY + E+ ++ GYR+ P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 227
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP+ L +M CW PE RPTF L + L+++
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 3e-35
Identities = 84/273 (30%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R +RL +G FG V+ GT+ +V +KT+ + LQE M
Sbjct: 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT----TKVAIKTLKPGTMMPEA--FLQEAQIMK 56
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H ++ + V E+ +++ + +L FL+ EG L ++VDM
Sbjct: 57 KLRHDKLVPLYAVVSEEPI--YIVTEFMGKGSLLDFLK------EGDGKYLKLPQLVDMA 108
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
QI G+ Y+ + +H+DL N +V D L +I D LAR L + + P+
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFPI 167
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E+ ++ F+ SDVW+FG+LL EL T + PY + E+ ++ GYR+ P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQG 227
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP+ L +M CW +P+ RPTF + S L+++
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 64/159 (40%), Positives = 98/159 (61%), Gaps = 5/159 (3%)
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS-DY 387
LT ++++ Q+ G+++L +K +H+DLA RN ++ + ++I D LARD++ DY
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229
Query: 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY--AEIDPFEMAA 445
GD P+KW+A ES+ K ++T SDVW+FGVLLWE+ +L PY +ID E
Sbjct: 230 VRKGD-ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCR 287
Query: 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L++G R+ P E++S+M CW NPE RPTF +L
Sbjct: 288 RLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 90/279 (32%), Positives = 131/279 (46%), Gaps = 28/279 (10%)
Query: 232 EGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EG FG+V Y DG E V VKT+ S +E + L H+NI+ G
Sbjct: 14 EGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKG 73
Query: 291 VSIED-HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
E LI Y +L+ +L K H L +++ QI G+ YLH
Sbjct: 74 CCSEQGGKGLQLIMEYVPLGSLRDYLPK---------HKLNLAQLLLFAQQICEGMAYLH 124
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS--DYHCLGDNENRPVKWLAIESLV 407
+ +H+DLA RN ++D+ ++I D LA+ + P +Y+ + ++ + PV W A+E L
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 408 HKTFSTASDVWAFGVLLWELTTL---AQQPYA-----------EIDPFEMAASLQDGYRL 453
FS ASDVW+FGV L+EL T Q P ++ + L+ G RL
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
P NCP E++ +M CW + RPTF L L+E H
Sbjct: 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 72/261 (27%), Positives = 134/261 (51%), Gaps = 11/261 (4%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V +G Y + +V +K + + +++E M+ L + I+ ++GV
Sbjct: 6 GNFGCVKKGVYKMRKK-QIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC 64
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ + L+ L +FL G +T VV++ Q+ MG++YL K
Sbjct: 65 --EAEALMLVMEMASGGPLNKFLS-------GKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSD-YHCLGDNENRPVKWLAIESLVHKTF 411
+H+DLA RN ++ ++ +I+D L++ L D Y+ P+KW A E + + F
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
S+ SDVW++G+ +WE + Q+PY ++ E+ + ++ G RL+ P CP E++++M CW
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCW 235
Query: 472 AMNPEGRPTFPQLHSCLQEFH 492
E RP F ++ ++ ++
Sbjct: 236 IYKWEDRPNFAKVEERMRTYY 256
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-34
Identities = 85/272 (31%), Positives = 138/272 (50%), Gaps = 28/272 (10%)
Query: 232 EGTFGRVYRGTYTE-EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G FG V Y +D E V VK + +++A + +E + L H NI+ G
Sbjct: 14 KGNFGSVELCRYDPLQDNTGEVVAVKKL-QHSTAEHLRDFEREIEILKSLQHDNIVKYKG 72
Query: 291 VSIE-DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
V + L+ Y Y +L+ +LQK + L ++++ QI G++YL
Sbjct: 73 VCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-------ERLDHRKLLLYASQICKGMEYLG 125
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD--YHCLGDNENRPVKWLAIESLV 407
K+ +H+DLATRN +V+ + R++I D L + + P D Y+ + + P+ W A ESL
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTK-VLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQ---PYAE----IDP--------FEMAASLQDGYR 452
FS ASDVW+FGV+L+EL T + + P AE + + + L++ R
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L P CP E++++M CW +P RP+F +L
Sbjct: 245 LPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-34
Identities = 70/252 (27%), Positives = 125/252 (49%), Gaps = 15/252 (5%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+ G + + +V +K + N A+ ++E M LSH ++ + GV
Sbjct: 15 GQFGVVHLGKWR----AQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ +++ + + L +L++ + L+ ++ MC + G++YL +
Sbjct: 69 TQ-QKPLYIVTEFMENGCLLNYLRQRQ-------GKLSKDMLLSMCQDVCEGMEYLERNS 120
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS 412
+H+DLA RNC+V ++++D + R + +Y PVKW E +S
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYS 179
Query: 413 TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWA 472
+ SDVW+FGVL+WE+ T + P+ + +E+ + G+RL +P ++ VM CW
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239
Query: 473 MNPEGRPTFPQL 484
PEGRPTF +L
Sbjct: 240 EKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 1e-33
Identities = 82/274 (29%), Positives = 139/274 (50%), Gaps = 15/274 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I +++ V G FG V G E V +KT+ + Q L E M
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIY-PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
H NI+ + GV + + P +I Y + +L FL+K +G T ++V M
Sbjct: 61 QFDHPNIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRK----HDG---QFTVIQLVGM 111
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR---DLFPSDYHCLGDNE 394
I G++YL +H+DLA RN +V+ L +++D L+R D + Y G
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK- 170
Query: 395 NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454
P++W A E++ ++ F++ASDVW++G+++WE+ + ++PY E+ ++ ++++GYRL
Sbjct: 171 -IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229
Query: 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488
P++CP L +M CW + RP F Q+ S L
Sbjct: 230 APMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 48/257 (18%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG FG VY + ++V +K + S+ + LL+E + L+H NI+ + GV
Sbjct: 3 EGGFGTVYLARDKKTG---KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
ED +L+ Y + +LK L++ + L+ E++ + LQI+ G++YLH
Sbjct: 60 F-EDENHLYLVMEYCEGGSLKDLLKENE-------GKLSEDEILRILLQILEGLEYLHSN 111
Query: 352 KLLHKDLATRNCVVD-DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
++H+DL N ++D D ++++ D L++ L ++A E L+ K
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKG 169
Query: 411 -FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
+S SD+W+ GV+L+EL EL ++
Sbjct: 170 YYSEKSDIWSLGVILYEL---------------------------------PELKDLIRK 196
Query: 470 CWAMNPEGRPTFPQLHS 486
+PE RP+ ++
Sbjct: 197 MLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 79/273 (28%), Positives = 137/273 (50%), Gaps = 15/273 (5%)
Query: 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHK 283
V++ V G FG V RG E V +KT+ + Q L E M H
Sbjct: 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 284 NILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIM 343
NI+ + GV + +I + + L FL++ +G T ++V M I
Sbjct: 66 NIIHLEGV-VTKSRPVMIITEFMENGALDSFLRQ----NDG---QFTVIQLVGMLRGIAA 117
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF-----PSDYHCLGDNENRPV 398
G++YL + +H+DLA RN +V+ L +++D L+R L P+ LG P+
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK--IPI 175
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
+W A E++ ++ F++ASDVW++G+++WE+ + ++PY ++ ++ +++ YRL P++
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD 235
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP L +M CW + RP F Q+ S L +
Sbjct: 236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 60/325 (18%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA 276
R R+RL V G FG+V + ++ V VK + + A+A + L+ E
Sbjct: 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI 63
Query: 277 MYGL-SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFL-------------------- 315
+ + +H N++ +LG + + +I + Y NL FL
Sbjct: 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGR 123
Query: 316 --------QKCKLCPEGVAHTLTT-------------QEVVDMCL-------------QI 341
+ + G A L + QE D+ Q+
Sbjct: 124 FRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQV 183
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL 401
G+++L +K +H+DLA RN ++ + ++I D LARD++ + + P+KW+
Sbjct: 184 ARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243
Query: 402 AIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY--AEIDPFEMAASLQDGYRLNQPVNC 459
A ES+ K ++T SDVW+FGVLLWE+ +L PY +I+ E L+DG R+ P N
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGTRMRAPENA 302
Query: 460 PDELFSVMAYCWAMNPEGRPTFPQL 484
E++ +M CW +P+ RPTF L
Sbjct: 303 TPEIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 77/266 (28%), Positives = 127/266 (47%), Gaps = 20/266 (7%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG+V G +V+VK + +AS + L+E L H N+L LG
Sbjct: 6 GWFGKVILGE-VNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC 64
Query: 293 IEDHTSPFL-IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
E +P+L + + +LK +L+ C+ T Q M +I +G+ +LHK
Sbjct: 65 TE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR---MACEIALGLLHLHKN 119
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESL--VHK 409
+H DLA RNC++ L ++I D L+ + + DY+ D P++W+A E + VH
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 410 TF-----STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL--QDGYRLNQP---VNC 459
+ S+VW+ GV +WEL L QPY + ++ + +L +P +
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL 239
Query: 460 PDELFSVMAYCWAMNPEGRPTFPQLH 485
D + VM +CW + PE RP+ ++H
Sbjct: 240 SDRWYEVMQFCW-LQPEQRPSAEEVH 264
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 23/258 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG+FG+VY + + V +K + +L+E + L H NI+ + V
Sbjct: 9 EGSFGKVYLARDKKTG---KLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
ED +L+ Y + +L L+K L+ E QI+ ++YLH K
Sbjct: 66 -FEDEDKLYLVMEYCEGGDLFDLLKKRG--------RLSEDEARFYLRQILSALEYLHSK 116
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD--YHCLGDNENRPVKWLAIESLVHK 409
++H+DL N ++D+ +++ D LAR L P + +G +++A E L+ K
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVG-----TPEYMAPEVLLGK 171
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPY-AEIDPFEMAASLQDGYR--LNQPVNCPDELFSV 466
+ A D+W+ GV+L+EL T + P+ + E+ + + E +
Sbjct: 172 GYGKAVDIWSLGVILYELLTG-KPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 467 MAYCWAMNPEGRPTFPQL 484
+ +PE R T +
Sbjct: 231 IRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-31
Identities = 56/164 (34%), Positives = 94/164 (57%), Gaps = 1/164 (0%)
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388
L+ ++V Q+ G+++L K +H+DLA RN ++ + ++I D LARD+ +
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY 295
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-L 447
+ P+KW+A ES+ + ++T SDVW+FG+LLWE+ TL PY E+ E + +
Sbjct: 296 ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI 355
Query: 448 QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+ GYR+ +P + DE++ +M CW E RP F QL + +
Sbjct: 356 KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 58/159 (36%), Positives = 93/159 (58%), Gaps = 5/159 (3%)
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS-DY 387
LT ++++ Q+ G+++L +K +H+DLA RN ++ + ++I D LARD++ DY
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY--AEIDPFEMAA 445
GD P+KW+A E++ + ++ SDVW+FGVLLWE+ +L PY +ID E
Sbjct: 236 VRKGD-ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCR 293
Query: 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L++G R+ P E++ M CW P RPTF +L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 54/156 (34%), Positives = 90/156 (57%), Gaps = 7/156 (4%)
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
Q+ G+ +L K +H+D+A RN ++ D +I D LARD+ + + N PV
Sbjct: 219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI----DPFEMAASLQDGYRLN 454
KW+A ES+ ++ SDVW++G+LLWE+ +L + PY I ++M ++ GY+++
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM---VKRGYQMS 335
Query: 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
+P P E++S+M CW + P RPTF Q+ +Q
Sbjct: 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 60/263 (22%), Positives = 111/263 (42%), Gaps = 27/263 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G+FG VY+ G + V VK + + + + +E + LSH NI+ ++
Sbjct: 9 SGSFGTVYKAK---HKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
ED +L+ Y + +L +L + L+ E + LQI+ G++YLH
Sbjct: 66 A-FEDKDHLYLVMEYCEGGDLFDYLSRGG--------PLSEDEAKKIALQILRGLEYLHS 116
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC---LGDNENRPVKWLAIESLV 407
++H+DL N ++D+ ++I D LA+ L S +G + L L
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL----LG 172
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP------FEMAASLQDGYRLNQPVNCPD 461
+ DVW+ GV+L+EL T + P++ + + + + +
Sbjct: 173 GNGYGPKVDVWSLGVILYELLT-GKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSE 231
Query: 462 ELFSVMAYCWAMNPEGRPTFPQL 484
E ++ C +P RPT ++
Sbjct: 232 EAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 54/159 (33%), Positives = 90/159 (56%), Gaps = 3/159 (1%)
Query: 328 TLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387
L T++++ Q+ G+ +L K +H+DLA RN ++ +I D LARD+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269
Query: 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE--MAA 445
+ + N PVKW+A ES+ + ++ SDVW++G+LLWE+ +L PY + P +
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSKFYK 328
Query: 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+++GYR+ P P E++ +M CW +P RPTF Q+
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-28
Identities = 55/161 (34%), Positives = 90/161 (55%), Gaps = 9/161 (5%)
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388
LTT +++ Q+ G+++L K +H+DLA RN ++ ++I D LARD+ +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-- 446
+ PVKW+A ES+ ++T SDVW++G+LLWE+ +L PY P + S
Sbjct: 294 VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY----PGMIVDSTF 349
Query: 447 ---LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
++ GYR+ +P + E++ +M CW PE RP+F L
Sbjct: 350 YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHL 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 84/275 (30%), Positives = 131/275 (47%), Gaps = 33/275 (12%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG+V + GV V+VK + NAS+ + + LQ+G L H NIL LG
Sbjct: 6 GWFGKVLLSEIYTDTGVAR-VVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQC 64
Query: 293 IEDHTSPFL-IYPYQDYTNLKRFLQKCKLCPE----GVAHTLTTQEVVDMCLQIIMGVQY 347
+E P+L ++ Y + +LK +L E + L Q M +I GV +
Sbjct: 65 VE--AIPYLLVFEYCELGDLKSYL-----SQEQWHRRNSQLLLLQR---MACEIAAGVTH 114
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIE--- 404
+HK LH DLA RNC + L +++ D + + DY D++ P++WLA E
Sbjct: 115 MHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 405 ----SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGY------RL 453
L+ + S+VWA GV LWEL A QPY+ + E + ++D +L
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488
P + + + V+ +CW ++PE R T ++H L
Sbjct: 235 ELPYS--ERWYEVLQFCW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 62/263 (23%), Positives = 111/263 (42%), Gaps = 28/263 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G+FG VY + G E + VK+V S ++ L +E + L H NI+ G
Sbjct: 10 RGSFGSVYLALDKD-TG--ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 291 VSIEDHTSPFLIYPYQDYT---NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
++ + I+ +Y +L L+K PE V T Q I+ G+ Y
Sbjct: 67 SERDEEKNTLNIF--LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------ILEGLAY 116
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----WLAI 403
LH ++H+D+ N +VD +++ D A+ L + V+ W+A
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG----EGTGSVRGTPYWMAP 172
Query: 404 ESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF--EMAASLQDGYRLNQPVNCPD 461
E + + + A+D+W+ G + E+ T + P++E+ + G P + +
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE 231
Query: 462 ELFSVMAYCWAMNPEGRPTFPQL 484
E + C +P+ RPT +L
Sbjct: 232 EAKDFLRKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|128745 smart00469, WIF, Wnt-inhibitory factor-1 like domain | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 5e-23
Identities = 35/79 (44%), Positives = 56/79 (70%), Gaps = 1/79 (1%)
Query: 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS 79
+PYS++V S +K+ L P +NIS +G++P ++Q F + L C+G +AEV V + + V+L
Sbjct: 59 VPYSLNVRSDDKEVLPRPIVNISLLGTVPHTLQVFQVELKCSGKRDAEVEVTVIVEVSLG 118
Query: 80 RNSNNVTSLNFKRKKICLR 98
++ N T LNF+RKKICL+
Sbjct: 119 -STKNPTPLNFRRKKICLQ 136
|
Occurs as extracellular domain in metazoan Ryk receptor tyrosine kinases. C. elegans Ryk is required for cell-cuticle recognition. WIF-1 binds to Wnt and inhibits its activity. Length = 136 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 61/258 (23%), Positives = 110/258 (42%), Gaps = 24/258 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG VY+ + +EV +K + + + ++ E + H NI+ G
Sbjct: 10 KGGFGEVYKARHKRTG---KEVAIKVIKLESKEKK-EKIINEIQILKKCKHPNIVKYYG- 64
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
S +++ + +LK L+ TLT ++ +C +++ G++YLH
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTN-------QTLTESQIAYVCKELLKGLEYLHSN 117
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV---KWLAIESLVH 408
++H+D+ N ++ +++ D L+ L SD N V W+A E +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SD----TKARNTMVGTPYWMAPEVING 171
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE--MAASLQDGYRLNQPVNCPDELFSV 466
K + +D+W+ G+ EL + PY+E+ P + + L P DE
Sbjct: 172 KPYDYKADIWSLGITAIELAEG-KPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDF 230
Query: 467 MAYCWAMNPEGRPTFPQL 484
+ C NPE RPT QL
Sbjct: 231 LKKCLQKNPEKRPTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|216849 pfam02019, WIF, WIF domain | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 4e-20
Identities = 34/78 (43%), Positives = 46/78 (58%), Gaps = 2/78 (2%)
Query: 20 LPYSISVE-STNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTL 78
PYS V S++ + L P LNIS G +P FS++LPC+G + E + +++ VT
Sbjct: 56 YPYSFDVLVSSDPEILKAPTLNISHSGEVPREASVFSVDLPCSGNRSGEAVFTVNLEVTN 115
Query: 79 SRNSNNVTSLNFKRKKIC 96
SR N T L FKRKKIC
Sbjct: 116 SRGKNG-TPLRFKRKKIC 132
|
The WIF domain is found in the RYK tyrosine kinase receptors and WIF, the Wnt-inhibitory- factor. The domain is extracellular and contains two conserved cysteines that may form a disulphide bridge. This domain is Wnt binding in WIF, and it has been suggested that RYK may also bind to Wnt. The WIF domain is a member of the immunoglobulin superfamily, and it comprises nine beta-strands and two alpha-helices, with two of the beta-strands (6 and 9) interrupted by four and six residues of irregular secondary structure, respectively. Considering that the activity of Wnts depends on the presence of a palmitoylated cysteine residue in their amino-terminal polypeptide segment, Wnt proteins are lipid-modified and can act as stem cell growth factors, it is likely that the WIF domain recognises and binds to Wnts that have been activated by palmitoylation and that the recognition of palmitoylated Wnts by WIF-1 is effected by its WIF domain rather than by its EGF domains. A strong binding affinity for palmitoylated cysteine residues would further explain the remarkably high affinity of human WIF-1 not only for mammalian Wnts, but also for Wnts from Xenopus and Drosophila. Length = 132 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 65/274 (23%), Positives = 116/274 (42%), Gaps = 45/274 (16%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVL-VKTVTDNASAVQ--------VSLLLQEGMAMYGLSHK 283
G+FG VY G + E++ VK V + + + L +E + L H+
Sbjct: 11 GSFGSVYLGM----NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 284 NILTVLGVSI-EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQE-------VV 335
NI+ LG S+ DH + FL Y P G L V
Sbjct: 67 NIVQYLGSSLDADHLNIFLEY-----------------VPGGSVAALLNNYGAFEETLVR 109
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
+ QI+ G+ YLH + ++H+D+ N +VD+K I+I+D +++ L ++ N
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGA 168
Query: 396 RP-----VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450
RP V W+A E + +++ +D+W+ G L+ E+ T + P+ + + + +
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGEN 227
Query: 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
P N E + + ++ RPT +L
Sbjct: 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 58/265 (21%), Positives = 121/265 (45%), Gaps = 42/265 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G+FG+VY DG + ++K + N S + L E + L+H NI+
Sbjct: 10 KGSFGKVYLVRRKS-DG--KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
S E+ ++ Y D +L + ++K K ++++D +Q+ + ++YLH
Sbjct: 67 -SFEEKGKLCIVMEYADGGDLSQKIKKQKKE----GKPFPEEQILDWFVQLCLALKYLHS 121
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK--------WLA 402
+K+LH+D+ +N + +++ D +++ L + + +L+
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVL----------SSTVDLAKTVVGTPYYLS 171
Query: 403 IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD-GYRLNQ----PV 457
E +K ++ SD+W+ G +L+EL TL + PFE +L + ++ + P+
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTL--KH-----PFE-GENLLELALKILKGQYPPI 223
Query: 458 NC--PDELFSVMAYCWAMNPEGRPT 480
EL ++++ +PE RP+
Sbjct: 224 PSQYSSELRNLVSSLLQKDPEERPS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 63/269 (23%), Positives = 117/269 (43%), Gaps = 37/269 (13%)
Query: 233 GTFGRVYRGTYTEED-------GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG-LSHKN 284
GTF +Y+G + G E V++K S + SL E ++ LSHK+
Sbjct: 6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLK---VLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344
++ + GV + D ++ Y + L FL + K + +D+ Q+
Sbjct: 63 LVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNV-------SLHWKLDVAKQLASA 113
Query: 345 VQYLHKKKLLHKDLATRNCVV-------DDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
+ YL KKL+H ++ +N +V I+++D + + +
Sbjct: 114 LHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------R 167
Query: 398 VKWLAIESL--VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455
+ W+A E + + + A+D W+FG L E+ + ++P + + E QD +RL
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM 227
Query: 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
P +C EL +++ CW +P RP+F +
Sbjct: 228 P-DCA-ELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 75.5 bits (184), Expect = 1e-14
Identities = 58/239 (24%), Positives = 105/239 (43%), Gaps = 19/239 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH-KNILTVLG 290
EG+FG VY + V +VL K + + V+ L+E + L+H NI+ +
Sbjct: 10 EGSFGEVYLARDRKL--VALKVLAKKLESKSKEVE--RFLREIQILASLNHPPNIVKLYD 65
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+D S +L+ Y D +L+ L+K G L+ E + + QI+ ++YLH
Sbjct: 66 F-FQDEGSLYLVMEYVDGGSLEDLLKKI-----GRKGPLSESEALFILAQILSALEYLHS 119
Query: 351 KKLLHKDLATRNCVVDDKL-RIQITDNALARDLFPSDYHCLGDNENRPV----KWLAIES 405
K ++H+D+ N ++D +++ D LA+ L ++A E
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 406 LVHKTF---STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461
L+ + S++SD+W+ G+ L+EL T E + + +L+ L P
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
|
Length = 384 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 30/227 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNA-SAVQVSLLLQEGMAMYGLSHKNILTVL 289
EGT+G VYR T E V +K V DN + +S L +E + L H NI+ +
Sbjct: 17 EGTYGIVYRARDTTSG---EIVALKKVRMDNERDGIPISSL-REITLLLNLRHPNIVELK 72
Query: 290 GVSIEDH-TSPFLIYPY--QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
V + H S FL+ Y QD +L + + + +V + LQ++ G+Q
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLL----------DNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL-AIES 405
YLH+ ++H+DL N ++ DK ++I D LAR W A E
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLAR---TYGLPAKPMTPKVVTLWYRAPEL 179
Query: 406 LV-HKTFSTASDVWAFGVLLWELTTLAQQPY----AEIDPFEMAASL 447
L+ T++TA D+WA G +L EL LA +P +EI+ ++ L
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAEL--LAHKPLLPGKSEIEQLDLIIQL 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEV--LVKTVTDNA------SAVQVSLLLQEGMAMYGLSHK 283
EGT+G+VY+ + E+ L K +N +A++ LLQ+ L H
Sbjct: 9 EGTYGQVYKA----RNKKTGELVALKKIRMENEKEGFPITAIREIKLLQK------LRHP 58
Query: 284 NILTVLGVSIEDHT-SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQII 342
NI+ + + S ++++ Y D+ +L L PE T ++ Q++
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL----DSPE---VKFTESQIKCYMKQLL 110
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK-WL 401
G+QYLH +LH+D+ N ++++ +++ D LAR P D NR + W
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR---PYTKRNSADYTNRVITLWY 167
Query: 402 -AIESLVHKT-FSTASDVWAFGVLLWEL 427
E L+ T + D+W+ G +L EL
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFL--QKCKLCPEGVAHTLTTQEVVDM 337
L H NI+ D + + Y + L + QK +L E + V+
Sbjct: 56 LQHPNIIAYYN-HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE--------EMVLWY 106
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH----CLGDN 393
QI+ V Y+HK +LH+D+ T N + I++ D +++ L S+Y +G
Sbjct: 107 LFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-GSEYSMAETVVGT- 164
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
P +++ E ++ SD+WA G +L+EL TL ++ + +P + + G
Sbjct: 165 ---PY-YMSPELCQGVKYNFKSDIWALGCVLYELLTL-KRTFDATNPLNLVVKIVQGNYT 219
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
EL S++ +PE RPT ++
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 9e-14
Identities = 60/265 (22%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 232 EGTFGRVYRGTYTEE-DGVE---EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
+GTF ++++G E D E EVL+K V D + + M LSHK+++
Sbjct: 5 QGTFTKIFKGIRREVGDYGELHKTEVLLK-VLDKSHRNYSESFFEAASMMSQLSHKHLVL 63
Query: 288 VLGVSI--EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
GV + ++ ++ Y + +L +L+K K + + +++ Q+ +
Sbjct: 64 NYGVCVCGDESI---MVQEYVKFGSLDTYLKKNK-------NLINISWKLEVAKQLAWAL 113
Query: 346 QYLHKKKLLHKDLATRNCVV----DDKLR----IQITDNALARDLFPSDYHCLGDNENRP 397
+L K L H ++ +N ++ D K I+++D ++ + P + L +
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLER---- 167
Query: 398 VKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456
+ W+ E + + + S A+D W+FG LWE+ + +P + +D + +D R P
Sbjct: 168 IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQLP 225
Query: 457 VNCPDELFSVMAYCWAMNPEGRPTF 481
EL +++ C P+ RP+F
Sbjct: 226 APKWTELANLINQCMDYEPDFRPSF 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 63/255 (24%), Positives = 123/255 (48%), Gaps = 20/255 (7%)
Query: 232 EGTFGRVY-----RGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNIL 286
+G+FG VY + E V +E+ V + N + VQ + QE + L H I+
Sbjct: 10 KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNET-VQAN---QEAQLLSKLDHPAIV 65
Query: 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
S + + +I Y + +L L++ K + TL+ +V + +Q+++GV
Sbjct: 66 K-FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK----TLSENQVCEWFIQLLLGVH 120
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC-LGDNENRPVKWLAIES 405
Y+H++++LH+DL +N + + L ++I D ++R L S C L +++ E+
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS---CDLATTFTGTPYYMSPEA 176
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465
L H+ + + SD+W+ G +L+E+ LA + + + + +G + P +L S
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHA-FEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235
Query: 466 VMAYCWAMNPEGRPT 480
+M +P RP+
Sbjct: 236 IMQSMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 48/271 (17%)
Query: 233 GTFGRVYRGTYTEEDG----VEEEVLVKTVTDNASAVQVSLLLQEGMAMYG-LSHKNILT 287
G+FG VY G +DG V+E V D + + L++ +A+ L H NI+
Sbjct: 11 GSFGSVYEG-LNLDDGDFFAVKE---VSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 288 VLGVSIEDHTSPFLIYPYQDYTN---LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344
LG E+ +Y + + L + L+K PE V T Q I++G
Sbjct: 67 YLGTEREEDN----LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--------ILLG 114
Query: 345 VQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----W 400
++YLH + +H+D+ N +VD +++ D +A+ + + + K W
Sbjct: 115 LEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYW 167
Query: 401 LAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459
+A E + + + A+D+W+ G + E+ T + P+++++ AA + G P
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGV--AAVFKIGRSKELPP-I 223
Query: 460 PDEL------FSVMAYCWAMNPEGRPTFPQL 484
PD L F + C +P RPT +L
Sbjct: 224 PDHLSDEAKDF--ILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 68/267 (25%), Positives = 121/267 (45%), Gaps = 35/267 (13%)
Query: 233 GTFGRVYRG---TYTEEDGVEEEVLVKTVTDNASAVQ---VSLLLQEGMAMYGLSHKNIL 286
GT+GRVY T E V++ L T+ + Q V L E + L H NI+
Sbjct: 12 GTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIV 71
Query: 287 TVLGV-SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
LG + E++ S FL Y ++ L+ E + T Q ++ G+
Sbjct: 72 QYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEGL 121
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR---DLFPSDYHCLGDNENRPVKWLA 402
YLH K +LH+DL N +VD +I+D +++ D++ +D + + V W+A
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---MSMQGSVFWMA 178
Query: 403 IE--SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460
E + +S D+W+ G ++ E+ ++P+++ + AA + G + + P P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRPWSDEEAI--AAMFKLGNKRSAPPIPP 235
Query: 461 DELFSV-------MAYCWAMNPEGRPT 480
D ++ + C+ +NP+ RPT
Sbjct: 236 DVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 67/256 (26%), Positives = 116/256 (45%), Gaps = 21/256 (8%)
Query: 238 VYRGTYTEEDGV------EEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
V +G+Y E V ++ V+ K NAS + QE + L H NI+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFL--QKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
+ +++ + + +L L QK KL PE +VV+ +QI M +QYLH
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE--------NQVVEWFVQIAMALQYLH 119
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC-LGDNENRPVKWLAIESLVH 408
+K +LH+DL T+N + I++ D +AR L + C + +++ E +
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL---ENQCDMASTLIGTPYYMSPELFSN 176
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMA 468
K ++ SDVWA G ++E+ TL + + D + + +G P + EL ++A
Sbjct: 177 KPYNYKSDVWALGCCVYEMATL-KHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235
Query: 469 YCWAMNPEGRPTFPQL 484
+ PE RP+ +
Sbjct: 236 TMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 71/262 (27%), Positives = 119/262 (45%), Gaps = 34/262 (12%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG VY+G E V +K + + + ++QE + L H NI+ +G
Sbjct: 11 GAFGVVYKGLNLETGDF---VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG- 66
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
SIE S ++I Y + +L++ ++K PE V Q++ G+ YLH++
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIKKFGPFPE--------SLVAVYVYQVLQGLAYLHEQ 118
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV---KWLAIESLVH 408
++H+D+ N + +++ D +A L +D ++ V W+A E +
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVS---KDDASVVGTPYWMAPEVIEM 173
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ------PVNCPDE 462
STASD+W+ G + EL T PY +++P MAA +R+ Q P E
Sbjct: 174 SGASTASDIWSLGCTVIELLT-GNPPYYDLNP--MAAL----FRIVQDDHPPLPEGISPE 226
Query: 463 LFSVMAYCWAMNPEGRPTFPQL 484
L + C+ +P RPT QL
Sbjct: 227 LKDFLMQCFQKDPNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 1e-12
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 52/218 (23%)
Query: 232 EGTFGRVYRGT---------------YTEEDGVEEEVLVKTVTDNASAV-QVSLLLQEGM 275
EGT+G VY+ EE+G+ ++A+ ++SLL +
Sbjct: 9 EGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI-----------PSTALREISLLKE--- 54
Query: 276 AMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVV 335
L H NI+ +L V I +L++ Y D +LK++L K L+ +
Sbjct: 55 ----LKHPNIVKLLDV-IHTERKLYLVFEYCDM-DLKKYLDKRPG-------PLSPNLIK 101
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
+ Q++ G+ Y H ++LH+DL +N +++ +++ D LAR F
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLRTYTHE-- 158
Query: 396 RPVKWL---AIESLV-HKTFSTASDVWAFGVLLWELTT 429
V L A E L+ K +STA D+W+ G + E+ T
Sbjct: 159 --VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 64/257 (24%), Positives = 104/257 (40%), Gaps = 66/257 (25%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLV-KTVTDNASAVQV---SLLLQEGMAMYGLSHKNILTV 288
G+FG+V LV K T A++V +++ + L+ +NIL+
Sbjct: 4 GSFGKVL--------------LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSR 49
Query: 289 LGVSIEDHTSPF---LIYPYQDYTN------------LKRFLQKCKLCPEGVAHTLTTQE 333
+ +H PF L Y +Q L L K E A +
Sbjct: 50 I-----NH--PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAE- 101
Query: 334 VVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC---L 390
I++ ++YLH ++++DL N ++D I++TD LA++L
Sbjct: 102 -------IVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154
Query: 391 GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450
G E +LA E L+ K + A D W+ GVLL+E+ L +P PF A ++
Sbjct: 155 GTPE-----YLAPEVLLGKGYGKAVDWWSLGVLLYEM--LTGKP-----PFY-AEDRKEI 201
Query: 451 YR--LNQPVNCPDELFS 465
Y L P+ P+ L
Sbjct: 202 YEKILKDPLRFPEFLSP 218
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 50/229 (21%), Positives = 91/229 (39%), Gaps = 53/229 (23%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV---SLLLQEGMAMYGLSHKNILTV 288
EG+F V + T+ A+++ L++E Y K +LT
Sbjct: 11 EGSFSTVVLAK-------------EKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR 57
Query: 289 LGVSIEDHTSPF---LIYPYQDYTNLKRFLQKCKLCPEG-VAHTLTTQEVVDM------C 338
L + P L Y +QD NL L+ P G + + +D
Sbjct: 58 L------NGHPGIIKLYYTFQDEENLYFVLE---YAPNGELLQYIRKYGSLDEKCTRFYA 108
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL--------FPSDYHCL 390
+I++ ++YLH K ++H+DL N ++D + I+ITD A+ L D +
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 391 GDNENRPVK----------WLAIESLVHKTFSTASDVWAFGVLLWELTT 429
+ + +++ E L K +SD+WA G +++++ T
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (162), Expect = 6e-12
Identities = 73/300 (24%), Positives = 124/300 (41%), Gaps = 71/300 (23%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290
+GTFG VY E + V +K + + + + L+E ++ L H NI+ +
Sbjct: 9 DGTFGSVYLARNKETGEL---VAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFL--QKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
V E+ + ++ Y + NL + + +K K E V + + QI+ G+ ++
Sbjct: 66 VFRENDEL-YFVFEYMEG-NLYQLMKDRKGKPFSESV--------IRSIIYQILQGLAHI 115
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV-------KWL 401
HK H+DL N +V ++I D LAR++ +RP +W
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI-----------RSRPPYTDYVSTRWY 164
Query: 402 -AIESLVHKTF-STASDVWAFGVLLWELTTLAQQPY----AEID-----------P---- 440
A E L+ T S+ D+WA G ++ EL TL +P +EID P
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTL--RPLFPGSSEIDQLYKICSVLGTPTKQD 222
Query: 441 ----FEMAASLQ------DGYRLNQPV-NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489
+++A+ L L+Q + N E ++ +P+ RPT Q LQ
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ---ALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 7e-12
Identities = 53/260 (20%), Positives = 102/260 (39%), Gaps = 28/260 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVK--TVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EG G VY+ T +EV +K + L++ E + M H NI+
Sbjct: 29 EGASGEVYKATDR---ATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYY 81
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
S +++ Y D +L + + + + ++ +C +++ G++YLH
Sbjct: 82 D-SYLVGDELWVVMEYMDGGSLTDIITQNFV-------RMNEPQIAYVCREVLQGLEYLH 133
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK---WLAIESL 406
+ ++H+D+ + N ++ +++ D A L N V W+A E +
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-----KSKRNSVVGTPYWMAPEVI 188
Query: 407 VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGY-RLNQPVNCPDELF 464
K + D+W+ G++ E+ + PY P + G L P E
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAE-GEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247
Query: 465 SVMAYCWAMNPEGRPTFPQL 484
+ C +PE RP+ +L
Sbjct: 248 DFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 42/176 (23%), Positives = 84/176 (47%), Gaps = 34/176 (19%)
Query: 327 HTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385
T + + ++ +Q+++ ++YLHK K+++H+DL N ++ + ++ ITD LA+ P
Sbjct: 108 QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE 167
Query: 386 D----------YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
Y C +N P + +DVWAFG +L+++ TL Q P+
Sbjct: 168 SKLTSVVGTILYSCPEIVKNEP-------------YGEKADVWAFGCILYQMCTL-QPPF 213
Query: 436 AEIDPFEMAASLQDGYRLNQPVNCPDELFS-----VMAYCWAMNPEGRPTFPQLHS 486
+ +A + + + +P+ P+ ++S V+ C + E RP Q+ +
Sbjct: 214 YSTNMLSLATKIVEA--VYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 61/260 (23%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 232 EGTFGRVY--RGTYTEEDGVEEEV-LVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTV 288
EG+FG++Y + E V +E+ L K A + ++L M H NI+T
Sbjct: 10 EGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-----KHPNIVTF 64
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
S +++ F++ Y D +L + + + GV + +++ +QI +G++++
Sbjct: 65 FA-SFQENGRLFIVMEYCDGGDLMKRINR----QRGV--LFSEDQILSWFVQISLGLKHI 117
Query: 349 HKKKLLHKDLATRNCVVDDKLRI-QITDNALARDLFPS---DYHCLGDNENRPVKWLAIE 404
H +K+LH+D+ ++N + + ++ D +AR L S Y C+G P +L+ E
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT----PY-YLSPE 172
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464
++ ++ +D+W+ G +L+EL TL + P+ + ++ + GY N +L
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTL-KHPFEGNNLHQLVLKICQGYFAPISPNFSRDLR 231
Query: 465 SVMAYCWAMNPEGRPTFPQL 484
S+++ + ++P RP+ +
Sbjct: 232 SLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 51/200 (25%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EGT+ VY+G D + V +K + ++E + L H NI+T+ +
Sbjct: 16 EGTYATVYKGRSKLTDNL---VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
I S L++ Y D +LK++L C +++ V Q++ G+ Y H++
Sbjct: 73 -IHTEKSLTLVFEYLD-KDLKQYLDDC-------GNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K+LH+DL +N +++++ +++ D LAR P+ + NE + + + L+ T
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY---SNEVVTLWYRPPDILLGST 180
Query: 411 -FSTASDVWAFGVLLWELTT 429
+ST D+W G + +E++T
Sbjct: 181 DYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 29/266 (10%)
Query: 232 EGTFGRVYRG-TYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G +G VY G T + ++V + T A+ + L +E + L H NI+ LG
Sbjct: 10 KGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG 69
Query: 291 VSIEDHT-SPFLIY-PYQDYTN-LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
++D+T S F+ + P ++ L RF PE V T Q I+ GV Y
Sbjct: 70 TCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQ--------ILDGVAY 117
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----WLAI 403
LH ++H+D+ N ++ I++ D AR L H N + + W+A
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 404 ESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDEL 463
E + + SD+W+ G ++E+ T + P A +D + L + +
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAAMFYIGAHRGLMPRL---PDS 233
Query: 464 FSVMAY-----CWAMNPEGRPTFPQL 484
FS A C + RP+ QL
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 50/215 (23%)
Query: 298 SPFLIYPYQDYTNLKRFLQKCKL------CPEGVAHT---------LTTQEVVDMCLQII 342
S ++I Y+ FL K KL G H L +V +QI+
Sbjct: 58 SSYIIRYYES------FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN------- 395
+G+ +LH KK+LH+D+ + N +D ++I D +A+ L DN N
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--------LLSDNTNFANTIVG 163
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM----AASLQDGY 451
P +L+ E K ++ SDVWA GV+L+E T PF+ A L+
Sbjct: 164 TPY-YLSPELCEDKPYNEKSDVWALGVVLYECCTGKH-------PFDANNQGALILKIIR 215
Query: 452 RLNQPVNCP--DELFSVMAYCWAMNPEGRPTFPQL 484
+ PV+ +L ++ C + RP QL
Sbjct: 216 GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQL 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 65/255 (25%), Positives = 120/255 (47%), Gaps = 25/255 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG+FGR + D ++ +K + S+ V +E + + + H NI+
Sbjct: 10 EGSFGRALLVQHVNSD---QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA-FKE 65
Query: 292 SIEDHTSPFLIYPYQDYTNL--KRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
S E +++ Y D +L K LQ+ KL PE ++ +Q+ +GVQ++H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE--------DTILQWFVQMCLGVQHIH 117
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYHC--LGDNENRPVK-WLAIES 405
+K++LH+D+ ++N + ++++ D AR L P Y C +G P + W E+
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIW---EN 174
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465
+ ++ SD+W+ G +L+EL TL + P+ + + G P + EL S
Sbjct: 175 M---PYNNKSDIWSLGCILYELCTL-KHPFQANSWKNLILKVCQGSYKPLPSHYSYELRS 230
Query: 466 VMAYCWAMNPEGRPT 480
++ + NP RP+
Sbjct: 231 LIKQMFKRNPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EGT+ V++G E V +K + ++E + L H NI+T+ +
Sbjct: 15 EGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
I L++ Y D ++LK++L C + ++ V Q++ G+ Y HK+
Sbjct: 72 -IHTERCLTLVFEYLD-SDLKQYLDNC-------GNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K+LH+DL +N ++++K +++ D LAR P+ + NE + + + L+ T
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY---SNEVVTLWYRPPDVLLGST 179
Query: 411 -FSTASDVWAFGVLLWELTT 429
+ST D+W G +L+E+ T
Sbjct: 180 EYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 39/221 (17%)
Query: 232 EGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EGTFG VY+ T +++L+ D L+E + L H N++ ++
Sbjct: 18 EGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA----LREIKILKKLKHPNVVPLI 73
Query: 290 GVSIE-------DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAH----TLTTQEVVDMC 338
+++E S +++ PY D+ L G+ LT ++
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDH----------DLS--GLLENPSVKLTESQIKCYM 121
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR---DLFPSDYHCLGDNEN 395
LQ++ G+ YLH+ +LH+D+ N ++D++ ++I D LAR P+ G
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 396 R-----PVKWL-AIESLVH-KTFSTASDVWAFGVLLWELTT 429
+ +W E L+ + ++TA D+W G + E+ T
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 58/267 (21%), Positives = 115/267 (43%), Gaps = 40/267 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G++G VY+ D + L + + S + + E + ++H NI++
Sbjct: 10 KGSYGSVYK-VKRLSDN-QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ D ++ Y + +L + + K K + QE+ + +Q++ G+Q LH++
Sbjct: 68 FL-DGNKLCIVMEYAPFGDLSKAISKRKK----KRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK-------WLAIE 404
K+LH+DL + N ++ ++I D +++ L + K ++A E
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVL-----------KKNMAKTQIGTPHYMAPE 171
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD-------GYRLNQPV 457
+ +S SD+W+ G LL+E+ T A PFE A S+QD G P
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAP-------PFE-ARSMQDLRYKVQRGKYPPIPP 223
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQL 484
+L + + + P+ RP ++
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL-------LLQEGMAMYGLSHKN 284
GT+GRVY+ +E + K D +S LL+E L H+N
Sbjct: 10 RGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRE------LKHEN 63
Query: 285 ILTVLGVSIEDHT-SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIM 343
+++++ V +E S +L++ Y ++ Q K + ++ V + QI+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYAEHD----LWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 344 GVQYLHKKKLLHKDLATRNCVV----DDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
GV YLH +LH+DL N +V ++ ++I D LAR LF + L D + V
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAPLKPLAD-LDPVVV 177
Query: 400 --WL-AIESLV-HKTFSTASDVWAFGVLLWELTTL 430
W A E L+ + ++ A D+WA G + EL TL
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 56/271 (20%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G+ G VY+ + + +K + + LL+E + ++ G
Sbjct: 12 GSSGVVYKVRH---KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH-KK 351
++ ++ Y D +L L+K PE V + + QI+ G+ YLH K+
Sbjct: 69 YKE-GEISIVLEYMDGGSLADLLKKVGKIPEPV--------LAYIARQILKGLDYLHTKR 119
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC---LGDNENRPVKWLAIESLVH 408
++H+D+ N +++ K ++I D +++ L + C +G V +++ E +
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGT-----VTYMSPERIQG 174
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYA---EIDPFEMAASLQDGYRLNQPVN-CPDELF 464
+++S A+D+W+ G+ L E L + P+ + FE+ ++ DG + P E
Sbjct: 175 ESYSYAADIWSLGLTLLEC-ALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233
Query: 465 SVMAYCWAMNPEGRPTFPQL--HSCLQEFHA 493
++ C +P+ RP+ +L H +++
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 232 EGTFGRVY--RGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILT 287
EGT+G VY R T E +++ + T T+ ++A++ LL+E L+H NI+
Sbjct: 10 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE------LNHPNIVK 63
Query: 288 VLGVSIEDHTSPFLIYPY--QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
+L V I +L++ + QD LK+F+ G+ L + Q++ G+
Sbjct: 64 LLDV-IHTENKLYLVFEFLHQD---LKKFMDASP--LSGIPLPL----IKSYLFQLLQGL 113
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYHCLGDNENRPVKWLAIE 404
+ H ++LH+DL +N +++ + I++ D LAR P + +E + + A E
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT---HEVVTLWYRAPE 170
Query: 405 SLVH-KTFSTASDVWAFGVLLWELTT 429
L+ K +STA D+W+ G + E+ T
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 62/224 (27%)
Query: 232 EGTFGRVYRGTY---------------TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA 276
EGT+G VY+G +EE+GV ++A++ LL+E
Sbjct: 10 EGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP-----------STAIREISLLKE--- 55
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H NI+ + V +++ + +LI+ + +LK++L P+G + + V
Sbjct: 56 ---LQHPNIVCLQDVLMQE-SRLYLIFEFLSM-DLKKYLDSL---PKG--QYMDAELVKS 105
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
QI+ G+ + H +++LH+DL +N ++D+K I++ D LAR
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF------------GI 153
Query: 397 PVK---------WL-AIESLVHKT-FSTASDVWAFGVLLWELTT 429
PV+ W A E L+ +ST D+W+ G + E+ T
Sbjct: 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 23/175 (13%)
Query: 286 LTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
LT L + + + F + Y + +L +Q C H +II G+
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC--------HKFDLPRATFYAAEIICGL 109
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV----KWL 401
Q+LH K ++++DL N ++D I+I D + ++ + LGD + ++
Sbjct: 110 QFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKE------NMLGDAKTCTFCGTPDYI 163
Query: 402 AIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456
A E L+ + ++T+ D W+FGVLL+E+ + Q P+ D E+ S+ R++ P
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEM-LIGQSPFHGHDEEELFQSI----RMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 66/265 (24%), Positives = 116/265 (43%), Gaps = 32/265 (12%)
Query: 233 GTFGRVYRGTYT-----EEDGVEEEVLVKTVTD--NASAVQVSLLLQEGMAMY-GLSHKN 284
GT ++Y G E+DG E +K + + S +SL E +M +SHK+
Sbjct: 6 GTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKH 65
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344
I+ + GV + D + ++ + ++ L F+ + + LTT + Q+
Sbjct: 66 IVLLYGVCVRDVEN-IMVEEFVEFGPLDLFMHR-------KSDVLTTPWKFKVAKQLASA 117
Query: 345 VQYLHKKKLLHKDLATRNCVV-------DDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
+ YL K L+H ++ T+N ++ + I+++D + + S C+ E P
Sbjct: 118 LSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL-SRQECV---ERIP 173
Query: 398 VKWLAIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456
W+A E + K S A+D W+FG LWE+ + P + E + L P
Sbjct: 174 --WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTP 231
Query: 457 VNCPDELFSVMAYCWAMNPEGRPTF 481
+C EL +M +C +P RP F
Sbjct: 232 -SC-KELADLMTHCMNYDPNQRPFF 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 47/200 (23%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EGT+ V++G + + V +K + ++E + L H NI+T+ +
Sbjct: 16 EGTYATVFKGRSKLTENL---VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
D S L++ Y D +LK+++ C + ++ V QI+ G+ Y H++
Sbjct: 73 VHTD-KSLTLVFEYLD-KDLKQYMDDC-------GNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K+LH+DL +N +++++ +++ D LAR P+ + NE + + + L+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY---SNEVVTLWYRPPDVLLGSS 180
Query: 411 -FSTASDVWAFGVLLWELTT 429
+ST D+W G + +E+ +
Sbjct: 181 EYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 53/211 (25%), Positives = 90/211 (42%), Gaps = 20/211 (9%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G+FGRV + G E +K + QV + QE + LSH I+ ++
Sbjct: 29 GSFGRV---RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM- 84
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
S +D + + + L L+K P VA ++++ +YLH
Sbjct: 85 CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF--------YHAELVLAFEYLHS 136
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K ++++DL N ++D+K +++TD A+ + + G E +LA E + K
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPE-----YLAPEVIQSKG 191
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
A D W GVLL+E P+ + PF
Sbjct: 192 HGKAVDWWTMGVLLYEFIA-GYPPFFDDTPF 221
|
Length = 329 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 59/277 (21%), Positives = 111/277 (40%), Gaps = 56/277 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG+VY+ +E G + V + S ++ + E + +H I+ +LG
Sbjct: 22 DGAFGKVYKAK-NKETGA---LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHT--------LTTQEVVDMCLQIIM 343
D +I + CP G LT ++ +C Q++
Sbjct: 78 FYWDGKLWIMI----------------EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE 121
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA---------RDLFPSDYHCLGDNE 394
+QYLH K++H+DL N ++ I++ D ++ RD F +
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY------ 175
Query: 395 NRPVKWLAIESLVHKTFSTA-----SDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-- 447
W+A E ++ +T +D+W+ G+ L E+ + + P+ E++P + +
Sbjct: 176 -----WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-EPPHHELNPMRVLLKIAK 229
Query: 448 QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ L+QP E + +PE RP+ QL
Sbjct: 230 SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EGT+ VY+G E V +K + +A S ++E M L H+NI+ + V
Sbjct: 10 EGTYATVYKGRNRTTG---EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
I L++ Y D +LK+++ GV L V Q++ G+ + H+
Sbjct: 67 -IHTENKLMLVFEYMD-KDLKKYMDT-----HGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALAR------DLFPSDYHCLGDNENRPVKWLAIES 405
++LH+DL +N +++ + +++ D LAR + F ++ L R L
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW---YRAPDVL---- 172
Query: 406 LVHKTFSTASDVWAFGVLLWELTT 429
L +T+ST+ D+W+ G ++ E+ T
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 57/239 (23%), Positives = 92/239 (38%), Gaps = 61/239 (25%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVS-------------LLLQEGMAMY 278
EGT+G+V + T + V +K V + V+ L+E M
Sbjct: 19 EGTYGKVEKAYDTLTG---KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNL----------KRFLQKCKLCPEGVAHT 328
+ H+NI+ ++ V +E D+ NL K +K +L
Sbjct: 76 EIKHENIMGLVDVYVE-----------GDFINLVMDIMASDLKKVVDRKIRL-------- 116
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-------- 380
T +V + LQI+ G+ LHK +H+DL+ N ++ K +I D LAR
Sbjct: 117 -TESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 381 -DLFPSDYHCLGDNENRPVKWL---AIESLVHKT-FSTASDVWAFGVLLWELTTLAQQP 434
L + + V L A E L+ + A D+W+ G + EL L +P
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL--LTGKP 232
|
Length = 335 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 83/283 (29%)
Query: 232 EGTFGRVYRGTY---------------TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA 276
EGT+G VY+ TE++GV ++A++ LL+E
Sbjct: 9 EGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP-----------STAIREISLLKE--- 54
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L+H NI+ +L V ++ +L++ + D +LK+++ + T ++
Sbjct: 55 ---LNHPNIVRLLDVVHSENKL-YLVFEFLD-LDLKKYM-------DSSPLTGLDPPLIK 102
Query: 337 MCL-QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
L Q++ G+ Y H ++LH+DL +N ++D + +++ D LAR
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF------------G 150
Query: 396 RPVK---------WL-AIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPY----AEIDP 440
PV+ W A E L+ + +ST D+W+ G + E+ ++P +EID
Sbjct: 151 VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN--RRPLFPGDSEIDQ 208
Query: 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQ 483
+R+ + + PDE V ++ P+ +PTFP+
Sbjct: 209 L---------FRIFRTLGTPDE--DVWPGVTSL-PDYKPTFPK 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 43/219 (19%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA------SAV-QVSLLLQEGMAMYGLSHKN 284
EGT+G+VY+ ++D E L K DN +A+ ++ +L Q L+H+N
Sbjct: 17 EGTYGQVYKAR--DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ-------LNHRN 67
Query: 285 ILTVLGVSIEDHTSP---------FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVV 335
I+ + + + + +L++ Y D+ +L L+ G+ H + +
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLE------SGLVH-FSEDHIK 119
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE- 394
Q++ G+ Y HKK LH+D+ N ++++K +I++ D LAR L+ S+ N+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPYTNKV 178
Query: 395 ----NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429
RP + L L + + A DVW+ G +L EL T
Sbjct: 179 ITLWYRPPELL----LGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 49/177 (27%), Positives = 77/177 (43%), Gaps = 42/177 (23%)
Query: 280 LSHKNILTVLGVSIEDHTSPFLIY---PYQDYTNLK------------RFLQKCKLCPEG 324
L+ K IL + PFL+ +QD +NL L+K PE
Sbjct: 49 LNEKRILQSI-------RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP 101
Query: 325 VAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384
VA Q +++ ++YLH ++++DL N ++D I+ITD A+ +
Sbjct: 102 VARFYAAQ--------VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153
Query: 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
Y G E +LA E ++ K + A D WA G+L++E+ LA P PF
Sbjct: 154 RTYTLCGTPE-----YLAPEIILSKGYGKAVDWWALGILIYEM--LAGYP-----PF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 50/218 (22%)
Query: 232 EGTFGRVYRGTYTEEDGV--------EEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHK 283
EGT+G VYR + + E+E +T S ++++LL+ L H
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPIT---SLREINILLK-------LQHP 64
Query: 284 NILTVLGVSI-EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQII 342
NI+TV V + + +++ Y ++ +LK + E + EV + LQ++
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLM-------ETMKQPFLQSEVKCLMLQLL 116
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK--- 399
GV +LH +LH+DL T N +++++ ++I D LAR+ + S P+K
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE-YGS-----------PLKPYT 164
Query: 400 ------WL-AIESLV-HKTFSTASDVWAFGVLLWELTT 429
W A E L+ K +STA D+W+ G + EL T
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 50/236 (21%), Positives = 102/236 (43%), Gaps = 39/236 (16%)
Query: 268 SLLLQEGMAMYGLSHKNILTVLGVSI-EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVA 326
L+ E + L H NI+ I + + +++ Y + +L + +QKCK +
Sbjct: 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK--- 100
Query: 327 HTLTTQEVVDMCLQIIMGVQYLH-----KKKLLHKDLATRNCVVDDKLRIQITDNALARD 381
+ + + + Q+++ + H +LH+DL N +D +++ D LA+
Sbjct: 101 -YIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
Query: 382 LFPSDYHCLGDNENRPVK-------WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP 434
L +++ K +++ E L H ++ SD+W+ G L++EL L P
Sbjct: 160 L---------GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL--SP 208
Query: 435 YAEIDPF------EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
PF ++A+ +++G P EL V+ ++P+ RP+ +L
Sbjct: 209 -----PFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EGT+G VY+ + G E V +K + S L+E + L+H NI+ +L
Sbjct: 9 EGTYGVVYKA-RDKLTG--EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V +L++ + D T+L + ++ L + Q++ G+ + H
Sbjct: 66 V-FRHKGDLYLVFEFMD-TDLYKLIK-------DRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP------VKWL-AI 403
+LH+DL N +++ + +++ D LAR RP +W A
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSP---------VRPYTHYVVTRWYRAP 167
Query: 404 ESLVH-KTFSTASDVWAFGVLLWELTTL 430
E L+ K +ST D+W+ G + EL +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 64/268 (23%), Positives = 111/268 (41%), Gaps = 37/268 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNAS---AVQVSLLLQEGMAMYGLSHKNILT 287
+G FGRVY Y + G E+ VK V D S +V+ L E + L H+ I+
Sbjct: 12 QGAFGRVYL-CYDVDTG--RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 288 VLGVSIEDHTSPFLIYPYQDYT---NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344
G +D T + + +Y ++K L+ E V T Q I+ G
Sbjct: 69 YYGCLRDDET----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ--------ILEG 116
Query: 345 VQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----W 400
V+YLH ++H+D+ N + D +++ D ++ L C + V W
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKSVTGTPYW 173
Query: 401 LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460
++ E + + + +DVW+ G + E+ T + P+AE + MAA + + P P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEA--MAAIFKIATQPTNPQ-LP 229
Query: 461 DELFSVMAY----CWAMNPEGRPTFPQL 484
+ + N + RP+ +L
Sbjct: 230 SHVSPDARNFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 65/230 (28%)
Query: 232 EGTFGRVYRG---------------TYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA 276
EGT+G+VY+ +E+G+ L ++SLL
Sbjct: 11 EGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR----------EISLLQM---- 56
Query: 277 MYGLSHKN-ILTVLGV--SIEDHTSP--FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTT 331
LS I+ +L V E + P +L++ Y D ++LK+F+ G L
Sbjct: 57 ---LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNG---RGPGRPLPA 109
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPSDYHCL 390
+ + Q++ GV + HK ++H+DL +N +VD K ++I D L R
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR---------- 159
Query: 391 GDNENRPVK---------WL-AIESLVHKT-FSTASDVWAFGVLLWELTT 429
+ PVK W A E L+ T +ST D+W+ G + E++
Sbjct: 160 --AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
QI++ + +H +K++H+DL + N + I++ D ++ S + +
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459
+LA E K +S +D+W+ GV+L+EL TL +P+ P + Q Y P C
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTL-HRPFK--GPSQREIMQQVLYGKYDPFPC 293
Query: 460 P--DELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
P + +++ + NP RPT QL H + +YV
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQL------LHTEFLKYV 329
|
Length = 478 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 47/222 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--------TD--NASAVQVSLLLQEGMAMYGLS 281
EGT+ VY+ E V +K + D N +A++ LLQE L
Sbjct: 10 EGTYAVVYKARDKETG---RIVAIKKIKLGERKEAKDGINFTALREIKLLQE------LK 60
Query: 282 HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQI 341
H NI+ +L V ++ L++ + + T+L++ ++ + LT ++ L
Sbjct: 61 HPNIIGLLDVFGHK-SNINLVFEFME-TDLEKVIKDKSI-------VLTPADIKSYMLMT 111
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV--- 398
+ G++YLH +LH+DL N ++ +++ D LAR F S NR +
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARS-FGSP--------NRKMTHQ 162
Query: 399 ---KWL-AIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPY 435
+W A E L + + D+W+ G + EL L + P+
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL--LLRVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 39/156 (25%), Positives = 83/156 (53%), Gaps = 19/156 (12%)
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFL--QKCKLCPEGVAHTLTTQEVVDM 337
+ H NI+ S E++ + +++ Y + +L + + Q+ L PE +++D
Sbjct: 56 MKHPNIVQYQE-SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE--------DQILDW 106
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS---DYHCLGDNE 394
+QI + ++++H +K+LH+D+ ++N + I++ D +AR L + C+G
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGT-- 164
Query: 395 NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL 430
P +L+ E ++ ++ SD+WA G +L+E+ TL
Sbjct: 165 --PY-YLSPEICENRPYNNKSDIWALGCVLYEMCTL 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 50/253 (19%), Positives = 106/253 (41%), Gaps = 16/253 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G+FG V++G ++ ++ V +K + + ++ + QE + + G
Sbjct: 14 KGSFGEVFKGI---DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
++D T ++I Y + L+ L +A L +I+ G+ YLH +
Sbjct: 71 YLKD-TKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---------EILKGLDYLHSE 120
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
K +H+D+ N ++ + +++ D +A L +D + W+A E + +
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
+ +D+W+ G+ EL + P++E+ P ++ + N L + C
Sbjct: 179 DSKADIWSLGITAIELAK-GEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 237
Query: 472 AMNPEGRPTFPQL 484
P RPT +L
Sbjct: 238 NKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 55/263 (20%), Positives = 111/263 (42%), Gaps = 29/263 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG++G VY+ + E + V +K V + +++E + I+ G
Sbjct: 13 EGSYGSVYKAIHKETG---QVVAIKVVPVEEDLQE---IIKEISILKQCDSPYIVKYYG- 65
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
S +T +++ +Y K+ + TLT +E+ + Q + G++YLH
Sbjct: 66 SYFKNTDLWIV---MEYCGAGSVSDIMKITNK----TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN---RPVKWLAIESLVH 408
K +H+D+ N +++++ + ++ D ++ L + P W+A E +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT----DTMAKRNTVIGTPF-WMAPEVIQE 173
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR----LNQPVNCPDELF 464
++ +D+W+ G+ E+ + PY++I P M A + L+ P E
Sbjct: 174 IGYNNKADIWSLGITAIEMAEG-KPPYSDIHP--MRAIFMIPNKPPPTLSDPEKWSPEFN 230
Query: 465 SVMAYCWAMNPEGRPTFPQLHSC 487
+ C +PE RP+ QL
Sbjct: 231 DFVKKCLVKDPEERPSAIQLLQH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 32/113 (28%), Positives = 60/113 (53%), Gaps = 11/113 (9%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV- 398
+I+ G+Q+LH K ++++DL N ++D I+I D + ++ + GDN
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE------NVFGDNRASTFC 157
Query: 399 ---KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ 448
++A E L ++ + D W+FGVLL+E+ + Q P+ D E+ S++
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM-LIGQSPFHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 67/253 (26%), Positives = 113/253 (44%), Gaps = 37/253 (14%)
Query: 233 GTFGRVYRGTYTEEDGVEE-EVLVKTVTDNA---SAVQVSLLLQEGMAMYGLSHKNILTV 288
GT+G VY+ +DG +E E +K + SA + LL+E L H N++ +
Sbjct: 12 GTYGHVYKAK--RKDGKDEKEYALKQIEGTGISMSACREIALLRE------LKHPNVIAL 63
Query: 289 LGVSIEDHTSP-FLIYPY--QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
V + +L++ Y D ++ +F + K + + L V + QI+ G+
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPM--QLPRSMVKSLLYQILDGI 121
Query: 346 QYLHKKKLLHKDLATRNCVV----DDKLRIQITDNALARDLFPSDYHCLGDNENRPVK-W 400
YLH +LH+DL N +V ++ R++I D AR LF S L D + V W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFW 180
Query: 401 LAIESLV--HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
L+ + ++ A D+WA G + EL L +P + Q+ + + P +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAEL--LTSEP--------IFHCRQEDIKTSNPFH 230
Query: 459 CP--DELFSVMAY 469
D +FSVM +
Sbjct: 231 HDQLDRIFSVMGF 243
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 33/273 (12%)
Query: 233 GTFGRVYRGTYTEEDGVEE-EVLVKTVTDNA---SAVQVSLLLQEGMAMYGLSHKNILTV 288
GT+G VY+ +DG ++ + +K + SA + LL+E L H N++++
Sbjct: 12 GTYGHVYKAK--RKDGKDDRDYALKQIEGTGISMSACREIALLRE------LKHPNVISL 63
Query: 289 LGVSIEDHTSP-FLIYPY--QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
V + +L++ Y D ++ +F + K + V L V + QI+ G+
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPV--QLPRGMVKSLLYQILDGI 121
Query: 346 QYLHKKKLLHKDLATRNCVV----DDKLRIQITDNALARDLFPSDYHCLGDNENRPVK-W 400
YLH +LH+DL N +V ++ R++I D AR LF S L D + V W
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFW 180
Query: 401 LAIESLV--HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
L+ + ++ A D+WA G + EL L +P ++ S + Y +Q
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAEL--LTSEPIFHCRQEDIKTS--NPYHHDQ--- 233
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
D +F+VM + + E P+ + +++F
Sbjct: 234 -LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF 265
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 30/104 (28%), Positives = 57/104 (54%), Gaps = 6/104 (5%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+I+ ++YLH K+++++DL N ++D + I++TD A+ L + G E
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE----- 163
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443
+LA E + K + A D WA G+L++E+ P+ + +PF +
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 35/146 (23%), Positives = 67/146 (45%), Gaps = 11/146 (7%)
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD--YHCLGDNEN 395
+++ +YLH + ++++DL N ++D +++ D A+ L + G E
Sbjct: 99 IACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE- 157
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI--DPFE-MAASLQDGYR 452
++A E +++K + + D W+ G+LL+EL T + P+ E DP E L+ +
Sbjct: 158 ----YVAPEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGEDDEDPMEIYNDILKGNGK 212
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGR 478
L P ++ NPE R
Sbjct: 213 LEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 44/198 (22%), Positives = 95/198 (47%), Gaps = 28/198 (14%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G+ GRV+ T + G + V++K + L E M + ++H +++ +
Sbjct: 77 GSEGRVFVAT---KPGQPDPVVLKIGQKGTT-------LIEAMLLQNVNHPSVIRMKDTL 126
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+ + ++ Y ++L +L K + P + L ++ QI+ G++YLH ++
Sbjct: 127 VSGAITCMVLPHYS--SDLYTYLTK-RSRPLPIDQALIIEK------QILEGLRYLHAQR 177
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALAR--DLFPSDYHCLGDNE-NRPVKWLAIESLVHK 409
++H+D+ T N ++D ++ I D A+ + P+ G E N P E L
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP------EVLARD 231
Query: 410 TFSTASDVWAFGVLLWEL 427
+++ +D+W+ G++L+E+
Sbjct: 232 KYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 30/179 (16%)
Query: 323 EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382
EG H Q + D+ QI+ G+ YLH++ ++H+D+ N +++ ++I D ++R L
Sbjct: 160 EG-THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
Query: 383 FPSDYHCLGDNENRPVKWLAIES-------LVHKTFS-TASDVWAFGVLLWELTTLAQQP 434
+ C N V +A S L H + A D+W+ GV + E
Sbjct: 219 AQTMDPC-----NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF------- 266
Query: 435 YAEIDPFEMA-----ASLQDGYRLNQPVNCP----DELFSVMAYCWAMNPEGRPTFPQL 484
Y PF + ASL ++QP P E ++ C P R + QL
Sbjct: 267 YLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQL 325
|
Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 17/107 (15%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV- 398
+I +G+ +LH K ++++DL N ++D + I+I D + ++ + G R
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE------NIFGGKTTRTFC 162
Query: 399 ---KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442
++A E + ++ + + D WAFGVLL+E+ LA QP PF+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM--LAGQP-----PFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 59/268 (22%), Positives = 117/268 (43%), Gaps = 20/268 (7%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G F VYR T DGV + + D A + ++E + L+H N++
Sbjct: 13 GQFSEVYRATCLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 71
Query: 293 IEDHTSPFLIYPYQDYTNLKR----FLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
IED+ ++ D +L R F ++ +L PE + V +Q+ ++++
Sbjct: 72 IEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPE--------KTVWKYFVQLCSALEHM 122
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH 408
H ++++H+D+ N + +++ D L R F S P +++ E +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPY-YMSPERIHE 180
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPY--AEIDPFEMAASL-QDGYRLNQPVNCPDELFS 465
++ SD+W+ G LL+E+ L Q P+ +++ + + + Q Y + +EL
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAAL-QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 466 VMAYCWAMNPEGRPTFPQLHSCLQEFHA 493
++ C +PE RP ++ + HA
Sbjct: 240 LVNMCINPDPEKRPDITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 45/214 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA----------MYGLS 281
EG++ VY+G +T A++ L E A + L
Sbjct: 15 EGSYATVYKG-------------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK 61
Query: 282 HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQI 341
H NI+T L I + L++ Y D T+LK+++ C G++ V Q+
Sbjct: 62 HANIVT-LHDIIHTKKTLTLVFEYLD-TDLKQYMDDC---GGGLSM----HNVRLFLFQL 112
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSDYHCLGDNE-----N 395
+ G+ Y H++++LH+DL +N ++ ++ +++ D LAR PS + NE
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY---SNEVVTLWY 169
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429
RP L L +ST+ D+W G + +E+ T
Sbjct: 170 RPPDVL----LGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 48/215 (22%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNA------SAVQVSLLLQEGMAMYGLSHKN 284
EGT+G V++ E E V +K V D+ SA++ LL+E L HKN
Sbjct: 10 EGTYGTVFKAK-NRETH--EIVALKRVRLDDDDEGVPSSALREICLLKE------LKHKN 60
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344
I+ + V D L++ Y D +LK++ C + + V Q++ G
Sbjct: 61 IVRLYDVLHSDKKLT-LVFEYCD-QDLKKYFDSCN-------GDIDPEIVKSFMFQLLKG 111
Query: 345 VQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIE 404
+ + H +LH+DL +N +++ +++ D LAR PV+ + E
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR------------AFGIPVRCYSAE 159
Query: 405 SLV-----------HKTFSTASDVWAFGVLLWELT 428
+ K +ST+ D+W+ G + EL
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 48/207 (23%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 232 EGTFGRVYRGTYTEEDG---VEEEVLVKTVTDN---ASAVQVSLLLQEGMAMYGLSHKNI 285
EG +G+V++ + G + V V+T + ++ +V++L + H N+
Sbjct: 11 EGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH----LETFEHPNV 66
Query: 286 LTVLGV----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE-GVAHTLTTQEVVDMCLQ 340
+ + V + T L++ + D +L +L K PE GV T+ + DM Q
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV---PEPGVP----TETIKDMMFQ 118
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
++ G+ +LH +++H+DL +N +V +I++ D LAR + + + +
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWY 175
Query: 401 LAIESLVHKTFSTASDVWAFGVLLWEL 427
A E L+ +++T D+W+ G + E+
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 43/156 (27%), Positives = 79/156 (50%), Gaps = 19/156 (12%)
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQK-CK-LCPEGVAHTLTTQEVVDM 337
LSH NI+ +ED + ++ Y L ++QK C L E ++
Sbjct: 56 LSHPNIIEYYENFLEDK-ALMIVMEYAPGGTLAEYIQKRCNSLLDE--------DTILHF 106
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRIQITDNALARDLFPSD--YHCLGDNE 394
+QI++ + ++H K +LH+DL T+N ++D K+ ++I D +++ L Y +G
Sbjct: 107 FVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGT-- 164
Query: 395 NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL 430
P +++ E K ++ SD+WA G +L+EL +L
Sbjct: 165 --PC-YISPELCEGKPYNQKSDIWALGCVLYELASL 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 53/220 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL----------- 280
EG +G VY+ V +K V V +S +EG+ + L
Sbjct: 9 EGAYGTVYKARDLNTGRF---VALKKV-----RVPLS---EEGIPLSTLREIALLKQLES 57
Query: 281 -SHKNILTVLGVS----IEDHTSPFLIYPY--QDYTNLKRFLQKCKLCPEGVAHTLTTQE 333
H NI+ +L V + L++ + QD L +L KC P+ L +
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD---LATYLSKC---PKPG---LPPET 108
Query: 334 VVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN 393
+ D+ Q++ GV +LH +++H+DL +N +V +++I D LAR
Sbjct: 109 IKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---------SF 159
Query: 394 ENR--PV---KWL-AIESLVHKTFSTASDVWAFGVLLWEL 427
E V W A E L+ +++T D+W+ G + EL
Sbjct: 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
I++ ++YLH K ++H+D+ N ++D++ + ITD +A + P P +
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPG-Y 165
Query: 401 LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
+A E L + +S A D W+ GV +E ++PY
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 56/281 (19%), Positives = 108/281 (38%), Gaps = 64/281 (22%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG+VY+ + E K + + ++ + E + H NI+ +
Sbjct: 15 DGAFGKVYKAQHKETGLFAA---AKIIQIESEE-ELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG--------VAHTLTTQEVVDMCLQIIM 343
++ LI + C G + LT ++ +C Q++
Sbjct: 71 YFYENKLWILI----------------EFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA---------RDLFPSDYHCLGDNE 394
+ +LH K++H+DL N ++ +++ D ++ RD F +
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY------ 168
Query: 395 NRPVKWLAIESLVHKTFSTA-----SDVWAFGVLLWELTTLAQQ--PYAEIDP----FEM 443
W+A E + +TF +D+W+ G+ L E LAQ P+ E++P ++
Sbjct: 169 -----WMAPEVVACETFKDNPYDYKADIWSLGITLIE---LAQMEPPHHELNPMRVLLKI 220
Query: 444 AASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
S + L+QP + C +P+ RPT +L
Sbjct: 221 LKS--EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 55/216 (25%)
Query: 309 TNLKRFLQKCKLCPEGVAHTLTTQEVV--DMCLQIIMGVQYLHKK-KLLHKDLATRNCVV 365
T+L +F +K LT E + + + I+ ++YLH K ++H+D+ N ++
Sbjct: 84 TSLDKFYKKVYD------KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI 137
Query: 366 DDKLRIQITD--------NALARDLFPSDYHCLGDNENRPVKWLAIE----SLVHKTFST 413
+ ++++ D +++A+ + D C +P ++A E L K +
Sbjct: 138 NRNGQVKLCDFGISGYLVDSVAKTI---DAGC------KP--YMAPERINPELNQKGYDV 186
Query: 414 ASDVWAFGVLLWELTTLAQQPYAEI-DPFEMAASLQDGYRLNQPVN-----CPDELFSV- 466
SDVW+ G+ + EL T PY PF+ +L Q V P E FS
Sbjct: 187 KSDVWSLGITMIELATGR-FPYDSWKTPFQ---------QLKQVVEEPSPQLPAEKFSPE 236
Query: 467 ----MAYCWAMNPEGRPTFPQL--HSCLQEFHAQLT 496
+ C N + RP +P+L H + ++ T
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 23/96 (23%), Positives = 48/96 (50%), Gaps = 6/96 (6%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+I++ ++YLH ++H+DL N ++D +++TD L++ L D+E +
Sbjct: 101 EIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 400 ------WLAIESLVHKTFSTASDVWAFGVLLWELTT 429
++A E ++ + S D W+ G +L+E
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 50/198 (25%), Positives = 97/198 (48%), Gaps = 17/198 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG++ VY+G ++ +G + V +K + ++E + GL H NI+ + +
Sbjct: 15 EGSYATVYKGK-SKVNG--KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
I + L++ Y +T+L +++ K P G L + V Q++ G+ Y+H++
Sbjct: 72 -IHTKETLTLVFEYV-HTDLCQYMDKH---PGG----LHPENVKLFLFQLLRGLSYIHQR 122
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
+LH+DL +N ++ D +++ D LAR PS + NE + + + L+ T
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY---SNEVVTLWYRPPDVLLGST 179
Query: 411 -FSTASDVWAFGVLLWEL 427
+ST D+W G + E+
Sbjct: 180 EYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 46/211 (21%), Positives = 79/211 (37%), Gaps = 29/211 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV----TDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EG G V++ E E V +K V + Q L+E A+ H ++
Sbjct: 10 EGAHGIVFKAKDRETG---ETVALKKVALRRLEGGIPNQA---LREIKALQACQHPYVVK 63
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+L V + L+ Y ++L L+ + L +V ++ GV Y
Sbjct: 64 LLDVFPHG-SGFVLVMEYM-PSDLSEVLRDEE-------RPLPEAQVKSYMRMLLKGVAY 114
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD----YHCLGDNENRPVKWLAI 403
+H ++H+DL N ++ ++I D LAR + H + R + L
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL-- 172
Query: 404 ESLVHKTFSTASDVWAFGVLLWELTTLAQQP 434
+ + D+WA G + EL L P
Sbjct: 173 --YGARKYDPGVDLWAVGCIFAEL--LNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 17/107 (15%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV- 398
+I++G+Q+LH++ ++++DL N ++D + I+I D + ++ LG
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE------GILGGVTTSTFC 157
Query: 399 ---KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442
++A E L ++ + A D WA GVLL+E+ LA Q PFE
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEM--LAGQS-----PFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 57/281 (20%), Positives = 111/281 (39%), Gaps = 49/281 (17%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G+FG VY+G ++ +E V +K + + ++ + QE +TVL
Sbjct: 14 KGSFGEVYKGI---DNRTKEVVAIKIIDLEEAEDEIEDIQQE------------ITVLSQ 58
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVA------HTLTTQEVVDMCLQIIMGV 345
SP++ Y Y + + G A L + + +I+ G+
Sbjct: 59 C----DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGL 114
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
YLH ++ +H+D+ N ++ ++ +++ D +A L +D + W+A E
Sbjct: 115 DYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEV 172
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDEL-- 463
+ + +D+W+ G+ EL + P +++ P + + P N P L
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRVLFLI--------PKNSPPTLEG 223
Query: 464 ------FSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498
+ C +P RPT +L H +TRY
Sbjct: 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK-----HKFITRY 259
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 14/143 (9%)
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSD---YHCLGDNENR 396
+++G+QYLH+ K++++DL N ++D + ++I D L + + D C G E
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPE-- 166
Query: 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-LQDGYRLNQ 455
+LA E L +++ A D W GVL++E+ + + P+ D E+ S + D R
Sbjct: 167 ---FLAPEVLTETSYTRAVDWWGLGVLIYEM-LVGESPFPGDDEEEVFDSIVNDEVRY-- 220
Query: 456 PVNCPDELFSVMAYCWAMNPEGR 478
P E S+M NPE R
Sbjct: 221 PRFLSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 43/199 (21%), Positives = 84/199 (42%), Gaps = 19/199 (9%)
Query: 233 GTFGRVYRG-TYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG VY + D +VL K+ D + QV+ + E M + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKS--DMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
S + +L+ Y + + ++ PE A + +++GV+ LH++
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAE--------VVLGVEDLHQR 116
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARD-LFPSDYHCLGDNENRPVKWLAIESLVHKT 410
++H+D+ N ++D +++TD L+R+ L + D +LA E+++
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-------YLAPETILGVG 169
Query: 411 FSTASDVWAFGVLLWELTT 429
SD W+ G +++E
Sbjct: 170 DDKMSDWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 58/270 (21%), Positives = 111/270 (41%), Gaps = 38/270 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
GTFG+VY + + ++ ++ ++ + E + L H N++ GV
Sbjct: 10 GGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK--EIADEMKVLELLKHPNLVKYYGV 67
Query: 292 SIEDHTSPFLIYPYQDYTN---LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
E H I+ +Y + L+ L+ ++ E V T LQ++ G+ YL
Sbjct: 68 --EVHREKVYIF--MEYCSGGTLEELLEHGRILDEHVIRVYT--------LQLLEGLAYL 115
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD--YHCLGDNENRPVKWLAIESL 406
H ++H+D+ N +D I++ D A L + + ++A E +
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 407 VHKTFS---TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL---NQPVNCP 460
A+D+W+ G ++ E+ T ++P++E+D Q + + ++P P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELD-----NEFQIMFHVGAGHKPP-IP 228
Query: 461 DEL-FSVMAY-----CWAMNPEGRPTFPQL 484
D L S C +P+ RPT +L
Sbjct: 229 DSLQLSPEGKDFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 65/292 (22%), Positives = 116/292 (39%), Gaps = 66/292 (22%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT--DNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G F VY+ + V V +K V + A L+E + L H N++ L
Sbjct: 12 KGQFSVVYKAICLLDGRV---VALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCK----LCPEGVAHTLTTQEVVDMCLQIIMGV 345
IE++ ++ D +L R ++ K L PE + + +Q+ +
Sbjct: 69 ASFIENN-ELNIVLELADAGDLSRMIKHFKKQKRLIPE--------RTIWKYFVQLCSAL 119
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
+++H K+++H+D+ N + +++ D L R F S K A S
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSS-------------KTTAAHS 165
Query: 406 LV-----------HKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM-AASLQDGYR 452
LV H+ ++ SD+W+ G LL+E+ L PF +L Y
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-------PFYGDKMNL---YS 215
Query: 453 LNQPV-NC-----PDELFS-----VMAYCWAMNPEGRPTFPQLHSCLQEFHA 493
L + + C P + +S +++ C +PE RP + +E HA
Sbjct: 216 LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 30/157 (19%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDK-------LRIQITD-----NALARDLFPSDY 387
Q+ + YL K L+H ++ +N ++ I+++D AL+R
Sbjct: 125 QLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------- 177
Query: 388 HCLGDNENR--PVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444
E R + W+A E + STA+D W+FG L E+ + P E P E
Sbjct: 178 ------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231
Query: 445 ASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTF 481
+ +RL +P +C EL ++++ C P RP+F
Sbjct: 232 RFYEKKHRLPEP-SCK-ELATLISQCLTYEPTQRPSF 266
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 32/112 (28%), Positives = 61/112 (54%), Gaps = 11/112 (9%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV- 398
+II G+Q+LHKK ++++DL N ++D I+I D + ++ + G+ +
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE------NMNGEGKASTFC 157
Query: 399 ---KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447
++A E L + ++ + D W+FGVLL+E+ + Q P+ D E+ S+
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEM-LIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 51/262 (19%), Positives = 108/262 (41%), Gaps = 34/262 (12%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G+FG V++G ++ ++ V +K + + ++ + QE +TVL
Sbjct: 14 KGSFGEVFKGI---DNRTQQVVAIKIIDLEEAEDEIEDIQQE------------ITVLSQ 58
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQ------EVVDMCLQIIMGV 345
SP++ Y Y + + G A L ++ M +I+ G+
Sbjct: 59 C----DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGL 114
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
YLH +K +H+D+ N ++ ++ +++ D +A L +D + W+A E
Sbjct: 115 DYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEV 172
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465
+ + + +D+W+ G+ EL + P +++ P + + + N P +
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAK-GEPPNSDMHPMRVLFLIP---KNNPPTLTGEFSKP 228
Query: 466 VMAY---CWAMNPEGRPTFPQL 484
+ C +P RPT +L
Sbjct: 229 FKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 31/239 (12%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA----SAVQVSLLLQEGMAMYGLSHKNILT 287
+G FGRVY Y + G E+ K V + ++ +VS L E + L H+ I+
Sbjct: 12 QGAFGRVYL-CYDVDTG--RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 288 VLGVSIEDHTSPFL--IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
G + D L Y ++K L+ E V T Q I+ G+
Sbjct: 69 YYGC-LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ--------ILEGM 119
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----WL 401
YLH ++H+D+ N + D +++ D ++ L C+ R V W+
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTPYWM 176
Query: 402 AIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460
+ E + + + +DVW+ G + E+ T + P+AE + MAA + QP N
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEA--MAAIFKIA---TQPTNPQ 229
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEE----EVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287
+G+FG+V E G +E ++L K V V+ +++ + +A+ G LT
Sbjct: 10 KGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG--KPPFLT 64
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
L + + + Y + +L +Q+ E A V +I +G+ +
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA--------VFYAAEIAIGLFF 116
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALAR----DLFPSDYHCLGDNENRPVKWLAI 403
LH K ++++DL N ++D + I+I D + + D + C P ++A
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-----GTP-DYIAP 170
Query: 404 ESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442
E + ++ + + D WAFGVLL+E+ LA Q PFE
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEM--LAGQA-----PFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 27/129 (20%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 325 VAHT-LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL- 382
V HT + +++ +CL ++ + YLH + ++H+D+ + + ++ RI+++D +
Sbjct: 110 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169
Query: 383 --FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440
P +G W+A E + + T D+W+ G+++ E+ + PY P
Sbjct: 170 KEVPKRKSLVGTP-----YWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEPP 223
Query: 441 FEMAASLQD 449
+ ++D
Sbjct: 224 LQAMRRIRD 232
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 36/274 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G VY E+V +K + V L +E AM +H N++
Sbjct: 11 VGATAVVYAAICLPN---NEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 292 SIEDHTSPFLIYPYQD---YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
+ +L+ PY ++ + E + T+ +EV+ G++YL
Sbjct: 68 FVVGDEL-WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL-KEVLK-------GLEYL 118
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK-------WL 401
H +H+D+ N ++ + ++I D ++ L GD + K W+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG-----GDRTRKVRKTFVGTPCWM 173
Query: 402 AIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQD---GYRLNQP 456
A E + + +D+W+FG+ EL T PY++ P + + +LQ+
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232
Query: 457 VNCPDELFSVM-AYCWAMNPEGRPTFPQL--HSC 487
+ F M + C +P RPT +L H
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA----SAVQVSLLLQEGMAMYGL 280
RL + +G FGRVY Y + G E+ VK V + ++ +V+ L E + L
Sbjct: 5 RLGKLLGQGAFGRVYL-CYDADTG--RELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 281 SHKNILTVLGV---SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
H+ I+ G +E S F+ + ++K L+ E V T Q
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGG--SIKDQLKSYGALTENVTRKYTRQ----- 114
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
I+ GV YLH ++H+D+ N + D +++ D ++ L CL +
Sbjct: 115 ---ILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKS 168
Query: 398 VK----WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
V W++ E + + + +D+W+ G + E+ T + P+AE + MAA +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEA--MAAIFKIA--- 222
Query: 454 NQPVN 458
QP N
Sbjct: 223 TQPTN 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 30/172 (17%)
Query: 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLA 359
F + Y + +L +Q+ + PE A + + I + + YLH++ ++++DL
Sbjct: 72 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE--------ISLALNYLHERGIIYRDLK 123
Query: 360 TRNCVVDDKLRIQITDNALARD-LFPSD---YHCLGDNENRPVKWLAIESLVHKTFSTAS 415
N ++D + I++TD + ++ L P D C N ++A E L + + +
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN------YIAPEILRGEDYGFSV 177
Query: 416 DVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
D WA GVL++E+ A PF++ S N N D LF V+
Sbjct: 178 DWWALGVLMFEMM-------AGRSPFDIVGSSD-----NPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 28/98 (28%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+I G++ LH+++++++DL N ++DD I+I+D LA + P G V
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKG--RVGTVG 166
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE 437
++A E + ++ ++ + D WA G LL+E+ Q P+ +
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 59/264 (22%), Positives = 120/264 (45%), Gaps = 44/264 (16%)
Query: 232 EGTFGRVYRGT--YTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILT 287
EGT+G VY+ T E +++ ++ + ++A++ LL+E + H NI+
Sbjct: 12 EGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKE------MQHGNIVR 65
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCL-QIIMGVQ 346
+ V + +L++ Y D +LK+ + P+ ++ L QI+ G+
Sbjct: 66 LQDV-VHSEKRLYLVFEYLDL-DLKKHMDSS---PD----FAKNPRLIKTYLYQILRGIA 116
Query: 347 YLHKKKLLHKDLATRNCVVDDKLR-IQITDNALARDL-FPSDYHCLGDNENRPVKWLAIE 404
Y H ++LH+DL +N ++D + +++ D LAR P +E + + A E
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT---HEVVTLWYRAPE 173
Query: 405 SLV-HKTFSTASDVWAFGVLLWELTTLAQQPY----AEIDPFEMAASLQDGYRLNQPVNC 459
L+ + +ST D+W+ G + E+ Q+P +EID +++ + +
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVN--QKPLFPGDSEIDEL---------FKIFRILGT 222
Query: 460 PDELFSVMAYCWAMNPEGRPTFPQ 483
P+E ++ P+ + FP+
Sbjct: 223 PNE--ETWPGVTSL-PDYKSAFPK 243
|
Length = 294 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 26/103 (25%), Positives = 54/103 (52%), Gaps = 18/103 (17%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
QII G+++LH+++++++DL N ++DD ++I+D LA +L + +K
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL----------KGGKKIK 152
Query: 400 -------WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
++A E L + + + D +A G L+E+ + P+
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 36/150 (24%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 282 HKNILTVLGV----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
H NI+ ++ V + T L++ + D +L+ +L K P G L + + D+
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVP--PPG----LPAETIKDL 113
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
Q + G+ +LH ++H+DL N +V ++++ D LAR
Sbjct: 114 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVT 170
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWEL 427
+ + A E L+ T++T D+W+ G + E+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 6e-06
Identities = 43/221 (19%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
GT+G+VY+G + + + ++ D ++ + + + + H+NI T G
Sbjct: 17 GTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHRNIATYYGAF 72
Query: 293 IEDH-----TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
I+ + +L+ + ++ ++ K +TL + + +C +I+ G+ +
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK------GNTLKEEWIAYICREILRGLSH 126
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE--NRPVKWLAIES 405
LH+ K++H+D+ +N ++ + +++ D ++ L D N P W+A E
Sbjct: 127 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPY-WMAPEV 182
Query: 406 LV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
+ T+ SD+W+ G+ E+ A P ++ P
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGA-PPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 60/277 (21%), Positives = 109/277 (39%), Gaps = 56/277 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG+VY+ +E GV + V D S ++ + E + H NI+ +L
Sbjct: 15 DGAFGKVYKAQ-NKETGV---LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG--------VAHTLTTQEVVDMCLQIIM 343
++ LI + C G + LT ++ +C Q +
Sbjct: 71 FYYENNLWILI----------------EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE 114
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA---------RDLFPSDYHCLGDNE 394
+ YLH+ K++H+DL N + I++ D ++ RD F +
Sbjct: 115 ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY------ 168
Query: 395 NRPVKWLAIESLVHKT-----FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-- 447
W+A E ++ +T + +DVW+ G+ L E+ + + P+ E++P + +
Sbjct: 169 -----WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI-EPPHHELNPMRVLLKIAK 222
Query: 448 QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ L QP E + C N + R T QL
Sbjct: 223 SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 57/274 (20%), Positives = 110/274 (40%), Gaps = 41/274 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EGT+G+VY+ + + + V +K + D + + + + +H NI T G
Sbjct: 16 EGTYGKVYKARHKKTG---QLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 292 SIE-DHTSP----FLIYPYQD---YTNL-KRFLQKCKLCPEGVAHTLTTQEVVDMCLQII 342
I+ + +L+ T+L K +K K E + + + +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW--------IAYILRETL 123
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH---CLGDNENRPVK 399
G+ YLH+ K++H+D+ +N ++ +++ D ++ L + +G P
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGT----PY- 178
Query: 400 WLAIESLVHK-----TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ----DG 450
W+A E + ++ SDVW+ G+ EL + P ++ P M A +
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELAD-GKPPLCDMHP--MRALFKIPRNPP 235
Query: 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L P N + ++ C N E RP +L
Sbjct: 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 58/264 (21%), Positives = 119/264 (45%), Gaps = 30/264 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG-LSHKNILTVLG 290
+GT+G VY + + + +K + + S + L E +A++ L H+NI+ LG
Sbjct: 18 KGTYGIVYAA---RDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQE--VVDMCLQIIMGVQYL 348
E+ F I+ Q L + K P L E ++ QI+ G++YL
Sbjct: 73 SDSENGF--FKIFMEQVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYL 124
Query: 349 HKKKLLHKDLATRNCVVDDKLRI-QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
H +++H+D+ N +V+ + +I+D ++ L + + + ++++A E +
Sbjct: 125 HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGINPCTETFTGTLQYMAPEVID 182
Query: 408 H--KTFSTASDVWAFGVLLWELTTLAQQPYAEI-DPFEMAASLQDGYRLNQPVNCPDELF 464
+ + +D+W+ G + E+ T + P+ E+ +P AA + G P P+ L
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELGEP--QAAMFKVGMFKIHP-EIPESLS 238
Query: 465 ----SVMAYCWAMNPEGRPTFPQL 484
+ + C+ +P+ R + L
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 41/155 (26%), Positives = 81/155 (52%), Gaps = 26/155 (16%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
QII G+++LH+++++++DL N ++D+ ++I+D LA +L G ++ +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD------GQSKTKGYA 158
Query: 400 ----WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY----AEIDPFEMAASLQDGY 451
++A E L + + + D +A GV L+E+ A+ P+ +++ E+ +
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRI---- 213
Query: 452 RLNQPVNCPDELFSVMA--YCWAM---NPEGRPTF 481
LN V PD+ FS + +C A+ +PE R F
Sbjct: 214 -LNDSVTYPDK-FSPASKSFCEALLAKDPEKRLGF 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 14/148 (9%)
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCL 339
L H+NI+++ + I + + T+L R L + L Q +
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLT---------SRPLEKQFIQYFLY 115
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
QI+ G++Y+H ++H+DL N ++++ ++I D LAR D G R +
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYYR 172
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWEL 427
I L + + D+W+ G + E+
Sbjct: 173 APEI-MLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 33/143 (23%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV- 398
+I +G+ +LH++ ++++DL N ++D + I+I D + ++ H + R
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE------HMVDGVTTRTFC 162
Query: 399 ---KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455
++A E + ++ + + D WA+GVLL+E+ Q P+ D E+ S+ + + ++
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSIME-HNVSY 220
Query: 456 PVNCPDELFSVMAYCWAMNPEGR 478
P + E S+ +P R
Sbjct: 221 PKSLSKEAVSICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 50/222 (22%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNL----KRFLQKCKLCPEGVAHTLTTQEVV 335
L+H N++ L IED+ ++ D +L K F ++ +L PE + V
Sbjct: 59 LNHPNVIKYLDSFIEDNELN-IVLELADAGDLSQMIKYFKKQKRLIPE--------RTVW 109
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
+Q+ V+++H ++++H+D+ N + +++ D L R F S
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVG 168
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455
P +++ E + ++ SD+W+ G LL+E+ L Q P+ D + + Q + +
Sbjct: 169 TPY-YMSPERIHENGYNFKSDIWSLGCLLYEMAAL-QSPFYG-DKMNLFSLCQKIEQCDY 225
Query: 456 PVNCPDELFS-----VMAYCWAMNPEGRPTFPQLHSCLQEFH 492
P P E +S +++ C +P+ RP +H ++ H
Sbjct: 226 P-PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 282 HKNILTVLGVSIEDHTSPFL-IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQ 340
H N+L+ L + H PF IY + ++ L K + P+ L++ V Q
Sbjct: 58 HDNVLSALDILQPPHIDPFEEIYVVTEL--MQSDLHKIIVSPQ----PLSSDHVKVFLYQ 111
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
I+ G++YLH +LH+D+ N +V+ ++I D LAR P D E +
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP-DESKHMTQEVVTQYY 170
Query: 401 LAIESLV-HKTFSTASDVWAFGVLLWELTT-----LAQQPYAEID 439
A E L+ + +++A D+W+ G + EL AQ P ++D
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 32/171 (18%), Positives = 74/171 (43%), Gaps = 22/171 (12%)
Query: 325 VAHT-LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383
V HT + +++ +CL ++ + +LH + ++H+D+ + + ++ R++++D
Sbjct: 107 VTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF----- 161
Query: 384 PSDYHCLGDNENRPVK--------WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
C ++ P + W+A E + + T D+W+ G+++ E+ + PY
Sbjct: 162 -----CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPY 215
Query: 436 AEIDPFEMAASLQDGY--RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
P + ++D +L L S + +P R T +L
Sbjct: 216 FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 1e-05
Identities = 54/273 (19%), Positives = 106/273 (38%), Gaps = 57/273 (20%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G+FG VY+ + + V +K + + ++ + QE + I G
Sbjct: 12 GSFGEVYKAIDKRTN---QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
++ + ++I Y + L+ KL E + + ++++G++YLH++
Sbjct: 69 LKG-SKLWIIMEYCGGGSCLDLLKPGKL-DE--------TYIAFILREVLLGLEYLHEEG 118
Query: 353 LLHKDLATRNCVV----DDKL-----RIQITDNALARDLF---PSDYHCLGDNENRPVKW 400
+H+D+ N ++ D KL Q+T R+ F P W
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF--------------W 164
Query: 401 LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460
+A E + + +D+W+ G+ EL + P +++ P M P N P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHP--MRV------LFLIPKNNP 215
Query: 461 DEL----FS-----VMAYCWAMNPEGRPTFPQL 484
L FS ++ C +P+ RP+ +L
Sbjct: 216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 23/103 (22%), Positives = 54/103 (52%), Gaps = 18/103 (17%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+I G++ LH+++++++DL N ++DD I+I+D LA ++ E ++
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI----------PEGETIR 159
Query: 400 -------WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
++A E + ++ ++ + D W G L++E+ + P+
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 24/181 (13%)
Query: 264 AVQVSLLLQEGMAMYGLSHKNILTVLGV----------SIEDHTSPFLIYPYQDY--TNL 311
V L+E + L H NI+ V V + T +Y Q+Y T+L
Sbjct: 43 PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDL 102
Query: 312 KRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD-DKLR 370
L++ L E L Q++ G++Y+H +LH+DL N ++ + L
Sbjct: 103 ANVLEQGPLSEEHA--RLFM-------YQLLRGLKYIHSANVLHRDLKPANVFINTEDLV 153
Query: 371 IQITDNALARDLFPSDYHCLGDNENRPVKWL-AIESLVHKT-FSTASDVWAFGVLLWELT 428
++I D LAR + P H +E KW + L+ ++ A D+WA G + E+
Sbjct: 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213
Query: 429 T 429
T
Sbjct: 214 T 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 27/106 (25%), Positives = 60/106 (56%), Gaps = 15/106 (14%)
Query: 331 TQEVVDMCL-QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC 389
T+E V L ++ + + +LH ++++DL N ++D++ I++TD L+++
Sbjct: 96 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI------ 149
Query: 390 LGDNENRP------VKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429
D+E + V+++A E + + + ++D W+FGVL++E+ T
Sbjct: 150 --DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 280 LSHKNILTVLGVSIEDHTSPFL-IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H+NI+ +L + F +Y + T+L + ++ LT +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS--------PQPLTDDHIQY 107
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
QI+ G++YLH ++H+DL N +V+ ++I D LAR + P + E
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167
Query: 397 PVKWL-AIE-SLVHKTFSTASDVWAFGVLLWEL 427
+W A E L ++ A D+W+ G + EL
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 65/273 (23%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVK-----TVTDNASAVQ--VSLLLQEGMAMYGLSHKNI 285
G +G VYRG + V V +K T D+ S +Q V+LL Q + NI
Sbjct: 12 GAYGAVYRGKHVPTGRV---VALKIINLDTPDDDVSDIQREVALLSQ----LRQSQPPNI 64
Query: 286 LTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLT-TQEVVDMCLQIIM- 343
G S ++I Y G TL + + + +I+
Sbjct: 65 TKYYG-SYLKGPRLWIIMEY---------------AEGGSVRTLMKAGPIAEKYISVIIR 108
Query: 344 ----GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
++Y+HK ++H+D+ N +V + +++ D +A L N+N +
Sbjct: 109 EVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL----------NQNSSKR 158
Query: 400 --------WLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450
W+A E + K + T +D+W+ G+ ++E+ T PY+++D F +
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAMMLIPK- 216
Query: 451 YRLNQPVNCPDELFS-----VMAYCWAMNPEGR 478
++P D +S +A C P+ R
Sbjct: 217 ---SKPPRLEDNGYSKLLREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 53/217 (24%), Positives = 100/217 (46%), Gaps = 42/217 (19%)
Query: 268 SLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKC-KLCPEGV 325
S L+ E M L HKNI+ + + +++ + D +L R +QKC K+ +
Sbjct: 57 SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIE 116
Query: 326 AHTLTTQEVVDMCLQIIMGVQYLHK-------KKLLHKDLATRNCVVDDKLR-------- 370
H +VD+ Q++ + Y H +++LH+DL +N + +R
Sbjct: 117 EHA-----IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 371 ---------IQITDNALARDL-FPSDYH-CLGDNENRPVKWLAIESLVH--KTFSTASDV 417
+I D L++++ S H C+G P W + E L+H K++ SD+
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGT----PYYW-SPELLLHETKSYDDKSDM 226
Query: 418 WAFGVLLWELTTLAQQPYAEIDPF-EMAASLQDGYRL 453
WA G +++EL + + P+ + + F ++ + L+ G L
Sbjct: 227 WALGCIIYELCS-GKTPFHKANNFSQLISELKRGPDL 262
|
Length = 1021 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 36/159 (22%), Positives = 75/159 (47%), Gaps = 27/159 (16%)
Query: 280 LSHKNILTVLGV-----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEV 334
+ H+N++ +L V S++ +L+ P+ T+L + ++ KL + +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMG-TDLGKLMKHEKLSEDRIQF------- 122
Query: 335 VDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394
+ Q++ G++Y+H ++H+DL N V++ ++I D LAR +D G
Sbjct: 123 --LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TDSEMTGYVV 177
Query: 395 NRPVKWL----AIESLVHKTFSTASDVWAFGVLLWELTT 429
R W I + +H ++ D+W+ G ++ E+ T
Sbjct: 178 TR---WYRAPEVILNWMH--YTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 14/195 (7%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G+FGRV TY ED + + QV + E + ++H + + G S
Sbjct: 41 GSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYG-S 99
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352
+D + +L+ + FL++ K P V Q I++ +YL
Sbjct: 100 FKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ--------IVLIFEYLQSLN 151
Query: 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS 412
++++DL N ++D I++TD A+ + Y G E ++A E L++
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPE-----YIAPEILLNVGHG 206
Query: 413 TASDVWAFGVLLWEL 427
A+D W G+ ++E+
Sbjct: 207 KAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 23/153 (15%)
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC-LGDNENRPVK 399
++ G+ YL K+LH+D+ N +V+ + ++++ D ++ L S +G N
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTN-----A 158
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-------PFEMAASLQDGYR 452
++A E + + + SDVW+ G+ EL L + PY +I P ++ + D
Sbjct: 159 YMAPERISGEQYGIHSDVWSLGISFMEL-ALGRFPYPQIQKNQGSLMPLQLLQCIVD--- 214
Query: 453 LNQPVNCPDELFS-----VMAYCWAMNPEGRPT 480
P P FS + C P+ RP
Sbjct: 215 -EDPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 57/273 (20%), Positives = 116/273 (42%), Gaps = 63/273 (23%)
Query: 231 MEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
GT V + TY E+E +V+ + ++ L+ + L+H +I+ +LG
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRK-----EIRLMAR-------LNHPHIIRMLG 70
Query: 291 VSIED-HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTT----QE--VVDMCLQIIM 343
+ ED H + F+ + + V+H L+ +E +++ Q++
Sbjct: 71 ATCEDSHFNLFVEW----------------MAGGSVSHLLSKYGAFKEAVIINYTEQLLR 114
Query: 344 GVQYLHKKKLLHKDLATRNCVVDD---KLRI-------QITDNALARDLFPSDYHCLGDN 393
G+ YLH+ +++H+D+ N ++D +LRI ++ F LG
Sbjct: 115 GLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL--LGT- 171
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
+ ++A E L + + + DVW+ G ++ E+ T A+ P+ + + + L +++
Sbjct: 172 ----IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKPPW---NAEKHSNHLALIFKI 223
Query: 454 ---NQPVNCPDELF----SVMAYCWAMNPEGRP 479
+ P+ L V C + PE RP
Sbjct: 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 45/193 (23%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV- 398
Q++ ++Y+H ++H+DL N +++ R+++ D LAR L L +N PV
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL-----SELEENPENPVL 169
Query: 399 ------KWL-AIESLVHKT-FSTASDVWAFGVLLWEL----------TTLAQ-------- 432
+W A E L+ T ++ D+W+ G +L E+ +TL Q
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229
Query: 433 -QPYAE-ID----PF--EMAASLQDGYRLNQPV---NCPDELFSVMAYCWAMNPEGRPTF 481
P AE I+ PF M SL R D+ ++ NP R T
Sbjct: 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289
Query: 482 PQL--HSCLQEFH 492
+ H + +FH
Sbjct: 290 EEALEHPYVAQFH 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 50/251 (19%), Positives = 105/251 (41%), Gaps = 24/251 (9%)
Query: 237 RVYRGTYTEEDGVEEEVLVKTVT--DNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294
+Y+G + ++ V+++T V + + E + + NIL + G I+
Sbjct: 35 SIYKGIFNNKE-----VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89
Query: 295 ---DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
D LI Y L+ L K K L+ + +DM + G+ L+K
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVLDKEK--------DLSFKTKLDMAIDCCKGLYNLYKY 141
Query: 352 -KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
+K+L + + +V + +++I + L + L + + K L + +
Sbjct: 142 TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKML---NDIFSE 198
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM-AASLQDGYRLNQPVNCPDELFSVMAY 469
++ D+++ GV+LWE+ T + P+ + E+ + L P++CP E+ ++
Sbjct: 199 YTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257
Query: 470 CWAMNPEGRPT 480
C + + RP
Sbjct: 258 CTSHDSIKRPN 268
|
Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 25/104 (24%), Positives = 53/104 (50%), Gaps = 4/104 (3%)
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLG 391
+ + +I+ G++ LH++ +++DL N ++DD I+I+D LA + +
Sbjct: 102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SI 158
Query: 392 DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
V ++A E L ++ ++ + D W G L++E+ Q P+
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 32/172 (18%)
Query: 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLA 359
FL+ Y + +L +Q+ + PE A + I + + +LH++ ++++DL
Sbjct: 72 FLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAE--------ICIALNFLHERGIIYRDLK 123
Query: 360 TRNCVVDDKLRIQITDNALARD-LFPSD---YHCLGDNENRPVKWLAIESLVHKTFSTAS 415
N ++D I++TD + ++ L P D C N ++A E L + + +
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPN------YIAPEILRGEEYGFSV 177
Query: 416 DVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467
D WA GVL++E+ A PF++ N +N D LF V+
Sbjct: 178 DWWALGVLMFEMM-------AGRSPFDIITD-------NPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 3e-05
Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 2/88 (2%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+I+ + YLH K++++DL N ++D I+ITD L ++ +D + P +
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI-TDAATMKTFCGTP-E 160
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWEL 427
+LA E L + A D W GV+++E+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 21/114 (18%), Positives = 52/114 (45%), Gaps = 13/114 (11%)
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
++ +C + + +++LH +++H+D+ + N ++ +++TD + P +
Sbjct: 116 QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-------E 168
Query: 393 NENRPVK-----WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
R W+A E + K + D+W+ G++ E+ + PY +P
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 25/125 (20%), Positives = 62/125 (49%), Gaps = 11/125 (8%)
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD----NALARDLFP 384
L +++ +C ++ + YLH + ++H+D+ + + ++ R++++D +++D+ P
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-P 172
Query: 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444
+G W+A E + + T D+W+ G+++ E+ + PY P +
Sbjct: 173 KRKSLVGTP-----YWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAM 226
Query: 445 ASLQD 449
L+D
Sbjct: 227 KRLRD 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 21/109 (19%), Positives = 51/109 (46%), Gaps = 3/109 (2%)
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
++ +C + + +++LH +++H+D+ + N ++ +++TD + P
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 175
Query: 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
P W+A E + K + D+W+ G++ E+ + PY +P
Sbjct: 176 MVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPL 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 50/237 (21%), Positives = 100/237 (42%), Gaps = 47/237 (19%)
Query: 226 LFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI 285
L V GT+G+VY+G + + G + V VT++ + + L+ M H+NI
Sbjct: 20 LVEVVGNGTYGQVYKGRHVKT-GQLAAIKVMDVTEDE---EEEIKLEINMLKKYSHHRNI 75
Query: 286 LTVLGVSIEDHTSP-------FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
T G I+ SP +L+ + ++ ++ K + L + +C
Sbjct: 76 ATYYGAFIK--KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK------GNALKEDWIAYIC 127
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
+I+ G+ +LH K++H+D+ +N ++ + +++ D ++ L +R V
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL------------DRTV 175
Query: 399 K----------WLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440
W+A E + T+ SD+W+ G+ E+ A P ++ P
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA-PPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 57/248 (22%), Positives = 98/248 (39%), Gaps = 55/248 (22%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G+FG+V + + AV+V LQ+ + K+I+ V
Sbjct: 5 KGSFGKVLLAKHKADGKF-------------YAVKV---LQKKAILKKKEQKHIMAERNV 48
Query: 292 SIEDHTSPFLI---YPYQ---------DYTN---LKRFLQKCKLCPEGVAHTLTTQEVVD 336
+++ PFL+ Y +Q DY N L LQ+ + PE A +
Sbjct: 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE---- 104
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSD---YHCLGD 392
I + YLH ++++DL N ++D + + +TD L + + S C G
Sbjct: 105 ----IASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GT 159
Query: 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452
E +LA E L + + D W G +L+E+ P+ D EM ++
Sbjct: 160 PE-----YLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDTAEMYDNI----- 208
Query: 453 LNQPVNCP 460
LN+P+
Sbjct: 209 LNKPLRLK 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 38/159 (23%), Positives = 76/159 (47%), Gaps = 28/159 (17%)
Query: 280 LSHKNILTVLGV-----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEV 334
+ H+N++ +L V S ++ +L+ PY T+L++ + H L+ +V
Sbjct: 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIM----------GHPLSEDKV 119
Query: 335 VDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394
+ Q++ G++Y+H ++H+DL N V++ ++I D LAR +D G
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH---ADAEMTGYVV 176
Query: 395 NRPVKWL----AIESLVHKTFSTASDVWAFGVLLWELTT 429
R W I + +H ++ D+W+ G ++ E+ T
Sbjct: 177 TR---WYRAPEVILNWMH--YNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 25/104 (24%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLG 391
Q + ++ G++ L +++++++DL N ++DD+ I+I+D LA + P G
Sbjct: 102 QRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRG 160
Query: 392 DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
V ++A E + ++ ++ + D W G L++E+ Q P+
Sbjct: 161 --RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 16/199 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV-SLLLQEGMAMYGLSHKNILTVLG 290
EG +G V + + E +E V +K D+ +V L+E + L +NI+ L
Sbjct: 11 EGAYGVVLKCRHKE---TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVE-LK 66
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+ +L++ Y + K L+ + P GV ++V Q+I + + HK
Sbjct: 67 EAFRRRGKLYLVFEYVE----KNMLELLEEMPNGVP----PEKVRSYIYQLIKAIHWCHK 118
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL-AIESLVHK 409
++H+D+ N ++ +++ D AR+L S+ E +W + E L+
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYTEYVATRWYRSPELLLGA 176
Query: 410 TFSTASDVWAFGVLLWELT 428
+ A D+W+ G +L EL+
Sbjct: 177 PYGKAVDMWSVGCILGELS 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 54/269 (20%), Positives = 101/269 (37%), Gaps = 43/269 (15%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
GT+G VY+ E+ V +++ QE + M H NI+ G
Sbjct: 20 GTYGDVYKARNVNTG----ELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG-- 73
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG-------VAHTLTTQEVVDMCLQIIMGV 345
Y + + C G V L+ ++ + + + G+
Sbjct: 74 --------------SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN---RPVKWLA 402
YLH K +H+D+ N ++ D +++ D ++ + + + ++ P W+A
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT----IAKRKSFIGTPY-WMA 174
Query: 403 IE-SLVHKT--FSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEMAASLQDGYRLNQ 455
E + V + ++ D+WA G+ EL L Q P ++ P F M S +L
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIELAEL-QPPMFDLHPMRALFLMTKSNFQPPKLKD 233
Query: 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ + + NP+ RPT +L
Sbjct: 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 24/157 (15%)
Query: 281 SHKNILTVLGVSIEDHTSPFL-IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVD- 336
H+NI+ +L + F +Y Q+ T+L + + TQ + +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYK--------------LIKTQHLSND 106
Query: 337 ----MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
QI+ G++Y+H +LH+DL N +++ ++I D LAR P H
Sbjct: 107 HIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166
Query: 393 NENRPVKWL-AIE-SLVHKTFSTASDVWAFGVLLWEL 427
E +W A E L K ++ A D+W+ G +L E+
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 34/132 (25%), Positives = 64/132 (48%), Gaps = 22/132 (16%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD-LFPSD---YHCLGDNEN 395
+I + + +LH++ ++++DL N ++D + I++TD + ++ + P D C N
Sbjct: 104 EISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN-- 161
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455
++A E L + + + D WA GVL++E+ A PF++ G N
Sbjct: 162 ----YIAPEILRGEDYGFSVDWWALGVLMFEMM-------AGRSPFDIV-----GMSDNP 205
Query: 456 PVNCPDELFSVM 467
N D LF V+
Sbjct: 206 DQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 25/88 (28%), Positives = 48/88 (54%), Gaps = 2/88 (2%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+I+ ++YLH + ++++D+ N ++D I+ITD L ++ SD + P +
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTP-E 160
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWEL 427
+LA E L + A D W GV+++E+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 40/170 (23%), Positives = 75/170 (44%), Gaps = 16/170 (9%)
Query: 325 VAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384
V L+ ++ +C + + G+ YLH K +H+D+ N ++ D +++ D +A +
Sbjct: 99 VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158
Query: 385 SDYHCLGDNEN---RPVKWLAIE-SLVHKT--FSTASDVWAFGVLLWELTTLAQQPYAEI 438
+ + ++ P W+A E + V K ++ D+WA G+ EL L Q P ++
Sbjct: 159 T----IAKRKSFIGTPY-WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL-QPPMFDL 212
Query: 439 DP----FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
P F M+ S +L + + NP+ RPT +L
Sbjct: 213 HPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 37/195 (18%), Positives = 79/195 (40%), Gaps = 15/195 (7%)
Query: 256 KTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFL 315
K D+ S + LL QE + L H NIL + I D +++ P Y + + L
Sbjct: 32 KINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-ELYVVSPLMAYGSCEDLL 90
Query: 316 QKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375
PEG+ + D ++ + Y+H K +H+ + + ++ ++ ++
Sbjct: 91 --KTHFPEGLPELAIAFILKD----VLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSG 144
Query: 376 NALARDLFPSD-----YHCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELT 428
+ + H + + + WL+ E L + ++ SD+++ G+ EL
Sbjct: 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204
Query: 429 TLAQQPYAEIDPFEM 443
P+ ++ +M
Sbjct: 205 N-GHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 2e-04
Identities = 21/114 (18%), Positives = 51/114 (44%), Gaps = 13/114 (11%)
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
++ +C + + + +LH +++H+D+ + N ++ +++TD + P +
Sbjct: 116 QIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------E 168
Query: 393 NENRPVK-----WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
R W+A E + K + D+W+ G++ E+ + PY +P
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 19/138 (13%)
Query: 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360
L++ Y D+T L + + PE + + + Q + V + HK +H+D+
Sbjct: 77 LVFEYCDHTVLNELEKNPRGVPEHL--------IKKIIWQTLQAVNFCHKHNCIHRDVKP 128
Query: 361 RNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV--KWL-AIESLVHKT-FSTASD 416
N ++ + +I++ D AR L D+ V +W A E LV T + D
Sbjct: 129 ENILITKQGQIKLCDFGFARILTGPG-----DDYTDYVATRWYRAPELLVGDTQYGPPVD 183
Query: 417 VWAFGVLLWELTTLAQQP 434
VWA G + EL L QP
Sbjct: 184 VWAIGCVFAEL--LTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 46/198 (23%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG++ VY+G + +G + V +K ++ ++E + GL H NI+ + +
Sbjct: 15 EGSYATVYKGI-SRING--QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
I + ++ Y +T+L +++ + P G L V Q++ G+ Y+H +
Sbjct: 72 -IHTKETLTFVFEYM-HTDLAQYMIQH---PGG----LHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
+LH+DL +N ++ +++ D LAR PS + +E + + + L+ T
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY---SSEVVTLWYRPPDVLLGAT 179
Query: 411 -FSTASDVWAFGVLLWEL 427
+S+A D+W G + E+
Sbjct: 180 DYSSALDIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 50/255 (19%), Positives = 97/255 (38%), Gaps = 57/255 (22%)
Query: 256 KTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI-YPYQDYTNL-- 311
KT+ TD +Q +L +E I+ G +++ +S I Y + +L
Sbjct: 32 KTITTDPNPDLQKQIL-RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS 90
Query: 312 --KRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369
K+ ++ E V + ++ G+ YLH +K++H+D+ N ++ K
Sbjct: 91 IYKKVKKRGGRIGEKVLGKIAES--------VLKGLSYLHSRKIIHRDIKPSNILLTRKG 142
Query: 370 RIQITD--------NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFG 421
++++ D N+LA + + ++A E + K +S SDVW+ G
Sbjct: 143 QVKLCDFGVSGELVNSLAGTFTGTSF------------YMAPERIQGKPYSITSDVWSLG 190
Query: 422 VLLWELTTL-------AQQPYAEID---------PFEMAASLQDGYRLNQPVNCPDELFS 465
+ L E+ + P I+ E+ +G + +E
Sbjct: 191 LTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG------IKWSEEFKD 244
Query: 466 VMAYCWAMNPEGRPT 480
+ C +P RPT
Sbjct: 245 FIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 232 EGTFGRVY------RGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI 285
+GTFG+V G Y +++EV+V + +V+ L E + H
Sbjct: 5 KGTFGKVILVKEKATGRYYAMKILKKEVIV-------AKDEVAHTLTENRVLQNSRHP-F 56
Query: 286 LTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
LT L S + H + Y + L L + ++ E A + I+ +
Sbjct: 57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSAL 108
Query: 346 QYLH-KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIE 404
YLH +K ++++DL N ++D I+ITD L ++ D + P ++LA E
Sbjct: 109 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-KDGATMKTFCGTP-EYLAPE 166
Query: 405 SLVHKTFSTASDVWAFGVLLWEL 427
L + A D W GV+++E+
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 19/161 (11%)
Query: 272 QEGMAMYGLSHKNILTVLGV-----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVA 326
+E + M ++HKNI+ +L V S+E+ +++ D NL + +Q
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--------- 121
Query: 327 HTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386
L + + + Q++ G+++LH ++H+DL N VV ++I D LAR S
Sbjct: 122 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 179
Query: 387 YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWEL 427
+ + A E ++ + D+W+ G ++ E+
Sbjct: 180 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 30/109 (27%), Positives = 55/109 (50%), Gaps = 6/109 (5%)
Query: 272 QEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTT 331
+E + M ++HKNI+++L V + + +QD L L LC + + L
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKS----LEEFQD-VYLVMELMDANLC-QVIQMELDH 118
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
+ + + Q++ G+++LH ++H+DL N VV ++I D LAR
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 57/275 (20%), Positives = 99/275 (36%), Gaps = 60/275 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV----TDNASAVQVSLLLQEGMAMYGLSHKNILT 287
GT+G VY+ E V +K + D+ +Q QE + H NI+
Sbjct: 13 SGTYGDVYKARDIATG---ELVAIKVIKLEPGDDFEIIQ-----QEISMLKECRHPNIVA 64
Query: 288 VLGVSIEDHTSPFLIYPY------QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQI 341
G + +++ Y QD + R L+ ++ +C +
Sbjct: 65 YFGSYLRRDKL-WIVMEYCGGGSLQDIYQVTR-------------GPLSELQIAYVCRET 110
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDD----KL-----RIQITDNALARDLFPSDYHCLGD 392
+ G+ YLH+ +H+D+ N ++ + KL Q+T R F +
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY---- 166
Query: 393 NENRPVKWLAIESL-VHKT--FSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEMAA 445
W+A E V + + D+WA G+ EL L Q P ++ P F ++
Sbjct: 167 -------WMAPEVAAVERKGGYDGKCDIWALGITAIELAEL-QPPMFDLHPMRALFLISK 218
Query: 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPT 480
S +L + C +P+ RPT
Sbjct: 219 SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 37/157 (23%), Positives = 72/157 (45%), Gaps = 27/157 (17%)
Query: 280 LSHKNILTVLGV-----SIEDHTSPFLIYPYQ--DYTNLKRFLQKCKLCPEGVAHTLTTQ 332
+ H+N++ +L V SIE+ +L+ D N+ + L+ +
Sbjct: 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC------------QKLSDE 118
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
V + Q++ G++Y+H ++H+DL N V++ ++I D LAR +D G
Sbjct: 119 HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQ---ADDEMTGY 175
Query: 393 NENRPVKWL-AIESLVH-KTFSTASDVWAFGVLLWEL 427
R W A E +++ ++ D+W+ G ++ EL
Sbjct: 176 VATR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 24/134 (17%), Positives = 61/134 (45%), Gaps = 20/134 (14%)
Query: 325 VAHT-LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383
V HT + +++ +CL ++ + LH + ++H+D+ + + ++ R++++D
Sbjct: 108 VTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF----- 162
Query: 384 PSDYHCLGDNENRPVK--------WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
C ++ P + W+A E + + D+W+ G+++ E+ + PY
Sbjct: 163 -----CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPY 216
Query: 436 AEIDPFEMAASLQD 449
P + ++D
Sbjct: 217 FNEPPLKAMKMIRD 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 27/159 (16%)
Query: 280 LSHKNILTVLGV-----SIEDHTSPFLIYPYQ--DYTNLKRFLQKCKLCPEGVAHTLTTQ 332
+ H+N++ +L V S+E+ +L+ D N+ KC+ LT
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQ--------KLTDD 120
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
V + QI+ G++Y+H ++H+DL N V++ ++I D LAR +D G
Sbjct: 121 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGY 177
Query: 393 NENRPVKWL-AIESLVH-KTFSTASDVWAFGVLLWELTT 429
R W A E +++ ++ D+W+ G ++ EL T
Sbjct: 178 VATR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 25/99 (25%), Positives = 54/99 (54%), Gaps = 14/99 (14%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--- 396
+II+ +++LHK ++++D+ N ++D + + +TD L+++ L + + R
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-------LSEEKERTYS 165
Query: 397 ---PVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLA 431
++++A E + K A D W+ G+L++EL T A
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 47/194 (24%), Positives = 87/194 (44%), Gaps = 23/194 (11%)
Query: 300 FLIYPYQDYTNLKRFLQKC-KLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKD 357
+ Y D +L + L++ PE L + + ++ G+ YLH+K K++H+D
Sbjct: 75 SICMEYMDGGSLDKILKEVQGRIPE---RILGK-----IAVAVLKGLTYLHEKHKIIHRD 126
Query: 358 LATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDV 417
+ N +V+ + +I++ D ++ L S L ++A E + +S SD+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYSVKSDI 182
Query: 418 WAFGVLLWELTTLAQQPYA-EIDPFEMAASLQDGYRLNQPV------NCPDELFSVMAYC 470
W+ G+ L EL T + PY E DP + L Y +N+P + + C
Sbjct: 183 WSLGLSLIELATG-RFPYPPENDPPDGIFELLQ-YIVNEPPPRLPSGKFSPDFQDFVNLC 240
Query: 471 WAMNPEGRPTFPQL 484
+P RP++ +L
Sbjct: 241 LIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLL----LQEGMAMYGL-SHKNIL 286
+G +G V E EE V +K +T+ +L L+E + HKNI
Sbjct: 10 QGAYGIVCSARNAETSE-EETVAIKKITN---VFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHT---LTTQEVVDMCLQIIM 343
+ + I + +Y Y++ L + L + + LT QI+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEE-------LMEADL--HQIIRSGQPLTDAHFQSFIYQILC 116
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP------ 397
G++Y+H +LH+DL N +V+ ++I D LAR EN
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE------NPGENAGFMTEYV 170
Query: 398 -VKWL-AIESLV-HKTFSTASDVWAFGVLLWELTTLAQQP 434
+W A E ++ ++++ A DVW+ G +L EL L ++P
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL--LGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 36/152 (23%), Positives = 65/152 (42%), Gaps = 10/152 (6%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+ +MG+Q+LH K +H+D+ N ++ + +++ D ++ L S + P
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPF- 189
Query: 400 WLAIESL-----VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--YR 452
W+A E + + T+ DVW+ G+ EL P A++ P +
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD-GDPPLADLHPMRALFKIPRNPPPT 248
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L+QP +E + C + E RPT L
Sbjct: 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 16/144 (11%)
Query: 298 SPFLI---YPYQDYTNLKRFLQKCKLCPEGVAH-----TLTTQEVVDMCLQIIMGVQYLH 349
SPFL+ Y +Q T L L E H QEV +I++ +++LH
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYIN-GGELFTHLSQRERFKEQEVQIYSGEIVLALEHLH 122
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD----YHCLGDNENRPVKWLAIES 405
K ++++D+ N ++D + +TD L+++ + Y G E +
Sbjct: 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182
Query: 406 LVHKTFSTASDVWAFGVLLWELTT 429
H A D W+ GVL++EL T
Sbjct: 183 GGH---DKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 7e-04
Identities = 32/142 (22%), Positives = 70/142 (49%), Gaps = 14/142 (9%)
Query: 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNC 363
+ D +L + L++ K PE + ++ + ++ G+ YL +K +++H+D+ N
Sbjct: 84 HMDGGSLDQVLKEAKRIPEEILGKVS--------IAVLRGLAYLREKHQIMHRDVKPSNI 135
Query: 364 VVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVL 423
+V+ + I++ D ++ L S + ++ +++ E L +S SD+W+ G+
Sbjct: 136 LVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 424 LWELTTLAQQPYAEIDPFEMAA 445
L EL + + P D E+ A
Sbjct: 192 LVEL-AIGRYPIPPPDAKELEA 212
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 23/100 (23%), Positives = 51/100 (51%), Gaps = 15/100 (15%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP-- 397
+I++ + +LH+ ++++D+ N ++D + + +TD L+++ + E R
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA-------EEEERAYS 165
Query: 398 ----VKWLAIESLVHKT--FSTASDVWAFGVLLWELTTLA 431
++++A E + + A D W+ GVL +EL T A
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 25/95 (26%), Positives = 46/95 (48%), Gaps = 13/95 (13%)
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
++ +QYLH+ +++H+D+ N ++ + + D A FP D N N+ W
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDI-----NANKYYGW 243
Query: 401 L------AIESLVHKTFSTASDVWAFGVLLWELTT 429
A E L + A D+W+ G++L+E+ T
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 18/107 (16%)
Query: 280 LSHKNILTVLGV-----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEV 334
++HKNI+++L V S+E+ +L+ D LC V H E
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD----------ANLCQ--VIHMELDHER 124
Query: 335 VDMCL-QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
+ L Q++ G+++LH ++H+DL N VV ++I D LAR
Sbjct: 125 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 51/199 (25%), Positives = 81/199 (40%), Gaps = 39/199 (19%)
Query: 280 LSHKNILTVLGVSIEDHTSP-FLIYPY-QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
L H I+ V SI P + PY + YT LK L+ E ++ L + V
Sbjct: 59 LIHPGIVPVY--SICSDGDPVYYTMPYIEGYT-LKSLLKSVWQK-ESLSKELAEKTSVGA 114
Query: 338 CLQIIM----GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-------DLFPSD 386
L I ++Y+H K +LH+DL N ++ + I D A DL D
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 387 YHCLG---DNENRPVK------WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE 437
+ P K ++A E L+ S ++D++A GV+L+++ TL+ PY
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS-FPYRR 233
Query: 438 ------------IDPFEMA 444
+ P E+A
Sbjct: 234 KKGRKISYRDVILSPIEVA 252
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 36/128 (28%), Positives = 63/128 (49%), Gaps = 20/128 (15%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR----DLFPSDYHCLGDNEN 395
+++ ++ LHK ++++DL N ++D + I + D L + D ++ C G E
Sbjct: 101 ELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPE- 158
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--L 453
+LA E L+ ++ A D W GVLL+E+ T P+ + + EM YR L
Sbjct: 159 ----YLAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDENVNEM-------YRKIL 206
Query: 454 NQPVNCPD 461
+P+ PD
Sbjct: 207 QEPLRFPD 214
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 2/88 (2%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+I+ + YLH ++++DL N ++D I+ITD L ++ SD + P +
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTP-E 160
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWEL 427
+LA E L + A D W GV+++E+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 23/106 (21%), Positives = 50/106 (47%), Gaps = 17/106 (16%)
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388
L + V+ QI G+ +LH ++++D+ N ++DD+ +++D LA +L
Sbjct: 92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL------ 145
Query: 389 CLGDNENRPVK-------WLAIESLVHKTFSTASDVWAFGVLLWEL 427
+ + + ++A E L + +S D +A G ++E+
Sbjct: 146 ----KDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 46/202 (22%), Positives = 79/202 (39%), Gaps = 19/202 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV-SLLLQEGMAMYGLSHKNILTVLG 290
EG +G V + E V +K ++ V L+E + L H+NI+ +
Sbjct: 11 EGAYGVVLK---CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+L++ Y + T L+ + P G L V Q++ + Y H
Sbjct: 68 AFRRKGRL-YLVFEYVERT----LLELLEASPGG----LPPDAVRSYIWQLLQAIAYCHS 118
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLF-PSDYHCLGDNENRPVKWL-AIESLVH 408
++H+D+ N +V + +++ D AR L + +W A E LV
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL---TDYVATRWYRAPELLVG 175
Query: 409 KT-FSTASDVWAFGVLLWELTT 429
T + DVWA G ++ EL
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 57/266 (21%), Positives = 104/266 (39%), Gaps = 41/266 (15%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL--LLQEGMAMYGLSHKNILTVLG 290
G+FG VY T + + E V VK ++ + +++E + L H N + G
Sbjct: 32 GSFGAVYFATNSHTN---EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 291 VSIEDHTSPFLI-YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
+++HT+ ++ Y ++L +K L E+ + + G+ YLH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKK----------PLQEVEIAAITHGALQGLAYLH 138
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV-- 407
++H+D+ N ++ + ++++ D A P++ P W+A E ++
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPY-WMAPEVILAM 192
Query: 408 -HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP--FEMAAS------LQDGYRLNQPVN 458
+ DVW+ G+ EL AE P F M A Q+ Q
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL--------AERKPPLFNMNAMSALYHIAQNDSPTLQSNE 244
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQL 484
D + YC P+ RP +L
Sbjct: 245 WTDSFRGFVDYCLQKIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 30/165 (18%)
Query: 337 MCLQIIMGVQYLHKKK-LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH-----CL 390
M + I+ + YL +K ++H+D+ N ++D +++ D ++ L S C
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGC- 177
Query: 391 GDNENRPVKWLAIESL----VHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-PFEMAA 445
++A E + + + +DVW+ G+ L EL T Q PY FE+
Sbjct: 178 -------AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKNCKTEFEVLT 229
Query: 446 S-LQDGYRLNQPVNCPDELFSVM-----AYCWAMNPEGRPTFPQL 484
LQ+ P P+E FS C + RP + +L
Sbjct: 230 KILQE----EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 28/223 (12%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVT----DNASAVQVSLLLQEGMAMYGLSHKNILTV 288
G FG VY Y + G E+ VK V ++ +V+ L E + L H I+
Sbjct: 13 GAFGEVYL-CYDADTG--RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 289 LGVSIEDHTSPFL--IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
G + D L Y ++K L+ E V T Q I+ GV
Sbjct: 70 YGC-LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ--------ILQGVS 120
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----WLA 402
YLH ++H+D+ N + D +++ D ++ + C+ + V W++
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPYWMS 177
Query: 403 IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445
E + + + +DVW+ + E+ T + P+AE + MAA
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEA--MAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 29/104 (27%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 328 TLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL--FPS 385
LT + + Q++ G++Y+H ++H+DL N +V++ ++I D +AR L P+
Sbjct: 103 PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162
Query: 386 DYHCLGDNENRPVKWL-AIE-SLVHKTFSTASDVWAFGVLLWEL 427
+ H E +W A E L ++TA D+W+ G + E+
Sbjct: 163 E-HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 29/124 (23%), Positives = 62/124 (50%), Gaps = 13/124 (10%)
Query: 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNC 363
+ D +L + L+K PE + ++ + +I G+ YL +K K++H+D+ N
Sbjct: 84 HMDGGSLDQVLKKAGRIPEQILGKVS--------IAVIKGLTYLREKHKIMHRDVKPSNI 135
Query: 364 VVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVL 423
+V+ + I++ D ++ L S + ++ +++ E L +S SD+W+ G+
Sbjct: 136 LVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLS 191
Query: 424 LWEL 427
L E+
Sbjct: 192 LVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 24/157 (15%)
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCL 339
L H+N++ ++ V +L++ + D+T L E + L V
Sbjct: 57 LRHENLVNLIEV-FRRKKRLYLVFEFVDHTVLDDL--------EKYPNGLDESRVRKYLF 107
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP-----SDYHCLGDNE 394
QI+ G+++ H ++H+D+ N +V +++ D AR L +DY
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY------- 160
Query: 395 NRPVKWL-AIESLVHKT-FSTASDVWAFGVLLWELTT 429
+W A E LV T + A D+WA G L+ E+ T
Sbjct: 161 -VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 39/168 (23%), Positives = 73/168 (43%), Gaps = 22/168 (13%)
Query: 335 VDMCLQIIM----GVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC 389
V++ +I + G+ YL+ +++H+D+ N +V+ + +I++ D ++ +L S
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---- 157
Query: 390 LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYA--EIDPFEMAASL 447
+ D +++ E + ++ SDVW+ G+ + EL L + P+A ID +
Sbjct: 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIEL-ALGKFPFAFSNIDDDGQDDPM 216
Query: 448 QDGYRLNQPVN-----CPDELFSVMA-----YCWAMNPEGRPTFPQLH 485
L Q V P F C +P RPT QL
Sbjct: 217 GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 48/222 (21%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV---SLLLQEGMAMYGLSHKNILTV 288
+GTFG+VY+ + K T A++V ++ + + + +NIL
Sbjct: 3 KGTFGQVYQ-------------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVR 49
Query: 289 -----------LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
L S + + +L+ Y L LQK E A
Sbjct: 50 TLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA------ 103
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSDYHCLGDNENR 396
++++ +++LHK ++++DL N ++D I + D L++ +L + +
Sbjct: 104 --ELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTNTFCG 158
Query: 397 PVKWLAIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAE 437
++LA E L+ K ++ D W+ GVL++E+ YAE
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 21/114 (18%), Positives = 52/114 (45%), Gaps = 13/114 (11%)
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
++ +C + + +++LH +++H+D+ + N ++ +++TD + P +
Sbjct: 116 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-------E 168
Query: 393 NENRPVK-----WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
R W+A E + K + D+W+ G++ E+ + PY +P
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 499 | |||
| KOG1024|consensus | 563 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0595|consensus | 429 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592|consensus | 604 | 100.0 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG3653|consensus | 534 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0200|consensus | 609 | 100.0 | ||
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052|consensus | 513 | 100.0 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| KOG4236|consensus | 888 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| KOG0671|consensus | 415 | 100.0 | ||
| KOG0608|consensus | 1034 | 100.0 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668|consensus | 338 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG0576|consensus | 829 | 99.97 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1152|consensus | 772 | 99.96 | ||
| KOG0195|consensus | 448 | 99.96 | ||
| KOG0665|consensus | 369 | 99.96 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0670|consensus | 752 | 99.95 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1167|consensus | 418 | 99.95 | ||
| KOG1290|consensus | 590 | 99.95 | ||
| KOG1345|consensus | 378 | 99.95 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164|consensus | 322 | 99.92 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1165|consensus | 449 | 99.88 | ||
| KOG1163|consensus | 341 | 99.88 | ||
| KOG1023|consensus | 484 | 99.88 | ||
| KOG0590|consensus | 601 | 99.87 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG0603|consensus | 612 | 99.86 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| KOG4158|consensus | 598 | 99.84 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1240|consensus | 1431 | 99.83 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0606|consensus | 1205 | 99.79 | ||
| KOG1033|consensus | 516 | 99.78 | ||
| KOG1166|consensus | 974 | 99.76 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG0590|consensus | 601 | 99.63 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| smart00469 | 136 | WIF Wnt-inhibitory factor-1 like domain. Occurs as | 99.53 | |
| KOG1266|consensus | 458 | 99.52 | ||
| PF02019 | 132 | WIF: WIF domain; InterPro: IPR003306 Wnt proteins | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0601|consensus | 524 | 99.39 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG1243|consensus | 690 | 99.22 | ||
| KOG0601|consensus | 524 | 99.21 | ||
| KOG0606|consensus | 1205 | 99.21 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG3087|consensus | 229 | 99.12 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| KOG3741|consensus | 655 | 99.01 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| KOG2137|consensus | 700 | 98.82 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.18 | |
| KOG0576|consensus | 829 | 98.13 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.1 | |
| KOG1235|consensus | 538 | 98.04 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.01 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| KOG1035|consensus | 1351 | 97.9 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.89 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.87 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.8 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.61 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.37 | |
| KOG1826|consensus | 2724 | 97.04 | ||
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.04 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.96 | |
| KOG1093|consensus | 725 | 96.87 | ||
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.63 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.35 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.27 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.06 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.65 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 95.41 | |
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 95.13 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.98 | |
| PLN02236 | 344 | choline kinase | 94.62 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.53 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.46 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.22 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.97 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 93.85 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.51 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.95 | |
| KOG2268|consensus | 465 | 92.93 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.84 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.52 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.11 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.04 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.21 | |
| KOG1236|consensus | 565 | 91.12 |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-77 Score=565.37 Aligned_cols=482 Identities=49% Similarity=0.815 Sum_probs=399.3
Q ss_pred ccceeEEeecCCccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCce
Q psy1789 7 SDNLEFGTRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVT 86 (499)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~ 86 (499)
+++|.||||+.+++||++.|+.|+..++.+|.+|||.+|+||.+++.|++.|+|+|...+++.+..++++.++ ..+|.+
T Consensus 64 i~~lsFTW~a~~~v~Y~i~v~sdd~~vl~~P~vnIs~~GeVP~tlq~f~velkCsG~r~~ev~Vt~~l~~~~n-s~kn~t 142 (563)
T KOG1024|consen 64 ISDLSFTWQADHPVPYSINVASDDTEVLPRPIVNISRIGEVPVTLQTFGVELKCSGTRNAEVTVTINLEVILN-STKNNT 142 (563)
T ss_pred ccceEEEEecCCcceeEEEEEeCcceecccceeeccccCcCCcchheeEEEEEecccccceEEEEEEEEEEEc-CCCCce
Confidence 6789999999999999999999999999999999999999999999999999999999999999999999887 567899
Q ss_pred EEEEeeeceeeccccCC--C--------CCCccccCCCccccchhHHHHHHHHHHHHHHHHHHHHhhhhhhccccccccc
Q psy1789 87 SLNFKRKKICLRVAADL--D--------EPSINVLDEPVSRLHLYNILAICAACVLITVVVIYSCACFVRNKKLRRHGEI 156 (499)
Q Consensus 87 ~~~~~~~~~~~~~~~~~--~--------~~~~~~~~~~~~~~~~~~ii~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (499)
.+.|++.|+|.+..... . +-..+....+.+... ..+++++++++++.+++++++..+.+.+|+......
T Consensus 143 ~l~fkrkKiC~~~~~~~~~~~~d~~~~~~~~~~~v~~p~s~~~-~f~V~v~va~a~v~lva~il~c~~~~s~Kr~~~~~~ 221 (563)
T KOG1024|consen 143 NLIFKRKKICLREEQDSAHEEYDDDDFDPMLRENVVPPASGLV-TFIVGVIVALALVSLVALILYCAKGPSKKRSNGVHL 221 (563)
T ss_pred eEEeehhhhhhcchhhhcccccccccccccccccccCCCcccE-EEeeeHHHHHHHHHHHHHHHHHHhcccchhhccCcc
Confidence 99999999999874311 1 111112222223322 223555555555555544444444444333221111
Q ss_pred cc-----cC-CCCCCCCCCCccCCCCcccCCCCCCCCCCCccCccCCCCccccccchhhHHhhcccceeeccceEEeeee
Q psy1789 157 LQ-----NG-SNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFKRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVN 230 (499)
Q Consensus 157 ~~-----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (499)
.. .. ...+....+++..|+......+ .+..+....+......+++..++.+..+.++|+++..++
T Consensus 222 i~tSs~~~l~~~qps~~st~y~~P~t~tpi~s---------ap~~r~~~ns~~~~~p~e~~~r~~~l~v~r~Rv~l~~ll 292 (563)
T KOG1024|consen 222 IKTSSFQRLPTIQPSAHSTIYVTPSTITPIYS---------APLTRSSPNSEYEHEPEEFNRRLQELTVQRCRVRLSCLL 292 (563)
T ss_pred cchhhhhcCCcCCccccCCcccCCCccccccC---------CCcccCCCCccccCChHHHhhhHHhhhhhhhheechhhh
Confidence 11 11 0111112223332222211111 111122223334456778889999999999999999999
Q ss_pred eeecceEEEEEEEeCCCc--eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCC
Q psy1789 231 MEGTFGRVYRGTYTEEDG--VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDY 308 (499)
Q Consensus 231 G~G~fG~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~ 308 (499)
.+|+||+||+|.|.+++. ..+.|.||++++.+++-|+..|..|...+..+.|||+.++.|+|+++...++++|.++..
T Consensus 293 qEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~ 372 (563)
T KOG1024|consen 293 QEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGV 372 (563)
T ss_pred hcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCc
Confidence 999999999998876654 336788999999999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCcc
Q psy1789 309 TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388 (499)
Q Consensus 309 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~ 388 (499)
|+|+.||..|+.......+.++..+...++.|++.|++|||.++|||.||.++|++||+..++||+|-.++|.++|.+++
T Consensus 373 gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYh 452 (563)
T KOG1024|consen 373 GNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYH 452 (563)
T ss_pred chHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCccccc
Confidence 99999999888766777788999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHH
Q psy1789 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMA 468 (499)
Q Consensus 389 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 468 (499)
|.+++..++..||+||.+.+..|+.++|||||||+||||+|.|+.||.+.+|+|+...+.+|+|..+|.+|||+++.+|.
T Consensus 453 cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMa 532 (563)
T KOG1024|consen 453 CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMA 532 (563)
T ss_pred ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHhhhcC
Q psy1789 469 YCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499 (499)
Q Consensus 469 ~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~~ 499 (499)
.||...|++||+++|++..|.+|+.++.+||
T Consensus 533 cCWallpeeRPsf~Qlv~cLseF~~qlt~YV 563 (563)
T KOG1024|consen 533 CCWALLPEERPSFSQLVICLSEFHTQLTRYV 563 (563)
T ss_pred HHHhcCcccCCCHHHHHHHHHHHHHHHhhcC
Confidence 9999999999999999999999999999997
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=471.19 Aligned_cols=284 Identities=33% Similarity=0.599 Sum_probs=258.3
Q ss_pred hhcccceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEE
Q psy1789 212 EKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289 (499)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~ 289 (499)
......++.+..+++.+.||+|.||+||+|+..+-. .....||||.+++..+.++.++|.+|++++..++|||||+|+
T Consensus 476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 345667888889999999999999999999875432 455899999999998888889999999999999999999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNC 363 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NI 363 (499)
|+|.+++. .++|+|||..|||.+||..+...... ....|+..+.+.||.|||.||+||-++.+|||||.++|+
T Consensus 556 GVC~~~~P-~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 556 GVCREGDP-LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC 634 (774)
T ss_pred EEEccCCe-eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence 99977555 59999999999999999875542211 134599999999999999999999999999999999999
Q ss_pred EEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy1789 364 VVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443 (499)
Q Consensus 364 lld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~ 443 (499)
|+.++..|||+||||+|.....+|+.......-+++|||||.+..++||++||||||||+|||++|.|+.||.+...+|+
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV 714 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV 714 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH
Confidence 99999999999999999999999998887788899999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 444 AASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 444 ~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.+.++++...+.|.+||.++++||..||+.+|.+||++.||...|+...+.-.
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 99999999999999999999999999999999999999999999999866533
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-56 Score=440.83 Aligned_cols=267 Identities=34% Similarity=0.623 Sum_probs=238.9
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
...+.+.+..+++++.||+|-||.||.|.+.+. ..||+|.++.. ....+.|.+|+.+|++|+|+|||+|+|+|.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~----~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS----TKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC----CcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 456778888888999999999999999999876 47999998764 222367899999999999999999999986
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
..+ .++||+|||++|+|.+||+... ...+...+.+.++.|||+||+||+++++|||||.++|||++++..+||
T Consensus 272 ~~~-piyIVtE~m~~GsLl~yLr~~~------~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 272 KQE-PIYIVTEYMPKGSLLDYLRTRE------GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred cCC-ceEEEEEecccCcHHHHhhhcC------CCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEE
Confidence 644 5799999999999999999622 346888999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
+||||||....+ +........-++.|.|||.+..++++.|||||||||+||||+|.|+.||.+....++...+..|.|.
T Consensus 345 sDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl 423 (468)
T KOG0197|consen 345 SDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL 423 (468)
T ss_pred cccccccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC
Confidence 999999954433 3334445556889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+.|..||++++++|..||+.+|++||||+.+...|+++...
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999999999999999988653
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=427.17 Aligned_cols=268 Identities=28% Similarity=0.510 Sum_probs=231.8
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
.++.+....+.+.+.+|+|+||+||+|.+.+. ..||||++.... .....+.|.+|+.+|.+++|||||+++|+|.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~----~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGT----DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCc----eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 34455555556668899999999999999874 349999997542 3333679999999999999999999999987
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceEEcCCC-cE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK-LLHKDLATRNCVVDDKL-RI 371 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~-iiHrDlk~~NIlld~~~-~~ 371 (499)
+......+|+|||++|+|.++++.. ....+++..+++++.|||+||+|||+++ ||||||||+|||++.++ ++
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~------~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~ 183 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKK------RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTL 183 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhc------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEE
Confidence 7654679999999999999999873 1357999999999999999999999999 99999999999999997 99
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-H
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV--HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-Q 448 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i-~ 448 (499)
||+|||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+| ++.||.+..+.++...+ .
T Consensus 184 KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t-~~~Pf~~~~~~~~~~~v~~ 260 (362)
T KOG0192|consen 184 KIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT-GEIPFEDLAPVQVASAVVV 260 (362)
T ss_pred EECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHh
Confidence 999999998765432 2334478999999999999 6699999999999999999999 99999999886665554 5
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 449 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.+.++..|..+++.+..++.+||+.||+.||++.+++..|+.+....
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 77888989999999999999999999999999999999999987754
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=431.48 Aligned_cols=286 Identities=27% Similarity=0.518 Sum_probs=253.6
Q ss_pred CCCCccccccchhhHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHH
Q psy1789 196 RRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGM 275 (499)
Q Consensus 196 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~ 275 (499)
...+|++-.++...|..+ |+...+.+.++||.|.||.|++|+++..+.....||||+++....+.+..+|+.|..
T Consensus 608 DP~TYEDPnqAvreFakE-----Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAs 682 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKE-----IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEAS 682 (996)
T ss_pred CCccccCccHHHHHhhhh-----cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhh
Confidence 456677666666667655 555677788999999999999999987766778999999999999999999999999
Q ss_pred HHhcCCCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy1789 276 AMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLH 355 (499)
Q Consensus 276 ~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiH 355 (499)
+|++++||||++|-|+. ......++|.|||+||+|+.||+.+. ..+++.+..-++++||.||.||-+.+.||
T Consensus 683 IMGQFdHPNIIrLEGVV-Tks~PvMIiTEyMENGsLDsFLR~~D-------GqftviQLVgMLrGIAsGMkYLsdm~YVH 754 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVV-TKSKPVMIITEYMENGSLDSFLRQND-------GQFTVIQLVGMLRGIASGMKYLSDMNYVH 754 (996)
T ss_pred hcccCCCCcEEEEEEEE-ecCceeEEEhhhhhCCcHHHHHhhcC-------CceEeehHHHHHHHHHHHhHHHhhcCchh
Confidence 99999999999999995 44555699999999999999999743 35899999999999999999999999999
Q ss_pred cCCCCCceEEcCCCcEEEcccccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q psy1789 356 KDLATRNCVVDDKLRIQITDNALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP 434 (499)
Q Consensus 356 rDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p 434 (499)
|||.++|||++.+..+|++||||+|.+..+... .......-+++|.|||.+...++|.++||||||++|||.++.|..|
T Consensus 755 RDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERP 834 (996)
T KOG0196|consen 755 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 834 (996)
T ss_pred hhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCc
Confidence 999999999999999999999999977543311 1111223467999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 435 YAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 435 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
|=++...++...+.+++|++.|.+||..+.+||+.||++|-.+||++.||+..|+++.+.
T Consensus 835 YWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 835 YWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999999999999999999999999999998653
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=426.12 Aligned_cols=270 Identities=26% Similarity=0.390 Sum_probs=217.8
Q ss_pred cCCCCccccccchhhHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHH
Q psy1789 195 KRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEG 274 (499)
Q Consensus 195 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~ 274 (499)
.+.++|.++..+|++|.+. ++||+|+||.||+|.+.++ ..||||++....... ..+|.+|+
T Consensus 62 ~~~fs~~el~~AT~~Fs~~--------------~~ig~Ggfg~VYkG~l~~~----~~vAVK~~~~~~~~~-~~eF~~Ei 122 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSES--------------NLIGEGGFGTVYKGVLSDG----TVVAVKRLSSNSGQG-EREFLNEV 122 (361)
T ss_pred cceeeHHHHHHHHhCCchh--------------cceecCCCeEEEEEEECCC----CEEEEEEecCCCCcc-hhHHHHHH
Confidence 3578999999999999988 9999999999999999765 689999887654432 45699999
Q ss_pred HHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Q psy1789 275 MAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK--- 351 (499)
Q Consensus 275 ~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~--- 351 (499)
.++++++|||+|+|+|||.+.+...+||||||+||+|.++|+.... . .|+|.+|++||.++|+||+|||+.
T Consensus 123 ~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~-----~-~L~W~~R~kIa~g~A~gL~yLH~~~~~ 196 (361)
T KOG1187|consen 123 EILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKG-----E-PLDWETRLKIALGAARGLAYLHEGCPP 196 (361)
T ss_pred HHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCC-----C-CCCHHHHHHHHHHHHHHHHHHccCCCC
Confidence 9999999999999999998766457999999999999999997321 1 789999999999999999999985
Q ss_pred CccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCC-CCccccccccccccCCCCCchhHHHHHHHHHHHHcC
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE-NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL 430 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~ 430 (499)
.||||||||+|||||+++++||+|||+|+.......+ .... .||.+|+|||+...+..|.|+|||||||+|+|++|
T Consensus 197 ~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit- 273 (361)
T KOG1187|consen 197 PIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT- 273 (361)
T ss_pred CEecCCCCHHHeeECCCCCEEccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHh-
Confidence 5999999999999999999999999999765431111 1122 79999999999999999999999999999999999
Q ss_pred CCCCCCCCC------HHHHH-HHHHcC-----CCCC-----CCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 431 AQQPYAEID------PFEMA-ASLQDG-----YRLN-----QPV-NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 431 g~~p~~~~~------~~~~~-~~i~~~-----~~~~-----~~~-~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
|+.+..... ..++. ..+.++ ..+. .+. .....+..++.+|++.+|.+||+|.||+++|+.+.
T Consensus 274 gr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 274 GRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 665554321 12221 111221 1111 111 23445778999999999999999999999996654
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=450.73 Aligned_cols=276 Identities=34% Similarity=0.677 Sum_probs=252.0
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCce--eEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGV--EEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+.+..+.+.+.||+|.||.||+|...+.++. ...||||.+....+.+...+|.+|..+|++++|||||+++|+|.+ .
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-S 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-C
Confidence 5678899999999999999999999876653 577999999998889999999999999999999999999999988 5
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++++|||++|+|..||++.+..... ...|+..+.+.++.|||+|+.||+++++|||||.++||||+....+||+||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~-~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQ-PSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCC-CCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 5569999999999999999987643332 467999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
||||.+...++........-+.+|||||.+..+.+|+|+|||||||++||++|.|..||.+.+..++...+..+-|..+|
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P 926 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP 926 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence 99998888888776666566789999999999999999999999999999999999999999999998866666699999
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..||+.++++|..||+.+|++||++..|++.+..+...+.
T Consensus 927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 9999999999999999999999999999999998876654
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-52 Score=392.20 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=226.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+..++++.++.||+|..|+|||+.++.++ +.+|+|++..+......+++.+|++++++.+||+||.++|.+......
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~---~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTG---KIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCC---eEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 34456667799999999999999998776 889999997776777778899999999999999999999986554435
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||++|||+.++... +.+++....+|+.+|++||.|||+ ++||||||||+|||++..|++||+|||
T Consensus 153 isI~mEYMDgGSLd~~~k~~--------g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV--------GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccc
Confidence 89999999999999999862 458999999999999999999996 899999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHcCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI-----DPFEMAASLQDGYR 452 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-----~~~~~~~~i~~~~~ 452 (499)
.++.+..+ ...+..||..|||||.+.+..|+.++||||||+.++|+++ |+.||... +..++...|..+..
T Consensus 225 VS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~-GrfP~~~~~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 225 VSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI-GRFPYPPPNPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred ccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh-CCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence 99988654 3457889999999999999999999999999999999999 88888874 77889999999888
Q ss_pred CCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 LNQPVN-CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ~~~~~~-~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+..|.. +++++..++..|+++||.+||+++|+++
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 888886 9999999999999999999999999975
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=394.53 Aligned_cols=264 Identities=36% Similarity=0.616 Sum_probs=234.6
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
.++++.++.+.+.||+|-||.|..+..... ..||||+++..+......+|..|+++|.+++||||++|+|+|..++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~----lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGP----LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCc----eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 467788999999999999999999997653 7899999998888888899999999999999999999999998865
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
. +++++|||++|+|.+||..++. ..+.......|+.|||.||+||.+.++|||||.++|||+|.++++||+||
T Consensus 609 P-icmI~EYmEnGDLnqFl~ahea------pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 609 P-LCMITEYMENGDLNQFLSAHEL------PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred c-hHHHHHHHhcCcHHHHHHhccC------cccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCc
Confidence 5 5999999999999999998542 22456667889999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHcC-----
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT-LAQQPYAEIDPFEMAASLQDG----- 450 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t-~g~~p~~~~~~~~~~~~i~~~----- 450 (499)
|++|.+...+++.......-+++|||||.+..+++|+++|||+|||+|||+++ +.+.||.....+++.+....-
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 99999988888888778888999999999999999999999999999999876 366799998887776654332
Q ss_pred --CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 451 --YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 451 --~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.-+..|.-|+.+++++|.+||..|-++||+++++...|++.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22456778999999999999999999999999999998874
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=403.10 Aligned_cols=269 Identities=28% Similarity=0.469 Sum_probs=230.4
Q ss_pred HhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEE
Q psy1789 211 HEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVL 289 (499)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~ 289 (499)
.....+|+|..+++.++..||+|+||+||+|+|.++ ||||++... -+..+.+.|++|+..+++-||.||+-++
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeecccccc------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeee
Confidence 344578999999999999999999999999999764 999999744 4666889999999999999999999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
|||.++. . .+|+.++++.+|..+||..+ ..|+..+.+.|+.|||+||.|||.++|||||||+.||+|++++
T Consensus 455 G~~~~p~-~-AIiTqwCeGsSLY~hlHv~e-------tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 455 GACMNPP-L-AIITQWCEGSSLYTHLHVQE-------TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL 525 (678)
T ss_pred hhhcCCc-e-eeeehhccCchhhhhccchh-------hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC
Confidence 9986544 3 99999999999999999743 4689999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCccccCCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 370 RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH---KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
.|||+||||+................|.+.|||||+++. .+|+..+||||||+++|||+| |..||.....+++.-.
T Consensus 526 kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt-g~lPysi~~~dqIifm 604 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT-GELPYSIQNRDQIIFM 604 (678)
T ss_pred cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh-CcCCcCCCChhheEEE
Confidence 999999999976544322223345567788999999974 569999999999999999999 9999996666666666
Q ss_pred HHcCCCCCC----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 447 LQDGYRLNQ----PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 447 i~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+-.|+.... ..+++.++++|+..||..++++||.+.+|+..|+++...+
T Consensus 605 VGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 605 VGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred ecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 655533222 2378999999999999999999999999999998887654
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=396.30 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=226.4
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|..++.||+|+|.+||+++..+.+ ..+|+|++.+. .+..+.+...+|+++.+.|+|||||+++++ +++....
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tg---e~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-FEDs~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTG---EVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-FEDSNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCC---cEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-eecCCce
Confidence 57889999999999999999985554 78999999763 355667889999999999999999999998 7888899
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
|+|.|+|++|+|..++.. ...+++.++..+++||+.||.|||+.+|||||||..|++|++++++||+|||||
T Consensus 94 YivLELC~~~sL~el~Kr--------rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKR--------RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred EEEEEecCCccHHHHHHh--------cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEeccccee
Confidence 999999999999999985 357999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
..+..... ...+.+||+.|+|||++....++..+||||+||+||-|+. |+|||...+-.+....|... ....|...
T Consensus 166 t~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~-G~PPFetk~vkety~~Ik~~-~Y~~P~~l 241 (592)
T KOG0575|consen 166 TQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV-GRPPFETKTVKETYNKIKLN-EYSMPSHL 241 (592)
T ss_pred eeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh-CCCCcccchHHHHHHHHHhc-Cccccccc
Confidence 98865432 3457899999999999999999999999999999999999 99999998888888888765 56678899
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+.++.+|+...|++||.+|||+++|+.
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999999999975
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=397.40 Aligned_cols=273 Identities=31% Similarity=0.579 Sum_probs=240.5
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEE-EEEEEecC--cccHHHHHHHHHHHHHHhcCCCCcceeEEe
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE-VLVKTVTD--NASAVQVSLLLQEGMAMYGLSHKNILTVLG 290 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g 290 (499)
.+.|.+..+++.+.++||+|+||.||+|++...++.... ||||.... .....+..+|.+|.++|+.++|||||+++|
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345778888889999999999999999999876552233 99999974 456788899999999999999999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
++.. ...+++|||++.||+|.++|.+.+ ..++..+++.++.++|.||+|||++++|||||.++|||++.++.
T Consensus 229 Va~~-~~Pl~ivmEl~~gGsL~~~L~k~~-------~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 229 VAVL-EEPLMLVMELCNGGSLDDYLKKNK-------KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred EEcC-CCccEEEEEecCCCcHHHHHHhCC-------CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe
Confidence 9755 445699999999999999999843 25999999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-Hc
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QD 449 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i-~~ 449 (499)
+||+||||++... .+........-++.|+|||.+....|+.++|||||||++||+++-|..||.+....++..++ ..
T Consensus 301 vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~ 378 (474)
T KOG0194|consen 301 VKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN 378 (474)
T ss_pred EEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc
Confidence 9999999998653 23222223356789999999999999999999999999999999888899999999999988 77
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
+++...|...|.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 379 ~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 379 GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 89999999999999999999999999999999999999999876543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=389.08 Aligned_cols=278 Identities=30% Similarity=0.540 Sum_probs=228.1
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEE
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSI 293 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 293 (499)
+.++..+|++.+.||+|+||.||+|.+... ......||||++.........+.+.+|+.++.++ +||||++++|+|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 567788999999999999999999986321 1223579999997655555567899999999999 8999999999987
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCC---------------------------------------------------
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------------------------------------------------- 322 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 322 (499)
......+++|||+++|+|.+++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 66666799999999999999998642100
Q ss_pred ---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccc
Q psy1789 323 ---EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399 (499)
Q Consensus 323 ---~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~ 399 (499)
......+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++...............++..
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 00123588999999999999999999999999999999999999999999999999986643322222234456778
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy1789 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGR 478 (499)
Q Consensus 400 y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R 478 (499)
|+|||++.+..++.++|||||||++|||++.|..||..... .+....+..+.....+..+++++.+++.+||+.||++|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999999999999878899987543 34445555665566677889999999999999999999
Q ss_pred CCHHHHHHHHHHHHHH
Q psy1789 479 PTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 479 Pt~~~v~~~L~~~~~~ 494 (499)
||+.|+++.|+++..+
T Consensus 322 Ps~~el~~~l~~~~~~ 337 (338)
T cd05102 322 PTFSALVEILGDLLQE 337 (338)
T ss_pred cCHHHHHHHHHHHHhc
Confidence 9999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=372.76 Aligned_cols=246 Identities=23% Similarity=0.419 Sum_probs=213.6
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|.+.+.||+|+||.||+|+++... ..||||.+.... ....++-+..|+.+|+.++|||||+|+++ .+.++..+|
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~---~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~-~~~~~~i~l 86 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSG---TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDC-IEDDDFIYL 86 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCC---ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEE-EecCCeEEE
Confidence 4666688999999999999998765 789999997664 55566778999999999999999999997 466778899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC------CcEEEcc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK------LRIQITD 375 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~------~~~kl~D 375 (499)
|||||.+|||..|++.. ..+++.+...++.|+|.||++||+++||||||||.||||+.. -.+||+|
T Consensus 87 VMEyC~gGDLs~yi~~~--------~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRR--------GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEeCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 99999999999999973 369999999999999999999999999999999999999864 4689999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--C
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--L 453 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--~ 453 (499)
||+||.+.+.. ...+.+|++-|||||++...+|+.|+|+||.|+++|||++ |++||....+.++...+..+.. +
T Consensus 159 FGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~-g~~Pf~a~t~~eL~~~~~k~~~~~~ 234 (429)
T KOG0595|consen 159 FGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT-GKPPFDAETPKELLLYIKKGNEIVP 234 (429)
T ss_pred cchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHHHhccccccC
Confidence 99999987544 3457889999999999999999999999999999999999 9999999999999888776543 3
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v 484 (499)
..+.....+..+++..-++.+|.+|-++.+-
T Consensus 235 ~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 235 VLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred chhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 3444566677788888889998888777653
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=387.41 Aligned_cols=268 Identities=32% Similarity=0.653 Sum_probs=242.0
Q ss_pred hcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 213 KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 213 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
.-.+|++.+.++.+.+.||-|.||.||.|.|+.-+ ..||||.++.+ ...+++|+.|..+|+.++|||+|+|+|+|
T Consensus 258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkys---lTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred CcchhhccchheeeeeccCCCcccceeeeeeeccc---eeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 34568888888999999999999999999998765 78999999765 44578999999999999999999999998
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
..... .|+|+|||.+|+|.+||++|.. ..++.-..+.++.||+.||+||..+++|||||.++|+|+.++..+|
T Consensus 333 T~EpP-FYIiTEfM~yGNLLdYLRecnr------~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 333 THEPP-FYIITEFMCYGNLLDYLRECNR------SEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred ccCCC-eEEEEecccCccHHHHHHHhch------hhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEE
Confidence 76554 5999999999999999998652 4577778899999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
|+||||+|.+..+.|.. .....-++.|.|||.+.-..++.|+|||+|||+|||+.|.|-.||.+.+.-++...+.+++|
T Consensus 406 vADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR 484 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR 484 (1157)
T ss_pred eeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc
Confidence 99999999887766543 33444578999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
...|..|++.+++||+.||+.+|++||++.|+.+.++.+..
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999987643
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=367.17 Aligned_cols=244 Identities=20% Similarity=0.303 Sum_probs=216.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
.+.++++++||+|+||+||..+..+++ +.+|+|++++.. .....+....|..+|.+++||.||.++-. +++.+.
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~---kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-FQt~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTG---KIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-FQTEEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccC---ceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-cccCCe
Confidence 446788899999999999999987655 789999997642 23346778899999999999999999865 788999
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
+|||+||+.||.|..+|++. ..+++..+.-++.+|+.||.|||+.+||||||||+|||||++|+++|+||||
T Consensus 100 LylVld~~~GGeLf~hL~~e--------g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE--------GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred EEEEEeccCCccHHHHHHhc--------CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEecccc
Confidence 99999999999999999862 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++.....+. ...+.+||+.|||||++.+..|+..+|+||+|+++|||++ |.+||...+..++.+.+..+..+..|..
T Consensus 172 ~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~-G~pPF~~~~~~~~~~~I~~~k~~~~p~~ 248 (357)
T KOG0598|consen 172 CKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLT-GKPPFYAEDVKKMYDKILKGKLPLPPGY 248 (357)
T ss_pred chhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhh-CCCCCcCccHHHHHHHHhcCcCCCCCcc
Confidence 996543322 3446899999999999999999999999999999999999 9999999999999999988765666667
Q ss_pred CcHHHHHHHHHhhhcCCCCCC
Q psy1789 459 CPDELFSVMAYCWAMNPEGRP 479 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RP 479 (499)
.+.+.++++...+..||++|.
T Consensus 249 ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCHHHHHHHHHHhccCHHHhc
Confidence 899999999999999999996
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=369.98 Aligned_cols=250 Identities=20% Similarity=0.264 Sum_probs=208.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHH------HHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAV------QVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
.+.|.+.+.||+|+||.|-+|.-+.++ +.||||++.+..... ......+|+++|++|+|||||+++++ ++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tg---k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-f~ 246 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTG---KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-FE 246 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccC---cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-ee
Confidence 456778899999999999999876665 899999996542211 12335699999999999999999998 56
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CcE
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LRI 371 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~---~~~ 371 (499)
.....|+|+|||++|+|.+++-.++ .+.+..-..++.|++.|+.|||++||+||||||+|||+..+ ..+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk--------~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~ll 318 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANK--------YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLL 318 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhcc--------ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEE
Confidence 6677799999999999999998743 46677778999999999999999999999999999999765 899
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCC---CCchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF---STASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASL 447 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~-~~~~i 447 (499)
||+|||+|+.....+ ...+.+||+.|.|||++.+..+ ..++|+||+||+||-++| |.+||.+..... +.+.+
T Consensus 319 KItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs-G~pPFS~~~~~~sl~eQI 394 (475)
T KOG0615|consen 319 KITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS-GYPPFSEEYTDPSLKEQI 394 (475)
T ss_pred Eecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec-cCCCcccccCCccHHHHH
Confidence 999999999875333 3347899999999999987653 358899999999999999 999999865544 66666
Q ss_pred HcCCC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 QDGYR---LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ~~~~~---~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+.- +.....++++..+++.++|..||++|||+.|+++
T Consensus 395 ~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 66532 2334478999999999999999999999999874
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=357.99 Aligned_cols=254 Identities=18% Similarity=0.296 Sum_probs=217.1
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc-eE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS-PF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~-~~ 300 (499)
.|++.+.||+|+||+|||+....++ +.+|.|.+.-. ......+....|+.+|+.|+|||||+++++.+..+.. +.
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g---~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDG---KLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCc---chhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 4556699999999999999876555 78899988633 4556677899999999999999999999965554444 78
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCceEEcCCCcEEEccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK--KK--LLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~--~~--iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
|||||+..|+|.+.++.-+. ..+.+++..+++++.|++.||.++|. .+ |+||||||.||+|+.+|.+||+||
T Consensus 97 ivmE~c~~GDLsqmIk~~K~----qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKK----QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred HHHHhhcccCHHHHHHHHHh----ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 99999999999999975432 23578999999999999999999999 45 999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
||+|.+..... .....+||+.||+||.+.+.+|+.||||||+||++|||+. -++||.+.+-.++-.++..+.-+..|
T Consensus 173 GL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca-L~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA-LQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh-cCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99998754432 3446789999999999999999999999999999999999 78999999888999999988666566
Q ss_pred -CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 -VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 -~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...++++.+++..|+..||+.||+.-.+++
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 467889999999999999999998544333
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=362.66 Aligned_cols=257 Identities=29% Similarity=0.568 Sum_probs=219.7
Q ss_pred EEeeeeeeecceEEEEEEEe-CCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 225 RLFSVNMEGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
.+.+.||+|.||.||+|.+. ........|+||.+.........+.|.+|++.+++++||||++++|+|.. ....++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-cccccccc
Confidence 46699999999999999998 34445589999999776666667899999999999999999999999874 44579999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++|+|.++|+... ...+++.++..|+.|+|.||.|||+++++|+||+++||++++++.+||+|||+++...
T Consensus 81 e~~~~g~L~~~L~~~~------~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKN------KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp E--TTEBHHHHHHHTC------TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccc------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999841 2468999999999999999999999999999999999999999999999999998774
Q ss_pred CCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHH
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDEL 463 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 463 (499)
.............+..|+|||.+....++.++||||||+++|||+|+++.||.+.+..++...+.++.+...+..++..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDI 234 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHH
Confidence 33333334455577889999999999999999999999999999998889999998888888888888888888999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 464 FSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 464 ~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
.+++.+||+.||++||++.++++.|
T Consensus 235 ~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 235 YSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=380.12 Aligned_cols=270 Identities=31% Similarity=0.625 Sum_probs=245.4
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
.....+.+..+.+.+.||+|-||.||+|.+.+. .+....||||+.+.+......+.|..|..+|++++||||++|+|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 345677888889999999999999999998765 4555679999999887777889999999999999999999999998
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
.+. ..|+|||.++.|.|..||+.++ ..|+......++.|++.||+|||+.++|||||..+|||+.+.-.+|
T Consensus 461 ~e~--P~WivmEL~~~GELr~yLq~nk-------~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 461 VEQ--PMWIVMELAPLGELREYLQQNK-------DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred ecc--ceeEEEecccchhHHHHHHhcc-------ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence 543 3599999999999999999754 4688899999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
|+||||+|.+...++.... ...-++.|||||.+.-..+|+++|||-|||.|||+++.|..||.+....++...+.+|.|
T Consensus 532 LaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR 610 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER 610 (974)
T ss_pred ecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC
Confidence 9999999998777665433 555688999999999999999999999999999999999999999988888889999999
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
++.|.+||+.++.+|.+||+.||.+||++.++...|+++..
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999876
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=360.32 Aligned_cols=264 Identities=27% Similarity=0.502 Sum_probs=226.5
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+...+|++.+.||+|+||.||+|.+.........+|+|.+....+......|.+|+..+++++||||++++|++. .+..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-RGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-cCCC
Confidence 456789999999999999999998765444457899999987666666678999999999999999999999864 4567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++++||||||+||+++.++.+|++|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-------~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE-------GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence 799999999999999997622 3589999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
+........ .......++..|+|||.+.+..++.++|||||||++||+++.|..||...+..++...+.++.....+..
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (266)
T cd05064 154 LQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRN 232 (266)
T ss_pred cccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCC
Confidence 765422211 1122334567899999999999999999999999999988668999998888888888877777777788
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
++..+.+++..||+.+|++||++.+|.+.|+++
T Consensus 233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 233 CPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=362.47 Aligned_cols=277 Identities=63% Similarity=1.119 Sum_probs=241.2
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCC-ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
.+.+.+|++.+.||+|+||.||+|...+.+ .....|++|++.......+.+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 456788999999999999999999987522 2247899999887666777788999999999999999999999988767
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++++||+++|+|.+++...+.........+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 77899999999999999998754322222356999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
|+++.+.+.+.........++..|+|||++.+..++.++||||||+++||+++.|++||...++.++...+..+.+...+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 99987766555444445566778999999999999999999999999999999789999988888888888777776677
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
..+++++.+++.+||+.||++|||+.++++.|+++.++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 78899999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=384.45 Aligned_cols=264 Identities=33% Similarity=0.618 Sum_probs=241.0
Q ss_pred eeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 227 FSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
.++||+|+||+||||.|-.+ ..+..+||+|++....+.....++..|...|.+++|||+++|+|+|..+. +.||++|
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlvtq~ 778 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLVTQL 778 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHHHHh
Confidence 48999999999999998544 33667999999987777767789999999999999999999999986544 6899999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
|+.|+|.+|++.++ ..+..+..+.|+.|||+||.|||+++++||||.++|||+.+-..+||+|||+|+.+.++
T Consensus 779 mP~G~LlDyvr~hr-------~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR-------DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred cccchHHHHHHHhh-------ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999754 45788899999999999999999999999999999999999999999999999998876
Q ss_pred CccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHH
Q psy1789 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465 (499)
Q Consensus 386 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 465 (499)
...........++.|||-|.+....|+.++|||||||++||++|.|..||.+....++.+.+..+.|..+|..|+-+++.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYM 931 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHH
Confidence 65544455556789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhcC
Q psy1789 466 VMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499 (499)
Q Consensus 466 l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~~ 499 (499)
+|.+||..|++.||+++++.....++.+...+|+
T Consensus 932 ~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl 965 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAEEFSRMARDPQRYL 965 (1177)
T ss_pred HHHHHhccCcccCccHHHHHHHHHHHhcCcceEe
Confidence 9999999999999999999999999999888875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=365.82 Aligned_cols=271 Identities=29% Similarity=0.600 Sum_probs=228.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
+...+|++.+.||+|+||.||+|++..++. ....||+|.+.........+.+.+|+.+++.++||||++++|+|...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--
Confidence 345678888999999999999999754432 33569999997665556667899999999999999999999997653
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG 154 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-------DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFG 154 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-------ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccc
Confidence 4589999999999999998632 358899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++...............++..|+|||++.+..++.++|||||||++|||++.|+.||.+....++...+..+.+...+.
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd05108 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 234 (316)
T ss_pred ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCC
Confidence 99876543322222233456789999999999999999999999999999987899998887777777777776777777
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhc
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~ 498 (499)
.++.++.+++.+||+.+|++||++.+++..|.++...-.+|
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~ 275 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence 88999999999999999999999999999999887654443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=363.02 Aligned_cols=270 Identities=31% Similarity=0.571 Sum_probs=218.7
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCC-------------ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEED-------------GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI 285 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI 285 (499)
+...+|++.+.||+|+||.||+|.+.+.. +....||+|.+...........|.+|+.++.+++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 45678899999999999999999864321 22357999999876556666789999999999999999
Q ss_pred eeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy1789 286 LTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP-----------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLL 354 (499)
Q Consensus 286 v~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~ii 354 (499)
++++|++.. ....++|+||+++|+|.+++....... ......+++.++..++.|++.||.|||+.+|+
T Consensus 82 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 82 IRLLGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eEEEEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999998655 456799999999999999997533211 11124588999999999999999999999999
Q ss_pred ccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCC
Q psy1789 355 HKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL-AQQ 433 (499)
Q Consensus 355 HrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~-g~~ 433 (499)
||||||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999876544433333445567889999999999999999999999999999874 456
Q ss_pred CCCCCCHHHHHHHHHc-------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 434 PYAEIDPFEMAASLQD-------GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 434 p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
||...+..+....+.. ......+..++..+.+++.+||+.||++|||+.||.+.|+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 8887766655443321 1122345578899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=368.90 Aligned_cols=252 Identities=20% Similarity=0.326 Sum_probs=221.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHT 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 297 (499)
-.+|.+++.||+|+|++|++|+...++ +.+|||++.+.. .+..++-...|-.+|.+| .||.|++|+.. +++..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~---keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-FQD~~ 147 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATG---KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-FQDEE 147 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCC---ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-eeccc
Confidence 346778899999999999999987765 899999997542 233345677889999999 89999999987 78888
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
.+|+|+||++||+|.+++++. ..|++.....++.+|+.||+|||++|||||||||+|||||+||++||+|||
T Consensus 148 sLYFvLe~A~nGdll~~i~K~--------Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY--------GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh--------CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecc
Confidence 999999999999999999983 469999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcc---------ccC--CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 378 LARDLFPSDYH---------CLG--DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 378 la~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
-|+.+.+.... ... ...+||..|.+||++.....+..+|+|+|||++|+|+. |.+||.+.+.--+.+.
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla-G~PPFra~NeyliFqk 298 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA-GQPPFRAANEYLIFQK 298 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc-CCCCCccccHHHHHHH
Confidence 99988653221 111 35789999999999999999999999999999999999 9999999988778888
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 447 LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
|.+- ...+|...++.+.+|+.+.|..||.+|+|.+||.+
T Consensus 299 I~~l-~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 299 IQAL-DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHh-cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 7764 67788899999999999999999999999988765
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=354.77 Aligned_cols=269 Identities=29% Similarity=0.585 Sum_probs=228.1
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCC-ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|++.+.||+|+||.||+|.+..++ .....+++|.+..........++..|+..+++++||||++++|++. ....
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCcc
Confidence 356778899999999999999985443 2335688999876545555577888999999999999999999863 3446
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||++
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHR-------DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 89999999999999997632 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+...+...........++..|+|||++.+..++.++|||||||++||++|.|+.||.+..+.+..+.+..+.....+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQIC 236 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCC
Confidence 87654433223334557778999999999999999999999999999998788999988888777777777777777778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhc
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~ 498 (499)
+.++.+++.+||..||++|||+.|+++.|..+.+.--+|
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~~ 275 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPRY 275 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcce
Confidence 899999999999999999999999999999987765554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=358.91 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=208.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC-ceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT-SPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~~~l 301 (499)
++..++.||+|+||.||++...+++ ...|||.+....... .+.+.+|+.+|.+++|||||+.+|....... ...+
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g---~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTG---ELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCC---cceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 3445599999999999999987643 679999987664333 6778999999999999999999996323233 5789
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCcEEEccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRIQITDNALAR 380 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-~~~~kl~DfGla~ 380 (499)
.|||+++|+|.+++.... ..|++..+..+.+|+++||+|||++|||||||||+|||++. ++.+||+|||+++
T Consensus 94 ~mEy~~~GsL~~~~~~~g-------~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG-------GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred eeeccCCCcHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 999999999999998732 15999999999999999999999999999999999999999 7999999999998
Q ss_pred ccCC-CCccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCC-CCHHHH-HHHHHcCCCCCCC
Q psy1789 381 DLFP-SDYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAE-IDPFEM-AASLQDGYRLNQP 456 (499)
Q Consensus 381 ~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~-~~~~~~-~~~i~~~~~~~~~ 456 (499)
.... ...........||+.|||||++..+. ...++|||||||++.||+| |.+||.+ ....+. .........+..|
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T-g~~PW~~~~~~~~~~~~ig~~~~~P~ip 245 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT-GKPPWSEFFEEAEALLLIGREDSLPEIP 245 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC-CCCcchhhcchHHHHHHHhccCCCCCCC
Confidence 7653 11112234578999999999999643 3459999999999999999 7999987 333332 3333344456788
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
..++++..+++.+|++.||++|||+.+++..-
T Consensus 246 ~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 246 DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 89999999999999999999999999998753
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=356.10 Aligned_cols=269 Identities=31% Similarity=0.622 Sum_probs=228.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
-.+|++.+.||+|+||.||+|...... .....+++|.+...........|.+|+.++.+++||||+++++++. ....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-KEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-CCCc
Confidence 346778899999999999999876543 2446899999976666666678999999999999999999999864 4556
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPE--------GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
.+++|||+++|+|.+++........ .....+++.+++.++.|++.||.|||+.+++||||||+||++++++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 7999999999999999986432111 11246899999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
+||+|||+++.....+.........++..|+|||++.+..++.++|||||||++|||++.|..||.+....++...+..+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999986654443333444556788999999999999999999999999999998788899888888888888877
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 451 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
.....+..+++++.+++.+||+.||++||++.||++.|+.
T Consensus 243 ~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 243 QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 7777778899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=371.69 Aligned_cols=275 Identities=29% Similarity=0.507 Sum_probs=223.3
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeC--CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTE--EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
.+.++..+|++.+.||+|+||.||+|++.. .......||||++.........+.+.+|+.++..+ +||||++++|+|
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 455667789999999999999999997532 12233689999997554445557789999999999 899999999996
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCC--------------------------------------------------
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCP-------------------------------------------------- 322 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------- 322 (499)
.. ....++||||+++|+|.++++......
T Consensus 109 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 109 TV-GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred cc-CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 44 556799999999999999997532100
Q ss_pred -----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 323 -----------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 323 -----------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
......+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 001125889999999999999999999999999999999999999999999999999866433
Q ss_pred CccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 386 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
..........++..|+|||++.+..++.++|||||||++|||+|+|..||..... ......+..+.+...+...+.++.
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 347 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMY 347 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHH
Confidence 2222222344567899999999999999999999999999999878889877543 345566666666666667789999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 465 SVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+++.+||+.||++||++.||++.|++.
T Consensus 348 ~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 348 DIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.12 Aligned_cols=272 Identities=33% Similarity=0.614 Sum_probs=226.2
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+..++|++.+.||+|+||.||+|.+.+. +.....+|+|++...........|.+|+.+++.++|+||+++++++ ..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-SQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-cC
Confidence 45677899999999999999999987532 2233679999987554555567799999999999999999999986 45
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPE--GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
+...++|+||+++|+|.+++........ .....+++..+..++.|++.||+|||+.+++||||||+||++++++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 5677999999999999999976332111 11235789999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++++..||.+....+....+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999986654433323333455778999999999999999999999999999999788999988887777777666556
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
..+..+++++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 6677889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=366.84 Aligned_cols=277 Identities=30% Similarity=0.555 Sum_probs=228.3
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEE
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSI 293 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 293 (499)
|.+++.+|++.+.||+|+||.||+|...+.. ...+.||+|++.........+.+.+|+.++.++ +|+||++++++|.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 5677889999999999999999999754321 233689999987655555556788999999999 8999999999987
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCC---------------------------------------------------
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------------------------------------------------- 322 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 322 (499)
..+...++++||+++|+|.+++.......
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 77777899999999999999997532110
Q ss_pred --CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCcccc
Q psy1789 323 --EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW 400 (499)
Q Consensus 323 --~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y 400 (499)
......++|..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 000136899999999999999999999999999999999999999999999999999876443332233344567789
Q ss_pred ccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy1789 401 LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF-EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRP 479 (499)
Q Consensus 401 ~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP 479 (499)
+|||++.+..++.++|||||||++|||++.|..||.+.... .....+..+.+...+...++++.+++.+||+.+|++||
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999999999999998688899765433 34455566666666777889999999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q psy1789 480 TFPQLHSCLQEFHA 493 (499)
Q Consensus 480 t~~~v~~~L~~~~~ 493 (499)
++.|+++.|+++.+
T Consensus 322 s~~ell~~l~~~~~ 335 (337)
T cd05054 322 TFSELVEILGDLLQ 335 (337)
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=371.33 Aligned_cols=278 Identities=29% Similarity=0.498 Sum_probs=224.9
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEe
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g 290 (499)
.+.+.+...+|++++.||+|+||.||+|..... ......||+|++...........+.+|+++++.+ +|+||++++|
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 445667778899999999999999999986432 1223579999997665555567789999999999 8999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccC-------------------------------------------------
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLC------------------------------------------------- 321 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------- 321 (499)
+|.. ....++||||+++|+|.++++.....
T Consensus 110 ~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 110 ACTH-GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred EecC-CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 8644 55679999999999999999753210
Q ss_pred -------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCcc
Q psy1789 322 -------------PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388 (499)
Q Consensus 322 -------------~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~ 388 (499)
.......+++.++++++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 0011235889999999999999999999999999999999999999999999999999866433222
Q ss_pred ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCcHHHHHHH
Q psy1789 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGYRLNQPVNCPDELFSVM 467 (499)
Q Consensus 389 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~l~ 467 (499)
.......++..|||||++.+..++.++|||||||++|||++.|+.||....... ....+..+.....+...+.++.+++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIM 348 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHH
Confidence 222334456789999999999999999999999999999976889998755433 3344455555666667789999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 468 AYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 468 ~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
.+||+.||++|||+.+|++.|+++.
T Consensus 349 ~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 349 KMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHh
Confidence 9999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=372.33 Aligned_cols=252 Identities=26% Similarity=0.450 Sum_probs=214.6
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
|+++.+.+.-++-||.|+-|.||+|++.+ ..||||+++... ..+|.-|++|+|+||+.|.|+|.+..
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~n-----etVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLHN-----ETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeeccC-----ceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCc
Confidence 33344444445889999999999999977 579999875321 25788899999999999999997755
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
. +++||||+..|.|...|+. .+.++......|..+||.||.|||.+.|||||||+-||||..+..+||+||
T Consensus 186 c-yCIiMEfCa~GqL~~VLka--------~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 186 C-YCIIMEFCAQGQLYEVLKA--------GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred e-eEEeeeccccccHHHHHhc--------cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccc
Confidence 4 5999999999999999987 357888999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QDGYRLNQ 455 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~ 455 (499)
|-++...... ..-..+||..|||||++.+...++|+||||||||||||+| |..||.+.+...+.--+ .+......
T Consensus 257 GTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT-~EiPYkdVdssAIIwGVGsNsL~Lpv 332 (904)
T KOG4721|consen 257 GTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT-GEIPYKDVDSSAIIWGVGSNSLHLPV 332 (904)
T ss_pred cchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh-cCCCccccchheeEEeccCCcccccC
Confidence 9998764432 3346789999999999999999999999999999999999 99999987755433222 23456778
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
|..||+.++-|+++||+..|..||+|.+++..|+=+..+
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 889999999999999999999999999999998765444
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=348.79 Aligned_cols=263 Identities=31% Similarity=0.581 Sum_probs=225.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|.+...+.....+++|.+...........|.+|+.++++++|+||+++++++. .....+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-KSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-cCCceE
Confidence 4568888999999999999999865433346899999876656666678999999999999999999999854 456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.++|+|||+++
T Consensus 82 iv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 82 IITEYMENGSLDKFLREND-------GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 9999999999999997632 268999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
...............++..|+|||.+.+..++.++||||||+++|||++.|..||......+....+....+...+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCP 234 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 76522222122233456789999999999999999999999999999987888998888777778887777777777899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+.+.+++.+||+.+|++||++.+|++.|+++
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=351.57 Aligned_cols=271 Identities=31% Similarity=0.610 Sum_probs=229.6
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
...++++.+.||+|+||.||+|++..++. ....||+|.+...........+.+|+.+++.++|+||++++++|.. ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 82 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--ST 82 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CC
Confidence 34578888999999999999998764432 2346899999766666667789999999999999999999999754 34
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++++||+++|+|.++++... ..+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENK-------DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence 589999999999999997622 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++...............++..|+|||.+.+..++.++|||||||++|||++.|..||......+....+..+.....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI 235 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCcc
Confidence 98764332222222334567899999999999999999999999999999988899988877777777777766666778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhcC
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~~ 499 (499)
++.++.+++.+||+.||++||++.++++.|+++...-++|+
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~ 276 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV 276 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeE
Confidence 89999999999999999999999999999999887766663
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=353.29 Aligned_cols=247 Identities=21% Similarity=0.368 Sum_probs=211.0
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc--C-CCceEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE--D-HTSPFLI 302 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~--~-~~~~~lv 302 (499)
..||+|++|.||+|.+.+ +.||||++.... .....+.|.+|+.++++++||||++++|++.+ . ....++|
T Consensus 26 ~~i~~g~~~~v~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNN-----KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEEEEEEECC-----EEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 678999999999999843 789999987542 23335778899999999999999999998755 2 3457899
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|||+++|+|.+++... ..+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.
T Consensus 101 ~Ey~~~g~L~~~l~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 101 LEYCTRGYLREVLDKE--------KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred EEeCCCCcHHHHHhhC--------CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 9999999999999862 3588999999999999999999984 899999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ-DGYRLNQPVN 458 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~ 458 (499)
..... ....++..|+|||++.+ ..++.++|||||||++|||+| |+.||...+..++...+. ...++..+..
T Consensus 173 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (283)
T PHA02988 173 LSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT-GKIPFENLTTKEIYDLIINKNNSLKLPLD 246 (283)
T ss_pred hcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcCCCCCCCCc
Confidence 53322 23457788999999976 789999999999999999999 899999888777766653 4455666667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
+++++.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999999999988753
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=369.77 Aligned_cols=279 Identities=29% Similarity=0.496 Sum_probs=229.3
Q ss_pred hcccceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEE
Q psy1789 213 KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVL 289 (499)
Q Consensus 213 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~ 289 (499)
..+.+.+++.+|++++.||+|+||.||+|+..... .....||||++.........+.|.+|+.++++++ ||||++++
T Consensus 28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 34678888999999999999999999999864321 2235799999976656666678999999999996 99999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCC-----------------------------------------------
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP----------------------------------------------- 322 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------------------------------------- 322 (499)
|+| ......++||||+++|+|.++++.+....
T Consensus 108 ~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 108 GAC-TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEE-ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 996 44566799999999999999997643100
Q ss_pred -----------------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy1789 323 -----------------------------------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATR 361 (499)
Q Consensus 323 -----------------------------------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~ 361 (499)
......+++.++..++.|++.||+|||+.+|+||||||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~ 266 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR 266 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence 001135889999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-
Q psy1789 362 NCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP- 440 (499)
Q Consensus 362 NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~- 440 (499)
|||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++.|..||.....
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999998764433222233445677899999999999999999999999999999868888876543
Q ss_pred HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 441 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
......+..+.+...+..++.++.+++.+||+.||++||++.+|.+.|+++.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 3344556666666677788999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=353.17 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=201.9
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc--CCCCcceeEEeEEEcCCC----
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG--LSHKNILTVLGVSIEDHT---- 297 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~~---- 297 (499)
+++.+++|+|+||.||||++.+ +.||||++.. .+.+.|.+|-++.+. ++|+||++++++- +...
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-----~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e-kr~t~~~~ 281 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-----RLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAE-KRGTADRM 281 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-----ceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchh-ccCCcccc
Confidence 3445899999999999999976 7899999964 445678888887764 6899999999983 3222
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEEcCC
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK---------KLLHKDLATRNCVVDDK 368 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~---------~iiHrDlk~~NIlld~~ 368 (499)
.++||+||.++|+|.+||.. +.++|....+|+..+++||+|||+. +|+|||||++|||+.+|
T Consensus 282 eywLVt~fh~kGsL~dyL~~---------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA---------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh---------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 57999999999999999996 5799999999999999999999963 59999999999999999
Q ss_pred CcEEEcccccccccCCCCccccCCCCCCccccccccccccCC------CCCchhHHHHHHHHHHHHcCCCC---------
Q psy1789 369 LRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT------FSTASDVWAFGVLLWELTTLAQQ--------- 433 (499)
Q Consensus 369 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwS~Gvvl~el~t~g~~--------- 433 (499)
+++.|+|||||..+.+..........+||.+|||||++.+.. .-.+.||||+|.|||||++....
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999999999887655444444588999999999997632 22579999999999999983321
Q ss_pred --CCCC-----CCHHHHHH-HHHcCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 434 --PYAE-----IDPFEMAA-SLQDGYRLNQPVN-----CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 434 --p~~~-----~~~~~~~~-~i~~~~~~~~~~~-----~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
||.. ...+++.+ .+.+..|+..|.. -..-+.+.+..||++||+.|.|+.-+.+.+.++..
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 2221 11233433 3455567776653 34569999999999999999999999999887653
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=336.24 Aligned_cols=239 Identities=20% Similarity=0.330 Sum_probs=217.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
-.+|+.++.||.|+||+|.+.+.+.++ ..+|+|++.+. ....|++...+|..+|+.+.||.++++++. +.+...
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g---~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-~~d~~~ 118 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSG---NYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-FKDNSN 118 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCC---ceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-eccCCe
Confidence 346777799999999999999987664 78999999765 355677888999999999999999999997 466778
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
++|||||.++|.|..+|+++ +.+++.....++.||+.||+|||+.+|++|||||+|||||.+|.+||+|||+
T Consensus 119 lymvmeyv~GGElFS~Lrk~--------~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKS--------GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred EEEEEeccCCccHHHHHHhc--------CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccc
Confidence 89999999999999999984 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
|+...... -+.+||+.|+|||.+....|..++|+|||||++|||+. |.+||...++.++.+.|..+ ...+|..
T Consensus 191 AK~v~~rT-----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla-G~pPF~~~~~~~iY~KI~~~-~v~fP~~ 263 (355)
T KOG0616|consen 191 AKRVSGRT-----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA-GYPPFYDDNPIQIYEKILEG-KVKFPSY 263 (355)
T ss_pred eEEecCcE-----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc-CCCCCcCCChHHHHHHHHhC-cccCCcc
Confidence 99875442 26789999999999999999999999999999999999 99999999999999999887 6778889
Q ss_pred CcHHHHHHHHHhhhcCCCCC
Q psy1789 459 CPDELFSVMAYCWAMNPEGR 478 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~R 478 (499)
.+.++++|+...++.|-.+|
T Consensus 264 fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 264 FSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCHHHHHHHHHHHhhhhHhh
Confidence 99999999999999999998
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=345.38 Aligned_cols=259 Identities=39% Similarity=0.767 Sum_probs=219.6
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
+.||+|+||.||+|.+.+.......+|+|.+.........+.+.+|+.+++.++||||++++++|...+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999986554445789999986554555667899999999999999999999987766666799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET-------HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999997532 2467888899999999999999999999999999999999999999999999986543221
Q ss_pred cc--cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHH
Q psy1789 388 HC--LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465 (499)
Q Consensus 388 ~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 465 (499)
.. ......++..|+|||++.+..++.++|||||||++|||++++.+||...+..+....+..+..+..+..+++++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYE 233 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 11 1123345678999999999999999999999999999999788889888888877777776666666678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 466 VMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 466 l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
++..||+.+|++||++.|+++.|+++..
T Consensus 234 li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 234 VMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=347.74 Aligned_cols=264 Identities=35% Similarity=0.676 Sum_probs=221.0
Q ss_pred EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-----Cc
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH-----TS 298 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~ 298 (499)
.+++.||+|+||.||+|.+..... ...+|+|.+... ......+.|.+|+.+++.++|+||++++++|.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~-~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDS-ILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCC-eeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356899999999999999865432 247899988654 34555678999999999999999999999875432 24
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++++||+++|+|.+++...+.. .....+++.....++.|++.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG--DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc--CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCc
Confidence 68999999999999998643211 1234589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++...............++..|+|||++.+..++.++||||||+++|||+++|+.||...+..++...+..+.....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 98765433322233445667899999999999999999999999999999988899998888787777877766666778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=349.44 Aligned_cols=271 Identities=36% Similarity=0.617 Sum_probs=229.6
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+..++|++.+.||+|+||.||+|...... .....+++|.+...........+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST- 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-
Confidence 466788999999999999999999886432 23468999998766555666789999999999999999999998644
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPE--GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
....++|+||+++|+|.+++........ .....+++..++.++.|++.||.|||+.+++||||||+||++++++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 5667999999999999999976432111 12235789999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
+|||+++.....+.........++..|+|||.+.+..++.++|||||||++||++|+|..||...+..+....+..+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 99999987654433222334456788999999998899999999999999999999888999988888887777776667
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
..|..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 778889999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=348.37 Aligned_cols=266 Identities=34% Similarity=0.722 Sum_probs=225.3
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC-----
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT----- 297 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 297 (499)
|++++.||+|+||.||+|.+..+.+....+|+|.+... ........+.+|+..++.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45679999999999999998765444478999998754 344556789999999999999999999998755332
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+++|+|..++...... .....+++.....++.|++.||+|||+++++||||||+||++++++.+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG--GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc--CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcc
Confidence 368999999999999999764321 112468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++...............++..|+|||++.+..++.++|||||||++|||+++|.+||.+.+..+..+.+..+.....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99876544333223334456789999999999999999999999999999998889999888888888888777777788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.+++++.+++.+||+.||++||++.|+++.|+++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=351.18 Aligned_cols=276 Identities=36% Similarity=0.602 Sum_probs=232.7
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
.+.+...+|++.+.||+|+||.||+|...... .....+++|.+...........+.+|+.++.++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 35567778999999999999999999876432 233689999998665555667799999999999 899999999996
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCV 364 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIl 364 (499)
.. +...+++|||+++|+|..+++...... ......+++..++.++.|++.||+|||+.+|+||||||+||+
T Consensus 86 ~~-~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 86 TQ-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred cC-CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 44 556799999999999999997643110 012346899999999999999999999999999999999999
Q ss_pred EcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy1789 365 VDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444 (499)
Q Consensus 365 ld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~ 444 (499)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++.|..||......+..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 99999999999999987654433222233345678999999999999999999999999999998788999988888888
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 445 ASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 445 ~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
..+..+.....+..++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 888777777778889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=350.68 Aligned_cols=269 Identities=34% Similarity=0.623 Sum_probs=226.2
Q ss_pred eEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
|++.+.||+|+||.||+|+..... .....+++|.+...........+.+|+.+++.++||||+++++.+.. ....++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcEE
Confidence 567799999999999999875321 12257999998776666666789999999999999999999998644 556799
Q ss_pred EEEeCCCCCHHHHHHhcccCC----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCP----------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV 365 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~----------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll 365 (499)
++||+++|+|.+++....... ......+++..++.++.|++.||+|||+.+++||||||+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 999999999999997643211 0112468999999999999999999999999999999999999
Q ss_pred cCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy1789 366 DDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445 (499)
Q Consensus 366 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~ 445 (499)
++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+|+|..||.+..+.++..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999866443322222334456789999999999999999999999999999997889999888888888
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 446 ~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
.+....+...+..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 887777777778889999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=348.47 Aligned_cols=269 Identities=29% Similarity=0.567 Sum_probs=224.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCC-ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+++.+.||+|+||.||+|.+...+ .....+++|.+...........|.+|+.++++++||||+++++++ ..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~ 82 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-TQEQPV 82 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-ecCCce
Confidence 456788899999999999999864322 233689999998665556667899999999999999999999985 445667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCP---------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~---------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
++||||+++|+|.+++....... ......+++.+.+.++.|++.||+|||+++++||||||+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 99999999999999996432100 011245899999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
+||+|||+++...............++..|+|||++.+..++.++|||||||++|||+++|.+||.+....++...+...
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 242 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR 242 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987654433223334456778999999998899999999999999999999788899888777777777776
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 451 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
.....+..+++++.+++.+||+.||++||++.+|.+.|..
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 243 QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 6666777889999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=348.20 Aligned_cols=274 Identities=34% Similarity=0.619 Sum_probs=227.5
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
+++...+|++.+.||+|+||.||+|...+. +.....+|+|.+...........+.+|+.++++++|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~- 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS- 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence 345678899999999999999999986531 22236799999876655555567889999999999999999999854
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPE--GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
.....++||||+++|+|.+++........ .....+++..+..++.|++.||.|||+++|+||||||+||++++++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 45567999999999999999976332111 1124567888999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++++..||...+..+....+..+..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999998665443332333344567899999999999999999999999999999988899998888887777776666
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
...+..+++++.+++.+||+.||++|||+.++++.|++.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 240 LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 666777889999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=369.21 Aligned_cols=264 Identities=31% Similarity=0.597 Sum_probs=235.9
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
.-|..+.+++.+.||+|.||.|++|.|....+....||||.+....-......|++|+.+|.+|+|+|+++|||+..+
T Consensus 105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-- 182 (1039)
T KOG0199|consen 105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-- 182 (1039)
T ss_pred eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--
Confidence 345566788889999999999999999887777789999999877555577899999999999999999999998543
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
....+|+|.++.|+|.+-|++.. ...|.......++.|||.||.||..+++|||||.++|+||-....+||+||
T Consensus 183 qp~mMV~ELaplGSLldrLrka~------~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DF 256 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAK------KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDF 256 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhcc------ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecc
Confidence 44689999999999999999722 246788899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 377 ALARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 377 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||.|.+...+. +.......-++.|.|||.+...+++.++|||+|||++|||+|+|+.||.+....++.+.+.++.+...
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR 336 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR 336 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC
Confidence 99998875443 33344555677899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
|..|+++++++|..||..+|++||||..|.+.+
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 999999999999999999999999999997544
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=347.96 Aligned_cols=277 Identities=30% Similarity=0.567 Sum_probs=230.2
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+.+..|.+.+.||+|+||.||++..... ......+++|.+... .....+.+.+|++++++++|+||+++++++. ..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCV-EG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cC
Confidence 4567788999999999999999986331 122356899988654 3445678999999999999999999999864 45
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccC-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLC-----PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
...++|+||+++++|.+++...... .......+++.+++.++.|++.||+|||+++++||||||+||++++++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 6779999999999999999754311 01122358999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||+|+|.+||...+..+....+..+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999866544333333444567789999999999999999999999999999997899998888877777777766
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhh
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~ 497 (499)
....+..++.++.+++.+||+.||.+|||+.++.+.|+++.....-
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~ 285 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPV 285 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccc
Confidence 5666667889999999999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=347.74 Aligned_cols=276 Identities=28% Similarity=0.548 Sum_probs=229.3
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
...+|.+.+.||+|+||.||+|+..... .....+++|.+... .....+.+.+|+.++++++|+||+++++++. ...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCG-DGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-cCC
Confidence 4456888899999999999999864321 12356888888654 3344567899999999999999999999864 456
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccC--------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLC--------PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
..++||||+++++|.+++...... .......+++..++.++.|++.||+|||+++|+||||||+||++++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 679999999999999999864321 011223589999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 370 RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||+|+|..||...+..+....+..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 99999999998665443333334455678899999999999999999999999999999988999988888777777777
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhh
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~ 497 (499)
+.....+..++.++.+++.+||+.+|++||++.+|++.|+++......
T Consensus 241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~ 288 (291)
T cd05094 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288 (291)
T ss_pred CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence 766666777899999999999999999999999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=350.72 Aligned_cols=278 Identities=33% Similarity=0.539 Sum_probs=232.0
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeC----CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEe
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTE----EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g 290 (499)
.+.+...+|.+.+.||+|+||.||+|+... .......+++|.+.........+.+.+|+.+++.+ +|+||+++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 345667788999999999999999998532 11223579999987655555667899999999999 8999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE--------GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
++.. ....+++|||+++|+|.+++........ .....+++.+++.++.|++.||.|||+++++||||||+|
T Consensus 89 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 89 ACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 8644 5567999999999999999987432110 012468899999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+++|..||......+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 99999999999999999876443332223334456789999999999999999999999999999997888998888888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 443 MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 443 ~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+...+..+.+...+..++.++.+++.+||+.+|++||++.|+++.|+++..-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 8888877777777788999999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.36 Aligned_cols=261 Identities=33% Similarity=0.675 Sum_probs=223.7
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
++....+.+.+.||+|+||.||+|...+.+ +.+++|.+.... .....+.+|+.++++++|+||+++++++.. ..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~---~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 75 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EP 75 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCC---ceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcC-CC
Confidence 455667888899999999999999987654 679999987542 234678899999999999999999998654 55
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+++++|.+++.... ...+++..++.++.|++.||+|||+.+++||||||+||++++++.+||+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~ 149 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECN------RQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 149 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCc
Confidence 6799999999999999997532 2458999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++........ .......+..|+|||.+.+..++.++|||||||++|||+++|..||...+..+....+..+.+...+.
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (263)
T cd05052 150 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPE 228 (263)
T ss_pred cccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 99876443222 11223345689999999999999999999999999999987889998888878777787777777788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 8999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=338.27 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=202.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.|+.+.++|+|+||.|||++.++++ +.||||++..... +.-.+..++|+++|+.++|+|+|.|+.++ .....++|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~Tg---qIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-rrkrklhL 78 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTG---QIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-RRKRKLHL 78 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcc---cEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-HhcceeEE
Confidence 4666789999999999999987766 8999999976544 44456678999999999999999999994 65677899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||++..=|.+.-+. .+.++.+...+++.|++.|+.|+|++++|||||||+||||+.++.+||+|||+||.
T Consensus 79 VFE~~dhTvL~eLe~~--------p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~ 150 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERY--------PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFART 150 (396)
T ss_pred EeeecchHHHHHHHhc--------cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHh
Confidence 9999995544444332 35689999999999999999999999999999999999999999999999999998
Q ss_pred cC-CCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---------
Q psy1789 382 LF-PSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--------- 450 (499)
Q Consensus 382 ~~-~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~--------- 450 (499)
+. +.+. .+.-+.|.-|.|||.+.+ ..|+..+||||.||++.||++ |.+.|.+.++.+....|...
T Consensus 151 L~~pgd~---YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 151 LSAPGDN---YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred hcCCcch---hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence 87 3332 234456778999999998 789999999999999999999 99999987766544333221
Q ss_pred -----------CCCCCCC----------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 -----------YRLNQPV----------NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 -----------~~~~~~~----------~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+.+.|. ..+.-+.+++..|++.||++|++.+|++.
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1112221 33445899999999999999999999874
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=345.71 Aligned_cols=260 Identities=19% Similarity=0.328 Sum_probs=218.2
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
++......|++.+.||.|.-+.||+|.....+ ..||||++.-+......+.+.+|+..|+.++||||++++.. +..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~---e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-Fvv 95 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTN---EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-FVV 95 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccC---CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-EEe
Confidence 45566778999999999999999999986655 78999999876555667899999999999999999999986 555
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
+..+|+||.||.+||+.+.+...- ...+++..+..|.+++++||.|||++|-||||||+.|||||++|.+||+|
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~------~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLad 169 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYY------PDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLAD 169 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHc------cccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcC
Confidence 677899999999999999998632 24589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccc-cC-CCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 376 NALARDLFPSDYHC-LG-DNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 376 fGla~~~~~~~~~~-~~-~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||.+-.+..+.... .. ....||+.|||||++.. ..|+.|+||||||++..||.+ |..||....+.++.-.-.++.
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~-G~aPf~k~pPmkvLl~tLqn~ 248 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH-GHAPFSKYPPMKVLLLTLQND 248 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc-CCCCcccCChHHHHHHHhcCC
Confidence 99976665433211 11 45689999999999754 569999999999999999999 999999999888654333332
Q ss_pred CC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RL---------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~---------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+ +.....+..+.+++..|+++||.+|||+.++++
T Consensus 249 pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 249 PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 22 111134567999999999999999999999975
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=349.56 Aligned_cols=268 Identities=32% Similarity=0.573 Sum_probs=224.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++.+.||+|+||.||+|...+. ....+.+|+|++.........+.|.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CCce
Confidence 4566779999999999999987543 123468999999866555556779999999999999999999999644 5567
Q ss_pred EEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
++++||+++++|.+++....... ......+++..+..++.|++.||.|||+.+|+||||||+||++++++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence 99999999999999996422100 1112458899999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+++|..||.+....++...+..+.
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999876544332222344567789999999989999999999999999999998888999888888888887776
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
....+..+++++.+++..||+.+|++||++.+|++.|+.
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 244 VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 666778899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=343.28 Aligned_cols=260 Identities=32% Similarity=0.615 Sum_probs=221.6
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
.+...+|++++.||+|+||.||+|...++ ..+++|.+.... ...+.+.+|+.++++++|+||+++++++ ....
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~----~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 74 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNS----TKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVV-TKEE 74 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCC----ceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCC
Confidence 46677899999999999999999987543 568999876432 2346789999999999999999999985 4566
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+++|+|.++++... ...+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg 148 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDE------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFG 148 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCc
Confidence 6799999999999999997632 2358899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++........ ......++..|+|||++....++.++|||||||++|||+|+|+.||......+....+....+...+.
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05072 149 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME 227 (261)
T ss_pred cceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 99876432221 12233456789999999999999999999999999999997899998888777777777776666666
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.+++++.+++.+||+.+|++||+++++.+.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 7899999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=348.08 Aligned_cols=273 Identities=34% Similarity=0.601 Sum_probs=225.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++.+.||+|+||.||+|...+++ ....+++|.+.........+.|.+|+.++.++ +||||+++++++ ......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-ENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC-CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-ccCCcce
Confidence 46788899999999999999886543 22457888887544455567789999999999 799999999985 4456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
+++||+++|+|.+++++..... ......+++..+..++.|++.||+|||+++|+||||||+|||+++++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997643211 11224689999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
|+|||++...... ........+..|+|||++.+..++.++|||||||++|||+|.|..||...+..+....+..+..
T Consensus 160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred ECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999998643211 1111223355799999999999999999999999999999878899998888887777777766
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhcC
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~~ 499 (499)
...+..+++++.+++.+||+.+|.+||++.++++.|+.+.+..+.|+
T Consensus 237 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 66777889999999999999999999999999999999988776653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=345.01 Aligned_cols=268 Identities=33% Similarity=0.636 Sum_probs=223.7
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
....|.+.+.||+|+||.||+|.+...+ .....+++|.............|.+|+.++++++|+||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CC
Confidence 4567888899999999999999986521 13378999988765555555779999999999999999999998655 44
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---cEEEc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL---RIQIT 374 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~---~~kl~ 374 (499)
..++|+||+++++|.++++..+.... ....+++..++.++.|++.||+|||+.+++||||||+||++++++ .+||+
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPE-RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 56999999999999999987543222 123689999999999999999999999999999999999998654 69999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++................+..|+|||++.+..++.++|||||||++|||++.|..||...+..+....+....+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 99999876443332222233445689999999999999999999999999999987899999888777777777666667
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
.+..++.++.+++.+||+.+|++||++.+|++.|+
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 77788999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=348.16 Aligned_cols=268 Identities=32% Similarity=0.612 Sum_probs=225.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
..+|.+.+.||+|+||.||+|...+. ......+|+|.+.........+.|.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCC
Confidence 45677779999999999999987543 123368999999876555556789999999999999999999999655 567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCP------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
.++||||+++|+|.++++...... ......+++..+..++.|++.||.|||+++++||||||+||+++.++.+|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence 799999999999999998643210 11234589999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++.|..||...+..+....+..+..
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999998654433332333445678899999999999999999999999999999878899988888787777777666
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
...+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus 243 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 243 LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 5666778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=358.08 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=216.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc----ccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEE
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN----ASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSI 293 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~ 293 (499)
....+|++++.||+|+||+|+.|....++ ..||+|++... ......+.+.+|+.++++++ ||||++++.+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~---~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~- 89 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTG---EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF- 89 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCC---CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE-
Confidence 34567899999999999999999887655 78999977653 11123455668999999999 99999999994
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CcEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-LRIQ 372 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~-~~~k 372 (499)
......++||||+.+|+|.+++.. ...+.+.+...++.|++.|++|||+++|+||||||+|||+|.+ +++|
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~--------~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVN--------KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHH--------cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEE
Confidence 555668999999999999999987 2468889999999999999999999999999999999999999 9999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT-FS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
|+|||++...... .......+||+.|+|||++.+.. |+ .++||||+||+||-|++ |+.||.+.+...+...+..+
T Consensus 162 l~DFG~s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~-G~~PF~d~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 162 LSDFGLSAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC-GRLPFDDSNVPNLYRKIRKG 238 (370)
T ss_pred EeccccccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCccHHHHHHHHhcC
Confidence 9999999976311 12345788999999999999977 86 89999999999999999 99999998888887777665
Q ss_pred CCCCCCCCC-cHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 451 YRLNQPVNC-PDELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 451 ~~~~~~~~~-~~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
....|..+ +.++..++.+|+..||.+|+|+.+++
T Consensus 239 -~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 -EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 56677777 99999999999999999999999998
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=344.39 Aligned_cols=270 Identities=31% Similarity=0.609 Sum_probs=232.0
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
...+|++.+.||+|+||.||+|.+...+. ....+++|.............+.+|+.++++++|+||++++++|.. ..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 82 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQ 82 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--Cc
Confidence 45678889999999999999999765432 3357999998766566666789999999999999999999999765 56
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||+
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK-------DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 799999999999999998632 3489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++...............++..|+|||.+....++.++|+||||+++||+++.|+.||......++...+..+.....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCC
Confidence 98765433222222233456899999999899999999999999999999878899998888888888887767777777
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhc
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~ 498 (499)
++.++.+++.+||..+|++||++.++++.|.++...-.||
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQRY 275 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcce
Confidence 8899999999999999999999999999999998777665
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=348.40 Aligned_cols=279 Identities=34% Similarity=0.551 Sum_probs=230.7
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCC----ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED----GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVL 289 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~ 289 (499)
..+++...+|.+++.||+|+||.||+++..+.+ .....+|+|.+...........+.+|+.+++++ +|+||++++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 345667788999999999999999999864321 122569999997654555567788999999999 799999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE--------GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATR 361 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~ 361 (499)
+++.. ....++|+||+++|+|.+++........ .....+++.+++.++.|++.||+|||+.+++||||||+
T Consensus 91 ~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 91 GACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 98654 5567999999999999999986432100 01235899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy1789 362 NCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441 (499)
Q Consensus 362 NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~ 441 (499)
||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||+++|..||......
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999986543222212222334568999999999999999999999999999999888999888777
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 442 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
++...+....+...+..++.++.+++.+||+.+|++||++.++++.|+++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 77777777767777778899999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=361.38 Aligned_cols=251 Identities=21% Similarity=0.390 Sum_probs=219.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
-+...|.-...||+|+.|.||.|...... +.||||++.... ....+.+.+|+.+|+..+|+|||.++..... .+.
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~---~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~de 344 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTK---QEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLV-GDE 344 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCC---ceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcc-cce
Confidence 34567888899999999999999876554 789999997542 2223668899999999999999999987444 466
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
+|+|||||++|+|.+.+.. ..+++.++..|+++++.||+|||.++|+|||||++|||++.++.+||+|||+
T Consensus 345 LWVVMEym~ggsLTDvVt~---------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTK---------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred eEEEEeecCCCchhhhhhc---------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeee
Confidence 8999999999999999986 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--CCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--RLNQP 456 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--~~~~~ 456 (499)
+..+..... .....+||+.|||||+.....|++|+||||||++++||+- |++||-..++......+.... +...+
T Consensus 416 caqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMve-GEPPYlnE~PlrAlyLIa~ng~P~lk~~ 492 (550)
T KOG0578|consen 416 CAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPKLKNP 492 (550)
T ss_pred eeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhc-CCCCccCCChHHHHHHHhhcCCCCcCCc
Confidence 988765543 4567889999999999999999999999999999999999 999999888888777665543 34556
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..++.++++++.+|++.|+++|+++.|+++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 789999999999999999999999999985
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=340.53 Aligned_cols=253 Identities=27% Similarity=0.594 Sum_probs=216.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.++|++.+.||+|+||.||++.+.+. ..+|+|.+..... ..+.|.+|+.++++++||||+++++++ ......+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~----~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 75 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQ----IKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVC-TQQKPLY 75 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccC----ceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEE-ccCCCEE
Confidence 35678889999999999999987653 5789998764322 235688999999999999999999986 4456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.++++... ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||+++
T Consensus 76 iv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 76 IVTEFMENGCLLNYLRQRQ-------GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEEcCCCCcHHHHHHhCc-------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcc
Confidence 9999999999999997522 258899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
........ ......++..|+|||++.+..++.++||||||+++|||+++|+.||...+..+....+..+.+...+...+
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 227 (256)
T cd05114 149 YVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS 227 (256)
T ss_pred ccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence 65433222 12233456689999999988999999999999999999997889999888888888888777776777788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
.++.+++.+||+.+|++||++.++++.|
T Consensus 228 ~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 228 MTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 9999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=379.47 Aligned_cols=276 Identities=34% Similarity=0.581 Sum_probs=241.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCc----eeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEe
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDG----VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g 290 (499)
.+++.+..+.+.+.+|+|.||.|++|....... ....||||.++......+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 678888888888999999999999998764322 25789999999887778889999999999998 6999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcc-cCCCCC-----C--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCK-LCPEGV-----A--HTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~-----~--~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
+|.+ .+..++|.||+..|+|..||+.++ ...... . ..++..+.+.++.|||.|++||++.++|||||.++|
T Consensus 370 ~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 370 ACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 9866 667799999999999999999876 100000 1 248999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccC-CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-H
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLG-DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-P 440 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~ 440 (499)
||+.++..+||+|||+||.....++.... +...-+..|||||.+....|+.|+|||||||+||||+|.|..||.+.. .
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999987666554322 221256789999999999999999999999999999999999999866 6
Q ss_pred HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 441 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
.++.+.+.+|.+.+.|..|+++++++|..||+.+|++||++.++.+.++...
T Consensus 529 ~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 7778899999999999999999999999999999999999999999998854
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=348.40 Aligned_cols=278 Identities=34% Similarity=0.561 Sum_probs=230.7
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCC----CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEe
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE----DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g 290 (499)
++.+...+|.+++.||+|+||.||+++..+. ......+|+|.+...........+.+|+.+++++ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3456677899999999999999999975321 1123579999988665566677899999999999 6999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
++.. ....++++||+++|+|.+++....... ......+++.++..++.|++.||.|||+++++||||||+|
T Consensus 86 ~~~~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 86 VCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEcc-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 8654 556799999999999999998643210 0112458999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
|++++++.+||+|||+++.....+.........++..|+|||.+.+..++.++|||||||++|||+++|..||......+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999866433322222223345679999999999999999999999999999998889998888888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 443 MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 443 ~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
....+..+.....+..++.++.+++.+||+.+|++||++.|+++.|+++...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 8888777766677778899999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=356.15 Aligned_cols=278 Identities=27% Similarity=0.482 Sum_probs=225.4
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEE
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSI 293 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 293 (499)
+.++..+|++.+.||+|+||.||+|.+... ....+.||||++...........+.+|+.++.++ +|+||++++++|.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 456678999999999999999999986432 1233789999997655555567788999999999 6899999999887
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCC--------------------------------------------------
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPE-------------------------------------------------- 323 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------- 323 (499)
..+...++++||+++|+|.++++.......
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 766677999999999999999976421000
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCC
Q psy1789 324 ---------GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394 (499)
Q Consensus 324 ---------~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~ 394 (499)
.....+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||+++..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 00134789999999999999999999999999999999999999999999999999865433222222234
Q ss_pred CCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhc
Q psy1789 395 NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAM 473 (499)
Q Consensus 395 ~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~ 473 (499)
.++..|+|||.+.+..++.++||||||+++|||++.|..||..... .+....+..+.+...+...++++.+++..||+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 4567899999999999999999999999999999878889876543 334455556656666666788999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHH
Q psy1789 474 NPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 474 ~P~~RPt~~~v~~~L~~~~~~ 494 (499)
||++||++.||++.|+.+.+.
T Consensus 322 ~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 322 EPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=343.63 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=203.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc--CCCCcceeEEeEEEcCCC-
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG--LSHKNILTVLGVSIEDHT- 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~~- 297 (499)
..++.+.+.||+|.||.||+|.|.++ .||||++... ..+.+.+|.++.+. |||+||+.+++.-..+.+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe-----~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGE-----DVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeeccccCC-----ceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 34688889999999999999999874 6999999643 33567778777765 799999999997444433
Q ss_pred --ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEcC
Q psy1789 298 --SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK--------KLLHKDLATRNCVVDD 367 (499)
Q Consensus 298 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~--------~iiHrDlk~~NIlld~ 367 (499)
.+|||.+|.++|||.+||.. .+++.+..++++..+|.||+|||-. .|.|||||+.|||+.+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r---------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk 351 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR---------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 351 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh---------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc
Confidence 47999999999999999986 5799999999999999999999953 5999999999999999
Q ss_pred CCcEEEcccccccccCCCC--ccccCCCCCCccccccccccccCC----C--CCchhHHHHHHHHHHHHc----C-----
Q psy1789 368 KLRIQITDNALARDLFPSD--YHCLGDNENRPVKWLAIESLVHKT----F--STASDVWAFGVLLWELTT----L----- 430 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--s~~~DvwS~Gvvl~el~t----~----- 430 (499)
++.+-|+|+|||-...... .....+..+||-+|||||++...- + -..+||||||.++||++. |
T Consensus 352 n~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~ee 431 (513)
T KOG2052|consen 352 NGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEE 431 (513)
T ss_pred CCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehh
Confidence 9999999999997654331 222345678999999999996432 2 256999999999999985 2
Q ss_pred CCCCCCCC-----CHHHHHHHHH-cCCCCCCCCC-----CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 431 AQQPYAEI-----DPFEMAASLQ-DGYRLNQPVN-----CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 431 g~~p~~~~-----~~~~~~~~i~-~~~~~~~~~~-----~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
.++||.+. +.+++.+.+. +..|+..|.. +...+.++|+.||..||+.|.|+-.+.+.|.++.+
T Consensus 432 y~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 432 YQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred hcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 24677653 2244444442 3456655542 34468899999999999999999999999999874
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=360.13 Aligned_cols=277 Identities=30% Similarity=0.511 Sum_probs=226.8
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGV 291 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~ 291 (499)
.++.+...++.+++.||+|+||.||+|++.+. ....+.||+|++.........+.+.+|+.++.++. ||||++++|+
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 45778888899999999999999999997542 12336799999986555555567899999999997 9999999998
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCC-------------------------------------------------
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP------------------------------------------------- 322 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------- 322 (499)
|.. ....++|+||+++|+|.++++..+...
T Consensus 110 ~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 110 CTK-GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred Ecc-CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 654 556799999999999999998643200
Q ss_pred -----------------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy1789 323 -----------------------------------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATR 361 (499)
Q Consensus 323 -----------------------------------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~ 361 (499)
......+++..++.++.|++.||+|||+.+++||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 011235788899999999999999999999999999999
Q ss_pred ceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy1789 362 NCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441 (499)
Q Consensus 362 NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~ 441 (499)
|||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||+++++.||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986533222112223456788999999999999999999999999999998778898775544
Q ss_pred H-HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 442 E-MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 442 ~-~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
+ ....+..+.++..|..++.++.+++.+||+.+|++||++.||++.|+++.
T Consensus 349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 4 34455666666677788999999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=338.05 Aligned_cols=251 Identities=31% Similarity=0.604 Sum_probs=212.9
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
+.||+|+||.||+|+...++ +.+|+|.............|.+|++++++++||||++++++|.. ....++|+||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADN---TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCC---ceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeecc
Confidence 36899999999999986554 67999988765555566789999999999999999999998654 556799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++... ...+++.+++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.......
T Consensus 77 ~~~L~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 77 GGDFLTFLRTE-------GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred CCcHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 99999999752 13588999999999999999999999999999999999999999999999999886543222
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 467 (499)
.........+..|+|||.+.+..++.++|||||||++|||++++.+||......+....+....+...+..++.++.+++
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 229 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLM 229 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHH
Confidence 11122223456799999999999999999999999999999878899988777776666666666667778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q psy1789 468 AYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 468 ~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
.+||+.+|++|||+.++.+.|+
T Consensus 230 ~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 230 ERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHcCCChhhCcCHHHHHHHHh
Confidence 9999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=340.39 Aligned_cols=263 Identities=29% Similarity=0.526 Sum_probs=222.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|.+...+.....+++|.+...........|..|+.+++.++||||+++++++ ..+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-TKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-CCCCceE
Confidence 346788899999999999999987654444679999987665566678899999999999999999999985 4556679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++
T Consensus 82 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 82 IITEFMENGALDSFLRQND-------GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred EEEecCCCCcHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccc
Confidence 9999999999999997532 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccc-CCCC--CCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 381 DLFPSDYHCL-GDNE--NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 381 ~~~~~~~~~~-~~~~--~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
.......... .... ..+..|+|||++.+..++.++|||||||++||+++.|..||...+..+....+....+...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 234 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPM 234 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcc
Confidence 6543221111 1111 124579999999999999999999999999999876889998888877777777666666677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=339.73 Aligned_cols=260 Identities=31% Similarity=0.582 Sum_probs=220.4
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
++.+.+|++.+.||+|+||.||+|.+.++ +.+|+|.+..... ..+.+.+|+.++++++|+||+++++++. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 74 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNT----TPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCT-LEE 74 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCC----eEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEe-cCC
Confidence 45677899999999999999999986543 5799999875432 2356889999999999999999999854 455
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+++++|.+++.... ...+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg 148 (261)
T cd05068 75 PIYIVTELMKYGSLLEYLQGGA------GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFG 148 (261)
T ss_pred CeeeeeecccCCcHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcc
Confidence 6799999999999999997522 2468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++........ .......+..|+|||++.+..++.++||||||+++|||+|+|+.||.+....+....+........+.
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05068 149 LARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP 227 (261)
T ss_pred eEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 99876432211 11122234679999999999999999999999999999998899999888777777776666666667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.+++++.+++.+||+.+|++||++.++.+.|+++
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 8899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=354.73 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=207.9
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~ 297 (499)
+..+||.+++.||.|+||.||+|+-...+ ..||||+++..-..-+.-.=++|+..|++|+ ||||++|..+..+.+.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~---~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETG---ELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCC---ceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 34568899999999999999999976655 5699999976532222233468999999998 9999999999655554
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
.+++|||||+ .+|.+.+... ...|++..+..|+.||++||+|+|.+|+.|||+||+|||+.....+||+|||
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~R-------~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKDR-------NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhhc-------CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccc
Confidence 8999999999 8999999863 3579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC----
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR---- 452 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~---- 452 (499)
+||....... .+.-+.|.-|.|||+++ .+.|+.+.||||+||+++|+.+ -++.|.+.+..+..-++.....
T Consensus 156 LARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~s-LrPLFPG~sE~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 156 LAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYS-LRPLFPGASEIDQIYKICEVLGTPDK 231 (538)
T ss_pred cccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHH-hcccCCCCcHHHHHHHHHHHhCCCcc
Confidence 9998754332 23445677899999986 5679999999999999999999 7888988876654444433111
Q ss_pred --------------CCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 453 --------------LNQP-----------VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 453 --------------~~~~-----------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
...| .+++.++.+++.+|++.||++|||+.|.++.
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111 1577899999999999999999999998763
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=347.00 Aligned_cols=273 Identities=32% Similarity=0.589 Sum_probs=224.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 299 (499)
-++|++.+.||+|+||.||+|.+..+ +....+++|.+...........+.+|+.++.++ +|+||+++++++ ..+...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccC-CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-CCCCCc
Confidence 34677889999999999999997653 222567888877655555667889999999999 899999999986 445667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPE--------GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
++|+||+++|+|.++++....... .....+++.+++.++.|++.||+|||+++++||||||+|||+++++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 999999999999999986432111 112368999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++..... ........+..|+|||++.+..++.++|||||||++|||+|.|.+||...+..+....+..+.
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 240 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 240 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence 99999998643211 111122345679999999888899999999999999999987889998877777777776666
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhc
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~ 498 (499)
+...+..++.++.+++.+||+.+|++||++.++++.|+++.+.-++|
T Consensus 241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 66667778899999999999999999999999999999987765554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=339.05 Aligned_cols=264 Identities=28% Similarity=0.567 Sum_probs=222.5
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|+..+.||+|+||.||+|+..........+++|.+.........+.+.+|++++++++|+||+++.+++ ......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 81 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-TKFKPA 81 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-ccCCCc
Confidence 3456777899999999999999986544334689999987665555667899999999999999999999986 445667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 82 MIITEYMENGALDKYLRDHD-------GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence 99999999999999997522 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccc-cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 380 RDLFPSDYHC-LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 380 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
+......... .......+..|+|||++.+..++.++|||||||++|||++.|+.||...+..+....+..+.+...+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 234 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMD 234 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCC
Confidence 8664322111 111222355799999999999999999999999999999878889988777777777777666666778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
++.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=337.55 Aligned_cols=252 Identities=28% Similarity=0.555 Sum_probs=214.8
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYT 309 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~g 309 (499)
||+|+||.||+|.+...+. ...+|+|++.........+.|.+|+.++++++|+||+++++++ + ....++|+||+++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~-~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKK-QIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-E-AEALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCC-ceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-c-CCCeEEEEEeCCCC
Confidence 7999999999998763321 1569999997765555667899999999999999999999986 3 34569999999999
Q ss_pred CHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCcc-
Q psy1789 310 NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH- 388 (499)
Q Consensus 310 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~- 388 (499)
+|.+++... ...+++.+++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~L~~~l~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGK-------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999999752 236899999999999999999999999999999999999999999999999999855432211
Q ss_pred ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHH
Q psy1789 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMA 468 (499)
Q Consensus 389 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 468 (499)
.......++..|+|||.+.+..++.++|||||||++||+++.|..||......+....+..+.+...+..+++++.+++.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMK 232 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11122234568999999998899999999999999999997689999988888888888888777788889999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 469 YCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 469 ~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+||..+|++||++.+|.+.|+++
T Consensus 233 ~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHcCCChhhCcCHHHHHHHHhhh
Confidence 99999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=338.95 Aligned_cols=264 Identities=29% Similarity=0.540 Sum_probs=223.2
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|++.+.||+|+||.||+|.....+.....+|+|.+.........+.|.+|+.++++++||||+++++++. .++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-KSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCcc
Confidence 34678889999999999999998765443346799999876555556678999999999999999999999864 45667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+++++||||||+||++++++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD-------GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 99999999999999997632 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccc-cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 380 RDLFPSDYHC-LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 380 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
+......... ......++..|+|||++.+..++.++||||||+++||+++.|..||...+..+....+.++.+...+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMD 233 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCC
Confidence 8664332111 111223356799999999999999999999999999988768889988877777777777766666777
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+++++.+++.+||+.+|++||++.++++.|+++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=351.44 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=208.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~ 299 (499)
..|+.++.||+|+||.||||+...++ +.||+|++..+. .........+||.+|++|+||||++|.+...+. ...+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tg---kivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETG---KIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccC---cEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 34555699999999999999987665 789999997553 344455678999999999999999999986665 5678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
|||+|||+ -||..++... .-.|+..++..++.|++.||+|||+++|+|||||.+|||||.+|.+||+|||||
T Consensus 194 YlVFeYMd-hDL~GLl~~p-------~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 194 YLVFEYMD-HDLSGLLSSP-------GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred EEEEeccc-chhhhhhcCC-------CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccce
Confidence 99999999 6898888752 236999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---C-----
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD---G----- 450 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~---~----- 450 (499)
+.+.+.... ..+..+.|.-|.|||.+++ ..|+.++|+||.||||.||++ |++.|.+.+..+....|-+ .
T Consensus 266 r~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~-gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 266 RFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL-GKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred eeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc-CCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 987665543 2456678899999999987 469999999999999999999 9999998776654444321 0
Q ss_pred CC-----------CCCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 YR-----------LNQP---------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 ~~-----------~~~~---------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
|. +..+ ...+....+|+..+|..||++|.|+.+++.
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 1111 145667999999999999999999998874
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=337.18 Aligned_cols=255 Identities=33% Similarity=0.584 Sum_probs=218.8
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
+.||+|+||.||+|++...++....+++|.+.........+.+.+|+.+++.++|+||+++++++. ....++|+||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence 468999999999998866654557899999986655455678999999999999999999999853 335699999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+|+|.+++... ..+++..+..++.|++.||+|||..+++||||||+||++++++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKR--------REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999862 2589999999999999999999999999999999999999999999999999986643322
Q ss_pred cc-cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHH
Q psy1789 388 HC-LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSV 466 (499)
Q Consensus 388 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 466 (499)
.. ......++..|+|||.+.+..++.++||||||+++|||+++|.+||...+..+....+........+..++..+.++
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 230 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI 230 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 11 11122345679999999999999999999999999999987899999888888888887777777778899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 467 MAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 467 ~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
+.+||..+|++||++.++++.|+++.
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 99999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=341.33 Aligned_cols=269 Identities=30% Similarity=0.577 Sum_probs=223.1
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+...++++.+.||+|+||.||++..... ......+++|.+... .......|.+|+++++.++|+||+++++++.. .
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTE-G 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-C
Confidence 3456788889999999999999975421 222367889988654 44556789999999999999999999998644 5
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCP-------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
...++++||+++|+|.+++....... ......+++..++.++.|++.||+|||+.+++||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 56799999999999999998643210 11123589999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 370 RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||+++|.+||......+....+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999998664433322233444567899999999999999999999999999999988999988877777777777
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
+.....+..+++++.+++.+||+.||.+||++++|.+.|+
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 7666777789999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=353.91 Aligned_cols=250 Identities=19% Similarity=0.305 Sum_probs=219.4
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
..|+..+.||+|.||.||||...... +.||+|++.-+......++..+|+.+|..++++||.+++|.. -.+..+++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~---k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsy-l~g~~Lwi 88 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTK---KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSY-LKGTKLWI 88 (467)
T ss_pred cccccchhccccccceeeeeeecccc---ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhe-eecccHHH
Confidence 34555699999999999999986655 889999998887777888999999999999999999999974 44667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+|||+.+|++.+.|..+ ..+++..+.-|++++..||.|||.++.+|||||+.|||+..+|.+||+|||.+..
T Consensus 89 iMey~~gGsv~~lL~~~--------~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSG--------NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred HHHHhcCcchhhhhccC--------CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeee
Confidence 99999999999999862 3457888899999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
+..... ......||+.|||||++....|+.|+||||||++.+||++ |.+|+...++..+...|-+...+.....+++
T Consensus 161 l~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~-GePP~s~~hPmrvlflIpk~~PP~L~~~~S~ 237 (467)
T KOG0201|consen 161 LTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAK-GEPPHSKLHPMRVLFLIPKSAPPRLDGDFSP 237 (467)
T ss_pred eechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhc-CCCCCcccCcceEEEeccCCCCCccccccCH
Confidence 754433 2367889999999999999999999999999999999999 9999999988665555555544544557899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++++..|+++||+.||++.++++
T Consensus 238 ~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 238 PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 9999999999999999999999986
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=343.12 Aligned_cols=271 Identities=32% Similarity=0.580 Sum_probs=224.2
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+...+|++.+.||+|+||.||++..... +.....+|+|.+.........+.|.+|+.++++++||||+++++++. .+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-VG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-CC
Confidence 3456788899999999999999987431 12337899999986655666678999999999999999999999864 45
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCP--------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
...++++||+++|+|.+++....... ......+++..++.++.|++.||+|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 56799999999999999998533210 0112358899999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
|++++++.++|+|||+++................+..|+|||.+.+..++.++|||||||++|||++.+..||.+....+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998865443322222233456679999999999999999999999999999986788988888888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 443 MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 443 ~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
....+..+.....+..++.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 777777665555666789999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=345.81 Aligned_cols=270 Identities=30% Similarity=0.584 Sum_probs=224.9
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
...+++..+.||+|+||.||+|.+..++. ....+|+|.+...........+.+|+.+++.++||||++++|+|... .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~ 82 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--T 82 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--C
Confidence 34567778999999999999998765432 33568999887665555556789999999999999999999987543 3
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++++||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHK-------DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccc
Confidence 579999999999999997632 3588999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++...............++..|+|||++.+..++.++|||||||++|||++.|+.||.+....+....+..+.+...+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPI 235 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence 98664332221222344567899999999999999999999999999999878899988777777777777666666667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhc
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~ 498 (499)
++.++.+++..||..+|++||++.++++.|.++.+.-.++
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 275 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRY 275 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhh
Confidence 8899999999999999999999999999999987665443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=336.41 Aligned_cols=252 Identities=30% Similarity=0.575 Sum_probs=214.1
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
.||+|+||.||+|.+.... ....+|+|++... ......+.+.+|+.+++.++|+||++++|++ + ....++|+||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK-SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-E-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCC-CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-c-CCCcEEEEecCC
Confidence 5899999999999875332 2267999998644 2345567899999999999999999999986 3 335689999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 79 LGPLNKFLQKN--------KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred CCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 99999999752 3588999999999999999999999999999999999999999999999999987643322
Q ss_pred ccc-CCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHH
Q psy1789 388 HCL-GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSV 466 (499)
Q Consensus 388 ~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 466 (499)
... .....++..|+|||.+....++.++|||||||++|||++.|+.||...+..++...+..+..+..|..++.++.++
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 230 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDL 230 (257)
T ss_pred eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 111 1223345789999999888899999999999999999987889999888888888888877777788899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 467 MAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 467 ~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+.+||+.||++||++.+|.+.|+++
T Consensus 231 i~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 231 MKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.49 Aligned_cols=278 Identities=34% Similarity=0.562 Sum_probs=231.3
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCC----ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED----GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVL 289 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~ 289 (499)
.++++...+|++++.||+|+||.||++.....+ .....+|+|.+.........+.+.+|+.+++++ +|+||++++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 346677778999999999999999999864321 122468999887655556667899999999999 899999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATR 361 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~ 361 (499)
++|.. ....++++||+++|+|.+++....... ......+++.+++.++.|++.||+|||+++++||||||+
T Consensus 85 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 85 GACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred EEEcc-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 98654 556799999999999999998643110 011245899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy1789 362 NCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441 (499)
Q Consensus 362 NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~ 441 (499)
||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++++..||...+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999986644332222223344567999999999999999999999999999999788999988888
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 442 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
+....+..+.....+..++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 8888887777777777889999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=360.74 Aligned_cols=247 Identities=20% Similarity=0.330 Sum_probs=218.9
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE 294 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 294 (499)
.+.-.+++++++||+|+||+|+++.++.++ +.+|||++++.. ....++....|.+++... +||.+++|++. ++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~---e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-fQ 439 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTN---EYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-FQ 439 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCC---cEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-cc
Confidence 455678999999999999999999998776 789999998652 334466777888887766 59999999985 88
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
..+++++||||..+|++..+.+. ..+++..+.-++..|+.||.|||+++|||||||.+|||||.+|++||+
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~---------~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHT---------DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEec---------ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEec
Confidence 89999999999999996655553 469999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
||||+|....... .+++.+||+.|||||++.+..|+.++|+|||||+||||+. |+.||.+.+.+++.+.|... .+.
T Consensus 511 DFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~-Gq~PF~gddEee~FdsI~~d-~~~ 586 (694)
T KOG0694|consen 511 DFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV-GESPFPGDDEEEVFDSIVND-EVR 586 (694)
T ss_pred ccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCC
Confidence 9999997653322 4568999999999999999999999999999999999999 99999999999999988765 566
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
.|..++.+..++|.+.+.++|++|.-+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCC
Confidence 788999999999999999999999876
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.47 Aligned_cols=267 Identities=31% Similarity=0.584 Sum_probs=227.3
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
++...+|.+.+.||+|+||.||+|.+.+..+....+++|...........+.+.+|+.++++++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--C
Confidence 35567788999999999999999997654333357999998766555666789999999999999999999998643 3
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK-------YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCc
Confidence 4589999999999999997622 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++........ ......++..|+|||.+....++.++||||||+++||+++.|..||......+....+..+.+...+.
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (270)
T cd05056 153 LSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPP 231 (270)
T ss_pred eeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 99866543322 12233345679999999988999999999999999999976899998888777777777777777778
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.++.++.+++.+||..+|++|||+.++++.|+++..+
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 8999999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=336.21 Aligned_cols=253 Identities=30% Similarity=0.622 Sum_probs=219.0
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+...+|++.+.||+|+||.||+|...+ ..+++|...... ..+.|.+|+.++++++|+|++++++++...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcC-----CcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence 455678889999999999999998753 568999886543 235788999999999999999999987676677
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++++||+++++|.+++.... ...+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~ 148 (256)
T cd05082 75 LYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL 148 (256)
T ss_pred eEEEEECCCCCcHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCcc
Confidence 899999999999999998632 23588999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++...... ....++..|+|||++.+..++.++||||||+++|||++.|+.||...+..+....+..+.....+..
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 223 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 88543221 2334456899999999999999999999999999999878999988888788778877767667778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
++..+.+++.+||+.+|++|||+.++++.|++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 89999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=347.41 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=210.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||+|+||.||+|....++ +.+|+|++.... ...+.+.+.+|+.++++++||||+++++++ .+....+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~ 77 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISE---HYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-HDQRFLY 77 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCC---CEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-ccCCeEE
Confidence 5788899999999999999986554 689999986432 233456788999999999999999999984 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++.....++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++
T Consensus 78 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~ 149 (291)
T cd05612 78 MLMEYVPGGELFSYLRNS--------GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149 (291)
T ss_pred EEEeCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcch
Confidence 999999999999999862 358899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
..... .....|+..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..+ ....+...+
T Consensus 150 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~ 222 (291)
T cd05612 150 KLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAG-KLEFPRHLD 222 (291)
T ss_pred hccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CcCCCccCC
Confidence 65322 123568889999999999999999999999999999999 89999988887777776654 445566778
Q ss_pred HHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
.++.+++.+||+.||.+||+ +.|+++
T Consensus 223 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 223 LYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 89999999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=352.94 Aligned_cols=246 Identities=21% Similarity=0.301 Sum_probs=211.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++.+.||+|+||.||+|+...++ +.+|+|++.... .....+.+.+|+.++++++||||+++++++ ..+...
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTG---EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-QDENRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-EcCCEE
Confidence 46888899999999999999986654 689999986432 223456788999999999999999999985 456678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++... ..+++.....++.|++.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 94 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 165 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA 165 (329)
T ss_pred EEEEcCCCCChHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCc
Confidence 9999999999999999862 35788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+...... ....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.++.+....+..+ +...|..+
T Consensus 166 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~-~~~~p~~~ 238 (329)
T PTZ00263 166 KKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA-GYPPFFDDTPFRIYEKILAG-RLKFPNWF 238 (329)
T ss_pred eEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CcCCCCCC
Confidence 8653322 23568899999999999999999999999999999999 89999888887777777665 45566678
Q ss_pred cHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
++++.+++.+||+.||.+||+ +.+++.
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 899999999999999999997 566653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=336.09 Aligned_cols=260 Identities=32% Similarity=0.566 Sum_probs=219.2
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
.+...+|++.+.||+|+||.||+|++.++ ..+++|.+..... ..+.|.+|+.++++++|+||+++++++ . ..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~-~-~~ 73 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVV-S-EE 73 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCC----ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEE-C-CC
Confidence 45677899999999999999999987544 4599999875322 235688999999999999999999974 3 34
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg 147 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEM------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 147 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhcc------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCC
Confidence 4699999999999999997522 2357899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++........ ......++..|+|||+..+..++.++||||||+++|||+|+|..||......+....+........+.
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05071 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226 (262)
T ss_pred ceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCcc
Confidence 99866433221 22234466789999999999999999999999999999998889998887777776666665555566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
.++.++.+++.+||+.+|++||++.++++.|+++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 78999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=353.49 Aligned_cols=248 Identities=21% Similarity=0.380 Sum_probs=219.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|.+.+.||+|+||.||||+-+.+. +.||+|.+.+. ..+...+.+.+|++++++++|||||.++.+ ++...+.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~---~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-fEt~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTI---QVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-FETSAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccce---eEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-hcccceEE
Confidence 45777799999999999999976554 89999999765 345567789999999999999999999998 67788889
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|.||+.+ +|..+|... ..|+++.+..|+.|+..||.|||+.+|+|||+||.||||+..+.+|++|||+||
T Consensus 78 vVte~a~g-~L~~il~~d--------~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQD--------GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred EEehhhhh-hHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhh
Confidence 99999995 999999873 369999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
...... ...+...||+-|||||...+..|+..+|+||+||++||+++ |++||......++...|... ....|.+.+
T Consensus 149 ~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~-G~PPF~a~si~~Lv~~I~~d-~v~~p~~~S 224 (808)
T KOG0597|consen 149 AMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYV-GQPPFYARSITQLVKSILKD-PVKPPSTAS 224 (808)
T ss_pred hcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhc-CCCCchHHHHHHHHHHHhcC-CCCCccccc
Confidence 875432 24457789999999999999999999999999999999999 99999988877888777664 444566889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+..++...+.+||.+|.|..+++.
T Consensus 225 ~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 225 SSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHHHhhcChhhcccHHHHhc
Confidence 99999999999999999999998864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=364.77 Aligned_cols=255 Identities=20% Similarity=0.229 Sum_probs=214.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
.|.+.+.||+|+||.||+|....... ..|++|.+... .......+.+|+.+++.++||||+++++++. ..+..+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~--~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~~~~~lv 143 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPK--EKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFK-SDDKLLLI 143 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCC--eEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-ECCEEEEE
Confidence 48888999999999999998654412 56788876543 3444567888999999999999999999864 45678999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
|||+++|+|.++++... .....+++.++..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 144 ~E~~~gg~L~~~l~~~~----~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRL----KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EECCCCCCHHHHHHHHH----hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999987522 11245889999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHH
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 462 (499)
.............||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+..+.....+..++++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~ 298 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT-LHRPFKGPSQREIMQQVLYGKYDPFPCPVSSG 298 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCccCCHH
Confidence 44322223345668999999999999999999999999999999999 89999888877777777666555566678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 463 LFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 463 ~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+.+++.+||+.||++||++.+++.
T Consensus 299 ~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 299 MKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999999864
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=357.33 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=222.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
-+++++.||.|+.|.|-.|++..++ +.+|||++.+. .+..+...+.+|+.+|+.+.|||+++|+++ ++...++|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TG---qlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-we~~~~ly 88 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETG---QLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-WENKQHLY 88 (786)
T ss_pred ceeccccccCCCCceehhhhccccc---ceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-eccCceEE
Confidence 3677899999999999999987665 88999999754 233445678899999999999999999999 56678889
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
||.||+++|.|.+++-. ...|++.+..+.+.||..|+.|||..+|+||||||+|+|||.++++||+|||+|.
T Consensus 89 lvlEyv~gGELFdylv~--------kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVR--------KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred EEEEecCCchhHHHHHh--------hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceee
Confidence 99999999999999987 3479999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
.-.+.. .-.+-+|++.|.|||++.+.+|. .++||||.||||+.|+| |+.||.+.+...+..+++.| ..+.|.++
T Consensus 161 Le~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt-G~LPFdDdNir~LLlKV~~G-~f~MPs~I 235 (786)
T KOG0588|consen 161 LEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT-GKLPFDDDNIRVLLLKVQRG-VFEMPSNI 235 (786)
T ss_pred cccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh-CCCCCCCccHHHHHHHHHcC-cccCCCcC
Confidence 665443 23467899999999999999985 89999999999999999 99999999988899999888 67888999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+.++.+|+.+++..||+.|.|++||++.
T Consensus 236 s~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 236 SSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred CHHHHHHHHHHhccCccccccHHHHhhC
Confidence 9999999999999999999999999874
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=336.34 Aligned_cols=258 Identities=32% Similarity=0.579 Sum_probs=219.0
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
.+...+|++.+.||+|+||.||+|...++ ..+++|.+...... .+.|.+|+.++++++|+|++++++++ . ..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~----~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~-~-~~ 73 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGN----TKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVV-S-EE 73 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCC----ceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEE-C-CC
Confidence 45667889999999999999999987543 46899988754322 35688999999999999999999985 3 34
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..+++|||+++++|.++++... ...+++.++..++.|++.||.|||+.+++||||||+||++++++.++|+|||
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGE------GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCce
Confidence 4699999999999999997522 2358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++........ ......++..|+|||++.+..++.++||||||+++|||+++|.+||...+..+....+....+...+.
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05070 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQ 226 (260)
T ss_pred eeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 99865433221 12233456789999999999999999999999999999998889998888888777777766666777
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
..+.++.+++.+||+.+|++|||+.++.+.|++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.57 Aligned_cols=255 Identities=29% Similarity=0.602 Sum_probs=216.1
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
+..+|++.+.||+|+||.||+|.+.+. ..+|+|.+..... ..+.|.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~----~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 74 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPI 74 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCC----CcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCc
Confidence 345788999999999999999987543 4699998864422 23578999999999999999999998644 5567
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+++|+||||+||++++++.+||+|||++
T Consensus 75 ~lv~e~~~~~~l~~~i~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~ 147 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREHG-------KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147 (256)
T ss_pred EEEEEcCCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccc
Confidence 99999999999999997632 25899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+........ ......++..|+|||++.+..++.++||||||+++|||+|.|..||...+..+....+..+.+...+...
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05113 148 RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226 (256)
T ss_pred eecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCC
Confidence 866443321 2223345678999999998899999999999999999998788999888777777777777666666678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
++++.+++.+||+.+|++||++.++++.|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=338.42 Aligned_cols=258 Identities=31% Similarity=0.578 Sum_probs=221.5
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|++++.||+|+||.||+|...+. ..+++|.+..... .....+.+|+.+++.++|+||+++++++. .....
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~----~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNR----VRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCS-VGEPV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCC----CcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEe-cCCCe
Confidence 445677889999999999999998663 6799999875532 23467889999999999999999999864 45667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||++
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPE------GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred EEEEeecccCCHHHHHhcCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccch
Confidence 99999999999999998532 245899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
......... .....++..|+|||.+.+..++.++||||||+++|||+++|+.||...+..+....+..+.+...+..+
T Consensus 152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (261)
T cd05148 152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKC 229 (261)
T ss_pred hhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCC
Confidence 866432221 223446778999999999999999999999999999999789999888887777777777777777889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
++++.+++.+||+.||++|||+.++++.|+.+
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 230 PQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=396.64 Aligned_cols=241 Identities=21% Similarity=0.276 Sum_probs=188.7
Q ss_pred EeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 226 LFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 226 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
..++||+|+||.||+|+....+ +.||||++...... ...|++.+++++|||||+++|+|.+ ....++||||
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~Ey 764 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNG---MQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHEY 764 (968)
T ss_pred cccEEccCCCeeEEEEEECCCC---cEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEeC
Confidence 3478999999999999975544 78999998654221 1346888999999999999999765 4567999999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH---KKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH---~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+++|+|.++++. ++|.++.+|+.|+|+||+||| +.+|+||||||+||+++.++.+++. ||.+...
T Consensus 765 ~~~g~L~~~l~~-----------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 765 IEGKNLSEVLRN-----------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCCcHHHHHhc-----------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 999999999963 889999999999999999999 5689999999999999999988875 6665433
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc---C------C
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP--FEMAASLQD---G------Y 451 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~--~~~~~~i~~---~------~ 451 (499)
.. .....++..|||||++.+..++.++|||||||++|||+| |+.||..... ..+..+... . .
T Consensus 833 ~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 833 CT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT-GKSPADAEFGVHGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred cc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHh-CCCCCCcccCCCCcHHHHHHHhcCccchhhee
Confidence 21 123357889999999999999999999999999999999 7888753211 111111110 0 0
Q ss_pred CC------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 452 RL------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 452 ~~------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.+ ..+.....++.+++.+||+.||++||||.|+++.|+++.+.
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 00 11112344678899999999999999999999999988653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=365.07 Aligned_cols=262 Identities=18% Similarity=0.231 Sum_probs=220.7
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
.....+|++.+.||+|+||.||+|+...++ +.+|||++... .+......+.+|+..+..++|+||+++++......
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDG---EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCC---CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 344568999999999999999999876554 78999998643 34555677889999999999999999887643321
Q ss_pred C-------ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 297 T-------SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 297 ~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
. ..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+++|+||||||+|||+++++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~----~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRA----KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhh----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC
Confidence 1 3579999999999999997532 1234689999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 370 RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLlt-G~~Pf~~~~~~~~~~~~~~ 259 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHKTLA 259 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHhc
Confidence 999999999987643322223345678999999999999999999999999999999999 8999998888777777766
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+.....+..+++++.+++.+||+.||++||++.++++.
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 65666677889999999999999999999999999763
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=341.75 Aligned_cols=269 Identities=33% Similarity=0.554 Sum_probs=219.6
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCc-------------eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDG-------------VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNIL 286 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv 286 (499)
...+|++.+.||+|+||.||+|...+.+. ....+|+|.+.........+.+.+|++++++++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 45678899999999999999998764332 12568999998766666778899999999999999999
Q ss_pred eEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy1789 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE---GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNC 363 (499)
Q Consensus 287 ~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NI 363 (499)
++++++.. +...++++||+++++|.+++........ .....+++..++.++.|++.||+|||+.+++||||||+||
T Consensus 83 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 83 RLLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99998654 4667999999999999999986431110 1123689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCHHH
Q psy1789 364 VVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL-AQQPYAEIDPFE 442 (499)
Q Consensus 364 lld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~-g~~p~~~~~~~~ 442 (499)
++++++.++|+|||+++.....+.........++..|+|||++.+..++.++|||||||++|||+++ +..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 9999999999999999876544433333455567889999999998999999999999999999984 567887766666
Q ss_pred HHHHHHcC-------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 443 MAASLQDG-------YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 443 ~~~~i~~~-------~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
....+... .....+..+++++.+++.+||+.||++|||+.||++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 55544332 112334467789999999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=334.78 Aligned_cols=253 Identities=32% Similarity=0.605 Sum_probs=214.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..++++.+.||+|+||.||+|.+... ..+++|.+..... ....|.+|+.++++++|+||+++++++ ......+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~ 75 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGK----IDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVC-TKQRPIF 75 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCC----ccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEE-cCCCceE
Confidence 34577889999999999999987543 5689998864322 224688899999999999999999985 4456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||+++
T Consensus 76 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 76 IVTEYMANGCLLNYLRERK-------GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred EEEecCCCCCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccce
Confidence 9999999999999997532 258999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
........ ......++..|+|||.+.+..++.++||||||+++|||+++|+.||...+..+....+....+...+..++
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05059 149 YVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAP 227 (256)
T ss_pred eccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCC
Confidence 65432221 11222345679999999999999999999999999999998899998887777777777777777777889
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
.++.+++.+||+.+|++|||+.|+++.|
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 9999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=335.59 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=215.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.||+|+||.||+|.+.+++ ....+++|.+.........+.+.+|+.++.++ +||||+++++++.. ....+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeC
Confidence 36899999999999986543 22567889887654555567889999999999 89999999998644 55679999999
Q ss_pred CCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 307 DYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
++|+|.+++....... ......+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999998643211 11224589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++.... .........+..|+|||++....++.++|||||||++|||+|.|+.||...+..+....+..+.+...+..
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 235 (270)
T cd05047 159 SRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 235 (270)
T ss_pred ccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCc
Confidence 863321 11111223456799999999999999999999999999999768899988877777777777666667777
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
++.++.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 8899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=340.33 Aligned_cols=269 Identities=29% Similarity=0.531 Sum_probs=221.6
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
++.+...+|++.+.||+|+||.||+|..... ......+|+|.+.........+.+.+|+.+++++ +|+||+++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3556677899999999999999999986321 2234689999987654555567899999999999 799999999986
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
. ..+..++++||+++|+|.++++... ...+++.++..++.|++.||+|||+++|+|+||||+|||++.++.++
T Consensus 109 ~-~~~~~~lv~e~~~~~~L~~~i~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 109 T-IGGPILVITEYCCYGDLLNFLRRKR------ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred e-cCCceEEEEEcCCCCcHHHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEE
Confidence 4 4556799999999999999997522 12389999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGY 451 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~-~~~~i~~~~ 451 (499)
|+|||+++...............++..|+|||.+.+..++.++|||||||++|||+|.|..||......+ ....+..+.
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~ 261 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence 9999999866433222122234456789999999999999999999999999999987888887765443 344555555
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+...+...++++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 5555667789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=350.84 Aligned_cols=243 Identities=19% Similarity=0.242 Sum_probs=206.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
+.||+|+||.||+++...++ +.+|+|++.... .......+.+|+.++++++||||+++++++ ......++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-~~~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKATG---KYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-QTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-EcCCEEEEEEeC
Confidence 46899999999999976554 689999987532 233456788999999999999999999985 556678999999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 77 ANGGELFFHLSRE--------RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred CCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 9999999999762 35899999999999999999999999999999999999999999999999999854322
Q ss_pred CccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHH
Q psy1789 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465 (499)
Q Consensus 386 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 465 (499)
.. ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+... ....|...++++.+
T Consensus 149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~ 224 (323)
T cd05571 149 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKS 224 (323)
T ss_pred CC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHH
Confidence 11 2234568999999999999999999999999999999999 89999887777766666543 44566788999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 466 VMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 466 l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
++.+||+.||++|| ++.++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 225 LLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 99999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=346.23 Aligned_cols=252 Identities=17% Similarity=0.245 Sum_probs=209.3
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+..++|++.+.||+|+||.||+++...++ ..+|+|.+.........+.+.+|+.++++++||||+++++++.. ++.
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 77 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSG---LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGE 77 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCC---cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCE
Confidence 34678999999999999999999986554 67999998766555556789999999999999999999998644 566
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEcccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEA--------KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred EEEEeecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence 79999999999999999862 3588999999999999999999986 69999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---------
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ--------- 448 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~--------- 448 (499)
+++..... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||...+..++...+.
T Consensus 150 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (331)
T cd06649 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI-GRYPIPPPDAKELEAIFGRPVVDGEEG 224 (331)
T ss_pred cccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhcccccccccC
Confidence 99865332 1234568889999999999999999999999999999999 899997665544433221
Q ss_pred -------------------------------------cCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 449 -------------------------------------DGYRLNQP-VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 449 -------------------------------------~~~~~~~~-~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
....+..+ ...++++.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111111 1357889999999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=332.74 Aligned_cols=258 Identities=31% Similarity=0.566 Sum_probs=217.2
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
.+...+|++.+.||+|+||.||+|.+... ..+++|.+..... ..+.+.+|+.++++++|+|++++++++ . ..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~----~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~-~~ 73 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGT----TKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVV-S-EE 73 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCC----ceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEE-c-CC
Confidence 35567899999999999999999987554 3588998764422 235688999999999999999999985 3 34
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..+++|||+++|+|.++++... ...+++..+..++.|++.||+|||+.+++||||||+||++++++.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGD------GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCc
Confidence 5689999999999999997632 2358899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++........ ......++..|+|||+..+..++.++|||||||++|||+|+|..||.+....+....+........+.
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05069 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ 226 (260)
T ss_pred cceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99865432221 12233456789999999999999999999999999999998899998887777777776666666666
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
..+..+.+++.+||+.||++||++++|++.|++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=340.35 Aligned_cols=270 Identities=32% Similarity=0.570 Sum_probs=215.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCC-----------CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCccee
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEE-----------DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~ 287 (499)
++..+|++.+.||+|+||.||++...+. .+....+|+|.+...........|.+|++++++++|+||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 4566899999999999999999876432 11224689999976655666678999999999999999999
Q ss_pred EEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccC----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy1789 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLC----PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNC 363 (499)
Q Consensus 288 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NI 363 (499)
+++++. .....++||||+++++|.+++...... .......+++..++.++.|++.||+|||+.+++||||||+||
T Consensus 82 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 82 LLGVCV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEEc-CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999964 456679999999999999999753211 011123478999999999999999999999999999999999
Q ss_pred EEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCHHH
Q psy1789 364 VVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL-AQQPYAEIDPFE 442 (499)
Q Consensus 364 lld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~-g~~p~~~~~~~~ 442 (499)
++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||+++ +..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999865443332233344557789999999999999999999999999999984 456887766655
Q ss_pred HHHHHHc-------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 443 MAASLQD-------GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 443 ~~~~i~~-------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
....+.. ......+..+++++.+++.+||+.||++||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 4433321 1112334467899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=339.63 Aligned_cols=271 Identities=32% Similarity=0.561 Sum_probs=216.5
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCC-------------CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEE-------------DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI 285 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-------------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI 285 (499)
++..+|++.+.||+|+||.||++...+. ......+|+|.+...........|.+|+.+++.++|+||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence 3456799999999999999999864321 112357999999766556666789999999999999999
Q ss_pred eeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 286 LTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP---EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 286 v~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
+++++++.. ....++++||+++|+|.+++....... ......+++.++..++.|++.||+|||+.+++||||||+|
T Consensus 82 ~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 82 IRLLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred ceEEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 999998644 456799999999999999998643211 1122458899999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCHH
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL-AQQPYAEIDPF 441 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~-g~~p~~~~~~~ 441 (499)
|++++++.++|+|||+++...............++..|+|||....+.++.++|||||||++|||+|+ +..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999866443332223334456789999999889999999999999999999984 56788776665
Q ss_pred HHHHHHHc-------CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 442 EMAASLQD-------GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 442 ~~~~~i~~-------~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
+....... ......+..+++.+.+++.+||+.||++||++.+|.+.|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 54433211 11223345688999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=349.83 Aligned_cols=250 Identities=18% Similarity=0.268 Sum_probs=212.5
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
...+|++.+.||+|+||.||+|.+...+. ..+|+|.+.... .....+.+.+|+.+++.++||||+++++++ ..+.
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~ 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDF--PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-KDES 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCC--eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-EeCC
Confidence 44568888999999999999998765432 579999886431 233456788999999999999999999985 5566
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRN--------KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCC
Confidence 789999999999999999862 358899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++..... .....||+.|||||++.+..++.++|||||||++|||++ |.+||...++......+..+ ....|.
T Consensus 177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 249 (340)
T PTZ00426 177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILV-GCPPFYANEPLLIYQKILEG-IIYFPK 249 (340)
T ss_pred CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Confidence 99865322 124568899999999999999999999999999999999 89999988877777777665 334566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRP-----TFPQLHSC 487 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~~ 487 (499)
..++++.+++.+|++.||++|+ +++++++.
T Consensus 250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 7889999999999999999995 78887653
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.71 Aligned_cols=248 Identities=16% Similarity=0.255 Sum_probs=203.4
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
|++.+.||+|+||.||+|....++ +.+|+|.+.... .......+.+|+.++++++|+||+++++++ ......++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-~~~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-ETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCC---ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-ccCCeEEE
Confidence 567799999999999999986654 789999986432 223345678999999999999999999985 44567899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++|+|..++.... ...+++..+..++.|++.||+|||+.+|+||||||+|||+++++.+||+|||+++.
T Consensus 78 v~e~~~~g~L~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMG------NPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred EEEecCCCcHHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 999999999998886422 23589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE----MAASLQDGYRLNQPV 457 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~----~~~~i~~~~~~~~~~ 457 (499)
...... .....||..|+|||++.+..++.++|||||||++|||++ |+.||...+... +...+. ......+.
T Consensus 152 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 226 (285)
T cd05631 152 IPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQ-GQSPFRKRKERVKREEVDRRVK-EDQEEYSE 226 (285)
T ss_pred cCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHh-CCCCCCCCCcchhHHHHHHHhh-cccccCCc
Confidence 532221 224568899999999999999999999999999999999 899998754322 222222 22334556
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
..+.++.+++.+||+.||++||+ +.++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 78899999999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=347.86 Aligned_cols=241 Identities=19% Similarity=0.255 Sum_probs=203.4
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
||+|+||.||+|+...++ +.+|+|++... ........+.+|+.++++++||||+++++++ ......++|+||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQ---RIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-QSPEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-ecCCeEEEEEcCCC
Confidence 689999999999986554 67999998643 2334456788999999999999999999985 45667899999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 77 GGELFHHLQRE--------GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC
Confidence 99999999762 3589999999999999999999999999999999999999999999999999986433221
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 467 (499)
......||..|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+... ....+..+++++.+++
T Consensus 149 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~t-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 224 (312)
T cd05585 149 --KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDENVNEMYRKILQE-PLRFPDGFDRDAKDLL 224 (312)
T ss_pred --ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHh-CCCCcCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHH
Confidence 2234568999999999999999999999999999999999 89999888777776666544 4456677899999999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q psy1789 468 AYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 468 ~~C~~~~P~~RPt~~~v~~ 486 (499)
.+||+.||++||++.++.+
T Consensus 225 ~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 225 IGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred HHHcCCCHHHcCCCCCHHH
Confidence 9999999999986544333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=332.83 Aligned_cols=258 Identities=32% Similarity=0.607 Sum_probs=220.8
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
.+....|++++.||+|+||.||+|...++ +.+|+|.+..... ..+.|.+|+.++++++|+||++++++. . ..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~-~~ 73 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGH----TKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-T-QE 73 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCC----ceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-c-cC
Confidence 46678899999999999999999986543 6799999875432 235788999999999999999999974 3 34
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+++||||||+||++++++.++|+|||
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg 147 (260)
T cd05067 74 PIYIITEYMENGSLVDFLKTPE------GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFG 147 (260)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCc
Confidence 5799999999999999987522 2368999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++........ ......++..|+|||++....++.++||||||+++||++++|++||...+..+....+..+.+...+.
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05067 148 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226 (260)
T ss_pred ceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Confidence 99866433222 12233456789999999999999999999999999999987899999888878777777776777777
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
..+.++.+++.+||+.+|++||+++++...|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=343.74 Aligned_cols=253 Identities=20% Similarity=0.303 Sum_probs=215.9
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 291 (499)
+.+..+.-..|+++.+||+|+||.||+|+-++++ ..+|+|++++. ....+++..+.|..+|...+.+.||+|+-.
T Consensus 133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg---~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTG---EIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred hccccCCcccchhheeeccccceeEEEEEEccCC---cEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 3444566778999999999999999999977765 78999999765 245667788999999999999999999876
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
+++...+||||||++||++..+|.. ...|++.....++.+++.|++-+|+.|+|||||||+|+|||..|++
T Consensus 210 -FQD~~~LYLiMEylPGGD~mTLL~~--------~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 210 -FQDKEYLYLIMEYLPGGDMMTLLMR--------KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred -ecCCCeeEEEEEecCCccHHHHHHh--------cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCE
Confidence 7889999999999999999999987 3479999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCC----------------------CCccc-----------------------cCCCCCCcccccccccc
Q psy1789 372 QITDNALARDLFP----------------------SDYHC-----------------------LGDNENRPVKWLAIESL 406 (499)
Q Consensus 372 kl~DfGla~~~~~----------------------~~~~~-----------------------~~~~~~gt~~y~aPE~~ 406 (499)
||+||||++.+.. .+... ..-..+||+.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 9999999964421 00000 00134589999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q psy1789 407 VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---RLNQPVNCPDELFSVMAYCWAMNPEGRPT 480 (499)
Q Consensus 407 ~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RPt 480 (499)
.+..|+..+|+||+|||||||+. |.+||...++.+....|..+. ..+....+++++.+||.+|+. ||++|.-
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLv-GyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLV-GYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999999999 999999999999888776542 223334678999999999999 9999975
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=335.91 Aligned_cols=259 Identities=34% Similarity=0.529 Sum_probs=208.2
Q ss_pred eEEeeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-CceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH-TSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~~l 301 (499)
|++.+.||+|+||+||++..... ......+|+|.+...........|.+|++++++++||||+++++++.... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999998765321 12236799999976555455678899999999999999999999875543 34789
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+|||+++|+|.+++.. ..+++.++..++.|++.||.|||+++|+||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~---------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPK---------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHH---------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999975 3489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---------------HHHHH
Q psy1789 382 LFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP---------------FEMAA 445 (499)
Q Consensus 382 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~---------------~~~~~ 445 (499)
....... .......++..|+|||.+.+..++.++||||||+++|||+| |..|+..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHh-CCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 6432211 11223345667999999999999999999999999999999 7777654321 11112
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 446 ~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
.+........+..++.++.+++..||+.+|++|||++++++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22223334445678899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=315.93 Aligned_cols=249 Identities=19% Similarity=0.245 Sum_probs=217.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++++++.||+|-||.||.|+.+.+. -.||+|++.+.. ...-.+.+.+|+++-+.|+||||++++|| +.+..+.|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~---~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-fhd~~riy 98 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSL---FIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-FHDSKRIY 98 (281)
T ss_pred hccccccccCCccccEeEeeeccCC---cEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-eeccceeE
Confidence 4667799999999999999987665 679999986542 11224568899999999999999999999 56677889
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
|++||.+.|+|...|...+ ...+++.....++.|+|.||.|+|.++||||||||+|+|++.++..||+|||-+.
T Consensus 99 LilEya~~gel~k~L~~~~------~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGR------MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred EEEEecCCchHHHHHHhcc------cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 9999999999999998532 3468889999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
... .....+.+||..|.+||+..+..++..+|+|++||+.||++. |.+||......+..+.+.+. +...|..++
T Consensus 173 ~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv-g~ppFes~~~~etYkrI~k~-~~~~p~~is 246 (281)
T KOG0580|consen 173 HAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV-GLPPFESQSHSETYKRIRKV-DLKFPSTIS 246 (281)
T ss_pred ecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh-cCCchhhhhhHHHHHHHHHc-cccCCcccC
Confidence 532 123457889999999999999999999999999999999999 99999998888888887764 677788999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.++.+++..|+.++|.+|.+..|++..
T Consensus 247 ~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 247 GGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hhHHHHHHHHhccCccccccHHHHhhh
Confidence 999999999999999999999998764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.72 Aligned_cols=243 Identities=18% Similarity=0.248 Sum_probs=204.6
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
+.||+|+||.||+++...++ +.||+|++.... .......+.+|+.+++.++||||+++++++ ......++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-~~~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QTHDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-ecCCEEEEEEeC
Confidence 46899999999999976544 689999986532 233456778899999999999999999985 556678999999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++.....
T Consensus 77 ~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 77 ANGGELFFHLSRE--------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred CCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 9999999998762 35899999999999999999999999999999999999999999999999998854322
Q ss_pred CccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHH
Q psy1789 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465 (499)
Q Consensus 386 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 465 (499)
.. ......||..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+... ....|..+++++.+
T Consensus 149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~ 224 (323)
T cd05595 149 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME-EIRFPRTLSPEAKS 224 (323)
T ss_pred CC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHH
Confidence 21 1234568899999999999999999999999999999999 89999887777666555443 34456678999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 466 VMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 466 l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
++.+||+.||++|| ++.++++
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 225 LLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 99999999999998 7887764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=330.74 Aligned_cols=260 Identities=33% Similarity=0.605 Sum_probs=221.5
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+++.+.+|++.+.||+|+||.||+|...+. +.+++|.+..... ..+.+.+|+.++++++|+||+++++++ ...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~----~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGT----TKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVC-SEE 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCC----ceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeee-ecC
Confidence 356788999999999999999999987543 6789999875432 235788999999999999999999985 445
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+++++|+||||+||++++++.+||+||
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~~------~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~ 147 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSGE------GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADF 147 (261)
T ss_pred CceEEEEeccCCCCHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcc
Confidence 56799999999999999997622 246899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
|+++....... .......++..|+|||.+.+..++.++||||||+++||++|+|+.||.+.+..+....+..+.+...+
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 226 (261)
T cd05034 148 GLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRP 226 (261)
T ss_pred ccceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 99986643221 11223334567999999999999999999999999999999889999888877777777777666667
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 7789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=329.56 Aligned_cols=259 Identities=31% Similarity=0.588 Sum_probs=220.1
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+++...+|++.+.||+|+||.||+|.+.+. ..+++|.+... ....+.|.+|+.++++++|+||+++++++.+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~----~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCC----ccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--
Confidence 356778999999999999999999986543 46889988653 2334678999999999999999999998544
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++++||+++|+|.+++.+.. ...+++.++..++.|++.||.|||+.+++||||||+||+++.++.+||+||
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSDE------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhCC------ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCC
Confidence 55799999999999999997622 235789999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
|+++........ ......++..|+|||++....++.++|+|||||++||++|+|+.||...+..+....+..+.....+
T Consensus 147 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd05073 147 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 225 (260)
T ss_pred cceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCc
Confidence 999765432221 1223345677999999999999999999999999999999889999988877777777777666666
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 7788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=316.26 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=203.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-HHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-VQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|...+.+|+|.||.||+|+...++ +.||||+++..... .......+|+..|+.++|+||+.|+++ +-.....-|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~---~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-F~~~~~l~l 78 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETG---KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-FPHKSNLSL 78 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCC---cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-ccCCCceEE
Confidence 5666799999999999999987665 78999999754222 122456799999999999999999998 555666799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+|||+ .+|...++.. ...|+..++..++.++.+||+|||++.|+||||||.|+|++++|.+||+|||+|+.
T Consensus 79 VfEfm~-tdLe~vIkd~-------~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~ 150 (318)
T KOG0659|consen 79 VFEFMP-TDLEVVIKDK-------NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARF 150 (318)
T ss_pred EEEecc-ccHHHHhccc-------ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhc
Confidence 999999 8999999863 24789999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL------- 453 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~------- 453 (499)
..+.+... +..+-|.-|.|||.+.+ ..|+..+||||.||++.||+- +.+.|.+.++.+....+-.....
T Consensus 151 f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll-r~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 151 FGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL-RVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred cCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc-cCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 86554322 22356778999999986 569999999999999999997 88878887665544444221110
Q ss_pred ---------------CCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 454 ---------------NQP-----VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 454 ---------------~~~-----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..+ ..+++++.+++..+|..||.+|+++.|++++
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000 1456678999999999999999999998864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=327.07 Aligned_cols=249 Identities=31% Similarity=0.619 Sum_probs=212.5
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
++||+|+||.||+|...++ ..+|+|.+...........|.+|+.++++++||||+++++++.. ....++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDK----TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCC----cEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCC
Confidence 3689999999999986543 67999998766555555678999999999999999999999654 556799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++.... ..+++..+..++.|++.||.|+|+++++||||||+||++++++.+||+|||+++.......
T Consensus 76 ~~~L~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 76 GGDFLSFLRKKK-------DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence 999999987522 3578999999999999999999999999999999999999999999999999875433222
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 467 (499)
. ......++..|+|||++.+..++.++||||||+++||+++.|..||......+....+..+.+...+..++.++.+++
T Consensus 149 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (250)
T cd05085 149 S-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227 (250)
T ss_pred c-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1 122234467899999999999999999999999999999878889988887777777777777777778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q psy1789 468 AYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 468 ~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
.+||+.+|++||++.|+++.|.
T Consensus 228 ~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 228 QRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=331.66 Aligned_cols=255 Identities=30% Similarity=0.531 Sum_probs=203.0
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCC
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDY 308 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~ 308 (499)
.||+|+||.||+|..... .....+++|.+...........|.+|+..++.++|+||++++|++.. ....++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecC-CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCC
Confidence 589999999999986443 23367899988765555556778999999999999999999998654 5567999999999
Q ss_pred CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCcc
Q psy1789 309 TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388 (499)
Q Consensus 309 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~ 388 (499)
|+|.+++..... ......++.....++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRG---MVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccc---cccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999986431 11234578889999999999999999999999999999999999999999999998765433322
Q ss_pred ccCCCCCCcccccccccccc-------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----CCCC
Q psy1789 389 CLGDNENRPVKWLAIESLVH-------KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-----LNQP 456 (499)
Q Consensus 389 ~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-----~~~~ 456 (499)
.......++..|+|||++.. ..++.++|||||||++|||++++..||......+.......... +..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 22234456778999999753 45788999999999999999988889988776655444332222 2233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
..++..+.+++..|| .||++|||+++|++.|.
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 467888999999999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=328.88 Aligned_cols=253 Identities=34% Similarity=0.654 Sum_probs=219.0
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+....|++.+.||+|+||.||+|...+ +.+++|.+..... ..+.+.+|+.++++++|+||+++++++.. ...
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~-----~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 74 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRG-----QKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNP 74 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecC-----cEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCC
Confidence 345577888999999999999998753 6799999976543 45789999999999999999999998654 666
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||+
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~ 148 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRG------RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL 148 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccc
Confidence 799999999999999998632 23589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++...... .....+..|+|||++.+..++.++||||||+++||+++.|+.||......++...+..+.+...+..
T Consensus 149 ~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05039 149 AKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG 223 (256)
T ss_pred cccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence 98663211 1233456799999999899999999999999999999878899988887777777777767777778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
+++++.+++.+||..+|++||++.|+++.|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 89999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=346.49 Aligned_cols=247 Identities=18% Similarity=0.297 Sum_probs=209.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||+|+||.||+|+...++ +.||+|++.... .......+.+|+.++..++||||+++++++ ......+
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-~~~~~~~ 77 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTG---EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-QDDEYLY 77 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-EcCCEEE
Confidence 5888999999999999999987554 689999986542 223456788999999999999999999985 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++
T Consensus 78 lv~e~~~g~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~ 149 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNL--------GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149 (333)
T ss_pred EEEeCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence 999999999999999762 358899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-CCCC---
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-LNQP--- 456 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~--- 456 (499)
.... ......||..|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..... ...+
T Consensus 150 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 223 (333)
T cd05600 150 GIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC-GFPPFSGSTPNETWENLKYWKETLQRPVYD 223 (333)
T ss_pred cccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh-CCCCCCCCCHHHHHHHHHhccccccCCCCC
Confidence 6533 2234568899999999999999999999999999999999 8999998877776655543211 1111
Q ss_pred ---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 457 ---VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 457 ---~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..+++++.+++.+||..+|++||++.++++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1458899999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=331.61 Aligned_cols=266 Identities=33% Similarity=0.663 Sum_probs=220.0
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-----C
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH-----T 297 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~ 297 (499)
|++.++||+|+||.||+|.+...++..+.+|+|.+... ......+.+.+|+.++++++||||+++++++.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 34568999999999999998765555588999998754 24445677899999999999999999999865432 1
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+.+|+|..++...... .....+++.....++.|++.||+|||+.+|+||||||+||++++++.+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG--EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccc
Confidence 247889999999999998643211 112358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++...............++..|++||.+.+..++.++||||||+++|||+++|++||...+..+....+..+.....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 99866443322223344456789999999999999999999999999999998889998888777777776665566666
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.+++++.+++.+||+.+|++||++.++++.|+++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=330.82 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=201.6
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCC
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDY 308 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~ 308 (499)
.||+|+||.||+|.+.+. .....+++|.+...........+.+|+.++++++||||++++|++.+ ....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCC-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence 589999999999987542 23367999998766555555678999999999999999999998644 5567999999999
Q ss_pred CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCcc
Q psy1789 309 TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388 (499)
Q Consensus 309 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~ 388 (499)
|+|.++++..+.. ....+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKA---ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999999864321 1234678888999999999999999999999999999999999999999999999765433332
Q ss_pred ccCCCCCCccccccccccccC-------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--C---CCCC
Q psy1789 389 CLGDNENRPVKWLAIESLVHK-------TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--R---LNQP 456 (499)
Q Consensus 389 ~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--~---~~~~ 456 (499)
.......++..|+|||++.+. .++.++||||||+++|||++.|+.||......+......... + +...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 223345577889999998642 368899999999999999976888998776655443322221 1 1222
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
...++.+.+++..|| .+|++|||++||++.|+
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 346788999999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=343.15 Aligned_cols=246 Identities=21% Similarity=0.330 Sum_probs=204.4
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHH---hcCCCCcceeEEeEEEcCCCc
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAM---YGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~H~nIv~l~g~~~~~~~~ 298 (499)
|++.+.||+|+||.||+|....++ +.+|||++.... .....+.+.+|+.++ +.++||||+++++++ .....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-~~~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTG---ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-QTEDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-EcCCE
Confidence 567899999999999999986554 689999986432 223345566676554 567899999999985 55667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|..+++. ..+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||+|||+
T Consensus 77 ~~lv~E~~~~~~L~~~~~~---------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT---------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccC
Confidence 8999999999999988864 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++....... ......|+..|||||.+.+..++.++|||||||++|||++ |+.||...+..+....+... ....|..
T Consensus 148 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~-~~~~p~~ 223 (324)
T cd05589 148 CKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV-GESPFPGDDEEEVFDSIVND-EVRYPRF 223 (324)
T ss_pred CccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCC
Confidence 875432221 2234568899999999999999999999999999999999 89999988877777666554 3446677
Q ss_pred CcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
+++++.+++.+||+.||++||+ +.++++
T Consensus 224 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 224 LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 8999999999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=345.28 Aligned_cols=244 Identities=18% Similarity=0.235 Sum_probs=205.7
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
+.||+|+||.||++....++ +.+|+|++.... .......+.+|+.+++.++||||+++++++ ......++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKASG---KYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-QTKDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-EcCCEEEEEEeC
Confidence 46899999999999876554 789999986532 234456788999999999999999999874 556678999999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
+++|+|..++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 77 VNGGELFFHLSRE--------RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred CCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 9999999998752 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHH
Q psy1789 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465 (499)
Q Consensus 386 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 465 (499)
.. ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+... ....|...+.++.+
T Consensus 149 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~ 224 (328)
T cd05593 149 AA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME-DIKFPRTLSADAKS 224 (328)
T ss_pred cc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhh-CCCCCCCCCHHHHHHHhccC-CccCCCCCCHHHHH
Confidence 11 1234568999999999999999999999999999999999 89999887776666555433 34556678999999
Q ss_pred HHHHhhhcCCCCCC-----CHHHHHHH
Q psy1789 466 VMAYCWAMNPEGRP-----TFPQLHSC 487 (499)
Q Consensus 466 l~~~C~~~~P~~RP-----t~~~v~~~ 487 (499)
++.+||+.||++|| ++.|+++.
T Consensus 225 li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 225 LLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 99999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=328.39 Aligned_cols=261 Identities=39% Similarity=0.724 Sum_probs=222.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
+.||+|+||.||+|...........+++|.+.........+.+.+|+..+..++|+||+++++++.. ....++++||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence 4689999999999998754122378999999876555456889999999999999999999998654 667799999999
Q ss_pred CCCHHHHHHhcccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCC
Q psy1789 308 YTNLKRFLQKCKLCP-EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~ 386 (499)
+++|.+++....... ......+++.++..++.|++.||+|||+++++||||||+||++++++.+||+|||.++......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 999999998631100 0012468999999999999999999999999999999999999999999999999998765443
Q ss_pred ccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHH
Q psy1789 387 YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSV 466 (499)
Q Consensus 387 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 466 (499)
.........++..|+|||.+....++.++||||||+++|||+++|..||...+..++...+..+.+...+..++.++.++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYEL 239 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHH
Confidence 22233345577889999999988999999999999999999997799999988888888888777778888899999999
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 467 MAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 467 ~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
+.+||+.+|++||++.|+++.|+
T Consensus 240 i~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 240 MLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=343.93 Aligned_cols=246 Identities=17% Similarity=0.276 Sum_probs=206.2
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+++...+....+.+|+|++.... .......+.+|+.+++.++||||+++++++ ..+...++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-QTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-ecCCeEEEEEe
Confidence 68999999999999875433334789999986432 223345678899999999999999999985 44567799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|.+++... ..+.+..+..++.|++.||+|||+.+|+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 81 YLSGGELFMHLERE--------GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCCchHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999999762 3578889999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......|+..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+..+ ....+..+++++.
T Consensus 153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 228 (323)
T cd05584 153 EGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLT-GAPPFTAENRKKTIDKILKG-KLNLPPYLTPEAR 228 (323)
T ss_pred CCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHH
Confidence 221 1234568999999999999999999999999999999999 89999988877766666554 4456677889999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 465 SVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 465 ~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
+++.+||+.||++|| ++.++++
T Consensus 229 ~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 229 DLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.50 Aligned_cols=254 Identities=32% Similarity=0.587 Sum_probs=214.7
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
+.||+|+||.||+|.+...++....+|+|.+.........+.+.+|+.++++++|+||+++++++.. ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 3689999999999998765444467999999876554567889999999999999999999998655 66799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+|+|.+++.... ...+++.....++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDA------LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhcc------cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999998632 13689999999999999999999999999999999999999999999999999987644221
Q ss_pred c-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCcHHHHH
Q psy1789 388 H-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ-DGYRLNQPVNCPDELFS 465 (499)
Q Consensus 388 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~ 465 (499)
. .......++..|+|||++.+..++.++|||||||++|||++.|+.||...+..+....+. .......+...+.++.+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYN 232 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHH
Confidence 1 122234567889999999999999999999999999999987899998877777665554 33444556678899999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 466 VMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 466 l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
++.+||+.+|++||++.++++.|.
T Consensus 233 li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 233 VMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=343.59 Aligned_cols=252 Identities=19% Similarity=0.328 Sum_probs=199.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----C
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH----T 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~ 297 (499)
+|++.+.||+|+||.||+|+...++ ..||+|++... ........+.+|+.++++++||||+++++++.... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTG---EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCC---CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 5888999999999999999976554 68999998643 22233457889999999999999999999865432 2
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||++ ++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||
T Consensus 78 ~~~lv~e~~~-~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg 148 (338)
T cd07859 78 DIYVVFELME-SDLHQVIKAN--------DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFG 148 (338)
T ss_pred eEEEEEecCC-CCHHHHHHhc--------ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCc
Confidence 4699999996 7899998752 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc-cccCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----
Q psy1789 378 LARDLFPSDY-HCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD----- 449 (499)
Q Consensus 378 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~----- 449 (499)
+++....... ........+|..|+|||++.+ ..++.++|||||||++|||+| |++||...+.......+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 227 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKNVVHQLDLITDLLGTP 227 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCC
Confidence 9986532211 111234568889999999876 678999999999999999999 8899977554322111100
Q ss_pred ------------------CCCCCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 ------------------GYRLNQP-------VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 ------------------~~~~~~~-------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
......+ ...+.++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000011 1456788999999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=335.67 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=201.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+|++.+.||+|+||.||+|....++ ..||+|.+...........+.+|+.++++++||||+++++++ ......++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~l 80 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTE---NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-HTERCLTL 80 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCC---CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-cCCCeEEE
Confidence 46888899999999999999876554 689999987543333345678999999999999999999985 55566799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||++ |+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++.
T Consensus 81 v~e~~~-~~l~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 81 VFEYLD-SDLKQYLDNCG-------NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred EEeCCC-cCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence 999998 59999987532 3578999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL------- 453 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~------- 453 (499)
...... ......++..|+|||.+.+ ..++.++|||||||++|||+| |++||...+..+....+......
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 153 KSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT-GRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred ccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 532221 1234567889999999875 568999999999999999999 88999877655543332211000
Q ss_pred -----------C-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 -----------N-----------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 -----------~-----------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .....++++.+++.+|++.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 01135678999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=335.54 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=199.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcC---CCCcceeEEeEEEc----
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGL---SHKNILTVLGVSIE---- 294 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~---- 294 (499)
+|++.+.||+|+||.||+|+....++ +.+|+|.+.... .......+.+|+.+++.+ +||||++++++|..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGG--RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCC--eEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 68888999999999999998743322 679999886432 122223456677766654 79999999998742
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++|+||++ ++|.+++.... ...+++.++..++.|++.||.|||+++|+||||||+|||+++++.+||+
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVP------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEc
Confidence 3445799999997 79999997532 2358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++..... .......++..|+|||.+.+..++.++|||||||++|||++ |++||.+.+..+....+.+.....
T Consensus 153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99999865332 12335568899999999999999999999999999999999 899998877665554443211100
Q ss_pred --------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 --------------------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 --------------------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+++.+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 01245677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=331.26 Aligned_cols=261 Identities=37% Similarity=0.678 Sum_probs=216.2
Q ss_pred eeeeeecceEEEEEEEeCCC---ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEED---GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|+..+.. ...+.+++|.+...........+.+|+.+++.++||||+++++++.. ....++|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence 36899999999999875422 22357899988765444556788999999999999999999998654 556799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-----cEEEcccccc
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-----RIQITDNALA 379 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-----~~kl~DfGla 379 (499)
|+++|+|.+++........ ....+++.+++.++.|++.||+|||+.+++|+||||+||+++++. .++|+|||++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 80 LMEGGDLLSYLRDARVERF-GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred ccCCCcHHHHHHHhhhccc-CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999999976432110 123588999999999999999999999999999999999999877 8999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+.....+.........++..|+|||++.+..++.++|||||||++|||+|.|+.||...+..+....+..+.+...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC 238 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence 86644333222233445678999999999999999999999999999998788999888877777777766666667788
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
+.++.+++.+||+.+|++||++.++++.|++
T Consensus 239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 239 PDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 9999999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=327.85 Aligned_cols=254 Identities=30% Similarity=0.527 Sum_probs=201.5
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCC
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDY 308 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~ 308 (499)
.||+|+||.||+|...+... ...+++|.+.........+.|.+|+.+++.++||||+++++.|.. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTG-VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCC-cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCC
Confidence 58999999999998654322 245778877655555556789999999999999999999998654 5567999999999
Q ss_pred CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCcc
Q psy1789 309 TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388 (499)
Q Consensus 309 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~ 388 (499)
|+|.++++.... ....+++.....++.|++.||+|||+.+++||||||+|||++.++.+||+|||+++.....+..
T Consensus 80 ~~L~~~l~~~~~----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 80 GDLKSYLSQEQW----HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CcHHHHHHhhhc----ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 999999986321 1234677788999999999999999999999999999999999999999999998654332222
Q ss_pred ccCCCCCCcccccccccccc-------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----CCCCCC
Q psy1789 389 CLGDNENRPVKWLAIESLVH-------KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-----YRLNQP 456 (499)
Q Consensus 389 ~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-----~~~~~~ 456 (499)
.......++..|+|||++.. ..++.++|||||||++|||++++..||...+..+....+... .++..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence 22334567889999999853 346789999999999999998788899877766655543322 123333
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
...++.+.+++..|| .+|++||++++|++.|.
T Consensus 236 ~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 457788999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=324.58 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=215.2
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
|.+.+.||+|+||.||+|....++ +.+++|.+... ........+.+|+.++++++||||+++++++.. ....++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 77 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADK---RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIV 77 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCC---cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEE
Confidence 667799999999999999986554 67999988643 344556789999999999999999999998644 5667999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+++++|.++++... ...+++..+..++.|++.||.|||+.+++|+||||+||++++++.++|+|||+++..
T Consensus 78 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 78 MEYAENGDLHKLLKMQR------GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EEeCCCCcHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 99999999999998632 246899999999999999999999999999999999999999999999999999866
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHH
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 462 (499)
..... ......++..|+|||++.+..++.++|+|||||++|||++ |+.||...+..+....+..+..+..+..++.+
T Consensus 152 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd08529 152 SDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPFDANNQGALILKIIRGVFPPVSQMYSQQ 228 (256)
T ss_pred cCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCccccCHH
Confidence 43322 1234457788999999999999999999999999999999 89999888877777777666666666678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 463 LFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 463 ~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 229 LAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHhhC
Confidence 9999999999999999999998763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=346.71 Aligned_cols=246 Identities=17% Similarity=0.249 Sum_probs=199.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++++.||+|+||.||+|+...++ +.||+|++...........+.+|+++++.++|+||+++++++ ......++|
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 150 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTG---RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNGEIQVL 150 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCC---CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-ccCCeEEEE
Confidence 3445589999999999999976544 689999997665555667899999999999999999999985 556677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+++|+|.... .+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++..
T Consensus 151 ~e~~~~~~L~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 151 LEFMDGGSLEGTH------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EecCCCCcccccc------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 9999999986432 3567788899999999999999999999999999999999999999999999865
Q ss_pred CCCCccccCCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCCCCC
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVH-----KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF---EMAASLQDGYRLN 454 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~---~~~~~i~~~~~~~ 454 (499)
..... ......||..|+|||++.. ...+.++|||||||++|||++ |+.||...... .....+.......
T Consensus 219 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 295 (353)
T PLN00034 219 AQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL-GRFPFGVGRQGDWASLMCAICMSQPPE 295 (353)
T ss_pred ccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCccHHHHHHHHhccCCCC
Confidence 43211 1234568899999998843 234568999999999999999 88998743322 2233333344455
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.+..++.++.+++.+||+.||++||++.|+++.
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 566788999999999999999999999999863
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=329.65 Aligned_cols=262 Identities=31% Similarity=0.525 Sum_probs=207.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeC-CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTE-EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~ 298 (499)
..++++.+.||+|+||.||+|.... .......+++|.+... .....+.|.+|++++++++||||+++++++... ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4578889999999999999998642 1112368999998654 345567899999999999999999999986543 345
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+++|+|.+++...+ ..+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~-------~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHR-------ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcC-------cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 789999999999999997522 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH----------------H
Q psy1789 379 ARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----------------F 441 (499)
Q Consensus 379 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~----------------~ 441 (499)
++........ .......++..|+|||++.+..++.++|||||||++|||+++ ..++..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY-SDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhc-CCcCCCcchhhhhhcccccccccchH
Confidence 9876433211 111222344569999999999999999999999999999994 333322110 1
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 442 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.+...+....+...+..+++++.+++.+||+.+|++|||+.||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 12223344444555667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=335.60 Aligned_cols=250 Identities=19% Similarity=0.273 Sum_probs=200.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||+|+...++ +.+|+|++.... .....+.+.+|+.+++.++|+||+++++++ ..+...++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 77 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETK---EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-RRRGKLYL 77 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCC---cEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-ecCCEEEE
Confidence 6888999999999999999986554 689999986542 233456788999999999999999999985 45667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||++++.+..+... ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 78 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~ 149 (287)
T cd07848 78 VFEYVEKNMLELLEEM--------PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARN 149 (287)
T ss_pred EEecCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence 9999998877655432 23589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---------- 451 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---------- 451 (499)
....... ......++..|+|||++.+..++.++|||||||++|||++ |++||...+..+....+....
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 150 LSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD-GQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 6432211 2224567889999999999999999999999999999999 889998765443222211100
Q ss_pred --------CCCC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 --------RLNQ-------------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 --------~~~~-------------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... ...+++++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 1125778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.08 Aligned_cols=251 Identities=19% Similarity=0.263 Sum_probs=205.1
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+..++|++.+.||+|+||.||++....++ ..+|+|.+...........+.+|+++++.++|+||+++++++.. ++.
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 77 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSG---LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGE 77 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCC---cEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCE
Confidence 45678899999999999999999986544 67899988765455556779999999999999999999998654 567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEcccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
.++||||+++|+|.+++... ..+++.....++.|++.||.|||+. +|+||||||+|||+++++.+||+|||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 78 ISICMEHMDGGSLDQVLKKA--------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred EEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCC
Confidence 89999999999999999762 3578999999999999999999985 79999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----------
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL---------- 447 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i---------- 447 (499)
+++..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI-GRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcchhHHHHHhcCcccCCccc
Confidence 98765322 1224467889999999999999999999999999999999 88888765443322111
Q ss_pred ----------------------------------HcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 ----------------------------------QDGYRLNQPV-NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ----------------------------------~~~~~~~~~~-~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.....+..+. ..++++.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 1111111111 25678999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=339.82 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=201.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhc-CCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYG-LSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
++||+|+||.||+|+..+++ +.||+|++.... .....+.+..|..++.. .+||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-~~~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTN---EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-QTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-EcCCEEEEEEc
Confidence 36899999999999986554 679999986532 22233455667777665 5899999999984 55667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~gg~L~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 77 YLNGGDLMFHIQSS--------GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred CCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 99999999999762 3588999999999999999999999999999999999999999999999999986533
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
.. .......||..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+... .+..+..+++++.
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 224 (316)
T cd05592 149 GE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI-GQSPFHGEDEDELFDSILND-RPHFPRWISKEAK 224 (316)
T ss_pred CC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHH
Confidence 22 12334568999999999999999999999999999999999 89999988877777666543 4556677899999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHH
Q psy1789 465 SVMAYCWAMNPEGRPTFP-QLH 485 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~-~v~ 485 (499)
+++.+||+.||++||++. +++
T Consensus 225 ~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 225 DCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999975 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.89 Aligned_cols=243 Identities=19% Similarity=0.295 Sum_probs=203.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCC-cceeEEeEEEcCCCce
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHK-NILTVLGVSIEDHTSP 299 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~ 299 (499)
+|++++.||+|+||.||+|+..+++ +.+|+|++.... .....+.+..|..++..++|+ +|+.++++ +...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTD---ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-FQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE-EEcCCEE
Confidence 3678899999999999999976554 689999986532 233456788899999999765 57777776 4556678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQV--------GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred EEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 9999999999999999762 35889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+....... ......||..|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+... ....|...
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~ 224 (324)
T cd05587 149 KENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQSIMEH-NVSYPKSL 224 (324)
T ss_pred eecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCCCC
Confidence 75322111 1224568899999999999999999999999999999999 89999988887777776654 45566778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
+.++.+++.+||+.||.+|++.
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 225 SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CHHHHHHHHHHhhcCHHHcCCC
Confidence 9999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=325.07 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=215.1
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++.+.||+|+||.||++....++ +.+++|.+.........+.+.+|+.+++.++|+||+++++++ ......+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSD---QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-EADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCC---ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-EECCEEEEE
Confidence 4678899999999999999876554 678999886554455667888999999999999999999985 556778999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+++|+|.+++.... ...+++.....++.|++.||.|||+++|+|+||||+||++++++.++|+|||+++..
T Consensus 77 ~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 77 MEYCDGGDLMQKIKLQR------GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred EeeCCCCcHHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 99999999999987522 235789999999999999999999999999999999999999999999999999765
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHH
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 462 (499)
..... ......++..|+|||++.+..++.++|+||||+++|||++ |..||...+.......+..+.....+..++.+
T Consensus 151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (255)
T cd08219 151 TSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILKVCQGSYKPLPSHYSYE 227 (255)
T ss_pred ccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhh-ccCCCCCCCHHHHHHHHhcCCCCCCCcccCHH
Confidence 43221 1223557888999999999999999999999999999999 88999887777776666666555566678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 463 LFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 463 ~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+.+++.+||+.||++||++.+++..
T Consensus 228 ~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 228 LRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHHhCCcccCCCHHHHhhc
Confidence 9999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.37 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=225.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.+|..++++|+|+||.++..+.+.++ +.+++|.+.-. .+....+...+|+.++++++|||||.+.+.+.+++...+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~---~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDD---KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCC---ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 46788899999999999998876655 68888888643 344445577899999999999999999998666665589
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||+|++||+|.+.+.+.+ ...++++.+..++.|++.|+.|||+.+|+|||||+.||+++.+..+||+|||+|+
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k------~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK 154 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQK------GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAK 154 (426)
T ss_pred EEEeecCCCCHHHHHHHHh------hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhh
Confidence 9999999999999998744 3468999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
.+.+.+. ...+..||+.||.||.+.+.+|..|+|||||||++|||++ -+++|...+...+...+..+.-...|...+
T Consensus 155 ~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~-lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys 231 (426)
T KOG0589|consen 155 ILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCT-LKPAFKASNMSELILKINRGLYSPLPSMYS 231 (426)
T ss_pred hcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHh-cccccCccchHHHHHHHhhccCCCCCcccc
Confidence 8876542 3457889999999999999999999999999999999999 889999999999988888877677788899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.++..++..|++.+|+.||++.+++..
T Consensus 232 ~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 232 SELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999999999876
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=323.14 Aligned_cols=250 Identities=32% Similarity=0.628 Sum_probs=213.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
+.||+|+||.||++...+ + +.+++|.+...........+.+|+.++++++|+||+++++++. .....++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~---~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-N---TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-QKQPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeC-C---CcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-cCCCeEEEEEcCC
Confidence 368999999999999765 3 7899999876655555678999999999999999999999864 4566799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++.... ..+++..+..++.+++.||.|||+++++||||||+||++++++.+||+|||+++.......
T Consensus 76 ~~~l~~~l~~~~-------~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 76 GGSLLTFLRKKK-------NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred CCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence 999999997522 3578999999999999999999999999999999999999999999999999986543222
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 467 (499)
.........+..|+|||.+.+..++.++|+|||||++|||+|++..||......+....+....+...+..++.++.+++
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 228 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM 228 (251)
T ss_pred eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence 22222333466799999999899999999999999999999988899988877777777766666666778899999999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q psy1789 468 AYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 468 ~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
.+||+.+|++|||+.|+++.|+
T Consensus 229 ~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 229 LQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHhccChhhCcCHHHHHHHhh
Confidence 9999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=334.26 Aligned_cols=255 Identities=19% Similarity=0.285 Sum_probs=207.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHH-------------HHHHHHHHHHHhcCCCCcc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ-------------VSLLLQEGMAMYGLSHKNI 285 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~E~~~l~~l~H~nI 285 (499)
..-++|++++.||+|.||.|-+|.....+ +.+|||++.+.....+ .+...+|+++|++++||||
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~---~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDG---KLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCC---cEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 34567999999999999999999876555 8999999965422111 2578899999999999999
Q ss_pred eeEEeEEEcC--CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy1789 286 LTVLGVSIED--HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNC 363 (499)
Q Consensus 286 v~l~g~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NI 363 (499)
|+|+.+ .++ .+.+|||+||+..|.+..-- .....|+..+..++++++..||+|||.+|||||||||+|+
T Consensus 171 V~LiEv-LDDP~s~~~YlVley~s~G~v~w~p--------~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNL 241 (576)
T KOG0585|consen 171 VKLIEV-LDDPESDKLYLVLEYCSKGEVKWCP--------PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNL 241 (576)
T ss_pred eEEEEe-ecCcccCceEEEEEeccCCccccCC--------CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhhe
Confidence 999998 443 35689999999988775321 1112389999999999999999999999999999999999
Q ss_pred EEcCCCcEEEcccccccccCCC---CccccCCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCC
Q psy1789 364 VVDDKLRIQITDNALARDLFPS---DYHCLGDNENRPVKWLAIESLVHKT----FSTASDVWAFGVLLWELTTLAQQPYA 436 (499)
Q Consensus 364 lld~~~~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwS~Gvvl~el~t~g~~p~~ 436 (499)
||+++|++||+|||.+...... +....-....||+.|||||.+.++. .+.+.||||+||+||.|+- |+.||-
T Consensus 242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf-G~~PF~ 320 (576)
T KOG0585|consen 242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF-GQLPFF 320 (576)
T ss_pred EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh-ccCCcc
Confidence 9999999999999998755221 1111123478999999999998733 3578999999999999998 999999
Q ss_pred CCCHHHHHHHHHcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 437 EIDPFEMAASLQDGYRLNQPV--NCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 437 ~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+....++..+|... ...+|. ++.+++.+|+.++|.+||++|.+..+|...
T Consensus 321 ~~~~~~l~~KIvn~-pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 321 DDFELELFDKIVND-PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred cchHHHHHHHHhcC-cccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 98888888888764 444454 468899999999999999999999998654
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.11 Aligned_cols=252 Identities=18% Similarity=0.267 Sum_probs=205.1
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.|++++.||+|+||+||+|+...++ +.+|+|++... ......+.+.+|+.+++.++|+||+++++++ .+....+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-~~~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTH---ALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-QDKDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-ecCCEEE
Confidence 4778899999999999999976654 78999998653 2334567789999999999999999999985 4566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~E~~~gg~L~~~l~~~--------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM--------EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 999999999999999762 358899999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCc---------------------------------------------cccCCCCCCccccccccccccCCCCCch
Q psy1789 381 DLFPSDY---------------------------------------------HCLGDNENRPVKWLAIESLVHKTFSTAS 415 (499)
Q Consensus 381 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 415 (499)
....... .+......||..|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence 4311000 0011234689999999999999999999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCC--CCCCCCcHHHHHHHHH--hhhcCCCCCCCHHHHHHH
Q psy1789 416 DVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRL--NQPVNCPDELFSVMAY--CWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 416 DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-~~~--~~~~~~~~~~~~l~~~--C~~~~P~~RPt~~~v~~~ 487 (499)
|||||||++|||+| |+.||...++.+....+... ... .....+++++.+++.+ |+..+|..||++.|+++.
T Consensus 230 DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 230 DWWSVGVILFEMLV-GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ceeehhhHHHHHHh-CCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999999 89999887766655444432 122 2233578899999987 667777789999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=338.76 Aligned_cols=243 Identities=19% Similarity=0.283 Sum_probs=204.1
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCce
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 299 (499)
+|++.+.||+|+||.||+|....++ +.+|+|.+.... .....+.+..|..++..+ +|++|+++++++ ...+..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTD---ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-QTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-ecCCEE
Confidence 3677899999999999999976554 689999987532 223345567788888776 588888888874 556678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|..++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||++
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQV--------GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred EEEEcCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCc
Confidence 9999999999999998762 35889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..++...+... ....|...
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 224 (323)
T cd05616 149 KENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEH-NVAYPKSM 224 (323)
T ss_pred eecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCcC
Confidence 75432221 1234568999999999999999999999999999999999 99999988887777776654 44566778
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
+.++.+++.+|++.||++|++.
T Consensus 225 s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 225 SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CHHHHHHHHHHcccCHHhcCCC
Confidence 9999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=325.80 Aligned_cols=260 Identities=19% Similarity=0.317 Sum_probs=211.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecC--cccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTD--NASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++.+.||+|+||.||+|+...++ +.+|||.+.. .........+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDR---KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCC---CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeE
Confidence 46788899999999999999986554 6899998753 2344555678999999999999999999998654 5567
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++++||+++|+|.+++..... ....+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~ 153 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKK----QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhh----ccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999999875321 1245889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCCCCC-
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI--DPFEMAASLQDGYRLNQP- 456 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~--~~~~~~~~i~~~~~~~~~- 456 (499)
+....... ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||... +..+....+.....+..+
T Consensus 154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08228 154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLFSLCQKIEQCDYPPLPT 230 (267)
T ss_pred eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhc-CCCCCccccccHHHHHHHHhcCCCCCCCh
Confidence 86543221 1223457788999999999899999999999999999999 67776543 234455555443333332
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
...+.++.+++.+||+.+|++||++.++++.|+.++
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 357788999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.71 Aligned_cols=265 Identities=14% Similarity=0.213 Sum_probs=217.4
Q ss_pred hhHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcc
Q psy1789 208 KDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNI 285 (499)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nI 285 (499)
......+....+...+|++.+.||+|+||.||+++...++ +.+|+|++... ......+.+.+|+.+++.++||||
T Consensus 29 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~i 105 (370)
T cd05596 29 EKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK---QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105 (370)
T ss_pred HHHHHhhccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCc
Confidence 3444556667778889999999999999999999986654 68999998642 122334567889999999999999
Q ss_pred eeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q psy1789 286 LTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV 365 (499)
Q Consensus 286 v~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll 365 (499)
+++++++ ..+...++||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+|+||||||+|||+
T Consensus 106 v~~~~~~-~~~~~~~lv~Ey~~gg~L~~~l~~---------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl 175 (370)
T cd05596 106 VQLHYAF-QDDKYLYMVMEYMPGGDLVNLMSN---------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (370)
T ss_pred ceEEEEE-ecCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999874 556678999999999999999875 247888899999999999999999999999999999999
Q ss_pred cCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy1789 366 DDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK----TFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441 (499)
Q Consensus 366 d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~ 441 (499)
++++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||++ |++||...+..
T Consensus 176 ~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~ 253 (370)
T cd05596 176 DKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLV 253 (370)
T ss_pred cCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh-CCCCcCCCCHH
Confidence 99999999999999865432221 22345689999999998753 48899999999999999999 89999988777
Q ss_pred HHHHHHHcCC-CCCCCC--CCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q psy1789 442 EMAASLQDGY-RLNQPV--NCPDELFSVMAYCWAMNPEG--RPTFPQLHSC 487 (499)
Q Consensus 442 ~~~~~i~~~~-~~~~~~--~~~~~~~~l~~~C~~~~P~~--RPt~~~v~~~ 487 (499)
.....+.... ....|. ..+.++.+++.+|++.+|.+ ||++.|+++.
T Consensus 254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 6666665432 233333 57899999999999999987 9999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=339.73 Aligned_cols=239 Identities=17% Similarity=0.249 Sum_probs=201.8
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|+...++ +.+|+|++.... .....+.+..|..++..+ +||||+++++++ ......++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-~~~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESG---RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-QTPDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCC---CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-EcCCEEEEEEc
Confidence 36899999999999986554 689999986432 223446677888888876 699999999984 55677899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||+|||+.+|+||||||+|||+++++.+||+|||+++....
T Consensus 77 y~~~g~L~~~i~~~--------~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 77 FVNGGDLMFHIQKS--------RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred CCCCchHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 99999999999762 3588999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... ....+...++++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 224 (320)
T cd05590 149 NGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILND-EVVYPTWLSQDAV 224 (320)
T ss_pred CCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHH
Confidence 221 2234568999999999999999999999999999999999 89999988888877777654 3445667889999
Q ss_pred HHHHHhhhcCCCCCCCHH
Q psy1789 465 SVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~ 482 (499)
+++.+||+.||++||++.
T Consensus 225 ~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 225 DILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHcccCHHHCCCCC
Confidence 999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=328.93 Aligned_cols=260 Identities=18% Similarity=0.335 Sum_probs=220.4
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
.|+..+.||+|+||.||+|.....+ ..+|+|.+...........+.+|+.++++++|+||+++++++.+ +...++|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 80 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQ---QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWII 80 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCC---EEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEE
Confidence 4556689999999999999876544 78999998765555666889999999999999999999998644 5677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
|||+++|+|.+++.. ..+++.+...++.|++.||+|||+.+++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~i~~---------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 81 MEYLGGGSALDLLRA---------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred EecCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 999999999999874 34788999999999999999999999999999999999999999999999999766
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHH
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 462 (499)
..... ......++..|+|||++.+..++.++|||||||++|||+| |.+||...++.+....+.....+..+..++.+
T Consensus 152 ~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06640 152 TDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK-GEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKP 228 (277)
T ss_pred cCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHH-CCCCCCCcChHhHhhhhhcCCCCCCchhhhHH
Confidence 43321 1223457788999999999999999999999999999999 89999887777666555555455555677889
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH------------HHHHHHHhhhc
Q psy1789 463 LFSVMAYCWAMNPEGRPTFPQLHSC------------LQEFHAQLTRY 498 (499)
Q Consensus 463 ~~~l~~~C~~~~P~~RPt~~~v~~~------------L~~~~~~l~~~ 498 (499)
+.+++.+||+.+|++||++.++++. |....++++||
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKRW 276 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHHHHHHHhc
Confidence 9999999999999999999999766 77777777766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=329.20 Aligned_cols=261 Identities=30% Similarity=0.531 Sum_probs=209.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~~ 300 (499)
-|++++.||+|+||.||++++... ......+++|.+...........+.+|+.+++.++|+||+++++++... ....+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356779999999999999986421 2233789999987665566667899999999999999999999987654 35578
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++++|.+++.+.. ..+++.++..++.|++.||+|||+++++||||||+||++++++.+||+|||+++
T Consensus 85 lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999997521 358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC-C--------------CHHHHH
Q psy1789 381 DLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE-I--------------DPFEMA 444 (499)
Q Consensus 381 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~-~--------------~~~~~~ 444 (499)
........ .......++..|+|||++.+..++.++|||||||++|||+| ++.|... . ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhc-CCCCCccccchhhhhcccccccccHHHHH
Confidence 76433211 11223456678999999999999999999999999999999 4433211 1 111222
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 445 ASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 445 ~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
..+..+.+...+..++.++.+++.+||+.+|++||++.++++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 33344445555667899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=342.83 Aligned_cols=252 Identities=17% Similarity=0.252 Sum_probs=204.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++++.||+|+||+||++....++ +.+|+|++.... .......+.+|+.++.+++|+||+++++.+ .+....+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-~~~~~~~ 77 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTG---HVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-QDKLNLY 77 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCC---CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-ecCCeEE
Confidence 5788899999999999999876554 789999986432 233456788899999999999999999984 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~E~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKK--------DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EEEcCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 999999999999999862 358999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCcc---------------------------------ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHH
Q psy1789 381 DLFPSDYH---------------------------------CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWEL 427 (499)
Q Consensus 381 ~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el 427 (499)
........ .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~el 229 (363)
T cd05628 150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHH
Confidence 64321100 001234689999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCcHHHHHHHHHhh--hcCCCCCCCHHHHHHH
Q psy1789 428 TTLAQQPYAEIDPFEMAASLQDG-YRLNQP--VNCPDELFSVMAYCW--AMNPEGRPTFPQLHSC 487 (499)
Q Consensus 428 ~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~l~~~C~--~~~P~~RPt~~~v~~~ 487 (499)
++ |+.||...+..+....+... .....| ..+++++.+++.+++ ..++..||++.||++.
T Consensus 230 l~-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 230 LI-GYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred Hh-CCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99 89999988887777666543 122223 246788999888743 3344567899998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=339.84 Aligned_cols=243 Identities=17% Similarity=0.269 Sum_probs=203.9
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
++||+|+||.||+|+....+ +.+|+|++.... .....+.+..|..++..+ +||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-~~~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD---EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-QTKDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-EcCCeEEEEEe
Confidence 36899999999999986544 689999986532 233445677888888865 799999999985 55667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 77 YVNGGDLMFQIQRS--------RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred CCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999998762 3588999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+... ....|..++.++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~ 224 (321)
T cd05591 149 NGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPFEADNEDDLFESILHD-DVLYPVWLSKEAV 224 (321)
T ss_pred CCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHH
Confidence 221 2234568899999999999999999999999999999999 89999988888877777654 3345566889999
Q ss_pred HHHHHhhhcCCCCCC-------CHHHHHH
Q psy1789 465 SVMAYCWAMNPEGRP-------TFPQLHS 486 (499)
Q Consensus 465 ~l~~~C~~~~P~~RP-------t~~~v~~ 486 (499)
+++..||+.||++|| ++.++++
T Consensus 225 ~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 225 SILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 999999999999999 6666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=342.13 Aligned_cols=244 Identities=18% Similarity=0.245 Sum_probs=204.8
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
+.||+|+||.||++....++ +.+|+|++.... .......+.+|++++..++||||+++++++ ......++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-~~~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATG---RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTHDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-EcCCEEEEEEeC
Confidence 46899999999999876544 689999986532 233456778899999999999999999874 556678999999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
+++|+|..++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 77 ANGGELFFHLSRE--------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred CCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9999999998752 358999999999999999999997 7999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||..|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+... ....|...++++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~ 224 (325)
T cd05594 149 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME-EIRFPRTLSPEAK 224 (325)
T ss_pred CCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeecc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHH
Confidence 221 1224568999999999999999999999999999999999 89999887777666665443 4455667899999
Q ss_pred HHHHHhhhcCCCCCC-----CHHHHHHH
Q psy1789 465 SVMAYCWAMNPEGRP-----TFPQLHSC 487 (499)
Q Consensus 465 ~l~~~C~~~~P~~RP-----t~~~v~~~ 487 (499)
+++.+||+.||++|+ ++.++++.
T Consensus 225 ~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=342.72 Aligned_cols=243 Identities=19% Similarity=0.260 Sum_probs=203.7
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.||+|+||.||+++........+.+|+|++.... .......+.+|+.++++++||||+++++++ ..+...++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-QTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-EcCCEEEEEEcCC
Confidence 67999999999999864332333789999987532 222345677899999999999999999985 5566789999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCC
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~ 386 (499)
++|+|.+++.+. ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 81 RGGDLFTRLSKE--------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999762 358999999999999999999999999999999999999999999999999998653321
Q ss_pred ccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHH
Q psy1789 387 YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSV 466 (499)
Q Consensus 387 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 466 (499)
. ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+... ....|...++++.++
T Consensus 153 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t-g~~p~~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~l 228 (318)
T cd05582 153 K--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GSLPFQGKDRKETMTMILKA-KLGMPQFLSPEAQSL 228 (318)
T ss_pred C--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeecc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHH
Confidence 1 1224568899999999999999999999999999999999 89999988877776666543 345566788999999
Q ss_pred HHHhhhcCCCCCCCHHH
Q psy1789 467 MAYCWAMNPEGRPTFPQ 483 (499)
Q Consensus 467 ~~~C~~~~P~~RPt~~~ 483 (499)
+.+||+.||++||++.+
T Consensus 229 i~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 229 LRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHhhcCHhHcCCCCC
Confidence 99999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=326.49 Aligned_cols=269 Identities=33% Similarity=0.609 Sum_probs=219.3
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+.+++|+++..||+|+||.||+|+..... ...+.+++|.+.........+.+.+|+.++++++|+||+++++++ ...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 80 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-REA 80 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-CCC
Confidence 34567888899999999999999975432 233679999987655554567899999999999999999999986 445
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCP-EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...++|+||+++|+|.+++....... ......+++..+..++.|++.||.|||+.+|+||||||+||++++++.++++|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 56799999999999999998643111 01122589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLN 454 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~ 454 (499)
||+++........ ......++..|+|||.+.+..++.++||||||+++|||+++|..||......+....+..+. ...
T Consensus 161 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 161 LSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred cccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 9998755433221 22234567789999999988899999999999999999997888998777666666655332 233
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
.+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 45578899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.32 Aligned_cols=243 Identities=21% Similarity=0.323 Sum_probs=204.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|....++ +.+|+|++.... .......+.+|..++..+ +||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-~~~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD---ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-QTKDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-EcCCEEEEEEc
Confidence 46899999999999986654 679999987532 233456677888888877 799999999984 55667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 77 YVNGGDLMFHIQRS--------GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred CCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 99999999998762 3589999999999999999999999999999999999999999999999999875322
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......|+..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+... ....+..+++++.
T Consensus 149 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 224 (318)
T cd05570 149 GGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELFQSILED-EVRYPRWLSKEAK 224 (318)
T ss_pred CCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcC-CCCCCCcCCHHHH
Confidence 221 1223468889999999999999999999999999999999 89999888877776666554 3445667899999
Q ss_pred HHHHHhhhcCCCCCCCH-----HHHHH
Q psy1789 465 SVMAYCWAMNPEGRPTF-----PQLHS 486 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~-----~~v~~ 486 (499)
+++.+||+.||++||++ .++++
T Consensus 225 ~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 225 SILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 99999999999999999 76654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=323.37 Aligned_cols=250 Identities=34% Similarity=0.644 Sum_probs=213.2
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
....|++.+.||+|+||.||+|...+ +.+++|...... ..+.+.+|+.++++++||||+++++++.. + ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~-~~ 73 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTG-----QKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-N-GL 73 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCC-----CceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-C-Cc
Confidence 34568888999999999999997533 568999886542 23578899999999999999999998643 3 35
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++++||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~ 147 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRG------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA 147 (254)
T ss_pred EEEEECCCCCCHHHHHHhcC------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccc
Confidence 99999999999999998632 235889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+..... ......+..|+|||++.+..++.++||||||+++|||+++|++||...+..+....+..+.+...+..+
T Consensus 148 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (254)
T cd05083 148 RVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC 222 (254)
T ss_pred eecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcC
Confidence 754321 112334567999999999999999999999999999998789999988887777777777777667788
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
++++.+++.+||+.+|++||+++++++.|++
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=321.49 Aligned_cols=252 Identities=28% Similarity=0.611 Sum_probs=213.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.++++.+.||+|+||.||+|.+..+ ..+++|.+...... ...|.+|++++++++||||+++++++ ......++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEK----RKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVC-TERSPICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCC----CeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEE-ccCCceEE
Confidence 4678889999999999999987543 56899988654221 24688999999999999999999985 44566799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++.
T Consensus 77 v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQR-------GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred EEEcCCCCcHHHHHHhCc-------cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceee
Confidence 999999999999997522 3578999999999999999999999999999999999999999999999999886
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
....... ......++.+|+|||++.+..++.++||||||+++|||++.|..||......++...+..+.+...+...++
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd05112 150 VLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQ 228 (256)
T ss_pred cccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCH
Confidence 5432221 122333567899999999999999999999999999999878899988887788888777766666667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
++.+++.+||+.+|++||++.++++.|
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.27 Aligned_cols=242 Identities=21% Similarity=0.333 Sum_probs=200.8
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhc-CCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYG-LSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|....++ +.+|+|++.... .......+..|..++.. ++||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-~~~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-QTKENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-EeCCEEEEEEe
Confidence 46899999999999986654 679999986542 12233556677777775 5999999999985 45667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 77 y~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 77 YLNGGDLMFHIQSC--------HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred CCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 99999999999762 3588999999999999999999999999999999999999999999999999875422
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... .+..+..++.++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 224 (316)
T cd05619 149 GDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI-GQSPFHGHDEEELFQSIRMD-NPCYPRWLTREAK 224 (316)
T ss_pred CCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHH
Confidence 211 1224568899999999999999999999999999999999 88999988877777666543 3445567889999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHH
Q psy1789 465 SVMAYCWAMNPEGRPTFP-QLH 485 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~-~v~ 485 (499)
+++.+||+.||++||++. ++.
T Consensus 225 ~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 225 DILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHhccCHhhcCCChHHHH
Confidence 999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=338.77 Aligned_cols=252 Identities=18% Similarity=0.244 Sum_probs=202.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCc
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 298 (499)
+|++++.||+|+||.||+++........+.+|+|++.... .....+.+.+|+.++..+ +|+||++++++ +..+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-FQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-EecCCE
Confidence 3778899999999999999875433333789999986431 223345678899999999 59999999987 455667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQR--------DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence 89999999999999999762 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHcCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEID----PFEMAASLQDGYRL 453 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~----~~~~~~~i~~~~~~ 453 (499)
++........ ......||..|+|||++.+. .++.++|||||||++|||+| |+.||.... ..++...+.. ..+
T Consensus 152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~-~~~ 228 (332)
T cd05614 152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT-GASPFTLEGERNTQSEVSRRILK-CDP 228 (332)
T ss_pred CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc-CCCCCCCCCCCCCHHHHHHHHhc-CCC
Confidence 9865432221 12245689999999999865 48899999999999999999 889986432 2233333333 344
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
..+...++++.+++.+||+.||++|| +++++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 55667889999999999999999999 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=343.48 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=206.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++++.||+|+||.||+|+...++ +.||||++.... .......+.+|+.++..++|+||+++++++ ......+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-~~~~~~~ 77 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTG---HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-QDENYLY 77 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-EcCCeEE
Confidence 5788899999999999999986554 689999996432 234456788999999999999999999985 5567789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~E~~~~g~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKK--------DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred EEECCCCCcHHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccce
Confidence 999999999999999862 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcc------------------------------------ccCCCCCCccccccccccccCCCCCchhHHHHHHHH
Q psy1789 381 DLFPSDYH------------------------------------CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLL 424 (499)
Q Consensus 381 ~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl 424 (499)
.+...... .......||+.|+|||++.+..++.++|||||||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 229 (364)
T cd05599 150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229 (364)
T ss_pred eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHH
Confidence 54321100 001124589999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q psy1789 425 WELTTLAQQPYAEIDPFEMAASLQDGY-RLNQP--VNCPDELFSVMAYCWAMNPEGRPT---FPQLHS 486 (499)
Q Consensus 425 ~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~l~~~C~~~~P~~RPt---~~~v~~ 486 (499)
|||++ |.+||...+..+....+.... ....+ ..+++++.+++.+|+. +|.+|++ +.|+++
T Consensus 230 ~el~~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 230 YEMLV-GYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHhhc-CCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999 899999888777666655432 22222 2468899999999996 8999998 877765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.49 Aligned_cols=260 Identities=19% Similarity=0.318 Sum_probs=214.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecC--cccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTD--NASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
++|++.+.||+|+||.||+|....++ +.+++|.+.. .......+.+.+|+.++++++|+||+++++++.. .+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDG---RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCC---CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeE
Confidence 46888899999999999999986444 6789998753 2334446789999999999999999999998654 5667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|..++.... .....+++.++..++.|++.||.|||+.+++||||||+||++++++.++|+|||++
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~ 153 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFK----KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred EEEEecCCCCCHHHHHHHhc----ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecccee
Confidence 99999999999999997532 11245899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI--DPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~--~~~~~~~~i~~~~~~~~~~ 457 (499)
+....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||... +..+....+..+.....+.
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd08224 154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEKCDYPPLPA 230 (267)
T ss_pred eeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHH-CCCCcccCCccHHHHHhhhhcCCCCCCCh
Confidence 76533221 1223457788999999999999999999999999999999 77887543 3344555555554444554
Q ss_pred -CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 458 -NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 458 -~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
..+.++.+++.+||+.+|++||++.+|++.|++++
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 67889999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=329.47 Aligned_cols=247 Identities=18% Similarity=0.319 Sum_probs=209.9
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
|+..+.||+|+||.||+|.+...+ ..+|+|.+.........+.+.+|+.++++++||||+++++++ ..+...++|+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 81 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTK---EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-LKGTKLWIIM 81 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCC---eEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-ccCCceEEEE
Confidence 444588999999999999876544 689999987655455667899999999999999999999985 4466779999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||+++...
T Consensus 82 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 82 EYLGGGSALDLLKP---------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EccCCCcHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEcccccccccc
Confidence 99999999999864 358899999999999999999999999999999999999999999999999998654
Q ss_pred CCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHH
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDEL 463 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 463 (499)
.... ......++..|+|||++.+..++.++|||||||++|||+| |+.|+....+.+....+.....+..+..++.++
T Consensus 153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06642 153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK-GEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF 229 (277)
T ss_pred Ccch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh-CCCCCcccchhhHHhhhhcCCCCCCCcccCHHH
Confidence 3221 1223457788999999999999999999999999999999 889988776666665555554555555678899
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 464 FSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 464 ~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++.+||+.+|++||++.++++
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 230 KEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred HHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=343.53 Aligned_cols=251 Identities=16% Similarity=0.268 Sum_probs=209.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||+|+||.||+|+...++ +.+|+|++.... .......+.+|+.++..++|+||+++++++ .++...+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~ 77 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTG---QVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-QDEEHLY 77 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCC---CEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-ecCCeEE
Confidence 6888999999999999999986544 789999986432 223456788999999999999999999985 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~ 149 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRK--------DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCK 149 (350)
T ss_pred EEEcCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCc
Confidence 999999999999999862 368999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC---------------------------ccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q psy1789 381 DLFPSD---------------------------YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQ 433 (499)
Q Consensus 381 ~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~ 433 (499)
...... .........||..|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~ 228 (350)
T cd05573 150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY-GFP 228 (350)
T ss_pred cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc-CCC
Confidence 654332 0012234568899999999999999999999999999999999 899
Q ss_pred CCCCCCHHHHHHHHHcC---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q psy1789 434 PYAEIDPFEMAASLQDG---YRLNQPVNCPDELFSVMAYCWAMNPEGRPT-FPQLHSC 487 (499)
Q Consensus 434 p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-~~~v~~~ 487 (499)
||...+..+....+... ........+++++.+++.+|+. ||.+||+ +.++++.
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99888776666555441 1222223468999999999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=326.27 Aligned_cols=244 Identities=22% Similarity=0.354 Sum_probs=195.2
Q ss_pred eeeeecceEEEEEEEeCC---------------------CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCccee
Q psy1789 229 VNMEGTFGRVYRGTYTEE---------------------DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~---------------------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~ 287 (499)
.||+|+||.||+|.+... .+....|++|.+.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 589999999999986421 1233568999886543 234467889999999999999999
Q ss_pred EEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q psy1789 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 288 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~ 367 (499)
++|+|.+ ....++||||+++|+|..++.... ..+++..+..++.|+++||+|||+++|+||||||+|||+++
T Consensus 81 ~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 81 VHGVCVR-GSENIMVEEFVEHGPLDVCLRKEK-------GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEEe-CCceEEEEecCCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEec
Confidence 9999765 445699999999999999997522 35889999999999999999999999999999999999986
Q ss_pred CC-------cEEEcccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy1789 368 KL-------RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEID 439 (499)
Q Consensus 368 ~~-------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~ 439 (499)
.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||++.|+.||....
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 43 4799999998644221 12346678999998875 5689999999999999999655889998776
Q ss_pred HHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 440 PFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 440 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
+.+.......... .+.....++.+++.+||+.+|++||++.+|++.|+
T Consensus 227 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 PSEKERFYEKKHR--LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hHHHHHHHHhccC--CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 6555444443322 33345578999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=326.54 Aligned_cols=249 Identities=21% Similarity=0.356 Sum_probs=217.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
..||++.+.||+|+||+|-+|.....+ +.||||.++++ .+++..-.+.+|+++|+.|+||||++++.+ ++..+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sg---R~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-FENkdK 127 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSG---REVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-FENKDK 127 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCC---cEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-hcCCce
Confidence 457888899999999999999864444 88999999765 345556678999999999999999999998 677888
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
..+||||..+|.|.+|+..+ +.|++.+..++++||..|+.|||.++++|||||.+|||||.++++||+||||
T Consensus 128 IvivMEYaS~GeLYDYiSer--------~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER--------GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred EEEEEEecCCccHHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccch
Confidence 89999999999999999984 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+..+....+ -.+.+|++-|.+||.+.+..|. +.+|-||+||+||-|+. |..||.+.+...+...+..|.-.+ .
T Consensus 200 SNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVy-GtMPFDG~Dhk~lvrQIs~GaYrE--P 273 (668)
T KOG0611|consen 200 SNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVY-GTMPFDGRDHKRLVRQISRGAYRE--P 273 (668)
T ss_pred hhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhh-cccccCCchHHHHHHHhhcccccC--C
Confidence 987654432 3478899999999999999885 88999999999999998 999999999888888887764322 2
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.-|.+..-|+++++..||++|.|+.||...
T Consensus 274 ~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 345678899999999999999999998764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.01 Aligned_cols=268 Identities=14% Similarity=0.222 Sum_probs=217.0
Q ss_pred cchhhHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCC
Q psy1789 205 DRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSH 282 (499)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H 282 (499)
...+.....+....+...+|++.+.||+|+||.||+++...++ +.+|+|++... ........+.+|+.+++.++|
T Consensus 26 ~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h 102 (370)
T cd05621 26 NRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102 (370)
T ss_pred HHHHHHHHHHHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC
Confidence 3334455566677888899999999999999999999986654 68999998642 122334568899999999999
Q ss_pred CcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 283 KNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 283 ~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
|||+++++++ ..+...++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|
T Consensus 103 p~iv~~~~~~-~~~~~~~lv~Ey~~gg~L~~~l~~---------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~N 172 (370)
T cd05621 103 PWVVQLFCAF-QDDKYLYMVMEYMPGGDLVNLMSN---------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN 172 (370)
T ss_pred CCEeeEEEEE-EcCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence 9999999984 556778999999999999999975 247889999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT----FSTASDVWAFGVLLWELTTLAQQPYAEI 438 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwS~Gvvl~el~t~g~~p~~~~ 438 (499)
||+++++.+||+|||+|+........ ......||+.|+|||++.+.. ++.++|||||||++|||++ |++||...
T Consensus 173 ILl~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~-G~~Pf~~~ 250 (370)
T cd05621 173 MLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV-GDTPFYAD 250 (370)
T ss_pred EEECCCCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh-CCCCCCCC
Confidence 99999999999999999876432221 223556899999999997643 7899999999999999999 89999887
Q ss_pred CHHHHHHHHHcCC-CCCCC--CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q psy1789 439 DPFEMAASLQDGY-RLNQP--VNCPDELFSVMAYCWAMNPEG--RPTFPQLHSC 487 (499)
Q Consensus 439 ~~~~~~~~i~~~~-~~~~~--~~~~~~~~~l~~~C~~~~P~~--RPt~~~v~~~ 487 (499)
+..+....+.... ....| ...++.+.+++..|+..++.+ ||++.|+++.
T Consensus 251 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 251 SLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 7766666555432 23333 356889999999999855543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=337.15 Aligned_cols=239 Identities=17% Similarity=0.231 Sum_probs=197.9
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHH-HHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGM-AMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||+||+|+...++ +.+|+|++.... .......+..|.. +++.++||||+++++++ ......++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-~~~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG---KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-QTADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-EeCCEEEEEEc
Confidence 46899999999999986554 789999986432 1222344555554 56789999999999985 45667799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 77 YVNGGELFFHLQRE--------RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred CCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 99999999999762 3588999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... ....+...+.++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 224 (323)
T cd05575 149 HSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDTAEMYDNILNK-PLRLKPNISVSAR 224 (323)
T ss_pred CCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhc-CCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHH
Confidence 211 2234568999999999999999999999999999999999 89999988877777666554 2334556789999
Q ss_pred HHHHHhhhcCCCCCCCHH
Q psy1789 465 SVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~ 482 (499)
+++.+|++.||++||++.
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 225 HLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHhhcCHHhCCCCC
Confidence 999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=336.92 Aligned_cols=242 Identities=15% Similarity=0.272 Sum_probs=197.6
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
++||+|+||.||+++....+ +.+|+|++.... .....+.+.+|..++..+ +||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-~~~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTR---RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-QTESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-EcCCEEEEEEe
Confidence 46899999999999986654 789999997532 233456688899999888 799999999985 55667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~~~~g~L~~~~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 77 FVSGGDLMFHMQRQ--------RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred CCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 99999999998752 3689999999999999999999999999999999999999999999999999875322
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--------HHH-HHHHHHcCCCCCC
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID--------PFE-MAASLQDGYRLNQ 455 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~--------~~~-~~~~i~~~~~~~~ 455 (499)
... ......||..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+ ....+.. .....
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 224 (329)
T cd05588 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGMSDNPDQNTEDYLFQVILE-KQIRI 224 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHH-CCCCcccccccccccccchHHHHHHHHc-CCCCC
Confidence 211 1234568899999999999999999999999999999999 899986321 112 2233333 24456
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCC------HHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPT------FPQLH 485 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt------~~~v~ 485 (499)
|..++.++.+++.+||+.||++||+ +.+++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 6778899999999999999999998 55654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=330.88 Aligned_cols=251 Identities=19% Similarity=0.298 Sum_probs=197.5
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|+...++ +.+|+|++...........+.+|+.+++.++||||+++++++ ......+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNG---KLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-HTKETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCC---CEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-ecCCeEE
Confidence 357889999999999999999986544 679999987543333334677899999999999999999985 4556779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++
T Consensus 80 lv~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 80 LVFEYVH-TDLCQYMDKHP-------GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred EEEECCC-cCHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 9999997 78888887521 358899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCC-------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF-EMAASLQDGY------- 451 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~-~~~~~i~~~~------- 451 (499)
...... .......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.... +....+....
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 152 AKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ-GVAAFPGMKDIQDQLERIFLVLGTPNEDT 228 (303)
T ss_pred eccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCccHHHHHHHHHHHhCCCChhh
Confidence 543221 12234567889999999875 458999999999999999999 88999875332 2222111000
Q ss_pred ----------CC-----CCC---------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ----------RL-----NQP---------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ----------~~-----~~~---------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+ ..+ ...++++.+++.+|++.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 000 123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=334.61 Aligned_cols=242 Identities=19% Similarity=0.275 Sum_probs=200.8
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhc-CCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYG-LSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|+...++ ..+|+|.+..... ....+.+..|..++.. .+||||+++++++ ......++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG---EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-QTKEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-EeCCEEEEEEC
Confidence 46899999999999987654 6799999865321 2234556778777775 4899999999985 55667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~~~~g~L~~~i~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 77 FLNGGDLMFHIQDK--------GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred CCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 99999999998762 3588999999999999999999999999999999999999999999999999875322
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||..|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... .+..+..++.++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~-g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 224 (316)
T cd05620 149 GDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI-GQSPFHGDDEDELFESIRVD-TPHYPRWITKESK 224 (316)
T ss_pred CCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHH
Confidence 211 1234568999999999999999999999999999999999 89999888777776666544 3455667889999
Q ss_pred HHHHHhhhcCCCCCCCHH-HHH
Q psy1789 465 SVMAYCWAMNPEGRPTFP-QLH 485 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~-~v~ 485 (499)
+++.+||+.||++||++. ++.
T Consensus 225 ~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 225 DILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=318.92 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=212.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.|++.+.||+|++|.||++....++ +.+++|.+... ......+.+.+|+.++++++|+|++++++.+...+...++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDG---KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCC---cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEE
Confidence 4788899999999999999976544 67999998643 2344556788999999999999999999875444556789
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
++||+++++|.+++.... ...+++.++..++.|++.||+|||+.+++||||||+||++++++.++|+|||+++.
T Consensus 78 v~e~~~~~~l~~~l~~~~------~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~ 151 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQK------GKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARV 151 (257)
T ss_pred EecccCCCcHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEE
Confidence 999999999999998522 24589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
...... ......++..|+|||++.+..++.++||||||++++||++ ++.||...+.......+..+..+..+...++
T Consensus 152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd08223 152 LENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT-LKHAFNAKDMNSLVYRIIEGKLPPMPKDYSP 228 (257)
T ss_pred ecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhcCCCCCccccCH
Confidence 532211 2234557888999999999999999999999999999999 7889987776666656655555555667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
++.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 229 ELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcC
Confidence 99999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=343.41 Aligned_cols=251 Identities=16% Similarity=0.221 Sum_probs=204.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++++.||+|+||.||++....++ +.+|+|++.... .....+.+.+|+.++++++||||+++++++ .+....+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-~~~~~~~ 77 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTG---KIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-QDAQYLY 77 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCC---CEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-EcCCeeE
Confidence 5788899999999999999876554 689999986432 234456788999999999999999999985 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKY--------DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred EEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999762 358899999999999999999999999999999999999999999999999996
Q ss_pred ccCCCCcc-----------c----------------------------------cCCCCCCccccccccccccCCCCCch
Q psy1789 381 DLFPSDYH-----------C----------------------------------LGDNENRPVKWLAIESLVHKTFSTAS 415 (499)
Q Consensus 381 ~~~~~~~~-----------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~ 415 (499)
........ . ......||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 229 (377)
T cd05629 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCce
Confidence 43211000 0 00124689999999999999999999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCcHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q psy1789 416 DVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRLNQPV--NCPDELFSVMAYCWAMNPEGR---PTFPQLHSC 487 (499)
Q Consensus 416 DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~--~~~~~~~~l~~~C~~~~P~~R---Pt~~~v~~~ 487 (499)
|||||||++|||+| |++||...+..+....+... .....|. .++.++.+++.+|+. +|.+| +++.|++..
T Consensus 230 DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 230 DWWSLGAIMFECLI-GWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred eeEecchhhhhhhc-CCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999999 89999887776665555432 1222232 478899999999997 67765 588888754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.43 Aligned_cols=244 Identities=22% Similarity=0.373 Sum_probs=194.4
Q ss_pred eeeeeecceEEEEEEEeCCC---------ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 228 SVNMEGTFGRVYRGTYTEED---------GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+.||+|+||.||+|++.... .....|++|.+.... ......|.+|+.+++.++||||+++++++.. +..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCC
Confidence 36899999999999864321 123468899876543 3344678899999999999999999999755 455
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc-------E
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR-------I 371 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~-------~ 371 (499)
.++|+||+++|+|..++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS-------DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCcee
Confidence 699999999999999987522 35899999999999999999999999999999999999987664 8
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
|++|||++...... ....++..|+|||.+. +..++.++|||||||++|||++.+..|+......+........
T Consensus 152 ~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (262)
T cd05077 152 KLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ 225 (262)
T ss_pred EeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC
Confidence 99999998754321 2345677899999987 5678999999999999999986688898876554443322222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 451 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
. ......++++.+++.+||+.||++||++.+|++.+
T Consensus 226 ~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 12233567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=338.71 Aligned_cols=250 Identities=16% Similarity=0.247 Sum_probs=207.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||+|+||.||++....++ +.+|+|++.... .....+.+.+|+.+++.++|+||+++++++ ......+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-~~~~~~~ 77 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATG---DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-QDKDNLY 77 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-ecCCeEE
Confidence 5788899999999999999976554 689999987542 233456788999999999999999999885 4566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~e~~~~~~L~~~l~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~ 150 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYE-------DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA 150 (330)
T ss_pred EEECCCCCCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCe
Confidence 9999999999999998632 358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLV------HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-L 453 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-~ 453 (499)
........ ......||..|+|||++. ...++.++|||||||++|||++ |+.||...+..+....+....+ .
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~ 228 (330)
T cd05601 151 RLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNNIMNFQRFL 228 (330)
T ss_pred ECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc-CCCCCCCCCHHHHHHHHHcCCCcc
Confidence 66433222 223456889999999987 4568899999999999999999 8999988777666665544322 2
Q ss_pred CCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 NQP--VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ~~~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..| ...++++.+++..|++ +|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 222 3578899999999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=320.12 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=208.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc----cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA----SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
.|++.+.||+|+||.||+|....++ +.+++|.+.... .....+.+.+|+.++++++||||+++++++ ..+..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~---~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~ 78 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTG---RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-RDDET 78 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCC---cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-ccCCe
Confidence 4677799999999999999876544 679999875431 223456788999999999999999999985 44567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||+
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~ 150 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAY--------GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGA 150 (263)
T ss_pred EEEEEEECCCCcHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 89999999999999999862 3588999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccc-CCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCCCCCC
Q psy1789 379 ARDLFPSDYHCL-GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QDGYRLNQP 456 (499)
Q Consensus 379 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~~ 456 (499)
++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+..... ........+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd06625 151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPTNPQLP 229 (263)
T ss_pred ceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh-CCCCccccchHHHHHHHhccCCCCCCC
Confidence 976543221111 123457788999999999999999999999999999999 88999876655544333 333445566
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..+++++.+++.+||..+|++|||+.|+++.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 6789999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=333.11 Aligned_cols=243 Identities=19% Similarity=0.298 Sum_probs=202.6
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~ 300 (499)
|++.+.||+|+||.||+|....++ +.||+|++.... .....+.+..|..++..+. |++|++++++ +...+..+
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-~~~~~~~~ 77 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTD---ELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-FQTVDRLY 77 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-EecCCEEE
Confidence 567799999999999999976554 689999986432 2233456778888888885 5667777776 56566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~i~~~--------~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~ 149 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQV--------GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149 (323)
T ss_pred EEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEecccccc
Confidence 999999999999999762 358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
....... ......||..|+|||++.+..++.++|||||||++|||++ |++||...+..+....+... ....|..++
T Consensus 150 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~i~~~-~~~~p~~~~ 225 (323)
T cd05615 150 EHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDELFQSIMEH-NVSYPKSLS 225 (323)
T ss_pred ccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCC
Confidence 5432221 1234568899999999999999999999999999999999 89999988877777666553 344566788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~ 482 (499)
.++.+++.+||+.+|++|++..
T Consensus 226 ~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 226 KEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred HHHHHHHHHHcccCHhhCCCCC
Confidence 9999999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=335.70 Aligned_cols=238 Identities=16% Similarity=0.286 Sum_probs=194.5
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|+...++ +.+|+|++... ......+.+.+|+.++.++ +||||+++++++ ......++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-~~~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE---RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-QTESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-EeCCEEEEEEe
Confidence 46899999999999987654 68999998753 2334456678898888776 899999999984 55667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~~~~~--------~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 77 YVNGGDLMFHMQRQ--------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred CCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 99999999988752 3589999999999999999999999999999999999999999999999999975432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--------CHHH-HHHHHHcCCCCCC
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI--------DPFE-MAASLQDGYRLNQ 455 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~--------~~~~-~~~~i~~~~~~~~ 455 (499)
... ......||..|+|||++.+..++.++|||||||++|||++ |+.||... ...+ +...+.. .....
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~ 224 (329)
T cd05618 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRI 224 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhh-CCCCCccCCCcCCcccccHHHHHHHHhc-CCCCC
Confidence 221 1234568999999999999999999999999999999999 88898521 1111 2222322 34456
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
|...+.++.+++.+||+.||++||+.
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 77788999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=326.87 Aligned_cols=248 Identities=16% Similarity=0.245 Sum_probs=203.0
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
|++.++||+|+||.||++....++ +.||+|++.... .......+.+|+.++++++|+||+++++++ ......++
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 77 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-ETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCC---ceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-cCCCeEEE
Confidence 677899999999999999876544 789999986432 122235577899999999999999999985 44567899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||+++|+|..++.... ...+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||+++.
T Consensus 78 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMG------NPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred EEeccCCCcHHHHHHhcC------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 999999999999887521 23589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA----ASLQDGYRLNQPV 457 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~----~~i~~~~~~~~~~ 457 (499)
..... ......|+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..... ..+.. .....+.
T Consensus 152 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~-g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~ 226 (285)
T cd05605 152 IPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVKREEVERRVKE-DQEEYSE 226 (285)
T ss_pred cCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHH-CCCCCCCCchhhHHHHHHHHhhh-cccccCc
Confidence 53222 1123467889999999999999999999999999999999 89999876543322 22222 2334455
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
..++.+.+++.+||+.||++|| +++++++
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 6889999999999999999999 7778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=324.87 Aligned_cols=262 Identities=31% Similarity=0.511 Sum_probs=212.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~ 299 (499)
..|++.+.||+|+||.||+|++... ......+|||.+.........+.|.+|+.+++.++|+||+++++++... ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4567779999999999999997543 2334789999997664444567899999999999999999999986542 3457
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-------DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-------cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 99999999999999998632 25899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC---------------HHHH
Q psy1789 380 RDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID---------------PFEM 443 (499)
Q Consensus 380 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~---------------~~~~ 443 (499)
........ ........++..|+|||++.+..++.++||||||+++|||+| |..|+.... ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT-YGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeec-cCCCcccccchhccccccccccccHHHH
Confidence 87653221 111223344567999999999999999999999999999999 666655421 1122
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 444 AASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 444 ~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
...+....+...+..++.++.+++.+||+.+|++|||+.||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 334444445555667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=317.52 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=214.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||.++...++ +.+++|.+... .+......+.+|+.++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDD---SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCC---cEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEE
Confidence 5788899999999999999876544 67899987643 345556778999999999999999999998644 667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+|||+++|+|.+++.... ...+++.++..++.|++.||.|||+.+++|+||||+||++++++.+||+|||+++.
T Consensus 77 ~~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 77 EMEYANGGTLYDKIVRQK------GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred EEEecCCCcHHHHHHhcc------ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 999999999999998632 23589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+..+.....+..++.
T Consensus 151 ~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08221 151 LGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-LKRTFDATNPLNLVVKIVQGNYTPVVSVYSS 227 (256)
T ss_pred cccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCCCCCccccCH
Confidence 643332 2234567889999999998889999999999999999999 7889988777777666665545555567889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
++.+++.+||+.+|++||++.++++.
T Consensus 228 ~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 228 ELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhhC
Confidence 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=335.69 Aligned_cols=242 Identities=17% Similarity=0.234 Sum_probs=198.0
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHH-HHHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEG-MAMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~-~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|+...++ +.+|+|++.... .......+..|. .+++.++|+||+++++++ ......++|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-~~~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE---KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-QTADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-EcCCeEEEEEe
Confidence 46899999999999976554 679999986432 112223444444 456789999999999985 55667799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|.+++... ..+.+.....++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 77 YINGGELFYHLQRE--------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred CCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 99999999999762 3578888999999999999999999999999999999999999999999999975432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+... ....+...++++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 224 (325)
T cd05602 149 HNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNK-PLQLKPNITNSAR 224 (325)
T ss_pred CCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhc-CCCCCCCCCHHHHHHHHHhC-CcCCCCCCCHHHH
Confidence 221 2234568999999999999999999999999999999999 89999888877776666543 2334457889999
Q ss_pred HHHHHhhhcCCCCCCCHHHHH
Q psy1789 465 SVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~~v~ 485 (499)
+++.+|++.||.+||++.+.+
T Consensus 225 ~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 225 HLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHHHHcccCHHHCCCCCCCH
Confidence 999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=342.15 Aligned_cols=250 Identities=18% Similarity=0.263 Sum_probs=202.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++++.||+|+||.||+|+...++ +.+|+|++.... ...+...+.+|+.+++.++|+||+++++++ .++...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-~~~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTK---ALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-QDKDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCC---CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-EeCCEEE
Confidence 5788899999999999999976554 689999986432 234456788999999999999999999985 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++.....++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 78 lv~E~~~gg~L~~~l~~~--------~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM--------GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 999999999999999762 357889999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCc---------------------------------------------cccCCCCCCccccccccccccCCCCCch
Q psy1789 381 DLFPSDY---------------------------------------------HCLGDNENRPVKWLAIESLVHKTFSTAS 415 (499)
Q Consensus 381 ~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 415 (499)
....... ........||+.|+|||++.+..++.++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 229 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence 4311000 0001234689999999999999999999
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q psy1789 416 DVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRLNQP--VNCPDELFSVMAYCWAMNPEGRPT---FPQLHS 486 (499)
Q Consensus 416 DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~l~~~C~~~~P~~RPt---~~~v~~ 486 (499)
|||||||++|||++ |++||...++.+....+... .....| ...++++.+++.+++ .+|++|++ +.++++
T Consensus 230 DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 230 DWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred eEEechHHHHHHHh-CCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999999 99999988776665555432 122222 357889999888876 59999997 776653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=318.50 Aligned_cols=256 Identities=40% Similarity=0.732 Sum_probs=218.8
Q ss_pred EEeeeeeeecceEEEEEEEeCCC-ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
++.+.||+|+||.||+++....+ .....+|+|.+.........+.+.+|+..+..++|+||+++++++.. ....+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEEE
Confidence 45689999999999999986533 12367999999766555466789999999999999999999998655 45679999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++++|.+++.... ...+++.++..++.|++.||+|||+.+++||||||+||++++++.++|+|||+++...
T Consensus 81 e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNR------PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhh------hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999998632 1128999999999999999999999999999999999999999999999999998765
Q ss_pred CCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHH
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDEL 463 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 463 (499)
........ ...++..|+|||.+.+..++.++||||||++++||+++|++||...+..++...+........+...+.++
T Consensus 155 ~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T smart00219 155 DDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEI 233 (258)
T ss_pred cccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHH
Confidence 44332221 23367889999999888999999999999999999998889998888888888888777777777889999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 464 FSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 464 ~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
.+++.+||..+|++|||+.|+++.|
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 234 YKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.80 Aligned_cols=248 Identities=17% Similarity=0.322 Sum_probs=212.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++.+.||.|+||.||+|+...++ ..+++|.+...........+.+|+.+++.++|+||+++++++.. +...++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 77 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTN---QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWII 77 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCC---eEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEE
Confidence 5677799999999999999986554 78999998765545556778999999999999999999998654 5677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||+|+||++++++.++|+|||+++..
T Consensus 78 ~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 78 MEYCGGGSCLDLLKP---------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred EEeeCCCcHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 999999999999985 25899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC-CcH
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN-CPD 461 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~-~~~ 461 (499)
..... ......++..|+|||++.+..++.++|||||||++|||+| |+.||...++.+....+.....+..+.. ++.
T Consensus 149 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (274)
T cd06609 149 TSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSK 225 (274)
T ss_pred ccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccCchHHHHHHhhhcCCCCCcccccCH
Confidence 53321 1224457788999999999999999999999999999999 8999988777666666665555554544 788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+++.+||..+|++|||++++++
T Consensus 226 ~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 226 PFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 9999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.22 Aligned_cols=243 Identities=24% Similarity=0.472 Sum_probs=197.8
Q ss_pred eeeeeecceEEEEEEEeCCC-------ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 228 SVNMEGTFGRVYRGTYTEED-------GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+.||+|+||.||+|.+.+.. .....+++|.+...... ...|.+|+.++++++|+||++++|++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR--DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec--CCcE
Confidence 46899999999999987543 12245778877544322 5788999999999999999999999766 4469
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-------cEEE
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-------RIQI 373 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-------~~kl 373 (499)
+|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK-------NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEe
Confidence 9999999999999998632 2589999999999999999999999999999999999999888 7999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK--TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
+|||+++.... .....++..|+|||++... .++.++|||||||++|||++++..|+...+..+.........
T Consensus 150 ~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~ 223 (259)
T cd05037 150 SDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH 223 (259)
T ss_pred CCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC
Confidence 99999986533 1233456679999999876 789999999999999999997788888776554444443322
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
.. +.....++.+++.+||..+|++|||+.++++.|+
T Consensus 224 ~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 RL--PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 22 2223478999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.32 Aligned_cols=259 Identities=19% Similarity=0.305 Sum_probs=210.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||+|+||.||+|....++ ..++||.+... ........+.+|+.+++.++|+||+++++++.. +...+
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~ 78 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDG---VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELN 78 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCC---ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEE
Confidence 4666799999999999999976554 67999987542 233445688999999999999999999998654 55679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+++||+++++|.+++.... .....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.
T Consensus 79 ~v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 79 IVLELADAGDLSRMIKHFK----KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCHHHHHHHhh----ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 9999999999999987532 112468999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCCCCC-CCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP--FEMAASLQDGYRLN-QPV 457 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~--~~~~~~i~~~~~~~-~~~ 457 (499)
....... ......++..|+|||++.+..++.++||||||+++|||++ |..||..... .+....+.....+. .+.
T Consensus 155 ~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd08229 155 FFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 231 (267)
T ss_pred ccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh-CCCCcccccchHHHHhhhhhcCCCCCCCcc
Confidence 6533221 1223457888999999999999999999999999999999 7888865432 23334443332222 233
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
..++++.+++.+||+.||++|||+.+|++.+++++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 232 HYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 57889999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=342.66 Aligned_cols=251 Identities=16% Similarity=0.224 Sum_probs=204.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.|++++.||+|+||.||+++...++ +.+|+|++.... .....+.+.+|+.+++.++|+||+++++.+ ..++..+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-~~~~~~~ 77 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTN---ALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-QDKDNLY 77 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCC---CEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-EcCCEEE
Confidence 5788999999999999999976554 789999986432 223346688999999999999999999985 5567789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++.....++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 78 lv~E~~~~g~L~~~i~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRL--------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 999999999999999762 357888999999999999999999999999999999999999999999999985
Q ss_pred ccCCCC-----------------------------------------ccccCCCCCCccccccccccccCCCCCchhHHH
Q psy1789 381 DLFPSD-----------------------------------------YHCLGDNENRPVKWLAIESLVHKTFSTASDVWA 419 (499)
Q Consensus 381 ~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS 419 (499)
...... ..+......||..|||||++.+..++.++||||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 229 (376)
T cd05598 150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229 (376)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence 331000 000112346899999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCcHHHHHHHHHhhhcCCCCCC---CHHHHHHH
Q psy1789 420 FGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---RLNQPVNCPDELFSVMAYCWAMNPEGRP---TFPQLHSC 487 (499)
Q Consensus 420 ~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RP---t~~~v~~~ 487 (499)
|||++|||++ |+.||...++.+....+.... .......++.++.+++.+|+ .+|.+|+ ++.++++.
T Consensus 230 lGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 230 VGVILYEMLV-GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ccceeeehhh-CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999 999999887766655554321 12222367889999999977 5999999 88888653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=324.61 Aligned_cols=245 Identities=18% Similarity=0.226 Sum_probs=197.3
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
||+|+||+||++....++ +.+|+|.+.... .....+.+..|+.+++.++|+||+++.+++ ......++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRATG---KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-QTKTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEccCC---cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-cCCCeEEEEEeCCC
Confidence 689999999999876554 689999986432 222345678899999999999999998874 55667899999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+|+|..++.... .....+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||+++.......
T Consensus 77 ~g~L~~~~~~~~----~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 152 (280)
T cd05608 77 GGDLRYHIYNVD----EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS 152 (280)
T ss_pred CCCHHHHHHhcc----ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence 999999886422 1134689999999999999999999999999999999999999999999999999976543322
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCcHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF----EMAASLQDGYRLNQPVNCPDEL 463 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~----~~~~~i~~~~~~~~~~~~~~~~ 463 (499)
......|+..|+|||++.+..++.++|||||||++|||++ |+.||...... +....+... ....+..+++++
T Consensus 153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 228 (280)
T cd05608 153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRILND-SVTYPDKFSPAS 228 (280)
T ss_pred --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHH
Confidence 1234568889999999999999999999999999999999 88998764322 222222222 234455688999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 464 FSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 464 ~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
.+++.+||+.||++|| +++++++
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 9999999999999999 5666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.93 Aligned_cols=251 Identities=17% Similarity=0.263 Sum_probs=196.4
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---- 295 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---- 295 (499)
...+|++++.||+|+||.||+|.....+ +.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTS---EKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCC---CEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 4568999999999999999999976554 689999886432 2234799999999999999998874321
Q ss_pred ---CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cE
Q psy1789 296 ---HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RI 371 (499)
Q Consensus 296 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~ 371 (499)
....++||||++ ++|.+++..... ....+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+
T Consensus 136 ~~~~~~l~lvmE~~~-~~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 136 NEKNIFLNVVMEFIP-QTVHKYMKHYAR----NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred CCCceEEEEEEecCC-ccHHHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCce
Confidence 123568999999 578777764221 124689999999999999999999999999999999999999664 79
Q ss_pred EEcccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
||+|||+|+....... .....+|..|+|||++.+ ..++.++|||||||++|||+| |.+||.+....+....+...
T Consensus 211 kL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred eeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Confidence 9999999986643221 123457889999999876 469999999999999999999 88999877654433322210
Q ss_pred C----------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 451 Y----------------------------RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 451 ~----------------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
. +...|...++++.+++.+||+.||.+|||+.|+++.
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 011233567899999999999999999999999743
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.45 Aligned_cols=250 Identities=22% Similarity=0.381 Sum_probs=208.5
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--------HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--------AVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
|.+.+.||+|+||.||+|.....+ +.+++|.+..... ....+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 77 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSG---ELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD- 77 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCC---cEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-
Confidence 556789999999999999875543 6799998854321 1234678899999999999999999998654
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++++||+++++|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~d 149 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNY--------GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISD 149 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecc
Confidence 56679999999999999999762 3588999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccc----cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 376 NALARDLFPSDYHC----LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 376 fGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 228 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIGENA 228 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhh-CCCCCCCccHHHHHHHHhccC
Confidence 99998765321110 1112357788999999999999999999999999999999 899998876655555555555
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+...+.++.+++.+||+.||.+||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 66667788999999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=322.81 Aligned_cols=255 Identities=17% Similarity=0.346 Sum_probs=212.6
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
.+......+|++.+.||.|+||.||+|....++ +.+++|.+..... ...+.+.+|+.+++.++|+||+++++++.
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~---~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 86 (296)
T cd06655 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATG---QEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFL- 86 (296)
T ss_pred HhcCCCcceEEEEEEEecCCCeEEEEEEEcCCC---cEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEe-
Confidence 344445578999999999999999999875544 6899998865432 23467889999999999999999999864
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++|+||+++++|..++.. ..+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~ 157 (296)
T cd06655 87 VGDELFVVMEYLAGGSLTDVVTE---------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLT 157 (296)
T ss_pred cCceEEEEEEecCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEc
Confidence 45677999999999999999875 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--C
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--R 452 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--~ 452 (499)
|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...++.+....+.... .
T Consensus 158 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T cd06655 158 DFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPE 234 (296)
T ss_pred cCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCcc
Confidence 9999886544322 1224467889999999999999999999999999999999 889998877655444443322 2
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+..+++++.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 2345578889999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=336.60 Aligned_cols=260 Identities=13% Similarity=0.204 Sum_probs=211.6
Q ss_pred hcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEe
Q psy1789 213 KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLG 290 (499)
Q Consensus 213 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g 290 (499)
.+....+...+|++.+.||+|+||.||+++...++ +.+|+|++... ......+.+.+|+.+++.++||||+++++
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~---~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCC---cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35556777889999999999999999999987655 78999998642 12333456789999999999999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
++ ..+...++||||+++|+|.+++.. ..++...+..++.|++.||+|||+++|+||||||+|||+++++.
T Consensus 111 ~~-~~~~~~~lv~Ey~~gg~L~~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 111 AF-QDDRYLYMVMEYMPGGDLVNLMSN---------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred EE-EcCCEEEEEEcCCCCCcHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC
Confidence 85 556678999999999999999975 24788899999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT----FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
+||+|||+++........ ......||+.|||||++.+.. ++.++|||||||++|||++ |++||...+.......
T Consensus 181 ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~ 258 (371)
T cd05622 181 LKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYSK 258 (371)
T ss_pred EEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 999999999876433221 223556899999999997543 8899999999999999999 8999998877766666
Q ss_pred HHcCC-CCCCC--CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q psy1789 447 LQDGY-RLNQP--VNCPDELFSVMAYCWAMNPEG--RPTFPQLHSC 487 (499)
Q Consensus 447 i~~~~-~~~~~--~~~~~~~~~l~~~C~~~~P~~--RPt~~~v~~~ 487 (499)
+.... ....+ ...+.++.+++..|+..++.+ ||++.|+++.
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 259 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 65432 22223 367899999999999843332 6788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=334.13 Aligned_cols=241 Identities=16% Similarity=0.221 Sum_probs=198.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHH-HHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGM-AMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|+...++ +.+|+|++.... .......+..|.. +++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-~~~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDG---KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-QTTEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-ecCCEEEEEEc
Confidence 36899999999999976544 689999986432 2223345555654 56779999999999985 45667799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++.. ...+++..+..++.|++.||+|||+.+|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 77 FVNGGELFFHLQR--------ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred CCCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 9999999999875 23589999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||..|+|||++.+..++.++|||||||++|||++ |..||...+..++...+... ....+...+.++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-G~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 224 (325)
T cd05604 149 QSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPFYCRDVAEMYDNILHK-PLVLRPGASLTAW 224 (325)
T ss_pred CCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhc-CCCCCCCCCHHHHHHHHHcC-CccCCCCCCHHHH
Confidence 211 2234568999999999999999999999999999999999 89999888877776666554 2334446788999
Q ss_pred HHHHHhhhcCCCCCCCHHHH
Q psy1789 465 SVMAYCWAMNPEGRPTFPQL 484 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~~v 484 (499)
+++.+|++.+|.+||++.+.
T Consensus 225 ~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 225 SILEELLEKDRQRRLGAKED 244 (325)
T ss_pred HHHHHHhccCHHhcCCCCCC
Confidence 99999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=319.35 Aligned_cols=249 Identities=18% Similarity=0.333 Sum_probs=212.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
-|++.+.||+|+||.||+|.....+ ..+|+|...........+.+.+|+.++.+++|+||+++++++. .+...++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCC---cEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-eCCeEEEE
Confidence 3556689999999999999875544 6899999875544556678999999999999999999999864 45667999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||||+||++++++.++|+|||+++..
T Consensus 81 ~e~~~~~~l~~~i~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 81 MEYLGGGSALDLLEP---------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred EEeCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 999999999999874 35889999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHH
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 462 (499)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.....+..+..++.+
T Consensus 152 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06641 152 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK-GEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 228 (277)
T ss_pred ccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHc-CCCCCCccchHHHHHHHhcCCCCCCCcccCHH
Confidence 43221 1223457788999999998899999999999999999999 89999887776666666555555556678899
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 463 LFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 463 ~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+.+++.+||+.+|++||++.++++.
T Consensus 229 ~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 229 LKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=333.22 Aligned_cols=249 Identities=18% Similarity=0.249 Sum_probs=197.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++.+.||+|+||.||++.....+ +.+|+|.+... ........+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLG---INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCC---ceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 357889999999999999999876544 78999998643 23344567889999999999999999999854322
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++||||++ ++|.+.++. .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 97 EFQDVYLVMELMD-ANLCQVIHM----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred ccceeEEEEeCCC-cCHHHHHhc----------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEe
Confidence 24689999998 567666653 47889999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG---- 450 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~---- 450 (499)
|||+++...... ......+|..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+...
T Consensus 166 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 241 (359)
T cd07876 166 DFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK-GSVIFQGTDHIDQWNKVIEQLGTP 241 (359)
T ss_pred cCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999997643221 2234567889999999999999999999999999999999 89999876543321111100
Q ss_pred -----------------CCCC--------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 451 -----------------YRLN--------------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 451 -----------------~~~~--------------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.++. .....++++.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 001235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.13 Aligned_cols=239 Identities=16% Similarity=0.229 Sum_probs=197.6
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHH-HHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGM-AMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
++||+|+||.||+|+...++ +.+|+|++.... .......+..|.. +++.++||||+++++++ ...+..++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-~~~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDG---SFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-QTAEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCC---CEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-EcCCEEEEEEc
Confidence 46899999999999986554 689999986432 1222344555554 57889999999999885 55667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 77 YVNGGELFFHLQRE--------RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred CCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 99999999988752 3578889999999999999999999999999999999999999999999999875422
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 464 (499)
... ......||..|+|||.+.+..++.++|||||||++|||++ |+.||...+..++...+... ....+...+.++.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 224 (321)
T cd05603 149 PEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY-GLPPFYSRDVSQMYDNILHK-PLQLPGGKTVAAC 224 (321)
T ss_pred CCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHH
Confidence 211 2234568899999999999999999999999999999999 89999988877776666554 3455667889999
Q ss_pred HHHHHhhhcCCCCCCCHH
Q psy1789 465 SVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~ 482 (499)
+++.+||+.||.+||+..
T Consensus 225 ~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 225 DLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHccCCHhhcCCCC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=314.35 Aligned_cols=250 Identities=23% Similarity=0.286 Sum_probs=201.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHH-HHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ-VSLLLQEGMAMYGLSHKNILTVLGVSIED-HTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~~ 300 (499)
+|+.++.|++|+||.||+|+++.++ ..||+|+++.+..... --.-++|+.+|.+++|||||.+-.+.... -+..|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~---eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTD---EIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcc---eeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4667799999999999999987776 7899999975432211 12347999999999999999988764332 34579
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||++ .+|+..++..+ +.+...+..-+..|+++|++|||...|+|||||++|+|+++.|.+||+||||||
T Consensus 154 ~VMe~~E-hDLksl~d~m~-------q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMK-------QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred eeHHHHH-hhHHHHHHhcc-------CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhh
Confidence 9999999 79999998743 578999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-------- 451 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 451 (499)
.+...- ...+..+-|.-|.|||.+++. .|++..|+||+|||+.|+++ +++.|.+....+....+-.-.
T Consensus 226 ~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~-~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 226 EYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT-QKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh-cCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 875431 123466778899999999874 59999999999999999999 888888876544433332110
Q ss_pred -------------CCC---------CCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 -------------RLN---------QPV-NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 -------------~~~---------~~~-~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+. ++. ..++.-++++...+..||.+|.|+.|.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 001 111 14578899999999999999999999775
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=328.05 Aligned_cols=250 Identities=19% Similarity=0.302 Sum_probs=199.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+|.+.+.||+|+||.||+|+....+ ..+|+|.+...........+.+|+.++++++|+||+++++++. .+...++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTE---NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-TDKSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCC---CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-eCCeEEE
Confidence 56888999999999999999876554 6799999865433333346778999999999999999999864 4566799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||+++.
T Consensus 82 v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 82 VFEYLD-KDLKQYMDDCG-------NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred EEeCCC-CCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence 999998 58888887522 3578999999999999999999999999999999999999999999999999975
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-------- 452 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-------- 452 (499)
...... ......++..|+|||.+.+ ..++.++|||||||++|||+| |++||...+..+....+.....
T Consensus 154 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 154 KSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS-GRPLFPGSTVEDELHLIFRLLGTPTEETWP 230 (309)
T ss_pred cCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 432221 1223456889999999865 568999999999999999999 8899987665443322211000
Q ss_pred -------------C--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 -------------L--------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 -------------~--------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+ .....+++++.+++.+|++.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 001246778999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=322.48 Aligned_cols=244 Identities=22% Similarity=0.427 Sum_probs=198.0
Q ss_pred eeeeeecceEEEEEEEeCCCc----eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDG----VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
+.||+|+||.||+|....... ....+++|.+... .....+.+.+|+.+++.++||||+++++++.. +...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEE
Confidence 468999999999998754321 2345888887543 23445678899999999999999999999655 45579999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc--------EEEcc
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR--------IQITD 375 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~--------~kl~D 375 (499)
||+++|+|.++++..+ ..+++..++.++.|++.||+|||+.+|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKKNK-------NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 9999999999998632 25899999999999999999999999999999999999987765 69999
Q ss_pred cccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
||++....+. ....++..|+|||++.+ ..++.++|||||||++|||++|+.+|+...+.......... +..
T Consensus 152 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--~~~ 223 (258)
T cd05078 152 PGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQ 223 (258)
T ss_pred cccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--ccc
Confidence 9988754332 23456778999999986 45899999999999999999966788877666554443333 334
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
.|.....++.+++.+||+.||++|||++++++.|
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 224 LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 4556678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=315.56 Aligned_cols=251 Identities=18% Similarity=0.296 Sum_probs=214.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||++....++ +.+++|.+... ........+.+|+.++++++|+||+++++++ ......++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDG---KQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-EENGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCC---CEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-cCCCeEEE
Confidence 4788899999999999999876544 68999988643 2344556889999999999999999999984 55667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|.+++.... ...+++.+++.++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 77 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 77 VMDYCEGGDLYKKINAQR------GVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred EEecCCCCcHHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 999999999999997522 23578999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
....... .....++..|+|||++.+..++.++|||||||+++||++ |+.||...+..+....+..+..+..+...+.
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08218 151 LNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAFEAGNMKNLVLKIIRGSYPPVSSHYSY 227 (256)
T ss_pred cCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc-CCCCccCCCHHHHHHHHhcCCCCCCcccCCH
Confidence 5432211 123457788999999999999999999999999999999 8889988777777776666666666778899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+++.+||+.+|++||++.+|++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 228 DLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 9999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=355.21 Aligned_cols=267 Identities=19% Similarity=0.245 Sum_probs=210.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++.+.||+|+||.||+|.....+ +.||+|++... ......++|.+|++++++++||||+++++++. +++..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg---~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-d~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCS---RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-DGDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCC---cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-eCCEE
Confidence 47899999999999999999976544 78999998653 23444578999999999999999999999864 45667
Q ss_pred EEEEEeCCCCCHHHHHHhcccC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLC---PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
+++|||+++|+|.+++...... .......+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+||
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEec
Confidence 9999999999999999753211 1112235678889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc----------------cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy1789 377 ALARDLFPSDY----------------HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440 (499)
Q Consensus 377 Gla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~ 440 (499)
|+++....... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...+.
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT-G~~PF~~~~~ 236 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT-LSFPYRRKKG 236 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCcch
Confidence 99986521100 001123468999999999999999999999999999999999 8899987554
Q ss_pred HHHHHHH--HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHH
Q psy1789 441 FEMAASL--QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRP-TFPQLHSCLQEFHA 493 (499)
Q Consensus 441 ~~~~~~i--~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-t~~~v~~~L~~~~~ 493 (499)
.+..... ...........+++.+.+++.+|++.||++|| +++++.+.|+.+.+
T Consensus 237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 4432221 11111112236788999999999999999995 66777777776644
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=323.08 Aligned_cols=250 Identities=17% Similarity=0.348 Sum_probs=206.6
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|++.+.||+|+||.||+|....++ +.+++|.+...... ..+.+.+|+.+++.++|+||+++++.+.. ....
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~ 92 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATG---QEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV-GDEL 92 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCC---cEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEE
Confidence 3468889999999999999999875544 67999988754333 34678899999999999999999998644 5678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++|+||+++++|.+++.. ..+++.++..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 93 ~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EEeecccCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999999875 34789999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--CCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--RLNQPV 457 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--~~~~~~ 457 (499)
+....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...++.+......... ....+.
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06654 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNPE 240 (296)
T ss_pred hhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCHHHhHHHHhcCCCCCCCCcc
Confidence 86543221 1223467889999999999989999999999999999999 889998766544332222211 122344
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+..+.+++.+||..+|++||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 67788999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=320.12 Aligned_cols=252 Identities=20% Similarity=0.358 Sum_probs=203.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIED---- 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~---- 295 (499)
..+|++.+.||+|+||.||+|...+.+ +.+|+|.+..... ....+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~---~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTG---QLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCC---cEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 345666799999999999999986554 7899999865432 235678899999998 799999999987643
Q ss_pred -CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 296 -HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEc
Confidence 235789999999999999998632 2468999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
|||+++...... .......|+..|+|||++. +..++.++|||||||++|||++ |+.||...++......+..
T Consensus 154 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~-g~~p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 154 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRALFLIPR 230 (272)
T ss_pred cCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh-CCCCccccCHHHHHHHHhc
Confidence 999998653221 1223456788999999986 3468899999999999999999 7888876655444433332
Q ss_pred C-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 G-YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 ~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .+...+..+++++.+++.+||..+|.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 2 222233467889999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=322.13 Aligned_cols=243 Identities=18% Similarity=0.218 Sum_probs=194.5
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
||+|+||.||++.....+ +.+|+|.+..... ......+..|++++++++||||+++++++ +.+...++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-~~~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTG---KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-ESKTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEccCC---cEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-ecCCeEEEEEecCC
Confidence 689999999999986654 7899999864321 12234456799999999999999999874 55667899999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+|+|..++.... ...+++..+..++.|++.||+|||+.+|+||||||+||++++++.++|+|||++.......
T Consensus 77 g~~L~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~- 149 (277)
T cd05607 77 GGDLKYHIYNVG------ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK- 149 (277)
T ss_pred CCCHHHHHHhcc------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-
Confidence 999999986522 2358899999999999999999999999999999999999999999999999987654322
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCcHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEMAASLQDGYRLNQPVNCPDEL 463 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~ 463 (499)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .++................++++
T Consensus 150 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd05607 150 --TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEES 226 (277)
T ss_pred --eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCcchhhHHHHHHHhhccccccccccCCHHH
Confidence 1123467889999999999999999999999999999999 8899875432 22222222221112223578999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 464 FSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 464 ~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++.+||+.||++||++.|+++
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchh
Confidence 99999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=314.56 Aligned_cols=250 Identities=19% Similarity=0.308 Sum_probs=211.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||++....++ +.+++|.+... .+......+.+|+.+++.++|+||+++++.. ......++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQ---KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-LEDKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCC---cEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-ecCCEEEE
Confidence 4788899999999999999876544 78999998643 2344567899999999999999999999974 45667799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CcEEEccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-LRIQITDNALAR 380 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~-~~~kl~DfGla~ 380 (499)
|+||+++++|.+++.... ...+++..+..++.|++.||+|||+++++|+||||+||+++++ +.+||+|||+++
T Consensus 77 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRC------NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred EEecCCCCCHHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 999999999999998632 2358999999999999999999999999999999999999855 568999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
...... ......++..|+|||.+.+..++.++||||||+++|||++ ++.||...+.......+........+..++
T Consensus 151 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd08220 151 ILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS-LKRAFEAANLPALVLKIMSGTFAPISDRYS 226 (256)
T ss_pred ecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh-CCCCcccCchHHHHHHHHhcCCCCCCCCcC
Confidence 664322 1223457788999999999889999999999999999999 788998877766666665555555666789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.++.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 227 PDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=320.78 Aligned_cols=248 Identities=20% Similarity=0.337 Sum_probs=204.6
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
|++.+.||+|+||.||+|.....+ ..+++|.+... .....+.+.+|+.+++.++|+||+++++++.. ....++|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~---~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETG---VLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCC---eEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEE
Confidence 456688999999999999976544 67888888654 34456788999999999999999999998654 56679999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++++|..++.... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++...
T Consensus 82 e~~~~~~l~~~~~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 82 EFCAGGAVDAVMLELE-------RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred EecCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 9999999999887521 358999999999999999999999999999999999999999999999999987653
Q ss_pred CCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--CCCCC
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--RLNQP 456 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--~~~~~ 456 (499)
... .......++..|+|||++. +..++.++|||||||++|||++ |++||...+..+....+.... ....+
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd06643 155 RTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEPPTLAQP 231 (282)
T ss_pred ccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc-CCCCccccCHHHHHHHHhhcCCCCCCCc
Confidence 221 1223456788999999984 4557889999999999999999 889998877666554444332 22345
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..++.++.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 567899999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=320.57 Aligned_cols=252 Identities=20% Similarity=0.341 Sum_probs=201.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|+...++ +.+|+|++..... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~---~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTG---ELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCC---eEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEE
Confidence 456888899999999999999976554 6899999865422 234567899999999999999999998644 56679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++++|.++++.. ..+++.++..++.|++.||.|||+.+|+||||||+||++++++.+||+|||+++
T Consensus 83 iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVT--------GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred EEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999999752 358899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCC---
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD-GYRL--- 453 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~-~~~~--- 453 (499)
....... ......++..|+|||.+. ...++.++|||||||++|||++ |+.||...++.+....+.. ....
T Consensus 155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06646 155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRALFLMSKSNFQPPKL 231 (267)
T ss_pred eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh-CCCCccccchhhhheeeecCCCCCCCC
Confidence 6532211 122345778899999984 4557899999999999999999 7788765554432222211 1111
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
.....++.++.+++.+||+.+|++||+++++++.|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11234678999999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=324.43 Aligned_cols=248 Identities=17% Similarity=0.259 Sum_probs=203.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++.+.||+|+||.||++....++ ..+++|.+...........+.+|++++.+++||||+++++++. .++..++|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv 77 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSG---LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-SDGEISIC 77 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCC---eEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCEEEEE
Confidence 5788899999999999999876554 6788898876545555667889999999999999999999864 46678999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+||+++++|.++++.. ..+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++.
T Consensus 78 ~ey~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 149 (308)
T cd06615 78 MEHMDGGSLDQVLKKA--------GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149 (308)
T ss_pred eeccCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccc
Confidence 9999999999999862 358899999999999999999997 5899999999999999999999999999875
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc------------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD------------ 449 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~------------ 449 (499)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+.......+..
T Consensus 150 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 150 LIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI-GRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHh-CCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 5322 1234567889999999988889999999999999999999 8888865544333222211
Q ss_pred ------------------------CCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 ------------------------GYRLNQPV-NCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 ------------------------~~~~~~~~-~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
...+..|. .++.++.+++.+||+.+|++|||+.||++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111 356789999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=330.59 Aligned_cols=239 Identities=17% Similarity=0.271 Sum_probs=195.7
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|+...++ +.+|+|++.... .....+.+.+|+.++.++ +|+||++++++ +......++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-~~~~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKND---QIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC-FQTTSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEE-EEeCCEEEEEEe
Confidence 46899999999999987655 789999997542 233456688999998887 69999999997 455667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~~~~~~L~~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 77 YVNGGDLMFHMQRQ--------RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred CCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 99999999998752 3589999999999999999999999999999999999999999999999999975332
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC------CHHH-HHHHHHcCCCCCCCC
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI------DPFE-MAASLQDGYRLNQPV 457 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~------~~~~-~~~~i~~~~~~~~~~ 457 (499)
... ......||..|+|||++.+..++.++|||||||++|||++ |+.||... +..+ ....+.. .....|.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~p~ 224 (327)
T cd05617 149 PGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDIITDNPDMNTEDYLFQVILE-KPIRIPR 224 (327)
T ss_pred CCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHh-CCCCCCccCCCcccccHHHHHHHHHh-CCCCCCC
Confidence 211 1234568999999999999999999999999999999999 88898532 1222 2223322 2444666
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~ 482 (499)
..+.++.+++.+||+.||++||++.
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 7889999999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=321.73 Aligned_cols=257 Identities=19% Similarity=0.310 Sum_probs=209.7
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
+..-.+...|++++.||+|+||.||+|+....+ +.+++|.+... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~---~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETG---ALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred hcccCcchhhhhhheecCCCCeEEEEEEECCCC---ceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 334455677889999999999999999886544 67999998754 34456778999999999999999999998644
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
+...++||||+++++|..++.... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+
T Consensus 81 -~~~~~lv~e~~~~~~l~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 152 (292)
T cd06644 81 -DGKLWIMIEFCPGGAVDAIMLELD-------RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLA 152 (292)
T ss_pred -CCeEEEEEecCCCCcHHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEc
Confidence 556799999999999999886522 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
|||++........ ......++..|+|||++. ...++.++|||||||++|||++ |++||...++.+....+..
T Consensus 153 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~ 229 (292)
T cd06644 153 DFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAK 229 (292)
T ss_pred cCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc-CCCCCccccHHHHHHHHhc
Confidence 9999875432211 122345677899999985 3457889999999999999999 8889887776655555544
Q ss_pred CCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 GYRL--NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 ~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+ ..+..++.++.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 230 SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 3222 234567789999999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=335.05 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=199.6
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----Cc
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH----TS 298 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~~ 298 (499)
|++++.||+|+||.||++....++ +.||+|++... ......+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDG---KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCC---CEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 566799999999999999875444 68999998643 23334567889999999999999999999864433 25
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+
T Consensus 79 ~~lv~e~~~-~~l~~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVS--------PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEEEeeccc-cCHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccc
Confidence 799999998 688888764 24689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--------
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD-------- 449 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~-------- 449 (499)
++........ ......++..|+|||++.+. .++.++|||||||++|||++ |++||...++.+....+..
T Consensus 150 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 150 ARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG-RRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred eeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 9865433221 22344578889999999874 47999999999999999999 8999987765543332211
Q ss_pred ----------------CCCC-------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 ----------------GYRL-------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 ----------------~~~~-------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
...+ ......++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0111 1122457889999999999999999999999763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=332.20 Aligned_cols=249 Identities=18% Similarity=0.240 Sum_probs=197.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++.+.||+|+||.||++.....+ +.+|+|++... ........+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCC---ceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 357889999999999999999875444 78999998653 23344567889999999999999999999854322
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++||||++ ++|.+++.. .+++..+..++.|++.||.|||+++|+||||||+|||+++++.+||+
T Consensus 93 ~~~~~~lv~e~~~-~~l~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 93 EFQDVYLVMELMD-ANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred ccceeEEEhhhhc-ccHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEe
Confidence 34689999998 567777653 47889999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD----- 449 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~----- 449 (499)
|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+..
T Consensus 162 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 162 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred eCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998653221 2234567889999999999999999999999999999999 8899987654332211110
Q ss_pred ------------------CCC------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 ------------------GYR------------------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 ------------------~~~------------------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
... ...+...+.++.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 00011234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=335.10 Aligned_cols=247 Identities=18% Similarity=0.270 Sum_probs=193.4
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
.+...+|++++.||+|+||.||++....++ +.||+|.... ..+.+|+.++++++||||+++++++ ....
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~---~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~-~~~~ 156 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTC---EHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTF-TYNK 156 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCC---CEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEE-EECC
Confidence 355678999999999999999999976654 6899996432 3467899999999999999999985 4456
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++|+|++. ++|..++... ..+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 157 ~~~lv~e~~~-~~L~~~l~~~--------~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG 227 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLAAK--------RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG 227 (391)
T ss_pred eeEEEEecCC-CCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCC
Confidence 6799999986 7899888752 358899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-------HHHHHHHH---
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-------PFEMAASL--- 447 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-------~~~~~~~i--- 447 (499)
+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.|+...+ .......+
T Consensus 228 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 228 AACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT-CHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred ccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHH-CCCCcCCcccccccCchhHHHHHHHHH
Confidence 99754322111 1224568999999999999999999999999999999999 554443211 00000000
Q ss_pred -----------------------HcC-CC-C-CCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 -----------------------QDG-YR-L-NQP-----VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 -----------------------~~~-~~-~-~~~-----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... .. + ..+ ...+.++.+++.+||+.||++|||+.|+++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00 0 000 134568999999999999999999999985
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=338.45 Aligned_cols=248 Identities=17% Similarity=0.225 Sum_probs=195.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
...|.+.+.||+|+||.||+|.....+ +.||||.... ..+.+|++++++++|+||+++++++.. ....+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~---~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYP---QRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVV-GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCC---CEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEE
Confidence 457999999999999999999986654 6899996432 235689999999999999999998654 45669
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+|++. ++|..++.... ..+++.+++.|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 237 lv~e~~~-~~L~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARL-------RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEccC-CCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 9999996 79999887521 368999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHHcCC--
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI-------DPFEMAASLQDGY-- 451 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-------~~~~~~~~i~~~~-- 451 (499)
...............||..|+|||++.+..++.++|||||||++|||++++.+.|... ...++...+....
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 6643322222234568999999999999999999999999999999998554444322 1122222222110
Q ss_pred ------------------------CCCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 ------------------------RLNQP-------VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 ------------------------~~~~~-------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+.... .....++.+|+.+||+.||.+|||+.|+++.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0234578999999999999999999999864
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=333.05 Aligned_cols=249 Identities=17% Similarity=0.223 Sum_probs=199.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---- 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---- 295 (499)
..+|++.+.||+|+||.||++.....+ +.+|||++... ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCC---cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 357889999999999999999876544 67999998653 2334456788999999999999999999975332
Q ss_pred -CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 296 -HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++||||++ ++|.+++.. .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 100 EFQDVYIVMELMD-ANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred ccCeEEEEEeCCC-CCHHHHHHh----------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEE
Confidence 234699999998 577777753 47889999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-- 452 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-- 452 (499)
|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+.....
T Consensus 169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 244 (364)
T cd07875 169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVIEQLGTP 244 (364)
T ss_pred eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999998653221 2234567889999999999999999999999999999999 8899987765544333221100
Q ss_pred -------------------CC--------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 453 -------------------LN--------------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 453 -------------------~~--------------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+. ......+++.+++.+|++.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 001124578999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.46 Aligned_cols=249 Identities=17% Similarity=0.242 Sum_probs=202.0
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
|+..+.||+|+||+||+|....++ +.+|+|.+.... .......+.+|++++++++|+||+.+.+++ ..++..++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATG---KMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-ETKDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCC---cEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-ecCCEEEE
Confidence 566789999999999999986554 789999986542 122234578899999999999999998875 44567799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
++||+++++|..++.... ...+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||+|||+++.
T Consensus 78 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMG------NPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred EEEeccCccHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 999999999999987522 23589999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---CCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD---GYRLNQPVN 458 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~ 458 (499)
...... .....|+..|+|||++.+..++.++|+|||||++|||++ |..||...........+.. ......+..
T Consensus 152 ~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 152 IPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227 (285)
T ss_pred cCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhhccccccCcc
Confidence 532211 124468899999999999999999999999999999999 8999987655433222221 112334556
Q ss_pred CcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
.+.++.+++..||+.||++||+ +.++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 7889999999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=319.19 Aligned_cols=244 Identities=17% Similarity=0.297 Sum_probs=200.1
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|+++++||+|+||.||+|....++ +.+|+|.+...........+.+|+.++++++||||+++++++.. ....++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTR---RILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCC---cEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEE
Confidence 5677899999999999999876554 67999998765455556789999999999999999999998654 5567999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+++++|..+. .+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++...
T Consensus 78 ~e~~~~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 78 TEFMDGGSLDVYR------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred EecCCCCChHHhh------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 9999999997652 3678889999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCCCCC
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-------FEMAASLQDGYRLNQ 455 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-------~~~~~~i~~~~~~~~ 455 (499)
.... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+....+........
T Consensus 146 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (279)
T cd06619 146 VNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL-GRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220 (279)
T ss_pred cccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHh-CCCCchhhcccccccchHHHHHHHhccCCCCC
Confidence 3321 234568889999999999999999999999999999999 8888865321 122222222222222
Q ss_pred -CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 456 -PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 456 -~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
....+.++.+++.+||+.+|++||+++|+++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 23467889999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=320.44 Aligned_cols=249 Identities=18% Similarity=0.248 Sum_probs=202.6
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
|+..+.||+|+||.||++....++ +.+|+|.+.... .......+.+|+.++++++|+||+.+++.+. .....++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~l 77 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-TKDALCL 77 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCC---ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-cCCEEEE
Confidence 566799999999999999987654 789999886432 2223356778999999999999999999854 4567899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++|+|.+++.... ...+++.++..++.|++.||.|||+.+|+||||||+||++++++.++|+|||++..
T Consensus 78 v~e~~~g~~L~~~l~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMG------EAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred EEEecCCCcHHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 999999999999986532 23589999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF---EMAASLQDGYRLNQPVN 458 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~---~~~~~i~~~~~~~~~~~ 458 (499)
...... .....|+..|+|||++.+..++.++|||||||++|||++ |+.||...... +....+........+..
T Consensus 152 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05630 152 VPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227 (285)
T ss_pred cCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCCccchHHHHHhhhhhhhhhcCcc
Confidence 532221 123468899999999999999999999999999999999 89999864321 22222222223344567
Q ss_pred CcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
+++++.+++..||+.||++||| +.|+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 8889999999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.52 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=217.5
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeE-E
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGV-S 292 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~-~ 292 (499)
..+++.+.++++.++|.+|||+.||.|.....+ ..+|+|++... .+...+...+|+.+|+.|+ |+|||.+++. .
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~---~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGG---KKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCC---ceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 456788889999999999999999999987664 68999998766 6777889999999999997 9999999993 2
Q ss_pred EcC-----CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCceEE
Q psy1789 293 IED-----HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK--KLLHKDLATRNCVV 365 (499)
Q Consensus 293 ~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~--~iiHrDlk~~NIll 365 (499)
... ..+.+|.||||.+|+|-+++.... ...|++.++++|+.|+++|+++||.. +|||||||-+||||
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl------q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl 179 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL------QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL 179 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHH------hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE
Confidence 221 245689999999999999998643 24599999999999999999999987 49999999999999
Q ss_pred cCCCcEEEcccccccccCCCCccc-------cCCCCCCcccccccccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy1789 366 DDKLRIQITDNALARDLFPSDYHC-------LGDNENRPVKWLAIESL---VHKTFSTASDVWAFGVLLWELTTLAQQPY 435 (499)
Q Consensus 366 d~~~~~kl~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwS~Gvvl~el~t~g~~p~ 435 (499)
+.+++.||||||-|......-... ..-....|+.|+|||++ .+...++|+|||||||+||-|+. ...||
T Consensus 180 s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy-~t~PF 258 (738)
T KOG1989|consen 180 SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY-FTTPF 258 (738)
T ss_pred cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH-hCCCc
Confidence 999999999999987554322110 01134568899999998 46789999999999999999998 88999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 436 AEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 436 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
.+..... .+...+........++.+.+||..||+.||++||++-||+..+.++..
T Consensus 259 e~sg~la---Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 259 EESGKLA---ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred CcCccee---EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 8753332 222223333334789999999999999999999999999999888754
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=306.23 Aligned_cols=247 Identities=19% Similarity=0.250 Sum_probs=207.6
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.|++.+.||+|.|+.||++....++ +.+|+|++.-. -+....+++.+|+.+-+.|+|||||+|... +......+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg---~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-i~~~~~~yl 87 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYL 87 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccch---HHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-hcccceeEE
Confidence 4566689999999999999865554 66777776422 233356788899999999999999999997 566777799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEEEccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQITDNAL 378 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~kl~DfGl 378 (499)
|+|+|.+|+|..-+-.. -.+++...-..++||+++|.|+|.++|||||+||+|+||.+ ..-+||+|||+
T Consensus 88 vFe~m~G~dl~~eIV~R--------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGv 159 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAR--------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGL 159 (355)
T ss_pred EEecccchHHHHHHHHH--------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccce
Confidence 99999999998766542 25788889999999999999999999999999999999963 34689999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---CCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR---LNQ 455 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~ 455 (499)
|..+.... ......||++|||||++...+|+..+|||+.||+||-|+. |.+||-+.+...+.+.+..+.- ...
T Consensus 160 Ai~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~-G~~PF~~~~~~rlye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 160 AIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYEQIKAGAYDYPSPE 235 (355)
T ss_pred EEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhccccCCCCcc
Confidence 99886222 3446789999999999999999999999999999999999 9999999888888888876632 223
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
...++++.++++++++..||++|.|+.|.+
T Consensus 236 w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 236 WDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 347899999999999999999999999876
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=315.04 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=202.4
Q ss_pred EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcCCCCc-ceeEEeEEEcCCC-----
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGLSHKN-ILTVLGVSIEDHT----- 297 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~----- 297 (499)
..++.||+|+||+||+|+...++ +.||+|++..+.. +..-....+|+.++++++|+| |++|++++...+.
T Consensus 14 ~~~eklGeGtyg~Vykar~~~~g---~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 14 EKVEKLGEGTYGVVYKARSKRTG---KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHhCCCCceEEEEEEEecCC---CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 33477999999999999987665 7899999975533 222344579999999999999 9999999766553
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++|+||++ -+|..++....... ..++...+..++.|++.||+|||+++|+||||||.||||+++|.+||+|||
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~----~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKP----QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccc
Confidence 7789999999 89999998744211 357778999999999999999999999999999999999999999999999
Q ss_pred cccccC-CCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----
Q psy1789 378 LARDLF-PSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---- 451 (499)
Q Consensus 378 la~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---- 451 (499)
+|+... +.. ..+...+|.-|.|||++.+. .|++..||||+||++.||++ +++.|.+....+....+-.-.
T Consensus 166 lAra~~ip~~---~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMR---TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred hHHHhcCCcc---cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 999664 222 23467788899999999986 79999999999999999999 888898877655444332210
Q ss_pred -------------CCCCC-----C-------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 -------------RLNQP-----V-------NCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 -------------~~~~~-----~-------~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
...++ . ....+..+++.+|++.+|.+|.|++..+.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00111 0 112378999999999999999999998875
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=322.62 Aligned_cols=252 Identities=19% Similarity=0.306 Sum_probs=206.5
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|++.+.||+|+||+||++....++ +.+|+|++.........+.+.+|+++++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 78 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTG---TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNI 78 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCC---cEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEE
Confidence 3456778899999999999999986544 67899988765555556789999999999999999999999654 5677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
++|+||+++++|.+++... ..+++.....++.+++.||.|||+ .+++||||||+||++++++.++|+|||+
T Consensus 79 ~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKG--------GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred EEEEecCCCCCHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCc
Confidence 9999999999999998762 358999999999999999999997 5899999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH-----------HHHHHH
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF-----------EMAASL 447 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~-----------~~~~~i 447 (499)
+...... ......++..|+|||++.+..++.++|||||||++||++| |+.||...... +....+
T Consensus 151 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 151 SGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred ccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh-CCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 8754221 1224568889999999998899999999999999999999 88898764431 122222
Q ss_pred HcCCCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 448 QDGYRLNQPV-NCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 448 ~~~~~~~~~~-~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
.....+..+. .++.++.+++.+||+.||++|||+.|+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 2222222222 3778999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.16 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=204.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-----cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-----SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
+|++.+.||+|+||.||+|...++ ..+|+|.+.... .......+.+|+.++++++|+||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~----~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQG----QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DN 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCC----CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CC
Confidence 356779999999999999986432 678999876331 23344678899999999999999999999654 56
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+++++|.+++... ..+++..+..++.|++.||+|||+.+|+|+||||+||++++++.++|+|||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 147 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRF--------GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFG 147 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccch
Confidence 779999999999999999752 357899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc----cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--CC
Q psy1789 378 LARDLFPSDY----HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD--GY 451 (499)
Q Consensus 378 la~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~--~~ 451 (499)
+++....... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...+.......+.. ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAAMFYIGAHRGL 226 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh-CCCccccCChHHHHHHhhhccCC
Confidence 9876532111 111224457889999999999999999999999999999999 8899987665543333322 23
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+..+++++.+++.+||+.+|++||++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 34456678899999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=317.78 Aligned_cols=248 Identities=20% Similarity=0.257 Sum_probs=196.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC----c
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT----S 298 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----~ 298 (499)
.|+-.+++|.|+||.||+|+...+. ..||||+...+..-. .+|+.+|++++|||||+|.-+.....+ .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~---~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETE---EEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCC---ceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 4556699999999999999997764 789999997553322 379999999999999999877544322 3
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CcEEEcccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-LRIQITDNA 377 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~-~~~kl~DfG 377 (499)
..||+|||| .+|.++++... ...+.++...+.-+..|+.+||.|||+.+|+||||||.|+|+|.+ |.+||+|||
T Consensus 97 lnlVleymP-~tL~~~~r~~~----~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYT----RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHh----hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 468999999 78999988421 113467788888999999999999999999999999999999966 999999999
Q ss_pred cccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC----
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR---- 452 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~---- 452 (499)
.|+.+.+.... ..-..|..|.|||.+.+ ..|+.+.||||.||++.||+- |++-|.+.+..+....+.+...
T Consensus 172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~-g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK-GQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc-CCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 99988655422 12223456999999987 569999999999999999998 8999998776554333322100
Q ss_pred -------C-----C------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 453 -------L-----N------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 453 -------~-----~------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+ . .....+++..+++.++++.+|.+|.++.|+++.
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0 0 122567899999999999999999999998753
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.94 Aligned_cols=249 Identities=16% Similarity=0.251 Sum_probs=203.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.|++++.||+|+||.||++.....+ +.+|+|++.... .......+.+|+.++..++|+||+++++++ .+....+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-~~~~~~~ 77 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTG---HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-QDKRNLY 77 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-EcCCEEE
Confidence 5778899999999999999986654 689999986431 233456788899999999999999999984 5567789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~E~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKK--------DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EEEeCCCCccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 999999999999999762 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcc---------------------------------ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHH
Q psy1789 381 DLFPSDYH---------------------------------CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWEL 427 (499)
Q Consensus 381 ~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el 427 (499)
........ .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel 229 (360)
T cd05627 150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeec
Confidence 54321100 001134689999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCHHHHHHHHHcCC-CCCCCC--CCcHHHHHHHHHhhhcCCCCCCC---HHHHH
Q psy1789 428 TTLAQQPYAEIDPFEMAASLQDGY-RLNQPV--NCPDELFSVMAYCWAMNPEGRPT---FPQLH 485 (499)
Q Consensus 428 ~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~--~~~~~~~~l~~~C~~~~P~~RPt---~~~v~ 485 (499)
+| |++||...++.+....+.... ....|. ..++++.+++.+++. ||.+|++ +.+++
T Consensus 230 ~t-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 230 LI-GYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred cc-CCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 99 899999888877766665421 222232 467899999988764 9999986 45554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.66 Aligned_cols=259 Identities=18% Similarity=0.301 Sum_probs=205.7
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc-
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE- 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~- 294 (499)
......+|++.+.||+|+||.||++.....+ +.+++|.+..... ....+.+|+.+++++ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNG---SKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCC---ceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 3345567888899999999999999986554 6799998764322 225677899999998 69999999998653
Q ss_pred ---CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 295 ---DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 295 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
.+...++||||+++++|.++++... .....+++..+..++.|++.||.|||+.+++||||||+||++++++.+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFL----KRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhh----ccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 3456799999999999999987421 112468899999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-----KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++ |+.||...+..+....
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~-g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD-GDPPLADLHPMRALFK 240 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc-CCCCCCCCchhHHHhh
Confidence 9999999986643222 1224468889999999853 457899999999999999999 8888887665444333
Q ss_pred HHcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 447 LQDGYR--LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 447 i~~~~~--~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+..... ...+..++.++.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 332221 22334567889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=319.41 Aligned_cols=252 Identities=19% Similarity=0.329 Sum_probs=209.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|....++ ..+++|.+... .....+.|.+|+.++++++|+||+++++++. .....+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETG---LFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYF-YENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCC---cEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-cCCeEE
Confidence 346778899999999999999986543 67999998654 3445578999999999999999999999865 456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++++|.+++...+ ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-------RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccch
Confidence 9999999999999997632 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-- 453 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-- 453 (499)
....... ......++..|+|||.+. ...++.++||||||+++|||++ |++||...+..+....+..+..+
T Consensus 152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (280)
T cd06611 152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ-MEPPHHELNPMRVLLKILKSEPPTL 228 (280)
T ss_pred hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh-CCCCcccCCHHHHHHHHhcCCCCCc
Confidence 5532211 122345788899999985 3457889999999999999999 89999888776666566554332
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..+..++.++.+++..||+.+|++||++.++++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 3345678899999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=313.26 Aligned_cols=255 Identities=20% Similarity=0.361 Sum_probs=216.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-CCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-DHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~~ 300 (499)
+|++.+.||.|+||.||++....++ +.+++|.+... ......+.+.+|+.++++++|+||+++++++.. .+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDG---KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCC---CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 4678899999999999999876554 67899988643 345556778999999999999999999997554 345578
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH-----KKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH-----~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
+++||+++++|.+++.... .....+++..++.++.|++.||.||| +.+++|+||||+||++++++.+||+|
T Consensus 78 ~~~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d 153 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCK----KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGD 153 (265)
T ss_pred EEehhccCCCHHHHHHHHh----hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEec
Confidence 9999999999999997632 11246899999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||++......... .....++..|+|||++.+..++.++||||||+++|+|++ |+.||...+..++...+..+.....
T Consensus 154 ~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd08217 154 FGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA-LSPPFTARNQLQLASKIKEGKFRRI 230 (265)
T ss_pred ccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHH-CCCcccCcCHHHHHHHHhcCCCCCC
Confidence 9999876443221 223457888999999999999999999999999999999 8999998887777777777766666
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+...+.++.+++.+||+.+|++||++.+|++.
T Consensus 231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 77888999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.39 Aligned_cols=255 Identities=16% Similarity=0.234 Sum_probs=207.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.|++.+.||+|+||.||++...... +.|++|.+.... .....+.+.+|+.+++.++|+||+++++.+ ..+...+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~ 77 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-ETKRHLC 77 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCC---cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-ecCCEEE
Confidence 5778899999999999999976554 689999886543 233456788999999999999999999985 4566779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||++++++.+||+|||+++
T Consensus 78 lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~ 149 (305)
T cd05609 78 MVMEYVEGGDCATLLKNI--------GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSK 149 (305)
T ss_pred EEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCcc
Confidence 999999999999999762 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCc-------------cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy1789 381 DLFPSDY-------------HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447 (499)
Q Consensus 381 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i 447 (499)
....... ........++..|+|||++.+..++.++|+|||||++|||++ |..||.+....++....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~-g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELFGQV 228 (305)
T ss_pred ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 4211100 001112356788999999999999999999999999999999 88899887777766655
Q ss_pred HcCC--CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 448 QDGY--RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 448 ~~~~--~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
..+. .+..+..+++++.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 4432 122223578999999999999999999997666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=313.03 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=203.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc----CCC
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE----DHT 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----~~~ 297 (499)
+|..++.||+|+||.|..+....++ +.||||++.+. ......++..+|+.+|+.++|+||+.++..... ...
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~---~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTG---EKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCC---CEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4444699999999999999987665 78999999743 455567888999999999999999999997432 234
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..|+|+|+|+ .+|.+.++. .+.|+......++.|+++||.|+|+.+|+||||||+|+|++.+...||+|||
T Consensus 100 DvYiV~elMe-tDL~~iik~--------~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKS--------QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred eeEEehhHHh-hHHHHHHHc--------CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccc
Confidence 5799999996 899999987 2359999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---------
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL--------- 447 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i--------- 447 (499)
+||..........-+....|.-|.|||.+.. ..||...||||.||++.||++ |++.|.+.+..+....+
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT-GKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc-CCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9998764311112234556778999998864 679999999999999999999 89988886543222111
Q ss_pred ---------------Hc-CCCCCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 ---------------QD-GYRLNQP-----VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ---------------~~-~~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. ...+..| .+..+.+.+++.+++..||.+|+|++|.++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11 1112222 267788999999999999999999999875
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=327.89 Aligned_cols=252 Identities=14% Similarity=0.224 Sum_probs=204.6
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||+|+||.||+++....+ +.+|+|++... ........+.+|+.++..++|+||+++++++ ......+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~ 77 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-QDENNLY 77 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCC---CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-ecCCEEE
Confidence 5788899999999999999987654 68999998642 1233345688899999999999999999975 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~ey~~~g~L~~~l~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~ 150 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFE-------DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL 150 (332)
T ss_pred EEEeccCCCcHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhe
Confidence 9999999999999998632 358899999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLN 454 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~ 454 (499)
........ ......||+.|+|||++. ...++.++|||||||++|||++ |+.||...+..+....+.... +..
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (332)
T cd05623 151 KLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHKERFQ 228 (332)
T ss_pred ecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc-CCCCCCCCCHHHHHHHHhCCCcccc
Confidence 65432221 223456899999999986 3568999999999999999999 899999888777766665432 222
Q ss_pred C---CCCCcHHHHHHHHHhhhcCCC--CCCCHHHHHHH
Q psy1789 455 Q---PVNCPDELFSVMAYCWAMNPE--GRPTFPQLHSC 487 (499)
Q Consensus 455 ~---~~~~~~~~~~l~~~C~~~~P~--~RPt~~~v~~~ 487 (499)
. ...+++++.+++.+|+..+++ .|+++.|+++.
T Consensus 229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 2 236789999999998865444 36888888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=313.62 Aligned_cols=251 Identities=19% Similarity=0.345 Sum_probs=206.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|....++ +.+++|.+...... ..+.+.+|+.++++++||||++++++. ......+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATG---ELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSY-LRRDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCC---CEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEE-EeCCEEE
Confidence 467889999999999999999986544 67999998755332 457889999999999999999999985 4466789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
++|||+++++|.+++.... ..+++.++..++.|++.||.|||+.+++|+||||+||++++++.+||+|||++.
T Consensus 77 l~~e~~~~~~l~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-------GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccch
Confidence 9999999999999987631 358899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCccccccccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CC---C
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHK---TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YR---L 453 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-~~---~ 453 (499)
....... ......++..|+|||.+.+. .++.++||||||+++|||+| |++||...++.+....+... .. .
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd06613 150 QLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE-LQPPMFDLHPMRALFLISKSNFPPPKL 226 (262)
T ss_pred hhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCccc
Confidence 6543211 12234577789999999877 89999999999999999999 88999877665544433322 11 1
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+...+.++.+++.+||..+|.+|||+.+|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=314.19 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=202.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc----ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CC
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN----ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HT 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~ 297 (499)
.|+..+.||+|+||.||+|.....+ ..+++|.+... ........+.+|+.++++++||||+++++++... ..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTG---RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCC---cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCC
Confidence 4666799999999999999876544 67899987532 2334556789999999999999999999986543 35
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+++++|.+++... ..+++.....++.|++.||+|||+.+|+||||||+||++++++.+||+|||
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAY--------GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence 578999999999999999762 358899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCCCCC
Q psy1789 378 LARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QDGYRLNQ 455 (499)
Q Consensus 378 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~ 455 (499)
+++........ .......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+..... .....+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd06651 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEAMAAIFKIATQPTNPQL 230 (266)
T ss_pred CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHH-CCCCccccchHHHHHHHhcCCCCCCC
Confidence 99865322111 11123457889999999999999999999999999999999 88999876654433333 22334445
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+...++.+.+++ .||..+|++||+++||++
T Consensus 231 ~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 556777888887 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=313.39 Aligned_cols=254 Identities=19% Similarity=0.313 Sum_probs=209.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++.+.||+|+||.||+|....++ ..+++|++.........+.+.+|+.+++.++|+||+++++.+ ......+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~iv 77 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNN---EKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-VVGDELWLV 77 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCC---cEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-eeCCEEEEE
Confidence 5788899999999999999976544 679999987554444667899999999999999999999985 446677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+++++|.++++.... ...+++.....++.|++.||+|||+.+++||||||+||++++++.++|+|||++...
T Consensus 78 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~ 152 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYP-----RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152 (267)
T ss_pred EeccCCCcHHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence 999999999999986321 135899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccc--cCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC---
Q psy1789 383 FPSDYHC--LGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP--- 456 (499)
Q Consensus 383 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~--- 456 (499)
....... ......++..|+|||++... .++.++|||||||++|||++ |+.||...+..+.............+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (267)
T cd06610 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT-GAAPYSKYPPMKVLMLTLQNDPPSLETGA 231 (267)
T ss_pred ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh-CCCCccccChhhhHHHHhcCCCCCcCCcc
Confidence 5433221 22344578899999999877 78999999999999999999 89999877665544444333221111
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 --VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 --~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+.++.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 256788999999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=312.71 Aligned_cols=249 Identities=20% Similarity=0.385 Sum_probs=207.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.++|++.+.||+|+||.||+|....++ +.+++|.+..... .+.+.+|+.++++++|+||+++++++.. ....+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETG---QVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCC---cEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEE
Confidence 356778899999999999999987644 6799999865422 5789999999999999999999998644 56779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.+||+|||++.
T Consensus 75 l~~e~~~~~~L~~~l~~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITN-------KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred EEEecCCCCcHHHHHHhCc-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccch
Confidence 9999999999999997522 468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--LNQPVN 458 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~ 458 (499)
....... ......++..|+|||++.+..++.++|||||||++|||++ |+.||...++.+....+..... ...+..
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 148 QLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE-GKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224 (256)
T ss_pred hcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHh-CCCCCCCcchhhhhhhhccCCCCCCCchhh
Confidence 6643321 1223457788999999999999999999999999999999 8889987665544333322211 223345
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.++.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 6789999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=352.17 Aligned_cols=258 Identities=21% Similarity=0.349 Sum_probs=205.9
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
......+|++++.||+|+||.||+++....+ ..+|+|.+... ........|..|+.+++.++|||||++++++...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg---~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQ---EFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCC---eEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3445568999999999999999999986654 68899988643 3444567889999999999999999999985443
Q ss_pred -CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCceEEcC
Q psy1789 296 -HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-------KLLHKDLATRNCVVDD 367 (499)
Q Consensus 296 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-------~iiHrDlk~~NIlld~ 367 (499)
....+|||||+++|+|.++|..... ....+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~----~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s 160 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYK----MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence 4557899999999999999976321 123689999999999999999999984 5999999999999964
Q ss_pred -----------------CCcEEEcccccccccCCCCccccCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHH
Q psy1789 368 -----------------KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELT 428 (499)
Q Consensus 368 -----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~ 428 (499)
...+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 3358999999998653322 1234568999999999864 45899999999999999999
Q ss_pred cCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 429 TLAQQPYAEIDPF-EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 429 t~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
| |+.||...+.. ++...+...... .....+.++.+|+..||+.+|.+||++.|++.
T Consensus 238 T-Gk~PF~~~~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 238 S-GKTPFHKANNFSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred H-CCCCCCcCCcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9 88999765543 334444433221 12356889999999999999999999999984
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=335.55 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=207.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEe---cCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC-c
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTV---TDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT-S 298 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~---~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-~ 298 (499)
-.++..+||+|+|-+||||.+..++ ..||.-.+ ....+....++|..|+.+|+.|+|+||++++.+|.+... .
T Consensus 41 y~k~~evLGrGafKtVYka~De~~g---iEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 41 YLKFDEVLGRGAFKTVYKAFDEEEG---IEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred eeehhhhcccccceeeeeccccccc---hhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3455689999999999999975543 44554333 233466677899999999999999999999999766543 3
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCceEEcC-CCcEEEcc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK--KLLHKDLATRNCVVDD-KLRIQITD 375 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~--~iiHrDlk~~NIlld~-~~~~kl~D 375 (499)
.-+|+|.|..|+|+.|+.+. +.++.+....|++||++||.|||++ +|||||||.+||+|+. .|.|||+|
T Consensus 118 in~iTEL~TSGtLr~Y~kk~--------~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKH--------RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeeeeecccCCcHHHHHHHh--------ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 57899999999999999984 4678889999999999999999987 7999999999999985 58999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE-IDPFEMAASLQDGYRLN 454 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~ 454 (499)
.|||+....+. .....||+.|||||+.. ..|++.+||||||+.|+||+| +..||.+ .++.++.+++..|.++.
T Consensus 190 LGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT-~eYPYsEC~n~AQIYKKV~SGiKP~ 263 (632)
T KOG0584|consen 190 LGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT-SEYPYSECTNPAQIYKKVTSGIKPA 263 (632)
T ss_pred hhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh-ccCChhhhCCHHHHHHHHHcCCCHH
Confidence 99999774432 22478999999999887 889999999999999999999 8999987 47889999999987765
Q ss_pred CCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVN-CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~-~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.-.. -.++++++|.+|+.. .++|||+.|+++
T Consensus 264 sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 264 ALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 4433 256899999999999 999999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=320.74 Aligned_cols=249 Identities=17% Similarity=0.348 Sum_probs=206.1
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|.....+ +.+|+|.+...... ..+.+.+|+.+++.++|+||+++++++. .....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATG---QEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYL-VGDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCC---CEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEE
Confidence 467888999999999999999875544 67999998754332 3466889999999999999999999864 456779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++.
T Consensus 93 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred EeecccCCCCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccce
Confidence 99999999999999875 357899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--RLNQPVN 458 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~ 458 (499)
...+... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...++......+.... ....+..
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T cd06656 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPELQNPER 240 (297)
T ss_pred EccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcchheeeeccCCCCCCCCccc
Confidence 6543322 1223457788999999999999999999999999999999 889997765543322222211 2223456
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.++.+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 7888999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=310.31 Aligned_cols=259 Identities=17% Similarity=0.223 Sum_probs=215.4
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
...+.-..+++++.||.|.-|+||++.+.+.+ ...|+|++.+.. +.....+...|.++|+.++||.++.||+. +
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~---~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-f 146 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTN---CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-F 146 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCC---ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-e
Confidence 34555567888899999999999999998765 789999997653 34445677889999999999999999998 6
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
+.+...+|+||||+||+|...+++.. ...+++..+..++.+|+.||+|||-.|||+|||||+||||-++|++-|
T Consensus 147 et~~~~cl~meyCpGGdL~~LrqkQp------~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 147 ETDKYSCLVMEYCPGGDLHSLRQKQP------GKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred eccceeEEEEecCCCccHHHHHhhCC------CCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEe
Confidence 77888899999999999999998733 457999999999999999999999999999999999999999999999
Q ss_pred cccccccccCC------C-C-------------------------cc----------------------ccCCCCCCccc
Q psy1789 374 TDNALARDLFP------S-D-------------------------YH----------------------CLGDNENRPVK 399 (499)
Q Consensus 374 ~DfGla~~~~~------~-~-------------------------~~----------------------~~~~~~~gt~~ 399 (499)
+||-|+....- . + .. ......+||..
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99998854421 0 0 00 00123458889
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy1789 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRLNQPVNCPDELFSVMAYCWAMNPEGR 478 (499)
Q Consensus 400 y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~R 478 (499)
|+|||++.+..++.++|+|+|||++|||+. |..||.+.+..+....+... ........++..+++||++.|.+||.+|
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLy-G~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLY-GTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHh-CCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 999999999999999999999999999999 99999999888877766543 2322223667899999999999999999
Q ss_pred CC----HHHHH
Q psy1789 479 PT----FPQLH 485 (499)
Q Consensus 479 Pt----~~~v~ 485 (499)
.. +.||.
T Consensus 380 lg~~rGA~eIK 390 (459)
T KOG0610|consen 380 LGSKRGAAEIK 390 (459)
T ss_pred hccccchHHhh
Confidence 88 55554
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=310.42 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=206.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc----cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA----SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+|+..+.||+|+||.||+|....++ ..+++|.+.... .....+.+.+|+.+++.++|+||+++++++ .....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDG---DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-REEDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCC---cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-ecCCe
Confidence 3566699999999999999986443 679999875432 234557889999999999999999999986 44567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++++||+++++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||++++++.+||+|||+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY--------GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence 79999999999999999762 3588999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD-GYRLNQP 456 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~~ 456 (499)
+....... ......++..|+|||.+.... ++.++|+|||||++|||++ |+.||......+....+.. ......+
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 224 (258)
T cd06632 149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GKPPWSQLEGVAAVFKIGRSKELPPIP 224 (258)
T ss_pred ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcccCcHHHHHHHHHhcccCCCcC
Confidence 88654332 123455788899999998776 8999999999999999999 8899987665444433333 3344556
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+++.+||+.+|++||++.+++.
T Consensus 225 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 225 DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 678899999999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=336.71 Aligned_cols=249 Identities=18% Similarity=0.210 Sum_probs=193.3
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC------CCcceeEEeE
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS------HKNILTVLGV 291 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~g~ 291 (499)
.....+|++.+.||+|+||+||+|.....+ +.||||++.... .....+..|+.++..++ |.+++.++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~---~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRK---EYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCC---eEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 445678999999999999999999876554 789999986432 22234556666666554 4568899998
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCC-
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKL- 369 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~- 369 (499)
+.....+.++|+|++ +++|.+++.+. ..+++..+..|+.|++.||+|||+ .+||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH--------GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCc
Confidence 666566788999988 57899888762 358999999999999999999998 5999999999999998765
Q ss_pred ---------------cEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q psy1789 370 ---------------RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP 434 (499)
Q Consensus 370 ---------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p 434 (499)
.+||+|||++..... ......||..|+|||++.+..|+.++|||||||++|||+| |++|
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt-G~~p 344 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT-GKLL 344 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh-CCCC
Confidence 499999998864321 2235678999999999999999999999999999999999 8999
Q ss_pred CCCCCHHHHHHHHHcCCC--------------------------CCC---------------CCCCcHHHHHHHHHhhhc
Q psy1789 435 YAEIDPFEMAASLQDGYR--------------------------LNQ---------------PVNCPDELFSVMAYCWAM 473 (499)
Q Consensus 435 ~~~~~~~~~~~~i~~~~~--------------------------~~~---------------~~~~~~~~~~l~~~C~~~ 473 (499)
|...+..+....+..... +.. .....+.+.+|+.+||+.
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 987765543332211100 000 001134577999999999
Q ss_pred CCCCCCCHHHHHH
Q psy1789 474 NPEGRPTFPQLHS 486 (499)
Q Consensus 474 ~P~~RPt~~~v~~ 486 (499)
||++|||+.|+++
T Consensus 425 dP~~R~ta~e~L~ 437 (467)
T PTZ00284 425 DRQKRLNARQMTT 437 (467)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999986
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.16 Aligned_cols=250 Identities=19% Similarity=0.248 Sum_probs=195.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-HHHHHHHHHHHHHhcC---CCCcceeEEeEEEcC---
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-VQVSLLLQEGMAMYGL---SHKNILTVLGVSIED--- 295 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~--- 295 (499)
+|++.+.||+|+||.||+|....++ +.+|+|.+...... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSG---HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCC---cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 4778899999999999999987654 78999988643211 1122345666666554 799999999986432
Q ss_pred -CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 296 -HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++++||++ ++|..++.... ...+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||+
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~ 150 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVP------PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLA 150 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEC
Confidence 234689999998 58999987522 2358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-- 452 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-- 452 (499)
|||+++...... ......++..|+|||++.+..++.++|||||||++|||++ |++||......+....+.....
T Consensus 151 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~~f~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07863 151 DFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKIFDLIGLP 226 (288)
T ss_pred ccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHh-CCcCcCCCCHHHHHHHHHHHhCCC
Confidence 999998653221 1234567889999999999999999999999999999998 8899887665544333221100
Q ss_pred --C----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 --L----------------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 --~----------------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .....+++++.+++.+|++.||++|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 227 PEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 001245778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=319.77 Aligned_cols=250 Identities=20% Similarity=0.316 Sum_probs=200.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+|++.+.||+|+||.||+|+...++ ..||+|.+...........+.+|+.++++++|+||+++++++ ......++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-~~~~~~~l 81 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTD---NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-HTEKSLTL 81 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCC---cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-ecCCeEEE
Confidence 46888899999999999999876554 679999986543333345677899999999999999999985 45667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||+++.
T Consensus 82 v~e~~~-~~l~~~l~~~~-------~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCG-------NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred EEeccc-cCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 999998 69999987532 3578999999999999999999999999999999999999999999999999975
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--------- 451 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--------- 451 (499)
...... ......++..|+|||.+.+ ..++.++|||||||++|||+| |++||...+..+....+....
T Consensus 154 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 154 KSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST-GRPLFPGSTVEEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred cCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCChhhch
Confidence 432211 1223456788999999875 458899999999999999999 889998776544332221100
Q ss_pred ---------CCC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ---------RLN-----------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ---------~~~-----------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ....+++++.+++.+|++.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 11246778999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.81 Aligned_cols=250 Identities=18% Similarity=0.337 Sum_probs=206.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++++.||+|+||.||++.....+ +.+|+|.+...........+.+|+.++++++|+||+++++++. .....++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~---~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv 77 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTG---VTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-IEGAVYMC 77 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCC---cEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-cCCeEEEE
Confidence 5778899999999999999986544 6799998876545555578899999999999999999999754 46677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+||+++++|..++.... ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 78 ~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 78 MEYMDAGSLDKLYAGGV-----ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred EeecCCCCHHHHHHhcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99999999999987621 12368999999999999999999997 5999999999999999999999999999876
Q ss_pred cCCCCccccCCCCCCccccccccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHHcCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKT------FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA---SLQDGYR 452 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~---~i~~~~~ 452 (499)
.... ......++..|+|||.+.+.. ++.++|+|||||++|||++ |+.||.......... .+..+..
T Consensus 153 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 153 LVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred ccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHh-CCCCCCCcchhhHHHHHHHHhhcCC
Confidence 5322 122345777899999986543 5889999999999999999 888987655443332 3334444
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+..+++++.+++.+||+.+|++||++.+++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 5566678999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=326.91 Aligned_cols=253 Identities=14% Similarity=0.206 Sum_probs=204.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
++|++.+.||+|+||.||+++...++ +.+|+|.+... ........+.+|..++..++|+||+++++++ ...+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-~~~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTE---RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-QDENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EcCCEE
Confidence 36888999999999999999986554 67999998642 1223345688899999999999999999985 556678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFE-------DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccce
Confidence 99999999999999998632 35889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVH-----KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRL 453 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-~~~ 453 (499)
+....... .......|++.|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+....+... .+.
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~-g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (331)
T cd05624 150 LKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHEERF 227 (331)
T ss_pred eeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh-CCCCccCCCHHHHHHHHHcCCCcc
Confidence 86643322 12234568999999999876 568899999999999999999 89999887777666655442 222
Q ss_pred CCC---CCCcHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q psy1789 454 NQP---VNCPDELFSVMAYCWAMNPEG--RPTFPQLHSC 487 (499)
Q Consensus 454 ~~~---~~~~~~~~~l~~~C~~~~P~~--RPt~~~v~~~ 487 (499)
..| ..+++++.+++.+|+..++.+ |++++++++.
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 223 346889999999999865543 4577777653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=330.61 Aligned_cols=237 Identities=19% Similarity=0.244 Sum_probs=192.0
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC---CCCcceeEEeEEEcCCCceEEEEE
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL---SHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
||+|+||.||+|+....+ +.+|+|++.... .......+..|..++... +||||+++++++ ......++|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-~~~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR---RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-QTDSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCC---CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-ecCCeEEEEEc
Confidence 689999999999976554 689999986431 122234455666666654 699999999984 55667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 77 ~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 77 YMSGGELFWHLQKE--------GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred CCCCChHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 99999999998752 3589999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDEL 463 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 463 (499)
... ......||..|+|||++.+. .++.++|||||||++|||+| |+.||...+..++...+..+.........++++
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 225 (330)
T cd05586 149 DNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC-GWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEG 225 (330)
T ss_pred CCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc-CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 221 22345689999999998764 48999999999999999999 899998888777776665543222223578899
Q ss_pred HHHHHHhhhcCCCCCCCH
Q psy1789 464 FSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 464 ~~l~~~C~~~~P~~RPt~ 481 (499)
.+++.+||+.||.+||++
T Consensus 226 ~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 226 RQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred HHHHHHHcCCCHHHCCCC
Confidence 999999999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.05 Aligned_cols=252 Identities=14% Similarity=0.218 Sum_probs=202.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++++.||+|+||.||+++....+ +.+|+|++... ......+.+.+|+.++..++|+||+++++++ ..+...+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~ 77 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTG---QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-QDENNLY 77 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-ecCCeEE
Confidence 6888999999999999999987654 68999998642 2233446688999999999999999999985 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 150 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFE-------DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCL 150 (331)
T ss_pred EEEecCCCCcHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCcee
Confidence 9999999999999997522 358899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVH-----KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLN 454 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~ 454 (499)
........ ......||+.|||||++.. ..++.++|||||||++|||++ |+.||...+..+....+.... ...
T Consensus 151 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~-g~~Pf~~~~~~~~~~~i~~~~~~~~ 228 (331)
T cd05597 151 RLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLVETYGKIMNHKEHFQ 228 (331)
T ss_pred ecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCccc
Confidence 65432221 1223468999999999973 457899999999999999999 899998877666655554321 122
Q ss_pred C---CCCCcHHHHHHHHHhhhc--CCCCCCCHHHHHHH
Q psy1789 455 Q---PVNCPDELFSVMAYCWAM--NPEGRPTFPQLHSC 487 (499)
Q Consensus 455 ~---~~~~~~~~~~l~~~C~~~--~P~~RPt~~~v~~~ 487 (499)
. ...+++++.+++.+|+.. ++..||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 2 234788999999997754 33347888888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=310.75 Aligned_cols=252 Identities=20% Similarity=0.278 Sum_probs=204.4
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc----ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-C
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN----ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-H 296 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~ 296 (499)
..|++.+.||+|+||.||+|...+++ ..+++|.+... ....+.+.+.+|+.++++++|+||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTG---RELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCC---cEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 35788899999999999999876544 68999987532 2234567889999999999999999999975443 3
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++++||+++++|.+++... ..+++....+++.|++.||+|||+++++|+||||+||++++++.++|+||
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Df 150 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSY--------GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDF 150 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcC
Confidence 4567999999999999999752 34788999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccc-cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCC
Q psy1789 377 ALARDLFPSDYHC-LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ-DGYRLN 454 (499)
Q Consensus 377 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~ 454 (499)
|+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+.......+. ....+.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06652 151 GASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIATQPTNPV 229 (265)
T ss_pred ccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhh-CCCCCCccchHHHHHHHhcCCCCCC
Confidence 9998654321111 1223457889999999999899999999999999999999 888988765544433333 223344
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.|...++.+.+++.+||. +|++||+++|+++
T Consensus 230 ~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 230 LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 555677889999999995 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.01 Aligned_cols=251 Identities=17% Similarity=0.240 Sum_probs=197.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+...+|++++.||+|+||.||++...+. ...+.|++|.+... ..+.+|+.++++++||||+++++++ .....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~-~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAY-RWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCC-ccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeE-eeCCE
Confidence 3456799999999999999999976432 23368999988653 2345899999999999999999985 44567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.+++||++. ++|.+++.. ...+++.+++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 161 ~~lv~e~~~-~~l~~~l~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDR--------SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred EEEEehhcC-CCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcc
Confidence 799999987 789888854 24689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH------
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEMAASLQ------ 448 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~----~~~~~~i~------ 448 (499)
++...............||..|+|||++.+..++.++|||||||++|||++ |+.||.+... ..+...+.
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~-g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV-KNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 986654333222334578999999999999999999999999999999999 7777754321 11111100
Q ss_pred -------------------cCCCCCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 449 -------------------DGYRLNQP-------VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 449 -------------------~~~~~~~~-------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
...++... ...+.++.+++.+||..||++|||+.|++..
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00011111 1245678899999999999999999999864
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=314.06 Aligned_cols=255 Identities=20% Similarity=0.381 Sum_probs=208.3
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc---------ccHHHHHHHHHHHHHHhc-CCCCcceeEEeEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN---------ASAVQVSLLLQEGMAMYG-LSHKNILTVLGVSI 293 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~ 293 (499)
|++.+.||+|+||.||+|....+. .+.+++|.+... ........+.+|+.++.+ ++||||+++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~--~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNG--QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCC--CceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 556789999999999999986622 267999987532 223345667888888865 79999999999864
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~k 372 (499)
. +...++++||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+|
T Consensus 80 ~-~~~~~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~ 154 (269)
T cd08528 80 E-NDRLYIVMDLIEGAPLGEHFNSLKE----KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT 154 (269)
T ss_pred c-CCeEEEEEecCCCCcHHHHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEE
Confidence 4 5677999999999999999865221 12468999999999999999999996 6899999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
|+|||++....... ......++..|+|||++.+..++.++||||||+++|||++ |++||...+.......+.....
T Consensus 155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 230 (269)
T cd08528 155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNMLSLATKIVEAVY 230 (269)
T ss_pred Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh-CCCcccccCHHHHHHHHhhccC
Confidence 99999998654332 2234567889999999999999999999999999999999 7899988777666666655433
Q ss_pred CCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 453 LNQPV-NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 453 ~~~~~-~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
...+. ..++++.+++.+||+.||++||++.|+..++.
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 33333 57889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=312.09 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=197.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
..||+|+||.||+|....++ ..+++|.+.... ....+.+.+|+.++++++|+||+++++++. .++..++++||++
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~---~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 88 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQ---VRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDS-ENGFFKIFMEQVP 88 (268)
T ss_pred EEEecCCceEEEEeEecCCC---cEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeec-cCCEEEEEEecCC
Confidence 78999999999999876544 679999887553 334578899999999999999999999864 4566799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCcEEEcccccccccCC
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTL--TTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRIQITDNALARDLFP 384 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l--~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-~~~~kl~DfGla~~~~~ 384 (499)
+++|.+++.... ..+ ++..+..++.|++.||+|||+.+|+||||||+||+++. ++.++|+|||++.....
T Consensus 89 ~~~L~~~l~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 89 GGSLSALLRSKW-------GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred CCCHHHHHHHhc-------ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999998521 224 78889999999999999999999999999999999986 67999999999876533
Q ss_pred CCccccCCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHHcCCCCCCCCCCc
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKT--FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA--ASLQDGYRLNQPVNCP 460 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~--~~i~~~~~~~~~~~~~ 460 (499)
.+. ......++..|+|||++.+.. ++.++|||||||++|||++ |++||...+..... ........+..+..++
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh-CCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 221 122345788999999987644 8899999999999999999 88898765432211 1111223344566788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 99999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=314.02 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=206.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~~l 301 (499)
+|+..+.||.|++|.||++.....+ +.+++|.+...........+.+|++++++++||||+++++++... ....++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTG---MIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCC---eEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 5778899999999999999986654 789999987654545567899999999999999999999986543 446799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||+++++|.+++..... ....+++.....++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++..
T Consensus 79 v~e~~~~~~L~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKK----RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEecCCCCHHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 9999999999998875321 134588999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHcCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI-----DPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-----~~~~~~~~i~~~~~~~~~ 456 (499)
..... .....++..|+|||.+.+..++.++||||||+++|||++ |..||... ...+....+.....+..+
T Consensus 155 ~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 155 LVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ-NRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred ccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 53221 123456778999999999999999999999999999999 88888754 334445554443222222
Q ss_pred ------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 ------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...++++.+++.+||+.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 134678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=315.84 Aligned_cols=245 Identities=19% Similarity=0.323 Sum_probs=209.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||+|+||.||++.....+ +.+|+|++.... .....+.+.+|++++++++||||+++++++ ......+
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 77 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSG---KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-QDDSNLY 77 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-EcCCeEE
Confidence 6888999999999999999986654 789999986432 234456788999999999999999999985 4456779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.+||+|||+++
T Consensus 78 ~v~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 149 (290)
T cd05580 78 LVMEYVPGGELFSHLRKS--------GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK 149 (290)
T ss_pred EEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence 999999999999999862 368999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
..... .....++..|+|||.+.+...+.++||||||+++|||++ |+.||...+..+....+..+ ....+...+
T Consensus 150 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 222 (290)
T cd05580 150 RVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA-GYPPFFDDNPIQIYEKILEG-KVRFPSFFS 222 (290)
T ss_pred ccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CccCCccCC
Confidence 76433 224567889999999998889999999999999999999 89999887766666655543 445566778
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
.++.+++.+||..||.+|| +++|+++
T Consensus 223 ~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 9999999999999999999 6667653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=315.10 Aligned_cols=247 Identities=19% Similarity=0.349 Sum_probs=205.0
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC---CCcceeEEeEEEcCCCceE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS---HKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~~ 300 (499)
|++.+.||+|+||.||+|.....+ +.+++|.+.........+.+.+|+.++++++ |||++++++++. .+...+
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-~~~~~~ 78 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTG---RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-KGPRLW 78 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCC---cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-eCCEEE
Confidence 556689999999999999986544 6899999876545555677889999999886 999999999864 456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++++|.+++.. ..+++.....++.|++.||.|||+.+|+|+||+|+||++++++.++|+|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06917 79 IIMEYAEGGSVRTLMKA---------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAA 149 (277)
T ss_pred EEEecCCCCcHHHHHHc---------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCcee
Confidence 99999999999999874 258999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC-C
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV-N 458 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~-~ 458 (499)
....... ......|+..|+|||.+.++ .++.++|||||||++|||++ |..||...+.......+.....+..+. .
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd06917 150 LLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT-GNPPYSDVDAFRAMMLIPKSKPPRLEDNG 226 (277)
T ss_pred ecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh-CCCCCCCCChhhhhhccccCCCCCCCccc
Confidence 7654332 12344678889999998754 47899999999999999999 899998876655444443332233333 3
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+.++.+++.+||+.||++||++.|+++
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 7889999999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=309.58 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=206.6
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||+|....++ +.+++|.+..... ....+.+.+|+.++++++|+||+++++++ ...+..++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTG---ELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-VHREKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCC---cEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-ecCCEEEE
Confidence 5778899999999999999876544 6899999875432 34668899999999999999999999985 44567799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.+||+|||++..
T Consensus 77 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--------RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred EEecCCCCcHHHHHhhc--------CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccc
Confidence 99999999999999862 3478999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccc--CCCCCCccccccccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCCCCC
Q psy1789 382 LFPSDYHCL--GDNENRPVKWLAIESLVHKT---FSTASDVWAFGVLLWELTTLAQQPYAEID-PFEMAASLQDGYRLNQ 455 (499)
Q Consensus 382 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~~~~~~~i~~~~~~~~ 455 (499)
......... .....++..|+|||++.+.. ++.++||||||+++||+++ |+.||...+ .......+..+..+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh-CCCCccCCcchHHHHHHHhcCCCCCC
Confidence 654332211 11345778899999998766 8999999999999999999 889997653 3333333443434444
Q ss_pred CCC--CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 PVN--CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~~~--~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
|.. ++.++.+++.+||+.+|++||++.|++.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 443 4889999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=315.40 Aligned_cols=248 Identities=23% Similarity=0.392 Sum_probs=201.8
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHH-HHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ-VSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
|++++.||+|+||+||+++...++ +.+|+|.+........ .....+|+..+++++|+||++++++... ....++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNG---QKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTT---EEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCC---eEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-ccccccc
Confidence 688899999999999999987765 6899999976643333 2344669999999999999999999544 6667999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
|||+++++|.+++.. ...+++..+..++.|+++||+|||+.+++|+||||+||++++++.++|+|||.+...
T Consensus 77 ~~~~~~~~L~~~l~~--------~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQK--------NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EEEETTEBHHHHHHH--------HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccccc--------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999984 246899999999999999999999999999999999999999999999999998754
Q ss_pred CCCCccccCCCCCCccccccccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHcCC---CCCC
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE---MAASLQDGY---RLNQ 455 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~---~~~~i~~~~---~~~~ 455 (499)
.. .........++..|+|||.+. +..++.++||||+|+++|||++ +..||......+ ......... ....
T Consensus 149 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T PF00069_consen 149 SE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT-GKLPFEESNSDDQLEIIEKILKRPLPSSSQQ 225 (260)
T ss_dssp TS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH-SSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccc-cccccccccchhhhhhhhhcccccccccccc
Confidence 11 112334566788999999998 8889999999999999999999 888988763222 222221110 1111
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
......++.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223489999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=315.58 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=200.0
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++.+.||+|+||.||+|....++ +.+++|++.... .....+.+.+|+.+++.++|+||+++++++. .....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETG---QIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-RKRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCC---cEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-eCCEEE
Confidence 36888899999999999999986544 789999886432 2223356789999999999999999999854 456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++++|..++.. ...+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+|||++.
T Consensus 77 ~v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 77 LVFEYCDHTVLNELEKN--------PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred EEEeccCccHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccce
Confidence 99999999999888764 2358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-------- 451 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 451 (499)
....... ......++..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+....
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 149 ILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT-GQPLWPGKSDVDQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred ecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7644321 1223446778999999876 558899999999999999999 889998766544332221100
Q ss_pred ------------CCCC----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ------------RLNQ----------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ------------~~~~----------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... ....+.++.+++.+||+.+|++||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 0135678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=314.35 Aligned_cols=255 Identities=16% Similarity=0.302 Sum_probs=205.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~--- 296 (499)
..+|++.+.||+|+||.||++...+++ +.+++|.+..... ....+.+|+.++.++ +|||++++++++...+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~---~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDG---SLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCC---CEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 467888899999999999999876544 6799998865322 235677899999988 8999999999876432
Q ss_pred -CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 297 -TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 297 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...++|+||+++|+|.++++.... ....+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLI----CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence 357999999999999999874221 124589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-----TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
||+++........ .....++..|+|||++... .++.++|||||||++|||++ |++||...+..+....+...
T Consensus 172 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~-g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 172 FGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD-GDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred cccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhh-CCCCCCCCcHHHHHHHHhcC
Confidence 9998865433221 2234578889999998643 36899999999999999999 89999887765554444433
Q ss_pred CCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 451 YRL--NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 451 ~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
... ..+.....++.+++.+||+.+|++||++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 222 2344567889999999999999999999998763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=322.40 Aligned_cols=250 Identities=16% Similarity=0.273 Sum_probs=194.4
Q ss_pred Eeeeeeee--cceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 226 LFSVNMEG--TFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 226 ~~~~lG~G--~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
++++||+| +||+||++....++ +.||+|++.... .....+.+.+|+.+++.++||||+++++++.. ++..++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTG---EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccC---cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEE
Confidence 45889999 68899999987655 789999997543 33445667789999999999999999999654 5567999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+++|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++||+.+...
T Consensus 78 ~e~~~~~~l~~~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 78 TSFMAYGSAKDLICTHF------MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred EeccCCCcHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 99999999999997532 134899999999999999999999999999999999999999999999999875443
Q ss_pred CCCCcc-----ccCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--
Q psy1789 383 FPSDYH-----CLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-- 453 (499)
Q Consensus 383 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-- 453 (499)
...... .......++..|+|||++.+ ..++.++|||||||++|||++ |+.||......+.......+..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (327)
T cd08227 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLLEKLNGTVPCL 230 (327)
T ss_pred ccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHH-CCCCCCCcchhHHHHHHhcCCcccc
Confidence 211110 01112345677999999976 468999999999999999999 89999765443322211111000
Q ss_pred -------------------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 -------------------------------------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 -------------------------------------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.....+++++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 001134568999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=313.89 Aligned_cols=249 Identities=18% Similarity=0.330 Sum_probs=200.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+|++.+.||+|+||.||+|+...++ +.+++|.+..... .....+.+|+.+++.++||||+++++++. .....++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTG---ELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYL-RRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCC---cEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCCEEEE
Confidence 45666699999999999999876554 6799999875532 33456788999999999999999999854 4567799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|.+++... ..+++.+...++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd06645 84 CMEFCGGGSLQDIYHVT--------GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQ 155 (267)
T ss_pred EEeccCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeE
Confidence 99999999999998752 3589999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCC---
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ-DGYRLN--- 454 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~--- 454 (499)
..... .......|+..|+|||++. ...++.++|||||||++|||++ +..||....+........ ....+.
T Consensus 156 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 156 ITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE-LQPPMFDLHPMRALFLMTKSNFQPPKLK 232 (267)
T ss_pred ccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc-CCCCcccccchhhHHhhhccCCCCCccc
Confidence 53221 1223456888999999985 4568899999999999999999 778876655433322222 111111
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....++..+.+++.+||+.+|++||++.+|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 12246788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=302.69 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=205.7
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-------cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCc
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-------SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 298 (499)
.+.+|.|..+.|-++..+.++ +..|+|++...+ .....+.-.+|+.+|+++ -||+|+.+.++ ++.+..
T Consensus 22 keilgrgvss~vrRci~k~t~---~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~-yes~sF 97 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETG---KEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV-YESDAF 97 (411)
T ss_pred HHHhcccchhhhhhhhhcccc---cceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee-ccCcch
Confidence 388999999999998876665 677888875322 123345667899999997 59999999998 677888
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+|.|+.|.|.++|.+ .-.+++.+..+|++|+.+|++|||.++||||||||+|||+|++.++||+|||+
T Consensus 98 ~FlVFdl~prGELFDyLts--------~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTS--------KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhcccchHHHHhhh--------heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 8999999999999999987 35799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLV------HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY- 451 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~- 451 (499)
|+.+.+... -...+||++|+|||.+. ...|+..+|+||.||+||-|+. |.+||-.....-+...+..|.
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa-GcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA-GCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc-CCCchhHHHHHHHHHHHHhccc
Confidence 998876542 23678999999999885 3568999999999999999999 778876655555666666652
Q ss_pred --CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 --RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 --~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+.+...+.+++.++++.+|++.||.+|.|++|.++
T Consensus 246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22333478889999999999999999999999875
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=308.90 Aligned_cols=252 Identities=20% Similarity=0.387 Sum_probs=208.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|.+.+.||+|+||.||+|.....+ ..+++|.+.... .....+.+.+|+.+++.++|+||+++++.+ ......++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-~~~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDS---EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-QENGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCC---ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-ccCCeEEE
Confidence 4678899999999999999987654 578999986431 223446788999999999999999999985 55667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cEEEccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDNALAR 380 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~kl~DfGla~ 380 (499)
|+||+++++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||||+||++++++ .+||+|||.+.
T Consensus 77 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 77 VMEYCDGGDLMKRINRQR------GVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred EEecCCCCcHHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccch
Confidence 999999999999997522 23579999999999999999999999999999999999999875 56999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
....... ......|+..|+|||++.+..++.++||||||+++|||++ |..||...+..+....+........+...+
T Consensus 151 ~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
T cd08225 151 QLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT-LKHPFEGNNLHQLVLKICQGYFAPISPNFS 227 (257)
T ss_pred hccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhcccCCCCCCCCC
Confidence 6643221 1223457888999999998899999999999999999999 888988777666655555554445555678
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.++.+++.+||..+|++|||+.|+++.
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 228 RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 899999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=313.89 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=197.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.|++.+.||+|+||.||+|+...++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++++. .+...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTG---QIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-QESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCC---cEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-eCCeEEE
Confidence 3677899999999999999976544 689999886432 2223356788999999999999999999864 4667799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||++ ++|.+++.... ....+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||+++.
T Consensus 77 v~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLP-----KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred EEecCC-CCHHHHHhcCC-----CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence 999998 78999987522 124689999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcC---------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QDG--------- 450 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i-~~~--------- 450 (499)
..... .......++..|+|||.+.+ ..++.++|||||||++|||+| |++||......+..... ...
T Consensus 151 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 151 FGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227 (285)
T ss_pred cCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 53221 11223456788999998865 457899999999999999999 88898865543322111 000
Q ss_pred --------------C----CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 --------------Y----RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 --------------~----~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .......+++++.+++.+||+.||++|||+.+|++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00012246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=319.85 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=216.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
-|.+.+.||+|.|..|-+|++.-++ .+||||++.+.. .......+.+|++.|+.++|||||+||.+ ++....+||
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTG---ekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-iDTQTKlyL 94 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-IDTQTKLYL 94 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhccc---ceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-hcccceEEE
Confidence 4666799999999999888765444 789999997642 33334567899999999999999999998 677888999
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-cCCCcEEEccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV-DDKLRIQITDNALAR 380 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll-d~~~~~kl~DfGla~ 380 (499)
|+|.-++|+|.+|+.+.+ ..+.+....+++.||+.|+.|||+..+|||||||+|+.+ ..-|-+||+|||++.
T Consensus 95 iLELGD~GDl~DyImKHe-------~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHE-------EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEecCCchHHHHHHhhh-------ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 999999999999998754 358899999999999999999999999999999999865 566899999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
.+.|... -+..+|+..|-|||.+++..|+ +++||||+||+||.|++ |++||++.++-+...+|.+. +...|..+
T Consensus 168 kf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC-Gq~PFqeANDSETLTmImDC-KYtvPshv 242 (864)
T KOG4717|consen 168 KFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC-GQPPFQEANDSETLTMIMDC-KYTVPSHV 242 (864)
T ss_pred cCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh-CCCccccccchhhhhhhhcc-cccCchhh
Confidence 7766542 3467899999999999999997 78999999999999999 99999999988888888775 56678889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++.++|+..++..||.+|.+.++|+.
T Consensus 243 S~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 243 SKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 999999999999999999999999864
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=306.59 Aligned_cols=250 Identities=20% Similarity=0.334 Sum_probs=212.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++.+.||+|++|.||+|+....+ +.+++|++.........+.+.+|+..+.+++|+||+++++++.. ....++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~---~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTG---KIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCC---cEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEE
Confidence 5778899999999999999987644 78999998766544556789999999999999999999998644 5677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~ 149 (264)
T cd06623 78 LEYMDGGSLADLLKKV--------GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV 149 (264)
T ss_pred EEecCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCcccee
Confidence 9999999999999862 468999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHcCCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI---DPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~---~~~~~~~~i~~~~~~~~~~~ 458 (499)
....... .....++..|+|||.+.+..++.++||||||+++|||+| |+.||... ...+....+........+..
T Consensus 150 ~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 150 LENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECAL-GKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226 (264)
T ss_pred cccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHh-CCCCCccccccCHHHHHHHHhcCCCCCCCcc
Confidence 6433221 123456788999999999999999999999999999999 88998776 44455555555545555556
Q ss_pred -CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 459 -CPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 459 -~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
++..+.+++.+||+.+|++||++.|+++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 88999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=312.83 Aligned_cols=249 Identities=19% Similarity=0.318 Sum_probs=207.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++.+.||+|+||.||++....++ +.+++|.+.........+.+.+|++.+++++||||+++++++.. ....+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTG---KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCC---cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEE
Confidence 4566789999999999999986544 78999998776555566788999999999999999999998655 4677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+||+++++|.+++.... ..+++.....++.|++.||+|||+ .+++|+||||+||++++++.++|+|||.+..
T Consensus 78 ~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~ 150 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ-------GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ 150 (265)
T ss_pred EEecCCCcHHHHHHHcc-------CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchh
Confidence 99999999999998632 468899999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHHcCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI-----DPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-----~~~~~~~~i~~~~~~~~~ 456 (499)
...... ....++..|+|||++.+..++.++||||||+++|||++ |+.||... ...+..+.+.....+..+
T Consensus 151 ~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (265)
T cd06605 151 LVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT-GRFPYPPENDPPDGIFELLQYIVNEPPPRLP 225 (265)
T ss_pred hHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCccccccccHHHHHHHHhcCCCCCCC
Confidence 532211 12567788999999999999999999999999999999 88888654 233344444444444444
Q ss_pred CC-CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 457 VN-CPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 457 ~~-~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.. +++++.+++..||..||++|||+.|++..
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 44 78899999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=313.27 Aligned_cols=253 Identities=19% Similarity=0.330 Sum_probs=202.5
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc----
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE---- 294 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~---- 294 (499)
....|++.+.||+|+||.||+|.....+ +.+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTG---QLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCC---cEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 3456777799999999999999986554 689999886542 2345688899999988 79999999998653
Q ss_pred -CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 295 -DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 295 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
.....+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+|+|+||||+||++++++.++|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTK------GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 2346799999999999999997532 235788999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ 448 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~ 448 (499)
+|||+++....... ......++..|+|||.+. ...++.++|||||||++|||++ |.+||....+.+....+.
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~-g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE-GAPPLCDMHPMRALFLIP 239 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh-CCCCccccCHHhhhhhHh
Confidence 99999875532211 123455788899999986 3568899999999999999999 888987766544333333
Q ss_pred cCCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 449 DGYR-LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 449 ~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... ......++.++.+++.+||+.||.+||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 2222 2223357889999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.53 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=201.1
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc---------HHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS---------AVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
+|.+.+.||+|+||.||+|....++ +.+|+|.+..... ....+.+.+|+.+++.++|+||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTG---EMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCC---ceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe-
Confidence 4667799999999999999875543 6799998753211 11235688899999999999999999986
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
......++|+||+++|+|.++++.. ..+++..+..++.|++.||.|||+.+++||||||+||++++++.++|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 78 TTEEYLSIFLEYVPGGSIGSCLRTY--------GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred ccCCceEEEEecCCCCcHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEE
Confidence 4566779999999999999999862 35889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT--FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ-DG 450 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~-~~ 450 (499)
+|||+++...............++..|+|||.+.... ++.++||||||+++||+++ |..||...+..+....+. ..
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 228 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRPWSDEEAIAAMFKLGNKR 228 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh-CCCCCcCcchHHHHHHhhccc
Confidence 9999998653221111223445788999999988755 8999999999999999999 888987655443332222 22
Q ss_pred CCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 451 YRLNQP----VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 451 ~~~~~~----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.....+ ..++.++.+++.+||+.+|++||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 222222 2458899999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=315.84 Aligned_cols=249 Identities=20% Similarity=0.347 Sum_probs=199.6
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||+|...+++ +.+|+|.+.... .....+.+.+|+++++.++|+||+++++++ ..+...++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~l 77 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETG---QIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-RRKKRLYL 77 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCC---CEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-ccCCeEEE
Confidence 5788899999999999999986544 679999876432 223446788999999999999999999985 55667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|..+... ...+++.++..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||+++.
T Consensus 78 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~ 149 (286)
T cd07846 78 VFEFVDHTVLDDLEKY--------PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART 149 (286)
T ss_pred EEecCCccHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence 9999999999887764 13489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD----------- 449 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~----------- 449 (499)
...... ......++..|+|||++.+ ..++.++||||||+++|||++ |++||......+....+..
T Consensus 150 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 150 LAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT-GEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred ccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 543321 1223457788999999875 457899999999999999999 7888876554332222111
Q ss_pred ---------CCC-C---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 ---------GYR-L---------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 ---------~~~-~---------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+.. + .....++..+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 0 011256788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=325.11 Aligned_cols=248 Identities=17% Similarity=0.265 Sum_probs=196.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---- 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---- 295 (499)
..+|++++.||+|+||.||+|....++ +.||||++.... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLR---QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCC---CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 357888899999999999999876554 689999986532 223445678999999999999999999875322
Q ss_pred -CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 296 -HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC---------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEc
Confidence 13458899988 5899888763 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR- 452 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~- 452 (499)
|||+++..... .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.||...+..+....+.....
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK-GKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999865322 223467889999999977 568999999999999999999 8899987654433322211000
Q ss_pred ---------------------CCCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 453 ---------------------LNQP--------VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 453 ---------------------~~~~--------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+..+ ...++.+.+++.+|++.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001 1345668899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=333.28 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=204.9
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
=+||+|+||+||-|++.+++ ..+|||-+....+ ...+-+..|+.+.+.++|+|||+++|.| ..+++.-+.||-.+
T Consensus 581 vVLGKGTYG~VYA~RD~~tq---vrIaIKEIpekds-r~~QPLhEEIaLH~~LrHkNIVrYLGs~-senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQ---VRIAIKEIPEKDS-REVQPLHEEIALHSTLRHKNIVRYLGSV-SENGFFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccce---eEEEeeecccccc-hhhccHHHHHHHHHHHhhHhHHHHhhcc-CCCCeEEEEeecCC
Confidence 48999999999999987765 6799999976543 3457789999999999999999999986 44567788999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-CCCcEEEcccccccccCC
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTL--TTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFP 384 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l--~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld-~~~~~kl~DfGla~~~~~ 384 (499)
+|+|...|+..= .+| .+.++-.+..||++||.|||++.|||||||-+|+|++ -.|.+||+|||-++.+..
T Consensus 656 GGSLSsLLrskW-------GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 656 GGSLSSLLRSKW-------GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred CCcHHHHHHhcc-------CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 999999998621 234 6778888999999999999999999999999999997 678999999999987754
Q ss_pred CCccccCCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHcCCCCCCCCCCc
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHK--TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM--AASLQDGYRLNQPVNCP 460 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~--~~~i~~~~~~~~~~~~~ 460 (499)
-. ..+.+..||..|||||++..+ .|+.++|||||||++.||.| |++||.+....+. .+.-.-...++.|.+.+
T Consensus 729 in--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT-GrPPF~ElgspqAAMFkVGmyKvHP~iPeels 805 (1226)
T KOG4279|consen 729 IN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT-GRPPFVELGSPQAAMFKVGMYKVHPPIPEELS 805 (1226)
T ss_pred CC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc-CCCCeeecCChhHhhhhhcceecCCCCcHHHH
Confidence 22 234578899999999999865 58999999999999999999 9999988644332 22112234678888999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+.+.++.+|+.+||.+||++.+++.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999999874
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=313.65 Aligned_cols=259 Identities=14% Similarity=0.207 Sum_probs=192.2
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHH----------HHHHHHHHHHhcCCCCccee
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV----------SLLLQEGMAMYGLSHKNILT 287 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~H~nIv~ 287 (499)
++...+|++.+.||+|+||.||+|...++......+++|........... .....+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 45567899999999999999999998665333356677764322211110 11223344566789999999
Q ss_pred EEeEEEcCCC---ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q psy1789 288 VLGVSIEDHT---SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCV 364 (499)
Q Consensus 288 l~g~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIl 364 (499)
+++++..... ..++++|+.. .++.+.+... ...++..+..++.|++.||+|||+.+|+||||||+|||
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil 158 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--------KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM 158 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--------ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9997554332 2356667655 4666666541 23578889999999999999999999999999999999
Q ss_pred EcCCCcEEEcccccccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy1789 365 VDDKLRIQITDNALARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID 439 (499)
Q Consensus 365 ld~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~ 439 (499)
++.++.++|+|||+|+........ .......||+.|+|||...+..++.++|||||||++|||++ |++||....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~-g~~P~~~~~ 237 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG-IKLPWKGFG 237 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCccc
Confidence 999999999999999866432211 11223468999999999999999999999999999999999 899998763
Q ss_pred H-HHH--------HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 440 P-FEM--------AASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 440 ~-~~~--------~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
. .+. ...+..+ ......+++++.+++..||+.+|++||++.++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchHHHHHhHHHHHHHhhhh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 2 221 1222221 112346789999999999999999999999999876
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=317.29 Aligned_cols=243 Identities=17% Similarity=0.333 Sum_probs=201.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
..||+|+||.||++....++ ..+|+|.+.... ....+.+.+|+..++.++|+||+++++.+. ..+..++||||++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~~~~lv~e~~~ 102 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTG---KQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYL-VGDELWVVMEFLE 102 (292)
T ss_pred hcccCCCCeEEEEEEECCCC---CEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHhee-cCCeEEEEEeCCC
Confidence 77899999999999875544 679999886543 334567889999999999999999999854 4567799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++.. ..+++.++..++.|++.||+|||+++|+||||||+||++++++.++|+|||++.......
T Consensus 103 ~~~L~~~~~~---------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~- 172 (292)
T cd06658 103 GGALTDIVTH---------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV- 172 (292)
T ss_pred CCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence 9999999864 348899999999999999999999999999999999999999999999999987543221
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCcHHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN--QPVNCPDELFS 465 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~ 465 (499)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+....... .....+..+.+
T Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (292)
T cd06658 173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250 (292)
T ss_pred -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHH
Confidence 11223457888999999999899999999999999999999 888998777666555444332222 22356788999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q psy1789 466 VMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 466 l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
++.+||..||++|||+.|+++.
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=324.72 Aligned_cols=245 Identities=18% Similarity=0.279 Sum_probs=192.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
...|++++.||+|+||.||+|+....+ ..||+|+.... ....|+.++++++|+||+++++++.. ....+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQP---DPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCC---ceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeE
Confidence 346999999999999999999986554 67899975433 23468999999999999999998655 45669
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+. ++|.+++... ...+++..+..|+.|++.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 134 lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKR-------SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205 (357)
T ss_pred EEEEccC-CcHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccc
Confidence 9999996 7899988752 2468999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH----------HHHHHHHc-
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF----------EMAASLQD- 449 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~----------~~~~~i~~- 449 (499)
...... ......||..|+|||++.+..++.++|||||||++|||++++.++|...... .+...+..
T Consensus 206 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~ 282 (357)
T PHA03209 206 FPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282 (357)
T ss_pred ccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence 532221 1224568899999999999999999999999999999999777666543211 11111110
Q ss_pred CC-CCCC------------------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 GY-RLNQ------------------------------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 ~~-~~~~------------------------------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+. .... ..+++.++.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 00 0000 01345667789999999999999999999763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=313.47 Aligned_cols=248 Identities=19% Similarity=0.325 Sum_probs=203.4
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
...+|++.+.||+|+||.||+|+...++ +.|++|.+... ......+.+.+|+.+++.++||||+++.++|.. ..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~ 88 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EH 88 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCC---cEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CC
Confidence 3456777899999999999999976544 68999988533 234455678999999999999999999999755 55
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++|+||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+|+||||+|+||++++++.+||+|||
T Consensus 89 ~~~lv~e~~~-g~l~~~~~~~~-------~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 89 TAWLVMEYCL-GSASDILEVHK-------KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred eEEEEHHhhC-CCHHHHHHHcc-------cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecC
Confidence 6799999998 67877776422 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
+++...+. ....++..|+|||++. ...++.++||||||+++|||+| |++||...+.......+.....+.
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 233 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNDSPT 233 (307)
T ss_pred cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc-CCCCCCCccHHHHHHHHhcCCCCC
Confidence 98765332 2345677899999885 4568899999999999999999 889998877666554444332222
Q ss_pred C-CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 Q-PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~-~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. +..++.++.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 2 3357889999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=314.74 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=195.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||+|+....+ ..+++|.+.... .......+.+|+.++++++|+||++++++. .+....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g---~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-~~~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-HSDKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCC---cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-ccCCceEE
Confidence 4778899999999999999986554 678999886432 222335677899999999999999999984 55667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
++||++ ++|.+++.... ..+++..+..++.|+++||.|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 77 v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCN-------GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred EEecCC-CCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 999998 68888876521 3589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--------- 451 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--------- 451 (499)
...... ......++..|+|||++.+. .++.++|||||||++|||+||+.++|...+..+....+....
T Consensus 149 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 149 FGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred cCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 532211 12234567889999998764 479999999999999999996655566555443333221100
Q ss_pred ----------CC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ----------RL---------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ----------~~---------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. .....+++++.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 011245788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=294.83 Aligned_cols=269 Identities=19% Similarity=0.279 Sum_probs=211.8
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
+...+..+||++.+.||+|||..||.++...++ ..+|+|++.-.. ..+.+..++|++..++++|||++++++++..
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~---~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTG---HLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcc---cchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 456788899999999999999999999854443 689999997654 5566788999999999999999999987543
Q ss_pred C----CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCC
Q psy1789 295 D----HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVVDDK 368 (499)
Q Consensus 295 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~--iiHrDlk~~NIlld~~ 368 (499)
+ ....||+++|...|+|.+.+...+.. ...+++.+.++|+.++++||++||+.. ..||||||.|||+.+.
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~k----g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~ 165 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIK----GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS 165 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhc----CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC
Confidence 2 33479999999999999999875532 347999999999999999999999986 9999999999999999
Q ss_pred CcEEEcccccccccCCC---C--cc--ccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q psy1789 369 LRIQITDNALARDLFPS---D--YH--CLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEI 438 (499)
Q Consensus 369 ~~~kl~DfGla~~~~~~---~--~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~ 438 (499)
+.++|.|||.++...-. + .. ........|..|.|||.+. +...++++|||||||+||+|+. +.-||...
T Consensus 166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf-~~sPfe~~ 244 (302)
T KOG2345|consen 166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF-GESPFERI 244 (302)
T ss_pred CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH-cCCcchHH
Confidence 99999999998755311 0 00 0012344678899999985 4557899999999999999998 77887642
Q ss_pred CH--HHHHHHHHc-CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 439 DP--FEMAASLQD-GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 439 ~~--~~~~~~i~~-~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
-. ..+.-.+.. ....+.....++.+.+++.+|++.||.+||+..+++..++.+.
T Consensus 245 ~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 245 YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 001111111 1122222347899999999999999999999999999988763
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=320.15 Aligned_cols=249 Identities=22% Similarity=0.281 Sum_probs=214.5
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHT 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~ 297 (499)
...|++.+.||+|.||.||+++.+.++ +.+|+|.+.+..- ......+.+|+.+|+++. |||||.+.++ +++..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg---~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-~e~~~ 109 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTG---KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-FEDPD 109 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCC---ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-EEcCC
Confidence 457888999999999999999987754 7899999975432 224467899999999998 9999999998 56677
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC----CcEEE
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK----LRIQI 373 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~----~~~kl 373 (499)
..++|||++.+|.|.+.+... .+++.....++.|++.++.|||+.||+||||||+|+|+... +.+|+
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~---------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK---------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc---------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEE
Confidence 889999999999999999862 28999999999999999999999999999999999999643 57999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-- 451 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-- 451 (499)
+|||+|+...+. ......+||+.|+|||++....|+..+||||.||++|.|++ |.+||.+....+....+..+.
T Consensus 181 ~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~-G~~PF~~~~~~~~~~~i~~~~~~ 256 (382)
T KOG0032|consen 181 IDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS-GVPPFWGETEFEIFLAILRGDFD 256 (382)
T ss_pred eeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh-CCCCCcCCChhHHHHHHHcCCCC
Confidence 999999987652 23446789999999999999999999999999999999998 999999888777766666552
Q ss_pred -CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 -RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 -~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+.....++.+.+++..++..||.+|+|+.++++
T Consensus 257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 22223467889999999999999999999999987
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.01 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=188.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-CCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-DHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~~lv~e~~ 306 (499)
..||+|+||.||+|+..+.. ..+.+|+|.+...... ..+.+|+.++++++||||+++++++.. .+...++++||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~-~~~~~aiK~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCC-CCceEEEEEECCCCCc---HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 68999999999999875321 2267999998754322 346789999999999999999998543 344578999998
Q ss_pred CCCCHHHHHHhcccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCcEEEcccccccc
Q psy1789 307 DYTNLKRFLQKCKLCPE-GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV----DDKLRIQITDNALARD 381 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll----d~~~~~kl~DfGla~~ 381 (499)
+ ++|..++........ .....+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 7 689888865332111 122358999999999999999999999999999999999999 4567899999999986
Q ss_pred cCCCCc-cccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHHcC
Q psy1789 382 LFPSDY-HCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDP---------FEMAASLQDG 450 (499)
Q Consensus 382 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~---------~~~~~~i~~~ 450 (499)
...... ........+|..|+|||++.+ ..++.++|||||||++|||++ |++||..... .+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh-CCCCccCCcccccccccccHHHHHHHHHh
Confidence 543211 112234567889999999987 458999999999999999999 8888864321 0111111000
Q ss_pred ------------------------CCC-------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 ------------------------YRL-------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 ------------------------~~~-------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ........++.+++.+|++.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=313.97 Aligned_cols=253 Identities=16% Similarity=0.226 Sum_probs=206.4
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH--HHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA--VQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||+|+||.||+|.....+ +.+++|.+...... ...+.+.+|+++++.++|+||+++++.+ ......+
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~ 77 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTG---KLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-QTETYLC 77 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCC---cEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-ecCCEEE
Confidence 6788899999999999999886644 78999998754322 3556789999999999999999999985 4566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||++.
T Consensus 78 lv~e~~~~~~L~~~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQP------GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred EEEEecCCCCHHHHHHhCC------CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 9999999999999987521 2468999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcc---------------------------ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q psy1789 381 DLFPSDYH---------------------------CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQ 433 (499)
Q Consensus 381 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~ 433 (499)
........ .......|+..|+|||++.+..++.++||||||+++|||++ |+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~-g~~ 230 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY-GTT 230 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh-CCC
Confidence 55322110 01112357888999999999999999999999999999999 899
Q ss_pred CCCCCCHHHHHHHHHcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q psy1789 434 PYAEIDPFEMAASLQDG-YRLNQPVNCPDELFSVMAYCWAMNPEGRPT----FPQLHS 486 (499)
Q Consensus 434 p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt----~~~v~~ 486 (499)
||...+..+....+... .........++++.+++.+||+.||++||+ ++|++.
T Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 231 PFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99887766655444432 222222236899999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=308.50 Aligned_cols=246 Identities=20% Similarity=0.318 Sum_probs=207.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|++.+.||.|+||.||+|....++ ..+++|.+.... .....+.+.+|++++++++||||+++++++ ..+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTK---KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-QDEENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCC---cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-cCCCeEE
Confidence 4778899999999999999976544 679999986432 234567899999999999999999999874 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++++|.+++... ..+++..+..++.|+++||.|||+++++|+||||+||++++++.++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK--------VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred EEEeCCCCCCHHHHHHhc--------CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 999999999999999862 368899999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP---FEMAASLQDGYRLNQPV 457 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~---~~~~~~i~~~~~~~~~~ 457 (499)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+. .+....... .....+.
T Consensus 149 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 223 (258)
T cd05578 149 KVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-GKRPYRGHSRTIRDQIRAKQET-ADVLYPA 223 (258)
T ss_pred ccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh-CCCCCCCCCccHHHHHHHHhcc-ccccCcc
Confidence 664332 1234557788999999999889999999999999999999 8889887663 333333332 4556667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCH--HHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTF--PQLH 485 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~--~~v~ 485 (499)
..+.++.+++.+||+.||.+||++ +|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 789999999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=309.18 Aligned_cols=251 Identities=20% Similarity=0.257 Sum_probs=201.4
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||+|....++ ..+++|++.... .......+.+|+.++++++|+||+++++++. .....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETG---ETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-HGSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCC---ceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-cCCeeEE
Confidence 4788899999999999999986554 679999986543 2334567899999999999999999999854 4667799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+ +++|.+++.... ..+++.++..++.|++.||+|||+.+++|+||||+||++++++.++|+|||++..
T Consensus 77 v~e~~-~~~L~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-------RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 99999 999999987522 4689999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL------- 453 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~------- 453 (499)
...... .......++..|+|||++.+. .++.++||||||+++|||+| |++||......+....+......
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 149 FSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN-GSPLFPGENDIEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred ccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc-CCcCcCCCCHHHHHHHHHHHcCCCChHHHh
Confidence 643321 112244578889999998754 46899999999999999999 68888776554433322211000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 454 ----------------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 454 ----------------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
....+.++++.+++.+||+.+|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0012456889999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=309.26 Aligned_cols=251 Identities=20% Similarity=0.336 Sum_probs=197.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHH-HhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA-MYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||+|....++ +.||+|++...........+..|+.. ++.++|+||+++++++.. +...++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~l 77 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTG---TIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWI 77 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCC---cEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEE
Confidence 5778899999999999999986554 78999998755332233455556654 666799999999998654 556799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
++||++ |+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||+++
T Consensus 78 v~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYD----KGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred Ehhhhc-ccHHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999997 789988875321 124689999999999999999999997 99999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCcccccccccccc----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVH----KTFSTASDVWAFGVLLWELTTLAQQPYAEI-DPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-~~~~~~~~i~~~~~~~~ 455 (499)
...... ......++..|+|||.+.+ ..++.++|+|||||++|||++ |+.||... ...+.............
T Consensus 153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd06617 153 YLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT-GRFPYDSWKTPFQQLKQVVEEPSPQL 228 (283)
T ss_pred cccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh-CCCCCCccccCHHHHHHHHhcCCCCC
Confidence 653221 1223457788999998865 457899999999999999999 88888653 22333333333333333
Q ss_pred C-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 P-VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~-~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+ ..++.++.+++.+||..+|++||++.++++
T Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3 357889999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=309.13 Aligned_cols=246 Identities=17% Similarity=0.336 Sum_probs=203.8
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
+.-.+.||+|++|.||+|.....+ +.+++|++... .....+.+.+|+.+++.++|+||+++++++. ..+..++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~---~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTG---RQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-VGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCC---CEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEE-cCCeEEEEE
Confidence 333489999999999999875544 67999988643 2334466889999999999999999999854 456679999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~ 166 (285)
T cd06648 96 EFLEGGALTDIVTH---------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166 (285)
T ss_pred eccCCCCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence 99999999999875 248899999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--CCCCCcH
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN--QPVNCPD 461 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~~~~ 461 (499)
... . ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...++.+....+....... .+..++.
T Consensus 167 ~~~-~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd06648 167 KEV-P-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVD-GEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSP 243 (285)
T ss_pred cCC-c-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHhcCCCCCcccccCCH
Confidence 221 1 1223457889999999998899999999999999999999 888988777766666665543222 2234788
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+++.+||+.+|++||++.++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 9999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=328.36 Aligned_cols=247 Identities=19% Similarity=0.349 Sum_probs=209.9
Q ss_pred EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
.++.-||.|+||+||+|..++.. ...|-|++... +...++.|.-|+++|....||+||+|++.++. ++.+|++.|
T Consensus 35 eIiGELGDGAFGKVyKA~nket~---~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliE 109 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETK---LLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIE 109 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccch---hhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEe
Confidence 34577899999999999976543 34556666443 55667899999999999999999999997444 566799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
||+||-.+..+-... +.|++.++.-+++|++.||.|||+++|||||||+.|||++-+|.++|+|||.+....
T Consensus 110 FC~GGAVDaimlEL~-------r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~- 181 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELG-------RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK- 181 (1187)
T ss_pred ecCCchHhHHHHHhc-------cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-
Confidence 999999999987633 579999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCC
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--LNQPV 457 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~~~ 457 (499)
......+...||+.|||||+.. ..+|+.++||||||++|.||.. +.+|..+.++..+.-.+.+... ..+|.
T Consensus 182 -~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq-iEPPHhelnpMRVllKiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 182 -STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSEPPTLLQPS 259 (1187)
T ss_pred -hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc-cCCCccccchHHHHHHHhhcCCCcccCcc
Confidence 2222456788999999999875 4679999999999999999998 9999999999888777765433 45677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.++..+.+++.+|+.+||..||++.++++
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 89999999999999999999999999974
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=305.57 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=202.0
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
||.|+||.||+++....+ +.+++|++.... .....+.+.+|+.+++.++|+||+++++++ .++...++++||++
T Consensus 1 lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKN---RTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-KDKKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECCCC---cEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-EcCCccEEEEecCC
Confidence 688999999999986544 789999986542 234457799999999999999999999985 45566799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++.+. ..+++..+..++.|++.||.|||+++++|+||||+||++++++.++|+|||+++......
T Consensus 77 ~~~L~~~l~~~--------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~- 147 (262)
T cd05572 77 GGELWTILRDR--------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147 (262)
T ss_pred CCcHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence 99999999862 348899999999999999999999999999999999999999999999999998764332
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHc-CCCCCCCCCCcHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID--PFEMAASLQD-GYRLNQPVNCPDELF 464 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~--~~~~~~~i~~-~~~~~~~~~~~~~~~ 464 (499)
......++..|+|||.+.+..++.++|+||||+++|||++ |..||...+ ..+....+.. ......|...++++.
T Consensus 148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (262)
T cd05572 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAK 224 (262)
T ss_pred --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHh-CCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHH
Confidence 1123456788999999998899999999999999999999 889988766 5555555543 345566667789999
Q ss_pred HHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 465 SVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
+++.+||+.+|++||+ ++|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=311.23 Aligned_cols=246 Identities=20% Similarity=0.356 Sum_probs=212.8
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
+.+++.||+|+||.||+|.++..+ +.+|+|.+.-+. ..+++..|+.+++..+.|.+|++||.++. +..+|+||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG---~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESG---HVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccC---cEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeeh
Confidence 345588999999999999987765 889999997553 45788999999999999999999998665 45579999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
|||..|+..+.++.. ..+|.+.++..|++..+.||+|||...-||||||+.||||+-+|.+||+|||.|..+.
T Consensus 108 EYCGAGSiSDI~R~R-------~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT 180 (502)
T KOG0574|consen 108 EYCGAGSISDIMRAR-------RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT 180 (502)
T ss_pred hhcCCCcHHHHHHHh-------cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh
Confidence 999999999999863 3579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCcH
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--LNQPVNCPD 461 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~ 461 (499)
. .....++..||+-|||||++..-.|+.++||||+|++..||.. |++||.+..+....-.+-.... ...|..+++
T Consensus 181 D--TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE-G~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 181 D--TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE-GRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSS 257 (502)
T ss_pred h--hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhc-CCCCcccccccceeEeccCCCCCCCCChHhhhh
Confidence 3 3334457789999999999999999999999999999999999 9999999887665544443322 234567899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.++++.|+-++|++|-|+.++++
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 9999999999999999999988864
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=306.46 Aligned_cols=255 Identities=19% Similarity=0.326 Sum_probs=205.3
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCC--
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDH-- 296 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~-- 296 (499)
...+|++.+.||+|+||.||+|.....+ +.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTG---QLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCC---cEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 3468899999999999999999986544 6799998875432 336788999999998 6999999999865432
Q ss_pred ---CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 297 ---TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 297 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
...++|+||+++++|.+++..... ....+++..+..++.|++.||.|||+.+++|+||+|+||++++++.+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRK----KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEE
Confidence 347999999999999999875321 1246899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-----KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ 448 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~ 448 (499)
+|||++........ ......++..|+|||++.. ..++.++|||||||++|||++ |++||...+.......+.
T Consensus 155 ~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 155 VDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELAD-GKPPLCDMHPMRALFKIP 231 (275)
T ss_pred CCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHh-CCCCccccchHHHHHHhh
Confidence 99999876533221 2234557888999998753 347889999999999999999 899998766555444444
Q ss_pred cCCCCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 449 DGYRLN--QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 449 ~~~~~~--~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...... .+..+++++.+++.+||..||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 332222 22346789999999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=314.39 Aligned_cols=244 Identities=17% Similarity=0.320 Sum_probs=202.2
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
...||+|+||.||+|.....+ +.+++|.+..... ...+.+.+|+.+++.++||||+++++++. .++..++++||+
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~iv~e~~ 100 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSG---RQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYL-VGEELWVLMEFL 100 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCC---CEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhhee-eCCeEEEEEecC
Confidence 367999999999999876444 6899999864422 23466889999999999999999999854 456679999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCC
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~ 386 (499)
++++|..++.. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 101 QGGALTDIVSQ---------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred CCCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 99999998764 358899999999999999999999999999999999999999999999999987553322
Q ss_pred ccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCcHHHH
Q psy1789 387 YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--LNQPVNCPDELF 464 (499)
Q Consensus 387 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~ 464 (499)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||...++.+....+..... ...+...++++.
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 248 (297)
T cd06659 172 P--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLR 248 (297)
T ss_pred c--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHH
Confidence 1 1224567889999999999999999999999999999999 8899887776665555543322 122335678999
Q ss_pred HHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 465 SVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+++.+||+.+|++||++.++++.
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhC
Confidence 99999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=302.37 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=206.3
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc----ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN----ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH- 296 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~- 296 (499)
..|++.+.||+|+||.||+|....++ ..+++|.+... ........+.+|++++++++|+||+++++++....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTG---RELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCC---CEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 46888899999999999999876544 68999987432 22345568899999999999999999999865433
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++++||+++++|.+++... ..+++.....++.|++.||.|||+++++|+||||+||++++++.++|+||
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~df 150 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAY--------GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDF 150 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcc
Confidence 4568999999999999999752 34789999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCC
Q psy1789 377 ALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ-DGYRLN 454 (499)
Q Consensus 377 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~ 454 (499)
|+++........ .......++..|+|||++.+..++.++|||||||++|||++ |++||......+....+. ...++.
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06653 151 GASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIFKIATQPTKPM 229 (264)
T ss_pred ccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHh-CCCCCCccCHHHHHHHHHcCCCCCC
Confidence 999865321111 01123457888999999999889999999999999999999 899998776555443333 334456
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.|...++++.+++.+||+ +|..||+..+++.
T Consensus 230 ~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 677888999999999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=303.82 Aligned_cols=251 Identities=20% Similarity=0.342 Sum_probs=213.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||+++...++ +.+++|.+.... .......+.+|+.++++++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDN---QFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCC---CEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEE
Confidence 4678899999999999999876544 678999886532 34445678899999999999999999998544 567899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|.+++..... ....+++..+..++.|++.||+|||+.+++|+||+|+||++++++.+||+|||+++.
T Consensus 77 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~ 152 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKK----KRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV 152 (256)
T ss_pred EehhcCCCCHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence 9999999999999876321 124689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
.... ......++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+..+....+..+..+..+...+.
T Consensus 153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08530 153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT-FAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ 227 (256)
T ss_pred hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCchhhCH
Confidence 6443 2223457788999999999999999999999999999999 8999998887777777766655666667889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+++.+||+.+|++||++.|+++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 228 DLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhc
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.03 Aligned_cols=250 Identities=17% Similarity=0.343 Sum_probs=205.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|....++ ..+++|.+..... ...+.+.+|+.++++++||||+++++++.. .+..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATG---QEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLV-GDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCC---CEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEE
Confidence 457888899999999999999865443 6799998864422 334678899999999999999999998644 55679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.
T Consensus 93 lv~e~~~~~~L~~~~~~---------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 93 VVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred EEEecCCCCcHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 99999999999999975 347899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL--NQPVN 458 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~ 458 (499)
...+... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...+..+....+.....+ ..+..
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd06647 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYLIATNGTPELQNPEK 240 (293)
T ss_pred ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhheeehhcCCCCCCCCccc
Confidence 6544332 1223467888999999998899999999999999999999 89999876654433333222122 22334
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.+.++.+++.+||+.+|++||++.+++..
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 67789999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=317.66 Aligned_cols=252 Identities=20% Similarity=0.301 Sum_probs=198.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----C
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH----T 297 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~ 297 (499)
.+|++.+.||+|+||.||+|....++ +.||+|.+...........+.+|+.++++++|+||+++++++.... .
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTG---VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCC---CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 57899999999999999999876554 6899999865433444567889999999999999999999854332 3
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~---------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT---------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccc
Confidence 4789999998 588887764 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcc-ccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----
Q psy1789 378 LARDLFPSDYH-CLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---- 451 (499)
Q Consensus 378 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---- 451 (499)
+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |++||...+.......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~-G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99865432211 11123467888999998765 568999999999999999999 889997655433221111100
Q ss_pred ---------------------CCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 ---------------------RLNQ-----PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 ---------------------~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.... ....++++.+++.+||+.+|++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 12356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=321.89 Aligned_cols=240 Identities=20% Similarity=0.330 Sum_probs=205.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
+-||.|+||.||-|+...+. ..||||++.-.. +...-+++..|+..|.+++|||++.+-|++.. +...||||||
T Consensus 32 rEIGHGSFGAVYfArd~~n~---evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVMEY 107 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVMEY 107 (948)
T ss_pred HHhcCCccceeEEeeccCcc---ceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHHHH
Confidence 78999999999999976655 789999996443 22334678999999999999999999997544 5556999999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
|- |+-.+.+...+ .+|.+-++..|+.+++.||+|||+.+.||||||+.||||++.|.|||+|||.|....|.
T Consensus 108 Cl-GSAsDlleVhk-------KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK-------KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred Hh-ccHHHHHHHHh-------ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 98 78888876543 47889999999999999999999999999999999999999999999999999876554
Q ss_pred CccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC-CCCCcH
Q psy1789 386 DYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ-PVNCPD 461 (499)
Q Consensus 386 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~ 461 (499)
....||+.|||||+++ .+.|+-|+||||+|++..||.- +++|+..++.......|.....+.. ..++++
T Consensus 180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE-RkPPlFnMNAMSALYHIAQNesPtLqs~eWS~ 252 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPTLQSNEWSD 252 (948)
T ss_pred ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhh-cCCCccCchHHHHHHHHHhcCCCCCCCchhHH
Confidence 3678999999999997 4679999999999999999999 9999988887776666655444433 347899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..++..|+++-|.+|||..++++
T Consensus 253 ~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 253 YFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHHhhCcccCCcHHHHhh
Confidence 9999999999999999999998875
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=309.88 Aligned_cols=250 Identities=20% Similarity=0.302 Sum_probs=200.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||+|...+++ +.+++|.+.... .....+.+.+|++++++++|+||+++++++.. ....++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~---~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~i 77 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATG---EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYL 77 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCC---cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEE
Confidence 6888999999999999999986554 689999886432 23345678999999999999999999998654 566799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
++||++++.+..+... ...+++.++..++.|++.||.|||+.+++||||+|+||++++++.+||+|||+++.
T Consensus 78 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~ 149 (288)
T cd07833 78 VFEYVERTLLELLEAS--------PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARA 149 (288)
T ss_pred EEecCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccc
Confidence 9999998777766554 23589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--------- 451 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--------- 451 (499)
....... ......++..|+|||++.+. .++.++||||||+++|||++ |++||......+....+....
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 150 LRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD-GEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 6543321 12234567789999999888 89999999999999999999 888887665443222211100
Q ss_pred -----------CC-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 -----------RL-----------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 -----------~~-----------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. ..+..++.++.+++.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 012234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.61 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=211.1
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|++|.||+++....+ +.+++|.+.... .....+.+.+|++++++++|+|++++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETG---DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCC---cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEE
Confidence 4677899999999999999876554 679999987553 22456789999999999999999999998544 567799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
++||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||++..
T Consensus 77 v~e~~~~~~L~~~~~~~--------~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--------GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred EEecCCCCcHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEecccccee
Confidence 99999999999999762 3689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
....... .....++..|+|||...+..++.++||||||+++|||++ |+.||...+................+...++
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIVQDDHPPLPEGISP 225 (254)
T ss_pred cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHhccCCCCCCCCCCH
Confidence 6543221 234557888999999988889999999999999999999 8889887766555444444555566677889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 226 ELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHHHHhCChhhCcCHHHHhc
Confidence 9999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.22 Aligned_cols=250 Identities=20% Similarity=0.250 Sum_probs=198.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc----HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS----AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+|++.+.||+|+||.||+|....++ +.+++|.+..... ......+.+|+.++++++|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETG---RIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCC---cEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCE
Confidence 4677899999999999999976554 6899999875432 2234567789999999999999999998654 667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+ +|+|.+++.... ..+++..+..++.|+++||.|||+.+++|+||||+||+++.++.++|+|||+
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS-------IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEcccee
Confidence 89999999 899999997521 2589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR----- 452 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~----- 452 (499)
++....... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...+..+....+.....
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (298)
T cd07841 149 ARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPTEE 225 (298)
T ss_pred eeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc-CCccccCCccHHHHHHHHHHcCCCchh
Confidence 986643221 1223345678999999865 467899999999999999999 6888876655443322211100
Q ss_pred -----------------CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 453 -----------------LN-----QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 453 -----------------~~-----~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.. .....+.++.+++.+||+.+|++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 012346789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=304.26 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=201.4
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-----cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-----SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
|+..+.||+|+||.||+|....++ +.+++|.+.... .....+.+.+|+.++++++|+||+++++++ ...+.
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~---~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 77 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTG---TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-CEDSH 77 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCC---cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-ccCCe
Confidence 566689999999999999875544 679999886432 122356789999999999999999999995 45567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cEEEcccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDNA 377 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~kl~DfG 377 (499)
.++|+||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg 149 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKY--------GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFG 149 (268)
T ss_pred EEEEEeccCCCcHHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccc
Confidence 79999999999999999762 3588999999999999999999999999999999999998775 69999999
Q ss_pred cccccCCCCcc--ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-HHcCC
Q psy1789 378 LARDLFPSDYH--CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE---MAAS-LQDGY 451 (499)
Q Consensus 378 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~---~~~~-i~~~~ 451 (499)
+++........ .......++..|+|||.+.+..++.++||||+|+++|||++ |..||...+... .... .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (268)
T cd06630 150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAEKHSNHLALIFKIASATT 228 (268)
T ss_pred cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcchHHHHHHHhccCC
Confidence 98766432111 11123457889999999998899999999999999999999 888886543222 1111 12233
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+...+.++.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 34555567889999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=308.41 Aligned_cols=250 Identities=19% Similarity=0.320 Sum_probs=194.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
++|++.+.||+|+||.||+|....++ +.+++|.+...........+.+|+.++++++|+||+++++++ ......++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTG---QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-HTKKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCC---cEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-ecCCeEEE
Confidence 46888899999999999999976544 679999986543222234567899999999999999999985 45667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||++ ++|.+++.... ..+++.....++.|++.||.|||+.+|+||||||+||++++++.+||+|||+++.
T Consensus 81 v~e~~~-~~L~~~~~~~~-------~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCG-------GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred EEecCC-CCHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence 999998 59999987532 3588999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCC-------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEID-PFEMAASLQDGYR------- 452 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~~~~~~~i~~~~~------- 452 (499)
...... ......++..|+|||++.+ ..++.++||||||+++|||++ |+.||.... ..+....+.+...
T Consensus 153 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 153 KSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT-GRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred cCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence 422111 1122346778999999875 558999999999999999999 888987654 2222111111000
Q ss_pred ---------------C--CCC-----CCCc--HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 ---------------L--NQP-----VNCP--DELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ---------------~--~~~-----~~~~--~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ..+ .... .++.+++.+|++.+|++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000 0122 67889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=312.01 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=188.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-CCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-DHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~~lv~e~~ 306 (499)
..||+|+||.||+|+..+.. ....+|+|.+..... ...+.+|+.++++++||||+++++++.. .+...++|+||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~-~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCC-ccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 68999999999999875432 236899998865432 2356789999999999999999998654 345678999998
Q ss_pred CCCCHHHHHHhcccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCcEEEcccccccc
Q psy1789 307 DYTNLKRFLQKCKLCP-EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV----DDKLRIQITDNALARD 381 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll----d~~~~~kl~DfGla~~ 381 (499)
+ ++|.+++....... ......+++..+..++.|++.||.|||+++|+||||||+|||+ ++++.+||+|||+++.
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 8 57888876432211 1123468999999999999999999999999999999999999 5668999999999986
Q ss_pred cCCCCcc-ccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH----------HHHHHHH-
Q psy1789 382 LFPSDYH-CLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF----------EMAASLQ- 448 (499)
Q Consensus 382 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~----------~~~~~i~- 448 (499)
....... .......+|..|+|||++.+ ..++.++|||||||++|||+| |++||...... .......
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t-g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh-CCCCcccccccccccccccHHHHHHHHHh
Confidence 5432211 11234567889999999976 458999999999999999999 88888643210 0000000
Q ss_pred -------------cC---------CC-------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 449 -------------DG---------YR-------------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 449 -------------~~---------~~-------------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. .+ ..........+.+++.+|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00 0001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=306.02 Aligned_cols=247 Identities=20% Similarity=0.305 Sum_probs=194.7
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcC-CCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIED-HTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~-~~~~~l 301 (499)
|++.+.||+|+||.||+|....++ +.+|+|.+.............+|+.++.++. |+||+++++++... .+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~---~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTG---KYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCC---cEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 467799999999999999976544 6799999875422222234457888888885 99999999987653 156799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||++ |+|.+++.... ..+++.++..++.|++.||+|||+.+++||||||+||++++ +.+||+|||+++.
T Consensus 78 v~e~~~-~~l~~~l~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 78 VFELMD-MNLYELIKGRK-------RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred EEecCC-ccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccc
Confidence 999998 68888887521 36899999999999999999999999999999999999999 9999999999986
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-------- 452 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-------- 452 (499)
...... .....++..|+|||++.. ..++.++|||||||++|||++ +.+||...+..+....+.....
T Consensus 149 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 149 IYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred cccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc-CCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 643221 123446788999997754 557899999999999999999 8999988766554433322110
Q ss_pred ---------CCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 ---------LNQ-----------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ---------~~~-----------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ....++++.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000 1245789999999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=308.27 Aligned_cols=249 Identities=19% Similarity=0.289 Sum_probs=196.6
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
|+.++.||+|+||.||+|+...++ +.++||.+.... .......+.+|++++++++||||+++++++ .+....++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTG---EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTENKLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCC---CEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-ccCCcEEEE
Confidence 677899999999999999976544 679999886432 222335788999999999999999999985 456677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+. ++|..++.... ...+++..+..++.|++.||+|||+.+++||||+|+||++++++.+||+|||+++..
T Consensus 78 ~e~~~-~~l~~~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 78 FEFLH-QDLKKFMDASP------LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred eeccc-cCHHHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 99996 68999987532 246899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---------
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--------- 452 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--------- 452 (499)
..... ......++..|+|||.+.+.. ++.++|||||||++|||+| |+.||...+..+....+.....
T Consensus 151 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 151 GVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred ccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 32211 112334677899999887644 6899999999999999999 7888876654332221111000
Q ss_pred ---------------C----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 ---------------L----NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ---------------~----~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .....++.++.+++.+||+.||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 001235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.55 Aligned_cols=247 Identities=22% Similarity=0.419 Sum_probs=206.7
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
|++.+.||+|++|.||++....++ +.+++|++..... ...+.+.+|+..++.++|+|++++++++.. ....++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~---~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~ 76 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTG---KEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVM 76 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCC---cEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEE
Confidence 567799999999999999986543 6899999876543 455788999999999999999999998544 56679999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||.+....
T Consensus 77 e~~~~~~L~~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 77 EFCSGGSLKDLLKSTN-------QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred ecCCCCcHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 9999999999997621 368999999999999999999999999999999999999999999999999998765
Q ss_pred CCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCcH
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV--NCPD 461 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~--~~~~ 461 (499)
.... .....++..|+|||++.+..++.++||||||+++|||++ |+.||...+..+.............+. .++.
T Consensus 150 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (253)
T cd05122 150 DTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-GKPPYSELPPMKALFKIATNGPPGLRNPEKWSD 225 (253)
T ss_pred cccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhcCCCCcCcccccCH
Confidence 4321 234567788999999998889999999999999999999 888998775555444443332333332 3478
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.73 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=215.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|++.+.||+|+||.||++....++ ..+++|++.... .......+.+|+++++.++|+|++++++.... ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDG---KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCC---cEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEE
Confidence 4778899999999999999986544 689999987542 23455678899999999999999999998544 577899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|.+++..... ....+++..+..++.+++.||.|||+.+++|+||+|+||++++++.++|+|||++..
T Consensus 77 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~ 152 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKK----EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152 (258)
T ss_pred EEEecCCCcHHHHHHHhhc----cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceee
Confidence 9999999999999986321 124689999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..++............+..+++
T Consensus 153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (258)
T cd08215 153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT-LKHPFEGENLLELALKILKGQYPPIPSQYSS 229 (258)
T ss_pred cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc-CCCCCCCCcHHHHHHHHhcCCCCCCCCCCCH
Confidence 54332 12234467888999999999999999999999999999998 8899988877777776666555566667899
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+++.+||..+|++|||+.++++
T Consensus 230 ~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 230 ELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.45 Aligned_cols=249 Identities=19% Similarity=0.324 Sum_probs=208.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~ 300 (499)
++++.+..||.|+.|.|+++++...+ ...|||.+....+....++++..+.++.+-+ .|.||+.+||... +...+
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~---~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~ 167 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTG---HIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVF 167 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccc---eEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHH
Confidence 34566789999999999999998765 7899999998888888888999988877654 8999999999655 44568
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
+.||.|. -.++.+|... .+++++...-++...+..||.||.++ +|||||+||+|||+|+.|++|++|||++
T Consensus 168 IcMelMs-~C~ekLlkri-------k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 168 ICMELMS-TCAEKLLKRI-------KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHH-HHHHHHHHHh-------cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccc
Confidence 8999987 5566666642 24688999999999999999999975 8999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEI-DPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-~~~~~~~~i~~~~~~~~ 455 (499)
..+..+. ..+...|.+.|||||.+. ..+|+.++||||||++++||+| |+.||.+- ..+++...+.+...+..
T Consensus 240 GrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT-g~yPy~~c~tdFe~ltkvln~ePP~L 315 (391)
T KOG0983|consen 240 GRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT-GQYPYKGCKTDFEVLTKVLNEEPPLL 315 (391)
T ss_pred ceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc-ccCCCCCCCccHHHHHHHHhcCCCCC
Confidence 8776544 345667888999999996 4579999999999999999999 99999874 45677777766544443
Q ss_pred CC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 PV--NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~~--~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+. .+++.+.+++..|+.+|+.+||...++++
T Consensus 316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 33 47899999999999999999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=305.99 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=199.1
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+|++.+.||+|++|.||+|+...++ ..+++|.+.........+.+.+|+.++++++|+||+++++++.. .+..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTG---EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCC---eEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEE
Confidence 4678899999999999999986544 78999998765433344667889999999999999999998654 5667999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||++ ++|.+++.... ....+++..+..++.|++.||.|||+.+++||||||+||++++++.++|+|||+++..
T Consensus 77 ~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~ 150 (284)
T cd07836 77 FEYMD-KDLKKYMDTHG-----VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF 150 (284)
T ss_pred EecCC-ccHHHHHHhcC-----CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence 99999 58999887532 1245899999999999999999999999999999999999999999999999999755
Q ss_pred CCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---------- 451 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---------- 451 (499)
..... ......++..|++||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+....
T Consensus 151 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07836 151 GIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNEDQLLKIFRIMGTPTESTWPG 227 (284)
T ss_pred cCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhhHHH
Confidence 32211 1223456788999999865 457899999999999999999 889998766544333221110
Q ss_pred -------CCCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 -------RLNQ-----------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 -------~~~~-----------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... ....+.++.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 1134678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=306.04 Aligned_cols=250 Identities=20% Similarity=0.371 Sum_probs=207.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
...|+..+.||+|+||.||+|.....+ ..+++|++..... ..+.+.+|++.++.++|+|++++++++.. ....+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 91 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATG---KEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELW 91 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCC---cEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEE
Confidence 345666799999999999999986443 6799999875533 45678899999999999999999998654 56779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~-------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNF-------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred EEEeccCCCcHHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 9999999999999998732 368999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--CCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN--QPVN 458 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--~~~~ 458 (499)
....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...++......+....... .+..
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd06614 165 QLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE-GEPPYLREPPLRALFLITTKGIPPLKNPEK 241 (286)
T ss_pred hhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcCCCCCcchhh
Confidence 5533211 1223456778999999998899999999999999999999 899998877665544443332222 2224
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.++.+++.+||+.+|.+||++.+++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 7889999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=301.99 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=204.6
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+|.+.+.||+|+||.||++.....+......++|..... ........+..|+.++++++||||+++++++. .....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-ERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-cCCceEE
Confidence 577889999999999999987654322223334433221 12223345678999999999999999999854 4556799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|..++..... ....+++.+++.++.|++.||.|||+.+++|+||||+||++++ +.+||+|||+++.
T Consensus 80 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKH----TGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred EEEeCCCCCHHHHHHHHhh----cccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 9999999999999975321 1246899999999999999999999999999999999999986 4699999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcH
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~ 461 (499)
...... ......++..|+|||.+.+..++.++|+||||+++|||++ +..||...+..+....+..+..+..+..++.
T Consensus 155 ~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (260)
T cd08222 155 LMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFLSVVLRIVEGPTPSLPETYSR 231 (260)
T ss_pred cCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcCCCCCCcchhcH
Confidence 644322 2234557788999999988889999999999999999999 8888877666666666666656666677889
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 232 QLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhh
Confidence 9999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=308.54 Aligned_cols=246 Identities=19% Similarity=0.320 Sum_probs=200.6
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
|...+.||+|+||.||+|+...++ ..+++|.+... ........+.+|++++++++|+|++++++++.. +...++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l 102 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTN---EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWL 102 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCC---cEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEE
Confidence 445589999999999999976544 67999988643 233445678899999999999999999998655 456699
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||++ |+|.+++... ...+++.++..++.|++.||.|||+.+|+||||+|+||++++++.+||+|||++..
T Consensus 103 v~e~~~-g~l~~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 103 VMEYCL-GSASDLLEVH-------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred EEeCCC-CCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 999997 6888877642 23589999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLNQPV 457 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~ 457 (499)
.... ....++..|+|||++. .+.++.++|||||||++|||++ |+.||...+..+....+.... ....+.
T Consensus 175 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd06635 175 ASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPTLQSN 247 (317)
T ss_pred cCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhccCCCCCCc
Confidence 4321 2345778899999984 4568999999999999999999 888887766655544444332 233344
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
.+++.+.+++.+||+.+|.+||++.++++.+
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 6788999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.95 Aligned_cols=250 Identities=18% Similarity=0.296 Sum_probs=194.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+|++.+.||+|+||.||+|.....+ ..+++|.+...........+.+|+.+++.++|+||+++++++ ..+...++
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~l 80 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRING---QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-HTKETLTF 80 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCC---cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-ecCCeEEE
Confidence 46888899999999999999876554 679999986543333334567899999999999999999985 44567799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 81 v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHP-------GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred EEeccc-CCHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 999996 78877775421 3478888999999999999999999999999999999999999999999999975
Q ss_pred cCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHc--C-------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPF-EMAASLQD--G------- 450 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~-~~~~~i~~--~------- 450 (499)
...... ......++..|+|||++.+. .++.++|||||||++|||+| |+.||...+.. +....+.. +
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 153 KSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ-GQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred cCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 432211 12234567889999998764 58899999999999999999 88898765432 21111110 0
Q ss_pred -------------CCCCC---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 -------------YRLNQ---------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 -------------~~~~~---------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..... ....+.++.+++.+|++.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 0123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=319.23 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=201.2
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-C-----CcceeEEeEE
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-H-----KNILTVLGVS 292 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~g~~ 292 (499)
....+|.+.++||+|+||.|-||....++ +.||||++++.. ....+-..|+.+|..|+ | -|+|+++++
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~---e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~- 256 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTG---EIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY- 256 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCC---cEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-
Confidence 33448999999999999999999987766 899999998763 33345568999999887 3 479999998
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--CCc
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD--KLR 370 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~--~~~ 370 (499)
+.-.++.+||+|.+. -+|.++|..++ ...|+...+..++.||+.||.+||+.+|||+||||+||||.+ ...
T Consensus 257 F~fr~HlciVfELL~-~NLYellK~n~------f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLS-TNLYELLKNNK------FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred cccccceeeeehhhh-hhHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCc
Confidence 566788899999998 89999999754 456999999999999999999999999999999999999974 347
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
+||.|||.|......-+ .-.-+..|.|||++++.+|+.+.||||||||+.||++ |.+.|.+.+..+....|.+-
T Consensus 330 vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~t-G~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFT-GEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred eeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhc-CccccCCCCHHHHHHHHHHH
Confidence 99999999986543332 2233456999999999999999999999999999999 89999988766544433221
Q ss_pred CCC---------------------------------------------------CCC-C----------CCcHHHHHHHH
Q psy1789 451 YRL---------------------------------------------------NQP-V----------NCPDELFSVMA 468 (499)
Q Consensus 451 ~~~---------------------------------------------------~~~-~----------~~~~~~~~l~~ 468 (499)
... ..| . .....+.+++.
T Consensus 404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk 483 (586)
T KOG0667|consen 404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK 483 (586)
T ss_pred hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence 000 011 0 11224899999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q psy1789 469 YCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 469 ~C~~~~P~~RPt~~~v~~ 486 (499)
+|++.||.+|+|..|.++
T Consensus 484 ~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 484 RCLEWDPAERITPAQALN 501 (586)
T ss_pred HHhccCchhcCCHHHHhc
Confidence 999999999999999875
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=302.81 Aligned_cols=246 Identities=18% Similarity=0.318 Sum_probs=203.2
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
||+|+||.||+++....+ +.+++|.+.... .....+.+.+|++++++++|+||+++++.+ ......++++||++
T Consensus 1 lg~g~~~~vy~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG---DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-QGKKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECCCC---CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-ecCcEEEEEEecCC
Confidence 588999999999986544 689999986542 224557789999999999999999999874 55667799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++... ..+++..+..++.|++.||+|||+++++|+||+|+||++++++.++|+|||++........
T Consensus 77 ~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 77 GGDLASLLENV--------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred CCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 99999999862 2589999999999999999999999999999999999999999999999999876543211
Q ss_pred ------cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC--
Q psy1789 388 ------HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC-- 459 (499)
Q Consensus 388 ------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~-- 459 (499)
........++..|+|||......++.++||||||+++||+++ |..||......+....+..+ ....+..+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 226 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNG-KIEWPEDVEV 226 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-CcCCCccccC
Confidence 012223456778999999998889999999999999999999 89999888877777666553 23334444
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
++++.+++.+||+.+|++|||+.++.+.|+
T Consensus 227 ~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 899999999999999999999966655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=295.99 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=209.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-CceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH-TSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~~ 300 (499)
+|+..+.||+|++|.||+|....++ +.+++|.+.... .....+.+.+|+..+++++|+||+++++.+.... ...+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTG---ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEE
Confidence 3567799999999999999986544 689999886543 2455678999999999999999999999865431 5679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+++||+++++|.+++... ..+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|+|||.+.
T Consensus 78 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~ 149 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKF--------GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAK 149 (260)
T ss_pred EEEEecCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEE
Confidence 999999999999999862 268999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHc-CCCCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-PFEMAASLQD-GYRLNQPVN 458 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~~~~~~~i~~-~~~~~~~~~ 458 (499)
...............++..|+|||.+.+...+.++||||||++++||++ |..||...+ .......+.. ......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAALYKIGSSGEPPEIPEH 228 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHhccccCCCcCCCcc
Confidence 7654432111234567788999999998889999999999999999999 888887765 2222223322 334455667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+.++.+++.+||+.+|++||++.|+++
T Consensus 229 ~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 229 LSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 7899999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.37 Aligned_cols=243 Identities=16% Similarity=0.261 Sum_probs=196.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHH-hcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAM-YGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.||+|+||.||+|.....+ +.+|+|++.... .......+..|..++ ...+|+|++++++++ ..++..++|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG---DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-QSKDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC---CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-EcCCeEEEEEe
Confidence 57899999999999876544 689999986532 122233445555544 456899999999986 44667899999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||++++++.+||+|||+++....
T Consensus 78 ~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 78 YLNGGDCASLIKTL--------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred ccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 99999999999762 3588999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCcH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---RLNQPVNCPD 461 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~ 461 (499)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+.... .......+++
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINWPEEVKEFCSP 222 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcccCCCCcccccCCH
Confidence 223457788999999998889999999999999999999 899998877776665554332 1222335789
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 462 ELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 462 ~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
++.+++.+||+.+|++||++.++.+.|.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 9999999999999999998876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.38 Aligned_cols=242 Identities=17% Similarity=0.228 Sum_probs=189.3
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHH---HhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMA---MYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~---l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
.||+|+||.||++....++ +.+|+|.+..... ......+.+|..+ +...+|+||+.+++++ ..++..++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-HTPDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECCCC---cEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-ecCCeEEEEE
Confidence 4799999999999876544 6899998864321 1222334445443 3345799999999885 4456679999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.++|+|||++....
T Consensus 77 e~~~~~~L~~~i~~~--------~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 77 DLMNGGDLHYHLSQH--------GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred ecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999999998762 358999999999999999999999999999999999999999999999999987543
Q ss_pred CCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCCCCCCCCCc
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF--EMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~ 460 (499)
... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||...... ..............+..++
T Consensus 149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd05633 149 KKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223 (279)
T ss_pred ccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh-CCCCcCCCCCcCHHHHHHHhhcCCcCCccccC
Confidence 221 123468889999999874 568999999999999999999 88898654321 1222222233445566788
Q ss_pred HHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRP-----TFPQLHSC 487 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RP-----t~~~v~~~ 487 (499)
+++.+++.+||+.||++|| +++++++.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999999999999 58887663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=312.79 Aligned_cols=249 Identities=19% Similarity=0.247 Sum_probs=198.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++.+.||+|+||.||+|....++ +.+|+|.+... ........+.+|+.++++++|+||+++++++....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTG---QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCC---CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 357888999999999999999976554 68999998643 23344566788999999999999999999854322
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++|+||+. ++|.+.+.. .++...+..++.|++.||+|||+++|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQM----------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEc
Confidence 34699999997 688888864 27889999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--- 451 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--- 451 (499)
|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+....
T Consensus 161 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 236 (353)
T cd07850 161 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR-GTVLFPGTDHIDQWNKIIEQLGTP 236 (353)
T ss_pred cCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999998653321 1223457788999999999999999999999999999999 888987665433222111100
Q ss_pred ------------------CCC--------------C-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 ------------------RLN--------------Q-------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 ------------------~~~--------------~-------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
++. . +...++++.+++.+||+.||++|||+.|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 11245678999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=308.00 Aligned_cols=252 Identities=17% Similarity=0.313 Sum_probs=195.5
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv 302 (499)
++..+.||+|+||.||++....++ +.+|+|.+...........+.+|+.++.++. |+||+++++++.. +...+++
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~ 81 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSG---TIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWIC 81 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCC---CEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEE
Confidence 344588999999999999986554 7899999876544455677899999999996 9999999998655 5566999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+||+. ++|.++..... ......+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 82 ~e~~~-~~l~~l~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMD-ISLDKFYKYVY---EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred Eeccc-CCHHHHHHHHH---HhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 99987 45555432110 00124689999999999999999999975 999999999999999999999999999976
Q ss_pred cCCCCccccCCCCCCccccccccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCC---
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHK---TFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRLN--- 454 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~--- 454 (499)
..... ......++..|+|||++.+. .++.++|||||||++|||++ |++||..... .+....+..+..+.
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd06616 158 LVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT-GKFPYPKWNSVFDQLTQVVKGDPPILSN 233 (288)
T ss_pred hccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHh-CCCCchhcchHHHHHhhhcCCCCCcCCC
Confidence 54322 11234578889999999876 68999999999999999999 8999876542 12222222221111
Q ss_pred -CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 455 -QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 455 -~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.+..++.++.+++.+||+.+|++|||+++|++.
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 123478899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.87 Aligned_cols=254 Identities=21% Similarity=0.285 Sum_probs=196.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCC---
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHT--- 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~--- 297 (499)
+|++.+.||+|+||.||+|....++ +.||+|....... ......+.+|+.+++.++ |+||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~---~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTG---KLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCC---cEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 5788899999999999999986554 7899998764322 222356788999999995 6999999998654332
Q ss_pred -ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCcEEEcc
Q psy1789 298 -SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRIQITD 375 (499)
Q Consensus 298 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-~~~~kl~D 375 (499)
..++||||++ ++|.+++..... .....+++..+..++.|++.||.|||+++|+||||||+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLD-SDLKKFMDSNGR---GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccC-cCHHHHHHHhcc---cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEee
Confidence 2699999999 489999876321 11246899999999999999999999999999999999999998 89999999
Q ss_pred cccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-- 452 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-- 452 (499)
||+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++ |.+||...+..+....+.....
T Consensus 155 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 155 LGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred cccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999886532211 1123345778999998865 457999999999999999999 7888877655443222211000
Q ss_pred -----------------CC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 -----------------LN--------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 -----------------~~--------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+. .....+.++.+++.+||+.||++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 01246788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=303.93 Aligned_cols=254 Identities=19% Similarity=0.326 Sum_probs=200.1
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDH 296 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~ 296 (499)
.+....|++.+.||+|+||.||+|.....+ +.+|||.+...........+..|+.++.+.+ |+||+++++++.. .
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~ 86 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTG---HVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-D 86 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCC---eEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-C
Confidence 344566788899999999999999986543 7899999976544444456677887776664 9999999999755 5
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...+++|||++ ++|..++.... ..+++..+..++.|++.||+|||+ .+|+||||+|+||++++++.+||+|
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRIQ-------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECc
Confidence 56799999986 57877776521 368999999999999999999997 5999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT----FSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDG 450 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~ 450 (499)
||++........ .....++..|+|||++.+.. ++.++||||||+++|||++ |+.||..... .+....+...
T Consensus 159 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~ 234 (296)
T cd06618 159 FGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT-GQFPYKNCKTEFEVLTKILQE 234 (296)
T ss_pred cccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh-CCCCCCcchhHHHHHHHHhcC
Confidence 999876533221 12335677899999987654 8899999999999999999 8889876432 3444444333
Q ss_pred CCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 451 YRLNQP--VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 451 ~~~~~~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.....+ ..+++++.+++.+||+.||++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 235 EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222222 2478899999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=302.27 Aligned_cols=250 Identities=19% Similarity=0.275 Sum_probs=199.3
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~~l 301 (499)
|++.+.||+|+||.||+|+..+.+ +.+++|.+.... .......+.+|+.+++.++|+|++++++++... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTG---ELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCC---eEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 456799999999999999986654 789999997553 233346788999999999999999999997654 267899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+++|+||||+||++++++.+||+|||+++.
T Consensus 78 v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~ 149 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPE-------VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARP 149 (287)
T ss_pred Eecccc-ccHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceee
Confidence 999998 58998887521 3689999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL------- 453 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~------- 453 (499)
....... ......++..|+|||.+.+ ..++.++||||||+++|||+| |+.||...+..+....+......
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 150 YTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL-GKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred ccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 6543211 1223456778999998765 458999999999999999999 78999876655443333221000
Q ss_pred -------------C---------CCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 -------------N---------QPVN-CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 -------------~---------~~~~-~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .... ++.++.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0011 3778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=306.40 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=200.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-Cc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH-TS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~ 298 (499)
..+|++.+.||+|+||.||+|....++ ..||+|.+..... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSG---EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCC---cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 456888899999999999999986544 6799999864321 112234568999999999999999999865433 45
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+. ++|.+++.... ..+++.++..++.|++.||+|||+.+++||||||+||++++++.+||+|||+
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~ 154 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP-------TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGL 154 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccce
Confidence 799999998 58999887532 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR----- 452 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~----- 452 (499)
++....... ......++..|+|||.+.+ ..++.++|||||||++|||++ |++||...++.+....+.....
T Consensus 155 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 155 ARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA-HKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred eeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 986643221 1223345678999999875 558999999999999999999 8899988777665544432110
Q ss_pred ----------------CCCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 ----------------LNQP--------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ----------------~~~~--------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+ ...++++.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 124678899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.28 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=197.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-CceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH-TSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-~~~~ 300 (499)
.|++.+.||+|+||.||+|....++ +.+++|.+..... ......+.+|+.++++++||||+++++++.... ...+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTG---EIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCC---cEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 5667799999999999999986544 6799999864322 222345678999999999999999999865442 6789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||++ ++|.+++.... ..+++..+..++.|++.||+|||+++++|+||||+||++++++.+||+|||+++
T Consensus 83 lv~e~~~-~~L~~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-------QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 9999998 59999987532 258999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-------- 451 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 451 (499)
....... ......++..|+|||.+.+. .++.++|+||||+++|||++ |.+||......+....+....
T Consensus 155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 155 EYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred eccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 6543211 11234467789999998764 46899999999999999999 888988766544333221100
Q ss_pred ----------------------CCCCCCC-CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ----------------------RLNQPVN-CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ----------------------~~~~~~~-~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+.. .++.+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0011112 4788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=312.01 Aligned_cols=256 Identities=20% Similarity=0.319 Sum_probs=207.5
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEe-cCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSI 293 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~-~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~ 293 (499)
-+.+.+..|++++.||.||.++||++...+. +.+|+|++ ..........-|.+|+..|.+|+ |.+||+|++| .
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~----~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY-E 429 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDK----QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY-E 429 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCC----cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee-e
Confidence 3567788999999999999999999986554 44555555 45566777889999999999995 9999999999 4
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
-.++.+|+||||-+ .+|..+|.+... ...+| .+..+..|++.|+.++|+.||||.||||.|.|+- .|.+||
T Consensus 430 v~d~~lYmvmE~Gd-~DL~kiL~k~~~------~~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKL 500 (677)
T KOG0596|consen 430 VTDGYLYMVMECGD-IDLNKILKKKKS------IDPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKL 500 (677)
T ss_pred ccCceEEEEeeccc-ccHHHHHHhccC------CCchH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEe
Confidence 45778899999876 899999987431 22334 8899999999999999999999999999999987 467999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCC-----------CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT-----------FSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
.|||+|..+.++.........+||+.||+||.+.... .++++||||+||+||+|+. |++||.......
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY-gktPf~~~~n~~ 579 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY-GKTPFGQIINQI 579 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh-cCCchHHHHHHH
Confidence 9999999998887777788899999999999996432 5689999999999999999 999998654221
Q ss_pred -HHHHHHcC-CCCCCCC-CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 443 -MAASLQDG-YRLNQPV-NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 443 -~~~~i~~~-~~~~~~~-~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
-...+.+. ...++|. ....++.++|..||+.||.+||+..+|++
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 12223222 3334443 23456999999999999999999999974
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=301.01 Aligned_cols=242 Identities=18% Similarity=0.245 Sum_probs=194.7
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
||+|+||+||++.....+ +.+++|.+.... .......+.+|+.+++.++||||+++++++ ...+..++|+||++
T Consensus 1 lg~g~~g~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKATG---KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-ETKDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcCCC---cEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-ecCCeEEEEEecCC
Confidence 688999999999876544 679999886432 222345677899999999999999999984 55667899999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++.... ...+++.++..++.|++.||.|||+.+++||||+|+||++++++.+||+|||+++......
T Consensus 77 ~~~L~~~l~~~~------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 149 (277)
T cd05577 77 GGDLKYHIYNVG------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK- 149 (277)
T ss_pred CCcHHHHHHHcC------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-
Confidence 999999998632 1358999999999999999999999999999999999999999999999999987653311
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCcHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEMAASLQDGYRLNQPVNCPDEL 463 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~ 463 (499)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .++..... ......+...++++
T Consensus 150 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 225 (277)
T cd05577 150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEA 225 (277)
T ss_pred --ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhh-CCCCCCCCcccccHHHHHhccc-cccccCCccCCHHH
Confidence 1223456778999999998889999999999999999999 8899876543 22222222 12334455678999
Q ss_pred HHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 464 FSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 464 ~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
.+++.+||+.||++|| ++.+++.
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHh
Confidence 9999999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=302.27 Aligned_cols=242 Identities=16% Similarity=0.300 Sum_probs=202.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
..||+|+||.||++....++ ..+++|.+... .......+.+|+.+++.++|+||+++++++ ...+..+++|||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSG---KLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSY-LVGDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCC---eEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEE-EeCCEEEEEEecCC
Confidence 67899999999999886554 78999988644 333456789999999999999999999985 44667799999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++.. ..+++.....++.|++.||+|||+.+++|+||||+||++++++.++|+|||++........
T Consensus 101 ~~~L~~~~~~---------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 101 GGALTDIVTH---------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred CCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 9999998764 3478999999999999999999999999999999999999999999999999875532211
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCcHHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL--NQPVNCPDELFS 465 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~ 465 (499)
......++..|+|||++.+..++.++|+|||||++|||++ |.+||...+..+....+...... .....++.++.+
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKG 248 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHH
Confidence 1223557888999999988889999999999999999999 88999887766665555443322 223357889999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q psy1789 466 VMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 466 l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++.+||+.+|.+||++.++++
T Consensus 249 li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhc
Confidence 999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=311.68 Aligned_cols=252 Identities=19% Similarity=0.330 Sum_probs=198.5
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcC-CCc
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIED-HTS 298 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~-~~~ 298 (499)
.+|++.+.||+|+||.||+|....++ ..+++|++... ........+.+|+.+++++ +|+||+++++++... ...
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTK---EVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCC---eEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 45667799999999999999976544 67999988542 2233445677899999999 999999999986543 345
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||++ ++|..++.. ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA---------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 799999998 699998875 2578999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcc---ccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Q psy1789 379 ARDLFPSDYH---CLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--- 451 (499)
Q Consensus 379 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--- 451 (499)
++........ .......++..|+|||.+.+ ..++.++||||||+++|||+| |+.||......+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL-GKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Confidence 9866443221 11223457888999998865 557899999999999999999 888987655443322211110
Q ss_pred ------------------------CC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 ------------------------RL---NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 ------------------------~~---~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.. .....++.++.+++.+||+.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 0112367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=301.36 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=209.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCc
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTS 298 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~ 298 (499)
++|.+.+.||+|+||.||+|....++ +.+++|++... ......+.+.+|..++++++ |+||+++++++ .....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETN---KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-QDEEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCC---CEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-cCCce
Confidence 36788899999999999999986544 68999988653 23344567889999999998 99999999984 55667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||++++++.++|+|||+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKY--------GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcc
Confidence 89999999999999999862 3699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcc------------------ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy1789 379 ARDLFPSDYH------------------CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440 (499)
Q Consensus 379 a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~ 440 (499)
+......... .......++..|+|||......++.++||||||++++|+++ |+.||...+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 227 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT-GKPPFRGSNE 227 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCccH
Confidence 9866433211 11223456788999999998889999999999999999999 8999988776
Q ss_pred HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q psy1789 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTF----PQLHS 486 (499)
Q Consensus 441 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~----~~v~~ 486 (499)
......+.. .....+...++++.+++.+||+.+|++||++ +|+++
T Consensus 228 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTFQKILK-LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHHh-cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 555555443 2445566778999999999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=302.15 Aligned_cols=256 Identities=17% Similarity=0.235 Sum_probs=204.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCc
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 298 (499)
+|++.+.||+|+||.||+++..........+|||++.... .....+.+.+|+.++.++ +|+||+++++. +..+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-~~~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-FQTDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-eecCCE
Confidence 3677899999999999999865433333679999886431 223345688999999999 59999999987 455667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+++||||||+||++++++.++|+|||+
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQR--------EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred EEEEEecCCCCcHHHHHhhc--------CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcc
Confidence 79999999999999998752 3588999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHcCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKT--FSTASDVWAFGVLLWELTTLAQQPYAEID----PFEMAASLQDGYR 452 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwS~Gvvl~el~t~g~~p~~~~~----~~~~~~~i~~~~~ 452 (499)
++........ ......++..|+|||.+.+.. .+.++||||||+++|||++ |..||.... ..++...+... .
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t-g~~p~~~~~~~~~~~~~~~~~~~~-~ 228 (288)
T cd05583 152 SKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT-GASPFTVDGEQNSQSEISRRILKS-K 228 (288)
T ss_pred cccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh-CCCCcccCcccchHHHHHHHHHcc-C
Confidence 8865443221 122345788999999987765 7899999999999999999 888886432 22333333332 3
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
...+..++.++.+++.+||+.||++|||+.++...|+.
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 44556678899999999999999999999888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=303.99 Aligned_cols=246 Identities=19% Similarity=0.310 Sum_probs=199.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+|...+.||+|+||.||+|+...++ ..+++|.+... ........+.+|+.+++.++|+|++++++++.. ....+
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 91 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAW 91 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCC---cEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeE
Confidence 3444588999999999999986544 67999988532 233445678899999999999999999998655 45679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+||+. |+|.+++.... ..+++.++..++.|++.||.|||+.+++||||||+||++++++.+||+|||++.
T Consensus 92 lv~e~~~-~~l~~~~~~~~-------~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 163 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (308)
T ss_pred EEEEccC-CCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccce
Confidence 9999997 68888876421 358899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-CC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN-QP 456 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-~~ 456 (499)
..... ....++..|+|||.+. ...++.++|||||||++|||++ |..||...+..+....+.....+. .+
T Consensus 164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06634 164 IMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPALQS 236 (308)
T ss_pred eecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc-CCCCCccccHHHHHHHHhhcCCCCcCc
Confidence 65432 2345778899999985 3568899999999999999999 788887766555444444333332 23
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..++.++.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 4678889999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=304.67 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=198.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++.+.||+|+||.||+|....++ +.+++|.+.... .......+.+|++++++++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTG---ELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCC---cEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 346777899999999999999986544 678999986432 2222346778999999999999999999865432
Q ss_pred ------CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 297 ------TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 297 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
...++|+||+++ ++..++... ...+++..+..++.|++.||+|||+.+|+||||||+||++++++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-------LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc
Confidence 367999999985 777777642 235899999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
+||+|||+++........ ......++..|+|||.+.+ ..++.++|||||||++|||++ |++||...+..+....+..
T Consensus 155 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~-g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 155 IKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQELAQLELISR 232 (302)
T ss_pred EEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence 999999999866433221 1123345678999998865 457899999999999999999 8899987665554433322
Q ss_pred CCC---C--------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 GYR---L--------------------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 ~~~---~--------------------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... + .....++.++.+++..||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 100 0 011246789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=301.49 Aligned_cols=249 Identities=20% Similarity=0.303 Sum_probs=195.9
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
|++.+.||+|++|.||+|....++ ..+++|++.... .......+.+|+.+++.++|+||+++++++. .....+++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-~~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTG---EIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-SENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCC---CEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-cCCeEEEE
Confidence 355689999999999999976544 679999886442 2223356888999999999999999999964 45678999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||++ ++|.+++.... ...+++..+..++.|++.||+|||+++++||||+|+||++++++.++|+|||+++..
T Consensus 77 ~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 77 FEFLD-LDLKKYMDSSP------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred EeccC-cCHHHHHhhCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 99996 79999987632 135899999999999999999999999999999999999999999999999999755
Q ss_pred CCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----------
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG----------- 450 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~----------- 450 (499)
..... ......++..|+|||++.+. .++.++||||||+++|||++ |++||...+..+....+...
T Consensus 150 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 150 GVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred CCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 32211 11233457789999988764 57899999999999999999 88898776553322211110
Q ss_pred -------------CC----CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 -------------YR----LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 -------------~~----~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. .......+.++.+++.+||+.+|++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=300.24 Aligned_cols=251 Identities=19% Similarity=0.261 Sum_probs=196.0
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++.+.||+|++|.||+|....++ +.+++|.+.... .....+.+.+|+.++++++|+||+++++++. .....+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTN---ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCC---cEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-cCCeEE
Confidence 46888899999999999999986544 679999886432 2233456889999999999999999999864 456789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCcEEEcccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRIQITDNALA 379 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-~~~~kl~DfGla 379 (499)
+|+||++ ++|.+++.... ...+++.....++.|++.||+|||+++++||||||+||++++ ++.+||+|||++
T Consensus 78 lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSP------DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred EEEeccc-ccHHHHHHhCC------CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence 9999997 68888876422 224678889999999999999999999999999999999985 567999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC------
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR------ 452 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~------ 452 (499)
+....... ......++..|+|||++.+. .++.++|||||||++|||+| |++||...+..+....+.....
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 151 RAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKIFRILGTPNEET 227 (294)
T ss_pred cccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 75432211 11234567889999998764 57899999999999999999 8899987655443322211000
Q ss_pred --------------CC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 --------------LN--------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 --------------~~--------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+. .....++++.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 01245778999999999999999999999986
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=297.95 Aligned_cols=240 Identities=17% Similarity=0.235 Sum_probs=190.3
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHH---HHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEG---MAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
+||+|+||.||++.....+ +.+|+|.+..... ......+..|. ..++...||||+.+++++ ...+..++|+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-HTPDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCC---CEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-ecCCEEEEEE
Confidence 4799999999999876544 6899998865321 11122334443 344556899999999874 5566789999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||+++...
T Consensus 77 e~~~g~~L~~~l~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 77 DLMNGGDLHYHLSQH--------GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred ecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999999998752 358999999999999999999999999999999999999999999999999987653
Q ss_pred CCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcCCCCCCCCCC
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEID---PFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~ 459 (499)
... .....|+..|+|||.+.++ .++.++|||||||++|||++ |+.||.... ..+. ...........+..+
T Consensus 149 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~-g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 222 (278)
T cd05606 149 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEI-DRMTLTMAVELPDSF 222 (278)
T ss_pred ccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHh-CCCCCCCCCccchHHH-HHHhhccCCCCCCcC
Confidence 221 1234688899999999754 68999999999999999999 888987653 2222 222233345556667
Q ss_pred cHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
+.++.+++.+|+..+|++|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 89999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=302.37 Aligned_cols=253 Identities=17% Similarity=0.250 Sum_probs=195.0
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH---- 296 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---- 296 (499)
.+|++.+.||+|+||.||+|....++ +.+|+|.+.... .......+.+|+.++++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTK---QIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCC---cEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 46888899999999999999976544 789999886432 2222345668999999999999999999875432
Q ss_pred ---CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 297 ---TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 297 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
...++|+||+. ++|.+++... ...+++.++..++.|++.||+|||+++++|+||||+||++++++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEE
Confidence 23599999998 5888888652 135899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcc--ccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Q psy1789 374 TDNALARDLFPSDYH--CLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD- 449 (499)
Q Consensus 374 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~- 449 (499)
+|||++......... .......++..|+|||.+.+. .++.++||||||+++|||+| |++||...+.......+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t-~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Confidence 999999865432211 111234567789999988764 47899999999999999999 8889887665443222211
Q ss_pred --CCCC---------------CC-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 --GYRL---------------NQ-------------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 --~~~~---------------~~-------------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... .. +....+.+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 00 0113456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=305.63 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=211.4
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGV 291 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 291 (499)
+..+.+..+.++.-++||+|+||.||-++...++ +.+|.|.+.+.. ........++|-.+|.+++-+.||.+ .|
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTG---KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl-aY 252 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATG---KMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL-AY 252 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecch---hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE-ee
Confidence 4446777888999999999999999999877665 788888885431 22334556789999999999988886 45
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
.++..+.++||+..|.+|+|.-+|.... ...++++.++.++.+|+.||++||+++||+|||||+|||||++|++
T Consensus 253 AfeTkd~LClVLtlMNGGDLkfHiyn~g------~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Ghv 326 (591)
T KOG0986|consen 253 AFETKDALCLVLTLMNGGDLKFHIYNHG------NPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHV 326 (591)
T ss_pred eecCCCceEEEEEeecCCceeEEeeccC------CCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCe
Confidence 5788888999999999999999998633 2479999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID----PFEMAASL 447 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~----~~~~~~~i 447 (499)
+|+|.|||..+...... ...+||.+|||||++.+..|+...|+||+||++|||+. |+.||.... .+++...+
T Consensus 327 RISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~-G~sPFr~~KeKvk~eEvdrr~ 402 (591)
T KOG0986|consen 327 RISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA-GHSPFRQRKEKVKREEVDRRT 402 (591)
T ss_pred EeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc-ccCchhhhhhhhhHHHHHHHH
Confidence 99999999988655433 34589999999999999999999999999999999999 888987532 22333333
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q psy1789 448 QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 482 (499)
.. ...+.+...+++++++.+..+++||++|.-.+
T Consensus 403 ~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 LE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 33 24556678999999999999999999997544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=308.53 Aligned_cols=251 Identities=20% Similarity=0.312 Sum_probs=198.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH---- 296 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---- 296 (499)
.+|.+.+.||+|+||.||+|....++ +.|+||.+... ........+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETN---EKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCC---CeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 47888999999999999999976544 78999988643 12233456778999999999999999999754332
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+.+++||||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRS--------SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcC
Confidence 34799999997 789988875 235899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc------
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD------ 449 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~------ 449 (499)
|+++....... ......++..|+|||.+.. ..++.++|||||||++|||++ |++||...+.......+..
T Consensus 153 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (337)
T cd07858 153 GLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG-RKPLFPGKDYVHQLKLITELLGSPS 229 (337)
T ss_pred ccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc-CCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99986543221 1223456788999998875 568999999999999999998 8889876543222111110
Q ss_pred ------------------CC---CC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 ------------------GY---RL---NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 ------------------~~---~~---~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.. .. .....+++++.+++.+||+.+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 00 0123577889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.42 Aligned_cols=258 Identities=17% Similarity=0.245 Sum_probs=187.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCcee------------E----EEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVE------------E----EVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN 284 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~------------~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n 284 (499)
..+|++++.||+|+||+||++......+.. . .++.|.+. ........+.+|+.++++++|+|
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK--AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh--cchHHHHHHHHHHHHHHhCCCCC
Confidence 457999999999999999999765432110 0 00111111 12234466889999999999999
Q ss_pred ceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q psy1789 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCV 364 (499)
Q Consensus 285 Iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIl 364 (499)
|+++++++ +.....++|+|++. ++|..++...... ........+...++.|++.||+|||+++||||||||+|||
T Consensus 225 Iv~l~~~~-~~~~~~~lv~e~~~-~~l~~~l~~~~~~---~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL 299 (501)
T PHA03210 225 ILKIEEIL-RSEANTYMITQKYD-FDLYSFMYDEAFD---WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF 299 (501)
T ss_pred cCcEeEEE-EECCeeEEEEeccc-cCHHHHHhhcccc---ccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99999985 44566799999986 6788877643211 1112345677889999999999999999999999999999
Q ss_pred EcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--HH-
Q psy1789 365 VDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID--PF- 441 (499)
Q Consensus 365 ld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~--~~- 441 (499)
++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++++.+|+.... +.
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 99999999999999987643221 122345689999999999999999999999999999999996556665432 11
Q ss_pred HHHHHHHcCC--CC-------------------C---------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 442 EMAASLQDGY--RL-------------------N---------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 442 ~~~~~i~~~~--~~-------------------~---------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++...+.... .. . .....+.++.+++.+|++.||.+|||+.|+++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111111000 00 0 01134567788899999999999999999986
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=294.99 Aligned_cols=246 Identities=19% Similarity=0.270 Sum_probs=211.3
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+..+.++++++||+|+||+|-+++-+.++ +.+|+|+++++ .....+..-..|-++|+..+||.+..| -|.++.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~---k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~L-KYsFQt 239 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATG---KLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSL-KYSFQT 239 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccC---ceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHh-hhhhcc
Confidence 344556777799999999999999865444 88999999865 234445667789999999999998775 455788
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
.+++++||||..+|.|.-+|... ..+++.....+..+|..||.|||+++||+||||.+|.|||.+|++||+|
T Consensus 240 ~drlCFVMeyanGGeLf~HLsre--------r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRE--------RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred CceEEEEEEEccCceEeeehhhh--------hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeee
Confidence 89999999999999999999863 3688888889999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
|||++.... +.......+||+.|+|||++....|+.++|+|.+||+||||++ |+.||...+...+...+... ...+
T Consensus 312 FGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmC-GRLPFyn~dh~kLFeLIl~e-d~kF 387 (516)
T KOG0690|consen 312 FGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMC-GRLPFYNKDHEKLFELILME-DLKF 387 (516)
T ss_pred cccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHh-ccCcccccchhHHHHHHHhh-hccC
Confidence 999986432 2224457899999999999999999999999999999999999 99999988877777766543 5667
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCC
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRP 479 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RP 479 (499)
|...+++++.++.-.+.+||.+|.
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhc
Confidence 889999999999999999999995
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=312.78 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=212.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..|.+...||+|.|+.|..|+...++ ..||+|.+.+. ......+.+.+|+.+|+.++|||||+++.+ .+....++
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~---~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-~~t~~~ly 131 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTG---TEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-IETEATLY 131 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCC---ceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-eeecceeE
Confidence 35778899999999999999987765 78999999764 334444568999999999999999999998 56677889
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||..+|.+.+|+.+. ..+.......++.|+.+|++|||++.|+|||||++|||||.++++||+|||++.
T Consensus 132 lV~eya~~ge~~~yl~~~--------gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKH--------GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred EEEEeccCchhHHHHHhc--------ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccce
Confidence 999999999999999973 345668899999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
.+.... .....+|++.|.|||+..+..|. +++|+||+||++|-|++ |..||.+.+-.++...+..+ +...|...
T Consensus 204 ~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~-GsLPFDG~~lk~Lr~rvl~g-k~rIp~~m 278 (596)
T KOG0586|consen 204 FFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE-GSLPFDGQNLKELRPRVLRG-KYRIPFYM 278 (596)
T ss_pred eecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee-cccccCCcccccccchheee-eeccccee
Confidence 875332 34578899999999999998874 89999999999999999 99999987776665554433 33345556
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+.+..+++++.+..+|.+|++++++.+
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhh
Confidence 778999999999999999999999975
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=298.50 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=195.4
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv 302 (499)
|++.+.||+|+||.||+|+..+++ +.+++|.+.............+|+..+++++ |+||+++++++.. +...++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETG---ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCC---cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEE
Confidence 456799999999999999986554 6799999865433223334567899999999 9999999998644 6677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||+ +|+|.+++.... ...+++.++..++.|++.||.|||+++++|+||+|+||++++++.++|+|||+++..
T Consensus 77 ~e~~-~~~l~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 77 FEYM-EGNLYQLMKDRK------GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred EecC-CCCHHHHHHhcc------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 9999 799999987632 246899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccCCCCCCccccccccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----------
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG----------- 450 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~----------- 450 (499)
..... .....++..|+|||++. +..++.++|+||||+++|||++ |++||......+....+...
T Consensus 150 ~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 150 RSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred cCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHh-CCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 43221 12345677899999885 4558999999999999999999 78888765544332222110
Q ss_pred -------CCCC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 -------YRLN-----------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 -------~~~~-----------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... .....+.++.+++.+||+.+|++|||++|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000 00123578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=303.40 Aligned_cols=258 Identities=22% Similarity=0.281 Sum_probs=195.4
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCce
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTSP 299 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~ 299 (499)
+|++.+.||+|+||.||+|..... +..+.+|+|.+.... .......+.+|+.++++++||||+++++++... +...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 477889999999999999998652 122789999987632 122235677899999999999999999997554 2568
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC----CCcEEEcc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD----KLRIQITD 375 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~----~~~~kl~D 375 (499)
++|+||++ ++|.+++..... .....+++..+..++.|++.||.|||+.+|+||||||+||+++. ++.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAE-HDLWQIIKFHRQ---AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCC-cCHHHHHHhhcc---CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECC
Confidence 99999998 577777754321 11236889999999999999999999999999999999999999 99999999
Q ss_pred cccccccCCCCc-cccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH----------H
Q psy1789 376 NALARDLFPSDY-HCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE----------M 443 (499)
Q Consensus 376 fGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~----------~ 443 (499)
||+++....... ........++..|+|||++.+. .++.++|||||||++|||++ +++||...+... +
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-cCCCCcCCcccccccchhHHHHH
Confidence 999986543221 1122344678889999988764 58999999999999999999 888987543211 0
Q ss_pred H---HHHH---------------------cCCCCCCC-----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 444 A---ASLQ---------------------DGYRLNQP-----------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 444 ~---~~i~---------------------~~~~~~~~-----------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ..+. .......+ ...+.++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0000 00001111 045567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=308.55 Aligned_cols=253 Identities=19% Similarity=0.300 Sum_probs=199.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc---CCC
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE---DHT 297 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---~~~ 297 (499)
.+|++.+.||+|+||.||+|....++ +.+++|++.... .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSG---KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCC---CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 57888899999999999999976654 689999986542 22334667889999999999999999987532 234
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++|+||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||+|||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHS--------DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred eEEEEEehhh-hhHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccc
Confidence 5799999996 789999875 2358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcc--ccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----
Q psy1789 378 LARDLFPSDYH--CLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD----- 449 (499)
Q Consensus 378 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~----- 449 (499)
+++........ .......++..|+|||.+.+ ..++.++|||||||++|||++ |++||...+.......+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~~~~~~~~~~~~~g~~ 231 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG-RRQLFPGKNYVHQLKLILSVLGSP 231 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc-CCCccCCCChHHHHHHHHHHhCCC
Confidence 99765432211 11123467888999999865 568999999999999999999 8999977654332211110
Q ss_pred ------------------CC--CCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 ------------------GY--RLNQ-----PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 ------------------~~--~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.. .... ....++++.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 0111 12467889999999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=305.89 Aligned_cols=255 Identities=17% Similarity=0.286 Sum_probs=193.6
Q ss_pred eeeeee--cceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEG--TFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G--~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
..||+| +||+||+++....+ +.||+|++.... .....+.+.+|+.+++.++||||+++++++. .+...++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTG---TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-TGSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCC---cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-cCCceEEEEe
Confidence 445655 99999999875544 789999986432 3445578899999999999999999999964 4566799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
|+.+|+|.+++.... ...+++..+..++.|++.||+|||+.+|+||||||+||++++++.++++||+.+.....
T Consensus 80 ~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~ 153 (328)
T cd08226 80 FMAYGSANSLLKTYF------PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVR 153 (328)
T ss_pred cccCCCHHHHHHhhc------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence 999999999998632 23588999999999999999999999999999999999999999999999986543321
Q ss_pred CCcc-----ccCCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC------
Q psy1789 385 SDYH-----CLGDNENRPVKWLAIESLVHK--TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY------ 451 (499)
Q Consensus 385 ~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~------ 451 (499)
.... .......++..|+|||++.+. .++.++|||||||++|||++ |++||......+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT-GRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 1100 001112345679999999764 47899999999999999999 889998765433322211110
Q ss_pred ----------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHH
Q psy1789 452 ----------------------------------------RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS--CLQ 489 (499)
Q Consensus 452 ----------------------------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~--~L~ 489 (499)
+...+..+++++.+++.+||+.||++|||+.|+++ .+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~ 312 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHH
Confidence 00111235677999999999999999999999974 344
Q ss_pred HHHH
Q psy1789 490 EFHA 493 (499)
Q Consensus 490 ~~~~ 493 (499)
.+.+
T Consensus 313 ~~~~ 316 (328)
T cd08226 313 QVKE 316 (328)
T ss_pred HHHH
Confidence 4433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.51 Aligned_cols=251 Identities=19% Similarity=0.282 Sum_probs=199.4
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
.....+|++.+.||+|+||.||+|....++ +.+|+|++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTG---QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCC---CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 345667999999999999999999876544 68999987543 22334466789999999999999999999876656
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++++||+. ++|.+++.. ..+++.....++.|++.||.|||+.+|+||||||+||++++++.++|+||
T Consensus 83 ~~~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 83 EDIYFVTELLG-TDLHRLLTS---------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred CcEEEEeehhc-cCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcc
Confidence 67799999985 689988864 34788889999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc------
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD------ 449 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~------ 449 (499)
|+++..... .....++..|+|||.+.+ ..++.++||||||+++|||+| |++||...+.......+.+
T Consensus 153 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t-g~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 153 GLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE-GKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred ccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 998754221 123456778999998866 568999999999999999999 8889876654322111110
Q ss_pred -----------------CC--CCCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 450 -----------------GY--RLNQP-----VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 450 -----------------~~--~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.. ....+ ..+++++.+++.+||+.+|++||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00111 2467889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=299.45 Aligned_cols=245 Identities=20% Similarity=0.347 Sum_probs=198.5
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+...+.||+|+||.||+|+....+ ..+++|.+... ........+.+|+.+++.++|+|++++++++.+ ....++
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~---~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 98 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTN---EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWL 98 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCC---cEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEE
Confidence 444578999999999999876544 67999988643 233445678899999999999999999998654 566799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+. |+|.+++... ...+++.++..++.|++.||.|||+.+++|+||||+||++++++.+||+|||++..
T Consensus 99 v~e~~~-~~l~~~l~~~-------~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 99 VMEYCL-GSASDLLEVH-------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred EEecCC-CCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 999997 6888887642 23589999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-CCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN-QPV 457 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-~~~ 457 (499)
... .....++..|+|||++. ...++.++|||||||++|||++ |.+||...+.......+.....+. ...
T Consensus 171 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 243 (313)
T cd06633 171 SSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNDSPTLQSN 243 (313)
T ss_pred cCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 322 22456788899999984 4568899999999999999999 888888776655555444332222 223
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.+++.+.+++.+||+.+|.+||++.+++..
T Consensus 244 ~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 244 EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 567889999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=296.04 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=195.0
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcC---CCCcceeEEeEEEcCCC--
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGL---SHKNILTVLGVSIEDHT-- 297 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~-- 297 (499)
|++.+.||+|+||.||+|+...++ +.+|+|.+..... ......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTG---RFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCC---CEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 467799999999999999986543 6899999864322 22234566787776554 69999999999755432
Q ss_pred --ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 298 --SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 298 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
..+++|||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||+|+||++++++.+||+|
T Consensus 78 ~~~~~l~~e~~~-~~l~~~l~~~~------~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~d 150 (287)
T cd07838 78 ELKLTLVFEHVD-QDLATYLSKCP------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIAD 150 (287)
T ss_pred CceeEEEehhcc-cCHHHHHHHcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEec
Confidence 2789999998 58999987632 12589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-- 453 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-- 453 (499)
||++........ .....++..|+|||++.+..++.++|||||||++|||++ +.+||......+....+......
T Consensus 151 fg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07838 151 FGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIFDVIGLPS 226 (287)
T ss_pred cCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHh-CCCcccCCChHHHHHHHHHHcCCCC
Confidence 999976533221 123346788999999999999999999999999999999 78899877665544433221000
Q ss_pred -----------------CC-------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 -----------------NQ-------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 -----------------~~-------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. ....++++.+++.+||+.||++||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 0123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.06 Aligned_cols=251 Identities=17% Similarity=0.248 Sum_probs=198.2
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCce
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 299 (499)
|++.+.||+|+||.||++...........+|+|++.... .....+.+.+|+.++.++ +|+||++++++ ++.+...
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-~~~~~~~ 80 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-FQTDTKL 80 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE-eecCCeE
Confidence 677899999999999999875322223679999986432 122346678899999999 59999999887 4556677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+++||||||+|||+++++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--------ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999999762 35889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHcCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHK--TFSTASDVWAFGVLLWELTTLAQQPYAEID----PFEMAASLQDGYRL 453 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~----~~~~~~~i~~~~~~ 453 (499)
+........ ......++..|+|||++.+. .++.++||||||+++|||++ |..||.... ..++...+... ..
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~-~~ 229 (290)
T cd05613 153 KEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT-GASPFTVDGEKNSQAEISRRILKS-EP 229 (290)
T ss_pred eeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc-CCCCCCcCCccccHHHHHHHhhcc-CC
Confidence 865332211 12234578889999998753 47889999999999999999 888886432 23333333332 33
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
..+..++..+.+++.+||+.||++|| ++.+++.
T Consensus 230 ~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 44566888999999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=305.10 Aligned_cols=252 Identities=20% Similarity=0.320 Sum_probs=203.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----C
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH----T 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----~ 297 (499)
+|++.+.||+|+||.||+|+....+ +.+++|.+.... .....+.+.+|+.+++.++|+||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTG---RKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCC---cEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 5788899999999999999976544 679999886543 2344567899999999999999999999865543 3
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||++ ++|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||++++++.++|+|||
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~--------~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg 148 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKS--------PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG 148 (330)
T ss_pred ceEEEecchh-hhHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccC
Confidence 6799999999 589988875 2368999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc-cccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--
Q psy1789 378 LARDLFPSDY-HCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-- 453 (499)
Q Consensus 378 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-- 453 (499)
++........ ........++..|+|||.+.+. .++.++|+||||+++|||++ |++||...+..+....+......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc-CCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 9987644321 0112234567789999999888 89999999999999999999 89999877665544333221100
Q ss_pred ----------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 454 ----------------------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 454 ----------------------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
......+.++.+++.+||+.+|++||++.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0012357789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=297.58 Aligned_cols=248 Identities=20% Similarity=0.278 Sum_probs=198.7
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
|++.+.||+|++|.||+|....++ +.+++|.+.... .......+.+|+.++++++|+||+++++++. .+...++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTG---EIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-HKGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCC---cEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-cCCCEEEE
Confidence 345689999999999999976544 779999886543 2234567889999999999999999999854 45677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||||+||++++++.+||+|||.+...
T Consensus 77 ~e~~~-~~l~~~l~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 77 FEFMD-TDLYKLIKDRQ-------RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred EeccC-CCHHHHHHhhc-------ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 99998 58988887621 36899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--------
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-------- 453 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-------- 453 (499)
..... ......++..|+|||.+.+. .++.++|+||||+++|||+| |+.||...+..+....+......
T Consensus 149 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 149 GSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS-RRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred CCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHcCCCchHhccc
Confidence 54331 11234467789999999876 78999999999999999999 78899876654433222111000
Q ss_pred ---------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 ---------------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ---------------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+++.++.+++..||+.||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011246778999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=301.87 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=195.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++.+.||+|+||.||+|+...++ +.+++|.+..... ......+.+|++++++++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTG---RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCC---cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 357889999999999999999976554 6789998854321 112245678999999999999999998754433
Q ss_pred ----CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 297 ----TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 297 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
...++|+||+. ++|...+... ...+++.++..++.|+++||+|||+++|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~~-------~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~ 155 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLENP-------SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILK 155 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhcc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 23689999998 5777777642 23589999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCcccc---------CCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 373 ITDNALARDLFPSDYHCL---------GDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
|+|||+++.......... .....++..|+|||.+.+. .++.++|||||||++|||++ |++||.+.+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~-g~~~~~~~~~~~ 234 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPILQGKSDID 234 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh-CCCCCCCCCHHH
Confidence 999999986543221111 1223457789999988654 58999999999999999999 899998766554
Q ss_pred HHHHHHcCCCC----------------------CCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 443 MAASLQDGYRL----------------------NQP-------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 443 ~~~~i~~~~~~----------------------~~~-------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+...... ..+ .....++.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 33332211000 000 123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.06 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=195.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH---- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---- 296 (499)
..+|++.+.||+|+||.||+|....++ +.|++|.+..... ...+.+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~---~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCD---KRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCC---cEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 468999999999999999999876554 6899998865433 34467889999999999999999998643322
Q ss_pred ---------CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-
Q psy1789 297 ---------TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD- 366 (499)
Q Consensus 297 ---------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld- 366 (499)
...++|+||++ ++|.+++.. ..+++.....++.|++.||.|||+.+|+||||||+||+++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~ 149 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ---------GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC
Confidence 24689999998 699888864 3588999999999999999999999999999999999998
Q ss_pred CCCcEEEcccccccccCCCCccc-cCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy1789 367 DKLRIQITDNALARDLFPSDYHC-LGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444 (499)
Q Consensus 367 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~ 444 (499)
+++.+||+|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++ |+.||...++.+..
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~~ 228 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKPLFAGAHELEQM 228 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Confidence 45678999999997653221111 1123356778999998754 568899999999999999999 88898766554433
Q ss_pred HHHHcC------------------------CCCCC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 445 ASLQDG------------------------YRLNQ-----PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 445 ~~i~~~------------------------~~~~~-----~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+... ..... ....+.++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 222111 01111 1246678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=327.72 Aligned_cols=245 Identities=21% Similarity=0.333 Sum_probs=194.2
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-----------
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED----------- 295 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----------- 295 (499)
+++||+||||.|||++.+-++ +.+|||++....+........+|+..|++|+|||||+++..|.+.
T Consensus 484 L~lLGkGGFG~VvkVRNKlDG---r~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~ 560 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDG---REYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA 560 (1351)
T ss_pred HHHhcCCCCceEEEEeecccc---hhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence 399999999999999976554 789999998776666678899999999999999999988432200
Q ss_pred --------------------------------------------------------------------------------
Q psy1789 296 -------------------------------------------------------------------------------- 295 (499)
Q Consensus 296 -------------------------------------------------------------------------------- 295 (499)
T Consensus 561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~ 640 (1351)
T KOG1035|consen 561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV 640 (1351)
T ss_pred cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence
Q ss_pred -------------------C--------CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCC-CHHHHHHHHHHHHHHHHH
Q psy1789 296 -------------------H--------TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTL-TTQEVVDMCLQIIMGVQY 347 (499)
Q Consensus 296 -------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l-~~~~~~~i~~~va~~L~y 347 (499)
+ ..+|+-||||+...|+++++.+. .. .....++++++|++||.|
T Consensus 641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--------~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--------FNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--------cchhhHHHHHHHHHHHHHHHH
Confidence 0 12466788888888888887632 11 467789999999999999
Q ss_pred HHhCCccccCCCCCceEEcCCCcEEEcccccccccC----------------CCCccccCCCCCCccccccccccccCC-
Q psy1789 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF----------------PSDYHCLGDNENRPVKWLAIESLVHKT- 410 (499)
Q Consensus 348 LH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~- 410 (499)
+|++|||||||||.||+||++..+||+|||+|+... ........+...||.-|+|||.+.+..
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999999998732 001111234677999999999997654
Q ss_pred --CCCchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1789 411 --FSTASDVWAFGVLLWELTTLAQQPYAE-IDPFEMAASLQDGYRLNQ---PVNCPDELFSVMAYCWAMNPEGRPTFPQL 484 (499)
Q Consensus 411 --~s~~~DvwS~Gvvl~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~~---~~~~~~~~~~l~~~C~~~~P~~RPt~~~v 484 (499)
|+.|+|+||+|||++||+. ||.. ++...+...++++.-+.. ..+..+.-.+++.+++++||++|||+.|+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 9999999999999999997 6654 344555666666544433 33444567889999999999999999999
Q ss_pred HH
Q psy1789 485 HS 486 (499)
Q Consensus 485 ~~ 486 (499)
+.
T Consensus 869 L~ 870 (1351)
T KOG1035|consen 869 LN 870 (1351)
T ss_pred hh
Confidence 74
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=301.14 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=194.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcC---CC
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIED---HT 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~---~~ 297 (499)
+|++.+.||+|+||.||++....... ...+|+|.+.... .....+.+.+|+.+++++ .|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSE-EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCc-CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 47788999999999999999865411 2679999986532 222346678899999999 599999999875332 23
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+|||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~--------~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg 150 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS--------GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG 150 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCC
Confidence 4678888887 789999875 2358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcc--ccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----
Q psy1789 378 LARDLFPSDYH--CLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG---- 450 (499)
Q Consensus 378 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~---- 450 (499)
+++........ .......|+..|+|||++.+ ..++.++|||||||++|||++ |++||...+.......+...
T Consensus 151 ~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 151 LARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG-RKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred CceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCcCCCCCCHHHHHHHHHHHhCCC
Confidence 99865432211 11123467889999998865 568999999999999999998 88998876543322211110
Q ss_pred -----------------------CCC---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 -----------------------YRL---NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 -----------------------~~~---~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ......+.++.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 011235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.46 Aligned_cols=246 Identities=16% Similarity=0.305 Sum_probs=188.9
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.+|.|+++.||+++. ++ +.+|+|++... ......+.+.+|+.+++.++|+||+++++++ ......+++|||+
T Consensus 8 ~~~~~~~~v~~~~~~~--~~---~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-~~~~~~~~~~e~~ 81 (314)
T cd08216 8 KCFEDLMIVHLAKHKP--TN---TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-IVDSELYVVSPLM 81 (314)
T ss_pred HhhcCCceEEEEEecC--CC---CEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-ecCCeEEEEEecc
Confidence 4444555555555543 22 68999998754 3455667899999999999999999999985 4456679999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCC
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~ 386 (499)
++|+|.+++.... ...+++.....++.|++.||+|||+.+|+||||||+||++++++.+||+|||.+.......
T Consensus 82 ~~~~l~~~l~~~~------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 82 AYGSCEDLLKTHF------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred CCCCHHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 9999999998632 2358899999999999999999999999999999999999999999999999987554322
Q ss_pred c-----cccCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCC------
Q psy1789 387 Y-----HCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA-ASLQDGYR------ 452 (499)
Q Consensus 387 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~-~~i~~~~~------ 452 (499)
. ........++..|+|||++.. ..++.++|||||||++|||++ |..||...+..... ..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN-GHVPFKDMPATQMLLEKVRGTVPCLLDKS 234 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCccccccC
Confidence 1 111233456778999999876 358899999999999999999 89999876543322 22211100
Q ss_pred --------C------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 --------L------------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 --------~------------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .......+++.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 000122357889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.26 Aligned_cols=246 Identities=18% Similarity=0.299 Sum_probs=193.9
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH---- 296 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---- 296 (499)
.+|.+.+.||+|+||.||+|....++ +.+|+|++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTG---EKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCC---cEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 47888899999999999999976544 689999886432 2223456789999999999999999999864332
Q ss_pred -CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 297 -TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 297 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...++|+||+. .+|..++. ..+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIMG----------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CceEEEEecccc-cCHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEee
Confidence 23589999997 47776653 2588999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-- 452 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-- 452 (499)
||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||...+.......+.....
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~-g~~pf~~~~~~~~~~~~~~~~~~~ 234 (342)
T cd07879 161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQILKVTGVP 234 (342)
T ss_pred CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998754221 123456778999999876 468999999999999999999 8899987664433322211100
Q ss_pred --------------------CCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 453 --------------------LNQ--------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 453 --------------------~~~--------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+.. ....+.++.+++.+||+.||++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 01356789999999999999999999999843
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=341.22 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=210.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
+..-+..||.|.||.||.|...+++ ...|+|-+.... .........+|..++..++|||+|+++|+ .-.++..++
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tG---ellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV-EvHRekv~I 1311 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTG---ELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV-EVHREKVYI 1311 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCcc---chhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce-eecHHHHHH
Confidence 4556689999999999999977665 568888776432 23445667899999999999999999998 444566789
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
.||||++|+|.+.++.. +..++.....+..|++.|++|||++|||||||||.||+||.+|.+|++|||.|..
T Consensus 1312 FMEyC~~GsLa~ll~~g--------ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG--------RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHhccCcHHHHHHhc--------chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999862 3466667777889999999999999999999999999999999999999999988
Q ss_pred cCCCCccc--cCCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCCC
Q psy1789 382 LFPSDYHC--LGDNENRPVKWLAIESLVH---KTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRLNQ 455 (499)
Q Consensus 382 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~~ 455 (499)
+.+..... .-....||+.|||||++.+ .....+.||||+|||++||+| |+.||...+. ..+.-.+..+..+..
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t-GkrPW~~~dne~aIMy~V~~gh~Pq~ 1462 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT-GKRPWAELDNEWAIMYHVAAGHKPQI 1462 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec-CCCchhhccchhHHHhHHhccCCCCC
Confidence 76552111 1125679999999999975 346789999999999999999 8999998654 567778888999999
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
|...+.+-.+++.+|++.||++|-++.|+++
T Consensus 1463 P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 9999999999999999999999988877664
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.44 Aligned_cols=247 Identities=22% Similarity=0.243 Sum_probs=194.1
Q ss_pred EeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHH-------------HHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 226 LFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAV-------------QVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 226 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
+.+.||+|+||.||+|.....+ +.+|+|.+....... ....+.+|+.+++.++|+||+++++++
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTG---KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY 89 (335)
T ss_pred hhhcccCCCceeEEEEEECCCC---CeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence 4478999999999999876544 689999886432211 012467899999999999999999986
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
. .....++|+||++ |+|.+++.. ...+++.....++.|++.||+|||+.+++|+||||+||+++.++.+|
T Consensus 90 ~-~~~~~~lv~e~~~-~~l~~~l~~--------~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 90 V-EGDFINLVMDIMA-SDLKKVVDR--------KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred e-cCCcEEEEEeccc-cCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 4 4567799999998 799999875 23588999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCc------------cccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy1789 373 ITDNALARDLFPSDY------------HCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEID 439 (499)
Q Consensus 373 l~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~ 439 (499)
|+|||+++....... ........++..|+|||++.+. .++.++|||||||++|||+| |.+||...+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCC
Confidence 999999976541110 0011123457789999998764 47999999999999999999 899998877
Q ss_pred HHHHHHHHHcCCC----C----------------C-------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 440 PFEMAASLQDGYR----L----------------N-------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 440 ~~~~~~~i~~~~~----~----------------~-------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+....+..... . . .....++++.+++.+||+.+|++||++.|++.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 6554443322100 0 0 01235778999999999999999999999986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=289.21 Aligned_cols=238 Identities=21% Similarity=0.288 Sum_probs=202.1
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
||+|+||.||++.....+ +.+++|.+.... .......+..|+.++++++|+||+++++.+ +.+...+++|||++
T Consensus 1 lg~G~~~~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTG---KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-QTEEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECCCC---cEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-ecCCeeEEEEecCC
Confidence 689999999999986543 689999886542 233566889999999999999999999884 55667899999999
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCc
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY 387 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~ 387 (499)
+++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||++........
T Consensus 77 ~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 77 GGELFSHLSKE--------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred CCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC
Confidence 99999999862 3589999999999999999999999999999999999999999999999999886643321
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 467 (499)
......++..|+|||...+...+.++|+||||+++||+++ |+.||...+..+....+.. .....+...++++.+++
T Consensus 149 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i 224 (250)
T cd05123 149 --RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLI 224 (250)
T ss_pred --cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHH
Confidence 2234567888999999998889999999999999999999 8999987776666666554 35566777899999999
Q ss_pred HHhhhcCCCCCCCHHH
Q psy1789 468 AYCWAMNPEGRPTFPQ 483 (499)
Q Consensus 468 ~~C~~~~P~~RPt~~~ 483 (499)
.+||..||++||++.+
T Consensus 225 ~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 225 SGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHhcCCHhhCCCccc
Confidence 9999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=301.32 Aligned_cols=247 Identities=19% Similarity=0.300 Sum_probs=196.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++.+.||+|+||.||+|.....+ ..||||.+... ........+.+|+.++++++|+||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCC---cEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 557889999999999999999876544 68999988543 23334456889999999999999999999854332
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++|+||+ +++|..++.. ..+++..+..++.|++.||+|||+.+|+||||||+||++++++.+||+
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~---------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH---------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEe
Confidence 2348999999 5799988864 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-- 451 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-- 451 (499)
|||+++..... .....++..|+|||.+.+ ..++.++|+|||||++||+++ |++||...+.......+....
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT-GKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999855321 123456778999999876 458999999999999999999 888998765433322211100
Q ss_pred ----------------------CC------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ----------------------RL------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ----------------------~~------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. .....+++++.+++.+|++.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 011256778999999999999999999999883
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=301.14 Aligned_cols=249 Identities=19% Similarity=0.260 Sum_probs=195.8
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC---
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED--- 295 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~--- 295 (499)
...+|.+.+.||+|+||.||+|....++ +.||+|++... ......+.+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTG---LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 91 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCC---eEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence 3467999999999999999999875544 78999998653 2333456788999999999999999999975432
Q ss_pred --CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 296 --HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 296 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
....+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKC---------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEE
Confidence 13357777776 6899888764 35899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY- 451 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~- 451 (499)
+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++ |++||...+.......+....
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Confidence 999998754321 123456788999999876 568899999999999999999 888987655433222211100
Q ss_pred -----------------------C-CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 -----------------------R-LN-----QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 -----------------------~-~~-----~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
. +. .....++++.+++.+|++.||.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 00 011357789999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=293.62 Aligned_cols=248 Identities=22% Similarity=0.309 Sum_probs=197.9
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
|++.+.||+|+||.||+|+...++ +.+++|.+.... .....+.+.+|+.++++++|+||+++++++. .....++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTG---EIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-TERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCC---cEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-cCCceEEE
Confidence 345688999999999999987654 789999987543 2233456788999999999999999999854 45677999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||++ ++|.+++.... ..+++..+..++.|++.||+|||+++|+||||+|+||++++++.+||+|||+++..
T Consensus 77 ~e~~~-~~l~~~i~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-------GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred ecCcC-cCHHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 99998 69999998631 35899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---------- 451 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---------- 451 (499)
..... ......++..|+|||.+.+. .++.++|||||||++|||++ +++||...+..+....+....
T Consensus 149 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 149 GIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT-GKPLFPGDSEIDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred CCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHHHhCCCcHHHHHh
Confidence 43221 12233456779999999876 88999999999999999999 788998765444332221100
Q ss_pred -------C---C--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 -------R---L--------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 -------~---~--------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. + ......+.++.+++..||+.+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0 000134678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=290.15 Aligned_cols=254 Identities=18% Similarity=0.296 Sum_probs=201.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc-CCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG-LSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..++-+..||.|+||+|+|-.++..+ +..|||+++........++++.|.+...+ -+-||||+++|.++..+.. |
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg---~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc-W 139 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSG---KLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC-W 139 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccC---cEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce-e
Confidence 33444488999999999999887665 88999999877666777888899877554 5799999999998886655 9
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
+.||.|+ -||+.+...--. -....++++-.-+|..-...||.||.+. +|||||+||+|||||..|.+||+|||++
T Consensus 140 iCMELMd-~SlDklYk~vy~---vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 140 ICMELMD-ISLDKLYKRVYS---VQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred eeHHHHh-hhHHHHHHHHHH---HHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 9999998 677766432100 0124688888999999999999999875 8999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCC--C
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRL--N 454 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~--~ 454 (499)
..+..+ ...+...|...|||||.+.. ..|+.+|||||||++|+|+.| |..||...+. ++....+..+..+ .
T Consensus 216 GqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAt-G~fPyr~w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 216 GQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVAT-GNFPYRKWDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred HhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeec-CCCCcchHHHHHHHHHHHHcCCCCeec
Confidence 876432 13345567778999999963 459999999999999999999 8999987643 4444455444322 2
Q ss_pred CCC---CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 455 QPV---NCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 455 ~~~---~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
++. +.+.++..++..|+.+|-+.||.+.++.+.
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 222 467899999999999999999999998753
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=289.46 Aligned_cols=232 Identities=21% Similarity=0.278 Sum_probs=182.9
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc-CCCCcceeEEeEEEcCCCceEEEEEeCCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG-LSHKNILTVLGVSIEDHTSPFLIYPYQDY 308 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~~lv~e~~~~ 308 (499)
+|+|+||.||++....++ ..+++|.+....... .|+..... .+|+||+++++++.. +...++||||+++
T Consensus 24 lg~g~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~-~~~~~iv~e~~~~ 93 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQ---KLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT-LKGHVLIMDYIKD 93 (267)
T ss_pred ecCCCceEEEEEEEcCCC---cEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec-CCeeEEEEEcCCC
Confidence 599999999999876554 678888876432111 12222221 279999999998544 5577999999999
Q ss_pred CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cEEEcccccccccCCCCc
Q psy1789 309 TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDNALARDLFPSDY 387 (499)
Q Consensus 309 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~kl~DfGla~~~~~~~~ 387 (499)
|+|.+++... ..+++.++..++.|+++||.|||+.+++||||||+||+++.++ .++|+|||+++.....
T Consensus 94 ~~L~~~l~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 94 GDLFDLLKKE--------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred CcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999999862 2689999999999999999999999999999999999999998 9999999998765322
Q ss_pred cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHc-CCCCCCCCCCcHHHH
Q psy1789 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM--AASLQD-GYRLNQPVNCPDELF 464 (499)
Q Consensus 388 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~--~~~i~~-~~~~~~~~~~~~~~~ 464 (499)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+. ...... ......+...+..+.
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT-GKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN 238 (267)
T ss_pred ----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence 23457888999999999999999999999999999999 8889875433221 111111 122233446889999
Q ss_pred HHHHHhhhcCCCCCCC-HHHHHH
Q psy1789 465 SVMAYCWAMNPEGRPT-FPQLHS 486 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt-~~~v~~ 486 (499)
+++.+||+.+|.+||+ ++|+++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhc
Confidence 9999999999999996 688874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=300.96 Aligned_cols=247 Identities=18% Similarity=0.290 Sum_probs=197.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC--
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT-- 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-- 297 (499)
..+|++.+.||+|+||.||+|+...++ +.+|+|++... ......+.+.+|+.+++.++|+||++++++....+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTG---RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCC---cEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 457889999999999999999986654 67999988643 223344667889999999999999999886433222
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 298 ---SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 298 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
..++|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+||++++++.+||+
T Consensus 91 ~~~~~~lv~e~~~-~~L~~~~~~---------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 91 DFQDVYLVTHLMG-ADLNNIVKC---------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccccEEEEEecCC-CCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEc
Confidence 3789999985 799999874 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
|||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||...+..+....+......
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Confidence 99999865322 123456778999999865 467899999999999999999 88999876655443333221110
Q ss_pred ------------------------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 ------------------------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ------------------------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
......++++.+++.+||+.+|++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 001135788999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=311.10 Aligned_cols=253 Identities=25% Similarity=0.347 Sum_probs=197.9
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC------CceEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH------TSPFL 301 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~------~~~~l 301 (499)
+.||+|+||.||+|+.+.++ +.||||++.........+...+|+++|++++|+|||++++. .++. ....+
T Consensus 19 e~LG~Ga~g~V~rgrnketG---~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~i-ee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETG---RLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDI-EETKFLGLVTRLPVL 94 (732)
T ss_pred hhhcCCccceeeeecccccc---cchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhccc-CCccccCcccccceE
Confidence 88999999999999977665 88999999887777778899999999999999999999997 3322 24689
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--CCC--cEEEcccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD--DKL--RIQITDNA 377 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld--~~~--~~kl~DfG 377 (499)
||||+.+|||...|.+.+ ....|++.+.+.++.+++.||.|||+++|+||||||.||++- ++| --||+|||
T Consensus 95 vmEyC~gGsL~~~L~~PE-----N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-----NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEeecCCCcHHHHhcCcc-----cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999998732 345799999999999999999999999999999999999883 334 35999999
Q ss_pred cccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcCC-
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF----EMAASLQDGY- 451 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~----~~~~~i~~~~- 451 (499)
.||.+...+ .-....||..|.+||+... +.|+..+|.|||||++||++| |..||...... ++...+....
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT-G~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT-GELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc-cCCCCCcCCCccccchhhhhhhccCC
Confidence 999886554 3457889999999999994 889999999999999999999 88888754322 1221111110
Q ss_pred -------------------CCCCCCCCcH----HHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHH
Q psy1789 452 -------------------RLNQPVNCPD----ELFSVMAYCWAMNPEGRP--TFPQLHSCLQEFHA 493 (499)
Q Consensus 452 -------------------~~~~~~~~~~----~~~~l~~~C~~~~P~~RP--t~~~v~~~L~~~~~ 493 (499)
..++|..... .+-..+...+..+|.+|- .+.+..+.+..+.+
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 0122222222 345566666777777887 66666666666544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.67 Aligned_cols=147 Identities=20% Similarity=0.297 Sum_probs=129.3
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++++.||+|+||.||+|.....+ +.||+|++... ........+.+|+.+++.++|+||+++++++ ......
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNS---KLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-QSANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCC---cEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-EECCEE
Confidence 57889999999999999999987544 78999998643 2344457788999999999999999999875 556678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 80 ~lVmEy~~g~~L~~li~~~--------~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--------GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 9999999999999999762 35788999999999999999999999999999999999999999999999998
Q ss_pred c
Q psy1789 380 R 380 (499)
Q Consensus 380 ~ 380 (499)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=283.97 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=197.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHH-HHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQ-VSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.|+.+..||+|+||.||+|.-.++++ ..+.+|+|+++.+..... -....+|+.+++.++|||++.|..+....+...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 46677999999999999997655433 335899999975522111 2345789999999999999999988666577789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC----CcEEEccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK----LRIQITDN 376 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~----~~~kl~Df 376 (499)
|++||.+ -+|.+.++-.+... ...++......|+.||+.|+.|||++-|+||||||.|||+..+ |.+||+|+
T Consensus 105 l~fdYAE-hDL~~II~fHr~~~---~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAE-HDLWHIIKFHRASK---AKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhh-hhHHHHHHHhccch---hccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999999 78999988755322 3579999999999999999999999999999999999999876 99999999
Q ss_pred ccccccCCCC-ccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC-------HHH--HHH
Q psy1789 377 ALARDLFPSD-YHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEID-------PFE--MAA 445 (499)
Q Consensus 377 Gla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-------~~~--~~~ 445 (499)
|+||.+...- .....+..+.|+-|.|||.+++. .||.+.||||.||++.||+| -++.|.+.+ +.. ...
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt-l~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT-LEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc-cCccccchhhhcccCCCchHHHHH
Confidence 9999775332 12234567789999999999875 59999999999999999999 566555421 111 111
Q ss_pred HHHcCC----CC------CCC--------------C------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 446 SLQDGY----RL------NQP--------------V------------NCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 446 ~i~~~~----~~------~~~--------------~------------~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.+..-. .. ..| . .-++..++++.+++..||-+|.|+.+.++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111100 00 000 0 123348899999999999999999988753
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=291.10 Aligned_cols=246 Identities=19% Similarity=0.294 Sum_probs=206.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGL-SHKNILTVLGVSIED 295 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 295 (499)
+....+.++.+||+|+||+|-+|..++++ ..+|||+++++.- ...++--..|-++|... +-|.++++.. |++.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtd---ELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS-cFQT 421 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTD---ELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS-CFQT 421 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcc---hhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH-Hhhh
Confidence 44456778899999999999999866555 7899999876421 11223345677777765 4566777665 6888
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
-+++|+||||+.+|+|..+++.- ..+.+..+..++.+||-||-|||++|||+||||.+||+||.+|++||+|
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~--------GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQV--------GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHh--------cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeee
Confidence 89999999999999999999873 3577888999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++.-.-.+. .+.+.+||+.|+|||.+.-.+|+..+|+|||||+||||+. |++||.+.+..++.+.+.+. ....
T Consensus 494 FGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla-GQpPFdGeDE~elF~aI~eh-nvsy 569 (683)
T KOG0696|consen 494 FGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQAIMEH-NVSY 569 (683)
T ss_pred cccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHc-cCcC
Confidence 999986543322 3447899999999999999999999999999999999999 99999999999998888764 5567
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCC
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPT 480 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt 480 (499)
|-..+.|+.++....+.+.|.+|.-
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cccccHHHHHHHHHHhhcCCccccC
Confidence 7788999999999999999999953
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=273.43 Aligned_cols=239 Identities=18% Similarity=0.261 Sum_probs=196.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEE---cCCCceEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSI---EDHTSPFLIY 303 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~---~~~~~~~lv~ 303 (499)
++||-|-.|+|-.+..+.++ +.+|+|++.+. ...++|+++.-.. .|||||+++++.. +....+++||
T Consensus 68 qvLG~GinGkV~~C~~k~T~---ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQ---EKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhhccccCCceEEEEeccch---hhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 78999999999999877665 78999998764 2335788765554 5999999999742 2345678999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---CCCcEEEccccccc
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD---DKLRIQITDNALAR 380 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld---~~~~~kl~DfGla~ 380 (499)
|.|++|.|...++..+ ...++++++..|+.||+.|+.|||+.+|.||||||+|+|.. .+...||+|||+|+
T Consensus 139 E~meGGeLfsriq~~g------~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRG------DQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred ecccchHHHHHHHHcc------cccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 9999999999998743 35699999999999999999999999999999999999996 45678999999999
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcCCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEMAASLQDGYRLNQP 456 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~----~~~~~~i~~~~~~~~~ 456 (499)
.-... ..-.+.+-|+.|.|||++...+|+...|+||+||+||-|++ |.+||-.... ..+...+..+ ...+|
T Consensus 213 ~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC-GyPPFYS~hg~aispgMk~rI~~g-qy~FP 287 (400)
T KOG0604|consen 213 ETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKRRIRTG-QYEFP 287 (400)
T ss_pred ccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc-CCCcccccCCccCChhHHhHhhcc-CccCC
Confidence 65422 12345667889999999999999999999999999999999 8899876543 3455666665 33344
Q ss_pred C----CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 V----NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. +++++.+++++..+..+|++|.|+.+++.
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 3 56788999999999999999999999874
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=275.59 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=202.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.||+|+|+.|-.++...++ +.+|||++.+. ......+..+|++++...+ |+||++|+.+ ++++.+.|||||-|
T Consensus 84 e~LGeGAyasVqtcv~i~t~---~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLief-FEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTG---KEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEF-FEDDTRFYLVFEKM 158 (463)
T ss_pred HHhcCccceeeeeeeeeccc---hhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHH-hcccceEEEEEecc
Confidence 78999999999998866555 78999999887 3445678889999999985 9999999998 67788889999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---cEEEcccccccccC
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL---RIQITDNALARDLF 383 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~---~~kl~DfGla~~~~ 383 (499)
.+|.|..++++. ..+++.+..++..+||.||.|||.+||.||||||+|||-.+.. -+||+||.|+....
T Consensus 159 ~GGplLshI~~~--------~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 159 RGGPLLSHIQKR--------KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred cCchHHHHHHHh--------hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 999999999983 4699999999999999999999999999999999999997543 47999998875432
Q ss_pred CC-Cccc----cCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--------------
Q psy1789 384 PS-DYHC----LGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEID-------------- 439 (499)
Q Consensus 384 ~~-~~~~----~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-------------- 439 (499)
.. +... .-.+.+|+..|||||+.. ...|+.+.|.||||||+|-|++ |.+||.+.-
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs-GYpPFvG~Cg~dCGWdrGe~Cr~ 309 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS-GYPPFVGHCGADCGWDRGEVCRV 309 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh-CCCCccCccCCcCCccCCCccHH
Confidence 11 1111 112556888999999874 3568999999999999999999 999998642
Q ss_pred -HHHHHHHHHcCCCCCCCC----CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 440 -PFEMAASLQDGYRLNQPV----NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 440 -~~~~~~~i~~~~~~~~~~----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+.+.|++| ..++|. .++++.++++...+..++.+|.++.+++.
T Consensus 310 CQ~~LFesIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 310 CQNKLFESIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 23467788877 556665 56889999999999999999999988865
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=254.95 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=196.6
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
.+.||+|+||+||+|+..++. ..||+|.++-+. .+.-.....+|+.+++.++|+|||+++++ ...+..+-||+||
T Consensus 7 mekigegtygtvfkarn~~t~---eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-lhsdkkltlvfe~ 82 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-LHSDKKLTLVFEF 82 (292)
T ss_pred HHhhcCCcceeeEecccCCcc---ceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-hccCceeEEeHHH
Confidence 488999999999999976654 789999986432 22233567899999999999999999998 5667778999999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
+. .+|..|..... ..++.+....++.|+.+||.|+|++++.||||||.|.||+.+|..|++|||+|+...-.
T Consensus 83 cd-qdlkkyfdsln-------g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN-------GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hh-HHHHHHHHhcC-------CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 98 78999988643 56899999999999999999999999999999999999999999999999999965322
Q ss_pred CccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC----CCCC----
Q psy1789 386 DYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR----LNQP---- 456 (499)
Q Consensus 386 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~----~~~~---- 456 (499)
..|. +....|.-|.+|.++.+.+ |++..|+||-||++.|+..-|++.|.+.+..+....+-.... ..+|
T Consensus 155 -vrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 -VRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred -eEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 2222 3456788899999998755 899999999999999999988998998877665544422110 0011
Q ss_pred -----------C---------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 -----------V---------NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 -----------~---------~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .....-++++...+.-+|.+|.++++.++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0 11223567888888889999999988765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=277.65 Aligned_cols=222 Identities=19% Similarity=0.230 Sum_probs=178.3
Q ss_pred ecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCCCCHH
Q psy1789 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLK 312 (499)
Q Consensus 233 G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~ 312 (499)
|.||.||++....++ +.+|+|.+.... .+.+|...+....||||+++++++. .....++++||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~---~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQ---QTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIV-SEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCC---cEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhhee-cCCeEEEEEecCCCCCHH
Confidence 899999999987655 689999986542 2334555555667999999999854 456779999999999999
Q ss_pred HHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCC
Q psy1789 313 RFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392 (499)
Q Consensus 313 ~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~ 392 (499)
+++... ..+++..+..++.|++.||+|||+++|+||||||+||++++++.++++|||++...... ..
T Consensus 74 ~~l~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~ 140 (237)
T cd05576 74 SHISKF--------LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CD 140 (237)
T ss_pred HHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cc
Confidence 999762 34899999999999999999999999999999999999999999999999988655332 12
Q ss_pred CCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhh
Q psy1789 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWA 472 (499)
Q Consensus 393 ~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~ 472 (499)
...++..|+|||.+.+..++.++||||+|+++|||++ |+.|+..... . +........|..+++++.+++.+|++
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~-g~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~li~~~l~ 214 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLT-GKTLVECHPS-G----INTHTTLNIPEWVSEEARSLLQQLLQ 214 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHH-CcchhhcCch-h----cccccccCCcccCCHHHHHHHHHHcc
Confidence 3345667999999988889999999999999999999 7766543211 1 11112234455678899999999999
Q ss_pred cCCCCCCCHHH
Q psy1789 473 MNPEGRPTFPQ 483 (499)
Q Consensus 473 ~~P~~RPt~~~ 483 (499)
.||++||++.+
T Consensus 215 ~dp~~R~~~~~ 225 (237)
T cd05576 215 FNPTERLGAGV 225 (237)
T ss_pred CCHHHhcCCCc
Confidence 99999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.29 Aligned_cols=239 Identities=22% Similarity=0.274 Sum_probs=196.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 299 (499)
...|.+...+|.|+|+.|-++....++ +..+||++.+.... -.+|+.++... +|+||+++.+.+ .+..+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~---~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~-~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTD---QEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVY-EDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccc---cchhheeccccccc-----cccccchhhhhcCCCcceeeccee-cCCcee
Confidence 445677788999999999999877665 78899999765222 23667666554 799999999985 666778
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-cCCCcEEEccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV-DDKLRIQITDNAL 378 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll-d~~~~~kl~DfGl 378 (499)
++|||.+.+|-|.+.+...+ ....++.+|+.+++.|+.|||++|||||||||+|||+ ++.++++|+|||.
T Consensus 392 ~~v~e~l~g~ell~ri~~~~---------~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~ 462 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP---------EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGF 462 (612)
T ss_pred eeeehhccccHHHHHHHhcc---------hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEech
Confidence 99999999988888777522 2337888999999999999999999999999999999 5899999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRLNQPV 457 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~~~~ 457 (499)
++...+. ....+-|..|.|||++....|++++|||||||+||||+| |+.||..... .++...+..+ ....
T Consensus 463 a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~-G~tp~~~~P~~~ei~~~i~~~---~~s~ 533 (612)
T KOG0603|consen 463 WSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT-GRTLFAAHPAGIEIHTRIQMP---KFSE 533 (612)
T ss_pred hhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh-CCCccccCCchHHHHHhhcCC---cccc
Confidence 9977543 223456778999999999999999999999999999999 8888876543 3555555433 3347
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++++++|+.+|++.||.+||+|.++..
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 88999999999999999999999999864
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=314.54 Aligned_cols=264 Identities=16% Similarity=0.235 Sum_probs=219.6
Q ss_pred hhhHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCc
Q psy1789 207 NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKN 284 (499)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~n 284 (499)
.+.+...+.+..+.+.+|+++++||+|+||.|...+.+.++ +.+|+|++.+. .......-|..|..+|..-+.+=
T Consensus 60 ~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~---~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~W 136 (1317)
T KOG0612|consen 60 YKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTE---KVYAMKILNKWEMLKRAETACFREERDIMVFGNSEW 136 (1317)
T ss_pred hHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccc---cchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHH
Confidence 34556667778888999999999999999999999987765 78999998652 12233456889999998878777
Q ss_pred ceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q psy1789 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCV 364 (499)
Q Consensus 285 Iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIl 364 (499)
|++|+= .++++.++|+|||||+||+|-..+.+. ..+++..+..++..|..||.-||+.|+|||||||+|||
T Consensus 137 iv~Lhy-AFQD~~~LYlVMdY~pGGDlltLlSk~--------~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvL 207 (1317)
T KOG0612|consen 137 IVQLHY-AFQDERYLYLVMDYMPGGDLLTLLSKF--------DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVL 207 (1317)
T ss_pred HHHHHH-HhcCccceEEEEecccCchHHHHHhhc--------CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeE
Confidence 888654 478899999999999999999999872 25899999999999999999999999999999999999
Q ss_pred EcCCCcEEEcccccccccCCCCccccCCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy1789 365 VDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-----KTFSTASDVWAFGVLLWELTTLAQQPYAEID 439 (499)
Q Consensus 365 ld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~ 439 (499)
||..|++||+|||-+-.+..+. .......+||+.|++||++.. +.|++.+|+||+||++|||+. |..||....
T Consensus 208 ld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly-G~TPFYads 285 (1317)
T KOG0612|consen 208 LDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY-GETPFYADS 285 (1317)
T ss_pred ecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc-CCCcchHHH
Confidence 9999999999999987665433 334557789999999999962 679999999999999999999 899998877
Q ss_pred HHHHHHHHHcC-CCCCCC--CCCcHHHHHHHHHhhhcCCCCCCC---HHHHH
Q psy1789 440 PFEMAASLQDG-YRLNQP--VNCPDELFSVMAYCWAMNPEGRPT---FPQLH 485 (499)
Q Consensus 440 ~~~~~~~i~~~-~~~~~~--~~~~~~~~~l~~~C~~~~P~~RPt---~~~v~ 485 (499)
..+....|.+. ....+| ..+++++++||...+. +|+.|.. ++++.
T Consensus 286 lveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 286 LVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 77777766543 345555 5789999999999886 5888887 66654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=269.95 Aligned_cols=237 Identities=25% Similarity=0.379 Sum_probs=198.4
Q ss_pred cceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCCCCHHH
Q psy1789 234 TFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKR 313 (499)
Q Consensus 234 ~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~ 313 (499)
+||.||+|+..+++ +.+++|++.........+.+.+|++.+++++|+||+++++++.. ....++++||+++++|.+
T Consensus 1 ~~g~v~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTG---KLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCC---cEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHH
Confidence 58999999987544 67999998765433325789999999999999999999998654 456799999999999999
Q ss_pred HHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCC
Q psy1789 314 FLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN 393 (499)
Q Consensus 314 ~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~ 393 (499)
++.... .+++..+..++.+++.++.|||+.+++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 77 ~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 145 (244)
T smart00220 77 LLKKRG--------RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT 145 (244)
T ss_pred HHHhcc--------CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence 997622 28899999999999999999999999999999999999999999999999998765432 2234
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCCCCCC--CcHHHHHHHHHh
Q psy1789 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE-IDPFEMAASLQDGYRLNQPVN--CPDELFSVMAYC 470 (499)
Q Consensus 394 ~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~--~~~~~~~l~~~C 470 (499)
..++..|++||.+.+..++.++||||||+++||+++ +..||.. .+...+...+........+.. ++.++.+++.+|
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLT-GKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKL 224 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHH
Confidence 557788999999998899999999999999999999 8889877 555556666655433322222 789999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q psy1789 471 WAMNPEGRPTFPQLHS 486 (499)
Q Consensus 471 ~~~~P~~RPt~~~v~~ 486 (499)
|..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=284.29 Aligned_cols=261 Identities=21% Similarity=0.279 Sum_probs=209.1
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc------cHHHHHHHHHHHHHHhcCCCCccee
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA------SAVQVSLLLQEGMAMYGLSHKNILT 287 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~H~nIv~ 287 (499)
+........||-++.+||+|+|+.||+|.+..++ +.||||+-..+. .+...+...+|-.+.+.|.||.||+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~Eq---RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQ---RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchh---heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 3344556678889999999999999999977665 789999864321 1222345678999999999999999
Q ss_pred EEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCceEE
Q psy1789 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK--KLLHKDLATRNCVV 365 (499)
Q Consensus 288 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~--~iiHrDlk~~NIll 365 (499)
+++|..-+.+..+-|+||+++.+|+-||..+ ..+++.++..|+.||+.||.||.+. +|||-||||.||||
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQh--------klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH--------KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhh--------hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 9999766667779999999999999999874 4689999999999999999999975 79999999999999
Q ss_pred cC---CCcEEEcccccccccCCCCcc-----ccCCCCCCccccccccccccC----CCCCchhHHHHHHHHHHHHcCCCC
Q psy1789 366 DD---KLRIQITDNALARDLFPSDYH-----CLGDNENRPVKWLAIESLVHK----TFSTASDVWAFGVLLWELTTLAQQ 433 (499)
Q Consensus 366 d~---~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~~~DvwS~Gvvl~el~t~g~~ 433 (499)
-+ -|.+||+||||++.+...++. ...+...||+-|++||.+.-+ +.+.|+||||.||++|.++. |+.
T Consensus 604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY-GrK 682 (775)
T KOG1151|consen 604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY-GRK 682 (775)
T ss_pred ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc-cCC
Confidence 64 478999999999988765543 234567899999999998643 57899999999999999999 888
Q ss_pred CCCCCC-HHHHHH--HHHcCCCCCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 434 PYAEID-PFEMAA--SLQDGYRLNQPV--NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 434 p~~~~~-~~~~~~--~i~~~~~~~~~~--~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
||.... ..++.. -+.+.....+|. -++.+...++++|+++.-++|....++..
T Consensus 683 PFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 683 PFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred CCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 887643 233332 223332333443 57889999999999999999998877653
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.23 Aligned_cols=256 Identities=18% Similarity=0.334 Sum_probs=212.0
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc-
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE- 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~- 294 (499)
.......+++.++||.|.+|.||+++...++ +.+|+|+........ ++...|.++++.. +|||++.++|+...
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~---~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTG---QLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecC---ceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 3344456777899999999999999977655 678888886554333 4556778888876 79999999998654
Q ss_pred ---CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 295 ---DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 295 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
.++.+|||||||.+||.-+.+.... ...+.|..+..|++.++.||.|||...++|||||-.||||+.++.+
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~------g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK------GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc------ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcE
Confidence 3467899999999999999998743 3579999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-----KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
||.|||.+..+... .....+..||+.|||||++.. ..|+..+|+||+|++..||.- |.+|+.++.+...+-.
T Consensus 163 KLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad-G~PPl~DmHPmraLF~ 239 (953)
T KOG0587|consen 163 KLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE-GAPPLCDMHPMRALFL 239 (953)
T ss_pred EEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC-CCCCccCcchhhhhcc
Confidence 99999999877432 223456789999999999964 457899999999999999998 9999999888776555
Q ss_pred HHcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 447 LQDGYR--LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 447 i~~~~~--~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+-.... ...|..+..++.+++..|+.+|-++||++.++++
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 543322 3345678999999999999999999999999874
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=290.57 Aligned_cols=244 Identities=18% Similarity=0.265 Sum_probs=214.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
-..++.+..||-|+||+|=+.+..... ...|+|++++. ....|.+....|..+|...+.+.||+||-. +.+..+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~---~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-frd~ky 494 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQK---ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-FRDSKY 494 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccc---hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-hccchh
Confidence 345677899999999999998876643 24778877643 345666778899999999999999999987 677788
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.|+.||-|-+|.|...|+.. ..++..+...++..+.+|++|||+++||+|||||+|.+||.+|-+||.|||+
T Consensus 495 vYmLmEaClGGElWTiLrdR--------g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDR--------GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred hhhhHHhhcCchhhhhhhhc--------CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhh
Confidence 89999999999999999973 4688889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLNQPV 457 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~ 457 (499)
|+.+.... .+-+.+||+.|.|||.+++..++.++|.||+|+++|||++ |.+||.+.++......+.+|. ...+|.
T Consensus 567 AKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~-G~pPFs~~dpmktYn~ILkGid~i~~Pr 642 (732)
T KOG0614|consen 567 AKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLT-GSPPFSGVDPMKTYNLILKGIDKIEFPR 642 (732)
T ss_pred HHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHc-CCCCCCCCchHHHHHHHHhhhhhhhccc
Confidence 99875433 2336899999999999999999999999999999999999 999999999999888887765 457788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCC
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPT 480 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt 480 (499)
.++....+++++....+|.+|.-
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhc
Confidence 89999999999999999999976
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=287.20 Aligned_cols=241 Identities=21% Similarity=0.293 Sum_probs=201.5
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
++||.|-||+||-|+.+.++ +.||||++.+.. ...+.+.+++|+.+|++++||.||.|-.. ++..++.++|||-+
T Consensus 570 evLGSGQFG~VYgg~hRktG---rdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTG---RDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-FETPERVFVVMEKL 645 (888)
T ss_pred hhccCCcceeeecceecccC---ceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-ecCCceEEEEehhh
Confidence 89999999999999987765 889999997642 34455788999999999999999999887 47778889999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CcEEEcccccccccC
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLF 383 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~---~~~kl~DfGla~~~~ 383 (499)
.+.=|.-.|.. + ...|++.....++.||+.||.|||.++|+|+||||+||||.+. -++||+|||+||.+.
T Consensus 646 ~GDMLEMILSs-E------kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg 718 (888)
T KOG4236|consen 646 HGDMLEMILSS-E------KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG 718 (888)
T ss_pred cchHHHHHHHh-h------cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc
Confidence 84444444443 2 3468999999999999999999999999999999999999754 479999999999886
Q ss_pred CCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCc
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---RLNQPVNCP 460 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~ 460 (499)
..++ .....||+.|+|||+++++.|...-|+||.||++|--++ |..||.+. +++-+.+++.. .+....+++
T Consensus 719 EksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS-GTFPFNEd--EdIndQIQNAaFMyPp~PW~eis 792 (888)
T KOG4236|consen 719 EKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS-GTFPFNED--EDINDQIQNAAFMYPPNPWSEIS 792 (888)
T ss_pred hhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec-ccccCCCc--cchhHHhhccccccCCCchhhcC
Confidence 6554 346889999999999999999999999999999999999 88898764 35556666542 233334788
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
.++.+++...++..-.+|-+..+-+
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhc
Confidence 8999999999999999999988764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=288.15 Aligned_cols=266 Identities=17% Similarity=0.166 Sum_probs=185.7
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCC-------------ceeEEEEEEEecCcccHHHHHH--------------HH
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEED-------------GVEEEVLVKTVTDNASAVQVSL--------------LL 271 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~-------------~~~~~vavK~~~~~~~~~~~~~--------------~~ 271 (499)
+..++|++.++||+|+||.||+|.+...+ ...+.||||++...... ..+. +.
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchhH
Confidence 34667888899999999999999753211 12257999998654221 1122 33
Q ss_pred HHHHHHhcCCCCcc-----eeEEeEEEcC-------CCceEEEEEeCCCCCHHHHHHhcccCC----------------C
Q psy1789 272 QEGMAMYGLSHKNI-----LTVLGVSIED-------HTSPFLIYPYQDYTNLKRFLQKCKLCP----------------E 323 (499)
Q Consensus 272 ~E~~~l~~l~H~nI-----v~l~g~~~~~-------~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------~ 323 (499)
.|+.++.+++|.|+ ++++|+|... ....+|||||+++|+|.++++...... .
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46667777766654 6777876431 345799999999999999998532100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccc
Q psy1789 324 GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAI 403 (499)
Q Consensus 324 ~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 403 (499)
-....++|..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++....... .......+++.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 0123467889999999999999999999999999999999999999999999999976533211 111223347789999
Q ss_pred cccccCCC----------------------CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---------HHH--H-Hc
Q psy1789 404 ESLVHKTF----------------------STASDVWAFGVLLWELTTLAQQPYAEIDPFEM---------AAS--L-QD 449 (499)
Q Consensus 404 E~~~~~~~----------------------s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~---------~~~--i-~~ 449 (499)
|.+..... ..+.||||+||+++||+++.-.|+........ ..+ . ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 99864321 23579999999999999944447654321110 001 0 11
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNP---EGRPTFPQLHS 486 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P---~~RPt~~~v~~ 486 (499)
..........++..++++.+++..+| .+|+|+.|+++
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11222233567889999999999766 68999999875
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=264.88 Aligned_cols=251 Identities=15% Similarity=0.247 Sum_probs=203.0
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcC-CCCcceeEEeE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGL-SHKNILTVLGV 291 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~ 291 (499)
..+.+.-..++++.+||+|+|.+|-.+++..++ +.+|+|+++++ +.....+....|-.+.... +||.+|.|..
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~---qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs- 318 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTD---QIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS- 318 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccc---eeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh-
Confidence 445666778999999999999999999998777 78899988654 2223334455666666554 7999999887
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
|++.+.++++|.||.++|+|.-+++.. +.|+++.+..+..+|+.||.|||++|||+||||.+|+|||.+|++
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqrq--------rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhhh--------hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCce
Confidence 588899999999999999998888762 468999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-------CHHHHH
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI-------DPFEMA 444 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-------~~~~~~ 444 (499)
||+|+|+++....... .+++.+||+.|+|||.+++..|+..+|+|++||+|+||+. |+.||.-. +.++..
T Consensus 391 kltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemma-grspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 391 KLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMA-GRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred eecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHc-CCCCcceecCCCcccchhHHH
Confidence 9999999987654332 3567899999999999999999999999999999999999 88888632 223332
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q psy1789 445 ASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPT 480 (499)
Q Consensus 445 ~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt 480 (499)
-.+.-......|...+-....++..-+++||.+|.-
T Consensus 468 fqvilekqiriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 468 FQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 222211233445566667888999999999999953
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.57 Aligned_cols=241 Identities=20% Similarity=0.290 Sum_probs=189.5
Q ss_pred eeeeeecce-EEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEEEEEe
Q psy1789 228 SVNMEGTFG-RVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 228 ~~lG~G~fG-~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~lv~e~ 305 (499)
+++|.|+-| .||+|.+.+ +.||||++..+ ..+...+|+..|+.- +|||||+++|. ..+..+.|+..|.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~-----R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~-E~d~qF~YIalEL 584 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEG-----REVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCS-EQDRQFLYIALEL 584 (903)
T ss_pred HHcccCCCCcEEEEEeeCC-----ceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEee-ccCCceEEEEehH
Confidence 788999998 579999865 78999998643 224456899999876 69999999997 6677888999999
Q ss_pred CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-----CCcEEEccccccc
Q psy1789 306 QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-----KLRIQITDNALAR 380 (499)
Q Consensus 306 ~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-----~~~~kl~DfGla~ 380 (499)
|. .+|.+++..... +. ..........+..|+++||+|||+.+||||||||.||||+. ...++|+|||+++
T Consensus 585 C~-~sL~dlie~~~~--d~--~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGL--DV--EMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hh-hhHHHHHhcccc--ch--hhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 98 899999987310 00 01111445788999999999999999999999999999975 2579999999999
Q ss_pred ccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 381 DLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 381 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
.+...... .......||-||+|||.+....-+.++||+|+||++|..+|||..||.+.- +-...|..+...-.....
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEP 737 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeecc
Confidence 88754332 234577899999999999999989999999999999999999999998642 222334333221111112
Q ss_pred cH--HHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 460 PD--ELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 460 ~~--~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
.+ ++.+|+.++++++|..||++.+|+
T Consensus 738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 738 LPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred CchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 22 899999999999999999999996
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=246.92 Aligned_cols=227 Identities=17% Similarity=0.287 Sum_probs=181.1
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc-CCCCcceeEEeEEEcC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG-LSHKNILTVLGVSIED 295 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~ 295 (499)
+++..+.+.-+..||+|+||.|-+-++..++ ...|+|.+...-..+..++.++|+.+..+ ...|.+|+++|..++
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg---~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r- 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSG---TIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR- 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCC---eEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-
Confidence 4444555555689999999999888876665 78999999876556666788899988665 579999999997544
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++.||.|. -||+.|-.+-- .....+++...-+|+..|.+||.|||++ .+||||+||+|||||.+|++|++
T Consensus 117 egdvwIcME~M~-tSldkfy~~v~----~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 117 EGDVWICMELMD-TSLDKFYRKVL----KKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred cccEEEeHHHhh-hhHHHHHHHHH----hcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEc
Confidence 556799999998 78888866422 1235688999999999999999999987 89999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccc----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHc
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLV----HKTFSTASDVWAFGVLLWELTTLAQQPYAE-IDPFEMAASLQD 449 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~-~~~~~~~~~i~~ 449 (499)
|||++..+..+- ..+-..|.-.|||||.+. ...|+.|+||||||+++.||.+ ++.||.. ..+++....+..
T Consensus 192 DFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~-lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 192 DFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI-LRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh-ccccccccCCHHHHHHHHhc
Confidence 999998775432 222345667799999885 3479999999999999999999 8888875 467777777766
Q ss_pred CCCCCCC
Q psy1789 450 GYRLNQP 456 (499)
Q Consensus 450 ~~~~~~~ 456 (499)
...+..|
T Consensus 268 ep~P~Lp 274 (282)
T KOG0984|consen 268 EPSPQLP 274 (282)
T ss_pred CCCCCCc
Confidence 5444444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.06 Aligned_cols=261 Identities=13% Similarity=0.160 Sum_probs=169.3
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCC-ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeE----E
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV----S 292 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~----~ 292 (499)
....++|++.+.||+|+||.||+|++.++. .....+|+|++...... +.+..| .+....+.++..+... .
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 345568899999999999999999987651 11268999987643221 112222 1222223333222111 1
Q ss_pred -EcCCCceEEEEEeCCCCCHHHHHHhcccCC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy1789 293 -IEDHTSPFLIYPYQDYTNLKRFLQKCKLCP------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLA 359 (499)
Q Consensus 293 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk 359 (499)
...+...++|+||+++++|.+++....... ...........+..++.|++.||+|||+++|+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 134556799999999999999997532100 0000112234567899999999999999999999999
Q ss_pred CCceEEcC-CCcEEEcccccccccCCCCccccCCCCCCccccccccccccC----------------------CCCCchh
Q psy1789 360 TRNCVVDD-KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK----------------------TFSTASD 416 (499)
Q Consensus 360 ~~NIlld~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~D 416 (499)
|+|||+++ ++.+||+|||+|+.+...... ......+++.|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999996 589999999999865432211 22345678899999966432 2445679
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----------CCCCCC----------CCCcHHHHHHHHHhhhcCCC
Q psy1789 417 VWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG----------YRLNQP----------VNCPDELFSVMAYCWAMNPE 476 (499)
Q Consensus 417 vwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~----------~~~~~~----------~~~~~~~~~l~~~C~~~~P~ 476 (499)
||||||++|||++ +..++... .......+... ...... ........+|+.+|++.||+
T Consensus 362 VwSlGviL~el~~-~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 362 IYSAGLIFLQMAF-PNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred cHHHHHHHHHHHh-CcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999999998 54443321 11111111100 000000 01223456899999999999
Q ss_pred CCCCHHHHHH
Q psy1789 477 GRPTFPQLHS 486 (499)
Q Consensus 477 ~RPt~~~v~~ 486 (499)
+|||+.|+++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999986
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=259.13 Aligned_cols=253 Identities=17% Similarity=0.270 Sum_probs=192.9
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-----
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED----- 295 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----- 295 (499)
..|+-...||+|.||.||+|+..+++ +.||+|++..++ ....-....+|+.+|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~---kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTG---KKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCcc---chhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 34444589999999999999976655 678888764322 222223457899999999999999999887432
Q ss_pred --CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 296 --HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 296 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
....+|||++++ -+|...|... ...++..++.+++.++..||.|+|...|+|||+|+.|+||+.++.+||
T Consensus 94 r~r~t~ylVf~~ce-hDLaGlLsn~-------~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl 165 (376)
T KOG0669|consen 94 RDRATFYLVFDFCE-HDLAGLLSNR-------KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL 165 (376)
T ss_pred cccceeeeeHHHhh-hhHHHHhcCc-------cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence 234799999998 6888888642 346889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcc--ccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Q psy1789 374 TDNALARDLFPSDYH--CLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL--- 447 (499)
Q Consensus 374 ~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i--- 447 (499)
+|||+|+.+..++.. ...++.+.|.-|.+||.+.+ ..|+++.|||.-||+|.||.| +.+-+++.........+
T Consensus 166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt-rspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT-RSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc-cCccccCChHHHHHHHHHHH
Confidence 999999876543221 11234556889999999987 569999999999999999999 77777765443332222
Q ss_pred HcCCCCC------------------C-------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 QDGYRLN------------------Q-------------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ~~~~~~~------------------~-------------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.....++ . |-.-.++..+++...+..||.+|+++.+++.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1111000 0 0012347889999999999999999998863
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=265.21 Aligned_cols=252 Identities=21% Similarity=0.243 Sum_probs=196.9
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC--C---c-ceeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH--K---N-ILTVL 289 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~---n-Iv~l~ 289 (499)
..+....+|.+.+.+|+|+||.|-.+.+...+ ..||||+++.-. ...+.-+-|+++|+++.+ | | +|++.
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~---~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETK---EHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCC---ceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 34555789999999999999999999876653 789999997543 334556679999999842 2 2 56666
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD--- 366 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld--- 366 (499)
+| ++-.++.++|+|.+. -|+.+||..+. ..+++...+..|+.|++++++|||+.+++|-||||+|||+-
T Consensus 158 ~w-FdyrghiCivfellG-~S~~dFlk~N~------y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 158 DW-FDYRGHICIVFELLG-LSTFDFLKENN------YIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred hh-hhccCceEEEEeccC-hhHHHHhccCC------ccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccc
Confidence 65 677888899999885 69999998633 45789999999999999999999999999999999999983
Q ss_pred -----------------CCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc
Q psy1789 367 -----------------DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429 (499)
Q Consensus 367 -----------------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t 429 (499)
.+..+||.|||-|+..... .+..+.|..|.|||++++-.++.++||||+||||.|+.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 1446899999999864332 245667888999999999999999999999999999999
Q ss_pred CCCCCCCCCCHHH---HHHHHHcCC-----------------CCCCCC-------------------------CCcHHHH
Q psy1789 430 LAQQPYAEIDPFE---MAASLQDGY-----------------RLNQPV-------------------------NCPDELF 464 (499)
Q Consensus 430 ~g~~p~~~~~~~~---~~~~i~~~~-----------------~~~~~~-------------------------~~~~~~~ 464 (499)
|...|+..+..| +++.+.... +..++. ..-.+++
T Consensus 305 -G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 305 -GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred -cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 788777665444 233322210 111111 1122599
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q psy1789 465 SVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+|+..++..||.+|+|+.|++.
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999875
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=274.17 Aligned_cols=252 Identities=17% Similarity=0.241 Sum_probs=200.0
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 291 (499)
+.+...+..-|..++.||-|+||+|.++.-.++. ..+|.|.+.+. -...++.....|..+|..-+.+=||+|+-.
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~---~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTR---ALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEeecchh---hHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 3344555667788899999999999999865554 68999999754 234556678889999999999999999864
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
+++.+.+|+||||+++|++-.+|-+. ..|.+.....++.+++.|+++.|..|+|||||||+|||||.+|++
T Consensus 698 -FQDkdnLYFVMdYIPGGDmMSLLIrm--------gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 698 -FQDKDNLYFVMDYIPGGDMMSLLIRM--------GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred -eccCCceEEEEeccCCccHHHHHHHh--------ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCce
Confidence 78888899999999999999999873 358888899999999999999999999999999999999999999
Q ss_pred EEcccccccccC---CCCcc-------------------------------------ccCCCCCCccccccccccccCCC
Q psy1789 372 QITDNALARDLF---PSDYH-------------------------------------CLGDNENRPVKWLAIESLVHKTF 411 (499)
Q Consensus 372 kl~DfGla~~~~---~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 411 (499)
||+||||++-+. .+.+. +.....+||..|+|||++....|
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 999999996542 00000 01123458999999999999999
Q ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy1789 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---RLNQPVNCPDELFSVMAYCWAMNPEGRP 479 (499)
Q Consensus 412 s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~l~~~C~~~~P~~RP 479 (499)
+..+|+||.|||||||+- |++||....+.+....+..+. ......+.+.+..++|.+... +++.|.
T Consensus 849 ~q~cdwws~gvil~em~~-g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLV-GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred cccchhhHhhHHHHHHhh-CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999999999998 999999887766554444332 223334678888887755432 355663
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=235.96 Aligned_cols=212 Identities=28% Similarity=0.474 Sum_probs=181.9
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCCC
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYT 309 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~g 309 (499)
||+|.+|.||++...+++ +.+++|++.........+.+.+|+..++.++|++|+++++++.. ....++++||++++
T Consensus 1 l~~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTG---KKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCC---cEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCC
Confidence 578999999999986533 68999999766443345778999999999999999999998644 46679999999999
Q ss_pred CHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCcEEEcccccccccCCCCcc
Q psy1789 310 NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRIQITDNALARDLFPSDYH 388 (499)
Q Consensus 310 sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-~~~~kl~DfGla~~~~~~~~~ 388 (499)
+|.+++.... ..+++..+..++.+++++|.|||+.+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 77 ~l~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 77 SLKDLLKENE-------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred cHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 9999998621 35889999999999999999999999999999999999999 89999999999986643321
Q ss_pred ccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHH
Q psy1789 389 CLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVM 467 (499)
Q Consensus 389 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 467 (499)
......+...|++||..... .++.++|+|++|++++|| +++.+++
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l 194 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLI 194 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHH
Confidence 12234466789999999887 889999999999999999 6899999
Q ss_pred HHhhhcCCCCCCCHHHHHHH
Q psy1789 468 AYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 468 ~~C~~~~P~~RPt~~~v~~~ 487 (499)
..|++.+|++||++.++++.
T Consensus 195 ~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 195 RKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHhhCCcccCcCHHHHhhC
Confidence 99999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=235.01 Aligned_cols=245 Identities=18% Similarity=0.318 Sum_probs=189.9
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcC-CC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIED-HT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~-~~ 297 (499)
....|++.+.+|+|.|+.||.|....++ .+++||+++.- ..+.+.+|+.+|..|+ ||||++|++...+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~---eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNN---EKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCC---ceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 3457888899999999999999865544 67889998643 3467889999999998 99999999985443 23
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCcEEEccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRIQITDN 376 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-~~~~kl~Df 376 (499)
.+.||+||..|.+...... .|+...+...+.+++.||.|||+.||+|||+||.|++||. .-..+|.|+
T Consensus 109 tpaLiFE~v~n~Dfk~ly~-----------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYP-----------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred CchhHhhhhccccHHHHhh-----------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeec
Confidence 4689999999999988765 4788889999999999999999999999999999999995 567999999
Q ss_pred ccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCC-CCCCCHHH-H----------
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQP-YAEIDPFE-M---------- 443 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p-~~~~~~~~-~---------- 443 (499)
|||....+..... -...+..|-.||.+.. ..|+..-|+|||||++.+|+- .+.| |.+.+..+ +
T Consensus 178 GLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF-rkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 178 GLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred chHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHh-ccCcccCCCCCHHHHHHHHHHhChH
Confidence 9999887664432 2234456889999876 568999999999999999998 5555 44443222 1
Q ss_pred --HHHHHc---------------CCCC--------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 444 --AASLQD---------------GYRL--------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 444 --~~~i~~---------------~~~~--------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+.+.+ ..+. +...-..+++.+++.+.+..|-.+|||++|.+.
T Consensus 254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111 0000 000124578999999999999999999999864
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=247.38 Aligned_cols=246 Identities=21% Similarity=0.346 Sum_probs=190.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-----CceEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH-----TSPFL 301 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~-----~~~~l 301 (499)
+.||-|+||.||..++..++ +.|+.|++.+- .+-...+.+.+|+.+|.-.+|.|++..++. .+.. .+.|+
T Consensus 59 RPIGYGAFGVVWsVTDPRdg---rrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDI-LQPph~dfFqEiYV 134 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSG---KRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDI-LQPANPSFFQELYV 134 (449)
T ss_pred CcccccceeEEEeccCCCCc---cchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHh-cCCCCchHHHHHHH
Confidence 88999999999998876544 78999988653 233445788999999999999999999887 3332 23567
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
++|.|. .+|...+-. .+.|+...+.-+..||++||.|||+.+|+||||||.|.|++++...||+|||+||.
T Consensus 135 ~TELmQ-SDLHKIIVS--------PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVS--------PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-hhhhheecc--------CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccc
Confidence 788887 677777654 45788888899999999999999999999999999999999999999999999997
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-----------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD----------- 449 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~----------- 449 (499)
-...+.. ..+....|..|.|||.+.+ ..|+.+.||||.||++.|++- ++..|+..++.+..+.+.+
T Consensus 206 ee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg-RrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 206 WDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ-RKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred cchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh-hhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 6544322 2334556778999999987 459999999999999999996 8888887666443332211
Q ss_pred ----C---------CCC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 450 ----G---------YRL---------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 450 ----~---------~~~---------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
| .+. ..+..-..+...+....+..||+.|.+..+.+..+
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1 110 11113334677788888899999999988876654
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=267.49 Aligned_cols=251 Identities=20% Similarity=0.331 Sum_probs=206.4
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
++.+|+++..+|.|+||.|||++....+ ...|+|+++-.... ..+...+|+.+++..+|+||+.++|-.. .....
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~---elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsyl-r~dkl 87 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSG---ELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYL-RRDKL 87 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccC---chhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhh-hhcCc
Confidence 4567888999999999999999987665 67888888655332 2355678999999999999999999744 45667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
|++|||+.+|+|.+.-+. ...+++.++..+++...+||+|||+++-+|||||-.|||+++.+.+|++|||.+
T Consensus 88 wicMEycgggslQdiy~~--------TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 88 WICMEYCGGGSLQDIYHV--------TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EEEEEecCCCcccceeee--------cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCch
Confidence 999999999999998875 347899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-C---CC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD-G---YR 452 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~-~---~~ 452 (499)
..+... -.......||+.|||||+.. .+.|..++|||+.|+...|+.- -++|..+..+......+.+ + .+
T Consensus 160 aqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e-Lqpplfdlhpmr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 160 AQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE-LQPPLFDLHPMRALFLMTKSGFQPPT 236 (829)
T ss_pred hhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh-cCCcccccchHHHHHHhhccCCCCCc
Confidence 766432 11233567999999999874 5779999999999999999988 6777666666665544432 2 23
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+..+.+.+-++++.|+.++|.+||++..+++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 3344577888999999999999999999988764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-29 Score=232.80 Aligned_cols=216 Identities=26% Similarity=0.331 Sum_probs=177.8
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
|++.+.||+|++|.||++...+.+ +.+++|.+.........+.+.+|+..+.+++|+|++++++++.. ....++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG---ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC---cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEE
Confidence 356689999999999999987644 67999999765433356789999999999999999999998644 56679999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
||+++++|.+++.... ..+++.....++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 77 e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 77 EYCEGGDLFDYLRKKG-------GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred eccCCCCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 9999999999998632 117899999999999999999999999999999999999999999999999998765
Q ss_pred CCCccccCCCCCCcccccccccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCHH-HHHHHHHcCCC
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESL-VHKTFSTASDVWAFGVLLWELTTLAQQPYAE-IDPF-EMAASLQDGYR 452 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~-~~~~-~~~~~i~~~~~ 452 (499)
..... ......++..|++||.+ ....++.++|||+||++++||++ |+.||.. .++. ++.+.+..+..
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW-GPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH-CCCCccccchhHHHHHHHHhcCCc
Confidence 43200 12234566789999998 67778889999999999999999 8999977 4444 56666666543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=255.82 Aligned_cols=198 Identities=23% Similarity=0.336 Sum_probs=167.5
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH--HH-----HHHHHHHHHHHhcCC---CCcceeEEeE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA--VQ-----VSLLLQEGMAMYGLS---HKNILTVLGV 291 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~-----~~~~~~E~~~l~~l~---H~nIv~l~g~ 291 (499)
..|..++.+|+|+||.|+.|.++.+. ..|+||.+.++.-- .+ .-..-.|+++|..++ |+||++++.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~---~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENN---YEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred ccceeeeeccccccceEEEeeecccc---eEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 35788899999999999999998764 78999998754211 11 122457999999997 9999999998
Q ss_pred EEcCCCceEEEEEeCC-CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 292 SIEDHTSPFLIYPYQD-YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
++++++.+|++|-.. +-+|.+++.. ...+++.+..-|+.||+.|+++||+++|||||||-+|+.+|.+|-
T Consensus 638 -FEddd~yyl~te~hg~gIDLFd~IE~--------kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 638 -FEDDDYYYLETEVHGEGIDLFDFIEF--------KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred -eecCCeeEEEecCCCCCcchhhhhhc--------cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe
Confidence 677888899999754 6799999986 346999999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYA 436 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~ 436 (499)
+||.|||-|....... -+...||.+|.|||++.+.+| +..-|||++|++||-++. +..||-
T Consensus 709 ~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy-kenpyy 770 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY-KENPYY 770 (772)
T ss_pred EEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe-ccCCCc
Confidence 9999999987554332 246789999999999999887 577999999999999998 777774
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=228.57 Aligned_cols=250 Identities=24% Similarity=0.460 Sum_probs=201.6
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecC-cccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTD-NASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+.++.+|.+...|+.|+|+|.+++ +++|++.- +.+....+.|..|.-.|+-..||||+.++|.|- ....+.+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd-----ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-sppnlv~ 264 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND-----IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-SPPNLVI 264 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc-----hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-CCCCceE
Confidence 4445567777889999999998865 45565542 234445577889999999999999999999974 4567799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-Ccccc-CCCCCceEEcCCCcEEEcccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHK-DLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHr-Dlk~~NIlld~~~~~kl~DfGla 379 (499)
+..||+.|+|...|++.. .-..+..+..+++.++|+|++|||+. +++-| -|.+..+++|++.+++|+- +-+
T Consensus 265 isq~mp~gslynvlhe~t------~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~ 337 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQT------SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADT 337 (448)
T ss_pred eeeeccchHHHHHHhcCc------cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccc
Confidence 999999999999999632 34578889999999999999999986 55544 5899999999999988751 211
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS---TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QDGYRLNQ 455 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~ 455 (499)
+ +........-.+.||+||.+....-+ .++|+|||.+++||+.| +..||.+..+.+...++ ..+.+...
T Consensus 338 k------fsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t-revpfadlspmecgmkialeglrv~i 410 (448)
T KOG0195|consen 338 K------FSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT-REVPFADLSPMECGMKIALEGLRVHI 410 (448)
T ss_pred e------eeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc-cccccccCCchhhhhhhhhccccccC
Confidence 1 11122233345679999999876644 67999999999999999 99999999998876554 57889999
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
|...+..+.++|.-|...||.+||.++.|+-.|++..
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 9999999999999999999999999999999998763
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=230.16 Aligned_cols=244 Identities=19% Similarity=0.247 Sum_probs=181.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC-----
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH----- 296 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~----- 296 (499)
||.-+..+|.|.- .|-.+.+.- ..+.|++|++... ......++..+|..++..+.|+||++++.+ +...
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v---~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~-ftP~~~l~~ 92 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQV---LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNV-FTPQKTLEE 92 (369)
T ss_pred eeeeecccCCCCc-eEEecchhh---ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeec-cCccccHHH
Confidence 3444456666665 444444322 2267888887532 122223566789999999999999999987 3322
Q ss_pred -CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 297 -TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 297 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...++|||||. ++|.+.++- .++-.++..|..|++.|+.|||+.+|+||||||+||++..+...||.|
T Consensus 93 ~~e~y~v~e~m~-~nl~~vi~~----------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 93 FQEVYLVMELMD-ANLCQVILM----------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred HHhHHHHHHhhh-hHHHHHHHH----------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeecc
Confidence 34589999999 899998873 367788999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG----- 450 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~----- 450 (499)
||+|+..... ...+....|..|.|||++.+..|.+++||||.||++.||++ |...|.+.+..+...++.+.
T Consensus 162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~-~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL-GTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred chhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh-ceEEecCchHHHHHHHHHHHhcCCC
Confidence 9999865332 23445566778999999999999999999999999999999 77777765432211111100
Q ss_pred ----------------CC-----CC----CCC-----------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 ----------------YR-----LN----QPV-----------NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 ----------------~~-----~~----~~~-----------~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+ .. .|. --.+.+.+++.+++..||++|.++++++.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00 00 000 11235889999999999999999999874
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=276.46 Aligned_cols=196 Identities=19% Similarity=0.165 Sum_probs=141.5
Q ss_pred CCC-CcceeEEeEEEc------CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy1789 280 LSH-KNILTVLGVSIE------DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352 (499)
Q Consensus 280 l~H-~nIv~l~g~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~ 352 (499)
++| .||.++++++.. .....++++||++ ++|.++|... ...+++.+++.++.||++||+|||+++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~g 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP-------DRSVDAFECFHVFRQIVEIVNAAHSQG 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc-------cccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 445 578888887411 1234577788885 7999999742 235899999999999999999999999
Q ss_pred ccccCCCCCceEEcC-------------------CCcEEEcccccccccCCCCc--------------cccCCCCCCccc
Q psy1789 353 LLHKDLATRNCVVDD-------------------KLRIQITDNALARDLFPSDY--------------HCLGDNENRPVK 399 (499)
Q Consensus 353 iiHrDlk~~NIlld~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~ 399 (499)
|+||||||+||||+. ++.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 45567777777764211000 000112357888
Q ss_pred cccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy1789 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRP 479 (499)
Q Consensus 400 y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP 479 (499)
|||||++.+..|+.++|||||||+||||++ +.+|+.... .....+.....+........+...++.+||+++|.+||
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rp 257 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFC-PVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRP 257 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhh-CCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCc
Confidence 999999999999999999999999999999 777755321 22222222222222222345677899999999999999
Q ss_pred CHHHHHH
Q psy1789 480 TFPQLHS 486 (499)
Q Consensus 480 t~~~v~~ 486 (499)
++.|+++
T Consensus 258 s~~eil~ 264 (793)
T PLN00181 258 SMSELLQ 264 (793)
T ss_pred ChHHHhh
Confidence 9999975
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=243.14 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=195.4
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC------CCcceeEEeE
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS------HKNILTVLGV 291 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~g~ 291 (499)
++...+|.+....|+|-|++|.+|.....+ ..||||++.++ +.+.+.=+.|+++|++|+ --+.++|+..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~---~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARG---QEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCC---CeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 455678999999999999999999875544 68999999875 334455578999999985 3467888776
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-Cc
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-LR 370 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~-~~ 370 (499)
+...++++||+|-+. -+|.+.|.+- +..-.|.......++.|+..||..|..++|+|.||||+|||+++. ..
T Consensus 503 -F~hknHLClVFE~Ls-lNLRevLKKy-----G~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 503 -FKHKNHLCLVFEPLS-LNLREVLKKY-----GRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred -hhhcceeEEEehhhh-chHHHHHHHh-----CcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence 455778999999887 7999999873 334568888899999999999999999999999999999999976 45
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD- 449 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~- 449 (499)
.||||||-|......... ....+..|.|||.+.+..|+...|+||.||+||||.| |+..|.+....+++....+
T Consensus 576 LKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYt-GkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYT-GKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred eeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeec-cceecCCCCcHHHHHHHHHh
Confidence 799999998765433221 1122335999999999999999999999999999999 8998888655444332211
Q ss_pred -----------CC----CC-------------------------CCC---------------C---CCcHHHHHHHHHhh
Q psy1789 450 -----------GY----RL-------------------------NQP---------------V---NCPDELFSVMAYCW 471 (499)
Q Consensus 450 -----------~~----~~-------------------------~~~---------------~---~~~~~~~~l~~~C~ 471 (499)
+. .. ..| . .....+.+|+..|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 10 00 000 0 11224889999999
Q ss_pred hcCCCCCCCHHHHHH
Q psy1789 472 AMNPEGRPTFPQLHS 486 (499)
Q Consensus 472 ~~~P~~RPt~~~v~~ 486 (499)
..||++|.|..|.++
T Consensus 731 ~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 731 ILDPEKRITVNQALK 745 (752)
T ss_pred ccChhhcCCHHHHhc
Confidence 999999999998875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=218.01 Aligned_cols=163 Identities=17% Similarity=0.287 Sum_probs=130.3
Q ss_pred CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCcc
Q psy1789 309 TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388 (499)
Q Consensus 309 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~ 388 (499)
|+|.++++..+ ..+++.+++.|+.|++.||.|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVRG-------RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc---
Confidence 78999998522 35999999999999999999999988 999999999999999 9999865332
Q ss_pred ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCC------CCCCCcH
Q psy1789 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRLN------QPVNCPD 461 (499)
Q Consensus 389 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~------~~~~~~~ 461 (499)
...|+..|||||++.+..++.++|||||||++|||+| |+.||..... ......+....... .+....+
T Consensus 63 ----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (176)
T smart00750 63 ----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALD-YELPYNEERELSAILEILLNGMPADDPRDRSNLESVSA 137 (176)
T ss_pred ----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHh-CCCCccccchhcHHHHHHHHHhccCCccccccHHHHHh
Confidence 2257889999999999999999999999999999999 8888876433 22233332222211 1112333
Q ss_pred --HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 462 --ELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 462 --~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
++.+++.+||+.+|++||++.|+++.+.....+
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 699999999999999999999999998877554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=234.06 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=198.3
Q ss_pred hHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCccee
Q psy1789 209 DLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILT 287 (499)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~ 287 (499)
++.+...........|+.++.||+|+|++||++++...+.....||+|.+...... .+..+|+++|..+. +.||+.
T Consensus 23 e~~~l~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~ 99 (418)
T KOG1167|consen 23 EIEQLRQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIK 99 (418)
T ss_pred HHHHHHhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhc
Confidence 33344444556677888999999999999999998763334489999999766544 56789999999985 999999
Q ss_pred EEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q psy1789 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 288 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~ 367 (499)
+.++ ...++...+|+||++.-+..+++.. ++..++..+++.+..||.|+|.+|||||||||+|+|.+.
T Consensus 100 ~~~~-~rnnd~v~ivlp~~~H~~f~~l~~~-----------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 100 LNGC-FRNNDQVAIVLPYFEHDRFRDLYRS-----------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR 167 (418)
T ss_pred chhh-hccCCeeEEEecccCccCHHHHHhc-----------CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc
Confidence 9995 7778888999999999999999875 778899999999999999999999999999999999985
Q ss_pred C-CcEEEcccccccccC-----------------C-----------------CCccc--------cCCCCCCcccccccc
Q psy1789 368 K-LRIQITDNALARDLF-----------------P-----------------SDYHC--------LGDNENRPVKWLAIE 404 (499)
Q Consensus 368 ~-~~~kl~DfGla~~~~-----------------~-----------------~~~~~--------~~~~~~gt~~y~aPE 404 (499)
. +.-.|.|||||.... + ..+.+ ......||+||.|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 4 567899999997211 1 00001 011345899999999
Q ss_pred cccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCHHH-------------HHH--HHHcC---CC------------
Q psy1789 405 SLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAE-IDPFE-------------MAA--SLQDG---YR------------ 452 (499)
Q Consensus 405 ~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~-~~~~~-------------~~~--~i~~~---~~------------ 452 (499)
++.. ..-++++||||-||+++-+++ ++.||-. .+..+ +.+ .+... +.
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls-~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~ 326 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLS-RRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRV 326 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhc-cccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHh
Confidence 9975 557899999999999999999 6666543 22211 110 00000 00
Q ss_pred ----C--------CCC--------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 ----L--------NQP--------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ----~--------~~~--------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .++ ...+..+++++.+|++.||.+|.|+++.++
T Consensus 327 ~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 327 NFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred chhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 000 112336899999999999999999999875
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-26 Score=224.88 Aligned_cols=136 Identities=19% Similarity=0.292 Sum_probs=112.0
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-----C---CcceeEE
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-----H---KNILTVL 289 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~ 289 (499)
.+...||.+.++||=|.|++||++.+.... +.||+|+.+.. +...+.-..||++|+.++ | ..||+|+
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~---r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNK---RYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCC---eEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 344589999999999999999999987665 78999998643 334456678999998874 3 3599999
Q ss_pred eEEEc---CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEE
Q psy1789 290 GVSIE---DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVV 365 (499)
Q Consensus 290 g~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIll 365 (499)
+.... .+.+.++|+|++. .+|..++.... .+.++...+.+|++||+.||.|||.+ +|||-||||+||||
T Consensus 149 D~FkhsGpNG~HVCMVfEvLG-dnLLklI~~s~------YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVLG-DNLLKLIKYSN------YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ccceecCCCCcEEEEEehhhh-hHHHHHHHHhC------CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 97433 2456899999987 78888888744 45789999999999999999999975 99999999999997
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=220.18 Aligned_cols=247 Identities=15% Similarity=0.252 Sum_probs=189.0
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~l 301 (499)
.|.+.+.+|+|.||.+-++.++..+ ..+++|-+..... ..++|.+|..---.| .|.||+.-+++.++..+..++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~---t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSK---TRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCc---eEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 4667799999999999999987765 7889998876533 347888887654444 699999999888888888889
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--CCCcEEEcccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD--DKLRIQITDNALA 379 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld--~~~~~kl~DfGla 379 (499)
++||++.|+|.+-+.. ..+.+.....++.|+++|+.|+|++++||||||.+||||- +...+||+|||+.
T Consensus 100 ~qE~aP~gdL~snv~~---------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA---------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred eeccCccchhhhhcCc---------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence 9999999999987764 3477888899999999999999999999999999999983 4468999999998
Q ss_pred cccCCCCccccCCCCCCccccccccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHc
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHK-----TFSTASDVWAFGVLLWELTTLAQQPYAEIDP-----FEMAASLQD 449 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-----~~~~~~i~~ 449 (499)
+..... . ....-+..|-+||..... ...+.+|+|.||++++.++| |.+||+.... .+..+|...
T Consensus 171 ~k~g~t-V----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~clt-G~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 171 RKVGTT-V----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLT-GKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred cccCce-e----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeec-CCCcchhhhccCchHHHHHHHhcc
Confidence 754211 1 122233458899987543 25688999999999999999 9999985322 223334332
Q ss_pred CCCCCCCC---CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 450 GYRLNQPV---NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 450 ~~~~~~~~---~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
..+..|. ..++.+..+.++-+.++|++|-...++.++...
T Consensus 245 -k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 245 -KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred -cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 2222332 467788899999999999999666666655444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=218.71 Aligned_cols=167 Identities=15% Similarity=0.107 Sum_probs=127.6
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc----ccHHHHHHHHHHHHHHhcCCCCccee-EEeEEEc
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN----ASAVQVSLLLQEGMAMYGLSHKNILT-VLGVSIE 294 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~-l~g~~~~ 294 (499)
...+|++.+.||+|+||+||+|.+...++ ..+|||++... ......+.|.+|+++|++++|+|++. ++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPG--TARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCC--eEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 34568888999999999999998764222 55899987533 12334567999999999999999985 4432
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEEcCCCcEEE
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDL-ATRNCVVDDKLRIQI 373 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDl-k~~NIlld~~~~~kl 373 (499)
+..++||||+++++|... .. .. ...++.|+++||.|||++||+|||| ||+|||++.++.+||
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~-----------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP-----------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc-----------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEE
Confidence 245999999999999632 11 01 1467889999999999999999999 999999999999999
Q ss_pred cccccccccCCCCcccc------CCCCCCcccccccccccc
Q psy1789 374 TDNALARDLFPSDYHCL------GDNENRPVKWLAIESLVH 408 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 408 (499)
+|||+|+.......... -....++..|+|||++.-
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999997654321111 124567788999999854
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-23 Score=207.50 Aligned_cols=261 Identities=17% Similarity=0.240 Sum_probs=197.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC----CcceeEEeEEEcCCCc
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH----KNILTVLGVSIEDHTS 298 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~g~~~~~~~~ 298 (499)
+|.+.+.||+|+||.||++...... ...+|+|.......... ..+..|+.++..+.+ +++..+++.....+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKP-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCC-ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 7899999999999999999976543 25788887765432222 256788888888763 5788888764334556
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-----CcEEE
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-----LRIQI 373 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~-----~~~kl 373 (499)
.++||+... .+|.++..... ...++..+.+.|+.|+..+|+++|+.|++||||||+|+++... ..+.|
T Consensus 96 ~~iVM~l~G-~sL~dl~~~~~------~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 96 NFIVMSLLG-PSLEDLRKRNP------PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred eEEEEeccC-ccHHHHHHhCC------CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 689988665 89999876522 3579999999999999999999999999999999999999854 46899
Q ss_pred ccccccc--ccCCCCcc---c--c-CCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy1789 374 TDNALAR--DLFPSDYH---C--L-GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445 (499)
Q Consensus 374 ~DfGla~--~~~~~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~ 445 (499)
.|||+|+ ........ . . .....||..|.++....+...+.+.|+||++-++.|+.. |..||..........
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~-g~LPW~~~~~~~~~~ 247 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK-GSLPWEALEMTDLKS 247 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc-CCCCCccccccchHH
Confidence 9999998 43222211 0 1 124559999999999999999999999999999999998 779997755322222
Q ss_pred HHH---cCCCCC-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 446 SLQ---DGYRLN-QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 446 ~i~---~~~~~~-~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.+. ...... .....+.++.+++..+-..+..++|....+...|++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 248 KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 221 111111 2334567888888888889999999999999998877654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-23 Score=202.26 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=198.3
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHH--HHHHHHHHHHHHhcCCCC-cceeEEeEEEcCCCceE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAV--QVSLLLQEGMAMYGLSHK-NILTVLGVSIEDHTSPF 300 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~-nIv~l~g~~~~~~~~~~ 300 (499)
|++.+.||.|+||.||++... ..+++|.+....... ....|.+|+.++..+.|+ +|+++.+.. ......+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-QDEGSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-ecCCEEE
Confidence 567789999999999999875 468888887553333 467899999999999988 799999985 4445469
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cEEEcccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDNALA 379 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~kl~DfGla 379 (499)
++++|+.++++.+++...... ..+.......++.|++.++.|+|+.+++|||+||+||+++... .+++.|||++
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRK-----GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEecCCCCcHHHHHHhcccc-----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 999999999999777652210 2688999999999999999999999999999999999999988 7999999999
Q ss_pred cccCCCCccc----cCCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH
Q psy1789 380 RDLFPSDYHC----LGDNENRPVKWLAIESLVH---KTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEMAASLQ 448 (499)
Q Consensus 380 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~----~~~~~~i~ 448 (499)
+......... ......++..|+|||.+.+ ..++...|+||+|++++++++ +..|+..... .+....+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~ 228 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEKNSSATSQTLKIIL 228 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCccccHHHHHHHHH
Confidence 8654433221 2346678999999999988 678999999999999999999 7888776552 34444444
Q ss_pred cCCCC--CCCCC--C----cHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 449 DGYRL--NQPVN--C----PDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 449 ~~~~~--~~~~~--~----~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..... ..+.. . ...+.+++..|+..+|..|.+..+....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 33222 11111 1 2578999999999999999998877654
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-21 Score=182.13 Aligned_cols=263 Identities=17% Similarity=0.258 Sum_probs=205.0
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDH 296 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~ 296 (499)
.+.+-.|++++.||+|+||..+.|+.--++ +.||||.-.......+ +..|-+..+.| .-++|...+=+. ..+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nn---e~VAIKfEPrkS~APQ---LrdEYr~YKlL~g~~GIP~vYYFG-qeG 96 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNN---EPVAIKFEPRKSEAPQ---LRDEYRTYKLLGGTEGIPQVYYFG-QEG 96 (449)
T ss_pred eEecccceeccccccCcceeeecccccccC---ceEEEEeccccCCcch---HHHHHHHHHHHcCCCCCCceeeec-ccc
Confidence 455667899999999999999999865444 7899998766555444 34566565555 468888876553 224
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-----CCcE
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-----KLRI 371 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-----~~~~ 371 (499)
-+-.||+|.+. -||+++..-|. +.++..+.+.||.|+..-++|+|++.+|.|||||+|.||.. ...+
T Consensus 97 ~~NiLVidLLG-PSLEDLFD~Cg-------R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~I 168 (449)
T KOG1165|consen 97 KYNILVIDLLG-PSLEDLFDLCG-------RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVI 168 (449)
T ss_pred chhhhhhhhhC-cCHHHHHHHhc-------CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceE
Confidence 45589999876 89999888764 47999999999999999999999999999999999999974 3468
Q ss_pred EEcccccccccCCCCccc-----cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Q psy1789 372 QITDNALARDLFPSDYHC-----LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF---EM 443 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~---~~ 443 (499)
.|.|||+|+.+....... ......||.+||+-.--++.+-+.+-|+=|+|-++...+- |..||++.... +-
T Consensus 169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLR-GsLPWQGLKA~tnK~k 247 (449)
T KOG1165|consen 169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKADTNKEK 247 (449)
T ss_pred EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhcc-CCCccccccCcchHHH
Confidence 999999999876543321 2346679999999999899999999999999999888887 99999986433 33
Q ss_pred HHHHHcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 444 AASLQDGYRLNQP----VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 444 ~~~i~~~~~~~~~----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.++|-+..+.... .+.|+++..-+.-.=..+-.+-|..+-+...+..+.+.++
T Consensus 248 YeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 248 YEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 3444333222111 2678899888888888899999999999998888887754
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=177.42 Aligned_cols=260 Identities=18% Similarity=0.299 Sum_probs=201.3
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC-CcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH-KNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~ 297 (499)
+....|++++.||.|+||.+|.|.....+ ..||||.-....... .+.-|..+.+.|+| ..|..+..|. ....
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~g---e~VAiK~Es~~a~hp---qL~yEskvY~iL~~g~GiP~i~~y~-~e~~ 84 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSG---EEVAIKLESSKAKHP---QLLYESKVYRILQGGVGIPHIRHYG-TEKD 84 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCC---ceEEEEeecccCCCc---chhHHHHHHHHhccCCCCchhhhhc-cccc
Confidence 45678999999999999999999876554 789999987665443 35678888888875 5666666663 4455
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CcEEEc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQIT 374 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~---~~~kl~ 374 (499)
+-.||||... .+|.+...-|. ..++..+.+.++-|+..-++|+|.+++|||||||+|.|..-+ ..+.+.
T Consensus 85 ynvlVMdLLG-PsLEdLfnfC~-------R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 85 YNVLVMDLLG-PSLEDLFNFCS-------RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred cceeeeeccC-ccHHHHHHHHh-------hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEE
Confidence 5689999886 89999887754 468999999999999999999999999999999999998743 468899
Q ss_pred ccccccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Q psy1789 375 DNALARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM---AAS 446 (499)
Q Consensus 375 DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~---~~~ 446 (499)
|||||+........ .......||.+|.+-....+...+.+-|+=|+|.+|...-- |..||++.....- .+.
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnr-G~LPWQglka~tk~QKyEk 235 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNR-GSLPWQGLKAATKKQKYEK 235 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeec-CCCcccccchhhHHHHHHH
Confidence 99999877543221 12346679999999888888888999999999999988876 9999998754322 223
Q ss_pred HHcCCCCCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 447 LQDGYRLNQP-----VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 447 i~~~~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+... +...+ ...|.|+.-.+.-|=...-++-|...-+.+...-+...|
T Consensus 236 I~Ek-K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 236 ISEK-KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHHh-hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 3221 12222 257889999999999999999999887777666555544
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=204.44 Aligned_cols=208 Identities=25% Similarity=0.442 Sum_probs=164.5
Q ss_pred HhcCCCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-cc
Q psy1789 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKL-LH 355 (499)
Q Consensus 277 l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~i-iH 355 (499)
|+.+.|.|+.+++|.|... ...+.|.+|+..|+|.+.+... ...++|.....++++++.||+|||...| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~-------~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNE-------DIKLDYFFILSFIRDISKGLAYLHNSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcc-------ccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence 4568999999999998876 5669999999999999999862 3579999999999999999999998876 89
Q ss_pred cCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCC-------CCCchhHHHHHHHHHHHH
Q psy1789 356 KDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT-------FSTASDVWAFGVLLWELT 428 (499)
Q Consensus 356 rDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~~DvwS~Gvvl~el~ 428 (499)
+.++++|+++|..+.+||+|||+....................-|.|||.+.... .+.++||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999999987653211111111122334699999997632 467899999999999999
Q ss_pred cCCCCCCCCC----CHHHHHHHHHc-CCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 429 TLAQQPYAEI----DPFEMAASLQD-GYRLNQPV-----NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 429 t~g~~p~~~~----~~~~~~~~i~~-~~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
+ ++-||... ++.++...+.+ +..+..|. +.++++..++..||..+|++||+++++-..++.+..
T Consensus 153 ~-r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 153 F-RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred h-ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9 88888752 34566666665 32222221 456689999999999999999999999888776644
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-23 Score=216.12 Aligned_cols=251 Identities=23% Similarity=0.219 Sum_probs=181.2
Q ss_pred EEeeeeeeecceEEEEEEEeCCCc--eeEEEEEEEecCcccHHH-HHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDG--VEEEVLVKTVTDNASAVQ-VSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
....++|.|.+|.|+......... ..+...+| ......... ...+..|..+-..++|+|++..+....+.... .-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-LQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-hh
Confidence 345899999999777765433221 11222232 112212222 22256677777889999998877664443333 34
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
.|||+++ +|..++... ..+...++-.++.|+..|+.|+|+.||.|||+|++|++++.++.+||+|||.+..
T Consensus 399 ~mE~~~~-Dlf~~~~~~--------~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSN--------GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred hhhcccH-HHHHHHhcc--------cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCccee
Confidence 4999998 999999862 2578889999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcc--ccCCCCCCccccccccccccCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHHHcCCC----
Q psy1789 382 LFPSDYH--CLGDNENRPVKWLAIESLVHKTFST-ASDVWAFGVLLWELTTLAQQPYAEIDPFEMA--ASLQDGYR---- 452 (499)
Q Consensus 382 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~--~~i~~~~~---- 452 (499)
..-.... .......|+-.|+|||.+....|.+ ..||||.|+++..|++ ++.||......+.. ......++
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~-~~~~Wk~a~~~~~~~~~~~~~~~~~~~~ 548 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL-GRFPWKVAKKSDNSFKTNNYSDQRNIFE 548 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec-CCCccccccccccchhhhcccccccccc
Confidence 5432221 2345677888999999999999985 6999999999999999 78888764333211 11111111
Q ss_pred -CC-CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 453 -LN-QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 453 -~~-~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+. .....+.+.+.++.++++.||.+|.|+++|++.
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00 112567789999999999999999999999863
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.4e-22 Score=184.49 Aligned_cols=175 Identities=10% Similarity=0.088 Sum_probs=133.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHH------HHHHHHHHhcCCCCcceeEEe
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSL------LLQEGMAMYGLSHKNILTVLG 290 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~------~~~E~~~l~~l~H~nIv~l~g 290 (499)
+...+|+..+++|+|+||.||.... + . ..+++|.+.... .+...+. +.+|+..+.+++|++|.....
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~-~---~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d 102 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-D-Y---GKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLND 102 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-C-C---CcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceE
Confidence 4477999999999999999998654 2 2 469999997543 2222233 578999999999999999988
Q ss_pred EEEcC-------CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy1789 291 VSIED-------HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNC 363 (499)
Q Consensus 291 ~~~~~-------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NI 363 (499)
+.... ....+|+|||+++.+|.++.. ++. ....+++.+|..+|+.|++|||+||+||
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Ni 166 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNF 166 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh------------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHE
Confidence 74322 234689999999999988732 222 2456999999999999999999999999
Q ss_pred EEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc
Q psy1789 364 VVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429 (499)
Q Consensus 364 lld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t 429 (499)
++++++ ++|.|||..+....... ...+.....|..++|+||||+++.-...
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 999988 99999998765421110 0114556667789999999999887654
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-23 Score=208.12 Aligned_cols=230 Identities=19% Similarity=0.244 Sum_probs=182.9
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
++|+|.||.|+...-..+.......|.|.+.+... .........|..++..++ ||.++++. |+++.+...+++.+|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lh-yafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLH-YAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeee-eeeccccchhHhhhhc
Confidence 36889999998865333333346677777754321 111124556778888887 99999875 4578888889999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCC
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~ 386 (499)
.+|+|...+.+ ...++..........++-+++++|+.+|+|||+|++||+++.+|++++.|||+++......
T Consensus 80 rgg~lft~l~~--------~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 80 RGGDLFTRLSK--------EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred ccchhhhcccc--------CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 99999988875 2357777788888899999999999999999999999999999999999999999765433
Q ss_pred ccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHH
Q psy1789 387 YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSV 466 (499)
Q Consensus 387 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 466 (499)
. .+||..|||||+.. .+...+|.||||++++||+| |..||.. ++...|... .+..|.....++.++
T Consensus 152 ~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~fellt-g~~pf~~----~~~~~Il~~-~~~~p~~l~~~a~~~ 217 (612)
T KOG0603|consen 152 I------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLT-GTLPFGG----DTMKRILKA-ELEMPRELSAEARSL 217 (612)
T ss_pred h------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhh-CCCCCch----HHHHHHhhh-ccCCchhhhHHHHHH
Confidence 2 27899999999998 67889999999999999999 8888887 455555442 566777888899999
Q ss_pred HHHhhhcCCCCCCCH
Q psy1789 467 MAYCWAMNPEGRPTF 481 (499)
Q Consensus 467 ~~~C~~~~P~~RPt~ 481 (499)
+...+..+|..|.-.
T Consensus 218 ~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 218 FRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHhhCHHHHhcc
Confidence 999999999999655
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=178.59 Aligned_cols=140 Identities=17% Similarity=0.166 Sum_probs=105.9
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-HH------------------------HHHHHHHHHHHhcCC
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-VQ------------------------VSLLLQEGMAMYGLS 281 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~E~~~l~~l~ 281 (499)
...||+|+||.||+|...+ + +.||||+++..... .. .....+|...+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~-g---~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTAN-G---EERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECCC-C---CEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3789999999999998752 2 78999999643210 00 112234889999998
Q ss_pred CCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCC
Q psy1789 282 HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL-HKKKLLHKDLAT 360 (499)
Q Consensus 282 H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yL-H~~~iiHrDlk~ 360 (499)
|+++.....+.. ... +|||||++++++...... ...++..+...++.|++.+|.|+ |+.+|+||||||
T Consensus 78 ~~~v~~p~~~~~--~~~-~iVmE~i~g~~l~~~~~~--------~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP 146 (190)
T cd05147 78 TAGIPCPEPILL--KSH-VLVMEFIGDDGWAAPRLK--------DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSE 146 (190)
T ss_pred HCCCCCCcEEEe--cCC-EEEEEEeCCCCCcchhhh--------cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 877644333211 222 899999998877655332 13588999999999999999999 688999999999
Q ss_pred CceEEcCCCcEEEccccccccc
Q psy1789 361 RNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 361 ~NIlld~~~~~kl~DfGla~~~ 382 (499)
+|||++ ++.++|.|||+|...
T Consensus 147 ~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 147 YNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHEEEE-CCcEEEEEccccccC
Confidence 999998 478999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.4e-21 Score=181.12 Aligned_cols=240 Identities=21% Similarity=0.271 Sum_probs=153.2
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecC--cccHHHHHHHHHHHHHHhcCCC-----------CcceeEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTD--NASAVQVSLLLQEGMAMYGLSH-----------KNILTVL 289 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~H-----------~nIv~l~ 289 (499)
.+..++.||.|+++.||.+++.+++ +.+|+|++.. .......+.+.+|......+.+ +-++.+-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~---~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETG---EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTT---EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred EEEEccccccCCceEEEEEEEccCC---ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 4556799999999999999987766 7899998843 3334446777777766655443 1122111
Q ss_pred eEEEc-------CC---C-----ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy1789 290 GVSIE-------DH---T-----SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLL 354 (499)
Q Consensus 290 g~~~~-------~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~ii 354 (499)
-.-.. .. . ..+++|+-+. +||.+++......... ...+...-++.+..|+.+.+++||+.|++
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 11011 01 0 2366777775 8888886532211111 22345556778889999999999999999
Q ss_pred ccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccC--------CCCCchhHHHHHHHHHH
Q psy1789 355 HKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK--------TFSTASDVWAFGVLLWE 426 (499)
Q Consensus 355 HrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~~~DvwS~Gvvl~e 426 (499)
|+||||+|++++.+|.+.|+||+....... ...+ ...+..|.+||..... .+|.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT-RYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTE-EEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCc-eeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999998764321 1111 2233569999987542 47899999999999999
Q ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC
Q psy1789 427 LTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGR 478 (499)
Q Consensus 427 l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R 478 (499)
|.| ++.||....+.....+ ..... . +.|+.+..++...++.||.+|
T Consensus 243 lWC-~~lPf~~~~~~~~~~~---~f~~C-~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWC-GRLPFGLSSPEADPEW---DFSRC-R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHH-SS-STCCCGGGSTSGG---GGTTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred HHH-ccCCCCCCCccccccc---cchhc-C-CcCHHHHHHHHHHccCCcccC
Confidence 999 8999986543322111 11111 2 778999999999999999988
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=180.97 Aligned_cols=258 Identities=16% Similarity=0.166 Sum_probs=177.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCc--------------------------------eeEEEEEEEecCc----ccH
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDG--------------------------------VEEEVLVKTVTDN----ASA 264 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~--------------------------------~~~~vavK~~~~~----~~~ 264 (499)
-++|++++.||+|.-..||.+.+.+.+. ..-+.|+|.+.+- .+.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 3468899999999999999998764110 0114566766432 222
Q ss_pred HHHHHHHHHHH------H-----------Hh----c-CCCCcceeEEeEEEcC--------------------------C
Q psy1789 265 VQVSLLLQEGM------A-----------MY----G-LSHKNILTVLGVSIED--------------------------H 296 (499)
Q Consensus 265 ~~~~~~~~E~~------~-----------l~----~-l~H~nIv~l~g~~~~~--------------------------~ 296 (499)
...+.+-+|.. . +. . -+|||||++.++.+++ +
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 33333444421 1 11 1 3699999998864321 1
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE--cCCC--cEE
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV--DDKL--RIQ 372 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll--d~~~--~~k 372 (499)
..+|+||.-.+ .+|.+++-. +..+.....-|+.|+++|+.|||++||.|||+|++|||+ |+|. ...
T Consensus 316 ~tlylvMkrY~-~tLr~yl~~---------~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 316 KTLYLVMKRYR-QTLREYLWT---------RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred ceEEEehhcch-hhHHHHHhc---------CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEE
Confidence 24578887666 789999875 456777888999999999999999999999999999998 3444 468
Q ss_pred EcccccccccCCC----CccccCCCCCCccccccccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 373 ITDNALARDLFPS----DYHCLGDNENRPVKWLAIESLVHKT------FSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 373 l~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
|+|||.+-..... .+....-...|...-||||+..... --.|+|.|+.|.+.||+++ ...||-......
T Consensus 386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg-~~NPFY~rGem~ 464 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFG-RSNPFYKRGEML 464 (598)
T ss_pred EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhc-cCCcccccchhe
Confidence 9999987432210 1111112344666789999986432 1268999999999999998 666765422111
Q ss_pred -HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q psy1789 443 -MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 443 -~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~ 489 (499)
-....++..-+..|..++..+.+++...++.||++|++..-....|+
T Consensus 465 L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 465 LDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred echhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 11234445567788899999999999999999999999765555443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=171.57 Aligned_cols=140 Identities=17% Similarity=0.157 Sum_probs=108.7
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-------------------------HHHHHHHHHHHHHhcCC
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-------------------------VQVSLLLQEGMAMYGLS 281 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~ 281 (499)
.+.||+|+||.||+|... ++ +.||||++...... .....+..|...+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g---~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DG---EELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC-CC---CEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 478999999999999875 22 78999998754210 00123457889999999
Q ss_pred CCcceeEEeEEEcCCCceEEEEEeCCCCCHHHH-HHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q psy1789 282 HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRF-LQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLA 359 (499)
Q Consensus 282 H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk 359 (499)
|+++.....+... ..+|||||++++++... +.. ..++..+...++.|++.+|.++|+ .||+|||||
T Consensus 78 ~~~i~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlk 145 (190)
T cd05145 78 EAGVPVPEPILLK---KNVLVMEFIGDDGSPAPRLKD---------VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLS 145 (190)
T ss_pred hCCCCCceEEEec---CCEEEEEEecCCCchhhhhhh---------ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 9988554443222 23899999998865443 332 246788999999999999999999 999999999
Q ss_pred CCceEEcCCCcEEEcccccccccC
Q psy1789 360 TRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 360 ~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
|+||+++ ++.++|+|||+|+...
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecC
Confidence 9999999 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=167.46 Aligned_cols=183 Identities=16% Similarity=0.049 Sum_probs=131.2
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc---HHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS---AVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv 302 (499)
...|++|+||+||.+...+ .+++.+.+..... ......|.+|+++|++++ |+++++++++ . ..+++
T Consensus 7 ~~~l~~~~f~~v~~~~~~~-----~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~-~~~lv 76 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGE-----RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D-GRHLD 76 (218)
T ss_pred ceeecCCCcceEEEeecCC-----ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c-CEEEE
Confidence 3789999999999665422 5666666654322 112236889999999995 5889999886 2 24999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEEcCCCcEEEcccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDL-ATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDl-k~~NIlld~~~~~kl~DfGla~~ 381 (499)
|||+.+.+|.+.+.. ....++.|++.+|.++|++||+|||| ||+|||++.++.++|+|||+|..
T Consensus 77 meyI~G~~L~~~~~~---------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 77 RSYLAGAAMYQRPPR---------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred EeeecCccHHhhhhh---------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 999999998654321 11357789999999999999999999 79999999999999999999985
Q ss_pred cCCCCcc----cc-------CCCCCCccccccccccccC-CCC-CchhHHHHHHHHHHHHcCCCCCC
Q psy1789 382 LFPSDYH----CL-------GDNENRPVKWLAIESLVHK-TFS-TASDVWAFGVLLWELTTLAQQPY 435 (499)
Q Consensus 382 ~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~s-~~~DvwS~Gvvl~el~t~g~~p~ 435 (499)
..+.... .. ..-...++.|++|+-..-. ..+ ...++++-|.-+|.++| ++.+.
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~-~~~~~ 207 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVT-RRVLH 207 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHh-ccCCc
Confidence 4432210 00 0011245567777654322 233 56788899999999999 55553
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-21 Score=204.85 Aligned_cols=247 Identities=18% Similarity=0.181 Sum_probs=174.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHH--HhcCCCCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA--MYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++...+.||.+.|=+|.+|+..++ .|+||++-+....-..+.|.++++- ....+|||.+.+.-+ ...+...|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG-----~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-~~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG-----LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-LVTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc-----eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-HHhhHHHH
Confidence 455569999999999999987654 4788888655433334444444333 445689999988765 34444457
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
||=+|.. .+|.+.|.. ...|...+...|+.|+..||.-+|..||.|+|||.+||||++=.=+.|+||.--|
T Consensus 98 lvRqyvk-hnLyDRlST--------RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 98 LVRQYVK-HNLYDRLST--------RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHHHHHh-hhhhhhhcc--------chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC
Confidence 7777776 577777764 2457788899999999999999999999999999999999976668899998765
Q ss_pred ccC-----CCCccccCCCCCCccccccccccccCC-----------CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy1789 381 DLF-----PSDYHCLGDNENRPVKWLAIESLVHKT-----------FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444 (499)
Q Consensus 381 ~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~ 444 (499)
... |.++...-++..+-..|+|||.+.... .+++-||||.||++.||++-|+++|.-. ++.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~ 245 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLL 245 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHH
Confidence 432 222222223333445799999886421 6788999999999999999888888531 111
Q ss_pred HHHHcC-CCCCCCC--CCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 445 ASLQDG-YRLNQPV--NCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 445 ~~i~~~-~~~~~~~--~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+.-..+ ..+++.. -....+++++..+++.||++|.++++.++.
T Consensus 246 aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111110 0000000 012368999999999999999999998875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=166.53 Aligned_cols=135 Identities=17% Similarity=0.193 Sum_probs=102.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-----CCCcceeEEeEEEcCC--Cce-
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-----SHKNILTVLGVSIEDH--TSP- 299 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~g~~~~~~--~~~- 299 (499)
+.||+|+||.||. .+.. ...+||++..... ...+.+.+|+.+++.+ +||||++++|+..++. +..
T Consensus 8 ~~LG~G~~~~Vy~--hp~~----~~k~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPED----AQRCIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred ceecCCCceEEEE--CCCC----cCeEEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 8999999999995 4332 2236888765422 2346789999999998 5799999999865543 232
Q ss_pred EEEEEe--CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCceEEcC----CCcEE
Q psy1789 300 FLIYPY--QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV-QYLHKKKLLHKDLATRNCVVDD----KLRIQ 372 (499)
Q Consensus 300 ~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L-~yLH~~~iiHrDlk~~NIlld~----~~~~k 372 (499)
.+|+|| +++|+|.+++... .+++. ..++.|++.++ +|||+++|+||||||+|||++. +..++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEE
Confidence 378999 5589999999751 24444 35678888788 9999999999999999999974 34899
Q ss_pred Eccccccc
Q psy1789 373 ITDNALAR 380 (499)
Q Consensus 373 l~DfGla~ 380 (499)
|+||+.++
T Consensus 150 LiDg~G~~ 157 (210)
T PRK10345 150 VCDNIGES 157 (210)
T ss_pred EEECCCCc
Confidence 99955444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-18 Score=158.97 Aligned_cols=135 Identities=17% Similarity=0.192 Sum_probs=109.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-------HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-------AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+.||+|++|.||+|.+.+ ..+++|+...... ......+.+|+.++..++|++|.....++.. ....+
T Consensus 2 ~~l~~G~~~~vy~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLG-----IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFI 75 (211)
T ss_pred cccccCceEEEEEEeeCC-----CceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCE
Confidence 678999999999998733 4578887643211 1123467889999999999998776666444 34568
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
++|||+++++|.+++... .+ .+..++.+++.+|.++|+.+++|+|++|.|||++ ++.++|+|||+++
T Consensus 76 lv~e~~~G~~L~~~~~~~-----------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN-----------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EEEEEeCCcCHHHHHHhc-----------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999999999998751 12 8899999999999999999999999999999999 7889999999876
Q ss_pred c
Q psy1789 381 D 381 (499)
Q Consensus 381 ~ 381 (499)
.
T Consensus 143 ~ 143 (211)
T PRK14879 143 F 143 (211)
T ss_pred C
Confidence 4
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-19 Score=190.21 Aligned_cols=206 Identities=23% Similarity=0.378 Sum_probs=150.8
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
.++.+++|..|+||.||..+++... +.+|.|+-+++ . ++ +||..+-|. ++.|
T Consensus 84 df~~IklisngAygavylvrh~~tr---qrfa~kiNkq~-------l------il-----Rnilt~a~n-------pfvv 135 (1205)
T KOG0606|consen 84 DFNTIKLISNGAYGAVYLVRHKETR---QRFAMKINKQN-------L------IL-----RNILTFAGN-------PFVV 135 (1205)
T ss_pred ccceeEeeccCCCCceeeeeccccc---cchhhcccccc-------h------hh-----hccccccCC-------ccee
Confidence 4556699999999999999876554 56777442211 0 11 233333221 2344
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
|+=...+.. ...++. +.+.+++|||+.+|+|||+||+|.+|..-|++|++|||+.+..
T Consensus 136 ------gDc~tllk~--------~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 ------GDCATLLKN--------IGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred ------chhhhhccc--------CCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhh
Confidence 433333332 112332 2278999999999999999999999999999999999999865
Q ss_pred CCCC------------ccc-cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 383 FPSD------------YHC-LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 383 ~~~~------------~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
.... .+. .....+||+.|+|||++....|+..+|+|++|+++||.+- |..||.+..++++...+..
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLV-gcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV-GCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHhe-eeeeccCCCHHHHHhhhhh
Confidence 3211 111 1235689999999999999999999999999999999998 8889999889998876654
Q ss_pred C--CCCCCCCCCcHHHHHHHHHhhhcCCCCCC
Q psy1789 450 G--YRLNQPVNCPDELFSVMAYCWAMNPEGRP 479 (499)
Q Consensus 450 ~--~~~~~~~~~~~~~~~l~~~C~~~~P~~RP 479 (499)
. .-++.....+.|+.+++.+.++.+|..|-
T Consensus 273 d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 3 22333456788999999999999999994
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-19 Score=180.19 Aligned_cols=173 Identities=18% Similarity=0.302 Sum_probs=134.4
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
++++.|+++...+|.+||...+. ....++...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-----~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-----GEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-----ccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhh
Confidence 46889999999999999985332 2346788899999999999999 999999999999999999999999999
Q ss_pred cccccCCCC----ccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCC
Q psy1789 378 LARDLFPSD----YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI-DPFEMAASLQDGYR 452 (499)
Q Consensus 378 la~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-~~~~~~~~i~~~~~ 452 (499)
+........ .....+...||..||+||.+.+..|+.|+||||||++|+|+++ +|... ........++++.-
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~----~f~T~~er~~t~~d~r~g~i 477 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI----QFSTQFERIATLTDIRDGII 477 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH----HhccHHHHHHhhhhhhcCCC
Confidence 987664333 1223446678999999999999999999999999999999998 33321 12223445555543
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 482 (499)
++....--++-+.++.+.+.+.|.+||++.
T Consensus 478 p~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 478 PPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred ChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 322222233567899999999999999433
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=180.69 Aligned_cols=251 Identities=15% Similarity=0.145 Sum_probs=173.1
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC---CCcceeEEeE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS---HKNILTVLGV 291 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~ 291 (499)
.+..+....|.+.+.||+|+||+||+|...++ +.||+|+-+....- +|.--.+++.+|+ -+.|+.+...
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~----~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNG----KLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCC----cEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHH
Confidence 34566778899999999999999999997652 89999987654321 1111122333333 1223333222
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-----
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD----- 366 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld----- 366 (499)
.--.+..+||+||.+.|+|.+++.. ...++|...+.++.|++.-+++||..+|||+||||+|.||.
T Consensus 763 -~~~~~~S~lv~ey~~~Gtlld~~N~--------~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 763 -HVFQNASVLVSEYSPYGTLLDLINT--------NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred -HccCCcceeeeeccccccHHHhhcc--------CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 1112334899999999999999984 34699999999999999999999999999999999999993
Q ss_pred --CCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy1789 367 --DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444 (499)
Q Consensus 367 --~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~ 444 (499)
+...++|.|||-+-.+..-.....-....+|-++-.+|+..+..++..+|.|.|.-+++-|+- |+. .
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF-G~y----------~ 902 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF-GKY----------M 902 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH-HHH----------H
Confidence 345789999999865532111111234556778899999999999999999999999999997 321 1
Q ss_pred HHHHcCCCCCC----CCCCcHH-HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 445 ASLQDGYRLNQ----PVNCPDE-LFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 445 ~~i~~~~~~~~----~~~~~~~-~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+ +..+..... +..+-.+ ..++....|..|-..=|...++...|++...+
T Consensus 903 q-~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 903 E-VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred H-hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 1 222222111 2222222 34566667765544447777777777665443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.3e-18 Score=178.97 Aligned_cols=140 Identities=19% Similarity=0.193 Sum_probs=107.4
Q ss_pred EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
...+.||+|+||.||+|.+.+.+...+....|..... ......+.+.+|++++..++|++++....++... ...++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-EEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-CCCEEE
Confidence 4468999999999999988654311111111111111 1112346788999999999999999877775543 345899
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
|||+++++|.+++.. ...++.+++.+|.|||+.+++||||||+|||+ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~~----------------~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLEG----------------NPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHHH----------------HHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999998752 46789999999999999999999999999999 5778999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.4e-18 Score=160.40 Aligned_cols=142 Identities=17% Similarity=0.146 Sum_probs=108.0
Q ss_pred eEEeeeeeeecceEEEEEE-EeCCCceeEEEEEEEecCcccH-----------------------HHHHHHHHHHHHHhc
Q psy1789 224 VRLFSVNMEGTFGRVYRGT-YTEEDGVEEEVLVKTVTDNASA-----------------------VQVSLLLQEGMAMYG 279 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~-~~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~ 279 (499)
|++.+.||+|+||.||+|. ...++ +.||+|++...... .....+..|...+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g---~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSG---KERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCC---cEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 6677999999999999998 32222 78999998643210 011345689999999
Q ss_pred CCCCc--ceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccc
Q psy1789 280 LSHKN--ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK-LLHK 356 (499)
Q Consensus 280 l~H~n--Iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~-iiHr 356 (499)
+.+.. +.+.+++ .. .++||||+++++|..+... ...+...+...++.|++.+|.|||+.+ |+||
T Consensus 107 L~~~~i~~p~~~~~----~~-~~lV~E~~~g~~L~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~ 173 (237)
T smart00090 107 LYEAGVPVPKPIAW----RR-NVLVMEFIGGDGLPAPRLK--------DVEPEEEEEFELYDDILEEMRKLYKEGELVHG 173 (237)
T ss_pred HHhcCCCCCeeeEe----cC-ceEEEEEecCCcccccccc--------cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeC
Confidence 87533 4455543 12 3899999999888765432 123556667899999999999999999 9999
Q ss_pred CCCCCceEEcCCCcEEEccccccccc
Q psy1789 357 DLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 357 Dlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
||||+||+++ ++.++|.|||.|...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=153.69 Aligned_cols=131 Identities=17% Similarity=0.227 Sum_probs=103.0
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-------cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-------SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.||+|+||.||+|.+.+ ..+++|...... .......+.+|++++..++|+++.....++.. ....++
T Consensus 1 ~ig~G~~~~vy~~~~~~-----~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG-----LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTI 74 (199)
T ss_pred CCCCCceEEEEEeecCC-----ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEE
Confidence 47999999999998643 568888754321 11223567889999999998876544444333 334589
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||+++++|.+++.... . .++.+++.+|.+||+.+++|+|++|.||+++ ++.+++.|||+++.
T Consensus 75 v~e~~~g~~l~~~~~~~~---------~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN---------D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEECCccHHHHHhhcH---------H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999999876411 0 8899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=152.16 Aligned_cols=137 Identities=18% Similarity=0.113 Sum_probs=105.3
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH---------------------HHHHHHHHHHHHHhcCCC
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA---------------------VQVSLLLQEGMAMYGLSH 282 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~l~H 282 (499)
|.+.+.||+|+||.||+|...++ +.+|||++...... .....+..|..++..+.|
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDG----NPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCC----CEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 55669999999999999987532 68999987543200 011235678888888888
Q ss_pred Cc--ceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy1789 283 KN--ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360 (499)
Q Consensus 283 ~n--Iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~ 360 (499)
++ ++..++. ...++||||+++++|...... .....++.+++.++.++|+.+|+||||||
T Consensus 93 ~~i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~--------------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p 153 (198)
T cd05144 93 EGFPVPKPIDW-----NRHAVVMEYIDGVELYRVRVL--------------EDPEEVLDEILEEIVKAYKHGIIHGDLSE 153 (198)
T ss_pred cCCCCCceeec-----CCceEEEEEeCCcchhhcccc--------------ccHHHHHHHHHHHHHHHHHCCCCcCCCCc
Confidence 74 4444442 234899999999998765321 23467889999999999999999999999
Q ss_pred CceEEcCCCcEEEcccccccccC
Q psy1789 361 RNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 361 ~NIlld~~~~~kl~DfGla~~~~ 383 (499)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.7e-16 Score=145.63 Aligned_cols=137 Identities=12% Similarity=0.089 Sum_probs=103.9
Q ss_pred eeee-eecceEEEEEEEeCCCceeEEEEEEEecCcc------------cHHHHHHHHHHHHHHhcCCCCcc--eeEEeEE
Q psy1789 228 SVNM-EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA------------SAVQVSLLLQEGMAMYGLSHKNI--LTVLGVS 292 (499)
Q Consensus 228 ~~lG-~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~H~nI--v~l~g~~ 292 (499)
..|| .|+.|+||+....+ ..++||.+.... .......+.+|..++.+++|++| +..+++.
T Consensus 37 ~~lg~~~g~gtv~~v~~~~-----~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPG-----VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeCC-----ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 5676 78888899887643 467888774321 11233567889999999998885 6777764
Q ss_pred EcCCCc---eEEEEEeCCC-CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q psy1789 293 IEDHTS---PFLIYPYQDY-TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK 368 (499)
Q Consensus 293 ~~~~~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~ 368 (499)
...... .++|+||+++ .+|.+++.. ..++.. .+.+++.+|.+||+.||+||||||+|||++.+
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---------~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQE---------APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPD 178 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhc---------CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC
Confidence 433222 3599999997 699998864 124433 36789999999999999999999999999998
Q ss_pred CcEEEccccccccc
Q psy1789 369 LRIQITDNALARDL 382 (499)
Q Consensus 369 ~~~kl~DfGla~~~ 382 (499)
+.++|+|||.++..
T Consensus 179 ~~v~LIDfg~~~~~ 192 (239)
T PRK01723 179 GKFWLIDFDRGELR 192 (239)
T ss_pred CCEEEEECCCcccC
Confidence 99999999988753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.3e-16 Score=144.22 Aligned_cols=137 Identities=18% Similarity=0.150 Sum_probs=95.4
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHH----------------------HHHHHHHhcCCCC
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLL----------------------LQEGMAMYGLSHK 283 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~----------------------~~E~~~l~~l~H~ 283 (499)
.+.||+|+||+||+|...+ + +.||||++..... ..+...+ ..|...+.++++.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~-~---~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDGD-G---EPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECCC-C---CEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 4789999999999998752 2 6899998865321 1111111 2455555555433
Q ss_pred c--ceeEEeEEEcCCCceEEEEEeCCCCCHHHH-HHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q psy1789 284 N--ILTVLGVSIEDHTSPFLIYPYQDYTNLKRF-LQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLA 359 (499)
Q Consensus 284 n--Iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk 359 (499)
. +.+.+++ ...++||||++++.+... +... ... .....++.+++.++.++|. .+|+|||||
T Consensus 78 ~~~~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~---------~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~ 142 (187)
T cd05119 78 GVPVPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV---------RLL-EDPEELYDQILELMRKLYREAGLVHGDLS 142 (187)
T ss_pred CCCCCceEec-----CCCEEEEEEeCCCCccChhhhhh---------hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCC
Confidence 2 4444443 124899999998554321 1110 011 5678899999999999999 999999999
Q ss_pred CCceEEcCCCcEEEcccccccccC
Q psy1789 360 TRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 360 ~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
|+||+++ ++.++|.|||.+....
T Consensus 143 p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhhEEEE-CCcEEEEECccccccc
Confidence 9999999 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.3e-17 Score=174.89 Aligned_cols=252 Identities=18% Similarity=0.194 Sum_probs=186.9
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceE
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~ 300 (499)
.|++.+.||+|+|+.|-........ ...+++|.+.... ..........|..+-+.+. |+|++++++. .......+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~--~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-~~~~~~~~ 97 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDP--ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-SSSPRSYL 97 (601)
T ss_pred cccccccccccccchhhhhhhcCCC--cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-cCCCcccc
Confidence 3445577899999999877653322 2566777665432 2333344445776666676 9999999997 45566669
Q ss_pred EEEEeCCCCCHHHHH-HhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEcCCC-cEEEcccc
Q psy1789 301 LIYPYQDYTNLKRFL-QKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH-KKKLLHKDLATRNCVVDDKL-RIQITDNA 377 (499)
Q Consensus 301 lv~e~~~~gsL~~~l-~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH-~~~iiHrDlk~~NIlld~~~-~~kl~DfG 377 (499)
+..+|..+|++...+ +.. ....+.........|+..++.|+| +.++.|||+||+|.+++..+ ..+++|||
T Consensus 98 ~~~~~s~g~~~f~~i~~~~-------~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~ 170 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPD-------STGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFG 170 (601)
T ss_pred cccCcccccccccccccCC-------ccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCch
Confidence 999999999998887 331 113556667888999999999999 99999999999999999999 99999999
Q ss_pred cccccCC-CCccccCCCCCC-ccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHHcCCC
Q psy1789 378 LARDLFP-SDYHCLGDNENR-PVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM--AASLQDGYR 452 (499)
Q Consensus 378 la~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~--~~~i~~~~~ 452 (499)
+|..... ...........| ++.|+|||...+. ......|+||.|+++.-+++ +..|+......+. ..+.....+
T Consensus 171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~ 249 (601)
T KOG0590|consen 171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLT-GELPWDFPSRKDGRYSSWKSNKGR 249 (601)
T ss_pred hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccccc-CCCCccccccccccceeecccccc
Confidence 9987765 333334445567 8899999999884 55788999999999999999 8888776543321 222222211
Q ss_pred --CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 453 --LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 453 --~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
........+...++..+++..+|+.|.+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 222335677889999999999999999988764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.8e-15 Score=130.37 Aligned_cols=132 Identities=22% Similarity=0.192 Sum_probs=108.7
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC--CcceeEEeEEEcCCCceEEEEE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH--KNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~~~~~lv~e 304 (499)
.+.||+|.++.||++...+ ..+++|....... ...+.+|...+..++| .++++++++. ...+..++++|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-----~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~-~~~~~~~~v~e 73 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-----EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASG-ESDGWSYLLME 73 (155)
T ss_pred ceecccccccceEEEEecC-----CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCccEEEEE
Confidence 4789999999999999744 4689998865533 4568899999999976 5889988874 44456799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK---KLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~---~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|++++.+..+ +......++.+++++|+++|.. +++|+|++|+||++++.+.+++.|||.++.
T Consensus 74 ~~~g~~~~~~---------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV---------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC---------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9997766532 4566788899999999999985 699999999999999999999999999874
Q ss_pred c
Q psy1789 382 L 382 (499)
Q Consensus 382 ~ 382 (499)
.
T Consensus 139 ~ 139 (155)
T cd05120 139 G 139 (155)
T ss_pred C
Confidence 3
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >smart00469 WIF Wnt-inhibitory factor-1 like domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=6e-14 Score=116.51 Aligned_cols=90 Identities=43% Similarity=0.794 Sum_probs=84.6
Q ss_pred ccceeEEeecCC--ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCC
Q psy1789 7 SDNLEFGTRPLG--HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNN 84 (499)
Q Consensus 7 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~ 84 (499)
+++|.|||++++ .++|.+.+++++..+|-.|.+||+.+|+||.+.+.|++.|.|+|...+++.+...+++.++ ...+
T Consensus 44 i~~v~FTW~s~~~~~~~y~~~l~s~D~~vl~~P~lnI~~~G~VP~~~~~f~V~l~CsG~~sa~~~V~l~l~~~~~-~~~~ 122 (136)
T smart00469 44 IHDLSFTWQALGQEYVPYSLNVRSDDKEVLPRPIVNISLLGTVPHTLQVFQVELKCSGKRDAEVEVTVIVEVSLG-STKN 122 (136)
T ss_pred cceEEEEEEcCCCeeeeeEEEEEeCCHHHcCCCcccccccccCCCCcEEEEEEEEecCCcceEEEEEEEEEEeeC-CCCC
Confidence 689999999988 4999999999999999999999999999999999999999999999999999999999877 4667
Q ss_pred ceEEEEeeeceee
Q psy1789 85 VTSLNFKRKKICL 97 (499)
Q Consensus 85 ~~~~~~~~~~~~~ 97 (499)
.+.++|.+.|+|.
T Consensus 123 ~tpl~~k~~K~C~ 135 (136)
T smart00469 123 PTPLNFRRKKICL 135 (136)
T ss_pred CCcEEEEEeeeec
Confidence 8999999999996
|
Occurs as extracellular domain in metazoan Ryk receptor tyrosine kinases. C. elegans Ryk is required for cell-cuticle recognition. WIF-1 binds to Wnt and inhibits its activity. |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=136.87 Aligned_cols=201 Identities=21% Similarity=0.279 Sum_probs=140.8
Q ss_pred HhcCCCCcceeEEeEEEcC----CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q psy1789 277 MYGLSHKNILTVLGVSIED----HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK- 351 (499)
Q Consensus 277 l~~l~H~nIv~l~g~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~- 351 (499)
|-.+.|.|||+++.|+.+. ..+..++.|||..|+|.+||++.+.+ ...+......+|+.||..||.|||+.
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~----~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN----QKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh----hhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 3345699999999986442 34568899999999999999875533 24577778889999999999999986
Q ss_pred -CccccCCCCCceEEcCCCcEEEcccccccccCCC---CccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHH
Q psy1789 352 -KLLHKDLATRNCVVDDKLRIQITDNALARDLFPS---DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWEL 427 (499)
Q Consensus 352 -~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el 427 (499)
.|+|+++..+-|++..++-+|++--.-.. ..+. ..........+-++|.+||+-.....+.++|||+||+..+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 79999999999999999988876322111 0000 000111233456789999998888889999999999999999
Q ss_pred HcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 428 TTLAQQPYAEIDPFEMAASLQDGY-RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 428 ~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.-+.-.|-......+....+.... ..+ .+--+.++..|++.+|..||+|++++..
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLE-----NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeecc-----CccccCcCcccccCCCCCCcchhhhhcC
Confidence 874333433332222222221110 011 1122457899999999999999998643
|
|
| >PF02019 WIF: WIF domain; InterPro: IPR003306 Wnt proteins constitute a large family of secreted molecules that are involved in intercellular signalling during development | Back alignment and domain information |
|---|
Probab=99.51 E-value=6e-14 Score=117.21 Aligned_cols=90 Identities=44% Similarity=0.740 Sum_probs=66.9
Q ss_pred cccceeEEeecCC--ccceEEEE-EecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCC
Q psy1789 6 CSDNLEFGTRPLG--HLPYSISV-ESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNS 82 (499)
Q Consensus 6 ~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~ 82 (499)
=+++|+|||++++ +++|.+.+ +++++.++..|.+||+.+|+||.+.+.|++.|+|+|...+++.+...+++......
T Consensus 40 ~i~~l~FtW~s~~~~~~~Y~~~~l~s~d~~~l~~P~lnIs~~G~VP~~~~~F~V~L~CtG~~~g~a~v~i~lni~~~~~~ 119 (132)
T PF02019_consen 40 EINYLNFTWQSLGKKPYPYNFDVLKSSDPSILPHPSLNISKSGEVPHSPQVFSVELPCTGKRSGEATVTIQLNITLPSSK 119 (132)
T ss_dssp T-SEEEEEEEE-SSS-EEEEEEEEEES-TTTBB--EESS-SEEEE-SS-EEEEEE--B-SSS-EEEEEEEEEEEEETT--
T ss_pred CcceEEEEEEcCCCceEEEEEEEEEccCcccccCCccccCCCeeccCCCEEEEEEEEecCccceEEEEEEEEEEEeCCCC
Confidence 3689999999987 79999999 88999999999999999999999999999999999999999999999999877544
Q ss_pred CCceEEEEeeecee
Q psy1789 83 NNVTSLNFKRKKIC 96 (499)
Q Consensus 83 ~~~~~~~~~~~~~~ 96 (499)
+.+.+.|.++|+|
T Consensus 120 -n~T~L~~kr~KiC 132 (132)
T PF02019_consen 120 -NGTPLRFKRRKIC 132 (132)
T ss_dssp -S-EEEE--TT-EE
T ss_pred -CceEEEEeecccC
Confidence 8899999999988
|
The name derives from the first 2 members of the family to be discovered: int-1 (mouse) and wingless (Drosophila) []. It is now recognised that Wnt signalling controls many cell fate decisions in a variety of different organisms, including mammals []. Wnt signalling has been implicated in tumourigenesis, early mesodermal patterning of the embryo, morphogenesis of the brain and kidneys, regulation of mammary gland proliferation and Alzheimer's disease [, ]. Wnt-mediated signalling is believed to proceed initially through binding to cell surface receptors of the frizzled family; the signal is subsequently transduced through several cytoplasmic components to B-catenin, which enters the nucleus and activates the transcription of several genes important in development []. Several non-canonical Wnt signalling pathways have also been elucidated that act independently of B-catenin. Canonical and noncanonical Wnt signaling branches are highly interconnected, and cross-regulate each other []. Members of the Wnt gene family are defined by their sequence similarity to mouse Wnt-1 and Wingless in Drosophila. They encode proteins of ~350-400 residues in length, with orthologues identified in several, mostly vertebrate, species. Very little is known about the structure of Wnts as they are notoriously insoluble, but they share the following features characteristics of secretory proteins: a signal peptide, several potential N-glycosylation sites and 22 conserved cysteines [] that are probably involved in disulphide bonds. The Wnt proteins seem to adhere to the plasma membrane of the secreting cells and are therefore likely to signal over only few cell diameters. Fifteen major Wnt gene families have been identified in vertebrates, with multiple subtypes within some classes. This entry represents the WIF domain, and is found in the RYK tyrosine kinase receptors and WIF the Wnt-inhibitory-factor. The domain is extracellular and contains two conserved cysteines that may form a disulphide bridge. This domain is Wnt binding in WIF, and it has been suggested that RYK may also bind to Wnt [].; GO: 0004713 protein tyrosine kinase activity; PDB: 2YGP_A 2YGO_A 2YGN_A 2D3J_A 2YGQ_A. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=141.81 Aligned_cols=143 Identities=16% Similarity=0.109 Sum_probs=100.5
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHH---------------------------------------H
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV---------------------------------------S 268 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~---------------------------------------~ 268 (499)
+.||.|++|.||+|++.++ +.||||+.......... -
T Consensus 123 ~plasaSigQVh~A~l~~G----~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDG----KEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEecCC----CEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 6799999999999998754 68999998654211100 0
Q ss_pred HHHHHHHHHhcC----CCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHH-
Q psy1789 269 LLLQEGMAMYGL----SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIM- 343 (499)
Q Consensus 269 ~~~~E~~~l~~l----~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~- 343 (499)
.|.+|...+.++ +|.+-+.+-.++.+-....+|||||+++++|.++..... ... .+.+++.+++.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-------~~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-------AGL---DRKALAENLARS 268 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-------cCC---CHHHHHHHHHHH
Confidence 244455544443 333334433333333344599999999999998875421 112 24556666666
Q ss_pred HHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 344 ~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
.+..+|..|++|+|+||.||++++++.+++.|||+++.+.+
T Consensus 269 ~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 269 FLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 47889999999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-13 Score=137.81 Aligned_cols=249 Identities=18% Similarity=0.191 Sum_probs=171.9
Q ss_pred eEEeeeeee--ecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCce
Q psy1789 224 VRLFSVNME--GTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 224 ~~~~~~lG~--G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 299 (499)
+.+.+.+|. |.+|.||.+.... ......+|+|.-....+ ......=.+|.....++ .|+|.++.... ++..+..
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-~e~~~~l 193 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-WEGSGIL 193 (524)
T ss_pred cccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-cccCCcc
Confidence 334478888 9999999998722 11226788887432211 11222234566666666 49999997776 4556677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCceEEcCC-CcEEEc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIM----GVQYLHKKKLLHKDLATRNCVVDDK-LRIQIT 374 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~----~L~yLH~~~iiHrDlk~~NIlld~~-~~~kl~ 374 (499)
++-+|++. .+|..+.+.. ...++....+.+..+..+ ||.++|..+++|-|+||.||++..+ ...+++
T Consensus 194 fiqtE~~~-~sl~~~~~~~-------~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP-------CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeecccc-chhHHhhhcc-------cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecC
Confidence 88888777 8888887752 234677777788888888 9999999999999999999999999 899999
Q ss_pred ccccccccCCCCccccC---CCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 375 DNALARDLFPSDYHCLG---DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
|||+...+...+..... -...+...|++||.+ .+-++...|+||+|.+..|..++-..|-.+.... ...+..++
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~ 342 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGY 342 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC--cccccccc
Confidence 99999887655432211 122455679999987 4567999999999999999998555554331110 00111111
Q ss_pred -CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 452 -RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 452 -~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
..+.-..-..++...+..+++.+|-.|++.+.+.
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 1111123345677789999999999999877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.8e-12 Score=111.57 Aligned_cols=127 Identities=17% Similarity=0.104 Sum_probs=93.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcce-eEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNIL-TVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.++.|.++.||+++..+ ..+++|....... ....+..|...+..+.+.+++ +++++ .. ...++||||+
T Consensus 4 ~~l~~G~~~~vy~~~~~~-----~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~--~~~~lv~e~i 73 (170)
T cd05151 4 SPLKGGMTNKNYRVEVAN-----KKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYF-DP--ETGVLITEFI 73 (170)
T ss_pred eecCCcccCceEEEEECC-----eEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEE-eC--CCCeEEEEec
Confidence 677889999999998642 6799998765432 112456888888887655544 45554 22 2348999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKL-----LHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~i-----iHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
++.++... . . ....++.+++++|+.||+.++ +|+|++|.||+++ ++.+++.|||.+..
T Consensus 74 ~G~~l~~~-~------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE-D------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc-c------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98877532 0 0 113456789999999999875 9999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.8e-10 Score=117.93 Aligned_cols=143 Identities=13% Similarity=0.092 Sum_probs=90.5
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHH---------------------------------HHH------
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAV---------------------------------QVS------ 268 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------~~~------ 268 (499)
+.||.|++|.||+|++.+++ +.||||+........ ..+
T Consensus 125 ~PlasaSiaQVh~A~l~~~G---~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~El 201 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNG---REVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDEL 201 (537)
T ss_pred hhhcCCCccEEEEEEECCCC---CEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhh
Confidence 78999999999999997633 789999997542110 011
Q ss_pred HHHHHHHHHhcC----CCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHH-H
Q psy1789 269 LLLQEGMAMYGL----SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQII-M 343 (499)
Q Consensus 269 ~~~~E~~~l~~l----~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va-~ 343 (499)
.|.+|...+.++ .+.+.+.+-.+..+-....+|||||++++.+.++-.-.. ...+.. .++...+ .
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-------~g~d~~---~la~~~v~~ 271 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-------AGTDMK---LLAERGVEV 271 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-------cCCCHH---HHHHHHHHH
Confidence 234444444433 244444433332232334589999999999987532100 112211 2222211 1
Q ss_pred HHHHHHhCCccccCCCCCceEEcCCC----cEEEcccccccccC
Q psy1789 344 GVQYLHKKKLLHKDLATRNCVVDDKL----RIQITDNALARDLF 383 (499)
Q Consensus 344 ~L~yLH~~~iiHrDlk~~NIlld~~~----~~kl~DfGla~~~~ 383 (499)
-+.-++..|++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 272 ~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 272 FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 23334568999999999999999888 99999999987663
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.4e-10 Score=116.72 Aligned_cols=219 Identities=17% Similarity=0.165 Sum_probs=142.1
Q ss_pred EEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCC
Q psy1789 251 EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLT 330 (499)
Q Consensus 251 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~ 330 (499)
..|.|...+.... ...+...+-+.-|+.+|||||++++.. .+..+..|||+|-+. -|..++.. +.
T Consensus 38 ~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t-~e~~~~~ylvTErV~--Pl~~~lk~-----------l~ 102 (690)
T KOG1243|consen 38 GPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDT-TEEEGTLYLVTERVR--PLETVLKE-----------LG 102 (690)
T ss_pred CceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhh-hcccCceEEEeeccc--cHHHHHHH-----------hH
Confidence 5677776665544 444556677888999999999999996 566778899999874 56777765 34
Q ss_pred HHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccC
Q psy1789 331 TQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409 (499)
Q Consensus 331 ~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 409 (499)
.....-.+.||+.||.|||+ .+++|++|.-+.|++++.|.-||++|-++........ ......--..|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 56677778999999999985 5899999999999999999999999998764432211 00011111235566544322
Q ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCC------CCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q psy1789 410 TFSTASDVWAFGVLLWELTTLAQQPYAE------IDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQ 483 (499)
Q Consensus 410 ~~s~~~DvwS~Gvvl~el~t~g~~p~~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~ 483 (499)
. -..|.|-||+++||++. |..+-.. .-+........+.. ...+..-+ ...+++..|....+--|=.+-+
T Consensus 181 ~--~s~D~~~Lg~li~el~n-g~~~~~~~~~~~~~ipk~~~~~~~k~~-~~~~~~r~-n~~~~~~~~~~~~gff~n~fvd 255 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFN-GSLLTKTDLSNTGKIPKALIELYCKKL-GATELKRP-NKLRFILECRLLGGFFRNDFVD 255 (690)
T ss_pred c--cchhhhhHHHHHHHHhC-cccCcchhhhccCccchhHHHHHHHHh-cccccccc-chhhHHHHHHhccccccchHHH
Confidence 2 45799999999999998 4221111 11101111110000 00011111 1566777777777777777777
Q ss_pred HHHHHHHH
Q psy1789 484 LHSCLQEF 491 (499)
Q Consensus 484 v~~~L~~~ 491 (499)
++..|+++
T Consensus 256 ~~~fLeel 263 (690)
T KOG1243|consen 256 TLLFLEEL 263 (690)
T ss_pred HHHHHHhc
Confidence 77777765
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.1e-11 Score=126.21 Aligned_cols=249 Identities=15% Similarity=0.124 Sum_probs=172.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHH-HHHHHHHHhcC-CCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL-LLQEGMAMYGL-SHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 298 (499)
..++.++..||.|.|+.|++......++ ..+++|.+.+.......+. -..|+.+...+ .|.++++....+.+.+ .
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~--~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGD--CIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-Q 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCC--ceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc-c
Confidence 4466778999999999999987542222 6788888765432211122 23455555554 5888888776644544 3
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CcEEEcccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-LRIQITDNA 377 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~-~~~kl~DfG 377 (499)
.++-.||+.++++...... ...++...++.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||
T Consensus 341 ~~ip~e~~~~~s~~l~~~~--------~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT--------SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccCchhhhcCcchhhhhHH--------HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccc
Confidence 4788899999998877633 3568888999999999999999999999999999999999886 788999999
Q ss_pred cccccCCCCccccCCCCCCccccc--cccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWL--AIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
.++.+.-.. . .....-+++ +++......+..+.|++|||..+.|.+++-..+..... ...+..+..+..
T Consensus 413 ~~t~~~~~~----~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~ 483 (524)
T KOG0601|consen 413 CWTRLAFSS----G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNL 483 (524)
T ss_pred cccccceec----c-cccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCC
Confidence 987432111 1 111122334 56666677788999999999999999983333332211 112223322222
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
+ ...+++..+.......++..||.+.++....+.
T Consensus 484 ~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 484 P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred C-chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 3 333778888889999999999998887665443
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.21 E-value=6e-12 Score=134.67 Aligned_cols=243 Identities=14% Similarity=0.114 Sum_probs=165.2
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
.+-+.+|.++.++.+.-.... ...+.|..... ....+.+....+-.++-..+||-+++..-- +.......|+++
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sg---h~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSG---HTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-FPCRSPLPLVGH 884 (1205)
T ss_pred cccccCCCCcccccCCccccc---cccchhhhccchhhccccccccCCccCccccCCCCceecccCC-CCCCCCcchhhH
Confidence 355557888888776533222 11222221110 011111222233333333345555543322 122344689999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccC-
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF- 383 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~- 383 (499)
|..+++|...|+... ..+.+-.......+..+++|||...++|||++|.|+++..++..+++|||......
T Consensus 885 ~~~~~~~~Skl~~~~--------~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNSG--------CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred HhccCCchhhhhcCC--------CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999733 23333444556678889999999999999999999999999999999998432211
Q ss_pred C-----C----------Cc---------c----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy1789 384 P-----S----------DY---------H----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435 (499)
Q Consensus 384 ~-----~----------~~---------~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~ 435 (499)
- . .. . .......+|..|.+||.+.+......+|+|++|++++|.++ |.+||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~-g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT-GIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc-CCCCC
Confidence 0 0 00 0 01123457889999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHcCCC--CCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q psy1789 436 AEIDPFEMAASLQDGYR--LNQPVNCPDELFSVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 436 ~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 482 (499)
....+.++.+.+..+.. +..+...+.++.+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99998888877765432 334456788999999999999999997765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.4e-10 Score=102.94 Aligned_cols=140 Identities=13% Similarity=0.146 Sum_probs=97.3
Q ss_pred eeeeeecceEEEEEEEeCCC---ceeEEEEEEEecCcc------------c---------HHHHHHHH----HHHHHHhc
Q psy1789 228 SVNMEGTFGRVYRGTYTEED---GVEEEVLVKTVTDNA------------S---------AVQVSLLL----QEGMAMYG 279 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~---~~~~~vavK~~~~~~------------~---------~~~~~~~~----~E~~~l~~ 279 (499)
..||.|--+.||.|...++. .....+|||+.+-.. . ....+.+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 67889999999999754310 012578999874211 0 00112233 78888888
Q ss_pred CCC--CcceeEEeEEEcCCCceEEEEEeCCCCCHHH-HHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccc
Q psy1789 280 LSH--KNILTVLGVSIEDHTSPFLIYPYQDYTNLKR-FLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL-HKKKLLH 355 (499)
Q Consensus 280 l~H--~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yL-H~~~iiH 355 (499)
+.. -++...+++ . .-+|||||+.++.+.. .+.. ..++..+...+..+++.+|..+ |+.++||
T Consensus 83 l~~~Gv~vP~pi~~----~-~~~lvME~Ig~~~~~~~~Lkd---------~~~~~~~~~~i~~~i~~~l~~l~H~~glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL----K-KHVLVMSFIGDDQVPAPKLKD---------AKLNDEEMKNAYYQVLSMMKQLYKECNLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe----c-CCEEEEEEcCCCCccchhhhc---------cccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 753 566777764 2 2389999998654422 2221 1244556778889999999999 8899999
Q ss_pred cCCCCCceEEcCCCcEEEccccccccc
Q psy1789 356 KDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 356 rDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+||++.|||++ ++.+.|.|||.|...
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999997 467999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.4e-10 Score=97.01 Aligned_cols=145 Identities=18% Similarity=0.200 Sum_probs=98.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcce--eEEeEEEcCCCceEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNIL--TVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv--~l~g~~~~~~~~~~lv~ 303 (499)
.++.+|+-+.|+++.+.+.....+.-..|..+... .+-..++..+|+++|.+++--.|. +++. ++.. .-.|+|
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~--~D~~-~~~i~M 89 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF--IDTY-GGQIYM 89 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE--EecC-CCeEEE
Confidence 77889999999999987653222233333333221 122245678899998887543332 2332 2323 338999
Q ss_pred EeCCC-CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---cEEEcccccc
Q psy1789 304 PYQDY-TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL---RIQITDNALA 379 (499)
Q Consensus 304 e~~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~---~~kl~DfGla 379 (499)
||.++ .++.+++...-. ..-.......++.++-+.+.-||..+|||+||.++||+|..++ .+.+.|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~------~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME------DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHcc------CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 99985 489999876321 1122333478889999999999999999999999999997554 4589999997
Q ss_pred cc
Q psy1789 380 RD 381 (499)
Q Consensus 380 ~~ 381 (499)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 53
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.6e-10 Score=105.18 Aligned_cols=142 Identities=17% Similarity=0.133 Sum_probs=100.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC--CcceeEEeEEEcCC--CceEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH--KNILTVLGVSIEDH--TSPFLIY 303 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~~~~--~~~~lv~ 303 (499)
+.|+.|.++.||++...++ ..+++|.............+.+|..+++.+++ .++.+++.++.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g----~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGG----RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCC----cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 6788899999999987542 46889987644221123567899999999875 34677787743321 2458999
Q ss_pred EeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q psy1789 304 PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK--------------------------------- 350 (499)
Q Consensus 304 e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~--------------------------------- 350 (499)
||+++.++...+.. ..++...+..++.+++++|.+||+
T Consensus 80 e~i~G~~l~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 80 ERVDGRVLRDRLLR---------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred EEeCCEecCCCCCC---------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 99998877654321 134555666666666666666662
Q ss_pred -----------------------CCccccCCCCCceEEcC--CCcEEEccccccccc
Q psy1789 351 -----------------------KKLLHKDLATRNCVVDD--KLRIQITDNALARDL 382 (499)
Q Consensus 351 -----------------------~~iiHrDlk~~NIlld~--~~~~kl~DfGla~~~ 382 (499)
..++|+|+.+.||+++. ++.+.|.||+.+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 24699999999999998 667899999987643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.2e-09 Score=96.14 Aligned_cols=130 Identities=18% Similarity=0.192 Sum_probs=93.4
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-c------cHHHHHHHHHHHHHHhcCCCC--cceeEEeEEEcCCCc
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-A------SAVQVSLLLQEGMAMYGLSHK--NILTVLGVSIEDHTS 298 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~------~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~~~~~ 298 (499)
..+++|+-..+|.+.+.+. .+.+|.-... - ..--..+..+|..++.+++-- +...++.+ + ...
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-----~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D-~~~ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-----PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--D-PDN 73 (204)
T ss_pred chhhCCcceeEEeeeccCc-----ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--c-CCC
Confidence 4567899999999877543 3444433211 1 111134567899998887533 44445554 3 333
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
..++|||.++-.|++.+... +..++..+-.-+.-||..+|+|+||.++||++.++. +.+.||||
T Consensus 74 ~~I~me~I~G~~lkd~l~~~---------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGL 137 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA---------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGL 137 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc---------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCc
Confidence 48999999999999998851 356677777888889999999999999999999776 89999999
Q ss_pred ccc
Q psy1789 379 ARD 381 (499)
Q Consensus 379 a~~ 381 (499)
+..
T Consensus 138 g~~ 140 (204)
T COG3642 138 GEF 140 (204)
T ss_pred ccc
Confidence 873
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=6.6e-09 Score=99.78 Aligned_cols=135 Identities=13% Similarity=0.082 Sum_probs=95.1
Q ss_pred ceEEEEEEEeCCCceeEEEEEEEecCcccHHHHH----------HHHHHHHHHhcCCCCcc--eeEEeEEEcC----CCc
Q psy1789 235 FGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVS----------LLLQEGMAMYGLSHKNI--LTVLGVSIED----HTS 298 (499)
Q Consensus 235 fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~----------~~~~E~~~l~~l~H~nI--v~l~g~~~~~----~~~ 298 (499)
...|++..+.+ +.+.||...........+ .+.+|...+.++...+| +..+++.... ...
T Consensus 35 ~rrvvr~~~~g-----~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 35 GRRTLRFELAG-----KSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred CceEEEEEECC-----EEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 33466766533 578889775433221111 36788888877754443 3344543221 224
Q ss_pred eEEEEEeCCCC-CHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-------CCc
Q psy1789 299 PFLIYPYQDYT-NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-------KLR 370 (499)
Q Consensus 299 ~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-------~~~ 370 (499)
.+||+|++++- +|.+++.... ....+...+..++.+++..+.-||..||+|+|++++|||++. +..
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~------~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWA------TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhc------ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCce
Confidence 58999999975 8999986421 123456678899999999999999999999999999999985 578
Q ss_pred EEEccccccc
Q psy1789 371 IQITDNALAR 380 (499)
Q Consensus 371 ~kl~DfGla~ 380 (499)
+.+.||+.++
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999875
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.6e-08 Score=101.47 Aligned_cols=221 Identities=17% Similarity=0.177 Sum_probs=150.9
Q ss_pred eEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc---CCCceEEEEEeCCC-CCH
Q psy1789 236 GRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE---DHTSPFLIYPYQDY-TNL 311 (499)
Q Consensus 236 G~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---~~~~~~lv~e~~~~-gsL 311 (499)
.+.||+...-++ ..++.|++..... .....-..-+++.+++.|.|+|++..+... .+..++|||+|.++ ++|
T Consensus 290 ~Ttyk~~s~~DG---~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 290 ITTYKATSNVDG---NAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ceeEeeeeccCC---ceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 467888765443 5688888832111 001111234677889999999999876331 24457899999985 778
Q ss_pred HHHHHhcccCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 312 KRFLQKCKLCP-------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 312 ~~~l~~~~~~~-------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
.++-....... ...+...+++..+.++.|++.||.++|+.|..-+-|.+.+||++.+.+++|+.-|+.-.+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 77765433211 11234578899999999999999999999999999999999999999999988887665543
Q ss_pred CCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHcCCCCCCCCCCcHHH
Q psy1789 385 SDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM-AASLQDGYRLNQPVNCPDEL 463 (499)
Q Consensus 385 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 463 (499)
+.. |-+. --.+-|.=.||.+++.|.|+....+......+. .+.+. ...+.++
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~--------~~yS~D~ 498 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT--------TTYSTDL 498 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh--------hhhhHHH
Confidence 321 0111 124678889999999999965544444433333 22222 2356788
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 464 FSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 464 ~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
++++.-....++++ -+..+++.++
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHHH
Confidence 88888888888886 5667776543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-08 Score=100.20 Aligned_cols=256 Identities=13% Similarity=0.118 Sum_probs=163.6
Q ss_pred EeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCccee--------EEeEEEcCC
Q psy1789 226 LFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILT--------VLGVSIEDH 296 (499)
Q Consensus 226 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~--------l~g~~~~~~ 296 (499)
++.-||+|+-+.+|---- - ...+-|+....--..+. +.+..|.+. .||-+-. |+|- +..
T Consensus 15 ~gr~LgqGgea~ly~l~e--~----~d~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~ 82 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--V----RDQVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGG--RRG 82 (637)
T ss_pred CCccccCCccceeeecch--h----hchhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCC--Ccc
Confidence 347889999999985321 1 12233555433222221 223334443 5665433 2232 112
Q ss_pred CceEEEEEeCCCC-CHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 297 TSPFLIYPYQDYT-NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 297 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...-+.|..+++- -...++.... ........+|...+++++.+|.+.+-||..|-+-+|+.++|+|+++++.+.|.|
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~t--RRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPAT--RRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ceeEEecccCCCccchhhhcCchh--hcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence 2245666665542 2333332111 111234578999999999999999999999999999999999999999999987
Q ss_pred cccccccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEID-----PFEMAA 445 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-----~~~~~~ 445 (499)
-.--....... .....+|...|.+||.-. +-.-+...|-|.+||++++++.||+.||.+.. +.....
T Consensus 161 sDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 43222111111 122456777899999754 34567889999999999999998899998742 111111
Q ss_pred HHHc-----------CCCC---CCCC-CCcHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHhhhc
Q psy1789 446 SLQD-----------GYRL---NQPV-NCPDELFSVMAYCWAM--NPEGRPTFPQLHSCLQEFHAQLTRY 498 (499)
Q Consensus 446 ~i~~-----------~~~~---~~~~-~~~~~~~~l~~~C~~~--~P~~RPt~~~v~~~L~~~~~~l~~~ 498 (499)
.|.. +.++ ..|. -.+..+..+..+|+.. ++.-|||.+..+..|.++.++|.++
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C 307 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC 307 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence 1211 1111 1121 3567899999999965 3568999999999999999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.1e-08 Score=89.78 Aligned_cols=125 Identities=23% Similarity=0.264 Sum_probs=81.5
Q ss_pred EEEEEEeCCCceeEEEEEEEecCccc-------------------------HHHHHHHHHHHHHHhcCCCC--cceeEEe
Q psy1789 238 VYRGTYTEEDGVEEEVLVKTVTDNAS-------------------------AVQVSLLLQEGMAMYGLSHK--NILTVLG 290 (499)
Q Consensus 238 Vy~~~~~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~E~~~l~~l~H~--nIv~l~g 290 (499)
||.|...++ ..+|+|....... ........+|.+.|.++..- ++.+.+.
T Consensus 2 Vy~~~~~~~----~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~ 77 (188)
T PF01163_consen 2 VYHAIDPDG----EEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD 77 (188)
T ss_dssp EEEEEECTT----EEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred EEEEECCCC----CEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence 888876544 6899998743210 01123467899999999765 5677776
Q ss_pred EEEcCCCceEEEEEeCC--CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCceEEcC
Q psy1789 291 VSIEDHTSPFLIYPYQD--YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY-LHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~y-LH~~~iiHrDlk~~NIlld~ 367 (499)
+. . -.|||||++ +..+..+... .++......++.++...+.. +|..||+|+||.+.|||+++
T Consensus 78 ~~----~-~~ivME~I~~~G~~~~~l~~~----------~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 78 YN----R-NVIVMEYIGEDGVPLPRLKDV----------DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD 142 (188)
T ss_dssp EE----T-TEEEEE--EETTEEGGCHHHC----------GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET
T ss_pred Ee----C-CEEEEEecCCCccchhhHHhc----------cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec
Confidence 52 2 289999999 6555544332 12234556778888886666 47889999999999999998
Q ss_pred CCcEEEccccccccc
Q psy1789 368 KLRIQITDNALARDL 382 (499)
Q Consensus 368 ~~~~kl~DfGla~~~ 382 (499)
+ .+.|.|||.|...
T Consensus 143 ~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 143 G-KVYIIDFGQAVDS 156 (188)
T ss_dssp T-CEEE--GTTEEET
T ss_pred c-eEEEEecCcceec
Confidence 8 8999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.7e-09 Score=112.03 Aligned_cols=147 Identities=20% Similarity=0.246 Sum_probs=107.9
Q ss_pred HHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEcccccccccCCC-CccccC------CCCCCccccccccccccCC
Q psy1789 339 LQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALARDLFPS-DYHCLG------DNENRPVKWLAIESLVHKT 410 (499)
Q Consensus 339 ~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~-~~~~~~------~~~~gt~~y~aPE~~~~~~ 410 (499)
.+++.||.|+|.. ++||+.|.|++|.++..+..||+.|+.+....+. ++.+.. .-......|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 4566999999976 8999999999999999999999999997655442 221111 0112234699999999988
Q ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA---SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 411 ~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
.+.++|+||+||++|-+..+|+.-+.......... ...+........++|.++.+-+.+.+..++..||++.++.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 99999999999999999875665554432222111 1111122334467899999999999999999999877764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.5e-07 Score=87.30 Aligned_cols=107 Identities=19% Similarity=0.160 Sum_probs=82.1
Q ss_pred HHHHHHHHHHhcCCCCc--ceeEEeEEEcCC---CceEEEEEeCCC-CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHH
Q psy1789 268 SLLLQEGMAMYGLSHKN--ILTVLGVSIEDH---TSPFLIYPYQDY-TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQI 341 (499)
Q Consensus 268 ~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~---~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~v 341 (499)
....+|...+..++... ....+++..... ...+||+|++++ -+|.+++.... .++......++.++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--------~~~~~~~~~ll~~l 127 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--------QLDPSQRRELLRAL 127 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--------ccchhhHHHHHHHH
Confidence 45667777776664333 345556543322 234899999997 48999998622 25667789999999
Q ss_pred HHHHHHHHhCCccccCCCCCceEEcCCC---cEEEccccccccc
Q psy1789 342 IMGVQYLHKKKLLHKDLATRNCVVDDKL---RIQITDNALARDL 382 (499)
Q Consensus 342 a~~L~yLH~~~iiHrDlk~~NIlld~~~---~~kl~DfGla~~~ 382 (499)
+..+.-||+.||+|+|+++.|||++.+. .+.+.||+.++..
T Consensus 128 ~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 128 ARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.5e-06 Score=79.50 Aligned_cols=140 Identities=10% Similarity=0.081 Sum_probs=99.7
Q ss_pred eeecceEEEEEEEeCCCceeEEEEEEEecCccc-----HHHHHHHHHHHHHHhcCCCCc--ceeEEeEEEcC---CCceE
Q psy1789 231 MEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-----AVQVSLLLQEGMAMYGLSHKN--ILTVLGVSIED---HTSPF 300 (499)
Q Consensus 231 G~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~---~~~~~ 300 (499)
|+||.+.|++-.+.+ +.+-+|.-.+... +.....|.+|...|.++...+ +.+...+.... ....+
T Consensus 27 ~rgG~SgV~r~~~~g-----~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~ 101 (216)
T PRK09902 27 RRNGMSGVQCVERNG-----KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRAL 101 (216)
T ss_pred CCCCcceEEEEEeCC-----cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEE
Confidence 457888899876644 3577887753211 123467899999988875333 33443221111 22358
Q ss_pred EEEEeCC-CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc--EEEcccc
Q psy1789 301 LIYPYQD-YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR--IQITDNA 377 (499)
Q Consensus 301 lv~e~~~-~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~--~kl~DfG 377 (499)
||+|-++ .-+|.+++.... ....+...+..++.+++..+.-||+.|+.|+|+-+.||+++.++. +++.||.
T Consensus 102 LVTe~L~g~~~L~~~l~~~~------~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHA------VSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEeCCCCccHHHHHhcCC------cCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 9999666 478999986522 234677888999999999999999999999999999999986666 9999998
Q ss_pred cccc
Q psy1789 378 LARD 381 (499)
Q Consensus 378 la~~ 381 (499)
-++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 6653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.3e-06 Score=80.16 Aligned_cols=136 Identities=18% Similarity=0.121 Sum_probs=95.7
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc---------------------HHHHHHHHHHHHHHhcCCC
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS---------------------AVQVSLLLQEGMAMYGLSH 282 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~H 282 (499)
..+++.||.|--+.||.|...++ .+++||.-+.... ........+|.++|.+|.-
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g----~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKG----RKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred HhhccccccCccceEEEEECCCC----CEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 34668999999999999987644 6788886532210 0112235678888998865
Q ss_pred C--cceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy1789 283 K--NILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360 (499)
Q Consensus 283 ~--nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~ 360 (499)
. .+..-+++ + +-.+||||.++--|... .++.+..-.|+..|++-+.-+-..|+||+|+.+
T Consensus 169 ~G~~VP~P~~~----n-RHaVvMe~ieG~eL~~~-------------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSe 230 (304)
T COG0478 169 EGVKVPKPIAW----N-RHAVVMEYIEGVELYRL-------------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSE 230 (304)
T ss_pred cCCCCCCcccc----c-cceeeeehcccceeecc-------------cCcccCHHHHHHHHHHHHHHHHHcCccccCCch
Confidence 5 67777765 2 23899999997555432 122334445555566656555588999999999
Q ss_pred CceEEcCCCcEEEcccccccc
Q psy1789 361 RNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 361 ~NIlld~~~~~kl~DfGla~~ 381 (499)
-||+++++|.+.+.||--+..
T Consensus 231 fNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 231 FNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred heEEEecCCCEEEEeCccccc
Confidence 999999999999999986653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.5e-06 Score=87.02 Aligned_cols=143 Identities=17% Similarity=0.132 Sum_probs=93.7
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHH-----------------------------H----------
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV-----------------------------S---------- 268 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------------~---------- 268 (499)
+.|+.++-|.||+|++.++ +.||||+...+-..... +
T Consensus 131 ~PiAsASIaQVH~A~L~sG----~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El 206 (517)
T COG0661 131 EPIASASIAQVHRAVLKSG----EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL 206 (517)
T ss_pred CchhhhhHhhheeEEecCC----CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence 7788999999999999874 78999998765322110 0
Q ss_pred HHHHHHHHHhcC----CCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHH
Q psy1789 269 LLLQEGMAMYGL----SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344 (499)
Q Consensus 269 ~~~~E~~~l~~l----~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~ 344 (499)
.+.+|..-+.++ ++..=+.+=.++++-.....|+|||++|-.+.+...... ..++. ..++..++++
T Consensus 207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-------~g~d~---k~ia~~~~~~ 276 (517)
T COG0661 207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-------AGIDR---KELAELLVRA 276 (517)
T ss_pred CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-------cCCCH---HHHHHHHHHH
Confidence 133444333332 222223333343443344599999999988888853211 23443 3333333332
Q ss_pred -HHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCC
Q psy1789 345 -VQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384 (499)
Q Consensus 345 -L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~ 384 (499)
+..+-..|++|.|..|.||+++.++++-+-|||+...+.+
T Consensus 277 f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 277 FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 3344457999999999999999999999999999887654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.2e-06 Score=76.17 Aligned_cols=102 Identities=16% Similarity=0.115 Sum_probs=78.5
Q ss_pred HHHHHHHhcCCC-CcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy1789 271 LQEGMAMYGLSH-KNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349 (499)
Q Consensus 271 ~~E~~~l~~l~H-~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH 349 (499)
..|..+++.+++ +++++++|+| + + +++.||.+.+++...-.. -.....-+|..|.+||.++++.+++++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G-~-~~v~E~~~~~~~~~~~~~-----l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---G-R-FYVVEYVGAGSLYGIYRP-----LSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---C-C-EEEEEeecCccccccccc-----cccccccCHHHHHHHHHHHHHHHHHHh
Confidence 357778888876 6999999998 2 2 889999997755421000 000113589999999999999999999
Q ss_pred hC---CccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 350 KK---KLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 350 ~~---~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+. .+.-.|++++|+-+++++++|+.|...+-..
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 73 5777999999999999999999998876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.3e-06 Score=90.24 Aligned_cols=182 Identities=12% Similarity=0.042 Sum_probs=128.5
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc-ceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN-ILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+-+++|+++++||.+...+ +....+.+... ....-++++|.+++||| .+..++- .+.+...++++++.
T Consensus 248 h~fvK~altknpKkRptae----klL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d-~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAE----KLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLED-YDGEDYLWIPMRIC 316 (829)
T ss_pred HHHHHHHhcCCCccCCChh----hheeceeeccc------hhhHHHHHHHHHccCCCCccccccc-CCcccccchhhhhh
Confidence 4456799999999875433 33335554332 23456888999999999 5555554 35566678899998
Q ss_pred CCC-CHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 307 DYT-NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 307 ~~g-sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
..| +-..-... ..-.+...+...+.+.-+++|+|+|+..-+||| ||+..+ ...|..||+.+..+.+.
T Consensus 317 s~~rs~~~~~~~-------se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 317 STGRSSALEMTV-------SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred cCCccccccCCh-------hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 876 11111000 011244455667778888999999998789999 777776 56899999998877544
Q ss_pred CccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy1789 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYA 436 (499)
Q Consensus 386 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~ 436 (499)
. ......++..|+|||+.....+..+.|+|+.|+-..++.- +-+|..
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap-~~pPr~ 431 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP-GLPPRS 431 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC-CCCCCC
Confidence 3 2345678899999999999999999999999997777765 555543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.4e-05 Score=69.14 Aligned_cols=140 Identities=14% Similarity=0.110 Sum_probs=86.6
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHH--HH------HHHHHHHHhcCC---CCcceeE
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV--SL------LLQEGMAMYGLS---HKNILTV 288 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~------~~~E~~~l~~l~---H~nIv~l 288 (499)
...+|...+++-......|.+-...+ +...+|.........+. .. ..+++..+.+++ --.+..+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~-----~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG-----KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC-----cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 34566777777776666666655433 56888887655332221 11 122333333332 2223333
Q ss_pred EeEEEcC----CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q psy1789 289 LGVSIED----HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCV 364 (499)
Q Consensus 289 ~g~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIl 364 (499)
+.++... ....+|+|||++|..|.+... ++. .++..+++++.-+|+.|+.|+|..|.|++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFL 167 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh------------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEE
Confidence 3322211 123468999999887766532 222 34566778899999999999999999999
Q ss_pred EcCCCcEEEcccccccc
Q psy1789 365 VDDKLRIQITDNALARD 381 (499)
Q Consensus 365 ld~~~~~kl~DfGla~~ 381 (499)
+++++ +++.||+..+.
T Consensus 168 v~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EECCc-EEEEECccccc
Confidence 99665 89999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.1e-05 Score=80.60 Aligned_cols=142 Identities=15% Similarity=0.206 Sum_probs=89.7
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHH------------------------------------HHHH
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV------------------------------------SLLL 271 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------~~~~ 271 (499)
+.||.-+.|.||+|+++++ +.||||+-...-..... -.|.
T Consensus 167 ~piaaASlaQVhrA~L~~G----~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~ 242 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNG----EDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFT 242 (538)
T ss_pred chhhhcchhheEEEEecCC----CEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchH
Confidence 7788899999999999874 78999998654322110 0244
Q ss_pred HHHHHH----hcCCCCcc---eeEEeEEEcCCCceEEEEEeCCCCCHHHH--HHhcccCCCCCCCCCCHHHHHHHHHHHH
Q psy1789 272 QEGMAM----YGLSHKNI---LTVLGVSIEDHTSPFLIYPYQDYTNLKRF--LQKCKLCPEGVAHTLTTQEVVDMCLQII 342 (499)
Q Consensus 272 ~E~~~l----~~l~H~nI---v~l~g~~~~~~~~~~lv~e~~~~gsL~~~--l~~~~~~~~~~~~~l~~~~~~~i~~~va 342 (499)
+|.+-. +.+.|-++ |.+=.+.++-.....|+||||+|..+.+. +.+ ..++...+..-+.++.
T Consensus 243 ~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~---------~gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 243 KEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK---------RGISPHDILNKLVEAY 313 (538)
T ss_pred HHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH---------cCCCHHHHHHHHHHHH
Confidence 444332 23445551 11222222323456999999999766655 333 2345444333333322
Q ss_pred HHHHHHHhCCccccCCCCCceEEc----CCCcEEEcccccccccCC
Q psy1789 343 MGVQYLHKKKLLHKDLATRNCVVD----DKLRIQITDNALARDLFP 384 (499)
Q Consensus 343 ~~L~yLH~~~iiHrDlk~~NIlld----~~~~~kl~DfGla~~~~~ 384 (499)
. +-+-..|++|+|-.|.||+++ .++.+.+-|||+.+.+..
T Consensus 314 ~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 314 L--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred H--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2 222345899999999999998 367899999999887643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.9e-05 Score=68.08 Aligned_cols=127 Identities=13% Similarity=0.133 Sum_probs=89.6
Q ss_pred cceEEeeeeeeecc-eEEEEEEEeCCCceeEEEEEEEecC---cc--------c--H-------HHHHHHHHHHHHHhcC
Q psy1789 222 CRVRLFSVNMEGTF-GRVYRGTYTEEDGVEEEVLVKTVTD---NA--------S--A-------VQVSLLLQEGMAMYGL 280 (499)
Q Consensus 222 ~~~~~~~~lG~G~f-G~Vy~~~~~~~~~~~~~vavK~~~~---~~--------~--~-------~~~~~~~~E~~~l~~l 280 (499)
..++.++.||.|.- |.|||.+..+ +.+|+|.+.. .. . . ...+-|..|++..++|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g-----~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRL 111 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG-----RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRL 111 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC-----eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHH
Confidence 57888899999999 9999999865 6899999321 00 0 0 2235689999998887
Q ss_pred C---CCcc--eeEEeEEEcC-----------------CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHH
Q psy1789 281 S---HKNI--LTVLGVSIED-----------------HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338 (499)
Q Consensus 281 ~---H~nI--v~l~g~~~~~-----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~ 338 (499)
+ +.++ |+.+||-.-+ .....+|.||.+... .+. ..-+
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------~~~----~~~~ 170 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------PLQ----IRDI 170 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------ccc----hhHH
Confidence 5 4566 8888884211 112356777776322 122 2335
Q ss_pred HHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 339 ~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
.++.+-|.-+|..||+-+|+|+.|.. .-||+|||.+
T Consensus 171 ~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 56677788899999999999999987 4578999853
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.1e-05 Score=85.02 Aligned_cols=83 Identities=12% Similarity=0.118 Sum_probs=55.7
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcc--eeEEeEEEcCC--CceEE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNI--LTVLGVSIEDH--TSPFL 301 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nI--v~l~g~~~~~~--~~~~l 301 (499)
.+.++.|.++.+|+-...++... ..+++|+............+.+|.++++.+. |.++ .+++++|.+.. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~-~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSV-KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcc-eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 37788899999999876443211 3466676543322222346789999999885 6665 78888864431 45799
Q ss_pred EEEeCCCCC
Q psy1789 302 IYPYQDYTN 310 (499)
Q Consensus 302 v~e~~~~gs 310 (499)
||||+++..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.90 E-value=6.7e-05 Score=82.81 Aligned_cols=201 Identities=19% Similarity=0.225 Sum_probs=138.2
Q ss_pred HHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce---EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHH
Q psy1789 266 QVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP---FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQII 342 (499)
Q Consensus 266 ~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va 342 (499)
+.....-|...+.++.|+|++.+++|..+....- .+.-|++..-++...+.. ....+..+.+.+..++.
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--------v~~i~~~~~r~~~~~~~ 296 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--------VGSIPLETLRILHQKLL 296 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--------ccccCHHHHHHHHHHHh
Confidence 3444456777888999999999999976643332 234477888888888776 24578888999999999
Q ss_pred HHHHHHHhCCccccCCCCC---ceEEcCCCcEEEc--ccccccccCCCCccccCCCCCCccccccccccccCCCCCc--h
Q psy1789 343 MGVQYLHKKKLLHKDLATR---NCVVDDKLRIQIT--DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTA--S 415 (499)
Q Consensus 343 ~~L~yLH~~~iiHrDlk~~---NIlld~~~~~kl~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~--~ 415 (499)
+||+|+|+....|.-+..+ +--.+.++...++ ||+..+.+..... ......+..|.++|......+..+ .
T Consensus 297 ~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~ 373 (1351)
T KOG1035|consen 297 EGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLT 373 (1351)
T ss_pred hhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhh
Confidence 9999999986666655555 4444566666666 8887776543322 112233445888888877666544 7
Q ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 416 DVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 416 DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
|+|.+|.....+..+...+-....+. .+ .+.....+..+....|+..++++|++..+++...
T Consensus 374 dL~~lgll~~~~~~~~~i~~~~~~~~----~~-------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 374 DLWCLGLLLLQLSQGEDISEKSAVPV----SL-------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHHHHHHHhhhhhcCcccccccchh----hh-------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99999999999998443332221111 11 1222233788899999999999999999987653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=68.83 Aligned_cols=137 Identities=17% Similarity=0.092 Sum_probs=79.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcc--eeEEeEEEcCCCceEEEEEe
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI--LTVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~g~~~~~~~~~~lv~e~ 305 (499)
..||+|..+.||+.. + ...++|........ ....+|.++++.+..-.+ .+.++++ +..+...+|||+
T Consensus 7 ~~i~~G~t~~~y~~~---~----~~~VlR~~~~~~~~---~~i~~E~~~l~~l~~~glpvP~~~~~~-~~~~~~glv~e~ 75 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---T----GKWMLKLYNPGFDK---ETIKREFDASRKVFSLGIPTPHPFDLV-EDGGRLGLIYEL 75 (226)
T ss_pred eeecCCCCcceeEec---C----CCEEEEeCCCCCCH---HHHHHHHHHHHHHHHcCCCCCceEEEE-ecCCeeeeeeee
Confidence 578999999999842 2 24667887654332 335778888887754433 5666664 334445789999
Q ss_pred CCCCC-HHHH---------------------HHhcccCCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHh--
Q psy1789 306 QDYTN-LKRF---------------------LQKCKLCPEGVAHTLTTQEVVDMCL----------QIIM-GVQYLHK-- 350 (499)
Q Consensus 306 ~~~gs-L~~~---------------------l~~~~~~~~~~~~~l~~~~~~~i~~----------~va~-~L~yLH~-- 350 (499)
++|.+ +... +|... .. ...+... ...+.. .+.. ...+|..
T Consensus 76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~---~~-~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~ 150 (226)
T TIGR02172 76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTK---CD-TSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVP 150 (226)
T ss_pred cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCC---CC-CCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCC
Confidence 99853 2111 11110 00 0111100 000100 1111 1223322
Q ss_pred --CCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 351 --KKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 351 --~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
..++|+|+.|.||++++++ +.|.||+.+..
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 1478999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00013 Score=68.41 Aligned_cols=145 Identities=23% Similarity=0.214 Sum_probs=80.9
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCC--cceeEEeEEEcC--CCceEEE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHK--NILTVLGVSIED--HTSPFLI 302 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~~~~--~~~~~lv 302 (499)
++.++.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.++++++... ....+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-----~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-----GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-----SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-----cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEE
Confidence 3678889999999998644 36888887544 3445677888887776433 356777653222 2335899
Q ss_pred EEeCCCCCHHH----------------HHHhcccCCCCCCCCCCHHH---------HHHH------------HHHHHH-H
Q psy1789 303 YPYQDYTNLKR----------------FLQKCKLCPEGVAHTLTTQE---------VVDM------------CLQIIM-G 344 (499)
Q Consensus 303 ~e~~~~gsL~~----------------~l~~~~~~~~~~~~~l~~~~---------~~~i------------~~~va~-~ 344 (499)
|+++++..+.. .+......... ...+.+.. .... ...+.. .
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPP-FSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL 152 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTT-CCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhccccccc-ccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence 99999888777 22111001000 01111111 0000 111222 2
Q ss_pred HHHHHh-------CCccccCCCCCceEEc-CCCcEEEccccccc
Q psy1789 345 VQYLHK-------KKLLHKDLATRNCVVD-DKLRIQITDNALAR 380 (499)
Q Consensus 345 L~yLH~-------~~iiHrDlk~~NIlld-~~~~~kl~DfGla~ 380 (499)
+..+++ ..++|+|+.+.||+++ +++.+.|.||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333332 2599999999999999 66666899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00026 Score=65.97 Aligned_cols=136 Identities=18% Similarity=0.132 Sum_probs=86.2
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHH----------------------H-HHHHHHHHHHhcCC--C
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ----------------------V-SLLLQEGMAMYGLS--H 282 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----------------------~-~~~~~E~~~l~~l~--H 282 (499)
..|..|--..||+|.-.+. ..+|||++........ . .....|..-|.++. +
T Consensus 54 g~istGKEA~Vy~a~~~~~----~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG 129 (268)
T COG1718 54 GCISTGKEANVYLAETGDG----RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129 (268)
T ss_pred eeecCCcceEEEeeccCCC----ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 4566677778999975333 6899999864321110 0 11223555555542 3
Q ss_pred CcceeEEeEEEcCCCceEEEEEeCCCCC-HHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCC
Q psy1789 283 KNILTVLGVSIEDHTSPFLIYPYQDYTN-LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLAT 360 (499)
Q Consensus 283 ~nIv~l~g~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~ 360 (499)
-.+.+-+++ . ...|||||++... -.-.|. -..+...+...+..++++.+.-|-. .++||+||..
T Consensus 130 VrvP~Pi~~-~----~nVLvMEfIg~~g~pAP~Lk---------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSE 195 (268)
T COG1718 130 VRVPEPIAF-R----NNVLVMEFIGDDGLPAPRLK---------DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSE 195 (268)
T ss_pred CCCCCceee-c----CCeEEEEeccCCCCCCCCcc---------cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchh
Confidence 334444443 1 1389999998431 100011 1122333577778888888888876 7999999999
Q ss_pred CceEEcCCCcEEEccccccccc
Q psy1789 361 RNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 361 ~NIlld~~~~~kl~DfGla~~~ 382 (499)
-|||++ ++.+.|.|+|-|...
T Consensus 196 yNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 196 YNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred hheEEE-CCeEEEEECcccccc
Confidence 999999 889999999988654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.0002 Score=68.15 Aligned_cols=141 Identities=14% Similarity=0.060 Sum_probs=79.6
Q ss_pred eeeecc-eEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEEEEeCC
Q psy1789 230 NMEGTF-GRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLIYPYQD 307 (499)
Q Consensus 230 lG~G~f-G~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv~e~~~ 307 (499)
|-.|.. ..||+....+ ..+.+|...... ...+.+|+.+++.+. +--+.+++++.. ..+..++|||+++
T Consensus 6 ~~~g~~~~~v~~~~~~~-----~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~~~~lv~e~i~ 75 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-----PGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGS-DDGRAWLLTSAVP 75 (244)
T ss_pred cCCCCCcCeEEEEcCCC-----CcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEe-cCCccEEEEEeeC
Confidence 334555 6889886432 357778775432 234567888877763 444567777643 3345699999999
Q ss_pred CCCHHHHHH----------------hcccCCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHH
Q psy1789 308 YTNLKRFLQ----------------KCKLCPEGVAHTLTT--QEVVDMCL--------------------QIIMGVQYLH 349 (499)
Q Consensus 308 ~gsL~~~l~----------------~~~~~~~~~~~~l~~--~~~~~i~~--------------------~va~~L~yLH 349 (499)
+.+|..... ..-..+.. ...+.. ........ .+...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 154 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVA-DCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE 154 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcc-cCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence 877764321 00000100 001110 01110000 0111122221
Q ss_pred -------hCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 350 -------KKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 350 -------~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
...++|+|+.|.|||++++..+.|.||+.|..
T Consensus 155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 12489999999999999988788999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00047 Score=63.13 Aligned_cols=131 Identities=17% Similarity=0.196 Sum_probs=86.2
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---------------cHHHHHHHHHHHHHHhcC------CCCcce
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---------------SAVQVSLLLQEGMAMYGL------SHKNIL 286 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~E~~~l~~l------~H~nIv 286 (499)
..||+|+.-.||.- +++ ....||+..... .....+++.+|+.-...+ .+..|.
T Consensus 7 ~~i~~G~~R~cy~H--P~d----p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDD----PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEEC--CCC----CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 78899999999953 333 347788886554 011234455665544443 488999
Q ss_pred eEEeEEEcCCCceEEEEEeCCC------CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy1789 287 TVLGVSIEDHTSPFLIYPYQDY------TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360 (499)
Q Consensus 287 ~l~g~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~ 360 (499)
+++|+. +.+.-+-+|+|.+.+ -+|.+++.. ..++. .+...+-+-..||-+.+|+.+|++|
T Consensus 81 r~~G~v-eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---------~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~ 146 (199)
T PF10707_consen 81 RFYGFV-ETNLGLGLVVELIRDADGNISPTLEDYLKE---------GGLTE----ELRQALDEFKRYLLDHHIVIRDLNP 146 (199)
T ss_pred cEeEEE-ecCCceEEEEEEEECCCCCcCccHHHHHHc---------CCccH----HHHHHHHHHHHHHHHcCCeecCCCc
Confidence 999994 545556889887643 468888864 23444 3333344555788889999999999
Q ss_pred CceEEcCC---C-cEEEcc-ccc
Q psy1789 361 RNCVVDDK---L-RIQITD-NAL 378 (499)
Q Consensus 361 ~NIlld~~---~-~~kl~D-fGl 378 (499)
.||++... . .+.|.| ||-
T Consensus 147 ~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ccEEEEecCCCceEEEEEeCCCC
Confidence 99999633 2 456666 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00032 Score=61.85 Aligned_cols=129 Identities=19% Similarity=0.165 Sum_probs=88.5
Q ss_pred EeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcce-eEEeEEEcCCCceEEEEE
Q psy1789 226 LFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNIL-TVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 226 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~~lv~e 304 (499)
..+.|++|++|.||+|.+.+ ..+|+|+-..++.. ..+..|.++|..+.-.++- +++.|. + -++.||
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~-----~~~a~Kvrr~ds~r---~~l~kEakiLeil~g~~~~p~vy~yg-~----~~i~me 92 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG-----GEVALKVRRRDSPR---RNLEKEAKILEILAGEGVTPEVYFYG-E----DFIRME 92 (201)
T ss_pred hhhhhhcccccEEEEeeccC-----ceEEEEEecCCcch---hhHHHHHHHHHHhhhcCCCceEEEec-h----hhhhhh
Confidence 33789999999999999876 47889987765443 4577899988888766553 466652 1 256699
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCceEEcCCCcEEEccccccccc
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLA-TRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk-~~NIlld~~~~~kl~DfGla~~~ 382 (499)
|..+-.|.++-.. .+.+. ...+++.---|-..||-|..|. |..++|-.+..+.|.||--|+..
T Consensus 93 ~i~G~~L~~~~~~-----------~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIG-----------GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhc-----------ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 9998888877553 12222 2344444333344588888875 55555555558999999988743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00084 Score=63.57 Aligned_cols=31 Identities=26% Similarity=0.152 Sum_probs=26.4
Q ss_pred CccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
.++|+|+.+.||+++++...-|.||+.|...
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g 195 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG 195 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence 4899999999999997766679999987643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.00012 Score=82.79 Aligned_cols=161 Identities=12% Similarity=0.031 Sum_probs=113.0
Q ss_pred HHHHHHHHHHhcCCCCcceeEEeEEE-cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q psy1789 268 SLLLQEGMAMYGLSHKNILTVLGVSI-EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346 (499)
Q Consensus 268 ~~~~~E~~~l~~l~H~nIv~l~g~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~ 346 (499)
+....|...++...|+++.....=.. ......+.+++|+..|.+...+-+.. .....++..-......+...+..
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~----ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGL----EESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcc----ccCCcchhchHHHHHHHHHhccc
Confidence 33445555666678999877654211 12233478899999999999987632 12233443333333333366677
Q ss_pred HHHhC-----CccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHH
Q psy1789 347 YLHKK-----KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFG 421 (499)
Q Consensus 347 yLH~~-----~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~G 421 (499)
-+|++ -.+|++||+-|.+|+.+..+|++++|+.+...+... ..+...+++-|+.|+....-+++.++|+|..|
T Consensus 1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRS 1427 (2724)
T ss_pred hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHH
Confidence 77754 379999999999999999999999999994433221 22355677789999999999999999999999
Q ss_pred HHHHHHHcCCCCCC
Q psy1789 422 VLLWELTTLAQQPY 435 (499)
Q Consensus 422 vvl~el~t~g~~p~ 435 (499)
+-+|+..- +..+|
T Consensus 1428 ~~ly~rs~-~n~~f 1440 (2724)
T KOG1826|consen 1428 LSLYLRSD-GNAYF 1440 (2724)
T ss_pred HHHHHHhc-ccHHH
Confidence 99999876 54444
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.014 Score=59.46 Aligned_cols=76 Identities=16% Similarity=0.087 Sum_probs=51.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-----cc-HHHHHHHHHHHHHHhcCC---CCcceeEEeEEEcCCCc
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-----AS-AVQVSLLLQEGMAMYGLS---HKNILTVLGVSIEDHTS 298 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-----~~-~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~ 298 (499)
+.||.|.++.||+....++. +.+.||.-... .+ ....+++..|.+.|..+. -.++++++.+ + ...
T Consensus 32 ~elggGn~N~VyrV~~~~g~---~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D-~~~ 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGG---KSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D-EEL 105 (401)
T ss_pred eEcCCCceEEEEEEEeCCCC---eEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C-CCC
Confidence 67888999999999875432 46888985311 11 223456677877777652 3467888887 2 234
Q ss_pred eEEEEEeCCCC
Q psy1789 299 PFLIYPYQDYT 309 (499)
Q Consensus 299 ~~lv~e~~~~g 309 (499)
.++||||+++.
T Consensus 106 ~~lVME~L~~~ 116 (401)
T PRK09550 106 AVTVMEDLSDH 116 (401)
T ss_pred CEEEEecCCCc
Confidence 58999999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0097 Score=58.45 Aligned_cols=77 Identities=12% Similarity=0.091 Sum_probs=52.6
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC---CcceeEEeEEEcC--CCceEE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH---KNILTVLGVSIED--HTSPFL 301 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~--~~~~~l 301 (499)
.+.||.|..+.||+-...++ .+.+|..+.... ...|..|...|+.+.- -.+.+++++|... .+..+|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-----~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-----NPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeecCCccceeEEEEEcCCC-----CEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 37899999999999764332 355666432111 2467889888887743 3677888876432 355799
Q ss_pred EEEeCCCCCH
Q psy1789 302 IYPYQDYTNL 311 (499)
Q Consensus 302 v~e~~~~gsL 311 (499)
|||+++++++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998654
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0038 Score=63.86 Aligned_cols=152 Identities=22% Similarity=0.295 Sum_probs=88.4
Q ss_pred HHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy1789 270 LLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349 (499)
Q Consensus 270 ~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH 349 (499)
+......++.+.|+|+...+.+......+..+|+|+.. -||.+.+.... +-.. +++
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~---------l~~~----------s~~---- 84 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN---------LKDE----------SLL---- 84 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc---------cchh----------hhc----
Confidence 44555678889999999999986555666788899886 78888887521 1100 001
Q ss_pred hCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc
Q psy1789 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429 (499)
Q Consensus 350 ~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t 429 (499)
.+++.|-. | .+++| -++. .+ .... .+|+||||+|.++.|+.-
T Consensus 85 ~~~~~~~~-----~-------~~~td-~~~t-----~~----~~~~----------------~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 85 AHGVLHLN-----I-------IYITD-HFLT-----KY----PSPI----------------GPKSDVWSLGFIILELYL 126 (725)
T ss_pred ccccceeh-----h-------hhccc-cccc-----cC----CCCC----------------CcchhhhhHHHHHHHHHH
Confidence 22333321 1 12223 0000 00 0111 149999999999999987
Q ss_pred CCCCCCCCCCHHHHHHHHHcCCCCC-----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1789 430 LAQQPYAEIDPFEMAASLQDGYRLN-----------QPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484 (499)
Q Consensus 430 ~g~~p~~~~~~~~~~~~i~~~~~~~-----------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v 484 (499)
|...+......+....+.+-.... .-..++....++...|....|..||...++
T Consensus 127 -~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 127 -GISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred -hhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 544444433333333222211111 112456678889999999999988866554
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.022 Score=54.50 Aligned_cols=139 Identities=19% Similarity=0.170 Sum_probs=74.6
Q ss_pred eeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcc-eeEEeEEEcCCCceEEEEEeCCCC
Q psy1789 231 MEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI-LTVLGVSIEDHTSPFLIYPYQDYT 309 (499)
Q Consensus 231 G~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~~lv~e~~~~g 309 (499)
..|-.+.+|+....+ ..+++|........... ...+|..+++.+....+ .++++.+ . .++|+||+++.
T Consensus 5 ~~G~tn~~y~~~~~~-----~~~vlR~~~~~~~~~~~-~r~~E~~~l~~l~~~g~~P~~i~~~-~----~~~v~e~i~G~ 73 (256)
T TIGR02721 5 SGGLTNRSWRIEHPG-----ISFVWRPQSPVCKALGV-DRQREYQILQALSALGLAPKPILVN-E----HWLLVEWLEGE 73 (256)
T ss_pred CCcCcCCeEEEEeCC-----ccEEEeeCCcccccccC-cHHHHHHHHHHHHhcCCCCceEEEe-C----CEEEEEeccCc
Confidence 347778899886322 46778876543221111 24578888887754333 4455542 2 27999999976
Q ss_pred CHHH--------------HHHhcccCCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHh--------CCccccC
Q psy1789 310 NLKR--------------FLQKCKLCPEGVAHTLTTQE-VVDMCLQI---------IMGVQYLHK--------KKLLHKD 357 (499)
Q Consensus 310 sL~~--------------~l~~~~~~~~~~~~~l~~~~-~~~i~~~v---------a~~L~yLH~--------~~iiHrD 357 (499)
.+.. .+.+--..+. ....++... ......++ ..-+..+-. ..++|+|
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 5432 1111000110 011222221 11111111 111222211 1489999
Q ss_pred CCCCceEEcCCCcEEEccccccccc
Q psy1789 358 LATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 358 lk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+.|.||++++++ +.|.||..|...
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCcC
Confidence 999999999877 789999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.036 Score=54.69 Aligned_cols=146 Identities=14% Similarity=0.083 Sum_probs=77.9
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCC--cceeEEeEE-----EcCCCce
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHK--NILTVLGVS-----IEDHTSP 299 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~g~~-----~~~~~~~ 299 (499)
+..++.|....+|+....+ ....+|+....... +....|.+++..|... ++.+.+... ....+..
T Consensus 27 i~~~~~G~~n~~y~v~t~~-----~~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDV-----GRYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred ccccCCccccceEEEEeCC-----CcEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 4667777778999876432 24667776543222 2233455555555322 233443321 1223456
Q ss_pred EEEEEeCCCCCHH-----------HH---HHhcccC-CCCCC---CCCCHHHHH------------HHHHHHHHHHHHHH
Q psy1789 300 FLIYPYQDYTNLK-----------RF---LQKCKLC-PEGVA---HTLTTQEVV------------DMCLQIIMGVQYLH 349 (499)
Q Consensus 300 ~lv~e~~~~gsL~-----------~~---l~~~~~~-~~~~~---~~l~~~~~~------------~i~~~va~~L~yLH 349 (499)
++++||++|..+. .. +|..... ..... ..-.|.... .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999874321 11 1211100 00000 011122111 11122344555564
Q ss_pred h-------CCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 350 K-------KKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 350 ~-------~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
. .+++|+|+.+.||++++++...|.||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 479999999999999988877899999765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.032 Score=52.54 Aligned_cols=75 Identities=16% Similarity=0.145 Sum_probs=43.9
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc-ceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN-ILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.|..|-.+.+|+....+++ ...+++|+...... .. -...+|..++..+...+ .+++++. .+ + .++|||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~--~~~~vlR~~~~~~~-~~-~d~~~E~~~~~~l~~~gl~P~v~~~-~~-~---~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDN--QDAVLVRVYGNKTE-LI-IDRERELRIHKLLSKHGLAPKLYAT-FQ-N---GLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCC--CCeEEEEEccCCcc-ce-ecHHHHHHHHHHHHhCCCCCeEEEE-eC-C---cEEEEee
Confidence 55666888899998754300 14677887653311 11 12236777777774333 4455543 22 1 4899999
Q ss_pred CCCCH
Q psy1789 307 DYTNL 311 (499)
Q Consensus 307 ~~gsL 311 (499)
++.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 87654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.046 Score=53.49 Aligned_cols=144 Identities=15% Similarity=0.044 Sum_probs=80.9
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc--ceeEEeE-----EEcCCCceE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN--ILTVLGV-----SIEDHTSPF 300 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~-----~~~~~~~~~ 300 (499)
+.+..|....+|+....+ ..+++|+.... .. .....|+.++..+++.+ +.+.+.. .....+..+
T Consensus 20 ~~i~~G~~n~~y~v~~~~-----~~~vLr~~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-----GRYVLTLFEKV-SA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred ecccCccccceEEEEeCC-----CcEEEEEcCCC-Ch---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 566667778999876433 34777887642 22 34556777777664333 4444432 112234568
Q ss_pred EEEEeCCCCCHHH-----------H---HHhcccC-CC--CCCCCCCHHHHH----------HHHHHHHHHHHHHHh---
Q psy1789 301 LIYPYQDYTNLKR-----------F---LQKCKLC-PE--GVAHTLTTQEVV----------DMCLQIIMGVQYLHK--- 350 (499)
Q Consensus 301 lv~e~~~~gsL~~-----------~---l~~~~~~-~~--~~~~~l~~~~~~----------~i~~~va~~L~yLH~--- 350 (499)
++++|++|..+.. . +|..... .. .......|.... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999998755421 1 1211100 00 001112232211 111223344555543
Q ss_pred ----CCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 351 ----KKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 351 ----~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
.+++|+|+.|.||+++++..+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 369999999999999998778899999775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.11 Score=51.56 Aligned_cols=30 Identities=20% Similarity=0.235 Sum_probs=26.1
Q ss_pred CccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+++|+|+.+.||+++++...-|.||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 799999999999999776668999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.022 Score=55.96 Aligned_cols=30 Identities=20% Similarity=0.246 Sum_probs=26.4
Q ss_pred CccccCCCCCceEEcCC----CcEEEcccccccc
Q psy1789 352 KLLHKDLATRNCVVDDK----LRIQITDNALARD 381 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~----~~~kl~DfGla~~ 381 (499)
.++|+|+.+.|||++++ +.+.+.||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.092 Score=52.46 Aligned_cols=82 Identities=11% Similarity=0.046 Sum_probs=47.9
Q ss_pred eeeeecceEEEEEEEeCCCceeEEEEEEEecCc------ccHHHHHHHHHHHHHHhcCC--CC-cceeEEeEEEcCCCce
Q psy1789 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN------ASAVQVSLLLQEGMAMYGLS--HK-NILTVLGVSIEDHTSP 299 (499)
Q Consensus 229 ~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~--H~-nIv~l~g~~~~~~~~~ 299 (499)
-||.|....||++...++. +.++||.-... ..+...++-.-|.+.|+... -| .+.+++.+ + ....
T Consensus 2 EigdGnlN~VfrV~~~~g~---~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D-~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGD---RAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--D-TEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCC---eeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--c-cccc
Confidence 3678999999999864321 46888875321 11222344455666665542 23 56677776 3 3344
Q ss_pred EEEEEeCCC-CCHHHHHH
Q psy1789 300 FLIYPYQDY-TNLKRFLQ 316 (499)
Q Consensus 300 ~lv~e~~~~-gsL~~~l~ 316 (499)
.+|||+++. ..|+..|-
T Consensus 76 ~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 76 VTVMEDLSHHKIARKGLI 93 (370)
T ss_pred eehHhhCccchHHHHHHH
Confidence 799999864 33444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.0031 Score=68.46 Aligned_cols=33 Identities=24% Similarity=0.523 Sum_probs=18.8
Q ss_pred cccccCceeEEE----EEeee---ccccCceEEEEEEEEE
Q psy1789 44 IGSIPTSIQTFS----INLPC---TGTMNAEVIVLISINV 76 (499)
Q Consensus 44 ~G~iP~~~~~l~----l~l~~---sg~ip~~~~~~~~l~~ 76 (499)
.|.||.+++.+. |+|++ +|.+|+.++.+.++..
T Consensus 455 ~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~ 494 (623)
T PLN03150 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRI 494 (623)
T ss_pred cCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCE
Confidence 466666655554 55554 5666666655554444
|
|
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.029 Score=53.04 Aligned_cols=73 Identities=15% Similarity=0.150 Sum_probs=57.1
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 93 (499)
.-.+.+||+|++....+.+.|..... -++.-..++..++.+..+|+++.++++..++-....|.+.+|.|+.+
T Consensus 163 g~~~~v~I~Y~~~~~~L~V~l~~~~~--~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWsF~s~ 235 (236)
T cd06899 163 GKPMQAWIDYDSSSKRLSVTLAYSGV--AKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFSSN 235 (236)
T ss_pred CCeEEEEEEEcCCCCEEEEEEEeCCC--CCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEEEEcC
Confidence 45789999999998888888865543 24445566666666788999999999999966677899999999753
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.16 Score=49.27 Aligned_cols=31 Identities=26% Similarity=0.321 Sum_probs=25.9
Q ss_pred CccccCCCCCceEEcCCCc-EEEccccccccc
Q psy1789 352 KLLHKDLATRNCVVDDKLR-IQITDNALARDL 382 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~-~kl~DfGla~~~ 382 (499)
.++|+|+.+.||++++++. .-|.||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 469999988754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.18 Score=50.62 Aligned_cols=145 Identities=14% Similarity=0.136 Sum_probs=79.4
Q ss_pred eeeeeecceEEEEEEEeCCC-ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcce-eEEeEEEcCCCceEEEEEe
Q psy1789 228 SVNMEGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNIL-TVLGVSIEDHTSPFLIYPY 305 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~g~~~~~~~~~~lv~e~ 305 (499)
..+-.|-...+|+..+.+.. ...+.+++|+..... ....++ .+|..++..+...++. ++++. .. + ..|+||
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR-~~E~~~~~~l~~~gl~P~~~~~-~~-~---g~v~ef 114 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDR-DDEIRTFECMSRHGQGPRLLGR-FP-N---GRVEEF 114 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeech-HHHHHHHHHHHHcCCCCceEEE-EC-C---ceEEEe
Confidence 34444788899998764321 122578888875542 222222 5677777777544443 45554 33 2 258999
Q ss_pred CCCCCHHHH-----------------HHhcccCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHHH---
Q psy1789 306 QDYTNLKRF-----------------LQKCKLCPEGVAHTLTTQEVVDMCLQI-----------------IMGVQYL--- 348 (499)
Q Consensus 306 ~~~gsL~~~-----------------l~~~~~~~~~~~~~l~~~~~~~i~~~v-----------------a~~L~yL--- 348 (499)
+++.+|... +|.... ........|.+..++..++ ...+..|
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~--~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDM--PGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCC--CCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 887555321 122110 1111112233333332211 1112222
Q ss_pred -Hh----CCccccCCCCCceEEcC-CCcEEEcccccccc
Q psy1789 349 -HK----KKLLHKDLATRNCVVDD-KLRIQITDNALARD 381 (499)
Q Consensus 349 -H~----~~iiHrDlk~~NIlld~-~~~~kl~DfGla~~ 381 (499)
.. ..++|+|+++.|||+++ ++.+.+.||..|..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 25899999999999986 47899999998764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.21 Score=49.76 Aligned_cols=145 Identities=17% Similarity=0.164 Sum_probs=76.7
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcc-eeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI-LTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.+..|-...+|+....+.......+++|+...... ... .-.+|..+++.+...++ .+++++ .. + -+|.+|+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~I-dR~~E~~il~~l~~~gl~P~~l~~-~~-~---G~i~~fi 92 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVI-DRERELQAIKYLSAAGFGAKLLGV-FG-N---GMIQSFI 92 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEe-chHHHHHHHHHHHhcCCCCceeEE-eC-C---cEeehhh
Confidence 334337777899887654321123688887754322 111 12467777777765555 355655 22 2 2588998
Q ss_pred CCCCHHH--------------H---HHhcccCCCCCCCCCCHHHHHHHHHHH----------------------HHHHH-
Q psy1789 307 DYTNLKR--------------F---LQKCKLCPEGVAHTLTTQEVVDMCLQI----------------------IMGVQ- 346 (499)
Q Consensus 307 ~~gsL~~--------------~---l~~~~~~~~~~~~~l~~~~~~~i~~~v----------------------a~~L~- 346 (499)
++..|.. . +|.... ......-.|....++..++ ..-+.
T Consensus 93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~--~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEI--PGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred cCCCCChHHCCCHHHHHHHHHHHHHHhCCCC--CCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 7654421 1 122110 0011111233333332221 11111
Q ss_pred ---HHHhC----CccccCCCCCceEEcC-CCcEEEcccccccc
Q psy1789 347 ---YLHKK----KLLHKDLATRNCVVDD-KLRIQITDNALARD 381 (499)
Q Consensus 347 ---yLH~~----~iiHrDlk~~NIlld~-~~~~kl~DfGla~~ 381 (499)
++... -..|.|+.+.|||+++ ++.+++.||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 12111 2689999999999975 57899999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.85 Score=44.96 Aligned_cols=148 Identities=16% Similarity=0.124 Sum_probs=79.5
Q ss_pred ecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC--CCcceeEEeEEEcCC-CceEEEEEeCCCC
Q psy1789 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS--HKNILTVLGVSIEDH-TSPFLIYPYQDYT 309 (499)
Q Consensus 233 G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~-~~~~lv~e~~~~g 309 (499)
|....+|..... + +..++..-.............+|..+++.+. ---....+++|.+.. +.+|.||+|.++.
T Consensus 36 G~sn~t~~~~~~--~---~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 36 GWSNDTFRLGDT--G---QKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred CcccceEEEecC--C---ceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 433445554432 1 5566662211222333455567777777653 223345567775554 5679999998862
Q ss_pred ------------------CHHHHHHhcccCCC------CC------CCCCCHHHHHHH--------HHHHHHHHHHHHhC
Q psy1789 310 ------------------NLKRFLQKCKLCPE------GV------AHTLTTQEVVDM--------CLQIIMGVQYLHKK 351 (499)
Q Consensus 310 ------------------sL~~~l~~~~~~~~------~~------~~~l~~~~~~~i--------~~~va~~L~yLH~~ 351 (499)
+|.++|...-..+. +. .+.-.|...... .-....-..||++.
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 22223221111100 00 011112222211 01122334566643
Q ss_pred --------CccccCCCCCceEEcCCCcEEEcccccccccCCC
Q psy1789 352 --------KLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385 (499)
Q Consensus 352 --------~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~ 385 (499)
.++|+|+.+.|++++.+.-+-|.||+++....|.
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 5899999999999999888999999999876553
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.1 Score=51.58 Aligned_cols=105 Identities=13% Similarity=0.122 Sum_probs=67.7
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCcccccccccc
Q psy1789 328 TLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESL 406 (499)
Q Consensus 328 ~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 406 (499)
.-.|++.+.++.+.+.-+.-+... ..=|||+.-.||||| +|++-|.||-++|.-.+.... .... .--|-.+
T Consensus 317 ~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~i-sy~r------ldhp~lF 388 (488)
T COG5072 317 ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGII-SYNR------LDHPDLF 388 (488)
T ss_pred cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccCCcee-eccc------cCchhhh
Confidence 357889999999888877777655 789999999999999 999999999999954332211 1111 1123333
Q ss_pred ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy1789 407 VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444 (499)
Q Consensus 407 ~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~ 444 (499)
. +.-+.+-|||-+ |--|+.|+..-|......-+.
T Consensus 389 ~-G~dd~QFeIYrl---Mr~l~~g~wa~F~P~TNvlWL 422 (488)
T COG5072 389 N-GVDDYQFEIYRL---MRRLLKGRWAQFEPITNVLWL 422 (488)
T ss_pred c-CccceeeeHHHH---HHHHhcCcHHhcccchhhHHH
Confidence 3 333667777753 444444444445554444433
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.97 E-value=1.2 Score=45.44 Aligned_cols=80 Identities=14% Similarity=0.096 Sum_probs=49.0
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---c---HHHHHHHHHHHHHHhcCC---CCcceeEEeEEEcCCCc
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---S---AVQVSLLLQEGMAMYGLS---HKNILTVLGVSIEDHTS 298 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~---~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~ 298 (499)
+.||-|....||+....+ ..+.||.-.... + +....+-..|...|+.+. ..++.+++++|. +.
T Consensus 38 ~eiggGn~N~VyrV~~~~-----~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de---d~ 109 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSSS-----GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR---TM 109 (418)
T ss_pred EEcCCCceeeEEEEEcCC-----ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC---CC
Confidence 778889999999976522 357888765211 0 012233344555555442 357888999863 23
Q ss_pred eEEEEEeCCC--CCHHHHH
Q psy1789 299 PFLIYPYQDY--TNLKRFL 315 (499)
Q Consensus 299 ~~lv~e~~~~--gsL~~~l 315 (499)
.+++|||++. ..+.+-+
T Consensus 110 ~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 110 ALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred CEEEEeecCCcceehhhhh
Confidence 4889999976 3444444
|
|
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.069 Score=50.51 Aligned_cols=70 Identities=16% Similarity=0.135 Sum_probs=54.9
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEe
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFK 91 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~ 91 (499)
--.+++||+||+....+.+.+.... .-+....++..++.+..+|+++.++++..++-..+.+.+..|+|+
T Consensus 167 g~~~~v~I~Yd~~~~~L~V~l~~~~---~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~F~ 236 (236)
T PF00139_consen 167 GKWHTVWIDYDASTKRLSVYLDDNS---SKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSWSFS 236 (236)
T ss_dssp TSEEEEEEEEETTTTEEEEEEEETT---TTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEEEEE
T ss_pred CcEEEEEEEEcCCccEEEEEEeccc---CCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEEEeC
Confidence 4678999999999998888887763 234456677666667899999999999999766678889999884
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.51 E-value=1.1 Score=44.40 Aligned_cols=139 Identities=15% Similarity=0.147 Sum_probs=75.0
Q ss_pred cceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc------ceeEEeEE---EcCCCceEEEEE
Q psy1789 234 TFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN------ILTVLGVS---IEDHTSPFLIYP 304 (499)
Q Consensus 234 ~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~---~~~~~~~~lv~e 304 (499)
.-..+|+....++ ..++|+.....+.. +...|...+..|.-.+ +..+=|-. .....+.+-+++
T Consensus 37 ~eN~~f~~~~~~g-----~~iLki~~~~~~~~---~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 37 EENSNFRVQTEDG-----RYILKIYRPGWTRA---EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccCceEEEEecCC-----CeEEEEecCCCCHH---HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3456888876543 24888887653333 3334455554442222 22222210 111136688999
Q ss_pred eCCCCCHHH-----H----------HHhccc-C---CCCCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC-
Q psy1789 305 YQDYTNLKR-----F----------LQKCKL-C---PEGVAHTLTTQE-------------VVDMCLQIIMGVQYLHKK- 351 (499)
Q Consensus 305 ~~~~gsL~~-----~----------l~~~~~-~---~~~~~~~l~~~~-------------~~~i~~~va~~L~yLH~~- 351 (499)
|++|..+.. . ||.... . ..+......|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999877762 1 111110 0 111122334430 111233444455555532
Q ss_pred -------C--ccccCCCCCceEEcCCCc-EEEccccccc
Q psy1789 352 -------K--LLHKDLATRNCVVDDKLR-IQITDNALAR 380 (499)
Q Consensus 352 -------~--iiHrDlk~~NIlld~~~~-~kl~DfGla~ 380 (499)
+ +||+|+.|.||++|.+.. +.+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 999999999999998875 8899999765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.95 E-value=0.53 Score=45.85 Aligned_cols=74 Identities=15% Similarity=0.235 Sum_probs=41.9
Q ss_pred EeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC---CCcceeEEeEEEcCCCceEEE
Q psy1789 226 LFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS---HKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 226 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~~lv 302 (499)
-.+.++-|....+|+.. .++ +.+.||+-.... ...|..|.+-|+.|. --.+.+.+++.... ...+|+
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~---~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-~~~fLl 90 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDG---GSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-DDAFLL 90 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS----EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-SCCEEE
T ss_pred eeEecCCCChhheEEEE--CCC---ccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-CCceEE
Confidence 34777878899999876 222 678899876322 235667777766663 44577788875443 345999
Q ss_pred EEeCCCC
Q psy1789 303 YPYQDYT 309 (499)
Q Consensus 303 ~e~~~~g 309 (499)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=92.93 E-value=0.091 Score=51.20 Aligned_cols=133 Identities=15% Similarity=0.087 Sum_probs=82.7
Q ss_pred EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-------------------ccHHHHH--HHHHHHHHHhcCCCC
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-------------------ASAVQVS--LLLQEGMAMYGLSHK 283 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-------------------~~~~~~~--~~~~E~~~l~~l~H~ 283 (499)
.+++.||-|--+-||.+...++ ...++|.-+.. .+...+. ...+|.+-|+.|.-+
T Consensus 95 svGnqIGVGKESDIY~v~d~~G----~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~ 170 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEG----NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYER 170 (465)
T ss_pred hhccccccccccceEEEecCCC----CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHc
Confidence 3568999999999999987544 34455432110 1111111 234577777776422
Q ss_pred --cceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy1789 284 --NILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATR 361 (499)
Q Consensus 284 --nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~ 361 (499)
-+..-+++ ++-++|||++.+-.|.+.-+- .+.. .+...+..-+--|-.+|+||+|..-=
T Consensus 171 gfpVPkpiD~-----~RH~Vvmelv~g~Pl~~v~~v-----------~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEF 231 (465)
T KOG2268|consen 171 GFPVPKPIDH-----NRHCVVMELVDGYPLRQVRHV-----------EDPP---TLYDDLMGLIVRLANHGLIHGDFNEF 231 (465)
T ss_pred CCCCCCcccc-----cceeeHHHhhcccceeeeeec-----------CChH---HHHHHHHHHHHHHHHcCceecccchh
Confidence 23333333 234899999987777654322 2222 23333444445566789999999999
Q ss_pred ceEEcCCCcEEEccccccc
Q psy1789 362 NCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 362 NIlld~~~~~kl~DfGla~ 380 (499)
||+++++..+++.||--.-
T Consensus 232 Nimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 232 NIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eeEEecCCCEEEeechHhh
Confidence 9999999999999997543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.54 Score=47.71 Aligned_cols=82 Identities=15% Similarity=0.056 Sum_probs=49.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-----ccHHHHHHHHHHHHHHhcCC---CCcceeEEeEEEcCCCce
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-----ASAVQVSLLLQEGMAMYGLS---HKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~ 299 (499)
+.||.|.-.-||++....+. +.|+||.-... ..+...++-.-|.+.|+... =..+.+++.+ + +...
T Consensus 35 ~eigdGnlN~VfrV~~~~~~---~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D-~e~~ 108 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKN---ISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D-SVMN 108 (409)
T ss_pred eEcCCCceEEEEEEeeCCCC---ceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C-cHHh
Confidence 77899999999999874212 46888875321 11222345556666666542 2346778876 3 3334
Q ss_pred EEEEEeCCC-CCHHHHH
Q psy1789 300 FLIYPYQDY-TNLKRFL 315 (499)
Q Consensus 300 ~lv~e~~~~-gsL~~~l 315 (499)
.+|||+++. ..|++.|
T Consensus 109 ~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 109 CCVMEDLSDHTILRTAL 125 (409)
T ss_pred hHHHHhCcccHHHHHHH
Confidence 789999854 2344443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.52 E-value=0.89 Score=44.82 Aligned_cols=30 Identities=17% Similarity=0.084 Sum_probs=27.4
Q ss_pred CccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
+++|+|+.+.|||+++++.+.+.||-.+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999998899999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.11 E-value=1.3 Score=45.07 Aligned_cols=78 Identities=15% Similarity=0.144 Sum_probs=44.7
Q ss_pred eeeeeecceEEEEEEEeCCCc---eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCccee-EEeEEEcCCCceEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDG---VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT-VLGVSIEDHTSPFLIY 303 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~g~~~~~~~~~~lv~ 303 (499)
+.|..|-.+.+|++...+..+ ..+.|.++.... ...... .-.+|..+++.+...++.. ++|. +. -++++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~-f~----~g~l~ 128 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVI-DNDLQYNIAKLLGDNNFGPKIIGR-FG----DFTIQ 128 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEe-ccHHHHHHHHHHHhCCCCCeEEEe-cC----CEEEE
Confidence 445448888999997654321 112355554322 111111 1246888888887666654 4554 33 27999
Q ss_pred EeCCCCCHH
Q psy1789 304 PYQDYTNLK 312 (499)
Q Consensus 304 e~~~~gsL~ 312 (499)
||+++..|.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999976553
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.04 E-value=3.2 Score=47.98 Aligned_cols=30 Identities=30% Similarity=0.360 Sum_probs=25.3
Q ss_pred CCccccCCCCCceEEcCCC--cEE-Eccccccc
Q psy1789 351 KKLLHKDLATRNCVVDDKL--RIQ-ITDNALAR 380 (499)
Q Consensus 351 ~~iiHrDlk~~NIlld~~~--~~k-l~DfGla~ 380 (499)
.++||.|+.+.|||++.+. ++. |.|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3699999999999999875 454 99999775
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.21 E-value=0.2 Score=48.87 Aligned_cols=35 Identities=23% Similarity=0.219 Sum_probs=24.9
Q ss_pred HHHHHHHHHHHHHHHHHHhC----CccccCCCCCceEEc
Q psy1789 332 QEVVDMCLQIIMGVQYLHKK----KLLHKDLATRNCVVD 366 (499)
Q Consensus 332 ~~~~~i~~~va~~L~yLH~~----~iiHrDlk~~NIlld 366 (499)
+-...+..|+|.-.-.+-+. ..+|-||||+|||+-
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF 317 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF 317 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence 34566778887654344332 589999999999983
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=91.12 E-value=0.65 Score=46.87 Aligned_cols=59 Identities=15% Similarity=0.188 Sum_probs=44.1
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEEc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL-HKKKLLHKDLATRNCVVD 366 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yL-H~~~iiHrDlk~~NIlld 366 (499)
..|+-+|+.+-++..++... ..++....+++.--+.||.-+ --.+.+|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~---------~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK---------SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc---------cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 36777899999999999852 244556667766666666443 346899999999999995
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 499 | ||||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-48 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-48 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-48 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-48 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-48 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-48 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-48 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-48 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-48 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-47 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-47 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-47 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-47 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-47 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-47 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-47 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-46 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-46 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-46 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-39 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-39 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-39 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-39 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-38 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-38 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-38 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-38 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-37 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-37 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-37 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-37 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-36 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-36 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-36 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-36 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-36 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-36 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-36 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-36 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-36 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-36 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-35 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-35 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-35 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-35 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-35 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-35 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-35 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-35 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-35 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-35 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-35 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-35 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-35 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-35 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-35 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-35 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-35 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-35 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-35 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-35 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-35 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-35 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-35 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-35 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-35 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-34 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-34 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-34 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-34 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-34 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-34 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-34 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-34 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-34 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-34 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-34 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-34 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-34 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-34 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-34 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-34 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-34 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-34 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-34 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-34 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-34 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-34 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-33 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-33 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-33 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-32 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-32 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-32 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-32 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-32 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-32 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-31 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-31 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-31 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-31 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-31 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-31 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-31 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-31 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-31 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-31 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-31 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-30 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-30 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-30 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-30 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-30 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-30 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-30 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-30 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-30 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-30 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-30 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-30 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-30 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-30 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-30 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-30 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-30 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-30 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-30 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-30 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-30 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-30 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-30 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-30 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-30 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-30 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-29 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-29 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-29 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-29 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-29 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-29 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-29 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-29 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-29 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-29 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-29 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-29 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-29 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-29 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-29 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-29 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-29 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-29 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-29 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-29 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-29 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-29 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-29 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-29 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-29 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-29 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-29 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-29 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-29 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-29 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-29 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-29 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-29 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-29 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-29 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-29 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-29 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-29 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-29 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-29 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-29 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-28 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-28 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-28 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-28 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-28 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-28 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-28 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-28 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-28 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-28 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-28 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-28 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-27 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-27 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-27 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-27 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-27 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-27 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-27 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-27 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-27 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-27 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-27 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-27 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-27 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-27 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-27 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-27 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-27 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-27 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-27 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-27 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-27 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-27 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-27 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-27 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-27 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-27 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-27 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-27 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-27 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-27 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-27 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-27 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-27 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-27 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-27 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-27 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-27 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-27 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-27 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-27 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-26 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-26 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-26 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-26 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-26 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-26 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-26 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-26 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-26 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-26 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-26 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-26 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-26 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-26 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-26 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-26 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-26 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-26 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-25 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-25 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-25 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-25 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-25 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-25 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-25 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-25 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-25 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-25 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-25 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-25 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-25 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-25 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-25 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-24 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-24 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-24 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-24 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-24 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-24 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-24 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-24 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-24 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-24 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-24 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-24 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-24 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-24 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-24 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-24 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-22 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-22 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-21 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-21 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-21 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-21 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-21 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-21 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-21 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-21 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-21 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-04 |
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = e-102
Identities = 104/298 (34%), Positives = 160/298 (53%), Gaps = 7/298 (2%)
Query: 203 LDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTV-TDN 261
+ +++L KL ++ I R + L + EG FG V G +EDG +V VKT+ DN
Sbjct: 15 VPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN 74
Query: 262 ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH----TSPFLIYPYQDYTNLKRFLQK 317
+S ++ L E M SH N++ +LGV IE P +I P+ Y +L +L
Sbjct: 75 SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY 134
Query: 318 CKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377
+ E + Q ++ + I +G++YL + LH+DLA RNC++ D + + + D
Sbjct: 135 SR--LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192
Query: 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE 437
L++ ++ DY+ G PVKW+AIESL + +++ SDVWAFGV +WE+ T PY
Sbjct: 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252
Query: 438 IDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
+ EM L G+RL QP +C DEL+ +M CW +P RPTF L L++ L
Sbjct: 253 VQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = 1e-99
Identities = 93/296 (31%), Positives = 152/296 (51%), Gaps = 8/296 (2%)
Query: 207 NKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAV 265
+ +L EKL ++ I + L + +G FG V +EDG +V VK + + ++
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67
Query: 266 QVSLLLQEGMAMYGLSHKNILTVLGVSIED-----HTSPFLIYPYQDYTNLKRFLQKCKL 320
+ L+E M H ++ ++GVS+ P +I P+ + +L FL +
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR- 126
Query: 321 CPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
L Q +V + I G++YL + +H+DLA RNC++ + + + + D L+R
Sbjct: 127 -IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440
++ DY+ G PVKWLA+ESL ++ SDVWAFGV +WE+ T Q PYA I+
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245
Query: 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496
E+ L G RL QP C +E++ +M CW+ +P+ RP+F L L+ L+
Sbjct: 246 AEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 3e-96
Identities = 106/356 (29%), Positives = 174/356 (48%), Gaps = 11/356 (3%)
Query: 146 RNKKLRRHGEILQNGSNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFKRRPSYSRLDD 205
+ RR + + + L+ + + + + L
Sbjct: 11 HHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSA 70
Query: 206 RNKDLHEKLSELTI--QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS 263
N +L + + + I V V G FG VY GT + DG + VK++
Sbjct: 71 LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130
Query: 264 AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE 323
+VS L EG+ M SH N+L++LG+ + SP ++ PY + +L+ F++
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---- 186
Query: 324 GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383
H T ++++ LQ+ G+++L KK +H+DLA RNC++D+K +++ D LARD++
Sbjct: 187 ---HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 384 PSDYHCLGDNENR--PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
++ + + PVKW+A+ESL + F+T SDVW+FGVLLWEL T PY +++ F
Sbjct: 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497
++ L G RL QP CPD L+ VM CW E RP+F +L S + +
Sbjct: 304 DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 5e-96
Identities = 103/301 (34%), Positives = 165/301 (54%), Gaps = 11/301 (3%)
Query: 200 YSRLDDRNKDLHEKLSELTIQRCRVRLFSVNM--EGTFGRVYRGTYTEEDGVEEEVLVKT 257
+ L N +L + + + I + + + G FG VY GT + DG + VK+
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 258 VTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQK 317
+ +VS L EG+ M SH N+L++LG+ + SP ++ PY + +L+ F++
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 318 CKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377
H T ++++ LQ+ G++YL KK +H+DLA RNC++D+K +++ D
Sbjct: 121 ET-------HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFG 173
Query: 378 LARDLFPSDYHCLGDNENR--PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
LARD++ +Y+ + + PVKW+A+ESL + F+T SDVW+FGVLLWEL T PY
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 436 AEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
+++ F++ L G RL QP CPD L+ VM CW E RP+F +L S + +
Sbjct: 234 PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
Query: 496 T 496
Sbjct: 294 I 294
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 7e-96
Identities = 102/295 (34%), Positives = 166/295 (56%), Gaps = 11/295 (3%)
Query: 205 DRNKDLHEKLSELTIQRCRVRLFSVNM--EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA 262
D + L ++ ++ I RV S + +G FG VY G Y ++ + +K+++
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT 61
Query: 263 SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP 322
QV L+EG+ M GL+H N+L ++G+ + P ++ PY + +L +F++ +
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--- 118
Query: 323 EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382
T ++++ LQ+ G++YL ++K +H+DLA RNC++D+ +++ D LARD+
Sbjct: 119 ----RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174
Query: 383 FPSDYHCLGDNENR--PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440
+Y+ + + + PVKW A+ESL F+T SDVW+FGVLLWEL T PY IDP
Sbjct: 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234
Query: 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
F++ L G RL QP CPD L+ VM CW +P RPTF L +++ + L
Sbjct: 235 FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 3e-88
Identities = 92/285 (32%), Positives = 154/285 (54%), Gaps = 5/285 (1%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA 276
+ R ++ + +G+FG VY G +D E V +KTV + AS + L E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK--LCPEGVAHTLTTQEV 334
M + +++ +LGV + +I +LK +L+ + + V + ++
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 335 VDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394
+ M +I G+ YL+ K +H+DLA RNC+V + ++I D + RD++ +DY+ G
Sbjct: 141 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 200
Query: 395 NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454
PV+W++ ESL F+T SDVW+FGV+LWE+ TLA+QPY + ++ + +G L+
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 260
Query: 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
+P NCPD LF +M CW NP+ RP+F ++ S ++E R V
Sbjct: 261 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 9e-88
Identities = 82/307 (26%), Positives = 141/307 (45%), Gaps = 14/307 (4%)
Query: 198 PSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE--VLV 255
P LD+ + L S+ R R++L G FG+V D V V
Sbjct: 3 PDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV 62
Query: 256 KTVTDNASAVQVSLLLQEG--MAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKR 313
K + + A+ + L+ E + G H N++ +LG + +I + + NL
Sbjct: 63 KMLKEGATHSEHRALMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 314 FLQKCK--------LCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV 365
+L+ + + LT + ++ Q+ G+++L +K +H+DLA RN ++
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181
Query: 366 DDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLW 425
+K ++I D LARD++ + + P+KW+A E++ + ++ SDVW+FGVLLW
Sbjct: 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241
Query: 426 ELTTLAQQPYAEID-PFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
E+ +L PY + E L++G R+ P E++ M CW P RPTF +L
Sbjct: 242 EIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 301
Query: 485 HSCLQEF 491
L
Sbjct: 302 VEHLGNL 308
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 271 bits (695), Expect = 1e-87
Identities = 97/335 (28%), Positives = 158/335 (47%), Gaps = 22/335 (6%)
Query: 183 TSASSNTSYASFKRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGT 242
T+ S P Y R+ L+ KL L R + EG FGRV++
Sbjct: 11 TTLPSELLLDRLHPNPMYQRMPL---LLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQAR 67
Query: 243 YTEEDGVEEEVLV--KTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300
E +V K + + ASA + +E M + NI+ +LGV
Sbjct: 68 APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK-PMC 126
Query: 301 LIYPYQDYTNLKRFLQKCK----------------LCPEGVAHTLTTQEVVDMCLQIIMG 344
L++ Y Y +L FL+ L+ E + + Q+ G
Sbjct: 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 186
Query: 345 VQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIE 404
+ YL ++K +H+DLATRNC+V + + ++I D L+R+++ +DY+ N+ P++W+ E
Sbjct: 187 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464
S+ + ++T SDVWA+GV+LWE+ + QPY + E+ ++DG L P NCP EL+
Sbjct: 247 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELY 306
Query: 465 SVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
++M CW+ P RP+F +H LQ + V
Sbjct: 307 NLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTV 341
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 269 bits (691), Expect = 4e-87
Identities = 78/282 (27%), Positives = 144/282 (51%), Gaps = 10/282 (3%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEE-EVLVKTVTDNASAVQVSLLLQEGMAM 277
++ + V G FG VY+G + E + V +K + + S +L E M
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 278 YGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
+ + ++ +LG+ + + LI + L ++++ K + +Q +++
Sbjct: 72 ASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHK-------DNIGSQYLLNW 122
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
C+QI G+ YL ++L+H+DLA RN +V ++ITD LA+ L + + P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
+KW+A+ES++H+ ++ SDVW++GV +WEL T +PY I E+++ L+ G RL QP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
C +++ +M CW ++ + RP F +L + RY+
Sbjct: 243 ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 1e-85
Identities = 86/346 (24%), Positives = 150/346 (43%), Gaps = 15/346 (4%)
Query: 151 RRHGEILQNGSNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFKRRPSYSRLDDRNKDL 210
H + N G L +P + ++T + ++ DL
Sbjct: 8 HHHDYDIPTTENLYFQGAMGSELQSPEYK--LSKLRTSTIMTDYNPNYCFAGKTSSISDL 65
Query: 211 HEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLV--KTVTDNASAVQVS 268
E + R + L G FG VY G + + V KT+ + S
Sbjct: 66 KE------VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL 119
Query: 269 LLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHT 328
L E + + +H+NI+ +GVS++ F++ +LK FL++ + +
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSL-PRFILLELMAGGDLKSFLRETRP-RPSQPSS 177
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD---DKLRIQITDNALARDLFPS 385
L +++ + I G QYL + +H+D+A RNC++ +I D +ARD++ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445
Y+ G PVKW+ E+ + F++ +D W+FGVLLWE+ +L PY E+
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
Query: 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+ G R++ P NCP ++ +M CW PE RP F + ++
Sbjct: 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 2e-85
Identities = 92/291 (31%), Positives = 147/291 (50%), Gaps = 19/291 (6%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLV--KTVTDNASAVQVSLLLQEGMA 276
R + L EG FG+V + T G V K + +NAS ++ LL E
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK----------------L 320
+ ++H +++ + G +D LI Y Y +L+ FL++ +
Sbjct: 80 LKQVNHPHVIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 321 CPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
LT +++ QI G+QYL + KL+H+DLA RN +V + +++I+D L+R
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440
D++ D + PVKW+AIESL ++T SDVW+FGVLLWE+ TL PY I P
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+ L+ G+R+ +P NC +E++ +M CW P+ RP F + L++
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 6e-85
Identities = 99/320 (30%), Positives = 159/320 (49%), Gaps = 19/320 (5%)
Query: 185 ASSNTSYASFKRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYT 244
+S + + S P + + + K E R ++ L EG FG+V
Sbjct: 3 SSHHHHHHSQD--PMLAGVSEYELPEDPKW-E--FPRDKLTLGKPLGEGAFGQVVMAEAV 57
Query: 245 EEDGVEEE----VLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299
D + + V VK + D+A+ +S L+ E M + HKNI+ +LG +D
Sbjct: 58 GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG-PL 116
Query: 300 FLIYPYQDYTNLKRFLQKCK--------LCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
++I Y NL+ +L+ + +T +++V Q+ G++YL +
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 176
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
K +H+DLA RN +V + ++I D LARD+ DY+ N PVKW+A E+L + +
Sbjct: 177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
+ SDVW+FGVL+WE+ TL PY I E+ L++G+R+++P NC +EL+ +M CW
Sbjct: 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCW 296
Query: 472 AMNPEGRPTFPQLHSCLQEF 491
P RPTF QL L
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 1e-84
Identities = 88/284 (30%), Positives = 141/284 (49%), Gaps = 11/284 (3%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLV--KTVTDNASAVQVSLLLQEGMA 276
I VR E FG+VY+G E+ V KT+ D A E M
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK--------LCPEGVAHT 328
L H N++ +LGV +D +I+ Y + +L FL V
Sbjct: 66 RARLQHPNVVCLLGVVTKDQ-PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388
L + V + QI G++YL ++HKDLATRN +V DKL ++I+D L R+++ +DY+
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY 184
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ 448
L N P++W+A E++++ FS SD+W++GV+LWE+ + QPY ++ ++
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244
Query: 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
+ L P +CP ++++M CW P RP F +HS L+ +
Sbjct: 245 NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 2e-84
Identities = 85/328 (25%), Positives = 161/328 (49%), Gaps = 16/328 (4%)
Query: 184 SASSNTSYASFKRRPSYSR---LDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYR 240
+ S +S + + + S + +++ + I+R + L EG FG+V+
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHH--IKRRDIVLKWELGEGAFGKVFL 59
Query: 241 GTYTEEDGVEEEVLV--KTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298
++++LV K + + AS +E + L H++I+ GV E
Sbjct: 60 AECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-P 117
Query: 299 PFLIYPYQDYTNLKRFLQKC-------KLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+++ Y + +L RFL+ + L +++ + Q+ G+ YL
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+H+DLATRNC+V L ++I D ++RD++ +DY+ +G P++W+ ES++++ F
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
+T SDVW+FGV+LWE+ T +QP+ ++ E + G L +P CP E++++M CW
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCW 297
Query: 472 AMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
P+ R + +H+ LQ Y+
Sbjct: 298 QREPQQRHSIKDVHARLQALAQAPPVYL 325
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 3e-84
Identities = 78/282 (27%), Positives = 139/282 (49%), Gaps = 10/282 (3%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277
+ +R V G FG V++G + E + ++ V +K + D + + +A+
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI 69
Query: 278 YGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
L H +I+ +LG+ S L+ Y +L +++ + L Q +++
Sbjct: 70 GSLDHAHIVRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHR-------GALGPQLLLNW 120
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
+QI G+ YL + ++H++LA RN ++ ++Q+ D +A L P D L P
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
+KW+A+ES+ ++ SDVW++GV +WEL T +PYA + E+ L+ G RL QP
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
C +++ VM CW ++ RPTF +L + RY+
Sbjct: 241 ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYL 282
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 3e-84
Identities = 88/291 (30%), Positives = 142/291 (48%), Gaps = 16/291 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEG--MA 276
+ ++ V EG FG+V + + DG+ + +K + + AS E +
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK--------LCPEGVAHT 328
G H NI+ +LG +L Y + NL FL+K + A T
Sbjct: 81 KLG-HHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388
L++Q+++ + G+ YL +K+ +H+DLA RN +V + +I D L+R + +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVY 195
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ 448
PV+W+AIESL + ++T SDVW++GVLLWE+ +L PY + E+ L
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255
Query: 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
GYRL +P+NC DE++ +M CW P RP+F Q+ L + YV
Sbjct: 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 306
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 4e-84
Identities = 78/282 (27%), Positives = 144/282 (51%), Gaps = 10/282 (3%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEE-EVLVKTVTDNASAVQVSLLLQEGMAM 277
++ + V G FG VY+G + E + V +K + + S +L E M
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 278 YGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
+ + ++ +LG+ + + LI + L ++++ K + +Q +++
Sbjct: 72 ASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHK-------DNIGSQYLLNW 122
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
C+QI G+ YL ++L+H+DLA RN +V ++ITD LA+ L + + P
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
+KW+A+ES++H+ ++ SDVW++GV +WEL T +PY I E+++ L+ G RL QP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
C +++ +M CW ++ + RP F +L + RY+
Sbjct: 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 2e-83
Identities = 102/359 (28%), Positives = 165/359 (45%), Gaps = 31/359 (8%)
Query: 146 RNKKLRRHGEILQNGSNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFKRRPSYSRLDD 205
+ LRR Q ++ ++ P + +S + A D
Sbjct: 22 KRIPLRR-----QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS--EYELPEDP 74
Query: 206 RNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE----VLVKTVTDN 261
+ R ++ L EG FG+V D + + V VK + D+
Sbjct: 75 ----------KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD 124
Query: 262 ASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK- 319
A+ +S L+ E M + HKNI+ +LG +D ++I Y NL+ +L+ +
Sbjct: 125 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP 183
Query: 320 -------LCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372
+T +++V Q+ G++YL +K +H+DLA RN +V + ++
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243
Query: 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQ 432
I D LARD+ DY+ N PVKW+A E+L + ++ SDVW+FGVL+WE+ TL
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 433 QPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
PY I E+ L++G+R+++P NC +EL+ +M CW P RPTF QL L
Sbjct: 304 SPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-83
Identities = 77/278 (27%), Positives = 133/278 (47%), Gaps = 7/278 (2%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLV--KTVTDNASAVQVSLLLQEGMA 276
+ R + L G FG VY G + + V KT+ + S L E +
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
+ +H+NI+ +GVS++ F++ +LK FL++ + +L +++
Sbjct: 87 ISKFNHQNIVRCIGVSLQSL-PRFILMELMAGGDLKSFLRETRP-RPSQPSSLAMLDLLH 144
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVD---DKLRIQITDNALARDLFPSDYHCLGDN 393
+ I G QYL + +H+D+A RNC++ +I D +ARD++ + Y+ G
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
PVKW+ E+ + F++ +D W+FGVLLWE+ +L PY E+ + G R+
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+ P NCP ++ +M CW PE RP F + ++
Sbjct: 265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 2e-83
Identities = 78/295 (26%), Positives = 138/295 (46%), Gaps = 15/295 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE--VLVKTVTDNASAVQVSLLLQEGMA 276
R R+ G FG+V T + V VK + +A + L+ E
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 277 MYGL-SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK----------LCPEGV 325
+ L +H NI+ +LG +I Y Y +L FL++ + E
Sbjct: 80 LSYLGNHMNIVNLLGACTIGG-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 326 AHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385
L ++++ Q+ G+ +L K +H+DLA RN ++ +I D LARD+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMA 444
+ + N PVKW+A ES+ + ++ SDVW++G+ LWEL +L PY + +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 445 ASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
+++G+R+ P + P E++ +M CW +P RPTF Q+ +++ ++ T ++
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI 313
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 5e-83
Identities = 96/286 (33%), Positives = 148/286 (51%), Gaps = 14/286 (4%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE----VLVKTVTDNASAVQVSLLLQEG 274
+ R R+ L EG FG+V D + V VK + +A+ +S L+ E
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 275 MAMYGL-SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK--------LCPEGV 325
M + HKNI+ +LG +D ++I Y NL+ +LQ +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 326 AHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385
L+++++V Q+ G++YL KK +H+DLA RN +V + ++I D LARD+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445
DY+ N PVKW+A E+L + ++ SDVW+FGVLLWE+ TL PY + E+
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304
Query: 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
L++G+R+++P NC +EL+ +M CW P RPTF QL L
Sbjct: 305 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 1e-82
Identities = 80/292 (27%), Positives = 145/292 (49%), Gaps = 12/292 (4%)
Query: 210 LHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQV 267
+H + I+R + L EG FG+V+ + V VK + D +
Sbjct: 3 MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAAR 61
Query: 268 SLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKC--------K 319
+E + L H++I+ GV + +++ Y + +L +FL+
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 320 LCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379
P L +++ + QI G+ YL + +H+DLATRNC+V L ++I D ++
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID 439
RD++ +DY+ +G + P++W+ ES++++ F+T SDVW+FGV+LWE+ T +QP+ ++
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
Query: 440 PFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
E+ + G L +P CP E++ VM CW P+ R +++ L
Sbjct: 241 NTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 9e-81
Identities = 83/274 (30%), Positives = 137/274 (50%), Gaps = 10/274 (3%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R V L + EG FG VY G YT G + V VKT + + + E + M
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H +I+ ++G+ E+ ++I Y L +L++ K ++L +V
Sbjct: 69 NLDHPHIVKLIGIIEEE--PTWIIMELYPYGELGHYLERNK-------NSLKVLTLVLYS 119
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
LQI + YL +H+D+A RN +V +++ D L+R + DY P+
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPI 178
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW++ ES+ + F+TASDVW F V +WE+ + +QP+ ++ ++ L+ G RL +P
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDL 238
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
CP L+++M CW +P RP F +L L + +
Sbjct: 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 2e-80
Identities = 87/300 (29%), Positives = 140/300 (46%), Gaps = 22/300 (7%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE--VLVKTVTDNASAVQVSLLLQEG-- 274
R + V G FG+V T V VK + + A + + L+ E
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 275 MAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK--------------- 319
M G SH+NI+ +LG +LI+ Y Y +L +L+ +
Sbjct: 102 MTQLG-SHENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 320 LCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379
L E + LT ++++ Q+ G+++L K +H+DLA RN +V ++I D LA
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID 439
RD+ + + N PVKW+A ESL ++ SDVW++G+LLWE+ +L PY I
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 440 P-FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498
+Q+G++++QP +E++ +M CWA + RP+FP L S L A
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 4e-80
Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 26/293 (8%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277
+ ++ EG FG+V Y DG E V VK + +A S QE +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87
Query: 278 YGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H++I+ G + + L+ Y +L+ +L + H++ +++
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---------HSIGLAQLLL 138
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP-SDYHCLGDNEN 395
QI G+ YLH + +H+DLA RN ++D+ ++I D LA+ + +Y+ + ++ +
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQ--------------PYAEIDPF 441
PV W A E L F ASDVW+FGV L+EL T ++
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494
+ L+ G RL +P CP E++ +M CW RPTF L L+ H +
Sbjct: 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 5e-80
Identities = 86/291 (29%), Positives = 139/291 (47%), Gaps = 13/291 (4%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE--VLVKTVTDNASAVQVSLLLQEG-- 274
R ++ G FG+V T + V VK + A A + L+ E
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 275 MAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK------LCPEGVAHT 328
M+ G H+NI+ +LG +I Y Y +L FL++ T
Sbjct: 103 MSHLG-QHENIVNLLGACTHGG-PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388
+T++++ Q+ G+ +L K +H+D+A RN ++ + +I D LARD+ +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASL 447
+ N PVKW+A ES+ ++ SDVW++G+LLWE+ +L PY I + +
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280
Query: 448 QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498
+DGY++ QP P ++S+M CWA+ P RPTF Q+ S LQE + R
Sbjct: 281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRE 331
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-79
Identities = 84/274 (30%), Positives = 136/274 (49%), Gaps = 10/274 (3%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
IQR R+ L EG FG V++G Y + V +KT + S LQE + M
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
H +I+ ++GV E+ ++I L+ FLQ K ++L ++
Sbjct: 72 QFDHPHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRK-------YSLDLASLILYA 122
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
Q+ + YL K+ +H+D+A RN +V +++ D L+R + S Y P+
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPI 181
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW+A ES+ + F++ASDVW FGV +WE+ +P+ + ++ +++G RL P N
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 241
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
CP L+S+M CWA +P RP F +L + L
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 1e-78
Identities = 81/290 (27%), Positives = 139/290 (47%), Gaps = 24/290 (8%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTY-TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277
++ ++ EG FG+V Y E D E+V VK++ + ++ L +E +
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77
Query: 278 YGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H+NI+ G+ ED + LI + +LK +L K K + + ++ +
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-------NKINLKQQLK 130
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP-SDYHCLGDNEN 395
+QI G+ YL ++ +H+DLA RN +V+ + +++I D L + + +Y+ + D+ +
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQ--------------PYAEIDPF 441
PV W A E L+ F ASDVW+FGV L EL T + ++
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+ +L++G RL P NCPDE++ +M CW P R +F L +
Sbjct: 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-77
Identities = 80/264 (30%), Positives = 123/264 (46%), Gaps = 13/264 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ G V VK+ + + LQE + SH NI+ ++GV
Sbjct: 124 RGNFGEVFSGRLR---ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 292 SIEDHTSPFLIYP-YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+ P I + FL+ L + ++ M G++YL
Sbjct: 181 CTQKQ--PIYIVMELVQGGDFLTFLRTEG-------ARLRVKTLLQMVGDAAAGMEYLES 231
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
K +H+DLA RNC+V +K ++I+D ++R+ Y G PVKW A E+L +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
+S+ SDVW+FG+LLWE +L PY + + ++ G RL P CPD +F +M C
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQC 351
Query: 471 WAMNPEGRPTFPQLHSCLQEFHAQ 494
WA P RP+F ++ LQ +
Sbjct: 352 WAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 6e-77
Identities = 81/291 (27%), Positives = 125/291 (42%), Gaps = 25/291 (8%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277
+ ++ S +G FG V Y D V VK + + Q +E +
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ-REIQIL 78
Query: 278 YGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L I+ GVS L+ Y L+ FLQ+ + L ++
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-------ARLDASRLLL 131
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP-SDYHCLGDNEN 395
QI G++YL ++ +H+DLA RN +V+ + ++I D LA+ L DY+ + +
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF-------------- 441
P+ W A ESL FS SDVW+FGV+L+EL T + + F
Sbjct: 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
+ L++G RL P CP E+ +M CWA +P+ RP+F L L
Sbjct: 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 7e-77
Identities = 88/281 (31%), Positives = 142/281 (50%), Gaps = 15/281 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
++R + + G +G VY G + V VKT+ ++ V+ L+E M
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWK---KYSLTVAVKTLKEDTMEVEE--FLKEAAVMK 64
Query: 279 GLSHKNILTVLGVSIEDHTSPFLI-YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
+ H N++ +LGV + PF I + Y NL +L++C ++ ++ M
Sbjct: 65 EIKHPNLVQLLGVCTRE--PPFYIITEFMTYGNLLDYLRECN------RQEVSAVVLLYM 116
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
QI ++YL KK +H+DLA RNC+V + +++ D L+R L D + P
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 175
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
+KW A ESL + FS SDVWAFGVLLWE+ T PY ID ++ L+ YR+ +P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 235
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498
CP++++ +M CW NP RP+F ++H + + +
Sbjct: 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 276
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 6e-76
Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 11/275 (4%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I+ R+ + + G G V G + V +K + + Q L E M
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMG 105
Query: 279 GLSHKNILTVLGVSIEDHTSPFLI-YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
H NI+ + GV +I Y + +L FL+ T ++V M
Sbjct: 106 QFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHD-------GQFTIMQLVGM 156
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR- 396
+ G++YL +H+DLA RN +VD L +++D L+R L +
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456
P++W A E++ +TFS+ASDVW+FGV++WE+ ++PY + ++ +S+++GYRL P
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAP 276
Query: 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+ CP L +M CW + RP F Q+ S L
Sbjct: 277 MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 6e-76
Identities = 84/295 (28%), Positives = 136/295 (46%), Gaps = 26/295 (8%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277
+ ++ +G FG V Y +D E V VK + + + +E +
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-HLRDFEREIEIL 96
Query: 278 YGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H NI+ GV LI Y Y +L+ +LQK K + +++
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------ERIDHIKLLQ 149
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS-DYHCLGDNEN 395
QI G++YL K+ +H+DLATRN +V+++ R++I D L + L +Y+ + +
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT---------------LAQQPYAEIDP 440
P+ W A ESL FS ASDVW+FGV+L+EL T + ++
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
F + L++ RL +P CPDE++ +M CW N RP+F L + + Q+
Sbjct: 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 6e-76
Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 26/292 (8%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYT-EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277
+ ++ +G FG V Y +D E V VK + + + +E +
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-HLRDFEREIEIL 65
Query: 278 YGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H NI+ GV LI Y Y +L+ +LQK K + +++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-------ERIDHIKLLQ 118
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS-DYHCLGDNEN 395
QI G++YL K+ +H+DLATRN +V+++ R++I D L + L ++ + +
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT---------------LAQQPYAEIDP 440
P+ W A ESL FS ASDVW+FGV+L+EL T + ++
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
F + L++ RL +P CPDE++ +M CW N RP+F L + +
Sbjct: 239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 4e-75
Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 10/276 (3%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
IQR R+ L EG FG V++G Y + V +KT + S LQE + M
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
H +I+ ++GV E+ ++I L+ FLQ K +L ++
Sbjct: 447 QFDHPHIVKLIGVITEN--PVWIIMELCTLGELRSFLQVRK-------FSLDLASLILYA 497
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
Q+ + YL K+ +H+D+A RN +V +++ D L+R + S Y P+
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPI 556
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW+A ES+ + F++ASDVW FGV +WE+ +P+ + ++ +++G RL P N
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 616
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494
CP L+S+M CWA +P RP F +L + L +
Sbjct: 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 5e-75
Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 19/273 (6%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
+ ++L +G FG V G Y V VK + ++A+A L E M
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNK-----VAVKCIKNDATAQA---FLAEASVMT 69
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H N++ +LGV +E+ +++ Y +L +L+ L ++
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFS 123
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
L + ++YL +H+DLA RN +V + +++D L ++ + PV
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPV 178
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E+L K FST SDVW+FG+LLWE+ + + PY I ++ ++ GY+++ P
Sbjct: 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 238
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP ++ VM CW ++ RP+F QL L+
Sbjct: 239 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 2e-74
Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 11/269 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V +G Y + +V +K + +++E M+ L + I+ ++GV
Sbjct: 20 CGNFGSVRQGVYRMRKK-QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ + L+ L +FL + + V ++ Q+ MG++YL +K
Sbjct: 79 CQAE--ALMLVMEMAGGGPLHKFLVGKR-------EEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD-YHCLGDNENRPVKWLAIESLVHKT 410
+H+DLA RN ++ ++ +I+D L++ L D Y+ P+KW A E + +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
FS+ SDVW++GV +WE + Q+PY ++ E+ A ++ G R+ P CP EL+++M+ C
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 249
Query: 471 WAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
W E RP F + ++ + L V
Sbjct: 250 WIYKWEDRPDFLTVEQRMRACYYSLASKV 278
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 2e-74
Identities = 84/283 (29%), Positives = 140/283 (49%), Gaps = 13/283 (4%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL--LLQEGMA 276
I +RL +G+FG V RG + G V VK + + + ++ ++E A
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
M+ L H+N++ + GV + ++ +L L+K + +
Sbjct: 75 MHSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQ-------GHFLLGTLSR 125
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP-SDYHCLGDNEN 395
+Q+ G+ YL K+ +H+DLA RN ++ + ++I D L R L D++ + ++
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL-QDGYRLN 454
P W A ESL +TFS ASD W FGV LWE+ T Q+P+ ++ ++ + ++G RL
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497
+P +CP ++++VM CWA PE RPTF L L E R
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-74
Identities = 74/275 (26%), Positives = 131/275 (47%), Gaps = 17/275 (6%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I + G FG V+ G + +D +V +KT+ + A + + ++E M
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKD----KVAIKTIREGAMSEED--FIEEAEVMM 58
Query: 279 GLSHKNILTVLGVSIEDHTSPFLI-YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
LSH ++ + GV +E P + + ++ L +L+ + + ++ M
Sbjct: 59 KLSHPKLVQLYGVCLEQA--PICLVTEFMEHGCLSDYLRTQR-------GLFAAETLLGM 109
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
CL + G+ YL + ++H+DLA RNC+V + I+++D + R + D + P
Sbjct: 110 CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFP 168
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
VKW + E +S+ SDVW+FGVL+WE+ + + PY E+ + G+RL +P
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 228
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
++ +M +CW PE RP F +L L E
Sbjct: 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-73
Identities = 76/266 (28%), Positives = 137/266 (51%), Gaps = 13/266 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL-LLQEGMAMYGLSHKNILTVLG 290
G FG V +G Y + + V VK + + A+ + LL E M L + I+ ++G
Sbjct: 27 SGNFGTVKKGYYQMKKV-VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+ + S L+ + L ++LQ+ + + + ++++ Q+ MG++YL +
Sbjct: 86 ICEAE--SWMLVMEMAELGPLNKYLQQNR--------HVKDKNIIELVHQVSMGMKYLEE 135
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFP-SDYHCLGDNENRPVKWLAIESLVHK 409
+H+DLA RN ++ + +I+D L++ L +Y+ + PVKW A E + +
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
FS+ SDVW+FGVL+WE + Q+PY + E+ A L+ G R+ P CP E++ +M
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 255
Query: 470 CWAMNPEGRPTFPQLHSCLQEFHAQL 495
CW + E RP F + L+ ++ +
Sbjct: 256 CWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 3e-73
Identities = 77/274 (28%), Positives = 136/274 (49%), Gaps = 17/274 (6%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I + G FG V G + + +V +K + + + + ++E M
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQY----DVAIKMIKEGSMSEDE--FIEEAKVMM 74
Query: 279 GLSHKNILTVLGVSIEDHTSPFLI-YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
LSH+ ++ + GV + P I Y L +L++ + H TQ++++M
Sbjct: 75 NLSHEKLVQLYGVCTKQR--PIFIITEYMANGCLLNYLREMR-------HRFQTQQLLEM 125
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
C + ++YL K+ LH+DLA RNC+V+D+ ++++D L+R + +Y P
Sbjct: 126 CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFP 184
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
V+W E L++ FS+ SD+WAFGVL+WE+ +L + PY E A + G RL +P
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
++++++M CW + RPTF L S + +
Sbjct: 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-73
Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 17/277 (6%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
++R + L G FG V G + + +V VK + + + + QE M
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQ----YDVAVKMIKEGSMSEDE--FFQEAQTMM 58
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYP-YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
LSH ++ GV +++ P I Y L +L+ L ++++M
Sbjct: 59 KLSHPKLVKFYGVCSKEY--PIYIVTEYISNGCLLNYLRSHG-------KGLEPSQLLEM 109
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
C + G+ +L + +H+DLA RNC+VD L ++++D + R + Y P
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-GTKFP 168
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
VKW A E + +S+ SDVWAFG+L+WE+ +L + PY E+ + G+RL +P
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH 228
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494
D ++ +M CW PE RPTF QL S ++ +
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 5e-73
Identities = 85/274 (31%), Positives = 141/274 (51%), Gaps = 15/274 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
+ R ++L G FG V+ G Y +V VK++ + + L E M
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHT----KVAVKSLKQGSMSPDA--FLAEANLMK 63
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H+ ++ + V ++ ++I Y + +L FL+ LT +++DM
Sbjct: 64 QLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPS------GIKLTINKLLDMA 115
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
QI G+ ++ ++ +H+DL N +V D L +I D LAR + ++Y + P+
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPI 174
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E++ + TF+ SDVW+FG+LL E+ T + PY + E+ +L+ GYR+ +P N
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
CP+EL+ +M CW PE RPTF L S L++F
Sbjct: 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-72
Identities = 78/273 (28%), Positives = 130/273 (47%), Gaps = 19/273 (6%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
+ ++L +G FG V G Y V VK + ++A+A L E M
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNK-----VAVKCIKNDATAQA---FLAEASVMT 241
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H N++ +LGV +E+ +++ Y +L +L+ L ++
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFS 295
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
L + ++YL +H+DLA RN +V + +++D L ++ + PV
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPV 350
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E+L K FST SDVW+FG+LLWE+ + + PY I ++ ++ GY+++ P
Sbjct: 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDG 410
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP ++ VM CW ++ RPTF QL L+
Sbjct: 411 CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 4e-72
Identities = 83/277 (29%), Positives = 137/277 (49%), Gaps = 14/277 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEE-EVLVKTVTDNASAVQVSLLLQEGMAM 277
I V V G FG VY+G G +E V +KT+ + Q L E M
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100
Query: 278 YGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
SH NI+ + GV + +I Y + L +FL++ + ++V M
Sbjct: 101 GQFSHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKD-------GEFSVLQLVGM 152
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL---FPSDYHCLGDNE 394
I G++YL +H+DLA RN +V+ L +++D L+R L + Y G
Sbjct: 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG--G 210
Query: 395 NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454
P++W A E++ ++ F++ASDVW+FG+++WE+ T ++PY E+ E+ ++ DG+RL
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270
Query: 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
P++CP ++ +M CW RP F + S L +
Sbjct: 271 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 8e-72
Identities = 81/291 (27%), Positives = 140/291 (48%), Gaps = 13/291 (4%)
Query: 204 DDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS 263
+D + +HE E + + + V G FG V G E V +KT+ +
Sbjct: 29 EDPTQTVHEFAKE--LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 264 AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI-YPYQDYTNLKRFLQKCKLCP 322
Q L E M H NI+ + GV + P +I Y + +L FL+K
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSFLRKHD--- 141
Query: 323 EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382
T ++V M I G++YL +H+DLA RN +++ L +++D L R L
Sbjct: 142 ----AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197
Query: 383 -FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
+ P++W + E++ ++ F++ASDVW++G++LWE+ + ++PY E+
Sbjct: 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ 257
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
++ ++ +GYRL P++CP L+ +M CW + RP F Q+ S L +
Sbjct: 258 DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 4e-71
Identities = 75/289 (25%), Positives = 142/289 (49%), Gaps = 12/289 (4%)
Query: 213 KLSELTIQRCRVRLFSVNM-EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLL 271
K +L ++R + + + + G FG V +G Y + +V +K + ++
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-QIDVAIKVLKQGTEKADTEEMM 384
Query: 272 QEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTT 331
+E M+ L + I+ ++GV + + L+ L +FL + +
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGKR-------EEIPV 435
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD-YHCL 390
V ++ Q+ MG++YL +K +H++LA RN ++ ++ +I+D L++ L D Y+
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495
Query: 391 GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450
P+KW A E + + FS+ SDVW++GV +WE + Q+PY ++ E+ A ++ G
Sbjct: 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555
Query: 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
R+ P CP EL+++M+ CW E RP F + ++ + L V
Sbjct: 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 1e-70
Identities = 86/274 (31%), Positives = 140/274 (51%), Gaps = 15/274 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
++R + + G +G VY G + V VKT+ ++ V+ L+E M
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEE--FLKEAAVMK 271
Query: 279 GLSHKNILTVLGVSIEDHTSPFLI-YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
+ H N++ +LGV + PF I + Y NL +L++C ++ ++ M
Sbjct: 272 EIKHPNLVQLLGVCTREP--PFYIITEFMTYGNLLDYLRECN------RQEVSAVVLLYM 323
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
QI ++YL KK +H++LA RNC+V + +++ D L+R + D + P
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 382
Query: 398 VKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
+KW A ESL + FS SDVWAFGVLLWE+ T PY ID ++ L+ YR+ +P
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 442
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP++++ +M CW NP RP+F ++H +
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 5e-70
Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R +RL +G FG V+ GT+ V +KT+ + + LQE M
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMSPEA--FLQEAQVMK 234
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H+ ++ + V E+ +++ Y +L FL+ L ++VDM
Sbjct: 235 KLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGET------GKYLRLPQLVDMA 286
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
QI G+ Y+ + +H+DL N +V + L ++ D LAR + ++Y P+
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPI 345
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E+ ++ F+ SDVW+FG+LL ELTT + PY + E+ ++ GYR+ P
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 405
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP+ L +M CW PE RPTF L + L+++
Sbjct: 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-69
Identities = 81/274 (29%), Positives = 139/274 (50%), Gaps = 15/274 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R ++L G FG V+ TY + +V VKT+ + +V+ L E M
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGSMSVEA--FLAEANVMK 238
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H ++ + V ++ ++I + +L FL+ + +++D
Sbjct: 239 TLQHDKLVKLHAVVTKEPI--YIITEFMAKGSLLDFLKSDE------GSKQPLPKLIDFS 290
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
QI G+ ++ ++ +H+DL N +V L +I D LAR + ++Y + P+
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPI 349
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E++ +F+ SDVW+FG+LL E+ T + PY + E+ +L+ GYR+ +P N
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 409
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492
CP+EL+++M CW PE RPTF + S L +F+
Sbjct: 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 8e-69
Identities = 83/273 (30%), Positives = 134/273 (49%), Gaps = 15/273 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R +RL +G FG V+ GT+ V +KT+ + + LQE M
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMSPEA--FLQEAQVMK 317
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H+ ++ + V E+ +++ Y +L FL+ L ++VDM
Sbjct: 318 KLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGET------GKYLRLPQLVDMA 369
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
QI G+ Y+ + +H+DL N +V + L ++ D LAR + ++Y P+
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPI 428
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E+ ++ F+ SDVW+FG+LL ELTT + PY + E+ ++ GYR+ P
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 488
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP+ L +M CW PE RPTF L + L+++
Sbjct: 489 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-68
Identities = 55/287 (19%), Positives = 119/287 (41%), Gaps = 32/287 (11%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEE----EVLVKTVTDNASAVQVSLLLQEG 274
I+ + +GTF ++++G E + EVL+K + S +
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF-EAA 63
Query: 275 MAMYGLSHKNILTVLGVSIEDHTSP-FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQE 333
M LSHK+++ GV + L+ + + +L +L+K K + +
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNK-------NCINILW 114
Query: 334 VVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD--------DKLRIQITDNALARDLFPS 385
+++ Q+ + +L + L+H ++ +N ++ + I+++D ++ + P
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 386 DYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444
D + W+ E + + K + A+D W+FG LWE+ + +P + +D
Sbjct: 175 DI------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228
Query: 445 ASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+D ++L P L +++ C P+ RP+F + L
Sbjct: 229 QFYEDRHQLPAPKAAE--LANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 1e-61
Identities = 76/351 (21%), Positives = 135/351 (38%), Gaps = 62/351 (17%)
Query: 203 LDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYT--EEDGVEEEVLVKTVTD 260
LD+ + L S+ R R++L G FG+V ++ V VK + +
Sbjct: 3 LDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE 62
Query: 261 NASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK 319
A+ + L+ E + + H N++ +LG + +I + + NL +L+ +
Sbjct: 63 GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
Query: 320 LCP----------------------------------EGVAHTLTTQEVVDMCLQIIMGV 345
+ A + +E ++
Sbjct: 123 NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182
Query: 346 QYLHKKKLLHKDL------------------------ATRNCVVDDKLRIQITDNALARD 381
+ L+K L + L A RN ++ +K ++I D LARD
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-P 440
++ + + P+KW+A E++ + ++ SDVW+FGVLLWE+ +L PY +
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302
Query: 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
E L++G R+ P E++ M CW P RPTF +L L
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-56
Identities = 64/272 (23%), Positives = 119/272 (43%), Gaps = 25/272 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G+FG VY+G + +V VK + + Q+ E + H NIL +G
Sbjct: 34 SGSFGTVYKGKW------HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
S + ++ + + ++L L + ++++D+ Q G+ YLH
Sbjct: 88 YSTAPQLA--IVTQWCEGSSLYHHLHASE-------TKFEMKKLIDIARQTARGMDYLHA 138
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLA---IESLV 407
K ++H+DL + N + + ++I D LA + + + + W+A I
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA-ASLQDGYR----LNQPVNCPDE 462
+S SDV+AFG++L+EL T Q PY+ I+ + + G NCP
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTG-QLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 463 LFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494
+ +MA C + RP+FP++ + ++E +
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILAEIEELARE 289
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-55
Identities = 61/282 (21%), Positives = 105/282 (37%), Gaps = 33/282 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG+ + T+ E E +++K L+E M L H N+L +GV
Sbjct: 20 KGCFGQAIKVTHRETG---EVMVMKE-LIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 292 SIEDHTSPFLIYP---YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
+ Y L+ ++ + V I G+ YL
Sbjct: 76 L----YKDKRLNFITEYIKGGTLRGIIKSMD-------SQYPWSQRVSFAKDIASGMAYL 124
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK--------- 399
H ++H+DL + NC+V + + + D LAR + G +
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 400 ---WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL--QDGYRLN 454
W+A E + +++ DV++FG++L E+ + P M L +
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR-VNADPDYLPRTMDFGLNVRGFLDRY 243
Query: 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496
P NCP F + C ++PE RP+F +L L+ L
Sbjct: 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-53
Identities = 72/275 (26%), Positives = 113/275 (41%), Gaps = 37/275 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV---TDNASAVQVSLLLQEGMAMYGLSHKNILTV 288
G FG+VYR + ++ V VK D + + + QE L H NI+ +
Sbjct: 17 IGGFGKVYRAFWIGDE-----VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
GV + + L+ + L R L + +V+ +QI G+ YL
Sbjct: 72 RGVCL-KEPNLCLVMEFARGGPLNRVLSG---------KRIPPDILVNWAVQIARGMNYL 121
Query: 349 HKKK---LLHKDLATRNCVVDDKLRIQITDNA--------LARDLFPSDY-HCLGDNENR 396
H + ++H+DL + N ++ K+ N LAR+ + G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG----- 176
Query: 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-LQDGYRLNQ 455
W+A E + FS SDVW++GVLLWEL T + P+ ID +A + L
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG-EVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
P CP+ +M CW +P RP+F + L
Sbjct: 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-52
Identities = 71/324 (21%), Positives = 119/324 (36%), Gaps = 44/324 (13%)
Query: 186 SSNTSYASFKRRPSYSRLDDRNKDLHE-KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYT 244
N S S + P + + +L I + G FG+VY G +
Sbjct: 3 EMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGE---LIGK----GRFGQVYHGRW- 54
Query: 245 EEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP---F 300
EV ++ + + + Q+ +E MA H+N++ +G SP
Sbjct: 55 -----HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC----MSPPHLA 105
Query: 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360
+I L ++ K L + + +I+ G+ YLH K +LHKDL +
Sbjct: 106 IITSLCKGRTLYSVVRDAK-------IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKS 158
Query: 361 RNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV---KWLAIE---------SLVH 408
+N D+ ++ ITD L D LA E
Sbjct: 159 KNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP-VNCPDELFSVM 467
FS SDV+A G + +EL + P+ + + G + N + E+ ++
Sbjct: 218 LPFSKHSDVFALGTIWYELHAR-EWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276
Query: 468 AYCWAMNPEGRPTFPQLHSCLQEF 491
+CWA E RPTF +L L++
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 24/267 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G+FG V+R + D V VK + + A +V+ L+E M L H NI+ +G
Sbjct: 47 AGSFGTVHRAEWHGSD-----VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 291 VSIEDHTSP---FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
T P ++ Y +L R L K G L + + M + G+ Y
Sbjct: 102 AV----TQPPNLSIVTEYLSRGSLYRLLHK-----SGAREQLDERRRLSMAYDVAKGMNY 152
Query: 348 LHKKK--LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
LH + ++H++L + N +VD K +++ D L+R + +W+A E
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT--PEWMAPEV 210
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-LQDGYRLNQPVNCPDELF 464
L + + SDV++FGV+LWEL TL QQP+ ++P ++ A+ RL P N ++
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATL-QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA 269
Query: 465 SVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+++ CW P RP+F + L+
Sbjct: 270 AIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 55/278 (19%), Positives = 120/278 (43%), Gaps = 37/278 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV------TDNASAVQVSLLLQEGMAMYGLSHKNI 285
+G FG V++G ++ V +K++ + + +E M L+H NI
Sbjct: 29 KGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 286 LTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
+ + G+ P ++ + +L L H + + + L I +G+
Sbjct: 86 VKLYGLMHN---PPRMVMEFVPCGDLYHRLLDKA-------HPIKWSVKLRLMLDIALGI 135
Query: 346 QYLHKKK--LLHKDLATRNCVVDDK-----LRIQITDNALARDLFPSDYHCLGDNENRPV 398
+Y+ + ++H+DL + N + + ++ D L++ S LG
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG-----NF 190
Query: 399 KWLAIESLV--HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA---ASLQDGYRL 453
+W+A E++ ++++ +D ++F ++L+ + T + P+ E ++ ++G R
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTG-EGPFDEYSYGKIKFINMIREEGLRP 249
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
P +CP L +V+ CW+ +P+ RP F + L E
Sbjct: 250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-49
Identities = 58/271 (21%), Positives = 109/271 (40%), Gaps = 27/271 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
E G +++G + D ++VK + + S + +E + SH N+L VLG
Sbjct: 20 ENHSGELWKGRWQGND-----IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 291 VSIEDHTSPF-LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
LI + Y +L L + + + V L + G+ +LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGT------NFVVDQSQAVKFALDMARGMAFLH 128
Query: 350 KKK--LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
+ + L +R+ ++D+ + +I+ + + W+A E+L
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF--QSPGRMY-----APAWVAPEALQ 181
Query: 408 HK---TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-LQDGYRLNQPVNCPDEL 463
K T ++D+W+F VLLWEL T + P+A++ E+ +G R P +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTR-EVPFADLSNMEIGMKVALEGLRPTIPPGISPHV 240
Query: 464 FSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494
+M C +P RP F + L++ +
Sbjct: 241 SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-46
Identities = 63/266 (23%), Positives = 112/266 (42%), Gaps = 28/266 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V + + +D V +K + + + E + ++H NI+ + G
Sbjct: 18 RGAFGVVCKAKWRAKD-----VAIKQIESESERKAF---IVELRQLSRVNHPNIVKLYGA 69
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK- 350
+ L+ Y + +L L + P T + CLQ GV YLH
Sbjct: 70 CLN---PVCLVMEYAEGGSLYNVLHGAEPLPY-----YTAAHAMSWCLQCSQGVAYLHSM 121
Query: 351 --KKLLHKDLATRNCVVDDKLR-IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
K L+H+DL N ++ ++I D A D+ + G W+A E
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKG-----SAAWMAPEVFE 176
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEID--PFEMAASLQDGYRLNQPVNCPDELFS 465
+S DV+++G++LWE+ T ++P+ EI F + ++ +G R N P + S
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITR-RKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 466 VMAYCWAMNPEGRPTFPQLHSCLQEF 491
+M CW+ +P RP+ ++ +
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 68/307 (22%), Positives = 118/307 (38%), Gaps = 61/307 (19%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVK--TVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G +G V+ G + E V VK T+ AS + E + H+NIL +
Sbjct: 47 KGRYGEVWMGKWRGEK-----VAVKVFFTTEEASWFR----ETEIYQTVLMRHENILGFI 97
Query: 290 GVSIEDHTSP---FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
I+ S +LI Y + +L +L+ TL + ++ + + G+
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS---------TTLDAKSMLKLAYSSVSGLC 148
Query: 347 YLH--------KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
+LH K + H+DL ++N +V I D LA F SD + + N V
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV-KFISDTNEVDIPPNTRV 207
Query: 399 ---KWLAIESL------VHKTFSTASDVWAFGVLLWELTT---------LAQQPYAEIDP 440
+++ E L H +D+++FG++LWE+ Q PY ++ P
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 441 FEMA------ASLQDGYRLNQPVN-----CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489
+ + R + P C ++ +M CWA NP R T ++ L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 490 EFHAQLT 496
+
Sbjct: 328 KMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 63/304 (20%), Positives = 117/304 (38%), Gaps = 59/304 (19%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G FG V+RG + E+ V VK + S + E L H+NIL +
Sbjct: 52 KGRFGEVWRGKWRGEE-----VAVKIFSSREERSWFRE----AEIYQTVMLRHENILGFI 102
Query: 290 GVSIEDHTSP---FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+D+ + +L+ Y ++ +L +L + +T+T + ++ + L G+
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLA 153
Query: 347 YLH--------KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP- 397
+LH K + H+DL ++N +V I D LA + +R
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213
Query: 398 -VKWLAIESL------VHKTFSTASDVWAFGVLLWELTTLA---------QQPYAEIDPF 441
+++A E L H +D++A G++ WE+ Q PY ++ P
Sbjct: 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273
Query: 442 EMAAS------LQDGYRL---NQPVNCP--DELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
+ + + R N+ +C + +M CW N R T ++ L +
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 491 FHAQ 494
Q
Sbjct: 334 LSQQ 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 71/301 (23%), Positives = 115/301 (38%), Gaps = 61/301 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVK--TVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G +G V+RG++ E+ V VK + D S + E L H+NIL +
Sbjct: 18 KGRYGEVWRGSWQGEN-----VAVKIFSSRDEKSWFRE----TELYNTVMLRHENILGFI 68
Query: 290 GVSIEDHTSP---FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+ S +LI Y + +L +LQ TL T + + L I G+
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---------TTLDTVSCLRIVLSIASGLA 119
Query: 347 YLH--------KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
+LH K + H+DL ++N +V + I D LA + + L N V
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV-MHSQSTNQLDVGNNPRV 178
Query: 399 ---KWLAIESLVHK------TFSTASDVWAFGVLLWELTTLA---------QQPYAEIDP 440
+++A E L D+WAFG++LWE+ + P+ ++ P
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 441 FEMAAS------LQDGYRLNQPVN-----CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489
+ + D R N P L +M CW NP R T ++ L
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 490 E 490
+
Sbjct: 299 K 299
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 55/320 (17%), Positives = 102/320 (31%), Gaps = 74/320 (23%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVK--TVTDNASAVQVSLLLQEG--MAMYGLSHKNILT 287
G +G VY+G+ E V VK + + + + E + + H NI
Sbjct: 23 RGRYGAVYKGSLDERP-----VAVKVFSFANRQN------FINEKNIYRVPLMEHDNIAR 71
Query: 288 VLGVSIED----HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIM 343
+ L+ Y +L ++L HT + +
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---------HTSDWVSSCRLAHSVTR 122
Query: 344 GVQYLH---------KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394
G+ YLH K + H+DL +RN +V + I+D L+ L + G+ +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 395 NRPVK------WLA-------IESLVHKTFSTASDVWAFGVLLWELTT--LAQQPYAEID 439
N + ++A + ++ D++A G++ WE+ P +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 440 PFEMA----------------ASLQDGYRLNQPVNCPD------ELFSVMAYCWAMNPEG 477
++MA ++ R P + L + CW + E
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 478 RPTFPQLHSCLQEFHAQLTR 497
R T + E R
Sbjct: 303 RLTAQXAEERMAELMMIWER 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 60/335 (17%), Positives = 112/335 (33%), Gaps = 67/335 (20%)
Query: 201 SRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVK--TV 258
+ + L Q ++L V G FG V++ E V VK +
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-----VAVKIFPI 57
Query: 259 TDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP---FLIYPYQDYTNLKRFL 315
D S E ++ G+ H+NIL +G + +LI + + +L FL
Sbjct: 58 QDKQSWQN----EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113
Query: 316 QKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH----------KKKLLHKDLATRNCVV 365
+ + ++ E+ + + G+ YLH K + H+D+ ++N ++
Sbjct: 114 KA---------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164
Query: 366 DDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----WLAIESLVH-----KTFSTASD 416
+ L I D LA F + + ++A E L + D
Sbjct: 165 KNNLTACIADFGLAL-KFEAG---KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220
Query: 417 VWAFGVLLWELTTL----------AQQPYAEIDPF-----EM-AASLQDGYRLNQPVNCP 460
++A G++LWEL + P+ E +M + R
Sbjct: 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ 280
Query: 461 DE-----LFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
L + CW + E R + + + +
Sbjct: 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 59/276 (21%), Positives = 104/276 (37%), Gaps = 42/276 (15%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTD-NASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G+F VY+G E EV + D + + +E + GL H NI+
Sbjct: 37 GSFKTVYKG-LDTETT--VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 292 SIEDHTSPFLIYPYQDYT---NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
I + LK +L++ K+ V + C QI+ G+Q+L
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV--------LRSWCRQILKGLQFL 145
Query: 349 HKKK--LLHKDLATRNCVVDDKL-RIQITDNALARDLFPSDYHCLGDNENRPVK----WL 401
H + ++H+DL N + ++I D LA + + V ++
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--------LKRASFAKAVIGTPEFM 197
Query: 402 AIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD 461
A E + + + + DV+AFG+ + E+ T + PY+E A + +P D
Sbjct: 198 APE-MYEEKYDESVDVYAFGMCMLEMATS-EYPYSECQN--AAQIYRRVTSGVKP-ASFD 252
Query: 462 ELFSVMA-----YCWAMNPEGRPTFPQL--HSCLQE 490
++ C N + R + L H+ QE
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 53/270 (19%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EG+FG+ TE+ + ++K + S+ + +E + + H NI+
Sbjct: 34 EGSFGKAILVKSTEDG---RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
S E++ S +++ Y + +L + + K +++D +QI + ++++H
Sbjct: 91 -SFEENGSLYIVMDYCEGGDLFKRINAQK------GVLFQEDQILDWFVQICLALKHVHD 143
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK--------WLA 402
+K+LH+D+ ++N + +Q+ D +AR L N + +L+
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL----------NSTVELARACIGTPYYLS 193
Query: 403 IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462
E +K ++ SD+WA G +L+EL TL + + + + G ++ +
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTL-KHAFEAGSMKNLVLKIISGSFPPVSLHYSYD 252
Query: 463 LFSVMAYCWAMNPEGRPTFPQL--HSCLQE 490
L S+++ + NP RP+ + + +
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 55/288 (19%), Positives = 114/288 (39%), Gaps = 46/288 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
G F VYR DG V +K V D A + ++E + L+H N++
Sbjct: 42 RGQFSEVYRAACLL-DG--VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 290 GVSIEDHTSPFLIYPYQDY-------TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQII 342
IED+ + + +K F ++ +L PE + V +Q+
Sbjct: 99 ASFIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPE--------RTVWKYFVQLC 146
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK--- 399
++++H ++++H+D+ N + +++ D L R ++
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF---------SSKTTAAHSLV 197
Query: 400 ----WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455
+++ E + ++ SD+W+ G LL+E+ L Q P+ D + + + + +
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL-QSPF-YGDKMNLYSLCKKIEQCDY 255
Query: 456 P----VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
P + +EL ++ C +PE RP ++ + HA +
Sbjct: 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-21
Identities = 42/284 (14%), Positives = 96/284 (33%), Gaps = 34/284 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ +D +K + + +++E A+ L H I+
Sbjct: 15 RGGFGVVFEAKNKVDD---CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 292 SIEDHTSPFLIYPYQDYT-----------NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQ 340
+E +T+ L NLK ++ E + + LQ
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-----RERSVCLHIFLQ 126
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK- 399
I V++LH K L+H+DL N +++ D L + +
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 400 ---------WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450
+++ E + ++S D+++ G++L+E L +++ +++
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE---LLYPFSTQMERVRTLTDVRNL 243
Query: 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
+ ++ + +P RP + ++ ++
Sbjct: 244 KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 51/294 (17%), Positives = 102/294 (34%), Gaps = 62/294 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAV----------QVSLLLQEGMAMYGLS 281
EG F V LV+ + D +E +
Sbjct: 39 EGGFSYVD--------------LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN 84
Query: 282 HKNILTVLGVSIEDHTSP---FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
H NIL ++ + + + +L+ P+ L +++ K + LT +++ +
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK----GNFLTEDQILWLL 140
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
L I G++ +H K H+DL N ++ D+ + + D + H G + +
Sbjct: 141 LGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN---QACIHVEGSRQALTL 197
Query: 399 KWLA-------------IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM-- 443
+ A H +DVW+ G +L+ + + P++M
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG--EG-----PYDMVF 250
Query: 444 ------AASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
A ++Q+ + Q L+ ++ ++P RP P L S L+
Sbjct: 251 QKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 48/271 (17%), Positives = 97/271 (35%), Gaps = 39/271 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGL-SHKNILTVL 289
G++G V++ E DG VK + L E + + H + +
Sbjct: 67 HGSYGEVFKVRSKE-DG--RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 290 GVSIEDHTSPFLIYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
E +Y + +L++ + +L +V ++ + +
Sbjct: 124 QAWEEGGI----LYLQTELCGPSLQQHCEAWG-------ASLPEAQVWGYLRDTLLALAH 172
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH--CLGDNENRPVKWLAIES 405
LH + L+H D+ N + + R ++ D L +L + GD ++A E
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-----YMAPE- 226
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD---- 461
L+ ++ TA+DV++ G+ + E+ ++ Q + P
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACN-------MELPHGGEGWQQLRQGYLPPEFTAGLSS 279
Query: 462 ELFSVMAYCWAMNPEGRPTFPQL--HSCLQE 490
EL SV+ +P+ R T L L++
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 51/280 (18%), Positives = 103/280 (36%), Gaps = 48/280 (17%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G FG+V++ + + + ++K V +N A +E A+ L H NI+ G
Sbjct: 21 SGGFGQVFKAKHRIDG---KTYVIKRVKYNNEKA------EREVKALAKLDHVNIVHYNG 71
Query: 291 VSIEDHTSPFLIYPYQDYTN---------------LKRFLQKCKLCPEGVAHTLTTQEVV 335
P + L+++++K + L +
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR------GEKLDKVLAL 125
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
++ QI GV Y+H KKL+++DL N + D +++I D L L
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR------T 179
Query: 396 RPV---KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452
R ++++ E + + + D++A G++L EL + FE + D
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------AFETSKFFTDLRD 233
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQE 490
+ +++ + PE RP ++ + +
Sbjct: 234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 55/275 (20%), Positives = 115/275 (41%), Gaps = 33/275 (12%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G++GR + DG + ++ K + + + + +L+ E + L H NI+
Sbjct: 16 TGSYGRCQKIRRKS-DG--KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 291 VSIEDHTSPFLIY-PYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
I+ + I Y + +L + K + L + V+ + Q+ + ++ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ----YLDEEFVLRVMTQLTLALKECH 128
Query: 350 KKKL-----LHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----- 399
++ LH+DL N +D K +++ D LAR L +++ K
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---------NHDTSFAKTFVGT 179
Query: 400 --WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457
+++ E + +++ SD+W+ G LL+EL L P+ E+A +++G P
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL-MPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQE 490
DEL ++ + RP+ ++ + + E
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 54/284 (19%), Positives = 97/284 (34%), Gaps = 36/284 (12%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGLS-HKNILTVL 289
G FG V++ DG +K A +V L+E A L H +++
Sbjct: 21 SGEFGSVFKCVKRL-DG--CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 290 GVSIEDHTSPFLIYPYQDYTN---LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
ED + +Y N L + + + E+ D+ LQ+ G++
Sbjct: 78 SAWAEDDH----MLIQNEYCNGGSLADAISENY----RIMSYFKEAELKDLLLQVGRGLR 129
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC--LGD------NENRPV 398
Y+H L+H D+ N + D + S+ +GD + V
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 399 K-----WLAIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452
+ +LA E L + T +D++A + + + D + ++ G
Sbjct: 190 EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA-EPLPRNGDQW---HEIRQGRL 245
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFHAQ 494
P E ++ +PE RP+ L HS L +
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 61/344 (17%), Positives = 120/344 (34%), Gaps = 56/344 (16%)
Query: 160 GSNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFKRRPSYSRLDDRNKDLHEKLSELTI 219
GS S ++G + A+ A + +S ++ +R D+ L EKL +
Sbjct: 1 GSGSVSSGQA---------HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY 51
Query: 220 QRCRVRLFSVNME----GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL---LLQ 272
+ + + G+FG V+R ++ G + VK +V L ++
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRM-KDKQTG--FQCAVK---------KVRLEVFRVE 99
Query: 273 EGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTN---LKRFLQKCKLCPEGVAHTL 329
E +A GLS I+ + G E + + + L + +++ PE
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPW----VNIFMELLEGGSLGQLIKQMGCLPEDR---- 151
Query: 330 TTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-LRIQITDNALARDLFPSDYH 388
+ Q + G++YLH +++LH D+ N ++ R + D A L P D
Sbjct: 152 ----ALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP-DGL 206
Query: 389 CLGDNENRPVK----WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444
+ +A E ++ K D+W+ ++ + P+ +
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFR--GP 263
Query: 445 ASL----QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L + P +C + P R + +L
Sbjct: 264 LCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMEL 307
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 47/286 (16%), Positives = 104/286 (36%), Gaps = 38/286 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGLSHKN--ILTV 288
G +V++ E + +K V + A + E + L + I+ +
Sbjct: 38 SGGSSKVFQVL--NEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
+++ + +L +L+K K E ++ V +
Sbjct: 94 YDY-EITDQYIYMVMECGN-IDLNSWLKKKKSIDP--------WERKSYWKNMLEAVHTI 143
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN-------------EN 395
H+ ++H DL N ++ D +++ D +A + P + D+ ++
Sbjct: 144 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF--EMAASLQDGYRL 453
+S S SDVW+ G +L+ +T + P+ +I ++ A + + +
Sbjct: 203 MSSSRENGKS--KSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHAIIDPNHEI 259
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFHAQLTR 497
P +L V+ C +P+ R + P+L H +Q + +
Sbjct: 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQ 305
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 46/285 (16%), Positives = 103/285 (36%), Gaps = 38/285 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGLSHKN--ILTV 288
G +V++ E + +K V + A + E + L + I+ +
Sbjct: 66 SGGSSKVFQVL--NEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
+++ + +L +L+K K + ++ V +
Sbjct: 122 YDY-EITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKN--------MLEAVHTI 171
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN-------------EN 395
H+ ++H DL N ++ D +++ D +A + P + D+ ++
Sbjct: 172 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF--EMAASLQDGYRL 453
+S S SDVW+ G +L+ +T + P+ +I ++ A + + +
Sbjct: 231 MSSSRENGKS--KSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHAIIDPNHEI 287
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFHAQLT 496
P +L V+ C +P+ R + P+L H +Q +
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 50/287 (17%), Positives = 102/287 (35%), Gaps = 42/287 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGLSHKN--ILTV 288
G +V++ E + +K V + A + E + L + I+ +
Sbjct: 19 SGGSSKVFQVL--NEKK--QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 289 LGVSIEDHTSPFLIYPYQDYTN--LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
IY + N L +L+K K E ++ V
Sbjct: 75 YDY-EITDQY---IYMVMECGNIDLNSWLKKKKSIDP--------WERKSYWKNMLEAVH 122
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN------------- 393
+H+ ++H DL N ++ D +++ D +A + P + D+
Sbjct: 123 TIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF--EMAASLQDGY 451
++ +S S SDVW+ G +L+ +T + P+ +I ++ A + +
Sbjct: 182 KDMSSSRENGKS--KSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHAIIDPNH 238
Query: 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFHAQLT 496
+ P +L V+ C +P+ R + P+L H +Q +
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 39/285 (13%), Positives = 91/285 (31%), Gaps = 36/285 (12%)
Query: 232 EGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EG F +VY T + +++ ++K V A+ + + Q + +
Sbjct: 75 EGAFAQVYEATQGDLNDAKNKQKFVLK-VQKPANPWEFYIGTQLMERLKPSMQHMFMKFY 133
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
L+ Y L + K PE + V+ ++++ ++ +H
Sbjct: 134 SA-HLFQNGSVLVGELYSYGTLLNAINLYKNTPE---KVMPQGLVISFAMRMLYMIEQVH 189
Query: 350 KKKLLHKDLATRNCVV-----------DDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
+++H D+ N ++ D + + D + D+
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM-----KLFPKGTIFTA 244
Query: 399 KW-----LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
K +E L +K ++ D + ++ + Y ++ + +R
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF---GTYMKVKNEGGECKPEGLFRR 301
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498
++ +E F VM +N P L Q+ ++
Sbjct: 302 LPHLDMWNEFFHVM-----LNIPDCHHLPSLDLLRQKLKKVFQQH 341
|
| >2ygn_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2d3j_A Length = 156 | Back alignment and structure |
|---|
Score = 72.5 bits (177), Expect = 3e-15
Identities = 16/80 (20%), Positives = 32/80 (40%), Gaps = 4/80 (5%)
Query: 20 LPYS-ISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTL 78
Y +S+ S + + +P +N+ +G++P + PC G + + + V
Sbjct: 68 YFYEFLSLRSLDXGIMADPTVNVPLLGTVPHXASVVQVGFPCLGXQDGVAAFEVDVIVM- 126
Query: 79 SRNSNNVTSLNFKRKKICLR 98
NS T L + I +
Sbjct: 127 --NSEGNTILXTPQNAIFFK 144
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 39/249 (15%)
Query: 195 KRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVL 254
K R++D + K+ GT+G VY+ ++ +++
Sbjct: 10 KLSSERERVEDLFEYEGCKVGR----------------GTYGHVYKAK-RKDGKDDKDYA 52
Query: 255 VKTVTD---NASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP--FLIYPYQDYT 309
+K + + SA + LL+E L H N++++ V H +L++ Y ++
Sbjct: 53 LKQIEGTGISMSACREIALLRE------LKHPNVISLQKV-FLSHADRKVWLLFDYAEH- 104
Query: 310 NLKRFLQKCKLCPEGVAHT-LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN----CV 364
+L ++ + L V + QI+ G+ YLH +LH+DL N
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 164
Query: 365 VDDKLRIQITDNALARDLFPSDYHCLGDNENRPV-KWL-AIESLV-HKTFSTASDVWAFG 421
++ R++I D AR LF S L D + V W A E L+ + ++ A D+WA G
Sbjct: 165 GPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 223
Query: 422 VLLWELTTL 430
+ EL T
Sbjct: 224 CIFAELLTS 232
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 39/309 (12%), Positives = 75/309 (24%), Gaps = 62/309 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVL 289
G V+ E E+ +K T A S ++ L + A L ++
Sbjct: 72 VGDRSVVFLVRDVERL---EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 290 -------------------------GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG 324
G + L+ P +L+
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187
Query: 325 VAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384
+ + Q+I L K L+H N + R+ + D + +
Sbjct: 188 -RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 385 SDYHCLGDNENRPVKWLAIESLVHKT--FSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442
PV + E L T F+ A + W G+ ++ + PF
Sbjct: 247 RGPASSV-----PVTYAPREFLNASTATFTHALNAWQLGLSIYRV--WCLFL-----PFG 294
Query: 443 MAASLQDGYRLNQPVNCPDELFSVMAYCWAM--------------NPEGRPTFPQL--HS 486
+ G + P C + + R +
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
Query: 487 CLQEFHAQL 495
+ ++
Sbjct: 355 EFLQLQNEI 363
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 46/219 (21%), Positives = 94/219 (42%), Gaps = 46/219 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDN------ASAV-QVSLLLQEGMAMYGLSHK 283
EG +G+V++ + G V +K V S + +V++L + H
Sbjct: 21 EGAYGKVFKARDLKNGG--RFVALKRVRVQTGEEGMPLSTIREVAVLRH----LETFEHP 74
Query: 284 NILTVLGV----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCL 339
N++ + V + T L++ + D +L +L K + T+ + DM
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP------EPGVPTETIKDMMF 127
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
Q++ G+ +LH +++H+DL +N +V +I++ D LAR ++ + +
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IY-----------SFQMA 175
Query: 400 --------WL-AIESLVHKTFSTASDVWAFGVLLWELTT 429
W A E L+ +++T D+W+ G + E+
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 58/301 (19%), Positives = 106/301 (35%), Gaps = 45/301 (14%)
Query: 217 LTIQRCRVRLFSVNMEGTFGRVY--RGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEG 274
+ + R+R+ V EG F VY + + + + +L N + +QE
Sbjct: 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI------IQEV 76
Query: 275 MAMYGLS-HKNILTVLGVSIEDHTSP------FLIYPYQDYTNLKRFLQKCKLCPEGVAH 327
M LS H NI+ + FL+ L FL+K +
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES-----RG 131
Query: 328 TLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385
L+ V+ + Q VQ++H++K ++H+DL N ++ ++ I++ D A +
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191
Query: 386 DYHCLGDNENRPVKWLA-------------IESLVHKTFSTASDVWAFGVLLWELTTLAQ 432
+ V+ I+ + D+WA G +L+ L
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ- 250
Query: 433 QPYAEIDPFE---MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQ 489
PFE + Y + S++ +NPE R + ++ LQ
Sbjct: 251 ------HPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
Query: 490 E 490
E
Sbjct: 305 E 305
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 57/244 (23%), Positives = 90/244 (36%), Gaps = 48/244 (19%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL---LLQEGMAMYGLSHKNILTV 288
+G FG VY + + +K V A + + L +E L H NIL +
Sbjct: 19 KGKFGNVYLAREKQSK---FILALK-VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
G D T +LI Y + R LQK E T T+ + + Y
Sbjct: 75 YGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE--------LANALSYC 125
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITD---NALARDLFPS------DYHCLGDNENRPVK 399
H K+++H+D+ N ++ ++I D + A + DY
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY------------ 173
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--LNQPV 457
L E + + D+W+ GVL +E L +P PFE A + Q+ Y+
Sbjct: 174 -LPPEMIEGRMHDEKVDLWSLGVLCYEF--LVGKP-----PFE-ANTYQETYKRISRVEF 224
Query: 458 NCPD 461
PD
Sbjct: 225 TFPD 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 58/266 (21%), Positives = 109/266 (40%), Gaps = 40/266 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL---LLQEGMAMYGLSHKNILTV 288
+G F + + + + E K V + ++ + E L+H++++
Sbjct: 51 KGGFAKCFEISDADTK---EVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
G ED+ F++ +L ++ K E A Q I++G QYL
Sbjct: 107 HGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ--------IVLGCQYL 157
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYH---CLGDNENRPVKWLAIE 404
H+ +++H+DL N +++ L ++I D LA + + + C N ++A E
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------YIAPE 211
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR------LNQPVN 458
L K S DVW+ G +++ L L +P PFE + L++ Y + P +
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTL--LVGKP-----PFE-TSCLKETYLRIKKNEYSIPKH 263
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQL 484
S++ +P RPT +L
Sbjct: 264 INPVAASLIQKMLQTDPTARPTINEL 289
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 58/266 (21%), Positives = 109/266 (40%), Gaps = 40/266 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL---LLQEGMAMYGLSHKNILTV 288
+G F + + + + E K V + ++ + E L+H++++
Sbjct: 25 KGGFAKCFEISDADTK---EVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
G ED+ F++ +L ++ K E A Q I++G QYL
Sbjct: 81 HGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ--------IVLGCQYL 131
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYH---CLGDNENRPVKWLAIE 404
H+ +++H+DL N +++ L ++I D LA + + + C N ++A E
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN------YIAPE 185
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR------LNQPVN 458
L K S DVW+ G +++ L L +P PFE + L++ Y + P +
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTL--LVGKP-----PFE-TSCLKETYLRIKKNEYSIPKH 237
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQL 484
S++ +P RPT +L
Sbjct: 238 INPVAASLIQKMLQTDPTARPTINEL 263
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 53/244 (21%), Positives = 89/244 (36%), Gaps = 48/244 (19%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQ---EGMAMYGLSHKNILTV 288
+G FG VY + + +K V + + + Q E L H NIL +
Sbjct: 24 KGKFGNVYLAREKQNK---FIMALK-VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
D +L+ + L + LQK E + T + + + Y
Sbjct: 80 YNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYC 130
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITD---NALARDLFPS------DYHCLGDNENRPVK 399
H++K++H+D+ N ++ K ++I D + A L DY
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDY------------ 178
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--LNQPV 457
L E + KT D+W GVL +E L P PF+ + S + +R +N +
Sbjct: 179 -LPPEMIEGKTHDEKVDLWCAGVLCYEF--LVGMP-----PFD-SPSHTETHRRIVNVDL 229
Query: 458 NCPD 461
P
Sbjct: 230 KFPP 233
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 42/222 (18%), Positives = 83/222 (37%), Gaps = 50/222 (22%)
Query: 232 EGTFGRVYRGTYTEED----------GVEEEVLVKTVTDNASAV-QVSLLLQEGMAMYGL 280
G +G VY+ S V +V+LL + +
Sbjct: 19 VGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL---PISTVREVALLRR----LEAF 71
Query: 281 SHKNILTVLGV----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
H N++ ++ V + L++ + D +L+ +L K L + + D
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP------PPGLPAETIKD 124
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
+ Q + G+ +LH ++H+DL N +V +++ D LAR ++ +
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IY-----------SY 172
Query: 397 PVK--------WL-AIESLVHKTFSTASDVWAFGVLLWELTT 429
+ W A E L+ T++T D+W+ G + E+
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 49/274 (17%), Positives = 107/274 (39%), Gaps = 29/274 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG+V + D +K + + ++S +L E M + L+H+ ++
Sbjct: 16 QGAFGQVVKARNAL-DS--RYYAIKKI--RHTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAHTLTTQE--VVDMCLQIIM 343
+E + + + L F+Q + C G + L Q + QI+
Sbjct: 71 WLERRNFVKPMTAVKKKSTL--FIQ-MEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK---- 399
+ Y+H + ++H+DL N +D+ ++I D LA+++ S D++N P
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 400 --------WLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450
++A E L ++ D+++ G++ +E+ ++ + S+
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRSVSIE 247
Query: 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ + N ++ +P RP L
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 65/224 (29%)
Query: 232 EGTFGRVYRGTYT--------------EEDGVEEEVLVKTVTDNASAV-QVSLLLQEGMA 276
EGT+G VY+ + E++G+ ++A+ ++SLL +
Sbjct: 31 EGTYGVVYKAKDSQGRIVALKRIRLDAEDEGI-----------PSTAIREISLLKE---- 75
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H NI++++ V I L++ + + +LK+ L + K L ++
Sbjct: 76 ---LHHPNIVSLIDV-IHSERCLTLVFEFME-KDLKKVLDENKT-------GLQDSQIKI 123
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
Q++ GV + H+ ++LH+DL +N +++ +++ D LAR F
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI----------- 171
Query: 397 PVKWL----------AIESLV-HKTFSTASDVWAFGVLLWELTT 429
PV+ A + L+ K +ST+ D+W+ G + E+ T
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 51/245 (20%), Positives = 85/245 (34%), Gaps = 67/245 (27%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV---SLLLQEGMA---------MYG 279
+G+F VYR T A+++ + + GM
Sbjct: 21 KGSFAGVYRAESIH-------------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQ-KCKLCPEGVAHTLTTQEVVDMC 338
L H +IL + ED +L+ + R+L+ + K E A Q
Sbjct: 68 LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ------ 120
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS-----------DY 387
II G+ YLH +LH+DL N ++ + I+I D LA L +Y
Sbjct: 121 --IITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178
Query: 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447
++ E SDVW+ G + + L L +P PF+ ++
Sbjct: 179 -------------ISPEIATRSAHGLESDVWSLGCMFYTL--LIGRP-----PFD-TDTV 217
Query: 448 QDGYR 452
++
Sbjct: 218 KNTLN 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 40/217 (18%), Positives = 86/217 (39%), Gaps = 36/217 (16%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G V+RG + + + +K + + V + ++E + L+HKNI+ + +
Sbjct: 19 QGATANVFRGRHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 292 SIEDHTS--PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
E+ T+ LI + +L L++ A+ L E + + ++ G+ +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEE-----PSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 350 KKKLLHKDLATRN----CVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--------- 396
+ ++H+++ N D + ++TD AR+ L D+E
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEY 181
Query: 397 --P--VKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429
P + + K + D+W+ GV + T
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 47/226 (20%), Positives = 90/226 (39%), Gaps = 66/226 (29%)
Query: 232 EGTFGRVYRGTYT---------------EEDGVEEEVLVKTVTDNASAV-QVSLLLQEGM 275
EGT+G V++ +++GV +SA+ ++ LL +
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-----------PSSALREICLLKE--- 57
Query: 276 AMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVV 335
L HKNI+ + V + L++ + D +LK++ C L + V
Sbjct: 58 ----LKHKNIVRLHDV-LHSDKKLTLVFEFCD-QDLKKYFDSCNG-------DLDPEIVK 104
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
Q++ G+ + H + +LH+DL +N +++ +++ + LAR F
Sbjct: 105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI---------- 153
Query: 396 RPVKWL----------AIESLV-HKTFSTASDVWAFGVLLWELTTL 430
PV+ + L K +ST+ D+W+ G + EL
Sbjct: 154 -PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 41/224 (18%), Positives = 89/224 (39%), Gaps = 52/224 (23%)
Query: 232 EGTFGRVYRG--TYT-------------EEDGVEEEVLVKTVTDNASAV-QVSLLLQEGM 275
+GTFG V++ T E++G +A+ ++ +L
Sbjct: 27 QGTFGEVFKARHRKTGQKVALKKVLMENEKEGF-----------PITALREIKILQL--- 72
Query: 276 AMYGLSHKNILTVLGVSIEDHTSP-------FLIYPYQDYTNLKRFLQKCKLCPEGVAHT 328
L H+N++ ++ + + +L++ + ++ +L L +
Sbjct: 73 ----LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV-------K 120
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388
T E+ + ++ G+ Y+H+ K+LH+D+ N ++ +++ D LAR +
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 389 CLGDNENRPV-KWL-AIESLVH-KTFSTASDVWAFGVLLWELTT 429
NR V W E L+ + + D+W G ++ E+ T
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 49/224 (21%), Positives = 92/224 (41%), Gaps = 65/224 (29%)
Query: 232 EGTFGRVYRGTYT--------------EEDGVEEEVLVKTVTDNASAV-QVSLLLQEGMA 276
EGT+G VY+ E++G+ ++ + ++S+L +
Sbjct: 12 EGTYGVVYKAQNNYGETFALKKIRLEKEDEGI-----------PSTTIREISILKE---- 56
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H NI+ + V I L++ + D +LK+ L C+ L +
Sbjct: 57 ---LKHSNIVKLYDV-IHTKKRLVLVFEHLD-QDLKKLLDVCE-------GGLESVTAKS 104
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
LQ++ G+ Y H +++LH+DL +N +++ + ++I D LAR
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF------------GI 152
Query: 397 PVKWL----------AIESLVH-KTFSTASDVWAFGVLLWELTT 429
PV+ A + L+ K +ST D+W+ G + E+
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 35/164 (21%), Positives = 72/164 (43%), Gaps = 37/164 (22%)
Query: 232 EGTFGRVYRGTYTE--------------EDGVEEEVLVKTVTDNASAV-QVSLLLQEGMA 276
GT+ VY+G E+G ++A+ ++SL+ +
Sbjct: 15 NGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-----------PSTAIREISLMKE---- 59
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H+NI+ + V I L++ + D +LK+++ + L V
Sbjct: 60 ---LKHENIVRLYDV-IHTENKLTLVFEFMD-NDLKKYMDSRTVGNTP--RGLELNLVKY 112
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
Q++ G+ + H+ K+LH+DL +N +++ + ++++ D LAR
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 55/312 (17%), Positives = 110/312 (35%), Gaps = 66/312 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G V+RG + + + +K + + V + ++E + L+HKNI+ + +
Sbjct: 19 QGATANVFRGRHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 292 SIEDHTS--PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
E+ T+ LI + +L L++ A+ L E + + ++ G+ +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEE-----PSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 350 KKKLLHKDLATRN----CVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--------- 396
+ ++H+++ N D + ++TD AR+ L D+E
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------LEDDEQFVSLYGTEEY 181
Query: 397 --P--VKWLAIESLVHKTFSTASDVWAFGVLLWELTT---------------------LA 431
P + + K + D+W+ GV + T +
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
Query: 432 QQPYAEIDPFEMAASLQDGYRLNQPVNCP------DELFSVMAYCWAMNPEGRPTFPQLH 485
+P I + A + + + PV+C L V+A + E F Q
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ-- 299
Query: 486 SCLQEFHAQLTR 497
E L R
Sbjct: 300 -FFAETSDILHR 310
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 42/164 (25%)
Query: 232 EGTFGRVYRGTYTE--------------EDGVEEEVLVKTVTDNASAV-QVSLLLQEGMA 276
EGT+ VY+G E+G +A+ +VSLL
Sbjct: 12 EGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-----------PCTAIREVSLLKD---- 56
Query: 277 MYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L H NI+T+ + I S L++ Y D +LK++L C + V
Sbjct: 57 ---LKHANIVTLHDI-IHTEKSLTLVFEYLD-KDLKQYLDDCGN-------IINMHNVKL 104
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
Q++ G+ Y H++K+LH+DL +N +++++ +++ D LAR
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 56/277 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+GT+G VY G + + +K + + L +E L HKNI+ LG
Sbjct: 32 KGTYGIVYAG-RDLSNQ--VRIAIKEI-PERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTL---------TTQEVVDM-CLQI 341
E+ +K F++ P G L ++ + QI
Sbjct: 88 FSENGF-------------IKIFME---QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDNALARDLFPSDYHCLGDNENRP--- 397
+ G++YLH +++H+D+ N +++ ++I+D ++ L G N
Sbjct: 132 LEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-------AGINPCTETFT 184
Query: 398 --VKWLAIE--SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
++++A E + + A+D+W+ G + E+ T + P+ E+ AA + G
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELGE-PQAAMFKVG-MF 241
Query: 454 NQPVNCPDEL------FSVMAYCWAMNPEGRPTFPQL 484
P+ + F + C+ +P+ R L
Sbjct: 242 KVHPEIPESMSAEAKAF--ILKCFEPDPDKRACANDL 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 40/304 (13%), Positives = 78/304 (25%), Gaps = 56/304 (18%)
Query: 232 EGTFGRVYRGT--------------------YTEEDGVEEEV----LVKTVTDNASAVQV 267
+ T ++EEV L++ + + A
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 268 SLLLQEGMAMYGLSHKNILTVLGV-SIEDHTSPFLIYP------YQDYTNLKRFLQKCKL 320
+ + K ++ V S F +YP L K
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 321 CPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
LT LQ+I + LH L+H L + V+D + + +T
Sbjct: 203 LVHHARLQLT--------LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 381 DLFPSDYHCLGDN----E-NRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435
+ E ++ + + D WA G++++ +
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI--WCADL- 311
Query: 436 AEIDPFEMAASLQDGYR--LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEF 491
P + G N P + +++ E R Q ++
Sbjct: 312 ----PIT-KDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
Query: 492 HAQL 495
+L
Sbjct: 367 RTEL 370
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 33/277 (11%), Positives = 94/277 (33%), Gaps = 50/277 (18%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMA------------MYG 279
+G F ++ + + K++ + S + + +
Sbjct: 41 QGKFNKIILCEKDNK-FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCL 339
+ ++ LT G+ I ++ ++IY Y + ++ +F + + + + Q + +
Sbjct: 100 IKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 340 QIIMGVQYLHKKK-LLHKDLATRNCVVDDKLRIQITDNALARDLFPS----------DYH 388
++ Y+H +K + H+D+ N ++D R++++D + ++
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIKGSRGTYEF- 216
Query: 389 CLGDNENRPVKWLAIESLVHKTF--STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446
+ E +++ D+W+ G+ L+ + PF + S
Sbjct: 217 ------------MPPEFFSNESSYNGAKVDIWSLGICLYVM--FYNVV-----PFSLKIS 257
Query: 447 LQDGYR--LNQPVNCPDELFSVMAYCWAMNPEGRPTF 481
L + + + + P + + F
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNF 294
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/310 (19%), Positives = 107/310 (34%), Gaps = 63/310 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V R + + E+V +K S E M L+H N+++ V
Sbjct: 24 TGGFGYVLRWIHQDTG---EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 292 -----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+ + P L Y + +L+++L + L + + I ++
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-----FENCCGLKEGPIRTLLSDISSALR 135
Query: 347 YLHKKKLLHKDLATRNCVVD---DKLRIQITDNALARDLFPSD----------YHCLGDN 393
YLH+ +++H+DL N V+ +L +I D A++L + Y
Sbjct: 136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQY------ 189
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT-----LAQQPYAEI---------D 439
LA E L K ++ D W+FG L +E T L + +
Sbjct: 190 -------LAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
Query: 440 PFEMAASLQDGYRLNQPVNCPDELFSV---MAYCWAM-----NPEGRPTFPQL--HSCLQ 489
+ L + + + P+ L + W + R T PQ C Q
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
Query: 490 EFHAQLTRYV 499
+ L+ +
Sbjct: 303 ALDSILSLKL 312
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 41/208 (19%), Positives = 74/208 (35%), Gaps = 45/208 (21%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+R E + K + + + + E M L H ++ +
Sbjct: 62 GAFGVVHRCV---EKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKC-------KLCPEGVAHTLTTQEVVDMCLQIIMGV 345
ED LI + ++ E + ++ EV++ Q G+
Sbjct: 117 FEDKYEMVLILEF------------LSGGELFDRIAAED--YKMSEAEVINYMRQACEGL 162
Query: 346 QYLHKKKLLHKDLATRN--CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK---- 399
+++H+ ++H D+ N C ++I D LA L N + VK
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL----------NPDEIVKVTTA 212
Query: 400 ---WLAIESLVHKTFSTASDVWAFGVLL 424
+ A E + + +D+WA GVL
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 40/299 (13%), Positives = 83/299 (27%), Gaps = 43/299 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT--DNASAVQVSLLLQEGMAMYGL--------- 280
+ T E E V + + + + +E + + L
Sbjct: 88 QEDPYAYLEATDQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 281 -SHKNILTVLGVSIEDHTSPF--LIYPYQDYTNLKRFL----QKCKLCPEG--------V 325
H + + + + +D L RF + L G
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 326 AHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385
+L + + LQ+I + LH L+H L + V+D + + +T +
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-RDGA 263
Query: 386 DYHCLGDNENRPVKWLAIESL-----VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440
P + A L + A D W G+ ++ + A P +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC-ADLPNTDDAA 322
Query: 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFHAQLTR 497
+ + N P + +++ E R Q ++ +L+
Sbjct: 323 LGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSA 376
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 49/275 (17%), Positives = 94/275 (34%), Gaps = 49/275 (17%)
Query: 232 EGTFGR-VYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVL 289
G G VYRG + +V VK + S +E + H N++
Sbjct: 34 HGAEGTIVYRGMFDNR-----DVAVKRI----LPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 290 GVSIEDHTSPFLIYPY-----QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344
+D ++ Q+Y K F E + + Q G
Sbjct: 85 CT-EKDRQFQYIAIELCAATLQEYVEQKDF-------------AHLGLEPITLLQQTTSG 130
Query: 345 VQYLHKKKLLHKDLATRNCVVDDK-----LRIQITDNALARDLFP--SDYHCLGDNENRP 397
+ +LH ++H+DL N ++ ++ I+D L + L +
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 398 VKWLAIESL---VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454
W+A E L + + D+++ G + + + + P+ + A L L+
Sbjct: 191 G-WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQANILLGACSLD 248
Query: 455 QPVNCPDELFSVMAY-----CWAMNPEGRPTFPQL 484
P++ V+A AM+P+ RP+ +
Sbjct: 249 CL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 6e-12
Identities = 40/221 (18%), Positives = 95/221 (42%), Gaps = 33/221 (14%)
Query: 272 QEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTT 331
+E LSH+NI++++ V E+ +L+ Y + L +++ L+
Sbjct: 60 REVHNSSQLSHQNIVSMIDVD-EEDDCYYLVMEYIEGPTLSEYIES--------HGPLSV 110
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY---- 387
++ QI+ G+++ H +++H+D+ +N ++D ++I D +A+ L +
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170
Query: 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447
H LG V++ + E + +D+++ G++L+E+ + P+ +A +
Sbjct: 171 HVLGT-----VQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIA--I 222
Query: 448 QDGYRLNQPV---------NCPDELFSVMAYCWAMNPEGRP 479
+ + V + P L +V+ + R
Sbjct: 223 K---HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 57/233 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSL---------LLQEGMAMYGLS 281
EG F VY+ + + V +K + + S + + LLQE LS
Sbjct: 20 EGQFATVYKARDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIKLLQE------LS 70
Query: 282 HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQI 341
H NI+ +L ++ L++ + + T+L+ ++ L LT + L
Sbjct: 71 HPNIIGLLDA-FGHKSNISLVFDFME-TDLEVIIKDNSL-------VLTPSHIKAYMLMT 121
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL 401
+ G++YLH+ +LH+DL N ++D+ +++ D LA+ F S P +
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-----------PNRAY 169
Query: 402 ----------AIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPY----AEID 439
A E L + + D+WA G +L EL L + P+ +++D
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL--LLRVPFLPGDSDLD 220
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 44/231 (19%), Positives = 82/231 (35%), Gaps = 56/231 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-------TDNASAV-QVSLLLQEGMAMYGLSHK 283
EG++G V++ + + V +K A+ ++ +L Q L H
Sbjct: 13 EGSYGVVFKCRNRDTG---QIVAIKKFLESEDDPVIKKIALREIRMLKQ-------LKHP 62
Query: 284 NILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIM 343
N++ +L V L++ Y D + L + + + V + Q +
Sbjct: 63 NLVNLLEV-FRRKRRLHLVFEYCD-HTVLHELDRYQ-------RGVPEHLVKSITWQTLQ 113
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL-- 401
V + HK +H+D+ N ++ I++ D AR L P +
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL------------TGPSDYYDD 161
Query: 402 --------AIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPY----AEID 439
+ E LV + DVWA G + EL + P +++D
Sbjct: 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS--GVPLWPGKSDVD 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 72/230 (31%)
Query: 232 EGTFGRVYRGTYT---------------EEDGVEEEVLVKTVTDNASAV-QVSLLLQEGM 275
EGT+G VY+ T EE+GV +A+ +VSLL +
Sbjct: 44 EGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV-----------PGTAIREVSLLKE--- 89
Query: 276 AMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVV 335
L H+NI+ + V + LI+ Y + +LK+++ K ++ + +
Sbjct: 90 ----LQHRNIIELKSVIHHN-HRLHLIFEYAE-NDLKKYMDKNP--------DVSMRVIK 135
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVD-----DKLRIQITDNALARDLFPSDYHCL 390
Q+I GV + H ++ LH+DL +N ++ + ++I D LAR F
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI----- 189
Query: 391 GDNENRPVKWL----------AIESLV-HKTFSTASDVWAFGVLLWELTT 429
P++ E L+ + +ST+ D+W+ + E+
Sbjct: 190 ------PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 56/268 (20%), Positives = 104/268 (38%), Gaps = 22/268 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G V + E+V +K + + LL+E AM H NI++
Sbjct: 25 SGATAVVQAAYCAPKK---EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT- 80
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
S +L+ ++ ++ E + L + + +++ G++YLHK
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK---WLAIESLV- 407
+H+D+ N ++ + +QI D ++ L V W+A E +
Sbjct: 141 GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA----------SLQDGYRLNQPV 457
+ + +D+W+FG+ EL T PY + P M SL+ G + + +
Sbjct: 201 VRGYDFKADIWSFGITAIELATG-AAPYHKYPP--MKVLMLTLQNDPPSLETGVQDKEML 257
Query: 458 NCPDELFSVM-AYCWAMNPEGRPTFPQL 484
+ F M + C +PE RPT +L
Sbjct: 258 KKYGKSFRKMISLCLQKDPEKRPTAAEL 285
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 49/234 (20%), Positives = 91/234 (38%), Gaps = 62/234 (26%)
Query: 232 EGTFGRVYRGTYTEEDGV----------EEEVLVKTVTDNASAV-QVSLLLQEGMAMYGL 280
EG++G V + + + +++++ K A+ ++ LL Q L
Sbjct: 35 EGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI------AMREIKLLKQ-------L 81
Query: 281 SHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQ 340
H+N++ +L V + +L++ + D + L+ + L Q V Q
Sbjct: 82 RHENLVNLLEV-CKKKKRWYLVFEFVD-HTILDDLELFP-------NGLDYQVVQKYLFQ 132
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
II G+ + H ++H+D+ N +V +++ D AR L P +
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------------AAPGEV 180
Query: 401 L----------AIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPY----AEID 439
A E LV + A DVWA G L+ E+ +P ++ID
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM--GEPLFPGDSDID 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 39/207 (18%), Positives = 67/207 (32%), Gaps = 43/207 (20%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+R T E K V + +E M L H ++ +
Sbjct: 168 GAFGVVHRVT---ERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDA- 222
Query: 293 IEDHTSPFLIYPYQ------DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
ED +IY + + + ++ E V+ Q+ G+
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHN-------------KMSEDEAVEYMRQVCKGLC 269
Query: 347 YLHKKKLLHKDLATRN--CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----- 399
++H+ +H DL N +++ D L L + + VK
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL----------DPKQSVKVTTGT 319
Query: 400 --WLAIESLVHKTFSTASDVWAFGVLL 424
+ A E K +D+W+ GVL
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 39/317 (12%), Positives = 84/317 (26%), Gaps = 73/317 (23%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ + D +K + + +++E A+ L H I+
Sbjct: 16 RGGFGVVFEAKN-KVDD--CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 292 SIEDHTSPFLIYPYQDY-------TNLKRFLQKCKLCPEGVAH----------------- 327
+E + + + L +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 328 --------------TLTT-------------QEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360
L + + +QI V++LH K L+H+DL
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 361 RNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK----------WLAIESLVHKT 410
N +++ D L + + +++ E +
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD---GYRLNQPVNCPDELFSVM 467
+S D+++ G++L+EL E + D + ++
Sbjct: 253 YSHKVDIFSLGLILFELLYSFS------TQMERVRIITDVRNLKFPLLFTQKYPQEHMMV 306
Query: 468 AYCWAMNPEGRPTFPQL 484
+ +P RP +
Sbjct: 307 QDMLSPSPTERPEATDI 323
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 45/201 (22%), Positives = 78/201 (38%), Gaps = 22/201 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G +G V E +K + + S S LL+E + L H NI+ +
Sbjct: 47 SGAYGEVLLCRDKVTH---VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 291 VSIEDHTSPFLIYPYQDYTNL-KRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
ED + +L+ L + + + + Q++ GV YLH
Sbjct: 104 F-FEDKRNYYLVMECYKGGELFDEIIHR---------MKFNEVDAAVIIKQVLSGVTYLH 153
Query: 350 KKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESL 406
K ++H+DL N +++ K I+I D L+ + + ++A E L
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAY-YIAPEVL 210
Query: 407 VHKTFSTASDVWAFGVLLWEL 427
K + DVW+ GV+L+ L
Sbjct: 211 -RKKYDEKCDVWSIGVILFIL 230
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 41/209 (19%), Positives = 68/209 (32%), Gaps = 48/209 (22%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G FG V+R E ++ + K V L+ +E + H+NIL +
Sbjct: 16 GEFGIVHRCV---ETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH--TLTTQEVVDMCLQIIMG 344
E +I+ + L +E+V Q+
Sbjct: 70 FESMEELVMIF---------------EFISGLDIFERINTSAFELNEREIVSYVHQVCEA 114
Query: 345 VQYLHKKKLLHKDLATRN--CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK--- 399
+Q+LH + H D+ N I+I + AR L +
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----------KPGDNFRLLF 164
Query: 400 ----WLAIESLVHKTFSTASDVWAFGVLL 424
+ A E H STA+D+W+ G L+
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 48/263 (18%), Positives = 103/263 (39%), Gaps = 78/263 (29%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQV---SLLLQEGMAMYGLSHKNILT 287
EG+F V L + + + A+++ +++E Y +++++
Sbjct: 40 EGSFSTVV--------------LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85
Query: 288 VLGVSIEDHTSPFLI---YPYQDYTNLK------------RFLQKCKLCPEGVAHTLTTQ 332
L DH PF + + +QD L ++++K E T +
Sbjct: 86 RL-----DH--PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 333 EVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
I+ ++YLH K ++H+DL N ++++ + IQITD A+ L
Sbjct: 139 --------IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV--------LSP 182
Query: 393 NENRPVKW--------LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP--YAEIDPFE 442
+ ++ E L K+ +SD+WA G ++++L +A P A + +
Sbjct: 183 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL--VAGLPPFRAG-NEYL 239
Query: 443 MAASLQDGYR--LNQPVNCPDEL 463
+ ++ + + P++
Sbjct: 240 I-------FQKIIKLEYDFPEKF 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 54/274 (19%), Positives = 104/274 (37%), Gaps = 58/274 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G+FG V++G + V +K + + ++ + QE + + G
Sbjct: 32 KGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD------MCLQIIMGV 345
++D ++I Y G A L +D + +I+ G+
Sbjct: 89 YLKDTKL-WIIMEY---------------LGGGSALDLLEPGPLDETQIATILREILKGL 132
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR-------PV 398
YLH +K +H+D+ N ++ + +++ D +A L D + + P
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG--------QLTDTQIKRNTFVGTPF 184
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
W+A E + + + +D+W+ G+ EL + P++E+ P M P N
Sbjct: 185 -WMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHP--MKVLFL------IPKN 234
Query: 459 CPDEL---FSV-----MAYCWAMNPEGRPTFPQL 484
P L +S + C P RPT +L
Sbjct: 235 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 268
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 47/202 (23%), Positives = 81/202 (40%), Gaps = 23/202 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G+FG V +E VK + LL+E + L H NI+ +
Sbjct: 36 KGSFGEVILCKDKITG---QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 290 GVSIEDHTSPFLIYPYQDYTNL-KRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
ED +L+ L + + + + + Q++ G+ Y+
Sbjct: 93 EF-FEDKGYFYLVGEVYTGGELFDEIISR---------KRFSEVDAARIIRQVLSGITYM 142
Query: 349 HKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
HK K++H+DL N +++ K I+I D L+ S + D ++A E
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAY-YIAPEV 199
Query: 406 LVHKTFSTASDVWAFGVLLWEL 427
L H T+ DVW+ GV+L+ L
Sbjct: 200 L-HGTYDEKCDVWSTGVILYIL 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 46/269 (17%), Positives = 99/269 (36%), Gaps = 47/269 (17%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G G VY +EV ++ + + + L++ E + M + NI+ L
Sbjct: 30 QGASGTVYTAMDVATG---QEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ +++ Y +L + + + +A +C + + +++LH
Sbjct: 86 YLVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQIAA---------VCRECLQALEFLHSN 135
Query: 352 KLLHKDLATRNCVVDDKLRI---------QITDNALARDLF---PSDYHCLGDNENRPVK 399
+++H+D+ + N ++ + QIT R P Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP--Y------------ 181
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEMAASLQDGYRLNQ 455
W+A E + K + D+W+ G++ E+ + PY +P + +A + L
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPPYLNENPLRALYLIATN--GTPELQN 238
Query: 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
P + C M+ E R + +L
Sbjct: 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 44/209 (21%), Positives = 76/209 (36%), Gaps = 45/209 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG+V++ E ++ K + + E M L H N++ +
Sbjct: 99 GGRFGQVHKCE---ETATGLKLAAKII-KTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKC-------KLCPEGVAHTLTTQEVVDMCLQIIMG 344
E L+ Y ++ E + LT + + QI G
Sbjct: 155 -FESKNDIVLVMEY------------VDGGELFDRIIDES--YNLTELDTILFMKQICEG 199
Query: 345 VQYLHKKKLLHKDLATRN--CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK--- 399
++++H+ +LH DL N CV D +I+I D LAR +K
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY----------KPREKLKVNF 249
Query: 400 ----WLAIESLVHKTFSTASDVWAFGVLL 424
+LA E + + S +D+W+ GV+
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 43/273 (15%), Positives = 92/273 (33%), Gaps = 44/273 (16%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G G +Y +G V++K + + A ++ + E + + H +I+ +
Sbjct: 90 HGGLGWIYLALDRNVNG--RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 292 ----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+++ Y +LKR L E + L+I+ + Y
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKG----------QKLPVAEAIAYLLEILPALSY 197
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP---VKWLAIE 404
LH L++ DL N ++ ++ ++++ D + ++ + A E
Sbjct: 198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI---------NSFGYLYGTPGFQAPE 247
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464
+ + A+D++ G L LT + + + D
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAALTLDLP-------TRN-GRYVDGLPEDDPVLKTYDSYG 298
Query: 465 SVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497
++ +P R T + +E AQLT
Sbjct: 299 RLLRRAIDPDPRQRFT-----TA-EEMSAQLTG 325
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 31/220 (14%), Positives = 76/220 (34%), Gaps = 21/220 (9%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
V Y E V V+ + + S V+ L E +H NI+
Sbjct: 38 EDLMTVNLARYKPTG---EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT 94
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
I D+ +++ + Y + K + + + + ++ + Y+H
Sbjct: 95 FIADNEL-WVVTSFMAYGSAKDLIC------THFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDY--HCLGDNENRPVK---WLA---I 403
+H+ + + ++ ++ ++ + + D VK WL+ +
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 404 ESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443
+ + + SD+++ G+ EL P+ ++ +M
Sbjct: 208 QQNLQ-GYDAKSDIYSVGITACELANG-HVPFKDMPATQM 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 39/225 (17%), Positives = 86/225 (38%), Gaps = 36/225 (16%)
Query: 272 QEGMAMYGLSHKNILTVLGVSIEDHTS---PFLIYPYQDYTNLKRFLQKCKLCPEGVAHT 328
+E L+H I+ V + + P+++ Y D L+ +
Sbjct: 61 REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--------EGP 112
Query: 329 LTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH 388
+T + +++ + + H+ ++H+D+ N ++ +++ D +AR + S
Sbjct: 113 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 389 C------LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442
+G ++L+ E + SDV++ G +L+E+ T + P+ P
Sbjct: 173 VTQTAAVIGT-----AQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVS 226
Query: 443 MAASLQDGYRLNQPV--------NCPDELFSVMAYCWAMNPEGRP 479
+A Q + + +L +V+ A NPE R
Sbjct: 227 VA--YQ---HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 55/280 (19%), Positives = 93/280 (33%), Gaps = 68/280 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVE--------EEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHK 283
G FG V+ E E E+VL ++ +V+L E + + H
Sbjct: 34 SGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL---EIAILSRVEHA 89
Query: 284 NILTVLGVSIEDHTSPFLIYPYQ-------DYTNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
NI+ VL + E+ L+ + + L E +A +
Sbjct: 90 NIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRL------DEPLASYIFR----- 137
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
Q++ V YL K ++H+D+ N V+ + I++ D A
Sbjct: 138 ---QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA-------------AYLE 181
Query: 397 PVKWL----------AIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445
K A E L+ + ++W+ GV L+ L E +PF
Sbjct: 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV-------FEENPFCELE 234
Query: 446 SLQDG-YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ P EL S+++ PE R T +L
Sbjct: 235 ETVEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKL 272
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 50/285 (17%), Positives = 98/285 (34%), Gaps = 50/285 (17%)
Query: 232 EGTFGRV-YRGTYTEEDGVEEEVLVKTVT-DNASAVQ--VSLLLQEGMAMYGLSHKNILT 287
G+ G V ++G++ V VK + D + LL + H N++
Sbjct: 25 YGSSGTVVFQGSFQGR-----PVAVKRMLIDFCDIALMEIKLLTE------SDDHPNVIR 73
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
++ + L+ ++ + E + + + QI GV +
Sbjct: 74 YYCS-ETTDRFLYIALELCNLN-LQDLVESKNVSDENLKL-QKEYNPISLLRQIASGVAH 130
Query: 348 LHKKKLLHKDL-------------ATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394
LH K++H+DL + LRI I+D L + S N
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK-KLDSGQSSFRTNL 189
Query: 395 NRPV---KWLAIESL-------VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444
N P W A E L + + + D+++ G + + + + + P+ D +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRE 247
Query: 445 ASLQDG-YRLNQPVNCPDELFSVMAY-----CWAMNPEGRPTFPQ 483
+++ G + L++ D A +P RPT +
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK 292
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 60/288 (20%), Positives = 105/288 (36%), Gaps = 78/288 (27%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG+VY+ E K + + S ++ + E + H I+ +LG
Sbjct: 29 DGAFGKVYKAKNKETG---ALAAAKVI-ETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKL------CPEG--------VAHTLTTQEVVDM 337
+ KL CP G + LT ++ +
Sbjct: 85 ----------------------YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVV 122
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI---------QITDNALARDLF---PS 385
C Q++ + +LH K+++H+DL N ++ + I + RD F P
Sbjct: 123 CRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP- 181
Query: 386 DYHCLGDNENRPVKWLAIESLVHKTFSTAS-----DVWAFGVLLWELTTLAQQPYAEIDP 440
Y W+A E ++ +T D+W+ G+ L E+ + + P+ E++P
Sbjct: 182 -Y------------WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI-EPPHHELNP 227
Query: 441 ----FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
++A S D L P E + NPE RP+ QL
Sbjct: 228 MRVLLKIAKS--DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 48/281 (17%), Positives = 95/281 (33%), Gaps = 71/281 (25%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG+ G V +V VK + D + LL E + M H N++ +
Sbjct: 55 EGSTGIVCLAREKHSG---RQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKL------CPEGVAHTLTTQEVVD------MCL 339
+L +L G + +Q ++ +C
Sbjct: 111 ----------------------YLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCE 148
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI---------QITDNALARDLF---PSDY 387
++ + YLH + ++H+D+ + + ++ R+ QI+ + R P Y
Sbjct: 149 AVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTP--Y 206
Query: 388 HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----FEM 443
W+A E + ++T D+W+ G+++ E+ + PY P +
Sbjct: 207 ------------WMAPEVISRSLYATEVDIWSLGIMVIEMVDG-EPPYFSDSPVQAMKRL 253
Query: 444 AASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
S +L L + +P+ R T +L
Sbjct: 254 RDS--PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 49/301 (16%), Positives = 100/301 (33%), Gaps = 69/301 (22%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G G V++ ++ + K + + +++E ++ + I+ G
Sbjct: 43 AGNGGVVFKVSHKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG- 98
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH-K 350
+ + + D +L + L+K PE + + + + +I G+ YL K
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--------LGKVSIAVIKGLTYLREK 150
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH----CLGDNENRPVKWLAIESL 406
K++H+D+ N +V+ + I++ D ++ L S + +++ E L
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGT--------RSYMSPERL 202
Query: 407 VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL------------- 453
+S SD+W+ G+ L E+ + P D E+
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVG-RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 454 -------------------------NQPVNCPDELFSV-----MAYCWAMNPEGRPTFPQ 483
P P +FS+ + C NP R Q
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
Query: 484 L 484
L
Sbjct: 322 L 322
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 41/204 (20%), Positives = 84/204 (41%), Gaps = 31/204 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ E E ++KT+ + S V + + E + L H NI+ + V
Sbjct: 32 SGAFGDVHLVE---ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCK--------LCPEGVAHTLTTQEVVDMCLQIIM 343
ED+ + +++ ++ C+ + + L+ V ++ Q++
Sbjct: 89 -FEDYHNMYIV------------METCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
+ Y H + ++HKDL N + D I+I D LA ++ + + +
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTAL-Y 192
Query: 401 LAIESLVHKTFSTASDVWAFGVLL 424
+A E + + D+W+ GV++
Sbjct: 193 MAPEVF-KRDVTFKCDIWSAGVVM 215
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 47/215 (21%), Positives = 79/215 (36%), Gaps = 52/215 (24%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTV-----TDNASAVQVSLLLQEGMAMYGLSHKNILT 287
G F V + E E K + + V + +E + + H NI+T
Sbjct: 23 GQFAIVKKCR---EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQ 340
+ V E+ T LI +L G +L+ +E Q
Sbjct: 80 LHDV-YENRTDVVLIL---------------ELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDK----LRIQITDNALARDLFPSDYHCLGDNENR 396
I+ GV YLH KK+ H DL N ++ DK I++ D LA ++ +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI----------EDGV 173
Query: 397 PVK-------WLAIESLVHKTFSTASDVWAFGVLL 424
K ++A E + ++ +D+W+ GV+
Sbjct: 174 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 4e-09
Identities = 44/214 (20%), Positives = 74/214 (34%), Gaps = 53/214 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G F V R E K + T SA L +E L H NI+ +
Sbjct: 16 KGAFSVVRRCV---HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQIIM 343
I++ + +L+ L G VA + + QI+
Sbjct: 73 S-IQEESFHYLV---------------FDLVTGGELFEDIVAREFYSEADASHCIQQILE 116
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSD----------YHCL 390
+ Y H ++H++L N ++ K +++ D LA ++ S+ Y
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY--- 173
Query: 391 GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLL 424
L+ E L +S D+WA GV+L
Sbjct: 174 ----------LSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 44/218 (20%), Positives = 76/218 (34%), Gaps = 58/218 (26%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTV-----TDNASAVQVSLLLQEGMAMYGLSHKNILT 287
G F V + E E K + + V + +E + + H N++T
Sbjct: 23 GQFAIVKKCR---EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQ 340
+ V E+ T LI +L G +L+ +E Q
Sbjct: 80 LHDV-YENRTDVVLIL---------------ELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 341 IIMGVQYLHKKKLLHKDL-------ATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN 393
I+ GV YLH KK+ H DL +N I++ D LA ++
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKN---IPIPHIKLIDFGLAHEI----------E 170
Query: 394 ENRPVK-------WLAIESLVHKTFSTASDVWAFGVLL 424
+ K ++A E + ++ +D+W+ GV+
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 28/266 (10%), Positives = 65/266 (24%), Gaps = 54/266 (20%)
Query: 223 RVRLFSVNMEGTFGRVYRGTYTEEDGV-EEEVLVKTV--TDNASAVQVSLLLQEGMAMYG 279
R RL + + ++ D + +V + V + L + +
Sbjct: 32 RYRLLIFHGGVPPLQFWQAL----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCL 339
+ + VL V + ++ + +L+ + + +
Sbjct: 88 IDKPGVARVLDV-VHTRAGGLVVAEWIRGGSLQEVA----------DTSPSPVGAIRAMQ 136
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
+ H+ + V + + A D P
Sbjct: 137 SLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDANP--------------- 181
Query: 400 WLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGYRLNQPV- 457
D+ G L+ L + P E +A + +D
Sbjct: 182 --------------QDDIRGIGASLYALLV-NRWPLPEAGVRSGLAPAERDTAGQPIEPA 226
Query: 458 ----NCPDELFSVMAYCWAMNPEGRP 479
+ P ++ +V A + R
Sbjct: 227 DIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 9e-09
Identities = 45/226 (19%), Positives = 82/226 (36%), Gaps = 65/226 (28%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVK--TVTDNASAVQ--------VSLLLQEGMAMYGLS 281
EG FG VY+G + V VK + + + + ++ +
Sbjct: 41 EGGFGVVYKGYV---NN--TTVAVKKLAAMVDITTEELKQQFDQEIKVMAK-------CQ 88
Query: 282 HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVD--MCL 339
H+N++ +LG S + L+Y Y +L L L + M
Sbjct: 89 HENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL-----------SCLDGTPPLSWHMRC 136
Query: 340 QIIMGV----QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
+I G +LH+ +H+D+ + N ++D+ +I+D LAR
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR-ASEK-----FAQT- 189
Query: 396 RPVKWLAIESLVHKTF------------STASDVWAFGVLLWELTT 429
+ S + T + SD+++FGV+L E+ T
Sbjct: 190 ------VMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 44/214 (20%), Positives = 74/214 (34%), Gaps = 53/214 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G F V R E K + T SA L +E L H NI+ +
Sbjct: 39 KGAFSVVRRCV---HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQIIM 343
I++ + +L+ L G VA + + QI+
Sbjct: 96 S-IQEESFHYLV---------------FDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSD----------YHCL 390
+ Y H ++H++L N ++ K +++ D LA ++ S+ Y
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGY--- 196
Query: 391 GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLL 424
L+ E L +S D+WA GV+L
Sbjct: 197 ----------LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 46/215 (21%), Positives = 80/215 (37%), Gaps = 52/215 (24%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTV-----TDNASAVQVSLLLQEGMAMYGLSHKNILT 287
G F V + + G +E K + + + V + +E + + H NI+T
Sbjct: 16 GQFAIVRKCR---QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQ 340
+ + E+ T LI +L G +LT E Q
Sbjct: 73 LHDI-FENKTDVVLIL---------------ELVSGGELFDFLAEKESLTEDEATQFLKQ 116
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDK----LRIQITDNALARDLFPSDYHCLGDNENR 396
I+ GV YLH K++ H DL N ++ DK RI++ D +A +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI----------EAGN 166
Query: 397 PVK-------WLAIESLVHKTFSTASDVWAFGVLL 424
K ++A E + ++ +D+W+ GV+
Sbjct: 167 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 48/274 (17%), Positives = 98/274 (35%), Gaps = 48/274 (17%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQE-GMAMYGLSHKNILTVLG 290
GT G+V++ + + + VK + + + + +L + + + I+ G
Sbjct: 35 SGTCGQVWKMRFRK---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH- 349
I + F+ K + PE + M + I+ + YL
Sbjct: 92 TFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGK--------MTVAIVKALYYLKE 142
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITD--------NALARDLF---PSDYHCLGDNENRPV 398
K ++H+D+ N ++D++ +I++ D + A+D +
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA------------- 189
Query: 399 KWLAIE-----SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FE--MAASLQDG 450
++A E + +DVW+ G+ L EL T Q PY FE ++
Sbjct: 190 -YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG-QFPYKNCKTDFEVLTKVLQEEP 247
Query: 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L + + S + C + RP + +L
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 45/214 (21%), Positives = 85/214 (39%), Gaps = 54/214 (25%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G+FG V + + ++E VK + +A S +L+E + L H NI+ +
Sbjct: 32 KGSFGEVLKCK---DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAHT-LTTQEVVDMCLQIIM 343
+ +ED +S +++ +L G + + + + Q+
Sbjct: 89 I-LEDSSSFYIV---------------GELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSD----------YHCL 390
G+ Y+HK ++H+DL N +++ K I+I D L+ + Y
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY--- 189
Query: 391 GDNENRPVKWLAIESLVHKTFSTASDVWAFGVLL 424
+A E L T+ DVW+ GV+L
Sbjct: 190 ----------IAPEVL-RGTYDEKCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 46/207 (22%), Positives = 88/207 (42%), Gaps = 34/207 (16%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G+FG V + + ++E VK + +A S +L+E + L H NI+ +
Sbjct: 32 KGSFGEVLKCK---DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQIIM 343
+ +ED +S +++ L G + + + + Q+
Sbjct: 89 I-LEDSSSFYIVGE---------------LYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
G+ Y+HK ++H+DL N +++ K I+I D L+ + + D +
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAY-Y 189
Query: 401 LAIESLVHKTFSTASDVWAFGVLLWEL 427
+A E L T+ DVW+ GV+L+ L
Sbjct: 190 IAPEVL-RGTYDEKCDVWSAGVILYIL 215
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 38/222 (17%), Positives = 73/222 (32%), Gaps = 37/222 (16%)
Query: 272 QEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTT 331
+E L +++ + E ++ + +L L++ L
Sbjct: 83 REARTAGRLQEPHVVPIHDFG-EIDGQLYVDMRLINGVDLAAMLRR--------QGPLAP 133
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH--- 388
V + QI + H H+D+ N +V + D +A +D
Sbjct: 134 PRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQ 191
Query: 389 ---CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445
+G + ++A E + +D++A +L+E T PY D +
Sbjct: 192 LGNTVGT-----LYYMAPERFSESHATYRADIYALTCVLYECLT-GSPPYQG-DQLSVMG 244
Query: 446 SLQDGYRLNQPV--------NCPDELFSVMAYCWAMNPEGRP 479
+ +NQ + P +V+A A NPE R
Sbjct: 245 A-----HINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 61/266 (22%), Positives = 104/266 (39%), Gaps = 41/266 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G F +V + EV +K + + + L +E M L+H NI+ +
Sbjct: 25 KGNFAKVKLARHIL---TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V IE + +LI Y + +L E A + QI+ VQY H+
Sbjct: 82 V-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR--------QIVSAVQYCHQ 132
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL--------- 401
K+++H+DL N ++D + I+I D + NE L
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFS-------------NEFTVGGKLDAFCGAPPY 179
Query: 402 -AIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRLNQPVN 458
A E K + DVW+ GV+L+ L + P+ + E+ + G YR+ P
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRERVLRGKYRI--PFY 236
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQL 484
+ +++ +NP R T Q+
Sbjct: 237 MSTDCENLLKRFLVLNPIKRGTLEQI 262
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 33/212 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV------------TDNASAVQVSLLLQEGMAMYG 279
G +G V E E +K + + + E +
Sbjct: 46 SGAYGEVLLCK---EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNL-KRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H NI+ + V ED +L+ + + L ++ + + H + ++
Sbjct: 103 LDHPNIIKLFDV-FEDKKYFYLVTEFYEGGELFEQIINR---------HKFDECDAANIM 152
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNEN 395
QI+ G+ YLHK ++H+D+ N ++++K L I+I D L+ L D
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK--LRDRLG 210
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWEL 427
++A E L K ++ DVW+ GV+++ L
Sbjct: 211 TAY-YIAPEVL-KKKYNEKCDVWSCGVIMYIL 240
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 5e-08
Identities = 43/212 (20%), Positives = 80/212 (37%), Gaps = 52/212 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G F V+ + + +K + + A + S L E + + H+NI+T+ +
Sbjct: 19 SGAFSEVFLVK---QRLTGKLFALKCI-KKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAHT-LTTQEVVDMCLQIIMG 344
E T +L+ +L G + T ++ + Q++
Sbjct: 75 -YESTTHYYLV---------------MQLVSGGELFDRILERGVYTEKDASLVIQQVLSA 118
Query: 345 VQYLHKKKLLHKDLATRNCVV---DDKLRIQITDNALARDLFPSD---------YHCLGD 392
V+YLH+ ++H+DL N + ++ +I ITD L++ Y
Sbjct: 119 VKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY----- 173
Query: 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLL 424
+A E L K +S A D W+ GV+
Sbjct: 174 --------VAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 75/283 (26%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG++G VY+ + E + V +K V + + +++E M +++ G
Sbjct: 39 EGSYGSVYKAIHKETG---QIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKL------CPEG--------VAHTLTTQEVVDM 337
+ + L C G TLT E+ +
Sbjct: 93 ----------------------YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI 130
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI---------QITDNALARDLF---PS 385
+ G++YLH + +H+D+ N +++ + Q+TD R+ P
Sbjct: 131 LQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP- 189
Query: 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----F 441
+ W+A E + ++ +D+W+ G+ E+ + PYA+I P F
Sbjct: 190 -F------------WMAPEVIQEIGYNCVADIWSLGITAIEMAEG-KPPYADIHPMRAIF 235
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ + +P D + C +PE R T QL
Sbjct: 236 MIPTN--PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 40/213 (18%), Positives = 72/213 (33%), Gaps = 55/213 (25%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G VYR + G ++ +K + V ++ E + LSH NI+ + +
Sbjct: 63 RGATSIVYRCK---QKGTQKPYALKVL---KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAHT-LTTQEVVDMCLQIIMG 344
E T L+ +L G V + ++ D QI+
Sbjct: 117 -FETPTEISLV---------------LELVTGGELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 345 VQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSD----------YHCLG 391
V YLH+ ++H+DL N + ++I D L++ + Y
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGY---- 216
Query: 392 DNENRPVKWLAIESLVHKTFSTASDVWAFGVLL 424
A E L + D+W+ G++
Sbjct: 217 ---------CAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 59/356 (16%), Positives = 117/356 (32%), Gaps = 78/356 (21%)
Query: 148 KKLRRHGEILQNGSNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFKRRPSYSRLDDRN 207
++L EI + + + + F+ + R
Sbjct: 100 ERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRG 159
Query: 208 KDLHEKLSELTIQR-CRVRLFSVNME--------------GTFGRVYRGTYTEEDGVEEE 252
+ + R C+ + +N+ G FG VY
Sbjct: 160 DVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY------------- 206
Query: 253 VLV-KTVTDNASAVQV---SLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI---YPY 305
K T A++ + + L+ + +L++ VS D PF++ Y +
Sbjct: 207 -GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL--VSTGDC--PFIVCMSYAF 261
Query: 306 Q---------DYTN---LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKL 353
D N L L + + E + II+G++++H + +
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--------IILGLEHMHNRFV 313
Query: 354 LHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCL-GDNENRPVKWLAIESLVHKT-F 411
+++DL N ++D+ ++I+D LA D H G + ++A E L +
Sbjct: 314 VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG-----YMAPEVLQKGVAY 368
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPF--EMAASLQDGYR--LNQPVNCPDEL 463
+++D ++ G +L++L L PF + R L V PD
Sbjct: 369 DSSADWFSLGCMLFKL--LRGHS-----PFRQHKTKDKHEIDRMTLTMAVELPDSF 417
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 49/273 (17%), Positives = 95/273 (34%), Gaps = 52/273 (19%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVK-----TVTDNASAVQVSLLLQEGMAM----YGLSH 282
+G FG V+ G D +V +K V + E + G H
Sbjct: 41 KGGFGTVFAGHRLT-DR--LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 283 KNILTVLGVSIEDHTSPFLIYPY-------QDYTNLKRFLQKCKLCPEGVAHTLTTQEVV 335
++ +L E L+ DY K L EG +
Sbjct: 98 PGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPL------GEGPSRCF------ 144
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPSDYH--CLGD 392
Q++ +Q+ H + ++H+D+ N ++D + ++ D L Y G
Sbjct: 145 --FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GT 201
Query: 393 NENRPVKWLAIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451
V + E + + + VW+ G+LL+++ + PFE + +
Sbjct: 202 ----RV-YSPPEWISRHQYHALPATVWSLGILLYDM--VCGDI-----PFERDQEILEA- 248
Query: 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
L+ P + + +++ C A P RP+ ++
Sbjct: 249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 8e-08
Identities = 46/219 (21%), Positives = 77/219 (35%), Gaps = 58/219 (26%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-----TDNASAVQVSLLLQEGMAMYGLSHKNIL 286
G F V + E + K + + V + +E + + H N++
Sbjct: 21 SGQFAVVKKCR---EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCL 339
T+ V E+ T LI +L G +LT +E +
Sbjct: 78 TLHEV-YENKTDVILIL---------------ELVAGGELFDFLAEKESLTEEEATEFLK 121
Query: 340 QIIMGVQYLHKKKLLHKDL-------ATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392
QI+ GV YLH ++ H DL RN K RI+I D LA +
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRN---VPKPRIKIIDFGLAHKI---------- 168
Query: 393 NENRPVK-------WLAIESLVHKTFSTASDVWAFGVLL 424
+ K ++A E + ++ +D+W+ GV+
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 9e-08
Identities = 52/286 (18%), Positives = 109/286 (38%), Gaps = 71/286 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQE-GMAMYGLSHKNILTVLG 290
G +G V + + + + VK + ++ + LL + ++M + +T G
Sbjct: 17 RGAYGVVEKMRHVPSGQI---MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 291 VSIEDH----------TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQ 340
+ TS Y K+ + K + PE + + + +
Sbjct: 74 ALFREGDVWICMELMDTSLDKFY--------KQVIDKGQTIPEDI--------LGKIAVS 117
Query: 341 IIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITD--------NALARDLF---PSDYH 388
I+ +++LH K ++H+D+ N +++ ++++ D + +A+D+
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP--- 174
Query: 389 CLGDNENRPVKWLAIE----SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-PFEM 443
++A E L K +S SD+W+ G+ + EL + PY PF+
Sbjct: 175 -----------YMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQ 222
Query: 444 AASLQDGYRLNQPVNCPDELFSV-----MAYCWAMNPEGRPTFPQL 484
+ + P + FS + C N + RPT+P+L
Sbjct: 223 LKQVVE----EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 42/204 (20%), Positives = 71/204 (34%), Gaps = 32/204 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+G F V R + +E + T SA L +E L H NI+ +
Sbjct: 21 KGAFSVVRRCV---KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQIIM 343
I + +LI L G VA + + QI+
Sbjct: 78 S-ISEEGHHYLI---------------FDLVTGGELFEDIVAREYYSEADASHCIQQILE 121
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNENRPVKW 400
V + H+ ++H++L N ++ K +++ D LA + P +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI-EVEGEQQAWFGFAGTPG-Y 179
Query: 401 LAIESLVHKTFSTASDVWAFGVLL 424
L+ E L + D+WA GV+L
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 38/213 (17%), Positives = 76/213 (35%), Gaps = 50/213 (23%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSH-KNILTVLG 290
G F V + +E K + + +L E + ++ +
Sbjct: 40 GKFAVVRQCI---SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG---------VAHTLTTQEVVDMCLQI 341
V E+ + LI + G +A ++ +V+ + QI
Sbjct: 97 V-YENTSEIILIL---------------EYAAGGEIFSLCLPELAEMVSENDVIRLIKQI 140
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNENRPV 398
+ GV YLH+ ++H DL +N ++ I+I D ++R + +
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI----------GHACEL 190
Query: 399 K-------WLAIESLVHKTFSTASDVWAFGVLL 424
+ +LA E L + +TA+D+W G++
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 50/287 (17%), Positives = 96/287 (33%), Gaps = 81/287 (28%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
G+FG VY E V +K + + S + +++E + L H N +
Sbjct: 64 HGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKL------CPEGVA-------HTLTTQEVVD 336
G +L++ C + L E+
Sbjct: 121 GC----------------------YLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 158
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA-----RDLF---PSDYH 388
+ + G+ YLH ++H+D+ N ++ + +++ D A + F P Y
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP--Y- 215
Query: 389 CLGDNENRPVKWLA---IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP----F 441
W+A I ++ + DVW+ G+ EL + P ++ +
Sbjct: 216 -----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPLFNMNAMSALY 263
Query: 442 EMAAS----LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+A + LQ G + + + + C P+ RPT L
Sbjct: 264 HIAQNESPALQSG-------HWSEYFRNFVDSCLQKIPQDRPTSEVL 303
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 38/243 (15%), Positives = 76/243 (31%), Gaps = 56/243 (23%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT----DNASAVQVSLLLQEGMAMYGLSHKNILT 287
+G++G V E+ +K + + V + E M L H NI
Sbjct: 36 QGSYGVVRVAI---ENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 288 VLGVSIEDHTSPFLI--------------------------------YPYQDYTNLKRFL 315
+ V ED L+ N +
Sbjct: 93 LYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 316 QKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN--CVVDDKLRIQI 373
E + + + ++ QI + YLH + + H+D+ N + I++
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 374 TDNALARDLFPSDYHCLGDNENRPVKWLA---------IESLVHKTFSTASDVWAFGVLL 424
D L+++ + + + E + A + + ++++ D W+ GVLL
Sbjct: 212 VDFGLSKEFYKLN-----NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 425 WEL 427
L
Sbjct: 267 HLL 269
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 59/491 (12%), Positives = 132/491 (26%), Gaps = 182/491 (37%)
Query: 114 PVSRLHLYNILAIC------AACVLI--------TVVVIYSCACFVRNKKLRRH------ 153
VSRL Y L A VLI T V + C + K++
Sbjct: 130 NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC----LSYKVQCKMDFKIF 185
Query: 154 ----G---------EILQN-----GSNSSTTGHTPFLLPAPVLNCGATSASSNTSYASFK 195
E+LQ N ++ + + ++ A +
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI----------HSIQAELR 235
Query: 196 R---RPSYSR----LDD--------------------RNKDLHEKLSELTIQRCRVRLFS 228
R Y L + R K + + LS T +
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT----TTHISL 291
Query: 229 VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-----AVQVSLLLQEGMAMYGLSHK 283
+ T T ++ + +L+K + + +
Sbjct: 292 DHHSMTL--------TPDEV--KSLLLKYLDCRPQDLPREVLTTNPRR------------ 329
Query: 284 NILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKC-------------KLC---PEGV-- 325
L+++ SI D + + + + + L ++ P
Sbjct: 330 --LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387
Query: 326 -AHTLTT--QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQITDNA-- 377
L+ +V+ + +++ LHK L+ K + +L++++ +
Sbjct: 388 PTILLSLIWFDVIKSDVMVVV--NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 378 ----LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQ 433
+ P + D+++ +L D + + + L + +
Sbjct: 446 HRSIVDHYNIPKTF----DSDDLIPPYL--------------DQYFYSHIGHHLKNI--E 485
Query: 434 PYAEIDPFE--------MAASL-QDGYRLNQPVNCPDELFSVMAY----CWAMNPEGRPT 480
+ F + + D N + + L + Y C + P
Sbjct: 486 HPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC-----DNDPK 540
Query: 481 FPQLHSCLQEF 491
+ +L + + +F
Sbjct: 541 YERLVNAILDF 551
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 44/217 (20%), Positives = 81/217 (37%), Gaps = 54/217 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQ---EGMAMYGLSHKNILTV 288
GTFG+V G + +V VK + + + ++ + E + H +I+ +
Sbjct: 21 VGTFGKVKIGEHQLTG---HKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 289 LGVSIEDHTSPFLIYPYQ------DYTNLKRFLQKCKLCPEGVAHT-LTTQEVVDMCLQI 341
V I T F++ Y DY H + E + QI
Sbjct: 77 YQV-ISTPTDFFMVMEYVSGGELFDYI---------------CKHGRVEEMEARRLFQQI 120
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL 401
+ V Y H+ ++H+DL N ++D + +I D L+ N ++L
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------------NMMSDGEFL 167
Query: 402 ----------AIESLVHKTFS-TASDVWAFGVLLWEL 427
A E + + ++ D+W+ GV+L+ L
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 54/281 (19%), Positives = 107/281 (38%), Gaps = 52/281 (18%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVK-----TVTDNASAVQVSLLLQEGMAMYGLSHK--N 284
G FG VY G D V +K ++D + + E + + +S
Sbjct: 53 SGGFGSVYSGIRVS-DN--LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 285 ILTVLGVSIEDHTSPFLIYPY-------QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
++ +L E S LI D+ + L E +A +
Sbjct: 110 VIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGAL------QEELARSF-------- 154
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPSDYH--CLGDNE 394
Q++ V++ H +LH+D+ N ++D ++ +++ D L + Y G
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GT-- 211
Query: 395 NRPVKWLAIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
V + E + + + ++ VW+ G+LL+++ + PFE + G ++
Sbjct: 212 --RV-YSPPEWIRYHRYHGRSAAVWSLGILLYDM--VCGDI-----PFEHDEEIIRG-QV 260
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
E ++ +C A+ P RPTF ++ H +Q+
Sbjct: 261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 44/225 (19%), Positives = 77/225 (34%), Gaps = 64/225 (28%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKT--------VTDNASAVQVSLLLQEGMAMYGLS-H 282
G V R +E VK + L+E + +S H
Sbjct: 27 RGVSSVVRRCI---HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 283 KNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVV 335
NI+ + E +T FL++ L +G TL+ +E
Sbjct: 84 PNIIQLKDT-YETNTFFFLVF---------------DLMKKGELFDYLTEKVTLSEKETR 127
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD--------- 386
+ ++ + LHK ++H+DL N ++DD + I++TD + L P +
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 387 -YHCLGDNENRPVKWLAIESL------VHKTFSTASDVWAFGVLL 424
Y LA E + H + D+W+ GV++
Sbjct: 188 SY-------------LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 53/216 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQ---EGMAMYGLSHKNILTV 288
EG+FG+V T+ + ++V +K + + ++ E + L H +I+ +
Sbjct: 19 EGSFGKVKLATHYKTQ---QKVALK-FISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 289 LGVSIEDHTSPFLIYPYQ-----DYTNLKRFLQKCKLCPEGVAHT-LTTQEVVDMCLQII 342
V I T ++ Y DY V +T E QII
Sbjct: 75 YDV-ITTPTDIVMVIEYAGGELFDYI---------------VEKKRMTEDEGRRFFQQII 118
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL- 401
++Y H+ K++H+DL N ++DD L ++I D L+ N +L
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS-------------NIMTDGNFLK 165
Query: 402 ---------AIESLVHKTFS-TASDVWAFGVLLWEL 427
A E + K ++ DVW+ G++L+ +
Sbjct: 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVM 201
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 62/356 (17%), Positives = 111/356 (31%), Gaps = 78/356 (21%)
Query: 147 NKKLRRHGEILQNGSNSSTTGHTPFLLPAPVLNCGATSASSNTS----------YASFKR 196
+K+ + QN + + P + V NC +
Sbjct: 96 DKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSV 155
Query: 197 RPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNM---EGTFGRVYRGTYTEEDGVEEEV 253
P LD + + L Q F +G FG V +
Sbjct: 156 APFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVC--------ACQ--- 204
Query: 254 LVKTVTDNASAVQV---SLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI---YPYQ- 306
T A + + + L+ K IL E S F++ Y Y+
Sbjct: 205 --VRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL-------EKVNSRFVVSLAYAYET 255
Query: 307 --------DYTN---LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLH 355
N LK + V +I G++ LH++++++
Sbjct: 256 KDALCLVLTLMNGGDLKFHIYHMG------QAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 356 KDLATRNCVVDDKLRIQITDNALARDLFPSDY---HCLGDNENRPVKWLAIESLVHKTFS 412
+DL N ++DD I+I+D LA + G ++A E + ++ ++
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVG-----YMAPEVVKNERYT 363
Query: 413 TASDVWAFGVLLWELTTLAQQPYAEIDPFE---MAASLQDGYR--LNQPVNCPDEL 463
+ D WA G LL+E+ +A Q PF+ ++ R P +
Sbjct: 364 FSPDWWALGCLLYEM--IAGQS-----PFQQRKKKIKREEVERLVKEVPEEYSERF 412
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 50/216 (23%), Positives = 83/216 (38%), Gaps = 43/216 (19%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG+VY+G DG V VK + + + E + H+N+L + G
Sbjct: 40 RGGFGKVYKGRL--ADG--TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVV---DMCLQIIMGV--- 345
+ T L+YPY ++ L + +I +G
Sbjct: 96 CMTP-TERLLVYPYMANGSVASCL-----------RERPESQPPLDWPKRQRIALGSARG 143
Query: 346 -QYLHKK---KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK-- 399
YLH K++H+D+ N ++D++ + D LA+ L D ++ V
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---------LMDYKDTHVTTA 194
Query: 400 ------WLAIESLVHKTFSTASDVWAFGVLLWELTT 429
+A E L S +DV+ +GV+L EL T
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 61/283 (21%), Positives = 120/283 (42%), Gaps = 63/283 (22%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS------AVQVSLLLQEGMAMYGLSHKNI 285
G FG+VY+G DG +V +K T +S ++ L H ++
Sbjct: 49 HGVFGKVYKGVL--RDG--AKVALKRRTPESSQGIEEFETEIETLSF-------CRHPHL 97
Query: 286 LTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
++++G E + LIY Y + NLKR L + +++ ++ +++C+ G+
Sbjct: 98 VSLIGFCDERNEM-ILIYKYMENGNLKRHLYG----SDLPTMSMSWEQRLEICIGAARGL 152
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
YLH + ++H+D+ + N ++D+ +ITD +++ D + + +
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISK-KGTE-----LDQTH-------LST 199
Query: 406 LVHKTF-------------STASDVWAFGVLLWELTT-----LAQQPYAEIDPFEMAASL 447
+V T + SDV++FGV+L+E+ + P ++ E A
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 448 QDGYRLNQPVN-------CPDELFSVMA---YCWAMNPEGRPT 480
+ +L Q V+ P+ L C A++ E RP+
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 27/134 (20%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH----CLGDNEN 395
+I G++YLH +K++H+D+ N +V + I+I D ++ + SD G
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GT--- 200
Query: 396 RPVKWLAIESLV--HKTFS-TASDVWAFGVLLWELTT--LAQQPYAEIDPFEMAASLQDG 450
P ++A ESL K FS A DVWA GV L+ PF +
Sbjct: 201 -PA-FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC---------PFM-DERIMCL 248
Query: 451 YR--LNQPVNCPDE 462
+ +Q + PD+
Sbjct: 249 HSKIKSQALEFPDQ 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 33/157 (21%), Positives = 61/157 (38%), Gaps = 32/157 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQ----EGMAMYGLSHKNILT 287
EG++G+V +E VK + ++ E + L HKN++
Sbjct: 15 EGSYGKVKEVLDSETL---CRRAVK-ILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 288 VLGV-SIEDHTSPFLIYPYQ--------DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
++ V E+ +++ Y D KRF P AH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF-------PVCQAHGY--------F 115
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375
Q+I G++YLH + ++HKD+ N ++ ++I+
Sbjct: 116 CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISA 152
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 42/224 (18%), Positives = 77/224 (34%), Gaps = 63/224 (28%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-------TDNASAVQVSLLLQEGMAMYGLS-HK 283
G V R E VK + + +E + ++ H
Sbjct: 104 RGVSSVVRRCV---HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 284 NILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVD 336
+I+T++ E + FL++ L +G L+ +E
Sbjct: 161 HIITLIDS-YESSSFMFLVF---------------DLMRKGELFDYLTEKVALSEKETRS 204
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD---------- 386
+ ++ V +LH ++H+DL N ++DD ++I+++D + L P +
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPG 264
Query: 387 YHCLGDNENRPVKWLAIESL------VHKTFSTASDVWAFGVLL 424
Y LA E L H + D+WA GV+L
Sbjct: 265 Y-------------LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 67/254 (26%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQV---SLLLQEGMAMYGLSHKNILTV 288
G+FGRV LVK A+++ +++ + L+ K IL
Sbjct: 52 GSFGRVM--------------LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 289 LGVSIEDHTSPFLI---YPYQDYTNLK------------RFLQKCKLCPEGVAHTLTTQE 333
+ + PFL+ + ++D +NL L++ E A Q
Sbjct: 98 V-----NF--PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ- 149
Query: 334 VVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN 393
I++ +YLH L+++DL N ++D + IQ+TD A+ + + G
Sbjct: 150 -------IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP 202
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP--YAEIDPFEMAASLQDGY 451
E LA E ++ K ++ A D WA GVL++E+ A P +A+ P ++ Y
Sbjct: 203 E-----ALAPEIILSKGYNKAVDWWALGVLIYEM--AAGYPPFFAD-QPIQI-------Y 247
Query: 452 R--LNQPVNCPDEL 463
++ V P
Sbjct: 248 EKIVSGKVRFPSHF 261
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 39/212 (18%), Positives = 66/212 (31%), Gaps = 54/212 (25%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292
G++G V + G K + V QE M L H NI+ +
Sbjct: 20 GSWGEVKIAV---QKGTRIRRAAKKI-PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74
Query: 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQIIMGV 345
ED+T +L+ +LC G V + + ++ V
Sbjct: 75 FEDNTDIYLVM---------------ELCTGGELFERVVHKRVFRESDAARIMKDVLSAV 119
Query: 346 QYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSD----------YHCLGD 392
Y HK + H+DL N + +++ D LA P Y
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYY----- 174
Query: 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLL 424
++ + L + D W+ GV++
Sbjct: 175 --------VSPQVL-EGLYGPECDEWSAGVMM 197
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 33/133 (24%), Positives = 64/133 (48%), Gaps = 22/133 (16%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH----CLGDNEN 395
QI+ G+++LH++ ++++DL N ++DD ++I+D LA +L G
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPG- 354
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE---MAASLQDGYR 452
++A E L+ + + + D +A GV L+E+ +A + PF ++ +
Sbjct: 355 ----FMAPELLLGEEYDFSVDYFALGVTLYEM--IAARG-----PFRARGEKVENKELKQ 403
Query: 453 --LNQPVNCPDEL 463
L Q V PD+
Sbjct: 404 RVLEQAVTYPDKF 416
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 41/216 (18%), Positives = 75/216 (34%), Gaps = 60/216 (27%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ--VSLLLQEGMAMYGLSHKNILTVL 289
G++ R E VK + + + +LL+ H NI+T+
Sbjct: 32 VGSYSVCKRCI---HKATNMEFAVKIIDKSKRDPTEEIEILLRY------GQHPNIITLK 82
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAH-TLTTQEVVDMCLQII 342
V +D +++ +L G + + +E + I
Sbjct: 83 DV-YDDGKYVYVVT---------------ELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 343 MGVQYLHKKKLLHKDL-------ATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
V+YLH + ++H+DL + + I+I D A+ L EN
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDES---GNPESIRICDFGFAKQLRA---------EN 174
Query: 396 RPVK-------WLAIESLVHKTFSTASDVWAFGVLL 424
+ ++A E L + + A D+W+ GVLL
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 38/220 (17%), Positives = 75/220 (34%), Gaps = 57/220 (25%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-------TDNASAVQVSLLLQEGMAMYGLSHKN 284
G G V E ++V ++ + A + E + L+H
Sbjct: 145 SGACGEVKLAF---ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAHT-LTTQEVVDM 337
I+ + + +++ +L G V + L
Sbjct: 202 IIKIKNF-FDA-EDYYIVL---------------ELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNE 394
Q+++ VQYLH+ ++H+DL N ++ + I+ITD ++ L E
Sbjct: 245 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----------GE 294
Query: 395 NRPVKWLA----------IESLVHKTFSTASDVWAFGVLL 424
++ L + S+ ++ A D W+ GV+L
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 60/283 (21%), Positives = 105/283 (37%), Gaps = 62/283 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLG 290
GT+G+VY+G + + + +K + + + + + QE + S H+NI T G
Sbjct: 34 NGTYGQVYKGRHVKTG---QLAAIKVM--DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCK------LCPEGVAHTLTTQEVVDMCLQIIMG 344
+ P L ++ C L +TL + + +C +I+ G
Sbjct: 89 -------AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 345 VQYLHKKKLLHKD------LATRNCVVDDKL-----RIQITDNALARDLF---PSDYHCL 390
+ +LH+ K++H+D L T N V KL Q+ R+ F P Y
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEV--KLVDFGVSAQLDRTVGRRNTFIGTP--Y--- 194
Query: 391 GDNENRPVKWLAIESLVHKTFSTAS-----DVWAFGVLLWELTTLAQQPYAEIDP----F 441
W+A E + A+ D+W+ G+ E+ P ++ P F
Sbjct: 195 ---------WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG-APPLCDMHPMRALF 244
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ + RL + + S + C N RP QL
Sbjct: 245 LIPRN--PAPRL-KSKKWSKKFQSFIESCLVKNHSQRPATEQL 284
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 33/151 (21%), Positives = 70/151 (46%), Gaps = 21/151 (13%)
Query: 282 HKNILTVLGVSIEDHTS--PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCL 339
NI+T+ + ++D S P L++ + + T+ K+ Q TLT ++
Sbjct: 90 GPNIITLADI-VKDPVSRTPALVFEHVNNTDFKQLYQ-----------TLTDYDIRFYMY 137
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLR-IQITDNALARDLFPSDYHCLGDNENRPV 398
+I+ + Y H ++H+D+ N ++D + R +++ D LA P + N
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY----NVRVAS 193
Query: 399 KWL-AIESLV-HKTFSTASDVWAFGVLLWEL 427
++ E LV ++ + + D+W+ G +L +
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 33/216 (15%), Positives = 75/216 (34%), Gaps = 49/216 (22%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT----DNASAVQVSLLLQEGMAMYGLSHKNILT 287
+G F V R ++ VK V ++ + L +E + L H +I+
Sbjct: 34 KGPFSVVRRCI---NRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNL-KRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+L ++++ + D +L +++ + QI+ ++
Sbjct: 91 LLET-YSSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHYMRQILEALR 144
Query: 347 YLHKKKLLHKDL-------ATRNCVVDDKLRIQITDNALARDLFPSD-----------YH 388
Y H ++H+D+ A++ ++ +++ +A L S +
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASK----ENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF- 199
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLL 424
+A E + + + DVW GV+L
Sbjct: 200 ------------MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 43/216 (19%), Positives = 76/216 (35%), Gaps = 51/216 (23%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG +G V EE V VK V + + +E L+H+N++ G
Sbjct: 17 EGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 292 SIEDHTSPFLIYPYQ------DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
+ +L Y D + P+ + + Q++ GV
Sbjct: 74 -RREGNIQYLFLEYCSGGELFDR-----------IEPDIG---MPEPDAQRFFHQLMAGV 118
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITD---NALARDLFPSDYHCLGDNENRPVKWL- 401
YLH + H+D+ N ++D++ ++I+D + R N + L
Sbjct: 119 VYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY-------------NNRERLLN 165
Query: 402 ---------AIESLVHKTFS-TASDVWAFGVLLWEL 427
A E L + F DVW+ G++L +
Sbjct: 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 45/279 (16%), Positives = 99/279 (35%), Gaps = 53/279 (18%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G +G V + + + + VK + + Q LL+ + M I+ G
Sbjct: 32 RGAYGSVNKMVHKPSG---QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH- 349
++ ++ T+ +F + + + + + + L + + +L
Sbjct: 89 -ALFREGDCWICMELMS-TSFDKFYKYVYSVLDD---VIPEEILGKITLATVKALNHLKE 143
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITD--------NALARDLF---PSDYHCLGDNENRPV 398
K++H+D+ N ++D I++ D +++A+
Sbjct: 144 NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRP------------- 190
Query: 399 KWLAIE----SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454
++A E S + + SDVW+ G+ L+EL T + PY + + + L +
Sbjct: 191 -YMAPERIDPSASRQGYDVRSDVWSLGITLYELATG-RFPYPKWNS--VFDQLT--QVVK 244
Query: 455 QPV----NCPDELFSV-----MAYCWAMNPEGRPTFPQL 484
N + FS + C + RP + +L
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (113), Expect = 3e-06
Identities = 21/181 (11%), Positives = 46/181 (25%), Gaps = 32/181 (17%)
Query: 232 EGTFGRVYRGTYT-----------EEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL 280
EG FG V++ E + KT + + +S L
Sbjct: 30 EGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89
Query: 281 SHKNILTVLGVSI-EDHTSPFLIYPYQDYTNLKRFLQKC-------------KLCPEG-- 324
+ + + V + P L+ + Y + K + G
Sbjct: 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID 149
Query: 325 ----VAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDNALA 379
+ + Q+ + + H+DL N ++ ++
Sbjct: 150 LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNG 209
Query: 380 R 380
+
Sbjct: 210 K 210
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 44/217 (20%), Positives = 83/217 (38%), Gaps = 54/217 (24%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQ---EGMAMYGLSHKNILTV 288
GTFG+V G + +V VK + + + ++ + E + H +I+ +
Sbjct: 26 VGTFGKVKVGKHELTG---HKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 289 LGVSIEDHTSPFLIYPYQ------DYTNLKRFLQKCKLCPEGVAHT-LTTQEVVDMCLQI 341
V I + F++ Y DY + L +E + QI
Sbjct: 82 YQV-ISTPSDIFMVMEYVSGGELFDYI---------------CKNGRLDEKESRRLFQQI 125
Query: 342 IMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL 401
+ GV Y H+ ++H+DL N ++D + +I D L+ N ++L
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------------NMMSDGEFL 172
Query: 402 ----------AIESLVHKTFS-TASDVWAFGVLLWEL 427
A E + + ++ D+W+ GV+L+ L
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYAL 209
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 35/156 (22%), Positives = 70/156 (44%), Gaps = 21/156 (13%)
Query: 280 LSHKNILTVLGV-----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEV 334
++HKNI+++L V ++E+ +L+ D NL + +Q L + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM----------ELDHERM 166
Query: 335 VDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394
+ Q++ G+++LH ++H+DL N VV ++I D LAR S
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TP 222
Query: 395 NRPVKWL-AIESLVHKTFSTASDVWAFGVLLWELTT 429
++ A E ++ + D+W+ G ++ E+
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 43/221 (19%), Positives = 76/221 (34%), Gaps = 61/221 (27%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVK-----TVTDNASAVQVSLLLQEGMAMYGLSHKNIL 286
EG +G V EE V VK D ++ +E L+H+N++
Sbjct: 17 EGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIK-----KEICINKMLNHENVV 68
Query: 287 TVLGVSIEDHTSPFLIYPYQ------DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQ 340
G + +L Y D + P+ + + Q
Sbjct: 69 KFYGH-RREGNIQYLFLEYCSGGELFDR-----------IEPDIG---MPEPDAQRFFHQ 113
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD---NALARDLFPSDYHCLGDNENRP 397
++ GV YLH + H+D+ N ++D++ ++I+D + R N
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY-------------NNR 160
Query: 398 VKWL----------AIESLVHKTFS-TASDVWAFGVLLWEL 427
+ L A E L + F DVW+ G++L +
Sbjct: 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 19/155 (12%)
Query: 280 LSHKNILTVLGVSIEDHTSPFL--IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVV 335
++HKNI+ +L V + +Y + NL + +Q L + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----------ELDHERMS 130
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
+ Q++ G+++LH ++H+DL N VV ++I D LAR S
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPY 186
Query: 396 RPVKWL-AIESLVHKTFSTASDVWAFGVLLWELTT 429
++ A E ++ + D+W+ G ++ E+
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 40/223 (17%), Positives = 75/223 (33%), Gaps = 63/223 (28%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-------TDNASAVQVSLLLQEGMAMYGLSHKN 284
G G V E ++V +K + A + E + L+H
Sbjct: 20 SGACGEVKLAF---ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEG------VAHT-LTTQEVVDM 337
I+ + + +++ +L G V + L
Sbjct: 77 IIKIKNF-FDAE-DYYIVL---------------ELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSD-------- 386
Q+++ VQYLH+ ++H+DL N ++ + I+ITD ++ L +
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 387 --YHCLGDNENRPVKWLA---IESLVHKTFSTASDVWAFGVLL 424
Y LA + S+ ++ A D W+ GV+L
Sbjct: 180 PTY-------------LAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 42/236 (17%), Positives = 90/236 (38%), Gaps = 41/236 (17%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL-LLQEGMAMYGLSHKNILTVLG 290
G++G V E V +K + + +L+E + L+H +++ VL
Sbjct: 63 TGSYGHVCEAYDKLEK---RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 291 VSIEDHTSPFL-IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ I F +Y + ++ K+ + LT + + +++GV+Y
Sbjct: 120 IVIPKDVEKFDELYVVLEIADSDFKKLFRTPV--------YLTELHIKTLLYNLLVGVKY 171
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES-- 405
+H +LH+DL NC+V+ +++ D LAR + + + + + +
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 406 ------------------------LVHKTFSTASDVWAFGVLLWELTTLAQQPYAE 437
L+ + ++ A DVW+ G + EL + ++ A
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 21/160 (13%)
Query: 280 LSHKNILTVLGVSIEDHTSPFL-IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
H+NI+T+ + D F +Y Q+ T+L R + L + + + +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI------- 118
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
Q + V+ LH ++H+DL N +++ +++ D LAR + S +
Sbjct: 119 --YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 397 PV-------KWL-AIESLV-HKTFSTASDVWAFGVLLWEL 427
+W A E ++ +S A DVW+ G +L EL
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 36/214 (16%), Positives = 75/214 (35%), Gaps = 54/214 (25%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLG 290
G G+V ++ +K + D+ QE + S +I+ +L
Sbjct: 39 LGVNGKVLECF---HRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILD 89
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKC-KLCPEG---------VAHTLTTQEVVDMCLQ 340
V Y++ + KR L + G T +E ++
Sbjct: 90 V-------------YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNENRP 397
I +Q+LH + H+D+ N + K +++TD A++
Sbjct: 137 IGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-----------TQNA 185
Query: 398 VK-------WLAIESLVHKTFSTASDVWAFGVLL 424
++ ++A E L + + + D+W+ GV++
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 45/201 (22%), Positives = 82/201 (40%), Gaps = 17/201 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG +G V V +K ++ L+E + H+NI+ + +
Sbjct: 37 EGAYGMVCSAYDNLNK---VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 292 SIEDHTSPFL-IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
+Y QD T+L + L+ L+ + QI+ G++Y+
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYKLLK---------TQHLSNDHICYFLYQILRGLKYI 144
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWL-AIESLV 407
H +LH+DL N +++ ++I D LAR P H E +W A E ++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 408 -HKTFSTASDVWAFGVLLWEL 427
K ++ + D+W+ G +L E+
Sbjct: 205 NSKGYTKSIDIWSVGCILAEM 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 43/208 (20%), Positives = 79/208 (37%), Gaps = 44/208 (21%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLG 290
EG+F + + VK ++ + +E A+ H NI+ +
Sbjct: 21 EGSFSICRKCV---HKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHE 73
Query: 291 VSIEDHTSPFLIYPYQDYTN----LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
V D FL+ + N +R +K + E + +++ V
Sbjct: 74 V-FHDQLHTFLV---MELLNGGELFERIKKK---------KHFSETEASYIMRKLVSAVS 120
Query: 347 YLHKKKLLHKDLATRNCVVDDK---LRIQITDNALARDLFPSDYHCLGDNENRPVK---- 399
++H ++H+DL N + D+ L I+I D AR P +N+P+K
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP---------DNQPLKTPCF 171
Query: 400 ---WLAIESLVHKTFSTASDVWAFGVLL 424
+ A E L + + D+W+ GV+L
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 41/205 (20%), Positives = 82/205 (40%), Gaps = 29/205 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSL-LLQEGMAMYGLSHKNILTVLG 290
G +G V T+ V VK ++ ++ + +E + + H+N++ +L
Sbjct: 39 SGAYGSVCAAFDTKTG---LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 291 VSIEDHTSPFL--IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
V + +Y +L ++ LT V + QI+ G++
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---------CQKLTDDHVQFLIYQILRGLK 146
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP--SDYHCLGDNENRPVKWL-AI 403
Y+H ++H+DL N V++ ++I D LAR + Y +W A
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA--------TRWYRAP 198
Query: 404 ESLV-HKTFSTASDVWAFGVLLWEL 427
E ++ ++ D+W+ G ++ EL
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 50/271 (18%), Positives = 94/271 (34%), Gaps = 42/271 (15%)
Query: 184 SASSNTSYASFKRRPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNM---------EGT 234
+ S S ++ ++ + K++ + + + G+
Sbjct: 7 TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGS 66
Query: 235 FGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294
FG VY+ + E V +K V + +E M L H NI+ +
Sbjct: 67 FGVVYQAKLCDSG---ELVAIKKVLQDKRFK-----NRELQIMRKLDHCNIVRLRYFFYS 118
Query: 295 DHTSPFLIYPY--QDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+Y DY + R + TL V Q+ + Y+H
Sbjct: 119 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAK----QTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 351 KKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPS----DYHCLGDNENRPVKWL-AIE 404
+ H+D+ +N ++D D +++ D A+ L Y C ++ A E
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--------SRYYRAPE 226
Query: 405 SLVH-KTFSTASDVWAFGVLLWELTTLAQQP 434
+ ++++ DVW+ G +L EL L QP
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAEL--LLGQP 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 39/219 (17%), Positives = 83/219 (37%), Gaps = 44/219 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA----VQVSLLLQEGMAMYGLSHKNILT 287
G+FG V++ E +EV +K V + +Q +++ + H N++
Sbjct: 50 NGSFGVVFQAKLVES----DEVAIKKVLQDKRFKNRELQ---IMRI------VKHPNVVD 96
Query: 288 VLGV-----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQII 342
+ +D L+ Y + R + T+ + Q++
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLK----QTMPMLLIKLYMYQLL 151
Query: 343 MGVQYLHKKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPS----DYHCLGDNENRP 397
+ Y+H + H+D+ +N ++D +++ D A+ L Y C
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-------- 203
Query: 398 VKWL-AIESLVH-KTFSTASDVWAFGVLLWELTTLAQQP 434
++ A E + ++T D+W+ G ++ EL + QP
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAEL--MQGQP 240
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 34/168 (20%), Positives = 65/168 (38%), Gaps = 24/168 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQ----------EGMAMYGLS 281
G++G V G +E V +K V + S + +L E +
Sbjct: 32 SGSYGAVCAGVDSEG----IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 282 HKNILTVLGVSIEDHTSPFL-IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
H NIL + + + +Y + T+L + + ++ ++ Q +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI-------VISPQHIQYFM 140
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386
I++G+ LH+ ++H+DL N ++ D I I D LAR+
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 49/289 (16%), Positives = 99/289 (34%), Gaps = 60/289 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G+FG +Y GT EEV +K Q L E + G+
Sbjct: 19 SGSFGDIYLGTDIAAG---EEVAIKLECVKTKHPQ---LHIESKIYKMMQGGV-----GI 67
Query: 292 SIEDHTSPFLIY--PYQDYT---------NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQ 340
P + + DY +L+ C + + V+ + Q
Sbjct: 68 -------PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-------RKFSLKTVLLLADQ 113
Query: 341 IIMGVQYLHKKKLLHKDLATRNCVV---DDKLRIQITDNALARDLF-PSDYHCLGDNENR 396
+I ++Y+H K +H+D+ N ++ + I D LA+ + + EN+
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173
Query: 397 P----VKWLAIESLVHKTFSTASDVWAFGVLLWEL-----------TTLAQQPYAEIDPF 441
++ +I + + S D+ + G +L +Q Y I
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233
Query: 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
+M+ ++ L + P E + + +C ++ + +P + L +
Sbjct: 234 KMSTPIEV---LCK--GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 27/172 (15%), Positives = 67/172 (38%), Gaps = 32/172 (18%)
Query: 280 LSHKNILTVLGVSIEDHTSPFL-IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVVD 336
L I+ + + I D F +Y + ++LK+ + LT + +
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT--------PIFLTEEHIKT 133
Query: 337 MCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR 396
+ +++G ++H+ ++H+DL NC+++ +++ D LAR + + ++
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193
Query: 397 PVKWLAIES---------------------LVHKTFSTASDVWAFGVLLWEL 427
+ L+ + ++ + D+W+ G + EL
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 35/160 (21%), Positives = 70/160 (43%), Gaps = 29/160 (18%)
Query: 280 LSHKNILTVLGVSIEDHTSPFL--IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVV 335
+ H+N++ +L V D T Y + T+L + ++ KL + + +
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV------ 134
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS--DYHCLGDN 393
Q++ G++Y+H ++H+DL N V++ ++I D LAR Y
Sbjct: 135 ---YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY------ 185
Query: 394 ENRPV--KWL-AIESLV-HKTFSTASDVWAFGVLLWELTT 429
V +W A E ++ ++ D+W+ G ++ E+ T
Sbjct: 186 ----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 32/209 (15%), Positives = 67/209 (32%), Gaps = 64/209 (30%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLG 290
G G+V + +E+ +K + D +E + S +I+ ++
Sbjct: 28 LGINGKVLQIF---NKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 78
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFL----QKC-------KLCPEGVAHTLTTQEVVDMCL 339
V Y++ ++ L + ++ G T +E ++
Sbjct: 79 V-------------YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 124
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVK 399
I +QYLH + H RD+ P + N +K
Sbjct: 125 SIGEAIQYLHSINIAH------------------------RDVKPENLLYTSKRPNAILK 160
Query: 400 W----LAIESLVHKTFSTASDVWAFGVLL 424
A E+ + + + D+W+ GV++
Sbjct: 161 LTDFGFAKETT-GEKYDKSCDMWSLGVIM 188
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 42/209 (20%), Positives = 76/209 (36%), Gaps = 59/209 (28%)
Query: 283 KNILTVLGVSIEDHTSPFLI---YPYQDYTNL-----------KRF-LQKCKLCPEGVAH 327
I+ L +H PFL+ Y +QD ++ R+ LQ+ E
Sbjct: 66 LQIMQGL-----EH--PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV- 117
Query: 328 TLTTQEVVDMCL---QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFP 384
L +++M + YL ++++H+D+ N ++D+ + ITD +A L
Sbjct: 118 ----------KLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 385 SDYH---CLGDNENRPVKWLAIESLVHKTF---STASDVWAFGVLLWELTTLAQQPYAEI 438
G ++A E + S A D W+ GV +EL L +
Sbjct: 168 ETQITTMA-GTKP-----YMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL--LRGRR---- 215
Query: 439 DPFEM--AASLQDGYR--LNQPVNCPDEL 463
P+ + + S ++ V P
Sbjct: 216 -PYHIRSSTSSKEIVHTFETTVVTYPSAW 243
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 50/262 (19%), Positives = 97/262 (37%), Gaps = 83/262 (31%)
Query: 233 GTFGRVYRGTYTEEDGVEEEVLV-KTVTDNASAVQV---SLLLQEGMAMYGLSHKNILTV 288
G+FGRV+ L+ A++V ++++ + + +L++
Sbjct: 17 GSFGRVH--------------LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 289 LGVSIEDHTSPFLI---YPYQDYTNLK------------RFLQKCKLCPEGVAHTLTTQE 333
+ H PF+I +QD + L+K + P VA +
Sbjct: 63 V-----TH--PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE- 114
Query: 334 VVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN 393
+ + ++YLH K ++++DL N ++D I+ITD A+
Sbjct: 115 -------VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK------------- 154
Query: 394 ENRPVKW--------LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP--YAEIDPFEM 443
V + +A E + K ++ + D W+FG+L++E+ LA Y + +
Sbjct: 155 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM--LAGYTPFYDS-NTMKT 211
Query: 444 AASLQDGYR--LNQPVNCPDEL 463
Y LN + P
Sbjct: 212 -------YEKILNAELRFPPFF 226
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 46/201 (22%), Positives = 86/201 (42%), Gaps = 51/201 (25%)
Query: 283 KNILTVLGVSIEDHTSPFLI---YPYQ---------DYTN---LKRFLQKCKLCPEGVAH 327
K++ +H PFL+ +Q +Y N L +Q+ + PE A
Sbjct: 60 KHVF----EQASNH--PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA- 112
Query: 328 TLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSD 386
+I + + YLH++ ++++DL N ++D + I++TD + + L P D
Sbjct: 113 -------RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165
Query: 387 Y---HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443
C G ++A E L + + + D WA GVL++E+ +A + PF++
Sbjct: 166 TTSTFC-GTPN-----YIAPEILRGEDYGFSVDWWALGVLMFEM--MAGRS-----PFDI 212
Query: 444 AASLQDGYRLNQPVNCPDELF 464
S + + + D LF
Sbjct: 213 VGSSDNPDQNTE-----DYLF 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 45/208 (21%), Positives = 84/208 (40%), Gaps = 65/208 (31%)
Query: 283 KNILTVLGVSIEDHTSPFLI---YPYQ---------DYTN---LKRFLQKCKLCPEGVAH 327
K++ +H PFL+ +Q +Y N L +Q+ + PE A
Sbjct: 103 KHVF----EQASNH--PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA- 155
Query: 328 TLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSD 386
+I + + YLH++ ++++DL N ++D + I++TD + + L P D
Sbjct: 156 -------RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208
Query: 387 ----------YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYA 436
Y +A E L + + + D WA GVL++E+ +A +
Sbjct: 209 TTSTFCGTPNY-------------IAPEILRGEDYGFSVDWWALGVLMFEM--MAGRS-- 251
Query: 437 EIDPFEMAASLQDGYRLNQPVNCPDELF 464
PF++ S + + + D LF
Sbjct: 252 ---PFDIVGSSDNPDQNTE-----DYLF 271
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 31/160 (19%), Positives = 69/160 (43%), Gaps = 30/160 (18%)
Query: 280 LSHKNILTVLGVSIEDHTSPFL--IYPYQDY--TNLKRFLQKCKLCPEGVAHTLTTQEVV 335
+ H+N++ +L V + Y + T+L++ + + +++
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL----------KFSEEKIQ 129
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS--DYHCLGDN 393
+ Q++ G++Y+H ++H+DL N V++ ++I D LAR Y
Sbjct: 130 YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY------ 183
Query: 394 ENRPV--KWL-AIESLV-HKTFSTASDVWAFGVLLWELTT 429
V +W A E ++ ++ D+W+ G ++ E+ T
Sbjct: 184 ----VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 35/211 (16%), Positives = 77/211 (36%), Gaps = 47/211 (22%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLG 290
G G+V + +E+ +K + D +E + S +I+ ++
Sbjct: 72 LGINGKVLQIF---NKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 122
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFL----QKC-------KLCPEGVAHTLTTQEVVDMCL 339
V Y++ ++ L + ++ G T +E ++
Sbjct: 123 V-------------YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMK 168
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLR---IQITDNALARDLFPSDYHCLGDNENR 396
I +QYLH + H+D+ N + K +++TD A++ ++
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS------HNSLTT 222
Query: 397 PVKW---LAIESLVHKTFSTASDVWAFGVLL 424
P +A E L + + + D+W+ GV++
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 32/130 (24%), Positives = 64/130 (49%), Gaps = 20/130 (15%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSDY---HCLGDNEN 395
+I +G+ +L K ++++DL N ++D + I+I D + + +++ C G +
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPD- 507
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--L 453
++A E + ++ + + D WAFGVLL+E+ LA Q PFE + ++ +
Sbjct: 508 ----YIAPEIIAYQPYGKSVDWWAFGVLLYEM--LAGQA-----PFE-GEDEDELFQSIM 555
Query: 454 NQPVNCPDEL 463
V P +
Sbjct: 556 EHNVAYPKSM 565
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 34/137 (24%), Positives = 55/137 (40%), Gaps = 34/137 (24%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPSD----------YH 388
+II + +LH K ++++DL N ++D + ++ D + + + Y
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY- 190
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ 448
+A E L + A D WA GVLL+E+ L PFE A +
Sbjct: 191 ------------IAPEILQEMLYGPAVDWWAMGVLLYEM--LCGHA-----PFE-AENED 230
Query: 449 DGYR--LNQPVNCPDEL 463
D + LN V P L
Sbjct: 231 DLFEAILNDEVVYPTWL 247
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 29/129 (22%), Positives = 58/129 (44%), Gaps = 18/129 (13%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC---LGDNENR 396
+I M + +LH+K ++++DL N +++ + +++TD L ++ G E
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE-- 186
Query: 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--LN 454
++A E L+ + A D W+ G L++++ L P PF + + L
Sbjct: 187 ---YMAPEILMRSGHNRAVDWWSLGALMYDM--LTGAP-----PFT-GENRKKTIDKILK 235
Query: 455 QPVNCPDEL 463
+N P L
Sbjct: 236 CKLNLPPYL 244
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 32/137 (23%), Positives = 62/137 (45%), Gaps = 34/137 (24%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR-DLFPS----------DYH 388
+I +G+ +L K ++++DL N ++D + I+I D + + +++ DY
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDY- 187
Query: 389 CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ 448
+A E + ++ + + D WAFGVLL+E+ LA Q PFE
Sbjct: 188 ------------IAPEIIAYQPYGKSVDWWAFGVLLYEM--LAGQA-----PFE-GEDED 227
Query: 449 DGYR--LNQPVNCPDEL 463
+ ++ + V P +
Sbjct: 228 ELFQSIMEHNVAYPKSM 244
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 24/106 (22%), Positives = 55/106 (51%), Gaps = 15/106 (14%)
Query: 340 QIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHC---LGDNENR 396
++ + + +LH ++++DL N ++D++ I++TD L+++ + G E
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-- 191
Query: 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442
++A E + + + ++D W+FGVL++E+ L PF+
Sbjct: 192 ---YMAPEVVNRRGHTQSADWWSFGVLMFEM--LTGTL-----PFQ 227
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 499 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 2ygo_A | 188 | WIF-1, WNT inhibitory factor 1; signaling protein, | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 2ygn_A | 156 | WIF-1, WNT inhibitory factor 1; signaling protein, | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.93 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.85 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.44 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 97.43 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.21 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 97.05 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.94 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 96.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.91 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 96.86 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 96.85 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 96.82 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 96.81 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 96.8 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 96.77 | |
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 96.75 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.71 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 96.63 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 96.61 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 96.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.58 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 96.55 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 96.55 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 96.52 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 96.51 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 96.5 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 96.5 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 96.48 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.44 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 96.42 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 96.39 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 96.38 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 96.37 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 96.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.8 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 94.53 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.12 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.74 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.5 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.39 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 92.49 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 88.8 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 86.73 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.47 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 83.78 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.6 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-63 Score=486.48 Aligned_cols=273 Identities=32% Similarity=0.567 Sum_probs=235.8
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
++....+++.+.||+|+||+||+|++.+. ....+.||||++.........+.|.+|+.++++++|||||+++|+|.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK- 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-
Confidence 45567788999999999999999998532 123378999999766555556789999999999999999999999755
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~ 367 (499)
+...+||||||++|+|.++|+...... ......++|.++++|+.|||.||+|||+++||||||||+|||||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 556799999999999999997643211 112346999999999999999999999999999999999999999
Q ss_pred CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i 447 (499)
++.+||+|||+|+.....+.....+...||+.|||||++.++.|+.++|||||||++|||+|.|++||.+.+..++...+
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999997765554444556789999999999999999999999999999999999889999999999999999
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 448 QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
..+.+++.|.++++++.+++.+||+.||++||||.||++.|+.+
T Consensus 261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99888889999999999999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-62 Score=481.71 Aligned_cols=276 Identities=30% Similarity=0.576 Sum_probs=238.9
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+.+++|.+.+.||+|+||+||+|++.+. ......||||++... +....+.|.+|+++|++++|||||+++|+|.+
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~- 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVE- 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-
Confidence 46778899999999999999999998542 122378999999765 45566889999999999999999999999754
Q ss_pred CCceEEEEEeCCCCCHHHHHHhccc-----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKL-----CPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
++..+||||||++|+|.++|+.... ........++|.+++.|+.|||+||+|||+++||||||||+|||||+++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 5667999999999999999986431 01122357999999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
+||+|||+|+.....+.........||+.|||||++.+..|+.++|||||||++|||+|.|+.||.+.+..++...+..+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999997765555444555678999999999999999999999999999999999889999999999999999988
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 451 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.++..|..+++++.+++.+||+.||++||||.||++.|+++.+..
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 888899999999999999999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-62 Score=482.05 Aligned_cols=276 Identities=29% Similarity=0.556 Sum_probs=230.8
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+.+.++.+.+.||+|+||+||+|++.+. ....+.||||++... +....+.|.+|+++|++++|||||+++|+|.+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 456778899999999999999999998642 123378999999754 45566889999999999999999999999754
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCP-------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~ 367 (499)
....+||||||++|+|.++++...... ......++|.+++.|+.|||+||+|||+++||||||||+|||||+
T Consensus 115 -~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 -GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 556799999999999999998754211 112346999999999999999999999999999999999999999
Q ss_pred CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i 447 (499)
++.+||+|||+|+.....+.....+...||+.|||||++.+..|+.++|||||||++|||+|.|+.||.+.+..++...+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999998765555445556789999999999999999999999999999999999889999999999999999
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 448 QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
..+.++..|..+++++.+++.+||+.||++||||.||++.|+.+.+.
T Consensus 274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 88888999999999999999999999999999999999999998764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=483.79 Aligned_cols=282 Identities=27% Similarity=0.488 Sum_probs=245.7
Q ss_pred hcccceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC-CcceeEE
Q psy1789 213 KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH-KNILTVL 289 (499)
Q Consensus 213 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~ 289 (499)
...+|++++++|++++.||+|+||+||+|++.+.+ ...+.||||++.........+.|.+|+.+|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34568899999999999999999999999987543 34578999999877777777889999999999965 8999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATR 361 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~ 361 (499)
|+|.+++...+||||||++|+|.++|+..+... ......++|.+++.++.|||+||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998776677899999999999999998643210 112346899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-
Q psy1789 362 NCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP- 440 (499)
Q Consensus 362 NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~- 440 (499)
|||+++++.+||+|||+|+...........+...||+.|||||++.+..|+.++|||||||++|||+|.|+.||.+.+.
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999999876554444445667899999999999999999999999999999999978999988654
Q ss_pred HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 441 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.++...+..+.++..|..+++++.+++.+||+.||++||||.||++.|+++.+.
T Consensus 295 ~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 456677888889999999999999999999999999999999999999998664
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-60 Score=467.21 Aligned_cols=265 Identities=26% Similarity=0.416 Sum_probs=220.1
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
..|+++.+++++.+.||+|+||+||+|++.+ .||||+++.. .+....+.|.+|+.++++++|||||+++|+|.
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4578888999999999999999999998643 4899998643 45666788999999999999999999999974
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
+ +..+||||||++|+|.++|+..+ ..++|.+++.|+.|||.||+|||+++||||||||+|||||+++.+||
T Consensus 103 ~--~~~~iVmEy~~gGsL~~~l~~~~-------~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 103 K--DNLAIVTQWCEGSSLYKHLHVQE-------TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp S--SSCEEEEECCSSCBHHHHHHTSC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEE
T ss_pred C--CeEEEEEEcCCCCCHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEE
Confidence 3 35699999999999999998632 36999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHc
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH---KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQD 449 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~-~~~~i~~ 449 (499)
+|||+|+.....+.........||+.|||||++.+ +.|+.++|||||||++|||+| |+.||.+.+..+ +...+..
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt-g~~Pf~~~~~~~~~~~~~~~ 252 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPYSHINNRDQIIFMVGR 252 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHHHHHT
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH-CCCCCCCCChHHHHHHHHhc
Confidence 99999997654433333456789999999999964 469999999999999999999 999998876544 4444544
Q ss_pred CCCC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 450 GYRL----NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 450 ~~~~----~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+... ..+.++++++.+++.+||+.||++||||.||++.|+.++..+
T Consensus 253 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 253 GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 4332 345578999999999999999999999999999999887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=452.31 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=217.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++++.||+|+||+||+|+...++ +.||||++... ......+.|.+|+.+|++++|||||++++++ ++++..|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-~~~~~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDG---RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-EENGSLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTC---CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-EECCEEE
Confidence 57999999999999999999987654 78999999654 3455678899999999999999999999985 5567789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
|||||+++|+|.+++...+ ...+++.+++.|+.||+.||+|||+++||||||||+||||++++.+||+|||+|+
T Consensus 100 iVmEy~~gg~L~~~i~~~~------~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 173 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQK------GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173 (350)
T ss_dssp EEEECCTTCBHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEES
T ss_pred EEEeCCCCCcHHHHHHHcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccce
Confidence 9999999999999997632 2357899999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
....... .....+||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..+..+..+..++
T Consensus 174 ~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~~~~~~~~~~s 250 (350)
T 4b9d_A 174 VLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT-LKHAFEAGSMKNLVLKIISGSFPPVSLHYS 250 (350)
T ss_dssp CCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred eecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCCccCC
Confidence 7643211 1234569999999999999999999999999999999999 999999999888888888776666777899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 251 YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=440.94 Aligned_cols=250 Identities=18% Similarity=0.284 Sum_probs=221.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
++|++++.||+|+||+||+|+...++ +.||||++.... .....+.+.+|+++|++++|||||+++++ ++++...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-~~~~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATS---REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-FQDDEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-EECSSEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCC---CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-EEeCCEE
Confidence 46999999999999999999987655 789999996432 12234678999999999999999999998 5667788
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
+|||||+++|+|.+++.+. ..+++.++..++.||+.||+|||+++|+||||||+||||++++.+||+|||+|
T Consensus 108 yivmEy~~gG~L~~~i~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla 179 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 179 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence 9999999999999999873 36999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+.+............+||+.|||||++.+..|+.++||||+||++|||+| |++||.+.+..++...+..+ ....|..+
T Consensus 180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~ 257 (311)
T 4aw0_A 180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEGLIFAKIIKL-EYDFPEKF 257 (311)
T ss_dssp EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT-CCCCCTTC
T ss_pred eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCccc
Confidence 98765444334456789999999999999999999999999999999999 99999998888888887765 45677889
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
++++.+|+.+||+.||++|||++|++
T Consensus 258 s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 99999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-57 Score=444.45 Aligned_cols=257 Identities=17% Similarity=0.208 Sum_probs=217.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
...|++.+.||+|+||.||+|+...++ +.||||++..... +.+|+.++++++|||||++++++ ++++..+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g---~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~-~~~~~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTG---FQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAV-REGPWVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEE-EETTEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCC---CEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEE-EECCEEE
Confidence 356888899999999999999987655 7899999975422 24799999999999999999985 5567789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cEEEcccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDNALA 379 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~kl~DfGla 379 (499)
|||||+++|+|.++++.. ..+++.++..++.||+.||+|||+++||||||||+||||+.++ .+||+|||+|
T Consensus 127 ivmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM--------GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp EEECCCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 999999999999999863 3699999999999999999999999999999999999999987 6999999999
Q ss_pred cccCCCCcc---ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CC
Q psy1789 380 RDLFPSDYH---CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--LN 454 (499)
Q Consensus 380 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~ 454 (499)
+.+...... ......+||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..... ..
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 277 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKIASEPPPIRE 277 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSTTTCCSCCHHHHHHSCCGGGG
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHHcCCCCchh
Confidence 977543221 12335679999999999999999999999999999999999 9999988776666666655432 23
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.+..+++++.+++.+||+.||++|||+.|+++.|.+..++..
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 566899999999999999999999999999999988877653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=444.74 Aligned_cols=250 Identities=16% Similarity=0.301 Sum_probs=218.8
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
....|++++.||+|+||+||+|+...++ +.||||++..... ...+.+.+|+.+|++++|||||++++++ .+++..
T Consensus 72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg---~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~~~ 146 (346)
T 4fih_A 72 PRSYLDNFIKIGEGSTGIVCIATVRSSG---KLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSY-LVGDEL 146 (346)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEE-EETTEE
T ss_pred hhHhcEEeEEeecCcCeEEEEEEECCCC---CEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEE
Confidence 3567999999999999999999987655 7899999964322 2235688999999999999999999985 556778
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
||||||+++|+|.+++.. ..+++.++..++.||+.||+|||+++||||||||+||||+.++.+||+|||+|
T Consensus 147 ~ivmEy~~gg~L~~~l~~---------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp EEEECCCTTEEHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCc
Confidence 999999999999999986 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--CCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN--QPV 457 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--~~~ 457 (499)
+.+..... .....+||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+....+.....+. .+.
T Consensus 218 ~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 294 (346)
T 4fih_A 218 AQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPRLKNLH 294 (346)
T ss_dssp EECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCCCSCGG
T ss_pred eecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCCccc
Confidence 97654322 2346789999999999999999999999999999999999 999999998888888887654433 334
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++++.+|+.+||+.||++|||+.|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 68999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=428.62 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=208.5
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc---CCCce
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE---DHTSP 299 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~---~~~~~ 299 (499)
+++.+.||+|+||+||+|.+..++ ..||+|++... ......+.|.+|+.++++++|||||++++++.. .+...
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCC---eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 478889999999999999987655 78999998643 345566789999999999999999999998643 23457
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcC-CCcEEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVVDD-KLRIQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~--iiHrDlk~~NIlld~-~~~~kl~Df 376 (499)
+|||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+||||+. ++.+||+||
T Consensus 105 ~lvmEy~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF 176 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRF--------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred EEEEeCCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence 9999999999999999863 46899999999999999999999988 999999999999984 799999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCCC-C
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-PFEMAASLQDGYRL-N 454 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~~~~~~~i~~~~~~-~ 454 (499)
|+|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+| |++||.+.+ ...+...+..+..+ .
T Consensus 177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyellt-g~~Pf~~~~~~~~~~~~i~~~~~~~~ 250 (290)
T 3fpq_A 177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVKPAS 250 (290)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred cCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHH-CCCCCCCCCcHHHHHHHHHcCCCCCC
Confidence 999864332 2235679999999998864 69999999999999999999 899997654 45566666665443 2
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+++++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34467889999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-56 Score=436.67 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=202.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC---c
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT---S 298 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~---~ 298 (499)
.+|.+.+.||+|+||+||+|++.+ +.||||++...... ...+..|+..+.+++|||||+++|+|.+++. .
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g-----~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRG-----EEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT-----EEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-----EEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 468889999999999999999843 78999999754322 2234457777788999999999999876543 4
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEcCCCc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK--------KLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~--------~iiHrDlk~~NIlld~~~~ 370 (499)
.+||||||++|+|.++|+. ..++|..+.+++.|+|.||+|||++ +||||||||+|||||+++.
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~---------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~ 146 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred EEEEecCCCCCcHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence 6999999999999999986 3589999999999999999999986 8999999999999999999
Q ss_pred EEEcccccccccCCCCccc--cCCCCCCccccccccccccC------CCCCchhHHHHHHHHHHHHcCCCCCC-------
Q psy1789 371 IQITDNALARDLFPSDYHC--LGDNENRPVKWLAIESLVHK------TFSTASDVWAFGVLLWELTTLAQQPY------- 435 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwS~Gvvl~el~t~g~~p~------- 435 (499)
+||+|||+|+......... ......||+.|||||++.+. .++.++|||||||++|||+| |.+|+
T Consensus 147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t-g~~~~~~~~~~~ 225 (303)
T 3hmm_A 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQ 225 (303)
T ss_dssp EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTTBCCCCC
T ss_pred EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH-CCCCCCcccccc
Confidence 9999999998765433221 22346799999999999764 46789999999999999999 65443
Q ss_pred ---CCC-----CHHHHHHHH-HcCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 436 ---AEI-----DPFEMAASL-QDGYRLNQPV-----NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 436 ---~~~-----~~~~~~~~i-~~~~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.+. ...++...+ ..+.++..|. ++++.+.+++.+||+.||++||||.||++.|+++.++
T Consensus 226 ~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 222 123333333 2344555443 2446789999999999999999999999999998654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=423.39 Aligned_cols=247 Identities=20% Similarity=0.328 Sum_probs=203.0
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++++.||+|+||+||+|+...++ +.||||++.... .....+.+.+|+.++++++|||||+++++ +++++..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-~~~~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTG---QKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-IKSKDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTC---CEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-EECSSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-EEECCEE
Confidence 36899999999999999999976554 789999996542 23335678999999999999999999998 4667788
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+ +|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+|
T Consensus 89 ~ivmEy~-~g~L~~~l~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla 159 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR--------DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLS 159 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS--------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred EEEEeCC-CCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCC
Confidence 9999999 58999999862 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
+...... .....+||+.|||||++.+..| +.++||||+||++|||+| |++||.+.+..++...+..+ ....|..
T Consensus 160 ~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt-g~~PF~~~~~~~~~~~i~~~-~~~~p~~ 234 (275)
T 3hyh_A 160 NIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC-RRLPFDDESIPVLFKNISNG-VYTLPKF 234 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHT-CCCCCTT
T ss_pred eecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcC-CCCCCCC
Confidence 8764332 2335689999999999998886 589999999999999999 99999998888888877765 4556778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++++.+++.+||+.||++|||+.|+++
T Consensus 235 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 9999999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=435.08 Aligned_cols=248 Identities=19% Similarity=0.274 Sum_probs=208.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.++|++++.||+|+||+||+|+...+....+.||||++.... .......+.+|+.+|++++|||||++++++ ++++..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-QTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-EETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EECCEE
Confidence 467999999999999999999875433334789999986432 111224578899999999999999999985 557778
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++.+. ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+|
T Consensus 102 ~ivmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKE--------VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EEEECCCTTCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EEEEEcCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 9999999999999999873 36999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+....... .....+||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..+ ....|..+
T Consensus 174 ~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~~ 249 (304)
T 3ubd_A 174 KESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT-GTLPFQGKDRKETMTMILKA-KLGMPQFL 249 (304)
T ss_dssp EC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCTTS
T ss_pred eeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHh-CCCCCCCcCHHHHHHHHHcC-CCCCCCcC
Confidence 86543322 2345789999999999999999999999999999999999 99999999988888887765 45667789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
++++.+++.+||+.||++|||+
T Consensus 250 s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 250 SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTC
T ss_pred CHHHHHHHHHHcccCHHHCCCC
Confidence 9999999999999999999995
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=445.76 Aligned_cols=250 Identities=16% Similarity=0.302 Sum_probs=219.3
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
....|++++.||+|+||.||+|+...++ +.||||++..... ...+.+.+|+.+|+.++|||||++++++ ..++..
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg---~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~~~ 223 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSG---KLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSY-LVGDEL 223 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEE-EETTEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCC---CEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEE-EECCEE
Confidence 4568999999999999999999987655 7899999964422 2235688999999999999999999985 556778
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
|||||||++|+|.+++.. ..+++.++..++.||+.||+|||+++||||||||+||||+.++.+||+|||+|
T Consensus 224 ~iVmEy~~gG~L~~~i~~---------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH---------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EEEEECCTTEEHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EEEEeCCCCCcHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999999975 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL--NQPV 457 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~ 457 (499)
+.+..... .....+||+.|||||++.+..|+.++|||||||++|||++ |++||.+.+..+....+.....+ ..+.
T Consensus 295 ~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 371 (423)
T 4fie_A 295 AQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMIRDNLPPRLKNLH 371 (423)
T ss_dssp EECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCSCTT
T ss_pred eECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHcCCCCCCcccc
Confidence 87654322 2346789999999999999999999999999999999999 99999999988888887765433 3445
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++++.+|+.+||+.||++|||+.|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 78999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=421.00 Aligned_cols=252 Identities=16% Similarity=0.220 Sum_probs=195.7
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC-----
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT----- 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~----- 297 (499)
+|++++.||+|+||+||+|+...++ +.||||++.........+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDD---CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTC---CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCC---CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 5889999999999999999987655 78999999766566667789999999999999999999998654332
Q ss_pred ------ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 298 ------SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 298 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
..++||||+++|+|.+++.... .....++..++.++.|++.||+|||+++||||||||+||||+.++.+
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~-----~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRC-----TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCC-----SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcC-----CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence 3689999999999999998632 22346778899999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCcc----------ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-H
Q psy1789 372 QITDNALARDLFPSDYH----------CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-P 440 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~ 440 (499)
||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... .
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~----Pf~~~~~~ 233 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----PFSTQMER 233 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS----CCSSHHHH
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc----CCCCccHH
Confidence 99999999976543211 11234579999999999999999999999999999999997 775422 1
Q ss_pred HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 441 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
......+.....+......++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2233334433222222234566889999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=412.49 Aligned_cols=253 Identities=17% Similarity=0.292 Sum_probs=209.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE----- 294 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----- 294 (499)
.++|++++.||+|+||+||+|+...++ +.||||++... ......+.+.+|+.+|+.++|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTG---QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCC---CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 358999999999999999999987655 78999999754 344556788999999999999999999998532
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
+....||||||++ |+|.+++.. ...+++.++..++.||+.||.|||+++||||||||+|||++.++.+||+
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~--------~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~ 200 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHS--------SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIG 200 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTS--------SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEe
Confidence 2356899999996 789999975 2469999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCc--cccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 375 DNALARDLFPSDY--HCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 375 DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
|||+|+.+..... .......+||+.|||||++.+. .|+.++||||+||++|||+| |++||.+.+..+....+....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~-G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHHHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHH-CCCCCCCCCHHHHHHHHHHhc
Confidence 9999987643321 1223467899999999998875 56999999999999999999 999999988777665553211
Q ss_pred C-----------------------CCCC-------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 R-----------------------LNQP-------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~-----------------------~~~~-------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ...+ ..+++++.+|+.+||+.||++|||+.|+++
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0011 246789999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=408.24 Aligned_cols=269 Identities=29% Similarity=0.531 Sum_probs=236.9
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+.+...+|++.+.||+|+||.||+|++..++ +.||||++.........+.|.+|+.++++++||||++++|++. .
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~ 183 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADN---TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-Q 183 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTC---CEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCC---eEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-c
Confidence 45677889999999999999999999986544 6899999987656666678999999999999999999999964 4
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|.++++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~D 256 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEG-------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISD 256 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECc
Confidence 556799999999999999998632 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++...............++..|+|||.+.+..++.++|||||||++|||+|+|..||...+..+....+..+.+...
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998654433322223334577899999999999999999999999999999988999999998888888888888888
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
|..+++++.+++.+||+.||++|||+.++++.|+++.++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 8899999999999999999999999999999999987753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=400.63 Aligned_cols=278 Identities=33% Similarity=0.538 Sum_probs=240.5
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCC----CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeE
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEE----DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGV 291 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~ 291 (499)
+.+...+|++++.||+|+||.||+|++... ......||||++.........+.+.+|+.+++++ +||||++++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 456678999999999999999999997531 1234789999998776777778899999999999 89999999998
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNC 363 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NI 363 (499)
+ ......++||||+++|+|.+++....... ......+++.+++.++.|++.||+|||+++|+||||||+||
T Consensus 156 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 156 C-TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp E-CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred E-ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 6 44566799999999999999998744210 01123589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy1789 364 VVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443 (499)
Q Consensus 364 lld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~ 443 (499)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+|+|+.||.+.+..++
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999998765544333344556788999999999999999999999999999999988999999888888
Q ss_pred HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 444 AASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 444 ~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
...+..+.+...+..+++++.+++.+||+.||++||++.|+++.|+++....
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 8888888888888899999999999999999999999999999999987654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=397.71 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=201.1
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 297 (499)
-..++|++++.||+|+||+||+|+........+.||+|++...... ..+.+|+++|+.+ +||||++++++ +++.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~---~~~~~E~~~l~~~~~h~nIv~l~~~-~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP---IRIAAELQCLTVAGGQDNVMGVKYC-FRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH---HHHHHHHHHHHHTCSBTTBCCCSEE-EEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH---HHHHHHHHHHHHhcCCCCCceEEEE-EEECC
Confidence 3457899999999999999999987644444589999998765433 4577899999988 69999999997 56677
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CcEEEccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-LRIQITDN 376 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~-~~~kl~Df 376 (499)
..++||||+++|+|.+++. .+++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeCCCcccHHHHHc-----------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 8899999999999999985 38899999999999999999999999999999999999977 79999999
Q ss_pred ccccccCCCCcc--------------------------ccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHc
Q psy1789 377 ALARDLFPSDYH--------------------------CLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTT 429 (499)
Q Consensus 377 Gla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t 429 (499)
|+|+........ ......+||+.|||||++.+. .|+.++||||+||++|||+|
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 999865432211 012245799999999999875 58999999999999999999
Q ss_pred CCCCCCCCC-CHHHHHHHHHc-------------------------------------C----------------CCCCC
Q psy1789 430 LAQQPYAEI-DPFEMAASLQD-------------------------------------G----------------YRLNQ 455 (499)
Q Consensus 430 ~g~~p~~~~-~~~~~~~~i~~-------------------------------------~----------------~~~~~ 455 (499)
|+.||... +..+....+.. . .....
T Consensus 243 -G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 243 -GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp -TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 88887543 33332222110 0 00011
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+++++.+|+.+||+.||++|||++|+++
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 2357889999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=390.47 Aligned_cols=270 Identities=29% Similarity=0.512 Sum_probs=235.2
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
..+...+|++.+.||+|+||.||+|.+...+.....||||++.........+.|.+|+.++++++||||+++++++ ...
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-TRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EeC
Confidence 3466789999999999999999999987554444789999998776677778899999999999999999999996 445
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++||||+++|+|.++++... ..+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHD-------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTT-------TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred CccEEEeeCCCCCcHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCC
Confidence 56799999999999999997521 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 377 ALARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 377 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
|+++....... ........+|+.|+|||.+.+..++.++|||||||++|||+++|+.||......++...+..+.+...
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC
Confidence 99987653321 11223445678899999999999999999999999999999988999999999888888888888888
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+..+++++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 889999999999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=396.24 Aligned_cols=283 Identities=27% Similarity=0.482 Sum_probs=239.2
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeC--CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEe
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTE--EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g 290 (499)
...+.+...+|++++.||+|+||.||+|++.+ .....+.||||++.........+.+.+|+.++.++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 45677889999999999999999999999754 23345889999998776677778899999999999 7999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCC------------------------------------------------
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP------------------------------------------------ 322 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------ 322 (499)
++...+...++||||+++|+|.++++......
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 98776666899999999999999998643200
Q ss_pred ----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCC
Q psy1789 323 ----------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGD 392 (499)
Q Consensus 323 ----------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~ 392 (499)
......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++............
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 0001238999999999999999999999999999999999999999999999999998765443333344
Q ss_pred CCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhh
Q psy1789 393 NENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471 (499)
Q Consensus 393 ~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~ 471 (499)
...+|..|+|||++.+..++.++|||||||++|||+|+|+.||.+... ......+..+.....+..+++++.+++..||
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 333 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 333 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence 566788999999999999999999999999999999878899987653 4455566666677778889999999999999
Q ss_pred hcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 472 AMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 472 ~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
+.||++|||+.|+++.|+++.+...
T Consensus 334 ~~dP~~Rps~~ell~~L~~~~~~~~ 358 (359)
T 3vhe_A 334 HGEPSQRPTFSELVEHLGNLLQANA 358 (359)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred cCChhhCCCHHHHHHHHHHHHHHhc
Confidence 9999999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=392.57 Aligned_cols=269 Identities=29% Similarity=0.587 Sum_probs=226.0
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
+...+|++.+.||+|+||.||+|++..++. ....||+|.+.........+.|.+|+.++++++||||++++++|...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 445689999999999999999999765432 33568999987655555567899999999999999999999997653
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg 162 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHK-------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHST-------TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred CeEEEEEecCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCc
Confidence 3689999999999999998632 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+|+...............+|..|+|||++.+..++.++|||||||++|||+|+|+.||......++...+..+.+...+.
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (327)
T 3poz_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242 (327)
T ss_dssp HHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCc
Confidence 99877554433333455678899999999999999999999999999999998899999888888888888887778888
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.++.++.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~ 281 (327)
T 3poz_A 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence 899999999999999999999999999999999876543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=380.65 Aligned_cols=272 Identities=31% Similarity=0.560 Sum_probs=225.6
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
.++.+...+|++.+.||+|+||.||+|.....+.....||+|++.........+.+.+|+.++++++||||+++++++ .
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c
Confidence 346777889999999999999999999986554444789999998766666778899999999999999999999985 3
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
++..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRK-------YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTT-------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred -cCccEEEEecCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEEC
Confidence 345699999999999999998632 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+++|..||......+....+..+.+..
T Consensus 159 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (281)
T 1mp8_A 159 DFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237 (281)
T ss_dssp C--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC
Confidence 99999876443221 22344567889999999999999999999999999999977899999888888888888777777
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.+..+++++.+++.+||+.||++|||+.|+++.|+++.++.+
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 888999999999999999999999999999999999977644
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=392.35 Aligned_cols=279 Identities=34% Similarity=0.562 Sum_probs=243.0
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCC----ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEe
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED----GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g 290 (499)
.+.+...+|++++.||+|+||.||+|+....+ .....||||++.........+.+.+|+.+++++ +||||+++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45677889999999999999999999975421 234689999998777777778899999999999 9999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
++ ......++||||+++|+|.+++....... ......+++.+++.++.|++.||+|||+++|+||||||+|
T Consensus 143 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 143 AC-TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EE-CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ee-ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 96 44566799999999999999998744211 0112459999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
||+++++.+||+|||+|+...............+|..|+|||++.+..++.++|||||||++|||+|+|..||...+..+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999877554433344456678899999999999999999999999999999998899999999889
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 443 MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 443 ~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+...+..+.+...+..+++++.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 88888888888888899999999999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=396.93 Aligned_cols=276 Identities=29% Similarity=0.559 Sum_probs=235.7
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+...+|++++.||+|+||.||+|++.+. ....+.||||++...........+.+|+.++++++||||+++++++ .
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-L 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-e
Confidence 346678899999999999999999997542 2233789999998766677777899999999999999999999996 4
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---cE
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL---RI 371 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~---~~ 371 (499)
.....++||||+++|+|.+++...+... .....+++.+++.++.|++.||+|||+++|+||||||+|||++.++ .+
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhcccc-CccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 4556699999999999999998754322 1224689999999999999999999999999999999999999554 59
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+|+...............+|+.|+|||.+.+..++.++|||||||++|||+|+|..||...+..++...+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999865333222233345578899999999999999999999999999999988899999999999888888888
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+...+..+++++.+++.+||+.||++|||+.+|++.|+.+.+.
T Consensus 304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 8888889999999999999999999999999999999988654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=398.89 Aligned_cols=268 Identities=37% Similarity=0.726 Sum_probs=225.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
...|++.+.||+|+||.||+|++.+.++....+|||.+.........+.|.+|+.++++++||||++++++|.+.+...+
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 34678889999999999999998766666678999999766555667889999999999999999999999877677789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++... ...+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+++
T Consensus 168 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp EEEECCTTCBHHHHHHCT-------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEECCCCCCHHHHHhhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccc
Confidence 999999999999999752 2358899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccc--cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 381 DLFPSDYHC--LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 381 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
......... ......+|..|+|||.+.+..++.++|||||||++|||+|++.+||...+..+....+..+.+...+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~ 320 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTT
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 664432211 123445778899999999999999999999999999999988999998877777777777777778888
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+++++.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 321 ~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999999987764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=378.78 Aligned_cols=269 Identities=38% Similarity=0.726 Sum_probs=232.0
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|++.+.||+|+||.||+|++.++++....+|+|.+.........+.+.+|+.++++++||||++++++|.+.+...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34578899999999999999999866554456799999987767777788999999999999999999999987777788
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||++++++.+||+|||++
T Consensus 103 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT-------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEEEeCCCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccc
Confidence 9999999999999999752 245899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcc--ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 380 RDLFPSDYH--CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 380 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+........ .......+|..|+|||.+.+..++.++||||||+++|||++++.+||...+..+....+..+.....+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence 876543221 122345577889999999999999999999999999999998889999888777777777777777788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.+++++.+++.+||+.||++|||+.|+++.|+++.+.+
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 89999999999999999999999999999999988764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=388.33 Aligned_cols=282 Identities=32% Similarity=0.564 Sum_probs=238.6
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 291 (499)
+..+.+...+|++++.||+|+||.||+|+..+.. ...+.||||++.........+.|.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4456788899999999999999999999987421 23478999999877666677889999999999999999999999
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCC----------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP----------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLH 355 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiH 355 (499)
+ ......++||||+++|+|.+++....... ......+++.+++.++.|++.||.|||+++|+|
T Consensus 119 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 119 C-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp E-CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred E-ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 6 44566799999999999999998743110 001256999999999999999999999999999
Q ss_pred cCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy1789 356 KDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435 (499)
Q Consensus 356 rDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~ 435 (499)
|||||+|||++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+|+|..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999987654333333345667889999999999999999999999999999999788999
Q ss_pred CCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 436 AEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 436 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.+.+..++...+..+.....+..+++++.+++.+||+.||++||++.++++.|+++.+.+.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 9988888888888877777788899999999999999999999999999999999876543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=412.90 Aligned_cols=250 Identities=15% Similarity=0.194 Sum_probs=209.2
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-----ccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-----ASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
.+.-++|+++++||+|+||+||+|+...++ +.+|+|++.+. ...........++.+++.++|||||+++++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg---~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~- 260 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA- 260 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCC---CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-
Confidence 556678999999999999999999987665 78999999642 122222333445677888999999999998
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
+++...+||||||+++|+|..+|... ..+++..+..++.||+.||+|||+++||||||||+|||||.+|++|
T Consensus 261 f~~~~~lylVmEy~~GGdL~~~l~~~--------~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 261 FHTPDKLSFILDLMNGGDLHYHLSQH--------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEE
T ss_pred EEECCEEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEE
Confidence 56678889999999999999999873 3699999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHH
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEI---DPFEMAASLQ 448 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~---~~~~~~~~i~ 448 (499)
|+|||+|+...... ....+||+.|||||++.. ..|+.++|||||||++|||+| |++||.+. +..++...+.
T Consensus 333 L~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLt-G~~PF~~~~~~~~~~i~~~i~ 407 (689)
T 3v5w_A 333 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTL 407 (689)
T ss_dssp ECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCGGGCCCHHHHHHHHH
T ss_pred ecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhhc
Confidence 99999998764432 235689999999999975 579999999999999999999 99999753 3334444444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHH
Q psy1789 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPT-----FPQLH 485 (499)
Q Consensus 449 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~~v~ 485 (499)
.. ....|..+++++.+|+.+||+.||++|++ +.||+
T Consensus 408 ~~-~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 408 TM-AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HC-CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CC-CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 43 45667789999999999999999999998 56664
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=381.12 Aligned_cols=290 Identities=35% Similarity=0.674 Sum_probs=234.6
Q ss_pred cchhhHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCC
Q psy1789 205 DRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHK 283 (499)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~ 283 (499)
+..+++..++....+...+|++.+.||+|+||.||+|.+...+.....||+|++... ......+.+.+|+.++++++||
T Consensus 17 ~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 96 (313)
T 3brb_A 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96 (313)
T ss_dssp -------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCT
T ss_pred CchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCC
Confidence 455667778889999999999999999999999999998776556678999998744 3455667899999999999999
Q ss_pred cceeEEeEEEcCCC----ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy1789 284 NILTVLGVSIEDHT----SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLA 359 (499)
Q Consensus 284 nIv~l~g~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk 359 (499)
||+++++++..... ..++|+||+++|+|.+++...... .....+++..++.++.|++.||.|||+++|+|||||
T Consensus 97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik 174 (313)
T 3brb_A 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE--TGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLA 174 (313)
T ss_dssp TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBT--TSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCS
T ss_pred CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhh--cCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 99999999765432 459999999999999999753321 123469999999999999999999999999999999
Q ss_pred CCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy1789 360 TRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID 439 (499)
Q Consensus 360 ~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~ 439 (499)
|+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||+++|.+||....
T Consensus 175 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 254 (313)
T 3brb_A 175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254 (313)
T ss_dssp GGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 99999999999999999999876544433334455678899999999999999999999999999999998899999888
Q ss_pred HHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 440 PFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 440 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..+....+..+.+...+..+++++.+++.+||+.||++|||+.++++.|+++.+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 255 NHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp GGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 888888888877788888999999999999999999999999999999999987753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=402.47 Aligned_cols=261 Identities=30% Similarity=0.610 Sum_probs=231.3
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+.+...+|++.+.||+|+||.||+|.+.+ +.||||++.... ..+.|.+|+.++++++||||+++++++.+
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 257 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETT-----EEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecC-----CeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence 4578889999999999999999999998753 689999997653 34678999999999999999999999877
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+
T Consensus 258 ~~~~~~iv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 258 EKGGLYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp TTSCEEEEEECCTTCBHHHHHHHHC------TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEEecCCCcHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEe
Confidence 6667899999999999999998743 2347999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++..... .....++..|+|||.+.+..++.++|||||||++|||+|.|+.||...+..++...+..+.+..
T Consensus 332 DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 406 (450)
T 1k9a_A 332 DFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 406 (450)
T ss_dssp CCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC
T ss_pred eCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999854322 1223567889999999999999999999999999999998899999888888888888888888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.|..+++++.+++.+||+.||++|||+.++++.|+++...
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 8999999999999999999999999999999999998653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=415.99 Aligned_cols=249 Identities=18% Similarity=0.221 Sum_probs=216.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
++|++++.||+|+||.||+|+...++ +.||+|++.... ....+.+.+|+.+|+.++|||||+++++ +++....+|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg---~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATG---NNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDA-FEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEE-EECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCC---CEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEE-EEECCEEEE
Confidence 47999999999999999999987655 789999987543 4445778999999999999999999998 566778899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC--CcEEEcccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK--LRIQITDNALA 379 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~--~~~kl~DfGla 379 (499)
|||||++|+|.+++... ...+++.++..++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+|
T Consensus 232 v~E~~~gg~L~~~i~~~-------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a 304 (573)
T 3uto_A 232 IYEFMSGGELFEKVADE-------HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 304 (573)
T ss_dssp EEECCCCCBHHHHHTCT-------TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSC
T ss_pred EEeecCCCcHHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccce
Confidence 99999999999999642 2468999999999999999999999999999999999999854 89999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C--CCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-L--NQP 456 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-~--~~~ 456 (499)
+.+.+.... ...+||+.|||||++.+..|+.++|||||||++|||++ |++||.+.+..+....+..... . ..+
T Consensus 305 ~~~~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 380 (573)
T 3uto_A 305 AHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDDSAF 380 (573)
T ss_dssp EECCTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred eEccCCCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence 987654322 24579999999999999999999999999999999999 9999999998888887766422 1 222
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+|+.+||+.||++|||+.|+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 468999999999999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=393.73 Aligned_cols=269 Identities=28% Similarity=0.532 Sum_probs=221.7
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
.+...+|++.+.||+|+||.||+|++...+.....||||++.........+.|.+|+.++++++||||++++|++. ...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-KSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCC
Confidence 4556788999999999999999998763333336799999987666677788999999999999999999999964 456
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||+++|+|.++++... ..+++.+++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHD-------AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTT-------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred ceEEEEeCCCCCcHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence 6799999999999999998622 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccc-cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 378 LARDLFPSDYHC-LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 378 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
+++......... ......+++.|+|||++.+..++.++|||||||++|||++.|+.||...+..++...+..+.+...+
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~ 272 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPP 272 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCC
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 998764332111 1122345678999999999999999999999999999998789999998888888888888777778
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
..++.++.+++.+||+.||++||++.||++.|+++.+.
T Consensus 273 ~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 273 MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 88999999999999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=374.35 Aligned_cols=280 Identities=35% Similarity=0.674 Sum_probs=241.8
Q ss_pred HHhhcccceeecc--ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCccee
Q psy1789 210 LHEKLSELTIQRC--RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT 287 (499)
Q Consensus 210 ~~~~~~~~~~~~~--~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~ 287 (499)
...++.+..++.. +|++.+.||+|+||.||+|.+.++......+|+|.+.........+.+.+|+.++++++||||++
T Consensus 7 ~~~~~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 86 (298)
T 3pls_A 7 LLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86 (298)
T ss_dssp HHHHTGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred HHhhhhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeee
Confidence 3445555555555 45567999999999999999876655556899999987767777789999999999999999999
Q ss_pred EEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q psy1789 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 288 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~ 367 (499)
+++++...+...++|+||+.+|+|.+++... ...+++.++..++.|++.||+|||+++|+||||||+||++++
T Consensus 87 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~ 159 (298)
T 3pls_A 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-------QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE 159 (298)
T ss_dssp CCEEECCSSSCCEEEECCCTTCBHHHHHHCT-------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred EEEEEecCCCCcEEEEecccCCCHHHHHhcc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 9999766565569999999999999999752 245899999999999999999999999999999999999999
Q ss_pred CCcEEEcccccccccCCCCcc--ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYH--CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~ 445 (499)
++.+||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||+||+.+||...+..+...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~ 239 (298)
T 3pls_A 160 SFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239 (298)
T ss_dssp TCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH
T ss_pred CCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH
Confidence 999999999999866443221 122345678899999999999999999999999999999998888898888888888
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 446 ~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.+..+.....+..+++++.+++.+||+.||++|||+.++++.|+++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 888887777888899999999999999999999999999999999988764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=379.98 Aligned_cols=279 Identities=33% Similarity=0.587 Sum_probs=240.5
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
..+.+...+|++.+.||+|+||.||+|..... ......||||++.........+.+.+|+.++++++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 45677788999999999999999999987432 1234789999998776777778899999999999999999999986
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE----------------GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHK 356 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------------~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHr 356 (499)
......++||||+++|+|.+++........ .....+++.+++.++.|++.||.|||+++|+||
T Consensus 96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 455667999999999999999987432110 012348999999999999999999999999999
Q ss_pred CCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy1789 357 DLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYA 436 (499)
Q Consensus 357 Dlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~ 436 (499)
||||+||++++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+|+|+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999877554444344456678899999999999999999999999999999997889999
Q ss_pred CCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 437 EIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 437 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.....++...+..+.....+..+++++.+++.+||+.||++||++.|+++.|+++.++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 8888888888888777778888999999999999999999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=385.10 Aligned_cols=285 Identities=33% Similarity=0.633 Sum_probs=220.2
Q ss_pred hHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCccee
Q psy1789 209 DLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILT 287 (499)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~ 287 (499)
+..+.+.+..+...+|++++.||+|+||.||+|++..++.....||||++.... .....+.+.+|+.++++++||||++
T Consensus 10 ~~~~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 89 (323)
T 3qup_A 10 ELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89 (323)
T ss_dssp ------CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred HHHHHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceeh
Confidence 334567778888999999999999999999999976654333479999997542 3344678999999999999999999
Q ss_pred EEeEEEcCCC-----ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 288 VLGVSIEDHT-----SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 288 l~g~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
+++++..... ..++|+||+++|+|.+++...... .....+++.++..++.|++.||+|||+++|+||||||+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~N 167 (323)
T 3qup_A 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG--ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167 (323)
T ss_dssp CCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC-----CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred hhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcc--ccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcce
Confidence 9999655332 238999999999999999764321 112358999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||+++|+.||...+..+
T Consensus 168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999999876554443344455678899999999999999999999999999999998899999988888
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 443 MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 443 ~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
....+..+.....+..+++++.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 248 IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 88888887777888899999999999999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=371.00 Aligned_cols=263 Identities=27% Similarity=0.575 Sum_probs=231.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+.+...+|++.+.||+|+||.||+|...++ ..||+|++...... .+.+.+|+.++++++||||+++++++ ..
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 76 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVC-LE 76 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTT----EEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCC----CeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEE-ec
Confidence 4667788999999999999999999998643 67999999765332 25688999999999999999999986 45
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQR-------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC
T ss_pred CCceEEEEEeCCCCcHHHHHHhcC-------cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecc
Confidence 566799999999999999997522 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++....... .......+|..|+|||.+.+..++.++||||||+++|||+++|+.||...+..+....+..+.+...
T Consensus 150 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (269)
T 4hcu_A 150 FGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 228 (269)
T ss_dssp TTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred cccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC
Confidence 999986644322 2333556778899999999999999999999999999999988999999998888888888877778
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
+...++++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 88899999999999999999999999999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=379.28 Aligned_cols=267 Identities=27% Similarity=0.479 Sum_probs=219.0
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
...+.+..++|++.+.||+|+||.||+|+..+ ..||||++.... .....+.|.+|+.++++++||||+++++++
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-----SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETT-----EEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECC-----CcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34567788899999999999999999998743 679999987543 455567899999999999999999999996
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCCc
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~--iiHrDlk~~NIlld~~~~ 370 (499)
......++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 104 -~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 104 -TQPPNLSIVTEYLSRGSLYRLLHKSG-----AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp -CSTTCCEEEEECCTTCBHHHHHHSTT-----HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC
T ss_pred -EECCceEEEEecCCCCcHHHHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc
Confidence 55566799999999999999998621 1224899999999999999999999999 999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-c
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ-D 449 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~-~ 449 (499)
+||+|||+++...... .......||..|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+. .
T Consensus 178 ~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 178 VKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHH-CCCTTTTSCHHHHHHHHHHS
T ss_pred EEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhc
Confidence 9999999998543321 12335678999999999999999999999999999999999 899999988877766654 4
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
..+...+..+++++.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 456667788999999999999999999999999999999988654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=403.27 Aligned_cols=264 Identities=31% Similarity=0.580 Sum_probs=231.5
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+.+...+|++.+.||+|+||.||+|.+.++ ..||||++..... ..+.|.+|+.++++++||||+++++++.
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~- 253 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKH----TKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT- 253 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTT----EEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCc----cEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence 34678888999999999999999999998643 6799999976432 2467999999999999999999999864
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++||||+++|+|.++++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 254 -~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~ 326 (454)
T 1qcf_A 254 -KEPIYIITEFMAKGSLLDFLKSDE------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIA 326 (454)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHSHH------HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEEC
T ss_pred -CCccEEEEeecCCCcHHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEe
Confidence 445799999999999999998532 1358899999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++........ ......+|+.|+|||.+....++.++|||||||++|||+|+|+.||.+.+..++...+..+.+..
T Consensus 327 DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 405 (454)
T 1qcf_A 327 DFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 405 (454)
T ss_dssp STTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC
T ss_pred eCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876433221 22344567899999999999999999999999999999998899999999888888888888888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
.+..+++++.+++.+||+.||++|||+.+|++.|+++..
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 888999999999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=369.31 Aligned_cols=264 Identities=29% Similarity=0.575 Sum_probs=231.0
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+.+...+|++.+.||+|+||.||+|...++ ..||+|++...... .+.+.+|+.++.+++||||+++++++ ..
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 74 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQ----YDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVC-SK 74 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCc----eeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEE-cc
Confidence 3567788999999999999999999987643 67999999765322 25688999999999999999999986 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++++|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHG-------KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECC
T ss_pred CCceEEEEEccCCCcHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEcc
Confidence 667799999999999999998632 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++........ ......+|..|+|||.+.+..++.++||||||+++|||+|+|+.||...+..+....+..+.....
T Consensus 148 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (268)
T 3sxs_A 148 FGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR 226 (268)
T ss_dssp TTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred Cccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC
Confidence 9999876544332 233455678899999999999999999999999999999988999999888888888888777777
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+..+++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 888899999999999999999999999999999988654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=382.67 Aligned_cols=270 Identities=29% Similarity=0.590 Sum_probs=225.9
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
+...+|++++.||+|+||.||+|.+..++. ...+|++|.+.........+.+.+|+.++++++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 456789999999999999999999865432 44568999887554444557889999999999999999999997553
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG 162 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHK-------DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTT
T ss_pred CceEEEEecCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCc
Confidence 3689999999999999998632 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++...............+|..|+|||.+.+..++.++|||||||++|||+++|+.||......++...+..+.....+.
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 242 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99876544333333445578899999999999999999999999999999998899999988888888888887788888
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhh
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~ 497 (499)
.++.++.+++.+||+.||++||++.|+++.|+++.+...+
T Consensus 243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 282 (327)
T 3lzb_A 243 ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 282 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence 8999999999999999999999999999999998765544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=368.72 Aligned_cols=269 Identities=31% Similarity=0.571 Sum_probs=231.2
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+.+...+|++.+.||+|+||.||+|++....+....||+|.+.........+.|.+|+.++++++||||+++++++ ..+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEE 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE-CSS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE-cCC
Confidence 4566778999999999999999999987665556789999998766666778899999999999999999999985 433
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+||
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK-------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT-------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred -CCEEEEecCCCCCHHHHHHhcc-------ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence 4589999999999999998632 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
|+++........ ......++..|+|||.+.+..++.++||||||+++|||+|.|+.||...+..+....+..+.....+
T Consensus 158 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 158 GLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp CGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 999876543221 2334557889999999999999999999999999999998788899887777777777777677777
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
..+++++.+++.+||+.||++|||+.|+++.|+++.+.-
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 889999999999999999999999999999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=386.61 Aligned_cols=268 Identities=28% Similarity=0.531 Sum_probs=228.4
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
+...+|++.+.||+|+||.||+|++..++. ....|++|.+.........+.+.+|+.++++++||||+++++++. +.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CC
Confidence 456789999999999999999999865432 345689998865433333456788999999999999999999863 34
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 160 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR-------GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG-------GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred ccEEEEEeCCCCCHHHHHHHcc-------ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCC
Confidence 5799999999999999998632 368899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++...............+|..|+|||.+.+..++.++||||||+++|||+|+|+.||......++...+..+.+...+.
T Consensus 161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 161 VADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240 (325)
T ss_dssp GGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCT
T ss_pred cccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCC
Confidence 99987655443344456678899999999999999999999999999999998899999888888888888887888888
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.++.++.+++.+||+.||++||++.|+++.|+++....
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 241 ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 89999999999999999999999999999999886543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=373.73 Aligned_cols=281 Identities=28% Similarity=0.491 Sum_probs=235.4
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeC--CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTE--EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
.+.+...+|++.+.||+|+||.||+|++.. .....+.||+|++.........+.+.+|+.+++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 456778899999999999999999998743 22344789999998776666678899999999999 999999999996
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCP----------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
......++||||+++|+|.+++....... ......+++.+++.++.|++.||.|||+++|+||||||+|
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 44566799999999999999998743210 0112358999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-H
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-F 441 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~ 441 (499)
|+++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+|+|+.||..... .
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 999999999999999998775544333334555778899999999999999999999999999999988899987654 3
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhh
Q psy1789 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497 (499)
Q Consensus 442 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~ 497 (499)
.....+....+...+..+++++.+++.+||+.||++|||+.|+++.|+++..+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 34455566666666778999999999999999999999999999999998876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=404.14 Aligned_cols=265 Identities=32% Similarity=0.657 Sum_probs=234.1
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
...+.+...+|++.+.||+|+||.||+|.+...+ ..||||++..... ..+.|.+|+.++++++||||++++|+|.
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGT---EEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCC---eEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 4557788889999999999999999999987644 7899999976532 2467999999999999999999999964
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
. ....++||||+++|+|.++++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 287 ~-~~~~~lv~E~~~~g~L~~~l~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 359 (495)
T 1opk_A 287 R-EPPFYIITEFMTYGNLLDYLRECN------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKV 359 (495)
T ss_dssp S-SSSCEEEEECCTTCBHHHHHHHSC------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred c-CCcEEEEEEccCCCCHHHHHHhcC------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEE
Confidence 4 556799999999999999998632 245899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
+|||+++........ ......+++.|+|||.+....++.++|||||||++|||+|+|..||.+.+..++...+..+.+.
T Consensus 360 ~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 438 (495)
T 1opk_A 360 ADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 438 (495)
T ss_dssp CCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred eecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999999976543322 3334556789999999999999999999999999999999889999998888888888888888
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
..+..+++++.+++.+||+.||++|||+.+|++.|+.+
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 88889999999999999999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=378.36 Aligned_cols=281 Identities=33% Similarity=0.534 Sum_probs=239.5
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCC----ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED----GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTV 288 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l 288 (499)
...+.+...+|++++.||+|+||.||+|++...+ .....||+|++.........+.+.+|+.+++++ +||||+++
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 3446778889999999999999999999975311 233689999998776777778899999999999 89999999
Q ss_pred EeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy1789 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE--------GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360 (499)
Q Consensus 289 ~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~ 360 (499)
++++. .....++||||+++|+|.+++........ .....+++.+++.++.|++.||+|||+++|+||||||
T Consensus 107 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 107 LGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEC-SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEc-cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 99964 45667999999999999999986432110 0123589999999999999999999999999999999
Q ss_pred CceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy1789 361 RNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440 (499)
Q Consensus 361 ~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~ 440 (499)
+||+++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+|+|+.||.+.+.
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999999998765544333344556788999999999999999999999999999999988999999888
Q ss_pred HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 441 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.++...+..+.+...+..+++++.+++.+||+.||++|||+.|+++.|+++....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 8888888887777788889999999999999999999999999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=373.82 Aligned_cols=270 Identities=30% Similarity=0.508 Sum_probs=219.6
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
..+...+|++++.||+|+||.||+|++... ....+.||||++... .....+.|.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345678999999999999999999986421 122378999999755 445567899999999999999999999987543
Q ss_pred -CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 296 -HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~ 156 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK-------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 156 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG-------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc-------cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEc
Confidence 345799999999999999998732 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-------------
Q psy1789 375 DNALARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP------------- 440 (499)
Q Consensus 375 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~------------- 440 (499)
|||+++....... ........++..|+|||.+.+..++.++||||||+++|||+| |..|+.....
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQGQ 235 (295)
T ss_dssp CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHH-TTCTTCSHHHHHHHHHCTTCCTH
T ss_pred cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHh-cccccCCChHHHHhhhcCccccc
Confidence 9999987643322 122334557788999999999999999999999999999999 6677654211
Q ss_pred ---HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 441 ---FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 441 ---~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
......+....+...+..+++++.+++.+||+.||++|||+.|+++.|+++.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 1234455556677778899999999999999999999999999999999998765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=368.64 Aligned_cols=266 Identities=29% Similarity=0.590 Sum_probs=230.3
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
...+.+..++|++.+.||+|+||.||+|.+.++ ..||+|++...... .+.+.+|+.++.+++||||+++++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~- 88 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVC- 88 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTT----EEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCC----CeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEE-
Confidence 355677888999999999999999999987643 67999999765332 25688999999999999999999985
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
......++||||+++|+|.+++.... ..+++.++..++.|++.||.|||+++|+||||||+||++++++.+||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl 161 (283)
T 3gen_A 89 TKQRPIFIITEYMANGCLLNYLREMR-------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161 (283)
T ss_dssp CSSSSEEEEECCCTTCBHHHHHHCGG-------GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEE
T ss_pred ecCCCeEEEEeccCCCcHHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEE
Confidence 55667799999999999999997532 35899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||+|+|+.||...+..+....+..+.+.
T Consensus 162 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3gen_A 162 SDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 240 (283)
T ss_dssp CSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC
Confidence 99999986643322 22334556788999999999999999999999999999998889999999888888888888777
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
..+..+++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 78888999999999999999999999999999999998765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=376.94 Aligned_cols=282 Identities=27% Similarity=0.483 Sum_probs=236.4
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeC--CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEe
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTE--EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g 290 (499)
...+.+...+|++++.||+|+||.||+|++.. .....+.||||++.........+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 34566788899999999999999999998754 22345789999998776666677899999999999 7999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
++...+...++|+||+++|+|.+++....... ......+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 97666666899999999999999998643210 0011238999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-H
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-F 441 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~ 441 (499)
|+++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+|+|+.||..... .
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 999999999999999998765443322333455678899999999999999999999999999999878899987653 4
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 442 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.....+..+.....+..+++++.+++.+||+.||++|||+.|+++.|+++.+.-
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 455566666667777788999999999999999999999999999999987653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=375.53 Aligned_cols=271 Identities=30% Similarity=0.551 Sum_probs=228.4
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
++...+|++.+.||+|+||.||+|.+...++ ....||||++...........+.+|+.++++++||||+++++++ ...
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-SKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-ecC
Confidence 5677889999999999999999999865432 34679999998766666777899999999999999999999995 556
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++|+||||||+||+++.++.+||+||
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKD-------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEeCCCCCcHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCC
Confidence 67799999999999999998632 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 377 ALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 377 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
|+++........ .......+|..|+|||.+.+..++.++||||||+++|||+|.|+.||...+..++...+..+.+...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 271 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 271 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence 999876433211 1122344678899999999999999999999999999999878999999888888888888877777
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
+..+++++.+++.+||+.||++||++.++++.|+++.+...
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 88899999999999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=398.28 Aligned_cols=263 Identities=32% Similarity=0.564 Sum_probs=224.9
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+.+...+|++.+.||+|+||.||+|.+.++ ..||||++...... .+.|.+|+.++++++||||+++++++.+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT----EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCC----ceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 4667888999999999999999999998653 57999999754322 3578999999999999999999999643
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 251 -~~~~iv~e~~~~gsL~~~l~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~D 323 (452)
T 1fmk_A 251 -EPIYIVTEYMSKGSLLDFLKGET------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 323 (452)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHH------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred -CceEEEehhhcCCCHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECC
Confidence 45799999999999999997532 23589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++........ ......++..|+|||.+.+..++.++|||||||++|||+|+|+.||.+....++...+..+.+...
T Consensus 324 fG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 402 (452)
T 1fmk_A 324 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402 (452)
T ss_dssp CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999876433221 223445678999999999999999999999999999999988999999998888888888888888
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
+..+++++.+++.+||+.||++|||+.+|++.|+++..
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 88999999999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=367.54 Aligned_cols=271 Identities=27% Similarity=0.511 Sum_probs=234.0
Q ss_pred cceeeccceEEee-eeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 216 ELTIQRCRVRLFS-VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 216 ~~~~~~~~~~~~~-~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
++.+...+|.+.+ .||+|+||.||+|.+...+ ....||+|++.........+.+.+|+.++++++||||+++++++ +
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~ 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCC-CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c
Confidence 3456677888887 9999999999999864321 12789999998766677778899999999999999999999996 3
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+
T Consensus 81 -~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 152 (287)
T 1u59_A 81 -AEALMLVMEMAGGGPLHKFLVGK-------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKIS 152 (287)
T ss_dssp -SSSEEEEEECCTTEEHHHHHTTC-------TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEEC
T ss_pred -CCCcEEEEEeCCCCCHHHHHHhC-------CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEEC
Confidence 34579999999999999999742 2458999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 375 DNALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 375 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||+|+|+.||...+..+....+..+.++
T Consensus 153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~ 232 (287)
T 1u59_A 153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232 (287)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred cccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC
Confidence 99999876543322 22234456889999999999999999999999999999998789999988888888888888778
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..+..+++++.+++..||+.||++||++.++++.|+++..+..
T Consensus 233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 8888999999999999999999999999999999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=362.36 Aligned_cols=263 Identities=27% Similarity=0.574 Sum_probs=230.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
++.+...+|++.+.||+|+||.||+|...++ ..||+|++...... .+.+.+|+.++++++||||+++++++. .
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 74 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL-E 74 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCC----CeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEc-c
Confidence 4667788999999999999999999998643 67999999765332 257889999999999999999999964 4
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~d 147 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQR-------GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSD 147 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECC
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCc-------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcc
Confidence 566799999999999999998632 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++....... .......++..|+|||.+.+..++.++||||||+++|||+++|+.||...+..+....+..+.+...
T Consensus 148 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~ 226 (267)
T 3t9t_A 148 FGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 226 (267)
T ss_dssp TTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred cccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 999987643221 2233456778899999999999999999999999999999988999999888888888888877777
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
+..+++++.+++.+||+.||++||++.++++.|+++.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 88889999999999999999999999999999999865
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=375.26 Aligned_cols=276 Identities=33% Similarity=0.609 Sum_probs=235.5
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeC--CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTE--EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
.++.+...+|++.+.||+|+||.||+|++.+ .+...+.||+|.+...........+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 4566778899999999999999999998763 12234789999998776666777899999999999999999999986
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccC--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLC--PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
......++||||+++|+|.+++...... .......+++..++.++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe
Confidence 4456679999999999999999763310 0111235789999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+|+|+.||...+..+....+..+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 99999999986644333333334556788999999999999999999999999999999889999998888888888777
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 451 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.....+..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 67777788999999999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=405.60 Aligned_cols=270 Identities=27% Similarity=0.506 Sum_probs=228.4
Q ss_pred ceeeccceEEee-eeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 217 LTIQRCRVRLFS-VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 217 ~~~~~~~~~~~~-~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
+.+...++.+.+ .||+|+||.||+|.+...+. ...||||++.........+.|.+|+.++++++||||++++|+|..
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSC-EEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCC-cEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 345556667666 89999999999998864322 267999999865444456789999999999999999999999754
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
+..++||||+++|+|.+++... ...+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~D 479 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGK-------REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISD 479 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTC-------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEee
Confidence 4579999999999999999752 24689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 376 NALARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 376 fGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
||+++....... ........+|+.|+|||++.+..++.++|||||||++|||+|.|+.||...+..++...+..+.+..
T Consensus 480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~ 559 (613)
T 2ozo_A 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 559 (613)
T ss_dssp CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC
T ss_pred ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999987643321 1122233456889999999999999999999999999999987899999998888888998888888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.+..+++++.+++.+||+.||++||++.+|++.|+.+...+.
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 899999999999999999999999999999999999876653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=379.54 Aligned_cols=279 Identities=32% Similarity=0.540 Sum_probs=227.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
++++...+|++.+.||+|+||.||+|+.... .+....||+|++.........+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4677889999999999999999999997432 2344789999998655555567899999999999 899999999986
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCP---------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKD 357 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrD 357 (499)
. .....++||||+++|+|.+++....... ......+++..++.++.|++.||+|||+++|+|||
T Consensus 119 ~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 119 T-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp C-SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred e-eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 4 4566799999999999999998643210 00123589999999999999999999999999999
Q ss_pred CCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy1789 358 LATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE 437 (499)
Q Consensus 358 lk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~ 437 (499)
|||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+|+|..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999998664433322333455678899999999999999999999999999999878899987
Q ss_pred CCHH-HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 438 IDPF-EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 438 ~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.... .....+..+.....+..+++++.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 6543 445566666677778889999999999999999999999999999999986653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=375.16 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=218.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
-.+|++.+.||+|+||.||+|+...++ +.||||++... ......+.+.+|+.+++.++||||+++++++ ......
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~ 89 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTG---REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-ETEKTL 89 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECCEE
Confidence 457999999999999999999986554 78999998654 3455567889999999999999999999985 556678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAH--------GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp EEEECCCTTCBHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred EEEEECCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999999999763 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
+...... ......||+.|+|||.+.+..++ .++|||||||++|||+| |+.||.+.+..++...+..+ ....|..
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~p~~ 236 (328)
T 3fe3_A 162 NEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS-GSLPFDGQNLKELRERVLRG-KYRIPFY 236 (328)
T ss_dssp GGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCTT
T ss_pred eecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCCC
Confidence 8764432 22356799999999999988875 79999999999999999 99999998888888777665 4456777
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++++.+++.+||+.||++|||+.|+++
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 8999999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=375.25 Aligned_cols=263 Identities=23% Similarity=0.384 Sum_probs=217.8
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
..+...+|++++.||+|+||.||+|....++ +.+|+|++... .....+.|.+|+.++++++||||+++++++.+ +
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~---~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 79 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETG---EVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-D 79 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-T
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCC---cEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-C
Confidence 3456788999999999999999999986654 68999988654 45566889999999999999999999999654 5
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df 152 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMD-------SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADF 152 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCC-------TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCC
T ss_pred CeeEEEEEecCCCcHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeec
Confidence 66799999999999999998632 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccc------------cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Q psy1789 377 ALARDLFPSDYHC------------LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-- 442 (499)
Q Consensus 377 Gla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~-- 442 (499)
|+++......... ......||+.|+|||.+.+..++.++||||||+++|||++ +..|+.......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG-RVNADPDYLPRTMD 231 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-TCCSSTTTSCBCTT
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhc-CCCCCcchhhhHHH
Confidence 9998764332211 0114568999999999999999999999999999999999 777766432211
Q ss_pred ----HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 443 ----MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 443 ----~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
...... ...+..+++++.+++.+||+.||++|||+.++++.|+++...+.
T Consensus 232 ~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 232 FGLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp SSBCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred Hhhhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 111111 12356788899999999999999999999999999999987764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=366.15 Aligned_cols=269 Identities=30% Similarity=0.555 Sum_probs=228.9
Q ss_pred cceeeccceEEee-eeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 216 ELTIQRCRVRLFS-VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 216 ~~~~~~~~~~~~~-~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
+..+...+|++.+ .||+|+||.||+|.+.... ..+.||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCC-ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 4456678899988 9999999999999765332 23789999997543 233457899999999999999999999996
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
. ....++|+||+++++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||
T Consensus 88 ~-~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 88 E-AESWMLVMEMAELGPLNKYLQQN--------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp E-SSSEEEEEECCTTEEHHHHHHHC--------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred C-CCCcEEEEEeCCCCCHHHHHHhC--------cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEE
Confidence 3 45579999999999999999872 35899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 374 TDNALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 374 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||+|+|+.||...+..++...+..+.+
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 238 (291)
T 1xbb_A 159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238 (291)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred ccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999876543322 2223445678899999999999999999999999999999978899999988888888888877
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
...+..+++++.+++.+||+.||++||++.++++.|+++....
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 8888899999999999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=376.88 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=214.6
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
..++.+...+|++.+.||+|+||.||+|++.+ +.||||++..... ....+.+|+.++++++||||+++++++.
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-----EYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETT-----EEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccccchhhchhhheecccCceEEEEEEECC-----CEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 34567778899999999999999999998753 7899999975432 3345667999999999999999999976
Q ss_pred cCCC---ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCC
Q psy1789 294 EDHT---SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK----------KLLHKDLAT 360 (499)
Q Consensus 294 ~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~----------~iiHrDlk~ 360 (499)
.... ..++||||+++|+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp 159 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKA---------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSG
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCCh
Confidence 5432 36999999999999999986 3489999999999999999999999 999999999
Q ss_pred CceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCC
Q psy1789 361 RNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-----TFSTASDVWAFGVLLWELTTLAQQPY 435 (499)
Q Consensus 361 ~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DvwS~Gvvl~el~t~g~~p~ 435 (499)
+|||++.++.+||+|||+|+...............||..|+|||++.+. .++.++|||||||++|||+| |+.||
T Consensus 160 ~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~pf 238 (322)
T 3soc_A 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS-RCTAA 238 (322)
T ss_dssp GGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TBTTS
T ss_pred HhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHh-CCCCC
Confidence 9999999999999999999876554433334456789999999999873 46678999999999999999 88888
Q ss_pred CCCC----------------HHHHHHHHHcC-CCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 436 AEID----------------PFEMAASLQDG-YRLNQPV-----NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 436 ~~~~----------------~~~~~~~i~~~-~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
.+.. ..++...+... .++..+. .+++++.+++.+||+.||++|||+.||++.|+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 6531 22233333222 2222221 234569999999999999999999999999999877
Q ss_pred Hh
Q psy1789 494 QL 495 (499)
Q Consensus 494 ~l 495 (499)
..
T Consensus 319 ~~ 320 (322)
T 3soc_A 319 LT 320 (322)
T ss_dssp HC
T ss_pred Hh
Confidence 53
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=364.56 Aligned_cols=265 Identities=32% Similarity=0.602 Sum_probs=230.7
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
++.+...+|++.+.||+|+||.||+|...++ ..||+|.+...... .+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-- 78 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT-- 78 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCC----cEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEc--
Confidence 5677888999999999999999999997543 67999999754322 357889999999999999999999853
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
.+..++|+||+++++|.+++.... ...+++.++..++.|++.||+|||+++|+||||||+||++++++.+||+|
T Consensus 79 ~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 79 QEPIYIITEYMENGSLVDFLKTPS------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHH------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred CCCcEEEEecCCCCCHHHHHhcCC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECC
Confidence 334699999999999999997521 12589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++........ ......++..|+|||.+.+..++.++||||||+++|||+++|+.||.+.+..+....+..+.+...
T Consensus 153 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T 1qpc_A 153 FGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231 (279)
T ss_dssp CTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC
Confidence 9999876543322 233455678899999999999999999999999999999988999999888888888888877777
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+..+++++.+++.+||+.||++|||+.++++.|+++....
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 8889999999999999999999999999999999987653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=376.80 Aligned_cols=280 Identities=31% Similarity=0.513 Sum_probs=233.6
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
.+.+...+|++.+.||+|+||.||+|.....+ ...+.||+|.+.........+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45677889999999999999999999975432 133579999998776666778899999999999 899999999996
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPE------GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld 366 (499)
......++||||+++|+|.+++........ .....+++..++.++.|++.||+|||+++|+||||||+|||++
T Consensus 120 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 120 -THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred -ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 445667999999999999999976431100 0123589999999999999999999999999999999999999
Q ss_pred CCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q psy1789 367 DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF-EMAA 445 (499)
Q Consensus 367 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~-~~~~ 445 (499)
.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+|+|..||.+.... ....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999986644333333345556788999999999999999999999999999999888999876543 3445
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 446 ~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.+..+.....+..+++++.+++.+||+.||++|||+.|+++.|+++..+.+
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 556666667777889999999999999999999999999999999877654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=366.69 Aligned_cols=269 Identities=32% Similarity=0.649 Sum_probs=236.1
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
+..+.+...+|++.+.||+|+||.||+|.+...+ ..||+|++..... ..+.+.+|+.++++++||||+++++++
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~- 78 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVC- 78 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGT---EEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCC---EEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEE-
Confidence 4567778889999999999999999999987654 7899999976533 346789999999999999999999985
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
......++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l 152 (288)
T 3kfa_A 79 TREPPFYIITEFMTYGNLLDYLRECN------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 152 (288)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHCC------TTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEE
T ss_pred ccCCCEEEEEEcCCCCcHHHHHHhcc------cCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEE
Confidence 55666799999999999999998632 245899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||+++|..||...+..+....+....+.
T Consensus 153 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (288)
T 3kfa_A 153 ADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231 (288)
T ss_dssp CCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC
Confidence 999999876543322 2234456778999999999999999999999999999999889999998888888888888788
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
..+..+++++.+++.+||+.||++|||+.|+++.|+++..+.
T Consensus 232 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 888899999999999999999999999999999999987653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=401.94 Aligned_cols=264 Identities=31% Similarity=0.561 Sum_probs=231.1
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+.+...+|++.+.||+|+||.||+|.+.++ ..||||++..... ..+.|.+|+.+|++++|+||+++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTT----EEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCC----ceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 45678889999999999999999999998654 5799999975432 23578999999999999999999999643
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+++|+||||||+|||+++++.+||+
T Consensus 334 --~~~~lv~e~~~~gsL~~~l~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 334 --EPIYIVTEYMSKGSLLDFLKGET------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp --SSCEEEECCCTTEEHHHHHSHHH------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred --ccceEeeehhcCCcHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEc
Confidence 45799999999999999997532 1358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++....... .......++..|+|||.+....++.++|||||||++|||+|+|+.||.+....++...+..+.+..
T Consensus 406 DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~ 484 (535)
T 2h8h_A 406 DFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 484 (535)
T ss_dssp CTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999987643221 223345577899999999999999999999999999999998899999999888888888888888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
.+..+++++.+++.+||+.||++|||+.+|++.|+++..
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 888999999999999999999999999999999987643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=373.06 Aligned_cols=275 Identities=29% Similarity=0.573 Sum_probs=227.9
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+...+|++++.||+|+||.||+|++.+. ....+.||||++...........+.+|+.++++++||||+++++++. .
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-Q 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-C
Confidence 35677899999999999999999985431 12236899999986666667778999999999999999999999964 4
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQ 372 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~k 372 (499)
....++||||+++|+|.+++....... .....+++..++.++.|++.||.|||+++|+||||||+|||++. +..+|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRP-SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCS-SSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccc-cccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 556799999999999999998754221 11245899999999999999999999999999999999999994 45699
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
|+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+|+|+.||...+..+....+..+..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999998654433322333455788999999999999999999999999999999988999999888888888888777
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
...+..+++++.+++.+||+.||++||++.++++.|+.+...
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 777888999999999999999999999999999999987654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=402.51 Aligned_cols=269 Identities=29% Similarity=0.543 Sum_probs=226.9
Q ss_pred ceeeccceEEee-eeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 217 LTIQRCRVRLFS-VNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 217 ~~~~~~~~~~~~-~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
+.+....+.+.+ .||+|+||.||+|.+.... ..+.||||++.... .....+.|.+|+.++++++||||++++++|..
T Consensus 363 ~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 363 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp SBCCGGGEEEEEEEEEECSSEEEEEEEEECSS-CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred ccccchhccccCCEeccCCCEEEEEEEEcCCC-cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 444555566544 8999999999999875432 23789999997542 23345789999999999999999999999743
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++||||+++|+|.+++... ..+++.++..|+.||+.||+|||+++|+||||||+|||+++++.+||+
T Consensus 442 --~~~~lv~E~~~~g~L~~~l~~~--------~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~ 511 (635)
T 4fl3_A 442 --ESWMLVMEMAELGPLNKYLQQN--------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 511 (635)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHC--------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred --CCEEEEEEccCCCCHHHHHhhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEE
Confidence 3468999999999999999862 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 375 DNALARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 375 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
|||+|+....... ........+|+.|+|||++.+..++.++|||||||++|||+|.|+.||.+.+..++...+..+.+.
T Consensus 512 DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~ 591 (635)
T 4fl3_A 512 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 591 (635)
T ss_dssp CTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC
T ss_pred EcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999987654322 122334456789999999999999999999999999999998789999999999999999988888
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..+..+++++.+++..||+.||++||++.+|++.|+++...+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 8899999999999999999999999999999999999987653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=363.92 Aligned_cols=260 Identities=30% Similarity=0.607 Sum_probs=221.0
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+.+...+|++.+.||+|+||.||+|+..+ +.||||++.... ..+.+.+|+.++++++||||+++++++.+.
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 86 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETT-----EEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcC-----CEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 356677899999999999999999998743 689999997653 346789999999999999999999987666
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++|+||+++|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~D 160 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 160 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHH------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred CCceEEEEecCCCCCHHHHHHhcc------cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEee
Confidence 667899999999999999998632 12488999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++...... ....++..|+|||.+.+..++.++||||||+++|||+|+|+.||...+..+....+..+.+...
T Consensus 161 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (278)
T 1byg_A 161 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 235 (278)
T ss_dssp CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC
T ss_pred ccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 99998653321 2335678899999999999999999999999999999878999998887788888877777778
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+..+++++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 888999999999999999999999999999999998764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=372.40 Aligned_cols=251 Identities=18% Similarity=0.238 Sum_probs=216.2
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
...+|++++.||+|+||+||+|+...++ +.+|+|++.... .......+.+|+.+++.++||||+++++++ ....
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-~~~~ 78 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QTHD 78 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-ECSS
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-EeCC
Confidence 4568999999999999999999986554 789999996432 122346788999999999999999999985 5566
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRE--------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeecc
Confidence 789999999999999999863 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |++||...+..++...+... ....|.
T Consensus 151 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~ 226 (337)
T 1o6l_A 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME-EIRFPR 226 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCT
T ss_pred chhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc-CCCCCCCCCHHHHHHHHHcC-CCCCCC
Confidence 9986433221 2335678999999999999999999999999999999999 89999988887777766654 445677
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
.+++++.+++.+||+.||++|| ++.|+++
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 8899999999999999999999 8888865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=368.41 Aligned_cols=251 Identities=17% Similarity=0.344 Sum_probs=213.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
-...+|++.+.||+|+||.||+|....++ +.||+|++...... ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 91 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATG---QEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV-GDE 91 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTC---CEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCC---cEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCE
Confidence 34568999999999999999999865544 78999998644222 23568899999999999999999998644 566
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 162 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162 (297)
T ss_dssp EEEEEECCTTCBHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCC
Confidence 7999999999999999986 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--CCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--YRLNQP 456 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~--~~~~~~ 456 (499)
++....... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..+....+... .....+
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (297)
T 3fxz_A 163 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNP 239 (297)
T ss_dssp CEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHCSCCCSCG
T ss_pred ceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCCc
Confidence 987654332 2335678999999999999999999999999999999999 89999988776655544332 233445
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 678999999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=357.47 Aligned_cols=258 Identities=23% Similarity=0.424 Sum_probs=221.0
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
..+...+|++.+.||+|+||.||+|++.+ ..+|||++... ......+.|.+|+.++++++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQG-----NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETT-----EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECC-----eeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 45667789999999999999999999853 67999999754 3455567899999999999999999999997554
Q ss_pred -CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCCcEE
Q psy1789 296 -HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 296 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~--iiHrDlk~~NIlld~~~~~k 372 (499)
....++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+++ |+||||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGT------NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCS------SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred CCCCeEeeecccCCCcHHHHHhhcc------cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCccee
Confidence 256799999999999999998632 235899999999999999999999998 99999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HH
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFST---ASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-LQ 448 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~-i~ 448 (499)
|+|||++.... .....+|+.|+|||.+.+..++. ++||||||+++|||+| |+.||...+..+.... ..
T Consensus 154 l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~ 225 (271)
T 3kmu_A 154 ISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFADLSNMEIGMKVAL 225 (271)
T ss_dssp EEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH-CSCTTTTSCHHHHHHHHHH
T ss_pred EEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCccccChHHHHHHHHh
Confidence 99999875432 22456789999999998766555 8999999999999999 8999998887766544 44
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 449 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
.+.++..+..+++++.+++..||+.||++|||+.|+++.|+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 566777788899999999999999999999999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=400.39 Aligned_cols=271 Identities=31% Similarity=0.566 Sum_probs=235.0
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
....+...+|++++.||+|+||.||+|.+...+.....||+|++.........+.|.+|+.++++++||||++++|++ .
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-e
Confidence 456777889999999999999999999987654445789999998766666678899999999999999999999986 3
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK-------FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT-------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEE
Confidence 345699999999999999998632 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++.|..||.+.+..+....+..+.+..
T Consensus 534 DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~ 612 (656)
T 2j0j_A 534 DFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612 (656)
T ss_dssp CCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC
T ss_pred ecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876443322 22344567899999999999999999999999999999987899999998888888888887888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.+..+++++.+++.+||+.||++|||+.|+++.|+++.++-
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 88899999999999999999999999999999999997653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=362.62 Aligned_cols=260 Identities=18% Similarity=0.299 Sum_probs=214.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+...+|++.+.||+|+||.||+|+....+ +.||+|++... ......+.|.+|+.++++++||||+++++++ ..+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~~~ 83 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILN---IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-EED 83 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTC---SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-ECS
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCC---CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-eeC
Confidence 45678999999999999999999976554 68999988532 3455567899999999999999999999985 556
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+||
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH--------GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred CeEEEEEeCCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeC
Confidence 6789999999999999999863 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN-- 454 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-- 454 (499)
|+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+..........+.
T Consensus 156 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T 4eqm_A 156 GIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHIQDSVPNVT 233 (294)
T ss_dssp SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH-SSCSSCSSCHHHHHHHHHSSCCCCHH
T ss_pred CCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhhccCCCcc
Confidence 999876433221 2234568999999999999999999999999999999999 899999887766554443332222
Q ss_pred --CCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q psy1789 455 --QPVNCPDELFSVMAYCWAMNPEGRP-TFPQLHSCLQEFH 492 (499)
Q Consensus 455 --~~~~~~~~~~~l~~~C~~~~P~~RP-t~~~v~~~L~~~~ 492 (499)
.+..+++.+.+++.+||+.||++|| +++++.+.|+++.
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 2356889999999999999999998 8999988887653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=370.23 Aligned_cols=274 Identities=31% Similarity=0.581 Sum_probs=226.8
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCc
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 298 (499)
...+|++.+.||+|+||.||+|+...++ ....+++|.+.........+.+.+|+.+++++ +||||+++++++ .....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGY 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE-EETTE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCC-cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee-eeCCc
Confidence 3457888999999999999999987554 22356999987655555667899999999999 899999999996 44667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
.++||||+++|+|.+++....... ......+++.+++.++.|++.||+|||+++|+||||||+||+++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 899999999999999998632000 011246899999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
+||+|||+++.... ........++..|+|||.+.+..++.++||||||+++|||+|.|+.||...+..++...+..+
T Consensus 181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 99999999974321 112234456788999999999999999999999999999998788999999888888888888
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhc
Q psy1789 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498 (499)
Q Consensus 451 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~ 498 (499)
.+...+..+++++.+++.+||+.||++|||+.|+++.|+++.++.+.+
T Consensus 258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 777788889999999999999999999999999999999998776544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=366.87 Aligned_cols=266 Identities=30% Similarity=0.482 Sum_probs=224.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~ 298 (499)
...|++++.||+|+||.||++.+... ....+.||||++.........+.+.+|+.++++++||||+++++++... ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 33459999999999999999976432 2234789999998776677778899999999999999999999997654 356
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~---------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR---------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred EEEEEecccCCcHHHHHhh---------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccc
Confidence 7899999999999999975 3489999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---------------HH
Q psy1789 379 ARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP---------------FE 442 (499)
Q Consensus 379 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~---------------~~ 442 (499)
++....... ........+|..|+|||.+.+..++.++||||||+++|||+| |+.||..... .+
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh-CCCcccccchhhhhhhcccccchhHHH
Confidence 987654322 122345567888999999999999999999999999999999 7778764321 12
Q ss_pred HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 443 MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 443 ~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
+...+..+.....+..+++++.+++.+||+.||++|||+.|+++.|+++.+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 334555666777788899999999999999999999999999999999988875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=373.85 Aligned_cols=247 Identities=17% Similarity=0.255 Sum_probs=209.0
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIED 295 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 295 (499)
+.-.+|++++.||+|+||+||+|+...++ +.+|+|++.... .....+.+.+|..++..+ +||||+++++++ ..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-~~ 95 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETG---DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-QT 95 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-EC
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCC---CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-Ee
Confidence 44567999999999999999999987654 789999996532 222345678899999987 799999999985 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 96 PDRLFFVMEFVNGGDLMFHIQKS--------RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcc
Confidence 67789999999999999999873 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++ |++||...+..++...+..+ ....
T Consensus 168 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~ 243 (353)
T 3txo_A 168 FGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEAENEDDLFEAILND-EVVY 243 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCC
T ss_pred ccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 999986433221 2345679999999999999999999999999999999999 99999999888888877765 4456
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
|..+++++.+++.+||+.||++||++
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 77789999999999999999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=362.14 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=206.8
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
....++...+|++.+.||+|+||.||+|++.+ .+|+|++... ......+.|.+|+.++++++||||+++++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 34567788899999999999999999998532 4899998644 3556678899999999999999999999974
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
. ....++|+||+++++|.+++... ...+++.+++.++.|++.||+|||+++|+||||||+||+++.++.+|
T Consensus 90 -~-~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 90 -T-APQLAIVTQWCEGSSLYHHLHAS-------ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp -C-SSSCEEEEECCCEEEHHHHHTTC----------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred -c-CCccEEEEEecCCCcHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence 3 34569999999999999999752 24589999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHH
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASLQ 448 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i~ 448 (499)
|+|||+++...............||..|+|||.+. +..++.++||||||+++|||++ |+.||..... ..+...+.
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~ 239 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIEMVG 239 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH-SSCTTSSCCCHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH-CCCCccccchHHHHHHHhc
Confidence 99999998654332222334556899999999997 6678999999999999999999 8999987544 34444444
Q ss_pred cCCCCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 449 DGYRLN----QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 449 ~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
.+.... ....+++++.+++.+||+.||++|||+.++++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 432221 23478899999999999999999999999999998874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=368.06 Aligned_cols=249 Identities=22% Similarity=0.219 Sum_probs=213.5
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-----HHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-----VQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
..+|++++.||+|+||.||+|+...++ +.+|+|++...... ...+.+.+|+.+++.++||||+++++++ ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~ 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTG---LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-EN 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-EC
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCC---CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-Ee
Confidence 457999999999999999999986554 68999998654221 1246788999999999999999999985 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----cE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL----RI 371 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~----~~ 371 (499)
....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||+++++ .+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~v 158 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ--------KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT--------CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred CCEEEEEEEcCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCE
Confidence 6678999999999999999975 23689999999999999999999999999999999999998876 79
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+..+.
T Consensus 159 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 159 KLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp EECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTTC
T ss_pred EEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcC
Confidence 999999998764432 2235679999999999999999999999999999999999 899999988888877776542
Q ss_pred CCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RLNQP----VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~~~~----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ..+ ..+++++.+++.+||..||++|||+.|+++
T Consensus 235 ~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y-DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C-CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2 222 467889999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=373.64 Aligned_cols=267 Identities=21% Similarity=0.343 Sum_probs=213.2
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
....+|++.+.||+|+||.||+|++.++ +.||||++..... ...+.+.+|+.+++.++||||+++++++ .....
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 109 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDG----AKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFC-DERNE 109 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTC----CEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEEC-CCTTC
T ss_pred HHHhccCccceeecCCCeeEEEEEECCC----CEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCe
Confidence 3456788889999999999999986432 6899999875533 3456789999999999999999999996 44566
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|.+++.... .....+++.+++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSD----LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSC----CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHhccC----CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 799999999999999987532 1123589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHH-cC-
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE---MAA---SLQ-DG- 450 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~---~~~---~i~-~~- 450 (499)
++...............||..|+|||.+.+..++.++||||||+++|||+| |+.||....+.+ ... ... .+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC-ARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHH-CCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHh-CCCcccccCcHHHHHHHHHhhhcccccc
Confidence 986543332223334558899999999999999999999999999999999 788886543221 111 111 11
Q ss_pred --------CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 451 --------YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 451 --------~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.....+..++.++.+++.+||+.||++|||+.|+++.|+.+.+..+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 0111122356679999999999999999999999999999876433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.35 Aligned_cols=259 Identities=22% Similarity=0.429 Sum_probs=216.5
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCc----eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDG----VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
.+...+|++.+.||+|+||.||+|.....+. ....||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 3567789999999999999999998865432 23579999986543 234467899999999999999999999964
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc---
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR--- 370 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~--- 370 (499)
.....++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 154 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKNK-------NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKT 154 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHTG-------GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGG
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccc
Confidence 4556799999999999999998732 34899999999999999999999999999999999999998887
Q ss_pred -----EEEcccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q psy1789 371 -----IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA 444 (499)
Q Consensus 371 -----~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~ 444 (499)
+||+|||+++...... ...++..|+|||.+.+ ..++.++||||||+++|||++|+.+|+...+.....
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 155 GNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp TBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred cccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 9999999987653321 2235678999999987 779999999999999999999888888887776655
Q ss_pred HHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 445 ASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 445 ~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
..... ....+...++++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 229 ~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 QFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHhhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 55544 334455668889999999999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=370.17 Aligned_cols=252 Identities=20% Similarity=0.339 Sum_probs=214.5
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE 294 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 294 (499)
.+...+|++.+.||+|+||.||+|+...++ +.||+|++..... ....+.+..|..++..+ +||||+++++++ .
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-~ 88 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-Q 88 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-E
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-E
Confidence 345568999999999999999999987655 7899999964311 12245677888888876 999999999985 5
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
+....++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 89 TKENLFFVMEYLNGGDLMYHIQSC--------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEe
Confidence 566789999999999999999863 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++ |++||.+.+..++...+... .+.
T Consensus 161 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-~~~ 236 (345)
T 1xjd_A 161 DFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMD-NPF 236 (345)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCC
T ss_pred EChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc-CCCCCCCCCHHHHHHHHHhC-CCC
Confidence 9999986533222 2345679999999999999999999999999999999999 89999998888887777665 455
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHH-HHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFP-QLH 485 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~-~v~ 485 (499)
.|..+++++.+++.+||+.||++||++. |++
T Consensus 237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 6777899999999999999999999997 664
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=360.62 Aligned_cols=267 Identities=30% Similarity=0.514 Sum_probs=218.9
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
.+...+|++++.||+|+||.||+|++... ....+.||+|++.........+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 44566799999999999999999986322 12338899999976544445578899999999999999999999976542
Q ss_pred -CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 297 -TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 297 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNK-------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHT-------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEEeCCCCcHHHHHHhcc-------ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECc
Confidence 55789999999999999996532 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---------------C
Q psy1789 376 NALARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI---------------D 439 (499)
Q Consensus 376 fGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~---------------~ 439 (499)
||+++....... ........+|..|+|||.+.+..++.++||||||+++|||+| |..|+... .
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT-YCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHH-ccCCCcchhhHHhhccCCcccccC
Confidence 999987654332 123345668888999999999999999999999999999999 66654321 1
Q ss_pred HHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 440 PFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 440 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
.......+..+.+...+..+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 23344556666677778889999999999999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=370.09 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=206.9
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+|++.+.||+|+||.||+|....++ +.||||++.........+.+.+|+.+++.++||||+++++++ ......++
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~l 82 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGNIQYL 82 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCC---cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCCeEEE
Confidence 57999999999999999999986554 789999987554444456788999999999999999999986 44667799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 83 FLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp EEECCTTEEGGGGSBT--------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCCcHHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence 9999999999999865 23589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPF--EMAASLQDGYRLNQPVN 458 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~ 458 (499)
..............||..|+|||++.+..+ +.++|||||||++|||++ |+.||...+.. .................
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSCTTSHHHHHHHTTCTTSTTGGG
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHHhcccccCCcccc
Confidence 643333333446679999999999988775 789999999999999999 89999865442 22333333323333356
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 234 IDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 8899999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=360.63 Aligned_cols=255 Identities=25% Similarity=0.469 Sum_probs=210.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
+...+|++.+.||+|+||.||+|++.+ +.||+|++.... ..+.|.+|+.++++++||||++++|++. +.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~ 73 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRA-----KDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACL---NP 73 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETT-----EEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCT---TT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECC-----eeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEc---CC
Confidence 456789999999999999999998753 679999986542 3467899999999999999999999853 23
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCceEEcCCCc-EEEc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK---KKLLHKDLATRNCVVDDKLR-IQIT 374 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~---~~iiHrDlk~~NIlld~~~~-~kl~ 374 (499)
.++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ ++|+||||||+||+++.++. +||+
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~ 148 (307)
T 2eva_A 74 VCLVMEYAEGGSLYNVLHGAE-----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC 148 (307)
T ss_dssp TEEEEECCTTCBHHHHHHCSS-----SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred cEEEEEcCCCCCHHHHHhccC-----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence 699999999999999998632 12357899999999999999999999 79999999999999998886 7999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID--PFEMAASLQDGYR 452 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~--~~~~~~~i~~~~~ 452 (499)
|||+++..... .....||..|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+....+..+.+
T Consensus 149 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 222 (307)
T 2eva_A 149 DFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAVHNGTR 222 (307)
T ss_dssp CCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH-TCCTTTTTCSSHHHHHHHHHTTCC
T ss_pred ccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH-CCCCchhhCccHHHHHHHHhcCCC
Confidence 99999765322 223458899999999999999999999999999999999 889987643 3344445566666
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+..+..+++++.+++.+||+.||++|||+.++++.|+.+.+.+
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 7777789999999999999999999999999999999886543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=367.77 Aligned_cols=248 Identities=19% Similarity=0.275 Sum_probs=211.6
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE 294 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 294 (499)
.+...+|++++.||+|+||+||+|+...++ +.+|+|++.... .....+.+..|..++..+ +||||+++++++ +
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-~ 91 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTD---ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-Q 91 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEE---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-E
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-E
Confidence 345578999999999999999999976543 789999986432 112345678899999987 899999999984 5
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQV--------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEE
Confidence 567789999999999999999863 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++ |++||...+..++...+... ...
T Consensus 164 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~ 239 (353)
T 2i0e_A 164 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEH-NVA 239 (353)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCC
T ss_pred eCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc-CCCCCCCCCHHHHHHHHHhC-CCC
Confidence 9999986432221 2345679999999999999999999999999999999999 89999998888887777665 455
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
.|..+++++.+++.+||+.||++||++
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 677899999999999999999999964
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=363.00 Aligned_cols=256 Identities=17% Similarity=0.246 Sum_probs=206.7
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
.+...+|++.+.||+|+||.||+++........+.+|+|++.... .......+.+|+.+++.++||||+++++++ .
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-Q 91 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-E
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-E
Confidence 345678999999999999999999985322233789999997542 223445688999999999999999999985 4
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE--------GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEE
Confidence 566789999999999999999863 358899999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...+..+....+... ...
T Consensus 164 Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~-~~~ 239 (327)
T 3a62_A 164 DFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLT-GAPPFTGENRKKTIDKILKC-KLN 239 (327)
T ss_dssp CCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHT-CCC
T ss_pred eCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhC-CCC
Confidence 9999986432221 2235578999999999999999999999999999999999 89999988887777766654 445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
.|..+++++.+++.+||+.||++|| ++.|+++
T Consensus 240 ~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 6677899999999999999999999 6667654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=353.01 Aligned_cols=254 Identities=29% Similarity=0.540 Sum_probs=206.5
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc---HHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS---AVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
++...+|++.+.||+|+||.||+|.+.+ ..+|||++..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 76 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIG-----DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL- 76 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETT-----EEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcC-----CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-
Confidence 3556789999999999999999999753 6799999865422 222467889999999999999999999964
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEEcC----
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK---LLHKDLATRNCVVDD---- 367 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~---iiHrDlk~~NIlld~---- 367 (499)
.....++||||+++++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||+++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSG---------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTS---------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred cCCceEEEEEcCCCCCHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 45667999999999999999864 35899999999999999999999998 899999999999986
Q ss_pred ----CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy1789 368 ----KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443 (499)
Q Consensus 368 ----~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~ 443 (499)
++.+||+|||+++...... .....||..|+|||.+.+..++.++||||||+++|||+| |+.||...+..+.
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 222 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT-GEVPFRGIDGLAV 222 (271)
T ss_dssp SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH-CCCTTTTSCHHHH
T ss_pred ccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 7789999999998654322 224568899999999999999999999999999999999 8999998877666
Q ss_pred HHHHH-cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 444 AASLQ-DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 444 ~~~i~-~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
...+. .......+..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 55443 3445566778999999999999999999999999999999754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=361.50 Aligned_cols=248 Identities=18% Similarity=0.289 Sum_probs=214.8
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
...+|++++.||+|+||.||+|+...++ +.+|+|++..... ....+.+.+|..+++.++||||+++++++ .+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~ 79 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNG---RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-QDAQ 79 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-ECSS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-EeCC
Confidence 3467999999999999999999986554 7899999864321 12346678999999999999999999985 5566
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHT--------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEEEEeCCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecC
Confidence 789999999999999999862 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+... ....|.
T Consensus 152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~p~ 224 (318)
T 1fot_A 152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNA-ELRFPP 224 (318)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHC-CCCCCT
T ss_pred cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCC
Confidence 99865332 234678999999999999999999999999999999999 89999988887777776654 345667
Q ss_pred CCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
..++++.+++.+||+.||++|| ++.|+++
T Consensus 225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 8899999999999999999999 7888764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=374.43 Aligned_cols=251 Identities=19% Similarity=0.216 Sum_probs=213.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|++++.||+|+||.||+|....++ +.+|+|++.... .....+.+.+|+.+++.++||||+++++++ ......
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~---~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~ 85 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAG---QEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-SEEGHH 85 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTT---EEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-ECSSEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCC---cEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-EECCEE
Confidence 357899999999999999999876554 789999987543 344567789999999999999999999985 556677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---CCCcEEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD---DKLRIQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld---~~~~~kl~Df 376 (499)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++ +++.+||+||
T Consensus 86 ~lv~E~~~gg~L~~~i~~~--------~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAR--------EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp EEEECCCBCCBHHHHHHHC--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred EEEEEeCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 9999999999999999862 3589999999999999999999999999999999999998 4678999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-CC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-NQ 455 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~~ 455 (499)
|+|+....... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+..+... ..
T Consensus 158 G~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 158 GLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV-GYPPFWDEDQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp SSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTCCCCCT
T ss_pred ceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh-CCCCCCCccHHHHHHHHHhCCCCCCc
Confidence 99987654322 2235679999999999999999999999999999999999 89999988888887777665322 11
Q ss_pred C--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 P--VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 367899999999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.69 Aligned_cols=247 Identities=17% Similarity=0.272 Sum_probs=209.2
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIED 295 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 295 (499)
+...+|++++.||+|+||.||+|+...++ +.+|+|++... ......+.+.+|..++.++ +||||+++++++ ..
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-~~ 81 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTD---RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-QT 81 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-EC
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCC---CEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-Ee
Confidence 34567999999999999999999987655 78999999754 2455567788999999887 899999999985 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEe
Confidence 67789999999999999999863 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---------CHHHHHHH
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI---------DPFEMAAS 446 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~---------~~~~~~~~ 446 (499)
||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||... ....+...
T Consensus 154 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 154 YGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp GGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTTTC-------CHHHHHHH
T ss_pred ccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh-CCCCcCCcccccccccccHHHHHHH
Confidence 999986432221 2345679999999999999999999999999999999999 88999652 22233444
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy1789 447 LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
+... ....|..++.++.+++.+||+.||++||++
T Consensus 231 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 231 ILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHC-CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHcC-CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 4443 455677889999999999999999999996
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=367.14 Aligned_cols=251 Identities=20% Similarity=0.257 Sum_probs=214.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|++.+.||+|+||.||+|....++ +.+|+|++... ......+.+.+|+.++++++||||+++++++ ......
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~ 103 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFH 103 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCEE
Confidence 357999999999999999999986554 78999999653 3455667899999999999999999999985 456677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CcEEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~---~~~kl~Df 376 (499)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+||
T Consensus 104 ~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAR--------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp EEEECCCCSCBHHHHHTTC--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 9999999999999999752 358999999999999999999999999999999999999865 45999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-CC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-NQ 455 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~~ 455 (499)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++ |++||.+.+..++...+..+... ..
T Consensus 176 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~~~ 251 (362)
T 2bdw_A 176 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPS 251 (362)
T ss_dssp TTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred CcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 9998764332 2234678999999999999999999999999999999999 89999988888877777655321 11
Q ss_pred C--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 456 P--VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 456 ~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+ ..+++++.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 2578999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=367.72 Aligned_cols=250 Identities=19% Similarity=0.286 Sum_probs=217.5
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.....+|++++.||+|+||.||+|+...++ +.||+|++.... .....+.+.+|+.+++.++||||+++++++ .+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~ 112 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESG---NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KD 112 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-EC
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCC---CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-Ec
Confidence 345578999999999999999999986554 689999986432 112346788999999999999999999985 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 184 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRI--------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcc
Confidence 66789999999999999999863 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++ |++||...+..++...+..+ ....
T Consensus 185 Fg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-~~~~ 257 (350)
T 1rdq_E 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSG-KVRF 257 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCC
T ss_pred cccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhh-CCCCCCCCCHHHHHHHHHcC-CCCC
Confidence 9999876432 224568999999999999999999999999999999999 89999998888888777765 4556
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
|..+++++.+++.+||+.||++||+ +.|+++
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 7789999999999999999999998 777764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=370.56 Aligned_cols=248 Identities=16% Similarity=0.271 Sum_probs=206.9
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE 294 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 294 (499)
.+...+|+++++||+|+||+||+|+...++ +.+|+|++.... .....+.+.+|..++.++ +||||+++++++ .
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~---~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-~ 123 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTD---RIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-Q 123 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-E
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-E
Confidence 345568999999999999999999987655 789999997542 233445678899998876 899999999985 5
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++||||+++|+|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~ 195 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQ--------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLT 195 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEe
Confidence 567789999999999999999863 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC---------HHHHHH
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID---------PFEMAA 445 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~---------~~~~~~ 445 (499)
|||+|+....... .....+||+.|+|||++.+..++.++|||||||++|||++ |++||.... ...+..
T Consensus 196 DFGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~-G~~Pf~~~~~~~~~~~~~~~~~~~ 272 (396)
T 4dc2_A 196 DYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQ 272 (396)
T ss_dssp CCTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSTTTTC------CCHHHHHH
T ss_pred ecceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh-CCCCCcccccccccchhhHHHHHH
Confidence 9999986432221 2345679999999999999999999999999999999999 899996421 122334
Q ss_pred HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy1789 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 446 ~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
.+... ....|..++.++.+++.+||+.||++||++
T Consensus 273 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 273 VILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHC-CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHhcc-ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 44433 556777899999999999999999999996
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=363.20 Aligned_cols=268 Identities=29% Similarity=0.452 Sum_probs=222.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCC-CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-CC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEE-DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-DH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~ 296 (499)
+...+|++.+.||+|+||.||+|++... ....+.||||++... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 5667899999999999999999986321 123378999999765 34556789999999999999999999998764 34
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR-------ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred ceEEEEEeecCCCCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence 55789999999999999998632 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---------------
Q psy1789 377 ALARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP--------------- 440 (499)
Q Consensus 377 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~--------------- 440 (499)
|+++....... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT-YCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCGGGSHHHHHHHHCC----CCHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHh-CCCCCccccchhhhhcccccccccH
Confidence 99987653322 223345668889999999999999999999999999999999 7777654322
Q ss_pred HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 441 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.++...+..+.+...+..+++++.+++.+||+.||++|||+.|+++.|+++....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2344555666677778889999999999999999999999999999999876543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=356.84 Aligned_cols=267 Identities=31% Similarity=0.559 Sum_probs=216.9
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+...+|++.+.||+|+||.||+|++...++....||+|++.... .....+.+.+|+.++++++||||+++++++..
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-
Confidence 455678999999999999999999986655555679999986542 23445789999999999999999999998644
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
.. .++|+||+++|+|.+++.... ..+++.++..++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~D 164 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQ-------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHG-------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred CC-ceeeEecccCCCHHHHHHhcc-------CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcc
Confidence 33 689999999999999998632 3589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCC
Q psy1789 376 NALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD-GYRL 453 (499)
Q Consensus 376 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~-~~~~ 453 (499)
||+++........ .......+|..|+|||.+.+..++.++||||||+++|||+++|+.||...+..+....+.. ....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (291)
T 1u46_A 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244 (291)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence 9999876543322 1233456778899999999999999999999999999999978999998888877766654 3445
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
..+..+++++.+++.+||+.||++|||+.++++.|+++..
T Consensus 245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 5667889999999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=360.33 Aligned_cols=250 Identities=17% Similarity=0.303 Sum_probs=213.3
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
....++..+.||+|+||.||+|+...++ +.||||++..... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 43 ~~~~~~~~~~lg~G~~g~V~~a~~~~~g---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 117 (321)
T 2c30_A 43 PRLLLDSYVKIGEGSTGIVCLAREKHSG---RQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEEL 117 (321)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEE
T ss_pred chhhhhccEEeccCCCeEEEEEEECCCC---cEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEE
Confidence 3445777889999999999999986544 7899999865432 234678899999999999999999998654 5567
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||++
T Consensus 118 ~lv~e~~~~~~L~~~l~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVSQ---------VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188 (321)
T ss_dssp EEEECCCCSCBHHHHHTT---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeee
Confidence 999999999999999874 35899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--CCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN--QPV 457 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--~~~ 457 (499)
+....... ......||..|+|||++.+..++.++||||||+++|||++ |+.||...+..+....+.....+. .+.
T Consensus 189 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2c30_A 189 AQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRDSPPPKLKNSH 265 (321)
T ss_dssp EECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSSCCCCTTGG
T ss_pred eecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCcCccc
Confidence 87643321 2235678999999999999999999999999999999999 899999888877777776554332 233
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++++.+++.+||+.||++|||+.|+++
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 57889999999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=378.05 Aligned_cols=265 Identities=15% Similarity=0.228 Sum_probs=220.3
Q ss_pred hHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH--HHHHHHHHHHHHHhcCCCCcce
Q psy1789 209 DLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA--VQVSLLLQEGMAMYGLSHKNIL 286 (499)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv 286 (499)
.+...+.+..+...+|+++++||+|+||+||+|+...++ +.+|+|++...... .....+.+|..++..++||||+
T Consensus 61 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv 137 (437)
T 4aw2_A 61 PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD---KVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137 (437)
T ss_dssp HHHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBC
T ss_pred cccchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCC---cEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEE
Confidence 344456667788899999999999999999999987655 78999998643111 1123488999999999999999
Q ss_pred eEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q psy1789 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366 (499)
Q Consensus 287 ~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld 366 (499)
++++++ .+....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+|
T Consensus 138 ~l~~~~-~~~~~~~lV~Ey~~gg~L~~~l~~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~ 209 (437)
T 4aw2_A 138 TLHYAF-QDDNNLYLVMDYYVGGDLLTLLSKF-------EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209 (437)
T ss_dssp CEEEEE-ECSSEEEEEECCCTTCBHHHHHHTT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred EEEEEE-eeCCEEEEEEecCCCCcHHHHHHHc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc
Confidence 999985 5566789999999999999999862 13589999999999999999999999999999999999999
Q ss_pred CCCcEEEcccccccccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy1789 367 DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441 (499)
Q Consensus 367 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~ 441 (499)
.++.+||+|||+|+........ ......||+.|+|||++. ...++.++|||||||++|||+| |++||...+..
T Consensus 210 ~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt-G~~Pf~~~~~~ 287 (437)
T 4aw2_A 210 MNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY-GETPFYAESLV 287 (437)
T ss_dssp TTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHH
T ss_pred CCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh-CCCCCCCCChh
Confidence 9999999999999876543322 234567999999999997 5679999999999999999999 99999998888
Q ss_pred HHHHHHHcC-CCCC---CCCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q psy1789 442 EMAASLQDG-YRLN---QPVNCPDELFSVMAYCWAMNPEG--RPTFPQLHS 486 (499)
Q Consensus 442 ~~~~~i~~~-~~~~---~~~~~~~~~~~l~~~C~~~~P~~--RPt~~~v~~ 486 (499)
+....+... .+.. ....+++++.+++.+|+..+|++ ||+++|+++
T Consensus 288 ~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 777666432 1222 23458999999999999888887 999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=362.86 Aligned_cols=264 Identities=18% Similarity=0.233 Sum_probs=213.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.......+|++.+.||+|+||.||+|+...++ +.||||++.........+.+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred cccCCCCCEEEEEEecCCCCeEEEEEEECCCC---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 34566789999999999999999999987654 789999997654334456788999999999999999999986554
Q ss_pred C-CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCc
Q psy1789 296 H-TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV----DDKLR 370 (499)
Q Consensus 296 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll----d~~~~ 370 (499)
. ...++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+++|+||||||+|||+ +.++.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSN-----AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGG-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCce
Confidence 3 367999999999999999986331 2348999999999999999999999999999999999999 88889
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccc--------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH--
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV--------HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-- 440 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-- 440 (499)
+||+|||+++....... .....||..|+|||++. +..++.++|||||||++|||+| |+.||.....
T Consensus 155 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~ 230 (319)
T 4euu_A 155 YKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPR 230 (319)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHH-SSCSEECTTCGG
T ss_pred EEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCccc
Confidence 99999999987654332 23456899999999987 5789999999999999999999 8899864322
Q ss_pred --HHHHHHHHcCCCC------------------C------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 441 --FEMAASLQDGYRL------------------N------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 441 --~~~~~~i~~~~~~------------------~------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.+....+..+... . .+...++.+.+++.+||+.||++|||+.|+++..++-
T Consensus 231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2333333222110 1 1113355788999999999999999999999887753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=357.77 Aligned_cols=253 Identities=20% Similarity=0.310 Sum_probs=207.4
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-------------------------HHHHHHHHH
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-------------------------VQVSLLLQE 273 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E 273 (499)
+...+|++.+.||+|+||.||+|+...++ +.||||++...... ...+.+.+|
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDN---TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTT---EEEEEEEEECC-------------------------------CHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCC---cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 34568999999999999999999976554 78999998654211 123568899
Q ss_pred HHHHhcCCCCcceeEEeEEEcC-CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy1789 274 GMAMYGLSHKNILTVLGVSIED-HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK 352 (499)
Q Consensus 274 ~~~l~~l~H~nIv~l~g~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~ 352 (499)
+.++++++||||+++++++... ....++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+++
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~ 157 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---------KPLSEDQARFYFQDLIKGIEYLHYQK 157 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999997553 4567999999999999775432 46899999999999999999999999
Q ss_pred ccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCC---CCCchhHHHHHHHHHHHHc
Q psy1789 353 LLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT---FSTASDVWAFGVLLWELTT 429 (499)
Q Consensus 353 iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwS~Gvvl~el~t 429 (499)
|+||||||+|||++.++.+||+|||+++....... ......||..|+|||.+.+.. ++.++|||||||++|||++
T Consensus 158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 99999999999999999999999999987654322 223467899999999998765 4788999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 430 LAQQPYAEIDPFEMAASLQDG-YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 430 ~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
|+.||...+...+...+... ........+++++.+++.+||+.||++|||+.|+++
T Consensus 236 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 236 -GQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -SSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -CCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 89999988777766665543 223334578999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=355.85 Aligned_cols=264 Identities=16% Similarity=0.229 Sum_probs=216.8
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIED 295 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~ 295 (499)
..+...+|++.+.||+|+||.||+|....++ +.||||++..... .+.+.+|+.+++.+ +|+|++++++++ ..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~ 77 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNN---QQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFG-QE 77 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTT---EEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEE-EE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCC---cEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeec-CC
Confidence 3456778999999999999999999975554 7899999865432 24577899999998 799999999985 45
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc-----
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR----- 370 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~----- 370 (499)
....++|+||+ +++|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~ 149 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLCG-------RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM 149 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred CceeEEEEEec-CCCHHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCe
Confidence 66779999999 899999998632 35899999999999999999999999999999999999987776
Q ss_pred EEEcccccccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC---HHH
Q psy1789 371 IQITDNALARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID---PFE 442 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~---~~~ 442 (499)
+||+|||+++........ .......||..|+|||.+.+..++.++||||||+++|||++ |+.||...+ ..+
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKAATNKQ 228 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCSCCHHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHc-CCCCcchhhccccHH
Confidence 999999999876543221 12345678999999999999999999999999999999999 899998743 333
Q ss_pred HHHHHHcC----CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 443 MAASLQDG----YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 443 ~~~~i~~~----~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
....+... ........+++++.+++.+||+.||++||++.+|++.|+++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 229 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 33332221 1111223678999999999999999999999999999999988765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=364.56 Aligned_cols=254 Identities=15% Similarity=0.206 Sum_probs=203.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC----
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT---- 297 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~---- 297 (499)
.+|++++.||+|+||.||+|+...++ +.||||++.........+.+.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDD---CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTC---CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCC---cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 46889999999999999999986554 78999999755455556789999999999999999999998755332
Q ss_pred ----------------------------------------------------ceEEEEEeCCCCCHHHHHHhcccCCCCC
Q psy1789 298 ----------------------------------------------------SPFLIYPYQDYTNLKRFLQKCKLCPEGV 325 (499)
Q Consensus 298 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 325 (499)
..++||||+++|+|.+++.... .
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~ 157 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-----S 157 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-----S
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-----C
Confidence 2689999999999999998632 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCcc----------ccCCCCC
Q psy1789 326 AHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH----------CLGDNEN 395 (499)
Q Consensus 326 ~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~ 395 (499)
....++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++........ .......
T Consensus 158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 345678889999999999999999999999999999999999999999999999876543211 1223457
Q ss_pred CccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCC
Q psy1789 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNP 475 (499)
Q Consensus 396 gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P 475 (499)
||+.|+|||.+.+..++.++|||||||++|||++ +..|+. +..+....+.....+......++++.+++.+||+.||
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-SFSTQM--ERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHS-CCCCHH--HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHH-cCCChh--HHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCC
Confidence 8999999999999999999999999999999999 544432 1223333343332222223456788999999999999
Q ss_pred CCCCCHHHHHH
Q psy1789 476 EGRPTFPQLHS 486 (499)
Q Consensus 476 ~~RPt~~~v~~ 486 (499)
++|||+.|+++
T Consensus 315 ~~Rps~~~~l~ 325 (332)
T 3qd2_B 315 TERPEATDIIE 325 (332)
T ss_dssp GGSCCHHHHHH
T ss_pred CcCCCHHHHhh
Confidence 99999999986
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=378.36 Aligned_cols=253 Identities=18% Similarity=0.234 Sum_probs=208.1
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+...+|++++.||+|+||.||+|+...++ +.||||++... ........+.+|+.+++.++||||+++++++. .
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~ 219 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATG---RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-T 219 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-E
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCC---CEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-e
Confidence 345578999999999999999999976554 78999998643 23344567889999999999999999999864 4
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++||||+++|+|..++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRE--------RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEEC
T ss_pred CCEEEEEEeeCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEc
Confidence 56789999999999999999863 368999999999999999999998 899999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+|+....... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...+..++...+... ...
T Consensus 292 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~i~~~-~~~ 367 (446)
T 4ejn_A 292 DFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELILME-EIR 367 (446)
T ss_dssp CCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCC
T ss_pred cCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh-CCCCCCCCCHHHHHHHHHhC-CCC
Confidence 9999986433222 2345679999999999999999999999999999999999 99999988888777766654 345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
.|..+++++.+++.+||+.||++|| ++.|+++
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 6778899999999999999999999 9999875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=362.52 Aligned_cols=249 Identities=20% Similarity=0.230 Sum_probs=213.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++++.||+|+||.||+|+...++ +.+|+|.+.... .....+.+|+.+++.++||||+++++++ .+....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSK---KTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESF-ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEE-EETTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCC---cEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEE-ecCCEEE
Confidence 457999999999999999999986654 789999987543 3346788999999999999999999986 4566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--CCcEEEccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD--KLRIQITDNAL 378 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~--~~~~kl~DfGl 378 (499)
+||||+++|+|.+++... ...+++.++..++.|++.||.|||+++|+||||||+|||++. ++.+||+|||+
T Consensus 78 lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-------AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEEeCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 999999999999999752 135899999999999999999999999999999999999997 78999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC---
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ--- 455 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~--- 455 (499)
++........ ....||+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+..+.....
T Consensus 151 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 226 (321)
T 1tki_A 151 ARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEYTFDEEA 226 (321)
T ss_dssp CEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCCCCCHHH
T ss_pred CeECCCCCcc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCCcCCCHHHHHHHHHcCCCCCChhh
Confidence 9876543321 23457889999999999889999999999999999999 8999998888887777665432211
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+++++.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1367899999999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=360.66 Aligned_cols=250 Identities=21% Similarity=0.208 Sum_probs=211.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-----HHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-----VQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
..+|++.+.||+|+||.||+|....++ +.+|+|++...... ...+.+.+|+.++++++||||+++++++ ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~ 85 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTG---LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-EN 85 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-EC
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCC---cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-Ee
Confidence 356899999999999999999986554 68999998643221 1246788999999999999999999985 45
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----cE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL----RI 371 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~----~~ 371 (499)
....++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||+++++ .+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 157 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAE--------KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 157 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT--------SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCE
T ss_pred CCEEEEEEEcCCCCCHHHHHHh--------cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCE
Confidence 6678999999999999999975 24689999999999999999999999999999999999999887 89
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+....
T Consensus 158 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~ 233 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANVSAVN 233 (326)
T ss_dssp EECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHTC
T ss_pred EEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHHhcC
Confidence 999999998764332 1234568999999999999999999999999999999999 899998887777766665432
Q ss_pred CCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RLN---QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~~---~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ....+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 12467889999999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=376.29 Aligned_cols=260 Identities=12% Similarity=0.198 Sum_probs=219.5
Q ss_pred hhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCCCCcceeEE
Q psy1789 212 EKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLSHKNILTVL 289 (499)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~ 289 (499)
..+.+..+...+|++++.||+|+||+||+|+...++ +.+|+|++..... ....+.+.+|+.+++.++||||++++
T Consensus 59 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~---~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 59 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR---KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred HHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCC---cEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 445667788889999999999999999999987654 7899999864211 11123478999999999999999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
+++ .+....++||||+++|+|.++++. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 136 ~~~-~~~~~~~lV~E~~~gg~L~~~l~~---------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g 205 (410)
T 3v8s_A 136 YAF-QDDRYLYMVMEYMPGGDLVNLMSN---------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 205 (410)
T ss_dssp EEE-ECSSEEEEEECCCTTEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EEE-EECCEEEEEEeCCCCCcHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC
Confidence 985 556778999999999999999976 2489999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCccccCCCCCCccccccccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy1789 370 RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT----FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~ 445 (499)
.+||+|||+|+........ ......||+.|+|||++.+.. ++.++|||||||++|||+| |++||...+..+...
T Consensus 206 ~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~ 283 (410)
T 3v8s_A 206 HLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTPFYADSLVGTYS 283 (410)
T ss_dssp CEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHH
T ss_pred CEEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh-CCCCCCCCChhhHHH
Confidence 9999999999876543322 234667999999999998765 8899999999999999999 999999988888777
Q ss_pred HHHcC---CCCCCCCCCcHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q psy1789 446 SLQDG---YRLNQPVNCPDELFSVMAYCWAMNPEG--RPTFPQLHS 486 (499)
Q Consensus 446 ~i~~~---~~~~~~~~~~~~~~~l~~~C~~~~P~~--RPt~~~v~~ 486 (499)
.+..+ ........+++++.+++.+||..+|.+ ||++.||++
T Consensus 284 ~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 284 KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 66543 223333478999999999999999988 999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=372.13 Aligned_cols=268 Identities=15% Similarity=0.235 Sum_probs=209.7
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCc--eeEEEEEEEecCcccHHH----------HHHHHHHHHHHhcCCCCccee
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDG--VEEEVLVKTVTDNASAVQ----------VSLLLQEGMAMYGLSHKNILT 287 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~H~nIv~ 287 (499)
...+|++++.||+|+||.||+|.+..+.. ..+.||||++........ ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999865421 236799999875532111 112445666788899999999
Q ss_pred EEeEEEcCC---CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q psy1789 288 VLGVSIEDH---TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCV 364 (499)
Q Consensus 288 l~g~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIl 364 (499)
+++++.... ...++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+++|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-------KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEE
Confidence 999976532 3479999999 999999998631 46999999999999999999999999999999999999
Q ss_pred Ec--CCCcEEEcccccccccCCCCccc-----cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy1789 365 VD--DKLRIQITDNALARDLFPSDYHC-----LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE 437 (499)
Q Consensus 365 ld--~~~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~ 437 (499)
++ .++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~Pf~~ 263 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT-GHLPWED 263 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCCTTGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCccc
Confidence 99 88999999999998764332211 1134458999999999999999999999999999999999 8999985
Q ss_pred CC-HHHHHHHHHcCCC---------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 438 ID-PFEMAASLQDGYR---------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 438 ~~-~~~~~~~i~~~~~---------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.. ............. ...+..+++++.+++..||+.||++||++.+|++.|+++.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 264 NLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp GTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 32 2221111111000 00124678999999999999999999999999999999987753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=362.83 Aligned_cols=261 Identities=19% Similarity=0.239 Sum_probs=213.5
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 297 (499)
+...+|++.+.||+|+||.||+|+...++ +.||||++...... +.+.+|+.+++++ +||||+++++++.. ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~ 78 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTN---EYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPC-GK 78 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTT---EEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEE-TT
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCC---cEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEec-CC
Confidence 45678999999999999999999976554 78999998654322 3578999999999 99999999998644 56
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc-----EE
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR-----IQ 372 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~-----~k 372 (499)
..++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+++|+||||||+|||++.++. +|
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 79 YNAMVLELL-GPSLEDLFDLCD-------RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred ccEEEEEeC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEE
Confidence 779999999 899999998632 36999999999999999999999999999999999999999887 99
Q ss_pred EcccccccccCCCCccc-----cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH
Q psy1789 373 ITDNALARDLFPSDYHC-----LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP---FEMA 444 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~---~~~~ 444 (499)
|+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+. .+..
T Consensus 151 l~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~Pf~~~~~~~~~~~~ 229 (330)
T 2izr_A 151 IIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLR-GSLPWQGLKADTLKERY 229 (330)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCSSHHHHH
T ss_pred EEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhc-CCCCccccccccHHHHH
Confidence 99999998764332211 1245678999999999999999999999999999999999 8999987433 3333
Q ss_pred HHHHcCCCCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 445 ASLQDGYRLN----QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 445 ~~i~~~~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..+....... ....++ ++.+++..||+.||.+||++.+|.+.|+++.++++
T Consensus 230 ~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 230 QKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 3332211111 112355 99999999999999999999999999999887754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=354.26 Aligned_cols=255 Identities=22% Similarity=0.437 Sum_probs=211.5
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc---HHHH---HHHHHHHHHHhcCCCCcceeEEeE
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS---AVQV---SLLLQEGMAMYGLSHKNILTVLGV 291 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~---~~~~~E~~~l~~l~H~nIv~l~g~ 291 (499)
.+...+|++.+.||+|+||.||+|+...++ +.||+|++..... .... +.+.+|+.++++++||||++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDK---SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTC---CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCc---eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 345678999999999999999999986554 7899999854321 2111 678999999999999999999998
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcCCC
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVVDDKL 369 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~--iiHrDlk~~NIlld~~~ 369 (499)
+ ... .++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++
T Consensus 92 ~-~~~--~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 92 M-HNP--PRMVMEFVPCGDLYHRLLDK-------AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp E-TTT--TEEEEECCTTCBHHHHHHCT-------TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCC
T ss_pred e-cCC--CeEEEEecCCCCHHHHHhcc-------cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccC
Confidence 5 333 37999999999999998752 246899999999999999999999999 99999999999998877
Q ss_pred c-----EEEcccccccccCCCCccccCCCCCCcccccccccc--ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 370 R-----IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESL--VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 370 ~-----~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
. +||+|||+++..... .....||..|+|||.+ ....++.++||||||+++|||++ |+.||......+
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 235 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT-GEGPFDEYSYGK 235 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH-SSCTTTTCCCCH
T ss_pred CCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc-CCCCCccccccH
Confidence 6 999999999854322 2345688999999998 45567899999999999999999 899998654333
Q ss_pred H--HH-HHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 443 M--AA-SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 443 ~--~~-~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
. .. .......+..+..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 236 IKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 2 33 3345566677788999999999999999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=358.30 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=201.7
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc--CCCCcceeEEeEEEcC-
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG--LSHKNILTVLGVSIED- 295 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~- 295 (499)
+...+|++.+.||+|+||.||+|++.+ +.||||++..... ..+..|.+++.. ++||||+++++++...
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQG-----ENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETT-----EEEEEEEECGGGH----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECC-----EEEEEEEeccccc----hhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 345689999999999999999998732 7899999865422 344556665554 8999999999986543
Q ss_pred --CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEE
Q psy1789 296 --HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH--------KKKLLHKDLATRNCVV 365 (499)
Q Consensus 296 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH--------~~~iiHrDlk~~NIll 365 (499)
....++||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL---------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT---------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh---------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE
Confidence 3447899999999999999964 35899999999999999999999 8999999999999999
Q ss_pred cCCCcEEEcccccccccCCCCccc--cCCCCCCccccccccccccC------CCCCchhHHHHHHHHHHHHcCC------
Q psy1789 366 DDKLRIQITDNALARDLFPSDYHC--LGDNENRPVKWLAIESLVHK------TFSTASDVWAFGVLLWELTTLA------ 431 (499)
Q Consensus 366 d~~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~~DvwS~Gvvl~el~t~g------ 431 (499)
+.++.+||+|||+|+......... ......||+.|+|||.+.+. .++.++|||||||++|||+| |
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~ 225 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGI 225 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT-TBCBTTB
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh-hhcCccc
Confidence 999999999999998654432221 12345789999999999877 45579999999999999999 6
Q ss_pred ----CCCCCCCC-----HHHHHHHHH-cCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 432 ----QQPYAEID-----PFEMAASLQ-DGYRLNQPV-----NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 432 ----~~p~~~~~-----~~~~~~~i~-~~~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+.||.... ...+...+. ...++..+. .+++++.+++.+||+.||++|||+.||++.|+++
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 77876532 122222222 222333332 2557899999999999999999999999999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=359.44 Aligned_cols=272 Identities=31% Similarity=0.506 Sum_probs=222.9
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeC-CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTE-EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
...+...+|++++.||+|+||.||+|++.. .....+.||||++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 345667789999999999999999998632 11223789999997653 3445789999999999999999999998654
Q ss_pred CC-CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 295 DH-TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 295 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
.. ...++|+||+++|+|.+++.... ..+++.+++.++.|++.||+|||+++|+||||||+||++++++.+||
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHK-------ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHST-------TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEE
Confidence 33 35799999999999999998632 35899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH------------
Q psy1789 374 TDNALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP------------ 440 (499)
Q Consensus 374 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~------------ 440 (499)
+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||+| |..|+.....
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT-YIEKSKSPPAEFMRMIGNDKQG 265 (326)
T ss_dssp CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHH-TTCGGGSHHHHHHHHHCTTCCT
T ss_pred ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHh-cCCCCCCCHHHHHHhhccccch
Confidence 999999876543321 22334567788999999999999999999999999999999 6666653210
Q ss_pred ----HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 441 ----FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 441 ----~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..+...+..+.+...+..+++++.+++.+||+.||++|||+.|+++.|+++.+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 12234445555666777899999999999999999999999999999999998875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.21 Aligned_cols=251 Identities=18% Similarity=0.327 Sum_probs=219.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++++.||+|+||.||+|....++ +.||+|++.........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 96 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQ---KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLW 96 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCC---cEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEE
Confidence 356889999999999999999876544 78999999765444456789999999999999999999998654 56679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++
T Consensus 97 lv~e~~~~~~L~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 167 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP---------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG 167 (303)
T ss_dssp EEEECCTTEEHHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccce
Confidence 99999999999999974 358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
....... ......|+..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+........+..++
T Consensus 168 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T 3a7i_A 168 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR-GEPPHSELHPMKVLFLIPKNNPPTLEGNYS 244 (303)
T ss_dssp ECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCCSSCC
T ss_pred ecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHcc-CCCCCCCcCHHHHHHHhhcCCCCCCccccC
Confidence 6643321 2235568899999999999999999999999999999999 899999888887777777666666777899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.++.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.33 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=204.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++++.||+|+||+||+|+...++ +.||+|++... ......+.+.+|+.++++++||||+++++++ ..+...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCC---ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-EeCCEEE
Confidence 47899999999999999999986654 78999999643 2333456788999999999999999999996 4466789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~e~~~~-~l~~~~~~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSC-------NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp EEEECCSE-EHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCC-CHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 99999995 666666542 2468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR------- 452 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~------- 452 (499)
....... ......+|..|+|||.+.+.. ++.++|||||||++|||+|++.++|...+..+....+.....
T Consensus 150 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred ecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 6643221 233567899999999998766 899999999999999999967777777776665554432100
Q ss_pred ---------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 ---------------------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ---------------------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
......+++++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0111246789999999999999999999999876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=367.34 Aligned_cols=250 Identities=17% Similarity=0.228 Sum_probs=205.2
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHH-HhcCCCCcceeEEeEEEcC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMA-MYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~-l~~l~H~nIv~l~g~~~~~ 295 (499)
+...+|++++.||+|+||.||+|+...++ +.+|+|++.... .......+.+|..+ ++.++||||+++++++ ..
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-~~ 110 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEE---VFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-QT 110 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTC---CEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-EC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCC---CEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-Ee
Confidence 34467999999999999999999987654 789999996542 23344566777776 5778999999999985 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRE--------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEee
Confidence 67789999999999999999863 3588999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |++||...+..++...+... ....
T Consensus 183 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~ 258 (373)
T 2r5t_A 183 FGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNK-PLQL 258 (373)
T ss_dssp CCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSBHHHHHHHHHHS-CCCC
T ss_pred CccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHhc-ccCC
Confidence 999986432221 2345678999999999999999999999999999999999 89999988888887777654 3455
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQL 484 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v 484 (499)
+..++.++.+++.+||+.||++||++.+.
T Consensus 259 ~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 259 KPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp CSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred CCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 67789999999999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=349.35 Aligned_cols=251 Identities=19% Similarity=0.255 Sum_probs=213.1
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH--HHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA--VQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
....+|++.+.||+|+||.||+|....++ ..+|+|++...... .....+.+|+.++++++||||+++++++ ...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 81 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSK---FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-HDA 81 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECS
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCC---cEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-ecC
Confidence 44568999999999999999999987654 68999998643211 1245688999999999999999999996 445
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKL--------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEec
Confidence 6679999999999999999863 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
|++....... .....|+..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+... ....+
T Consensus 154 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~ 227 (279)
T 3fdn_A 154 GWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRV-EFTFP 227 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHT-CCCCC
T ss_pred cccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH-CCCCCCCCcHHHHHHHHHhC-CCCCC
Confidence 9987543322 234568899999999999999999999999999999999 89999988877777666554 44566
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..+++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 7789999999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=366.74 Aligned_cols=251 Identities=19% Similarity=0.307 Sum_probs=210.1
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+...+|++++.||+|+||.||++....++ +.+|+|++.... .....+.+.+|+.+++.++||||+++++++ ..
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~---~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~ 86 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTK---KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-QD 86 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-EC
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-Ee
Confidence 455678999999999999999999987654 789999986432 112246788999999999999999999985 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|..++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~D 158 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQQ--------NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITD 158 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEecCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEec
Confidence 6678999999999999999986 23589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHc
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVH---KTFSTASDVWAFGVLLWELTTLAQQPYAEI---DPFEMAASLQD 449 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~---~~~~~~~~i~~ 449 (499)
||+|+...... ......||+.|+|||++.. ..++.++|||||||++|||++ |+.||... ...++...+..
T Consensus 159 FG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 234 (384)
T 4fr4_A 159 FNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPYHIRSSTSSKEIVHTFET 234 (384)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCCTTSCHHHHHHHHHH
T ss_pred cceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh-CCCCCCCCCCccHHHHHHHHhh
Confidence 99998764332 2345679999999999974 458999999999999999999 89999743 33444444443
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCC-HHHHH
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRPT-FPQLH 485 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-~~~v~ 485 (499)
. ....|..+++++.+++.+||+.||++||+ +.++.
T Consensus 235 ~-~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 235 T-VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp C-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred c-ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 3 45567788999999999999999999998 66654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.60 Aligned_cols=260 Identities=17% Similarity=0.246 Sum_probs=206.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
....+|++.+.||+|+||.||+|+...++ +.||||++... ........+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDH---RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCC---ceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 34568999999999999999999976554 78999999754 34455678999999999999999999999865433
Q ss_pred C---ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 297 T---SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 297 ~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
. ..++||||+++|+|.++++.. ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl 157 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV 157 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEE
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEE
Confidence 2 248999999999999999863 35899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 374 TDNALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 374 ~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
+|||+++........ .......||..|+|||.+.+..++.++||||||+++|||+| |+.||...+..+..........
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~~~~~~~ 236 (311)
T 3ork_A 158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVREDP 236 (311)
T ss_dssp CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHCCC
T ss_pred eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCC
Confidence 999999866443221 12234568999999999999999999999999999999999 8999998887766544433322
Q ss_pred CC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH-HHHHH
Q psy1789 453 LN---QPVNCPDELFSVMAYCWAMNPEGRPTFPQLH-SCLQE 490 (499)
Q Consensus 453 ~~---~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~-~~L~~ 490 (499)
.. ....+++++.+++.+||+.||++||+..+++ +.+.+
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 11 1245889999999999999999999766654 34433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=364.48 Aligned_cols=254 Identities=17% Similarity=0.243 Sum_probs=208.1
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc----cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA----SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
..+|++.+.||+|+||.||+|....++ +.||||++.... .....+.+.+|+.+++.++||||+++++++ ...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETG---QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-SSD 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-EET
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCC---CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-EeC
Confidence 457999999999999999999986554 789999985321 111246789999999999999999999985 446
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc---EEE
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR---IQI 373 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~---~kl 373 (499)
...++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRAD----AGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence 678999999999999988875321 1235899999999999999999999999999999999999987654 999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.. .++...+..+...
T Consensus 175 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~-~~~~~~i~~~~~~ 250 (351)
T 3c0i_A 175 GGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS-GCLPFYGTK-ERLFEGIIKGKYK 250 (351)
T ss_dssp CCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCSSH-HHHHHHHHHTCCC
T ss_pred ecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH-CCCCCCCcH-HHHHHHHHcCCCC
Confidence 99999987654322 2335678999999999999999999999999999999999 889998743 4444444443221
Q ss_pred CCC---CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 NQP---VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ~~~---~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 367899999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=361.96 Aligned_cols=255 Identities=17% Similarity=0.310 Sum_probs=205.5
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCC--CcceeEEeEEE
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSH--KNILTVLGVSI 293 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H--~nIv~l~g~~~ 293 (499)
+.+...+|++++.||+|+||.||++...++ +.||||++... ......+.+.+|+.++.+++| +||+++++++.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKK----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTS----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCC----CEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 456778999999999999999999986432 67999998643 345556789999999999976 99999999964
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
.+...++||| +.+|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+|||++ ++.+||
T Consensus 80 -~~~~~~lv~e-~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 80 -TDQYIYMVME-CGNIDLNSWLKKK--------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp -CSSEEEEEEC-CCSEEHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred -eCCEEEEEEe-CCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEE
Confidence 4567799999 5679999999872 3689999999999999999999999999999999999997 578999
Q ss_pred cccccccccCCCCccccCCCCCCcccccccccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-HH
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-----------KTFSTASDVWAFGVLLWELTTLAQQPYAEID-PF 441 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~~ 441 (499)
+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.... ..
T Consensus 149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~ 227 (343)
T 3dbq_A 149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQI 227 (343)
T ss_dssp CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCSHH
T ss_pred eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh-CCCcchhhhhHH
Confidence 99999987654433333445679999999999975 678999999999999999999 889998643 22
Q ss_pred H-HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 442 E-MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 442 ~-~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
. ....+........+...++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 3 233333445556677788999999999999999999999999753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=355.68 Aligned_cols=251 Identities=20% Similarity=0.281 Sum_probs=201.7
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
..++|++++.||+|+||.||+|+..++ +.||+|++.... .....+.+.+|+.++++++||||+++++++ ..+..
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~ 93 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQG----RIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-HSERC 93 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTS----CEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-CCSSC
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCC----CEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-ccCCE
Confidence 346799999999999999999997543 689999986542 222346788999999999999999999985 55667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~lv~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 165 (311)
T 3niz_A 94 LTLVFEFME-KDLKKVLDENK-------TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL 165 (311)
T ss_dssp EEEEEECCS-EEHHHHHHTCT-------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcCCC-CCHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcC
Confidence 899999999 68888887522 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN--- 454 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--- 454 (499)
++....... ......+|..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+....+....+.......
T Consensus 166 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 166 ARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp CEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred ceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 987643221 2234567899999999976 568999999999999999999 889998765544433332110000
Q ss_pred --------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 --------------------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 --------------------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+++++.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 01245678999999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=366.06 Aligned_cols=248 Identities=19% Similarity=0.262 Sum_probs=206.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH--HHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA--VQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
-.+|++.+.||+|+||.||+|....++ +.||+|++...... .....+.+|+.+++.++||||+++++++ .....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~ 83 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQ---QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-TTPTD 83 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCE
Confidence 357999999999999999999986554 78999998643111 1124688999999999999999999996 44567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+ +|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+|||+++++.+||+|||+
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEK--------KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred EEEEEECC-CCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecc
Confidence 79999999 68999998763 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
++...... ......||+.|+|||.+.+..+ +.++|||||||++|||++ |+.||.+....++...+..+ ....|.
T Consensus 155 s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~ 229 (336)
T 3h4j_B 155 SNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV-GRLPFDDEFIPNLFKKVNSC-VYVMPD 229 (336)
T ss_dssp TBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH-SSCSSBCSSSTTCBCCCCSS-CCCCCT
T ss_pred ceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh-CCCCCCCccHHHHHHHHHcC-CCCCcc
Confidence 98664432 2235678999999999988776 789999999999999999 89999875543333222222 334566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++++.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 230 FLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 78999999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=353.49 Aligned_cols=258 Identities=19% Similarity=0.324 Sum_probs=219.1
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-CCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-DHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~ 298 (499)
..+|++.+.||+|+||.||+|....++ +.+|+|.+... ......+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCC---cEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 457999999999999999999986554 78999998654 345566789999999999999999999998653 4566
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEEcCCCcEEE
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK-----LLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~-----iiHrDlk~~NIlld~~~~~kl 373 (499)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTK----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred EEEEEeCCCCCCHHHHHHhhcc----cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 7999999999999999986431 1235899999999999999999999998 999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||+| |+.||...+..++...+..+...
T Consensus 158 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~~~~~~ 234 (279)
T 2w5a_A 158 GDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIREGKFR 234 (279)
T ss_dssp CCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCC
T ss_pred ecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCcccCHHHHHHHHhhcccc
Confidence 999999866432211 112357888999999999999999999999999999999 89999998888888888877776
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCL 488 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L 488 (499)
..+..+++++.+++.+||+.||++||++.|+++.+
T Consensus 235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 77778999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.86 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=195.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++++.||+|+||.||+|....++ +.||+|++.........+.+.+|+.++++++||||+++++++ ..++..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTG---VYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-HTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSC---CEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-CCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCC---cEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-EECCeEE
Confidence 357888899999999999999876544 789999987543333345688999999999999999999985 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||++ |+|.+++...... .....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVG--NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSS--SCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEecC-CCHHHHHHhcccc--ccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 9999999 7999999764321 122458999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR------- 452 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~------- 452 (499)
....... ......+|..|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+....+.....
T Consensus 157 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 157 AFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp ETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred ecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 6643221 2234568899999999976 468999999999999999999 8999998877665554432100
Q ss_pred --------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 --------------------------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 --------------------------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+..+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0112256789999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=366.39 Aligned_cols=260 Identities=15% Similarity=0.264 Sum_probs=208.6
Q ss_pred cceeeccceEEeeeeeee--cceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEG--TFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G--~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
.+.....+|++++.||+| +||.||+|+...++ +.||||++... ......+.+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTG---EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCC---CEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 344566789999999999 99999999987554 78999999654 3455567888999999999999999999996
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
. .....++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 96 ~-~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~k 168 (389)
T 3gni_B 96 I-ADNELWVVTSFMAYGSAKDLICTHF------MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 168 (389)
T ss_dssp E-ETTEEEEEEECCTTCBHHHHHHHTC------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred E-ECCEEEEEEEccCCCCHHHHHhhhc------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 4 4667899999999999999998632 23589999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCc-----cccCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy1789 373 ITDNALARDLFPSDY-----HCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445 (499)
Q Consensus 373 l~DfGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~ 445 (499)
|+|||++........ ........||..|+|||++.+ ..++.++|||||||++|||++ |+.||.+.+..+...
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN-GHVPFKDMPATQMLL 247 (389)
T ss_dssp ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTCCSTTHHH
T ss_pred EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Confidence 999999865432111 111223468889999999987 679999999999999999999 899998754433222
Q ss_pred HHHcCC---------------------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCC
Q psy1789 446 SLQDGY---------------------------------------------RLNQPVNCPDELFSVMAYCWAMNPEGRPT 480 (499)
Q Consensus 446 ~i~~~~---------------------------------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt 480 (499)
.+..+. ....+..+++++.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 327 (389)
T 3gni_B 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327 (389)
T ss_dssp HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCC
T ss_pred HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC
Confidence 211110 00123356788999999999999999999
Q ss_pred HHHHHH
Q psy1789 481 FPQLHS 486 (499)
Q Consensus 481 ~~~v~~ 486 (499)
+.|+++
T Consensus 328 a~ell~ 333 (389)
T 3gni_B 328 ASTLLN 333 (389)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=346.02 Aligned_cols=250 Identities=20% Similarity=0.248 Sum_probs=213.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.++|++.+.||+|+||.||+|....++ +.||+|++... ......+.+.+|+.++++++||||+++++++ ......
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 80 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTG---LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFH 80 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCC---ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-EcCCEE
Confidence 467999999999999999999986654 68999998654 3455567889999999999999999999986 455667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc---EEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR---IQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~---~kl~Df 376 (499)
++|+||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++. +||+||
T Consensus 81 ~~v~e~~~~~~l~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Df 152 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR--------EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 152 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeec
Confidence 9999999999999998863 35899999999999999999999999999999999999986655 999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-C-
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-N- 454 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~- 454 (499)
|++....... ......||..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+..+... .
T Consensus 153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 153 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp TTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHH-CCCCCCCCchhHHHHHHHhccccCCc
Confidence 9998664332 2234678999999999999999999999999999999999 89999988887777766554321 1
Q ss_pred -CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 -QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 -~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+++++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 22367899999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=358.83 Aligned_cols=248 Identities=19% Similarity=0.304 Sum_probs=209.9
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
...+|++.+.||+|+||.||+|+...++ +.||||++... ......+.+.+|+.++++++||||+++++++.. ..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 127 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EH 127 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TT
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCC---eEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CC
Confidence 3456899999999999999999976554 78999998643 234445789999999999999999999998654 56
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||+. |+|.+++.... ..+++.++..++.|++.||.|||+++|+||||||+|||+++++.+||+|||
T Consensus 128 ~~~lv~e~~~-g~l~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 128 TAWLVMEYCL-GSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp EEEEEEECCS-EEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred eEEEEEecCC-CCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeecc
Confidence 7799999998 78888886532 468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL- 453 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~- 453 (499)
+++..... ....||+.|+|||++. ...++.++|||||||++|||+| |++||...+..+....+.....+
T Consensus 200 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~ 272 (348)
T 1u5q_A 200 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPA 272 (348)
T ss_dssp TCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCC
Confidence 99865322 2456899999999985 5679999999999999999999 88999887776655555444333
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+..+++++.+++.+||+.||++|||+.++++
T Consensus 273 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 334578999999999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=364.38 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=208.9
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
+..+...+|++.+.||+|+||.||+|...++ +.||||++...........+.+|+.+++.++||||+++++++. .
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 98 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADG----TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-T 98 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSS----CCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC-C
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCC----CEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe-c
Confidence 3445566788889999999999999985432 6799999976544333446889999999999999999999964 4
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEEcCCCcEE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK---KLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~---~iiHrDlk~~NIlld~~~~~k 372 (499)
....++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERP----ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCS----TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEeccCCCHHHHHHhcc----ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 556699999999999999998632 1234599999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CCHHHHHHHH
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE-----IDPFEMAASL 447 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~-----~~~~~~~~~i 447 (499)
|+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||+| |+.||.. ........++
T Consensus 175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT-GQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH-CCCSBCHHHHTTTSCSBHHHHH
T ss_pred eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh-CCCcccccccccccchhHHHHH
Confidence 9999999876433322 2334568999999999999999999999999999999999 8889852 1111122222
Q ss_pred HcCCCC-------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 448 QDGYRL-------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 448 ~~~~~~-------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
...... ..+...++++.+++.+||+.||++|||+.||++.|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 221111 1112334679999999999999999999999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=370.14 Aligned_cols=261 Identities=18% Similarity=0.202 Sum_probs=216.0
Q ss_pred hhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEE
Q psy1789 212 EKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVL 289 (499)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~ 289 (499)
..+.+..+...+|++++.||+|+||+||+++...++ +.||+|++.+.. .....+.+.+|..++..++||||++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~---~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG---QVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 345667788899999999999999999999986554 789999996431 112234588999999999999999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
+++ .+....++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||+|.++
T Consensus 128 ~~~-~~~~~~~lVmE~~~gg~L~~~l~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g 199 (412)
T 2vd5_A 128 FAF-QDENYLYLVMEYYVGGDLLTLLSKFG-------ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG 199 (412)
T ss_dssp EEE-ECSSEEEEEECCCCSCBHHHHHHHHS-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS
T ss_pred EEE-eeCCEEEEEEcCCCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC
Confidence 985 55677899999999999999998632 3589999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCccccCCCCCCccccccccccc-------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 370 RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV-------HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
++||+|||+++........ ......||+.|+|||++. ...++.++|||||||++|||++ |++||...+..+
T Consensus 200 ~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~ 277 (412)
T 2vd5_A 200 HIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY-GQTPFYADSTAE 277 (412)
T ss_dssp CEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH-SSCTTCCSSHHH
T ss_pred CEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh-CCCCCCCCCHHH
Confidence 9999999999876543322 233567999999999997 3578999999999999999999 899999888877
Q ss_pred HHHHHHcCC-C---CCCCCCCcHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q psy1789 443 MAASLQDGY-R---LNQPVNCPDELFSVMAYCWAMNPEGR---PTFPQLHS 486 (499)
Q Consensus 443 ~~~~i~~~~-~---~~~~~~~~~~~~~l~~~C~~~~P~~R---Pt~~~v~~ 486 (499)
....+.... . +..+..+++++.+++.+||. +|.+| |+++|+++
T Consensus 278 ~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 766665321 1 22235789999999999999 99998 58888764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=348.01 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=216.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
..+|++.+.||+|+||.||+|....++ +.+|+|++... ......+.+.+|+.+++.++||||+++++++ .....
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 89 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTK---EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-EDNDF 89 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCC---ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-ccCCE
Confidence 468999999999999999999986654 68999998644 2445667899999999999999999999996 44667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+++++|.+++... ..+++.++..++.|++.||+|||+++|+||||||+||++++++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 161 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccC
Confidence 79999999999999998762 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
++....... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+....+... ....+..
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 237 (294)
T 2rku_A 162 ATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKN-EYSIPKH 237 (294)
T ss_dssp CEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT-CCCCCTT
T ss_pred ceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhhc-cCCCccc
Confidence 986643221 2234568899999999999999999999999999999999 89999988777766666554 3455667
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+++++.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 238 INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 89999999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=363.83 Aligned_cols=249 Identities=18% Similarity=0.222 Sum_probs=212.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+|++.+.||+|+||.||+|....++ +.+|+|++.... ......+.+|+.+++.++||||+++++++ ......++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~l 125 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATG---RVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVL 125 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEE-ECSSEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCC---CEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEE-EeCCEEEE
Confidence 57999999999999999999986554 689999987553 33446789999999999999999999985 45667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--CCcEEEcccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD--KLRIQITDNALA 379 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~--~~~~kl~DfGla 379 (499)
||||+++|+|.+++... ...+++.++..++.|++.||+|||+++|+||||||+|||++. ++.+||+|||++
T Consensus 126 v~E~~~gg~L~~~l~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAE-------DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp EEECCCCCBHHHHTTCT-------TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccc
Confidence 99999999999998742 135899999999999999999999999999999999999984 578999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR---LNQP 456 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~~ 456 (499)
+........ ....||..|+|||++.+..++.++|||||||++|||+| |..||.+.+..+....+..... ....
T Consensus 199 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 274 (387)
T 1kob_A 199 TKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCDWEFDEDAF 274 (387)
T ss_dssp EECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred eecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 876543321 23468999999999999999999999999999999999 8999998887777666654321 2223
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+++.+||+.||++|||+.|+++
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 468899999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=350.06 Aligned_cols=261 Identities=16% Similarity=0.244 Sum_probs=214.5
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|+...++ +.||||++...... +.+.+|+.+++.++|+|++..++++.......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG---EEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT---EEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCC---cEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 468999999999999999999976554 78999998654322 357899999999999998888888777777789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCcEEEcccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV---DDKLRIQITDNA 377 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll---d~~~~~kl~DfG 377 (499)
+||||+ +++|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||+ ++++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 153 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCS-------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEec-CCCHHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCC
Confidence 999999 899999998532 358999999999999999999999999999999999999 588999999999
Q ss_pred cccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Q psy1789 378 LARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP---FEMAASLQD 449 (499)
Q Consensus 378 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~---~~~~~~i~~ 449 (499)
+++........ .......||..|+|||.+.+..++.++|||||||++|||++ |+.||...+. .+....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSSSSHHHHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCcCchhhhhhhhhhcc
Confidence 99876543221 11245678999999999999999999999999999999999 8899876432 112222111
Q ss_pred ----CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 450 ----GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 450 ----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
......+..+++++.+++.+||+.||++|||+.++++.|+++..+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 11111225678999999999999999999999999999999987754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=351.42 Aligned_cols=261 Identities=16% Similarity=0.243 Sum_probs=211.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|+....+ +.||||++.... ..+.+.+|+.+++.++|+|++..++++.......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAG---EEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCC---ceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 467999999999999999999976554 789999875432 22457889999999999999998888777778889
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCcEEEcccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV---DDKLRIQITDNA 377 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll---d~~~~~kl~DfG 377 (499)
+||||+ +++|.+++.... ..+++.++..++.|++.||.|||+++|+||||||+|||+ ++++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCS-------RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 899999998532 358999999999999999999999999999999999999 789999999999
Q ss_pred cccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH-
Q psy1789 378 LARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF---EMAASLQ- 448 (499)
Q Consensus 378 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~---~~~~~i~- 448 (499)
+++........ .......||..|+|||.+.+..++.++|||||||++|||++ |+.||...+.. +....+.
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSSSSHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc-CCCCCcccchhhhhhhhhhhhc
Confidence 99876543221 12235678999999999999999999999999999999999 89999764321 1111111
Q ss_pred ---cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 449 ---DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 449 ---~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..........+++++.+++.+||+.||++|||+.++++.|+++.++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 233 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 111111124678999999999999999999999999999999988764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=353.49 Aligned_cols=246 Identities=19% Similarity=0.221 Sum_probs=196.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 298 (499)
..+|++.+.||+|+||+||+|+...++ +.||||++... ........+..|+..+.++ +||||++++++|. .+..
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-~~~~ 131 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDG---RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-EGGI 131 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTS---CEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCC---eEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-eCCE
Confidence 357999999999999999999987544 78999998643 3334445556666665554 9999999999964 4667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWG-------ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred EEEEEecc-CCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcccee
Confidence 89999999 589999987632 3599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLNQPV 457 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~ 457 (499)
++...... ......||+.|+|||++.+ .++.++|||||||++|||++|+.+|+.. +....+..+. ....+.
T Consensus 204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~ 275 (311)
T 3p1a_A 204 LVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTA 275 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHT
T ss_pred eeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCccccc
Confidence 98764332 2335568999999998875 7999999999999999999954555442 2222333222 222345
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++++.+++.+||+.||++|||+.|+++
T Consensus 276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 276 GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 68899999999999999999999999986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.15 Aligned_cols=263 Identities=18% Similarity=0.295 Sum_probs=207.5
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++.+.||+|+||.||+|....++ +.||+|++... ......+.+.+|+.++++++||||+++++++.. ....
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 107 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDG---VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNEL 107 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTC---CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCC---ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcE
Confidence 47899999999999999999976544 68999998742 345566789999999999999999999999654 5567
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKK----QKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEEEecCCCCCHHHHHHHhcc----cccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 999999999999999975321 1245899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHHcCCCCCC-C
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI--DPFEMAASLQDGYRLNQ-P 456 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~--~~~~~~~~i~~~~~~~~-~ 456 (499)
+....... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+. +..+....+.....+.. +
T Consensus 184 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (310)
T 2wqm_A 184 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSPFYGDKMNLYSLCKKIEQCDYPPLPS 260 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTC---CCHHHHHHHHHTTCSCCCCT
T ss_pred eeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccchhHHHHHHHhhcccCCCCcc
Confidence 86543221 2234567889999999999999999999999999999999 77888653 33445555554433333 3
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
..+++++.+++.+||+.||++|||+.++++.|+++++..
T Consensus 261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 261 DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 568899999999999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=373.71 Aligned_cols=252 Identities=20% Similarity=0.317 Sum_probs=216.6
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+...+|++++.||+|+||.||+|+...++ +.||||++..... ....+.+.+|+.+++.++||||+++++++ ..
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~ 87 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTG---HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-ST 87 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTC---CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-EC
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EE
Confidence 344568999999999999999999986544 7899999864321 12245788999999999999999999986 44
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~D 159 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICK--------NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIAD 159 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTS--------SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEe
Confidence 5678999999999999999975 23589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+..++...+..+ ...
T Consensus 160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~ 234 (476)
T 2y94_A 160 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC-GTLPFDDDHVPTLFKKICDG-IFY 234 (476)
T ss_dssp CSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSSCCSSSHHHHHHHHTT-CCC
T ss_pred ccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh-CCCCCCCCCHHHHHHHHhcC-CcC
Confidence 999987644322 235678999999999998776 689999999999999999 89999988877777777765 345
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.|..+++++.+++.+||+.||++|||+.|+++
T Consensus 235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 56678999999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.83 Aligned_cols=263 Identities=20% Similarity=0.313 Sum_probs=202.0
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHH--HHHHHhcCCCCcceeEEeEEEc
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQ--EGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+...+|++++.||+|+||.||+|+..+ +.||||++..... ..+.. |+..+..++|+||+++++++..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 78 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDE-----RPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDER 78 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETT-----EEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECC-----eEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccc
Confidence 44566789999999999999999998733 7899999965432 23333 4444556899999999985432
Q ss_pred ----CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCC
Q psy1789 295 ----DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK---------KLLHKDLATR 361 (499)
Q Consensus 295 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~---------~iiHrDlk~~ 361 (499)
.....++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+
T Consensus 79 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~ 149 (336)
T 3g2f_A 79 VTADGRMEYLLVMEYYPNGSLXKYLSL---------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149 (336)
T ss_dssp ECTTSCEEEEEEECCCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGG
T ss_pred cccCCCceEEEEEecCCCCcHHHHHhh---------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccc
Confidence 23346899999999999999986 2468999999999999999999999 9999999999
Q ss_pred ceEEcCCCcEEEcccccccccCCCCc------cccCCCCCCcccccccccccc-------CCCCCchhHHHHHHHHHHHH
Q psy1789 362 NCVVDDKLRIQITDNALARDLFPSDY------HCLGDNENRPVKWLAIESLVH-------KTFSTASDVWAFGVLLWELT 428 (499)
Q Consensus 362 NIlld~~~~~kl~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwS~Gvvl~el~ 428 (499)
|||++.++.+||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|||+
T Consensus 150 Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell 229 (336)
T 3g2f_A 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229 (336)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH
Confidence 99999999999999999987643221 112234568999999999987 45678999999999999999
Q ss_pred cCCCCCCCCCCH-----------------HHHHHHH-HcCCCCCCCCC------CcHHHHHHHHHhhhcCCCCCCCHHHH
Q psy1789 429 TLAQQPYAEIDP-----------------FEMAASL-QDGYRLNQPVN------CPDELFSVMAYCWAMNPEGRPTFPQL 484 (499)
Q Consensus 429 t~g~~p~~~~~~-----------------~~~~~~i-~~~~~~~~~~~------~~~~~~~l~~~C~~~~P~~RPt~~~v 484 (499)
||+.++|..... .++...+ ....++..+.. +++++.+++.+||+.||++|||+.|+
T Consensus 230 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp TTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 955555543221 1111111 12233333333 34579999999999999999999999
Q ss_pred HHHHHHHHHHhhh
Q psy1789 485 HSCLQEFHAQLTR 497 (499)
Q Consensus 485 ~~~L~~~~~~l~~ 497 (499)
++.|+++.+.+.|
T Consensus 310 l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 310 EERMAELMMIWER 322 (336)
T ss_dssp HHHHHHHHHCCCC
T ss_pred HHHHHHHHHHHHh
Confidence 9999999876654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=355.20 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=216.6
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
...+|++++.||+|+||.||++....++ +.+|+|++... ......+.+.+|+.+++.++|+||+++++++. ...
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~ 114 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTK---EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-DND 114 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCC
Confidence 3468999999999999999999986654 68999998643 24456678999999999999999999999964 466
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||+++++|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 186 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRR--------KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG 186 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCCCCCHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeecc
Confidence 779999999999999998762 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+++....... ......|+..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+... ....+.
T Consensus 187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~ 262 (335)
T 2owb_A 187 LATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKN-EYSIPK 262 (335)
T ss_dssp TCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHT-CCCCCT
T ss_pred CceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH-CcCCCCCCCHHHHHHHHhcC-CCCCCc
Confidence 9987643221 2234568899999999999999999999999999999999 89999988777666655544 344566
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+++++.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78999999999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=366.57 Aligned_cols=253 Identities=20% Similarity=0.343 Sum_probs=199.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcC-CC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIED-HT 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~-~~ 297 (499)
..+|++++.||+|+||.||+|....++ +.||||++... ......+.+.+|+.++..++ ||||+++++++... ..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTG---EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTC---CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCC---CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 357999999999999999999986654 78999998643 34555677889999999997 99999999986543 33
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||++ |+|..++.. ..+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6799999999 799999986 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc-------------------cccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDY-------------------HCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAE 437 (499)
Q Consensus 378 la~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~ 437 (499)
+|+....... ........||..|+|||++.+ ..++.++|||||||++|||++ |++||.+
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~ 233 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC-GKPIFPG 233 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCC
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh-CCCCCCC
Confidence 9986532110 111234578999999999986 679999999999999999999 8999998
Q ss_pred CCHHHHHHHHHcCCCC----------------------------------------------CCCCCCcHHHHHHHHHhh
Q psy1789 438 IDPFEMAASLQDGYRL----------------------------------------------NQPVNCPDELFSVMAYCW 471 (499)
Q Consensus 438 ~~~~~~~~~i~~~~~~----------------------------------------------~~~~~~~~~~~~l~~~C~ 471 (499)
.+..+....+...... ..+..+++++.+++.+||
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 8766654444221100 012267889999999999
Q ss_pred hcCCCCCCCHHHHHHH
Q psy1789 472 AMNPEGRPTFPQLHSC 487 (499)
Q Consensus 472 ~~~P~~RPt~~~v~~~ 487 (499)
+.||++|||+.|+++.
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=364.03 Aligned_cols=254 Identities=17% Similarity=0.305 Sum_probs=205.4
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCC--CCcceeEEeEEE
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLS--HKNILTVLGVSI 293 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~ 293 (499)
..+...+|++++.||+|+||.||+|....+ +.||||++... ......+.+.+|+.++++++ |+||+++++++.
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKK----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTC----CEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCC----CEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 445567899999999999999999986542 68999998643 34556688999999999996 599999999865
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
. ....++||| +.+++|.+++... ..+++.++..++.|++.||.|||+++|+||||||+|||++ ++.+||
T Consensus 127 ~-~~~~~lv~E-~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl 195 (390)
T 2zmd_A 127 T-DQYIYMVME-CGNIDLNSWLKKK--------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 195 (390)
T ss_dssp C-SSEEEEEEE-CCSEEHHHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEE
T ss_pred c-CCEEEEEEe-cCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEE
Confidence 4 556899999 5679999999872 3688999999999999999999999999999999999996 578999
Q ss_pred cccccccccCCCCccccCCCCCCcccccccccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-HH
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-----------KTFSTASDVWAFGVLLWELTTLAQQPYAEID-PF 441 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~~ 441 (499)
+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++ |++||.... ..
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQI 274 (390)
T ss_dssp CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHH
T ss_pred EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH-CCCcchhhhHHH
Confidence 99999987654433333345679999999999875 468999999999999999999 889998653 33
Q ss_pred HHHHHH-HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 442 EMAASL-QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 442 ~~~~~i-~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.....+ ........+...++++.+++.+||+.||++|||+.|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 333333 334445566677899999999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=361.70 Aligned_cols=246 Identities=20% Similarity=0.214 Sum_probs=203.8
Q ss_pred EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEE
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e 304 (499)
...+.||+|+||.||+|....++ +.||+|++.... ....+.+.+|+.++++++||||+++++++. .....++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATG---LKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFE-SKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTC---CEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCC---cEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEe
Confidence 33678999999999999986554 789999997653 345578999999999999999999999964 4567799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE--cCCCcEEEccccccccc
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV--DDKLRIQITDNALARDL 382 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll--d~~~~~kl~DfGla~~~ 382 (499)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+|+||||||+|||+ ++++.+||+|||+++..
T Consensus 167 ~~~~~~L~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 167 YVDGGELFDRIIDES-------YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp CCTTCEEHHHHHHTG-------GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred CCCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 999999999997522 358999999999999999999999999999999999999 56789999999999876
Q ss_pred CCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCC--CCCCC
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLN--QPVNC 459 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~--~~~~~ 459 (499)
..... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.... ... ....+
T Consensus 240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 315 (373)
T 2x4f_A 240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDNDAETLNNILACRWDLEDEEFQDI 315 (373)
T ss_dssp CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTS
T ss_pred CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhccCCCChhhhccC
Confidence 54332 234568999999999999999999999999999999999 899999888777666655432 211 12467
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++++.+++.+||+.||++|||+.|+++
T Consensus 316 ~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 316 SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 899999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=350.71 Aligned_cols=260 Identities=18% Similarity=0.187 Sum_probs=208.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
-.+|++.+.||+|+||.||+|....++ +.||+|++... ......+.+.+|+.++++++||||+++++++.. ...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRE---RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTT---EEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCC---eEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCe
Confidence 357999999999999999999986554 78999998654 234456789999999999999999999999644 567
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+++++|.+++... ..+++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 180 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ--------GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI 180 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred EEEEEEecCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCcc
Confidence 79999999999999999863 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL--NQP 456 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~ 456 (499)
++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...+...+...+...... ..+
T Consensus 181 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 181 ASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIPRPSTVR 258 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHH-SSCSSCSCHHHHHHHHHHSCCCCGGGTS
T ss_pred Cccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHH-CCCCCCCchHHHHHHHhccCCCCccccC
Confidence 9866433221 2234568899999999999999999999999999999999 89999887666555555443221 234
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRP-TFPQLHSCLQEFHAQ 494 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RP-t~~~v~~~L~~~~~~ 494 (499)
..+++++.+++.+||+.||++|| +++++++.|+++.+.
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 57889999999999999999999 999999999876443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=359.57 Aligned_cols=248 Identities=17% Similarity=0.160 Sum_probs=193.4
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|++.+.||+|+||.||+|+...++ +.||||++.... ..+.+.+|+.++++++||||+++++++. .....
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQ---KPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFE-TPTEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEE-CSSEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCC---cEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEe-cCCeE
Confidence 3467999999999999999999986554 689999997543 2356889999999999999999999964 45667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~kl~Df 376 (499)
++||||+++|+|.+++... ..+++.++..++.|++.||.|||+.+|+||||||+|||++. ++.+||+||
T Consensus 124 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEK--------GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEECCCCSCBHHHHHTTC--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccC
Confidence 9999999999999999752 35899999999999999999999999999999999999975 899999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCCC--
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGYRL-- 453 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~-~~~~i~~~~~~-- 453 (499)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+......
T Consensus 196 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~i~~~~~~~~ 271 (349)
T 2w4o_A 196 GLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDERGDQFMFRRILNCEYYFI 271 (349)
T ss_dssp C-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCTTCHHHHHHHHHTTCCCCC
T ss_pred ccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh-CCCCCCCCcccHHHHHHHHhCCCccC
Confidence 9998654322 2234568999999999999999999999999999999999 788887655443 44555443221
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 -NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 -~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.....++.++.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222468899999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=349.66 Aligned_cols=249 Identities=20% Similarity=0.296 Sum_probs=200.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.+|++++.||+|+||.||+|+...+ +.+|+|++.... .....+.+.+|+.++++++||||+++++++ ......+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKKRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-ECSSCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCC----CEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-ccCCeEE
Confidence 4789999999999999999987332 679999986442 222235678999999999999999999986 4456779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 77 lv~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 77 LVFEHLD-QDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp EEEECCS-EEHHHHHHTST-------TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred EEEEecC-CCHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 9999999 59999997632 358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----CC---
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG----YR--- 452 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~----~~--- 452 (499)
....... ......+|..|+|||.+.+ ..++.++|||||||++|||+| |++||.+.+..+....+... ..
T Consensus 149 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T 1ob3_A 149 AFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (288)
T ss_dssp HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHHCCCChhhc
Confidence 6542211 1234567899999999976 458999999999999999999 89999887766554433210 00
Q ss_pred ----------C-----------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 ----------L-----------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ----------~-----------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .....+++++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 011247889999999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=345.11 Aligned_cols=248 Identities=18% Similarity=0.228 Sum_probs=210.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|....++ ..+|+|++...... ..+.+.+|+.++++++||||+++++++ ......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTR---IRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETF-EDNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCC---cEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCeEE
Confidence 357999999999999999999986654 67899988654222 246788999999999999999999986 4566679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCcEEEcccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV---DDKLRIQITDNA 377 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll---d~~~~~kl~DfG 377 (499)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+++|+||||||+||++ +.++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHK--------RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEECCCSCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEeccCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 999999999999999863 358999999999999999999999999999999999999 788999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC-
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP- 456 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~- 456 (499)
+++...... ......+|..|+|||.+.+. ++.++||||||+++|||++ |+.||...+..+....+..+......
T Consensus 155 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T 3f3z_A 155 LAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLC-GYPPFSAPTDSEVMLKIREGTFTFPEK 229 (277)
T ss_dssp TCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred cceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCCCCCch
Confidence 998765433 22355689999999998654 8999999999999999999 89999988887777777665322211
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 --VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 --~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 267899999999999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=351.76 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=202.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++++.||+|+||.||+|....++ +.||+|++.... .....+.+.+|+.++++++||||+++++++. .....+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTG---QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-RKRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCC---cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-cCCeEE
Confidence 57999999999999999999986554 689999886543 3444577889999999999999999999964 466779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++++|..++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++
T Consensus 79 lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRY--------QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR 150 (311)
T ss_dssp EEEECCSEEHHHHHHHT--------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeCCCchHHHHHhh--------hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence 99999999999999875 2358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--------- 450 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~--------- 450 (499)
....... ......+|..|+|||.+.+ ..++.++||||||+++|||+| |++||.+.+..+....+...
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 151 LLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS-GVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp ECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhcccccccc
Confidence 7643322 2234568899999999986 678999999999999999999 89999887766544333211
Q ss_pred -----------CCCCCC----------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 -----------YRLNQP----------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 -----------~~~~~~----------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.....+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 111111 257788999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=345.56 Aligned_cols=252 Identities=18% Similarity=0.217 Sum_probs=215.5
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH--HHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA--VQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+...+|++.+.||+|+||.||+|+...++ +.||+|++...... ...+.+.+|+.++++++||||+++++++ .
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 84 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNK---FIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-H 84 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCC---cEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-E
Confidence 3455678999999999999999999986554 78999998643211 1235788999999999999999999996 4
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++|+||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 156 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKH--------GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIA 156 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEEC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEe
Confidence 466779999999999999999863 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||++....... .....|+..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+... ...
T Consensus 157 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~-~~~ 230 (284)
T 2vgo_A 157 DFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV-GMPPFDSPSHTETHRRIVNV-DLK 230 (284)
T ss_dssp CCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT-CCC
T ss_pred cccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHH-CCCCCCCCCHhHHHHHHhcc-ccC
Confidence 999987653221 234568999999999999999999999999999999999 89999988777766666553 445
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+++++.+++.+||+.||++||++.|+++
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 66778999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=364.53 Aligned_cols=262 Identities=15% Similarity=0.228 Sum_probs=203.0
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHH----------HHHHHHHHHHHhcCCCCcceeE
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ----------VSLLLQEGMAMYGLSHKNILTV 288 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~H~nIv~l 288 (499)
+...+|++++.||+|+||.||+|.....+.....+|+|+......... ...+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 345689999999999999999999875333347899999875532211 1246678889999999999999
Q ss_pred EeEEEcC---CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q psy1789 289 LGVSIED---HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV 365 (499)
Q Consensus 289 ~g~~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll 365 (499)
++++... ....++||||+ +++|.+++... ..+++.+++.++.|++.||+|||+++|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 184 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--------GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--------GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEE
Confidence 9997552 55679999999 89999998762 268999999999999999999999999999999999999
Q ss_pred cCCC--cEEEcccccccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q psy1789 366 DDKL--RIQITDNALARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI 438 (499)
Q Consensus 366 d~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~ 438 (499)
+.++ .+||+|||+|+........ .......||..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~ 263 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC-GKLPWEQN 263 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCTTGGG
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh-CCCCcccc
Confidence 9887 9999999999876432111 11134578999999999999999999999999999999999 89999642
Q ss_pred --CHHHHHHHHHcCCCCCC---------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 439 --DPFEMAASLQDGYRLNQ---------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 439 --~~~~~~~~i~~~~~~~~---------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
+........ ....... +..+++++.+++.+||+.||++||++.+|++.|+++
T Consensus 264 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 264 LKDPVAVQTAK-TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp TTCHHHHHHHH-HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccccHHHHHHH-HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 222221111 1111111 226889999999999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=348.44 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=205.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
++|++.+.||+|+||.||+|....++ ..+|+|++.........+.+.+|+.++++++||||+++++++ ......++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSG---LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCC---ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-ecCCeEEE
Confidence 46888999999999999999976554 689999987654444457789999999999999999999996 45667799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCcEEEccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV---DDKLRIQITDNAL 378 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll---d~~~~~kl~DfGl 378 (499)
||||+++|+|.+++..... ....+++..+..++.|++.||+|||+++|+||||||+||++ +.++.+||+|||+
T Consensus 98 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQA----RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EECCCSCCBHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred EEEeCCCCcHHHHHHhhhh----cccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 9999999999999965321 12468999999999999999999999999999999999999 4568899999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC--CC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN--QP 456 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~--~~ 456 (499)
++...... ......+|..|+|||.+. ..++.++||||||+++|||++ |+.||.+.+..+............ ..
T Consensus 174 a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (285)
T 3is5_A 174 AELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT-GCLPFTGTSLEEVQQKATYKEPNYAVEC 248 (285)
T ss_dssp CCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCCCCCC--
T ss_pred ceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHh-CCCCCCCCCHHHHHhhhccCCccccccc
Confidence 98654322 223556899999999875 578999999999999999999 899999888777666554432221 12
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...++++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 347899999999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=352.54 Aligned_cols=250 Identities=21% Similarity=0.208 Sum_probs=212.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-----HHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-----VQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
..+|++++.||+|+||.||+|+...++ +.+|+|++...... ...+.+.+|+.++++++||||+++++++ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTG---LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-EN 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-EC
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCC---eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-ec
Confidence 357899999999999999999986554 68999998653221 1246788999999999999999999985 44
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----cE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL----RI 371 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~----~~ 371 (499)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||++++++ .+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~ 158 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK--------ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC--------SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCE
Confidence 66779999999999999999852 3589999999999999999999999999999999999999887 79
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+....
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANITSVS 234 (321)
T ss_dssp EECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHTTC
T ss_pred EEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcc
Confidence 999999998764432 1234568999999999999999999999999999999999 899999888777777666542
Q ss_pred CCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RLNQ---PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~~~---~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... +...++++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2111 1467889999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=359.68 Aligned_cols=261 Identities=16% Similarity=0.229 Sum_probs=212.1
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCc-----eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCccee--------
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDG-----VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILT-------- 287 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-------- 287 (499)
..+|++.+.||+|+||.||+|+...+.. ..+.||+|++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 5789999999999999999999865311 2378999998754 35779999999999999988
Q ss_pred -------EEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy1789 288 -------VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLAT 360 (499)
Q Consensus 288 -------l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~ 360 (499)
+++++...+...++||||+ +++|.+++.... ...+++.+++.++.|++.||.|||+++|+||||||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp 187 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP------KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTA 187 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG------GGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH
Confidence 6777666567789999999 899999998632 24699999999999999999999999999999999
Q ss_pred CceEEcCCC--cEEEcccccccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q psy1789 361 RNCVVDDKL--RIQITDNALARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQ 433 (499)
Q Consensus 361 ~NIlld~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~ 433 (499)
+|||++.++ .+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||+| |+.
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~ 266 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLY-GFL 266 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SCC
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHh-CCC
Confidence 999999998 9999999999876432211 11234578999999999999999999999999999999999 889
Q ss_pred CCCCCC--HHHHHHHHH---cCCCCCCC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 434 PYAEID--PFEMAASLQ---DGYRLNQP------VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 434 p~~~~~--~~~~~~~i~---~~~~~~~~------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
||.... ...+..... .. ....+ ..+++++.+++.+||+.||++|||+.++++.|+++.++++
T Consensus 267 pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 267 PWTNCLPNTEDIMKQKQKFVDK-PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTGGGTTCHHHHHHHHHHHHHS-CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcccCCcCHHHHHHHHHhccCC-hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 998753 333322221 11 11111 2468999999999999999999999999999999988764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=359.14 Aligned_cols=250 Identities=19% Similarity=0.281 Sum_probs=197.2
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|++.+.||+|+||.||+++...++ +.||||++...... .+.+.+|+.+++.++||||+++++++. .....
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTK---ELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVIL-TPTHL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTC---CEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCC---cEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEe-eCCEE
Confidence 4568999999999999999999986554 78999999754321 245789999999999999999999964 46678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc--EEEcccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR--IQITDNA 377 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~--~kl~DfG 377 (499)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||
T Consensus 92 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNA--------GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEEeCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 9999999999999999762 35899999999999999999999999999999999999987765 9999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHc-CC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTA-SDVWAFGVLLWELTTLAQQPYAEIDP----FEMAASLQD-GY 451 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DvwS~Gvvl~el~t~g~~p~~~~~~----~~~~~~i~~-~~ 451 (499)
+|+...... ......||+.|+|||++.+..++.+ +|||||||++|||++ |+.||...+. ......+.. ..
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 164 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH-SSCSCC----CCCHHHHHHHHHTTCC
T ss_pred ccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh-CCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 998543221 2234568999999999998888766 899999999999999 8999986433 233333332 22
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.......+++++.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 333344688999999999999999999999999763
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=352.45 Aligned_cols=266 Identities=20% Similarity=0.290 Sum_probs=194.0
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.+.+...+|++.+.||+|+||.||+|....++ +.||||++.........+.+.+|+.++++++||||+++++++..
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 84 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKK---EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV- 84 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCC---cEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-
Confidence 35667789999999999999999999865443 68999998765444556778999999999999999999998654
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+++|+|.+++.............+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEe
Confidence 55679999999999999999753322222235689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCc---cccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 376 NALARDLFPSDY---HCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 376 fGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+++....... ........||..|+|||.+.+ ..++.++||||||+++|||++ |+.||......+.........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT-GAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHHHTSS
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh-CCCCCccCchhhHHHHHhccC
Confidence 999986543211 111234568899999999976 578999999999999999999 899998876655444333322
Q ss_pred CC---------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RL---------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~---------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. .....+++++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 21 122357889999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=347.05 Aligned_cols=252 Identities=20% Similarity=0.269 Sum_probs=208.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
.+|++++.||+|+||.||+|....++ +.||+|++.........+.+.+|+.+++.++||||+++++++. .....++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 82 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-EGNIQYL 82 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCC---cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-cCCEEEE
Confidence 47899999999999999999986544 6899999875544445578899999999999999999999864 4566799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 83 FLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEECCTTEEGGGGSBT--------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCcHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 9999999999998864 23589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPF--EMAASLQDGYRLNQPVN 458 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~ 458 (499)
..............|+..|+|||.+.+..+ +.++||||||+++|||++ |+.||...... .................
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKTYLNPWKK 233 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH-SSCCCSCSCTTSHHHHHHHTTCTTSTTGGG
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCchHHHHHHHhhhcccccCchhh
Confidence 543332223345678999999999987775 789999999999999999 88999765432 22223222222222346
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 234 IDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 7899999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=371.88 Aligned_cols=248 Identities=19% Similarity=0.241 Sum_probs=199.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++++.||+|+||.||+|....++ +.||||++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTT---EEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCC---CEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 568999999999999999999976654 78999999754 34555678899999999999999999999864322
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~----------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~ 206 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh----------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEE
Confidence 346999999995 57666653 48999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL- 453 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~- 453 (499)
|||+|+...... ......||..|+|||++.+..|+.++|||||||++|||++ |++||.+.+..+....+......
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 207 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp CCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999998664322 2335678999999999999999999999999999999999 89999988766554433221100
Q ss_pred --------------------CCCC--------------C------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 --------------------NQPV--------------N------CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 --------------------~~~~--------------~------~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... . .++++.+|+.+||+.||++|||+.|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0 1457899999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=342.99 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=211.1
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
.........|++.+.||+|+||.||+|....++ ..||+|.+... ......+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 19 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhcccCceeEEeeeeccCCCCeEEEEeEecCCc---eEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 334455667999999999999999999986654 67999988643 34556678999999999999999999999864
Q ss_pred cC---CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEc-C
Q psy1789 294 ED---HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVVD-D 367 (499)
Q Consensus 294 ~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~--iiHrDlk~~NIlld-~ 367 (499)
.. ....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++ +
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~ 167 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRF--------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 167 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECC
Confidence 42 34579999999999999999863 35899999999999999999999998 99999999999998 7
Q ss_pred CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI-DPFEMAAS 446 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-~~~~~~~~ 446 (499)
++.+||+|||+++....... ....||..|+|||.+. +.++.++||||||+++|||++ |+.||... +..+....
T Consensus 168 ~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 241 (290)
T 1t4h_A 168 TGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRR 241 (290)
T ss_dssp TSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHH
T ss_pred CCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHh-CCCCCCCcCcHHHHHHH
Confidence 89999999999976543321 2346889999999876 569999999999999999999 88898874 44445555
Q ss_pred HHcCCCC-CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 447 LQDGYRL-NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 447 i~~~~~~-~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+..+..+ ..+...++++.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 5544332 234467789999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=368.39 Aligned_cols=266 Identities=18% Similarity=0.236 Sum_probs=214.6
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.......+|++.+.||+|+||.||+|+...++ +.||||++.........+.+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp EEECSSEEEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCCCCCCceEEEEEEEcCCCeEEEEEEECCCC---cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 34556789999999999999999999987654 789999997654334456788999999999999999999987554
Q ss_pred C-CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCc
Q psy1789 296 H-TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV----DDKLR 370 (499)
Q Consensus 296 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll----d~~~~ 370 (499)
. ...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++|+||||||+|||+ +.++.
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 154 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSN-----AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGG-----TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEE
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCcee
Confidence 3 357999999999999999976321 2248999999999999999999999999999999999999 88889
Q ss_pred EEEcccccccccCCCCccccCCCCCCcccccccccccc--------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC---
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH--------KTFSTASDVWAFGVLLWELTTLAQQPYAEID--- 439 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~--- 439 (499)
+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++|||+| |+.||....
T Consensus 155 ~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~t-g~~Pf~~~~~~~ 230 (396)
T 4eut_A 155 YKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT-GSLPFRPFEGPR 230 (396)
T ss_dssp EEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHH-SSCSEECTTCTT
T ss_pred EEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCccc
Confidence 9999999998764432 2235668999999999875 567889999999999999999 888986432
Q ss_pred -HHHHHHHHHcCCCCC------------------CC------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 440 -PFEMAASLQDGYRLN------------------QP------VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 440 -~~~~~~~i~~~~~~~------------------~~------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
..+....+..+.... .+ ..+++.+.+++.+||+.||++||++.|+++.++++.+
T Consensus 231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 233444443332110 11 1245578899999999999999999999999887754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=354.10 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=205.8
Q ss_pred EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc---ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN---ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
..++.||+|+||.||+|...+ +.+|||++... ......+.+.+|+.+++.++||||+++++++ ......++
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~l 107 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVNN-----TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLCL 107 (307)
T ss_dssp TTCCEEEECSSEEEEEEESSS-----CEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEE
T ss_pred ccCCccccCCCeEEEEEEECC-----ceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-ecCCceEE
Confidence 345899999999999998632 67999998643 2234457799999999999999999999996 44566799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||+++.
T Consensus 108 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDG-----TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182 (307)
T ss_dssp EEECCTTCBHHHHHHTGGG-----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCcHHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccc
Confidence 9999999999999985321 24589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHcC-------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF----EMAASLQDG------- 450 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~----~~~~~i~~~------- 450 (499)
..............||..|+|||.+.+ .++.++||||||+++|||+| |++||...... .+...+...
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT-GLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH-CCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred cccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH-CCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 654333333445678999999998865 58999999999999999999 88898764322 222222211
Q ss_pred ---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 451 ---YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 451 ---~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
.....+...++++.+++.+||+.||++|||+.++++.|+++.+
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1112233456789999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=352.29 Aligned_cols=254 Identities=19% Similarity=0.258 Sum_probs=201.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc----HHHHHHHHHHHHHHhcC---CCCcceeEEeE
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS----AVQVSLLLQEGMAMYGL---SHKNILTVLGV 291 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l---~H~nIv~l~g~ 291 (499)
+...+|++.+.||+|+||.||+|+...++ +.||+|++..... ......+.+|+.+++++ +||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSG---HFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTC---CEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCC---cEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 34568999999999999999999875544 7899999863211 11113455666666655 59999999999
Q ss_pred EEcCCC----ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q psy1789 292 SIEDHT----SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 292 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~ 367 (499)
+..... ..++||||++ |+|.+++.... ...+++.++..++.|++.||+|||+++|+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAP------PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 155 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCC------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 765443 4689999998 69999998632 234899999999999999999999999999999999999999
Q ss_pred CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i 447 (499)
++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++ |++||...+..+....+
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i 231 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLGKI 231 (308)
T ss_dssp TSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTT-SSCSCCCSSHHHHHHHH
T ss_pred CCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 9999999999998654322 2234567899999999999999999999999999999999 89999988777665554
Q ss_pred HcCCCC----C----------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 QDGYRL----N----------------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ~~~~~~----~----------------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...... . ....+++++.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 321100 0 01256789999999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=355.82 Aligned_cols=257 Identities=19% Similarity=0.248 Sum_probs=214.1
Q ss_pred hcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 213 KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 213 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
......+...+|++.+.||+|+||.||+|....++ +.||+|++.........+.+.+|+.+++.++||||+++++++
T Consensus 24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 100 (360)
T 3eqc_A 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100 (360)
T ss_dssp HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred hhcccccccccceeeeeecCCCCeEEEEEEECCCC---cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence 34445677889999999999999999999986554 789999998766666678899999999999999999999986
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~ 371 (499)
.. +...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+
T Consensus 101 ~~-~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~ 171 (360)
T 3eqc_A 101 YS-DGEISICMEHMDGGSLDQVLKKA--------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171 (360)
T ss_dssp EE-TTEEEEEECCCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCE
T ss_pred EE-CCEEEEEEECCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCE
Confidence 54 56679999999999999999863 3589999999999999999999996 99999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA------ 445 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~------ 445 (499)
||+|||+++..... ......||..|+|||.+.+..++.++|||||||++|||+| |+.||...+..++..
T Consensus 172 kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 246 (360)
T 3eqc_A 172 KLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQV 246 (360)
T ss_dssp EECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHH-TSCCSSCCCHHHHHHHHC---
T ss_pred EEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHhcccc
Confidence 99999998754221 2234568899999999999999999999999999999999 889998765544322
Q ss_pred ------------------------------------HHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 446 ------------------------------------SLQDGYRLNQP-VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 446 ------------------------------------~i~~~~~~~~~-~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+.....+..+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 22222222222 246889999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=357.47 Aligned_cols=261 Identities=17% Similarity=0.208 Sum_probs=206.5
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc----cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA----SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
..+|++.+.||+|+||.||+|....++ +.+|+|++.... .....+.+.+|+.++++++||||+++++++ ...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~ 100 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTR---AIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-EDE 100 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECS
T ss_pred hhheeecceeeecCCeEEEEEEECCCC---ceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-ccC
Confidence 457999999999999999999976554 689999986431 234457899999999999999999999996 446
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCC--------------------------------CCCCCCCHHHHHHHHHHHHHH
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPE--------------------------------GVAHTLTTQEVVDMCLQIIMG 344 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------~~~~~l~~~~~~~i~~~va~~ 344 (499)
...++||||+++|+|.+++........ .....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 678999999999999999853111000 001234677889999999999
Q ss_pred HHHHHhCCccccCCCCCceEEcCCC--cEEEcccccccccCCCCc--cccCCCCCCcccccccccccc--CCCCCchhHH
Q psy1789 345 VQYLHKKKLLHKDLATRNCVVDDKL--RIQITDNALARDLFPSDY--HCLGDNENRPVKWLAIESLVH--KTFSTASDVW 418 (499)
Q Consensus 345 L~yLH~~~iiHrDlk~~NIlld~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Dvw 418 (499)
|+|||+++|+||||||+|||++.++ .+||+|||+++....... ........||+.|+|||.+.+ ..++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 899999999986532211 112235678999999999975 6789999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 419 AFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLNQP--VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 419 S~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
||||++|||++ |+.||...+..+....+.... ....+ ..+++++.+++.+||+.||++||++.|+++
T Consensus 261 slG~il~el~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 261 SAGVLLHLLLM-GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHH-CCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999999999 899999888777666555432 22222 247899999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=352.29 Aligned_cols=257 Identities=23% Similarity=0.407 Sum_probs=203.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc--CCCCcceeEEeEEEcCC--
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG--LSHKNILTVLGVSIEDH-- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~-- 296 (499)
..+|++.+.||+|+||.||+|+..+ +.||||++..... ..+..|.+++.. ++||||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRG-----EKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETT-----EEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccceEEEeEeecCCCeEEEEEEECC-----ceEEEEEEecccc----chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 4579999999999999999998753 7899999864422 234445555544 59999999999976543
Q ss_pred -CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEcC
Q psy1789 297 -TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK--------KLLHKDLATRNCVVDD 367 (499)
Q Consensus 297 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~--------~iiHrDlk~~NIlld~ 367 (499)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS---------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCceEEEEeccCCCcHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 567999999999999999976 3589999999999999999999998 9999999999999999
Q ss_pred CCcEEEcccccccccCCCCccc--cCCCCCCccccccccccccCCCCCc------hhHHHHHHHHHHHHcCC--------
Q psy1789 368 KLRIQITDNALARDLFPSDYHC--LGDNENRPVKWLAIESLVHKTFSTA------SDVWAFGVLLWELTTLA-------- 431 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------~DvwS~Gvvl~el~t~g-------- 431 (499)
++.+||+|||+++......... ......||..|+|||.+.+..++.+ +|||||||++|||+| |
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t-g~~~~~~~~ 256 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVE 256 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT-TBCBTTBCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh-ccCcccccc
Confidence 9999999999997664332211 1224578999999999988777765 999999999999999 6
Q ss_pred --CCCCCCCC-----HHHHHHHHH-cCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 432 --QQPYAEID-----PFEMAASLQ-DGYRLNQPV-----NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 432 --~~p~~~~~-----~~~~~~~i~-~~~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
+.||.... .......+. ...++..+. .+++++.+++.+||+.||++|||+.|+++.|+++.++..
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 66766532 122332222 223333332 567789999999999999999999999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=354.21 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=199.5
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEE-
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSI- 293 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~- 293 (499)
...+...+|++.+.||+|+||.||+|+...++ +.||+|++... .....+.+.+|+.++.++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSG---REYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTC---CEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCC---cEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 45666779999999999999999999986554 68999998654 3445577899999999996 999999999864
Q ss_pred ------cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEE
Q psy1789 294 ------EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVV 365 (499)
Q Consensus 294 ------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~--iiHrDlk~~NIll 365 (499)
......++|+||+. |+|.+++..... ...+++.+++.++.|++.||.|||+++ |+||||||+|||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMES-----RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL 171 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-----TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE
Confidence 23344689999997 899999875321 235999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEcccccccccCCCCccc----------cCCCCCCcccccccccc---ccCCCCCchhHHHHHHHHHHHHcCCC
Q psy1789 366 DDKLRIQITDNALARDLFPSDYHC----------LGDNENRPVKWLAIESL---VHKTFSTASDVWAFGVLLWELTTLAQ 432 (499)
Q Consensus 366 d~~~~~kl~DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~~DvwS~Gvvl~el~t~g~ 432 (499)
+.++.+||+|||+++......... ......+|..|+|||.+ .+..++.++|||||||++|||+| |+
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~-g~ 250 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-RQ 250 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHH-SS
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHh-CC
Confidence 999999999999998764332111 11134588899999998 56778999999999999999999 88
Q ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 433 QPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 433 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.||......+. +........+...++++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 251 ~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 251 HPFEDGAKLRI---VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp CCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCcchhHHHh---hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 99876544332 2223334445567788999999999999999999999999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=356.66 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=199.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
++|++++.||+|+||.||+|+...++ +.||+|++...........+.+|+.++++++||||+++++++ ......++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTD---NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-HTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-ECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCC---cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-eeCCEEEE
Confidence 47899999999999999999986554 789999997554333333566899999999999999999996 44666799
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||++ |+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 78 v~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDCG-------NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp EEECCS-EEHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred Eecccc-cCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 999998 69999998632 3589999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC------
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN------ 454 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~------ 454 (499)
...... ......+|..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+.+..+....+.......
T Consensus 150 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 150 KSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQLHFIFRILGTPTEETWP 226 (324)
T ss_dssp C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCCChHhch
Confidence 543221 2234567899999999986 668999999999999999999 899999888776655443211100
Q ss_pred -----------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 -----------------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 -----------------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+++++.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 01246788999999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.48 Aligned_cols=254 Identities=19% Similarity=0.287 Sum_probs=208.0
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+...+|++.+.||+|+||.||+|....++ +.||+|++..... ....+.+.+|+.+++.++||||+++++++ .
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 81 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTG---HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-S 81 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCC---ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-e
Confidence 3455678999999999999999999986544 6899999864321 12245788999999999999999999986 4
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++|+||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~ 153 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKH--------GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 153 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEe
Confidence 456779999999999999999863 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
|||+++....... .....++..|+|||.+.+..+ +.++||||||+++|||++ |+.||...+..+....+..+ ..
T Consensus 154 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~ 228 (276)
T 2h6d_A 154 DFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC-GTLPFDDEHVPTLFKKIRGG-VF 228 (276)
T ss_dssp CCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CC
T ss_pred ecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-cc
Confidence 9999987644321 234568889999999988765 689999999999999999 89999988877777777655 33
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..+..+++++.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 4566789999999999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.28 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=196.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|++++.||+|+||.||+|....++ +.||||++.... .....+.+.+|+.++++++||||+++++++ ..+...
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 108 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTN---ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-HHNHRL 108 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTT---EEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-EETTEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCC---ceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-ecCCEE
Confidence 457999999999999999999876554 789999997543 233346688999999999999999999996 456678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-----cCCCcEEEc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV-----DDKLRIQIT 374 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll-----d~~~~~kl~ 374 (499)
++||||++ |+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+ ++++.+||+
T Consensus 109 ~lv~e~~~-~~L~~~~~~~--------~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKN--------PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEEECCS-EEHHHHHHHC--------TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEEEecCC-CCHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence 99999999 6999999873 358999999999999999999999999999999999999 455669999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 453 (499)
|||+++....... ......+|..|+|||++.+. .++.++|||||||++|||++ |++||...+..+....+......
T Consensus 180 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 180 DFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH-CCCCcCCCCHHHHHHHHHHHhCC
Confidence 9999986643221 22345678899999999874 48999999999999999999 89999888776655444321110
Q ss_pred C-----------------CC------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 N-----------------QP------------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ~-----------------~~------------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 00 015788999999999999999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=375.40 Aligned_cols=256 Identities=17% Similarity=0.253 Sum_probs=215.3
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
...+...+|++.++||+|+||.||+|+...++ +.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg---~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~- 253 (576)
T 2acx_A 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATG---KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY- 253 (576)
T ss_dssp TSCCCGGGEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred hcCccccceEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-
Confidence 44577889999999999999999999986554 789999986431 112245688999999999999999999985
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
......++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~------~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL 327 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMG------QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRI 327 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSS------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEE
Confidence 55667899999999999999998632 234899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHc
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID----PFEMAASLQD 449 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~----~~~~~~~i~~ 449 (499)
+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++ |++||.... ..++...+..
T Consensus 328 ~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLlt-G~~PF~~~~~~~~~~~i~~~i~~ 403 (576)
T 2acx_A 328 SDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIKREEVERLVKE 403 (576)
T ss_dssp CCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHH-SSCSSSCSSSCCCHHHHHHHHHH
T ss_pred EecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh-CCCCCcccccchhHHHHHHHhhc
Confidence 99999987654322 124579999999999999999999999999999999999 899998653 3445555544
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
. ....+..+++++.+++.+||+.||++|| ++.|+++
T Consensus 404 ~-~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 V-PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp C-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred c-cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 3 4556678899999999999999999999 6777764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=355.81 Aligned_cols=252 Identities=19% Similarity=0.283 Sum_probs=208.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH---- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---- 296 (499)
..+|++++.||+|+||.||+|....++ +.||||++.........+.+.+|+.++.+++||||+++++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNK---VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCC---eEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 468999999999999999999976554 7899999986666666788999999999999999999999864432
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++|+||++ |+|.+++.. ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Df 172 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT---------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDF 172 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEcccC-cCHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeC
Confidence 45799999999 699999976 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcc-ccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Q psy1789 377 ALARDLFPSDYH-CLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--- 451 (499)
Q Consensus 377 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--- 451 (499)
|+++........ .......||..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+....
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH-SSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH-CCCCCCCCChHHHHHHHHHHhCCC
Confidence 999876433221 11235578999999998764 458999999999999999999 889998876555443332100
Q ss_pred ----------------------CCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ----------------------RLN-----QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ----------------------~~~-----~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ....+++++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 01356789999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=345.22 Aligned_cols=254 Identities=18% Similarity=0.266 Sum_probs=211.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc---HHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-CCC
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS---AVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-DHT 297 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~ 297 (499)
.+|++++.||+|+||.||+|....++ +.+|+|++..... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETL---CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTC---CEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred cceeEeeEEecCCCeEEEEEEECCCC---cEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 57889999999999999999875544 6899999865321 1235678999999999999999999998653 345
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||++++ |.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg 154 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVP------EKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALG 154 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHST------TCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEehhccCC-HHHHHHhCc------ccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccc
Confidence 679999999966 878877532 2468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKT--FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
+++...+...........|+..|+|||.+.+.. ++.++||||||+++|||++ |+.||...+..+....+..+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~i~~~-~~~~ 232 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT-GLYPFEGDNIYKLFENIGKG-SYAI 232 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHC-CCCC
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh-CCCCCCCchHHHHHHHHhcC-CCCC
Confidence 998765433222334566899999999998654 3789999999999999999 89999988887777777665 4456
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
+..+++++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 67889999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=344.64 Aligned_cols=257 Identities=18% Similarity=0.331 Sum_probs=196.2
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHH-HHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ-VSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
+.+..++|++.+.||+|+||.||+|....++ +.||+|++........ .+.+.++...++.++||||+++++++..
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~- 77 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSG---QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR- 77 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCC---eEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-
Confidence 3567789999999999999999999986554 7899999976543333 3444555556888999999999999654
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++||||++ |+|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 78 ~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~ 152 (290)
T 3fme_A 78 EGDVWICMELMD-TSLDKFYKQVID----KGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMC 152 (290)
T ss_dssp SSSEEEEEECCS-EEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred cCCEEEEEehhc-cchHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEe
Confidence 566799999998 699888765321 124699999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CHHHH-HHHHH
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESL----VHKTFSTASDVWAFGVLLWELTTLAQQPYAEI-DPFEM-AASLQ 448 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-~~~~~-~~~i~ 448 (499)
|||+++...... ......||..|+|||.+ .+..++.++||||||+++|||+| |+.||... ..... ...+.
T Consensus 153 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~ 228 (290)
T 3fme_A 153 DFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI-LRFPYDSWGTPFQQLKQVVE 228 (290)
T ss_dssp CC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH-TSCSSCCCSCHHHHHHHHHH
T ss_pred ecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH-CCCCccccCchHHHHHHHhc
Confidence 999998664332 22344688999999996 56678999999999999999999 88898763 33333 33444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 449 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.......+..+++++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 229 EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 43333334578999999999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=345.09 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=186.5
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH--HHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA--VQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++.+.||+|+||.||+|+...++ +.||+|++...... ...+.+.+|+.++++++||||+++++++ ......
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTG---LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-EDSNYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-ECSSEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCC---ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-ccCCeE
Confidence 46899999999999999999975544 68999998643211 1236788999999999999999999996 446677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 159 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-------VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecce
Confidence 9999999999999999852 246899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+....... ......||..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+... ....+..+
T Consensus 160 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 235 (278)
T 3cok_A 160 TQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI-GRPPFDTDTVKNTLNKVVLA-DYEMPSFL 235 (278)
T ss_dssp EECC------------------------------CTHHHHHHHHHHHHHH-SSCSSCCCSCC-----CCSS-CCCCCTTS
T ss_pred eeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHh-CCCCCCChhHHHHHHHHhhc-ccCCcccc
Confidence 86643221 1224568899999999999999999999999999999999 88999876544443333221 23455678
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+.++.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 236 SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 899999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=384.47 Aligned_cols=248 Identities=19% Similarity=0.280 Sum_probs=214.3
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE 294 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 294 (499)
.+...+|+++++||+|+||.||+|+...++ +.||||++.... .....+.+..|..++..+ +|+||++++++ ++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~---~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-~~ 412 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTD---ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-FQ 412 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSC---CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-CB
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCC---cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-EE
Confidence 445678999999999999999999987655 789999986431 112345678899999987 79999999997 56
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
+....+|||||+++|+|..++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQV--------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEEC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEe
Confidence 677889999999999999999873 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+|+....... ......||+.|+|||++.+..|+.++|||||||++|||++ |++||.+.+..++...+... ...
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~-~~~ 560 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQSIMEH-NVA 560 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHSS-CCC
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc-CCCCCCCCCHHHHHHHHHhC-CCC
Confidence 9999986433222 2345679999999999999999999999999999999999 99999999888888888765 456
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTF 481 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~ 481 (499)
.|..+++++.+|+..||+.||++||++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 777899999999999999999999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=354.27 Aligned_cols=255 Identities=19% Similarity=0.231 Sum_probs=210.0
Q ss_pred hcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-----CCccee
Q psy1789 213 KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-----HKNILT 287 (499)
Q Consensus 213 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~ 287 (499)
...+..+...+|++++.||+|+||.||+|+...++ +.||||++... ....+.+..|+.+++.++ ||||++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNK---KYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCC---eEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 35566677889999999999999999999986554 78999999753 334466788999998886 999999
Q ss_pred EEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q psy1789 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 288 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~ 367 (499)
+++++.. ....++||||+ +++|.+++.... ...+++.++..++.|++.||+|||+++|+||||||+|||+++
T Consensus 101 ~~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 101 YHGKFMY-YDHMCLIFEPL-GPSLYEIITRNN------YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172 (360)
T ss_dssp EEEEEEE-TTEEEEEECCC-CCBHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred ccceeeE-CCeeEEEEcCC-CCCHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcc
Confidence 9998644 56779999999 899999998632 235899999999999999999999999999999999999975
Q ss_pred -------------------------CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHH
Q psy1789 368 -------------------------KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGV 422 (499)
Q Consensus 368 -------------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gv 422 (499)
++.+||+|||+|+..... .....||..|+|||++.+..++.++|||||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 789999999999864322 23567899999999999999999999999999
Q ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-------------------------CCCC--------------------
Q psy1789 423 LLWELTTLAQQPYAEIDPFEMAASLQDGYRL-------------------------NQPV-------------------- 457 (499)
Q Consensus 423 vl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-------------------------~~~~-------------------- 457 (499)
++|||+| |+.||...+..+....+...... ..|.
T Consensus 248 il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 248 VLAELYT-GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHH-SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHH-CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 9999999 89999887766655444321110 0111
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+.+.+++.+||+.||++|||+.|+++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 12367889999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=353.85 Aligned_cols=268 Identities=18% Similarity=0.237 Sum_probs=213.2
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE- 294 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~- 294 (499)
.+.+...+|++.+.||+|+||.||+++...++ +.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDG---HFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTC---CEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCC---cEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 34567789999999999999999999975554 78999988654 34556789999999999999999999999753
Q ss_pred --CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 295 --DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 295 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
.....++|+||+++|+|.+++..... ....+++.+++.++.|++.||+|||+++|+||||||+||+++.++.+|
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~k 174 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKD----KGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV 174 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHT----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEE
Confidence 23457899999999999999986431 124689999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccc-------cCCCCCCccccccccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCC--H
Q psy1789 373 ITDNALARDLFPSDYHC-------LGDNENRPVKWLAIESLVHKT---FSTASDVWAFGVLLWELTTLAQQPYAEID--P 440 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~~DvwS~Gvvl~el~t~g~~p~~~~~--~ 440 (499)
|+|||+++......... ......||..|+|||.+.... ++.++||||||+++|||++ |+.||.... .
T Consensus 175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~~~~ 253 (317)
T 2buj_A 175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF-GEGPYDMVFQKG 253 (317)
T ss_dssp ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH-SSCTTHHHHHTT
T ss_pred EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh-CCCChhhhhccc
Confidence 99999987653211000 001234688999999987654 7899999999999999999 888885321 1
Q ss_pred HHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 441 FEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 441 ~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
......+........+..+++++.+++.+||+.||++|||+.++++.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 254 DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 1223334444445555678999999999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=342.13 Aligned_cols=250 Identities=21% Similarity=0.231 Sum_probs=208.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-----HHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-----VQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
..+|++.+.||+|+||.||+|+...++ +.+|+|.+...... ...+.+.+|+.++++++||||+++++++. .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTG---KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-N 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCC---CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-C
Confidence 457999999999999999999986544 68999988643211 12467899999999999999999999964 4
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----cE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL----RI 371 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~----~~ 371 (499)
....++||||+++++|.+++... ..+++.++..++.|++.||.|||+++|+||||||+||+++.++ .+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK--------ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCE
T ss_pred CCeEEEEEeecCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCce
Confidence 56679999999999999999762 3589999999999999999999999999999999999999877 89
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+....
T Consensus 152 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 227 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGETKQETLTNISAVN 227 (283)
T ss_dssp EECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTTC
T ss_pred EEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHH-CCCCCCCcchHHHHHHhHhcc
Confidence 9999999986643321 234568899999999999999999999999999999999 889999888777766665442
Q ss_pred CCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RLN---QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~~---~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... .+...++++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 211 12467889999999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=367.32 Aligned_cols=259 Identities=15% Similarity=0.115 Sum_probs=199.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHH---HHHhcCCCCcceeEE----
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEG---MAMYGLSHKNILTVL---- 289 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~---~~l~~l~H~nIv~l~---- 289 (499)
....+|++.+.||+|+||.||+|+...++ +.||||++... ......+.|.+|+ ..+++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCC---CEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCC---cEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 34678999999999999999999975544 68999998632 2333457889999 556667899999998
Q ss_pred ---eEEEcCCC----------------ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy1789 290 ---GVSIEDHT----------------SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350 (499)
Q Consensus 290 ---g~~~~~~~----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~ 350 (499)
+++...+. ..++||||+ +|+|.+++........ ....+++..++.|+.|++.||+|||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS-THKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT-TTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc-ccccccHHHHHHHHHHHHHHHHHHHh
Confidence 55332211 368999999 5899999986432211 12345678999999999999999999
Q ss_pred CCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccC-----------CCCCchhHHH
Q psy1789 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-----------TFSTASDVWA 419 (499)
Q Consensus 351 ~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DvwS 419 (499)
++|+||||||+|||++.++.+||+|||+|+.... ......| ..|+|||++.+. .++.++||||
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 9999999999999999999999999999986422 1224456 889999999987 8999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHH
Q psy1789 420 FGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS--CLQEFHAQ 494 (499)
Q Consensus 420 ~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~--~L~~~~~~ 494 (499)
|||++|||+| |+.||...+..+....+.. ....+++++.+++.+||+.||++|||+.|+++ .++++.+.
T Consensus 299 lG~il~ellt-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 299 LGLVIYWIWC-ADLPITKDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp HHHHHHHHHH-SSCCC------CCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred HHHHHHHHHH-CCCCCcccccccchhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 9999999999 8999976554332222222 23577899999999999999999999999985 45554443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.90 Aligned_cols=246 Identities=17% Similarity=0.253 Sum_probs=193.5
Q ss_pred ceEEe-eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHh-cCCCCcceeEEeEEEc---CCC
Q psy1789 223 RVRLF-SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY-GLSHKNILTVLGVSIE---DHT 297 (499)
Q Consensus 223 ~~~~~-~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~---~~~ 297 (499)
+|.+. +.||+|+||+||+|....++ +.||||++... ..+.+|+.++. ..+||||+++++++.. +..
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~---~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQ---EKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeccceeeeccCeEEEEEEECCCC---CEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 45555 79999999999999986554 78999999643 34567888764 4689999999998533 245
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEEEc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQIT 374 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~kl~ 374 (499)
..++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRG------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEE
Confidence 6799999999999999998522 235899999999999999999999999999999999999997 7899999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE----MAASLQDG 450 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~----~~~~i~~~ 450 (499)
|||+++...... ......||..|+|||++.+..++.++|||||||++|||++ |+.||...+... +...+..+
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~i~~~ 282 (400)
T 1nxk_A 207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTRIRMG 282 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH-SSCSCCCCTTCSSCCSHHHHHHHT
T ss_pred ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh-CCCCCCCCccccccHHHHHHHHcC
Confidence 999998654322 2235678999999999999999999999999999999999 889987654321 23333332
Q ss_pred -CCCCC--CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 451 -YRLNQ--PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 451 -~~~~~--~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
..... ...+++++.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22221 24688999999999999999999999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=352.56 Aligned_cols=239 Identities=20% Similarity=0.284 Sum_probs=181.3
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.||+|+||.||+|....++ +.||||++.... ...+.+|+.+++.++ ||||+++++++ .+....++||||+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~-~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSN---QAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVF-HDQLHTFLVMELL 88 (325)
T ss_dssp CCSEEETTEEEEEEEETTTC---CEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEE-ECSSEEEEEECCC
T ss_pred CccccCCCeEEEEEEECCCC---CEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEE-EcCCEEEEEEEcc
Confidence 78999999999999986554 789999996542 345678999999997 99999999995 5566779999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC---cEEEcccccccccC
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL---RIQITDNALARDLF 383 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~---~~kl~DfGla~~~~ 383 (499)
++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+++...
T Consensus 89 ~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 89 NGGELFERIKKK--------KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp CSCBHHHHHHHC--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred CCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999872 4689999999999999999999999999999999999998665 89999999998654
Q ss_pred CCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHcCCCCCCC
Q psy1789 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-------FEMAASLQDGYRLNQP 456 (499)
Q Consensus 384 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-------~~~~~~i~~~~~~~~~ 456 (499)
.... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||...+. .++...+..+......
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 161 PDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS-GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp C------------------------CCCCHHHHHHHHHHHHHHHHH-SSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred CCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 3322 2234567899999999999999999999999999999999 8999976432 3455555544221111
Q ss_pred ---CCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 457 ---VNCPDELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 457 ---~~~~~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
..+++++.+++.+||+.||++|||+.|++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 25789999999999999999999999886
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=370.89 Aligned_cols=254 Identities=17% Similarity=0.228 Sum_probs=213.2
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
..+...+|++.++||+|+||.||+|+...++ +.||+|++..... ....+.+.+|+.++++++||||+++++++ .
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg---~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-~ 255 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATG---KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-E 255 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-E
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCC---cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-e
Confidence 4466789999999999999999999986554 7899999964321 12245788999999999999999999985 5
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++||||+++|+|..++.... .....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~----~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVD----EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSS----TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhh----cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEe
Confidence 5677899999999999999998632 112469999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHHcC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI----DPFEMAASLQDG 450 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~----~~~~~~~~i~~~ 450 (499)
|||+++....... ......||+.|+|||++.+..++.++|||||||++|||+| |++||... ...++...+...
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt-G~~PF~~~~~~~~~~~~~~~i~~~ 408 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA-ARGPFRARGEKVENKELKQRVLEQ 408 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh-CCCCCCCCccchhHHHHHHHHhhc
Confidence 9999987644322 2234579999999999999999999999999999999999 89999764 345555555543
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHH
Q psy1789 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFP 482 (499)
Q Consensus 451 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~ 482 (499)
....|..+++++.+++.+||+.||++||++.
T Consensus 409 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 409 -AVTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred -ccCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 4456778899999999999999999999763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=340.50 Aligned_cols=247 Identities=18% Similarity=0.222 Sum_probs=204.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++.+.||+|+||.||+|....++ +.||+|++... ........+.+|+..+..+ +||||+++++++. .....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-~~~~~ 86 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDG---CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-EDDHM 86 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-ETTEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCC---ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-cCCeE
Confidence 57899999999999999999986544 78999998753 2333456788999999998 9999999999864 45677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC------------
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD------------ 367 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~------------ 367 (499)
++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+++|+||||||+||+++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYR----IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred EEEEEecCCCcHHHHHHhhcc----cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 999999999999999986321 1135899999999999999999999999999999999999984
Q ss_pred -------CCcEEEcccccccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy1789 368 -------KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEID 439 (499)
Q Consensus 368 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~ 439 (499)
...+||+|||+++..... ....||..|+|||.+.+. .++.++|||||||++|||++ +.+++...
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~~~- 234 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG-AEPLPRNG- 234 (289)
T ss_dssp -------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT-CCCCCSSS-
T ss_pred cccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc-CCCCCcch-
Confidence 447999999999876432 234588999999999876 56789999999999999998 66655433
Q ss_pred HHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 440 PFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 440 ~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+....+..+..+..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 --DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --HHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 233455555566677789999999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=343.48 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=207.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-------
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE------- 294 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~------- 294 (499)
.+|++.+.||+|+||.||+|....++ +.||+|++.... +.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDG---KTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTC---CEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cccceeeeeccCCceEEEEEEEcCCC---eEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 46889999999999999999986544 789999987543 346789999999999999999998532
Q ss_pred --------CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q psy1789 295 --------DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366 (499)
Q Consensus 295 --------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld 366 (499)
.....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR------GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV 156 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGG------GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc
Confidence 1334689999999999999998632 24689999999999999999999999999999999999999
Q ss_pred CCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 367 DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 367 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
+++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ +..|+.. ..+....
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-~~~~~~~--~~~~~~~ 230 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH-VCDTAFE--TSKFFTD 230 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS-CCSSHHH--HHHHHHH
T ss_pred CCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh-cCCcchh--HHHHHHH
Confidence 99999999999998765432 1234568899999999999999999999999999999999 5555432 2223333
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 447 LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+..+ ..+..++.++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 231 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 231 LRDG---IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHTT---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred hhcc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 3332 234567899999999999999999999999999999886553
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=344.39 Aligned_cols=248 Identities=21% Similarity=0.267 Sum_probs=209.1
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++.+.||+|+||.||+|+...++ +.||+|++..... ...+.+.+|+.++++++||||+++++++ ......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTG---KLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIY-ESTTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCC---CEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhc-ccCCEEE
Confidence 457999999999999999999986544 6899999975432 2335688999999999999999999985 4566779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCcEEEcccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV---DDKLRIQITDNA 377 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll---d~~~~~kl~DfG 377 (499)
+|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||++ ++++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER--------GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EEECCCCSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEEcCCCccHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 999999999999999763 358999999999999999999999999999999999999 788999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC---C
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL---N 454 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~ 454 (499)
+++...... .....|+..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+..+... .
T Consensus 155 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (304)
T 2jam_A 155 LSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYEETESKLFEKIKEGYYEFESP 229 (304)
T ss_dssp TTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHCCCCCCTT
T ss_pred cceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 997543221 122347889999999999999999999999999999999 89999988887777777655321 2
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+++++.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23468899999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=353.82 Aligned_cols=247 Identities=19% Similarity=0.300 Sum_probs=200.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++++.||+|+||.||+|....++ +.||||++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC---CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCC---CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 468999999999999999999986554 78999998543 34555678899999999999999999999864432
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 170 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH---------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 170 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEecC-CCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEE
Confidence 3459999999 7999999986 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-- 451 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-- 451 (499)
|||+++..... .....+|..|+|||++.+ ..++.++|||||||++|||++ |++||.+.+..+....+....
T Consensus 171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEIMKVTGT 244 (367)
T ss_dssp CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999865322 234568899999999987 789999999999999999999 899999877655443332100
Q ss_pred -------------------------C---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 -------------------------R---LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 -------------------------~---~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. .......++++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 0112356889999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=365.23 Aligned_cols=254 Identities=19% Similarity=0.325 Sum_probs=189.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---- 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---- 295 (499)
..+|++++.||+|+||.||+|....++ +.||||++... ......+.+.+|+.+|++++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEK---RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCC---cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 368999999999999999999976554 78999998653 3455667899999999999999999999986432
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||++ |+|.+++.. ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|
T Consensus 129 ~~~~~lv~e~~~-~~L~~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~D 199 (458)
T 3rp9_A 129 FDELYVVLEIAD-SDFKKLFRT--------PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199 (458)
T ss_dssp CCCEEEEECCCS-EEHHHHHHS--------SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECC
T ss_pred CceEEEEEeccc-cchhhhccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecc
Confidence 246799999986 899999975 24699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcc-------------------------ccCCCCCCcccccccccc-ccCCCCCchhHHHHHHHHHHHHc
Q psy1789 376 NALARDLFPSDYH-------------------------CLGDNENRPVKWLAIESL-VHKTFSTASDVWAFGVLLWELTT 429 (499)
Q Consensus 376 fGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwS~Gvvl~el~t 429 (499)
||+|+........ .......||..|+|||++ ....++.++|||||||++|||+|
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999876422110 112345679999999986 46679999999999999999998
Q ss_pred C----------CCCCCCCCCHH--------------------HHHHHHH-----------------------cCCCC---
Q psy1789 430 L----------AQQPYAEIDPF--------------------EMAASLQ-----------------------DGYRL--- 453 (499)
Q Consensus 430 ~----------g~~p~~~~~~~--------------------~~~~~i~-----------------------~~~~~--- 453 (499)
+ ++++|.+.+.. +....+. .....
T Consensus 280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (458)
T 3rp9_A 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG 359 (458)
T ss_dssp TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence 4 56666553310 1111110 00000
Q ss_pred ----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 ----NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ----~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.....+++++.+|+.+||+.||++|||+.|+++
T Consensus 360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 011245889999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.83 Aligned_cols=246 Identities=21% Similarity=0.258 Sum_probs=204.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|++.+.||+|+||.||+|....++ +.+|+|++..... .+.+|++++.++ +||||+++++++ .+....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~-~~~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATN---MEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVY-DDGKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEE-ECSSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCC---CEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEE-EcCCEE
Confidence 346899999999999999999986654 7899999975432 234678888777 799999999985 556778
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC----CcEEEcc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK----LRIQITD 375 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~----~~~kl~D 375 (499)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||+.++ +.+||+|
T Consensus 92 ~lv~E~~~gg~L~~~i~~~--------~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQ--------KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp EEEECCCCSCBHHHHHHTC--------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred EEEEeCCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 9999999999999999862 358999999999999999999999999999999999998543 3599999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHHHcCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE---IDPFEMAASLQDGYR 452 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~---~~~~~~~~~i~~~~~ 452 (499)
||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.. ....++...+..+..
T Consensus 164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~Pf~~~~~~~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 164 FGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-GYTPFANGPDDTPEEILARIGSGKF 240 (342)
T ss_dssp CTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH-SSCSSCSSTTSCHHHHHHHHHHCCC
T ss_pred CCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc-CCCCCCCCCcCCHHHHHHHHccCCc
Confidence 999986643322 2235678999999999998889999999999999999999 8899875 345566666665432
Q ss_pred C---CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 L---NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ~---~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ..+..+++++.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2 122468999999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=355.76 Aligned_cols=243 Identities=22% Similarity=0.331 Sum_probs=204.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-------HHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-------AVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
.+|++.+.||+|+||.||+|+...++ +.||||++..... ....+.+.+|+.++++++||||+++++++ .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-~ 99 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKN---KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-E 99 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTT---EEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE-E
T ss_pred cceEEEeEEEecCCEEEEEEEECCCC---cEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-e
Confidence 57999999999999999999976655 7899999865421 11234577899999999999999999985 5
Q ss_pred CCCceEEEEEeCCCC-CHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 295 DHTSPFLIYPYQDYT-NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 295 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
.....++||||+.+| +|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL 171 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRH--------PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKL 171 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEE
Confidence 566779999999877 999999862 35899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
+|||+++....... .....||+.|+|||++.+..+ +.++|||||||++|||++ |+.||..... .. ...
T Consensus 172 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~-----~~--~~~ 240 (335)
T 3dls_A 172 IDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF-EENPFCELEE-----TV--EAA 240 (335)
T ss_dssp CCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH-SSCSCSSGGG-----GT--TTC
T ss_pred eecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh-CCCchhhHHH-----HH--hhc
Confidence 99999987644322 224568999999999998887 789999999999999999 8889876321 11 123
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
...+..+++++.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34456689999999999999999999999999864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=351.12 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=207.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc--CCCCcceeEEeEEEcCC--
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG--LSHKNILTVLGVSIEDH-- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~g~~~~~~-- 296 (499)
..+|++.+.||+|+||.||+|+..+ +.||||++.... .+.+.+|.+++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRG-----EEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETT-----EEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred cccEEEEeeecCCCCcEEEEEEEcC-----ccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 4578999999999999999998742 789999996542 2456778888776 79999999999976544
Q ss_pred -CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEEcC
Q psy1789 297 -TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH--------KKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 297 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH--------~~~iiHrDlk~~NIlld~ 367 (499)
...++|+||+++|+|.+++.. ..+++.+++.++.|++.||+||| +.+|+||||||+|||++.
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred cceeEEEEeecCCCcHHHHHhc---------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence 267999999999999999986 35899999999999999999999 889999999999999999
Q ss_pred CCcEEEcccccccccCCCCcc--ccCCCCCCccccccccccccCC------CCCchhHHHHHHHHHHHHcCC--------
Q psy1789 368 KLRIQITDNALARDLFPSDYH--CLGDNENRPVKWLAIESLVHKT------FSTASDVWAFGVLLWELTTLA-------- 431 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwS~Gvvl~el~t~g-------- 431 (499)
++.+||+|||+++........ .......||..|+|||.+.+.. ++.++|||||||++|||+||+
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999866443221 1234557899999999998763 347899999999999999932
Q ss_pred -CCCCCCCC-----HHHHHHHHHc-CCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 432 -QQPYAEID-----PFEMAASLQD-GYRLNQPV-----NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 432 -~~p~~~~~-----~~~~~~~i~~-~~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
+.||.... ..++...+.. ..++..+. .+++.+.+++.+||+.||++|||+.||++.|+++.++.
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 67876542 2334444432 33333332 34568999999999999999999999999999998764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=354.80 Aligned_cols=266 Identities=12% Similarity=0.153 Sum_probs=207.8
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeC--CCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC---CCcceeEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTE--EDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS---HKNILTVL 289 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~ 289 (499)
.++.+...+|++.+.||+|+||.||+|.+.. .....+.||||++.... ...+..|+.++..++ |+||++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 4566778899999999999999999995322 11123789999997653 235667777777776 99999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-- 367 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-- 367 (499)
+++.. .+..++||||+++|+|.+++...+.. ....+++.+++.|+.|++.||+|||+++|+||||||+|||++.
T Consensus 134 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 134 SAHLF-QNGSVLVGELYSYGTLLNAINLYKNT---PEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEC-SSCEEEEECCCCSCBHHHHHHHHHTS---TTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred eeeec-CCCcEEEEeccCCCcHHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence 99655 45669999999999999999864321 1246999999999999999999999999999999999999998
Q ss_pred ---------CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q psy1789 368 ---------KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI 438 (499)
Q Consensus 368 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~ 438 (499)
++.+||+|||+|+...............||..|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~ 288 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF-GTYMKVKN 288 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH-SSCCCEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh-CCCccccC
Confidence 89999999999976532222223345679999999999999999999999999999999999 78887543
Q ss_pred CHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHH
Q psy1789 439 DPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGR-PTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 439 ~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~R-Pt~~~v~~~L~~~~~~ 494 (499)
+.... .+. ........++.+.+++..|++.+|.+| |++.++.+.|+++...
T Consensus 289 ~~~~~--~~~---~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 289 EGGEC--KPE---GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ETTEE--EEC---SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCce--eec---hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 22110 000 111112346789999999999999999 7788888888887554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=356.46 Aligned_cols=268 Identities=24% Similarity=0.356 Sum_probs=215.1
Q ss_pred hcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeE
Q psy1789 213 KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGV 291 (499)
Q Consensus 213 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~ 291 (499)
.+.++.+...+|++.+.||+|+||.||+|...+ .+++|++.... .....+.+.+|+.++++++||||++++++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 456677888899999999999999999998753 38888886432 22223567789999999999999999999
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
+.. ....++|+||+++++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++ ++.+
T Consensus 98 ~~~-~~~~~iv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 98 CMS-PPHLAIITSLCKGRTLYSVVRDA-------KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp EEC-SSCEEEECBCCCSEEHHHHTTSS-------CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CC
T ss_pred Eec-CCceEEEeecccCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCE
Confidence 654 55679999999999999999752 13589999999999999999999999999999999999998 6799
Q ss_pred EEcccccccccCCCCc---cccCCCCCCcccccccccccc---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy1789 372 QITDNALARDLFPSDY---HCLGDNENRPVKWLAIESLVH---------KTFSTASDVWAFGVLLWELTTLAQQPYAEID 439 (499)
Q Consensus 372 kl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~ 439 (499)
||+|||+++....... ........|+..|+|||.+.. ..++.++||||||+++|||++ |+.||....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~~~~ 247 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA-REWPFKTQP 247 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH-SSCSSSSCC
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Confidence 9999999876532111 112234458899999999874 457899999999999999999 899999888
Q ss_pred HHHHHHHHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 440 PFEMAASLQDGYRLNQP-VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 440 ~~~~~~~i~~~~~~~~~-~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..+....+..+..+... ..+++++.+++.+||+.||++|||+.++++.|+++.++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 248 AEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 88777777666554433 3678899999999999999999999999999998876644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=351.28 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=202.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|++++.||+|+||.||+|+...++ +.||+|++... ......+.+.+|+.++++++||||+++++++. .....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~ 99 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTG---RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-KKKRW 99 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTC---CEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCC---ceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-cCCEE
Confidence 357999999999999999999986554 78999998644 34445567889999999999999999999964 46677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++++|..++.. ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus 100 ~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELF--------PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp EEEEECCSEEHHHHHHHS--------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCcchHHHHHhh--------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence 999999999999988764 235899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---------
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD--------- 449 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~--------- 449 (499)
+....... ......+|..|+|||.+.+. .++.++|||||||++|||++ |++||...+..+....+..
T Consensus 172 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (331)
T 4aaa_A 172 RTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLGNLIPRH 248 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 86543221 22345688999999999875 78999999999999999999 8899988776554333221
Q ss_pred -----------CCCCC----------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 -----------GYRLN----------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 -----------~~~~~----------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+.... ....+++++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00100 01256889999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.91 Aligned_cols=249 Identities=19% Similarity=0.265 Sum_probs=209.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH------------HHHHHHHHHHHHHhcCCCCcceeE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA------------VQVSLLLQEGMAMYGLSHKNILTV 288 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~H~nIv~l 288 (499)
..+|++++.||+|+||.||+|+...++ +.+|+|++...... ...+.+.+|+.++++++||||+++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGH---SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTC---CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCC---cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 467999999999999999999986654 68999998654211 224678899999999999999999
Q ss_pred EeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q psy1789 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK 368 (499)
Q Consensus 289 ~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~ 368 (499)
++++ ......++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 112 ~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 112 FDVF-EDKKYFYLVTEFYEGGELFEQIINR--------HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182 (504)
T ss_dssp EEEE-ECSSEEEEEEECCTTCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESST
T ss_pred EEEE-EcCCEEEEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecC
Confidence 9996 5566789999999999999999763 358999999999999999999999999999999999999977
Q ss_pred C---cEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy1789 369 L---RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445 (499)
Q Consensus 369 ~---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~ 445 (499)
+ .+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|||++ |.+||.+.+..++..
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~ 257 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC-GYPPFGGQNDQDIIK 257 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred CCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 5 69999999998764432 223566899999999986 569999999999999999999 899999988888888
Q ss_pred HHHcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 446 SLQDGYRLNQ---PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 446 ~i~~~~~~~~---~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+..... ...+++++.+++.+||+.||.+|||+.|+++
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 7776532211 1467899999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=358.05 Aligned_cols=253 Identities=17% Similarity=0.305 Sum_probs=199.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++++.||+|+||.||+|....++ +.||||++... ......+.+.+|+.++++++|+||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTE---KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTT---EEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCC---cEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 458999999999999999999987655 78999999753 34555678999999999999999999999865443
Q ss_pred -CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 297 -TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 297 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
...++||||++ |+|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~--------~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~D 172 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKT--------PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHS--------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEecCC-cCHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEcc
Confidence 56799999998 699999985 24599999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcc--------------------ccCCCCCCcccccccccc-ccCCCCCchhHHHHHHHHHHHHc-----
Q psy1789 376 NALARDLFPSDYH--------------------CLGDNENRPVKWLAIESL-VHKTFSTASDVWAFGVLLWELTT----- 429 (499)
Q Consensus 376 fGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DvwS~Gvvl~el~t----- 429 (499)
||+|+........ .......||..|+|||++ ....++.++|||||||++|||++
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9999876433211 112456789999999986 56679999999999999999996
Q ss_pred -----CCCCCCCCCCH-----------------HH------------------------HHHHHHcCCCCCCC-------
Q psy1789 430 -----LAQQPYAEIDP-----------------FE------------------------MAASLQDGYRLNQP------- 456 (499)
Q Consensus 430 -----~g~~p~~~~~~-----------------~~------------------------~~~~i~~~~~~~~~------- 456 (499)
++.++|.+.+. .+ ....+... ....+
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 331 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF-PHRKPINLKQKY 331 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS-CCCCCCCHHHHS
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC-CCCCCCCHHHHC
Confidence 24555544321 00 11111111 11111
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+|+.+||+.||++|||+.|+++
T Consensus 332 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 332 PSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 257889999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=353.53 Aligned_cols=248 Identities=18% Similarity=0.235 Sum_probs=197.5
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++++.||+|+||.||+|.....+ +.||||++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCC---ceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 468999999999999999999876554 78999998653 34555678899999999999999999999864433
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++||||++ |+|.+++.. .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus 101 ~~~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 169 (371)
T 2xrw_A 101 EFQDVYIVMELMD-ANLCQVIQM----------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 169 (371)
T ss_dssp TCCEEEEEEECCS-EEHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred cccceEEEEEcCC-CCHHHHHhh----------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEE
Confidence 25799999998 688888863 48899999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+++...... ......||..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.......
T Consensus 170 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 170 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK-GGVLFPGTDHIDQWNKVIEQLGTP 245 (371)
T ss_dssp CCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHC-CCCC
T ss_pred Eeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998654321 2234568899999999999999999999999999999999 899999887766555544322111
Q ss_pred C-----------------------------------CC------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 Q-----------------------------------PV------NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~-----------------------------------~~------~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. +. ..++++.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 00 01567899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=345.17 Aligned_cols=258 Identities=20% Similarity=0.346 Sum_probs=207.2
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSI 293 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 293 (499)
.+......+|++.+.||+|+||.||+|+...++ +.||+|++..... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTG---QLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCC---CeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 344455678999999999999999999986544 6899999865432 235688999999998 8999999999976
Q ss_pred cC-----CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC
Q psy1789 294 ED-----HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK 368 (499)
Q Consensus 294 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~ 368 (499)
.. ....++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+|+||||||+||+++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK------GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSG------GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC
Confidence 53 456799999999999999998632 2468999999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy1789 369 LRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443 (499)
Q Consensus 369 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~ 443 (499)
+.+||+|||+++....... ......|+..|+|||.+. +..++.++|||||||++|||+| |+.||...+..+.
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~ 242 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE-GAPPLCDMHPMRA 242 (326)
T ss_dssp CCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHH
T ss_pred CCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHh-CCCCCCCCcHHHH
Confidence 9999999999986543211 223456889999999997 5678999999999999999999 8999988877666
Q ss_pred HHHHHcCCC-CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 444 AASLQDGYR-LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 444 ~~~i~~~~~-~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+..... ...+..+++++.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 555544322 2234568899999999999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=345.05 Aligned_cols=252 Identities=18% Similarity=0.331 Sum_probs=206.5
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
...+|++++.||+|+||.||+|+...++ +.+|+|++.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETG---ALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTC---CEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCC---cEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeE
Confidence 4568999999999999999999986544 689999986542 2334678899999999999999999998654 5677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus 92 ~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLELD-------RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EEEEECCTTEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred EEEEEeCCCCcHHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999987632 35899999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL- 453 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~- 453 (499)
...... ........|+..|+|||.+. +..++.++||||||+++|||++ |+.||...+..+....+.....+
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRVLLKIAKSDPPT 241 (302)
T ss_dssp HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc-CCCCCccCCHHHHHHHHhccCCcc
Confidence 643211 11123456889999999984 6778999999999999999999 89999988877766555544332
Q ss_pred -CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 -NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 -~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+..++.++.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 234567899999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=349.09 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=210.0
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---c----HHHHHHHHHHHHHHhcC-CCCcceeEEeEEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---S----AVQVSLLLQEGMAMYGL-SHKNILTVLGVSI 293 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~----~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~ 293 (499)
.+|++.+.||+|+||.||+|++..++ +.||||++.... . ....+.+.+|+.+++++ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATG---HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhcccceEEecCCCEEEEEEEECCCC---cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE-
Confidence 57999999999999999999986544 689999986432 1 22245688999999998 799999999986
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl 373 (499)
......++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK--------VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEE
Confidence 4466779999999999999999862 35899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCcccccccccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH------KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i 447 (499)
+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...+..+....+
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPFWHRRQILMLRMI 317 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH-CCCCCCCCCHHHHHHHH
Confidence 99999987654322 235678999999999864 368899999999999999999 89999888777776666
Q ss_pred HcCCCC-CCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 QDGYRL-NQP--VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ~~~~~~-~~~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+... ..+ ..++.++.+++.+||+.||++|||+.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 554322 111 367889999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=349.90 Aligned_cols=251 Identities=20% Similarity=0.274 Sum_probs=199.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH----HHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA----VQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
..+|++++.||+|+||.||+|+...++ +.||||++...... ...+.+.+|+.+++.++||||+++++++ ...
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 84 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-GHK 84 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCC---SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCC---cEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-eeC
Confidence 457889999999999999999976544 68999998643221 1124678999999999999999999985 556
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++||||+++ +|..++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDN-------SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTC-------CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEEcCCC-CHHHHHHhc-------CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEec
Confidence 667999999995 899988752 235888999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--- 452 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--- 452 (499)
|+++....... ......+|..|+|||.+.+. .++.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 157 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~~~~~~~~~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 157 GLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPT 233 (346)
T ss_dssp GGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99987643221 23355689999999999764 58999999999999999999 8999988877665554432100
Q ss_pred -CCC-----------------------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 -LNQ-----------------------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 -~~~-----------------------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ...+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 0345689999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.07 Aligned_cols=252 Identities=20% Similarity=0.230 Sum_probs=206.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----C
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED----H 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~----~ 296 (499)
..+|++.+.||+|+||.||+|+...++ +.||||++...........+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTG---EIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCC---cEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 457899999999999999999986554 789999997666666677889999999999999999999986443 2
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++|+||++ |+|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST---------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDF 156 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEeccC-ccHHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEec
Confidence 56799999998 799999986 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccc--------cCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy1789 377 ALARDLFPSDYHC--------LGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447 (499)
Q Consensus 377 Gla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i 447 (499)
|+++......... ......||..|+|||.+.+ ..++.++|||||||++|||++ |++||.+.+..+....+
T Consensus 157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHH
T ss_pred ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Confidence 9998764322110 1123468999999998765 779999999999999999999 89999887755443322
Q ss_pred Hc---CC----------------------CCC------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 QD---GY----------------------RLN------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ~~---~~----------------------~~~------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. .. ... ....+++++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11 00 000 01357889999999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=365.47 Aligned_cols=262 Identities=18% Similarity=0.259 Sum_probs=211.2
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
....+|++++.||+|+||.||+|+...++ +.||||++...... ..+.+|+.+++.++|++.+..+.++......
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTC---CEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCC---cEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 34578999999999999999999976554 78999988654322 3477899999999886655555544555677
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCcEEEcc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV---DDKLRIQITD 375 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll---d~~~~~kl~D 375 (499)
.+|||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||+++|+||||||+|||| +.++.+||+|
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 149 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred EEEEEECC-CCCHHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEe
Confidence 79999999 899999998632 359999999999999999999999999999999999999 6889999999
Q ss_pred cccccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Q psy1789 376 NALARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP---FEMAASL 447 (499)
Q Consensus 376 fGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~---~~~~~~i 447 (499)
||+++........ .......||..|+|||.+.+..++.++|||||||++|||++ |+.||.+... .+....+
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCCSSHHHHHHHH
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccccchhHHHHHHHH
Confidence 9999876543321 12235678999999999999999999999999999999999 8999987543 2222222
Q ss_pred Hc----CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 448 QD----GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 448 ~~----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
.. ......+..+++++.+++..||+.||++||++.+|++.|+++....
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11 1111122467899999999999999999999999999999987754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.34 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=206.5
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|++++.||+|+||.||+|+...++ ..+|+|++.... .......+.+|+.+++.++||||+++++++ ......
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~ 111 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTH---VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRNY 111 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTC---CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCC---cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCEE
Confidence 347999999999999999999986554 689999986542 122246788999999999999999999996 456677
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~kl~Df 376 (499)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 112 ~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 183 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHR--------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDF 183 (494)
T ss_dssp EEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEecCCCCcHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEEC
Confidence 9999999999999998763 35899999999999999999999999999999999999976 455999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-CC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-NQ 455 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~~ 455 (499)
|+|+...... ......||+.|+|||++. ..++.++|||||||++|||++ |++||.+.+..++...+..+... ..
T Consensus 184 G~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 184 GLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKVEKGKYTFDS 258 (494)
T ss_dssp TTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCCCCS
T ss_pred CCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 9998764332 223567899999999876 569999999999999999999 89999998888888777665322 11
Q ss_pred C--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 P--VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+ ..+++++.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1 367899999999999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=345.56 Aligned_cols=250 Identities=17% Similarity=0.236 Sum_probs=197.7
Q ss_pred cceEEe-eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc-CCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLF-SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG-LSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~-~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+|++. +.||+|+||.||+|+...++ +.||||++..... ...+.+.+|+.++.+ ++||||+++++++. .....
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITS---QEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFE-EEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSC---CEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCC---cEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-eCCEE
Confidence 356664 78999999999999875544 7899999965432 234678899999988 47999999999964 46678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc---EEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR---IQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~---~kl~Df 376 (499)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+||
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Df 158 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR--------RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDF 158 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred EEEEEcCCCCcHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEc
Confidence 9999999999999999863 35899999999999999999999999999999999999998776 999999
Q ss_pred ccccccCCCCc-----cccCCCCCCcccccccccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH------
Q psy1789 377 ALARDLFPSDY-----HCLGDNENRPVKWLAIESLVH-----KTFSTASDVWAFGVLLWELTTLAQQPYAEIDP------ 440 (499)
Q Consensus 377 Gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~------ 440 (499)
|+++....... ........||..|+|||.+.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS-GYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHH-SSCSCCCCCCSCSCC-
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHH-CCCCCccccccccccc
Confidence 99986542211 011123458999999999975 568999999999999999999 8899876531
Q ss_pred ---------HHHHHHHHcCCCCCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 441 ---------FEMAASLQDGYRLNQP----VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 441 ---------~~~~~~i~~~~~~~~~----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+...+..+. ...+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 238 RGEACPACQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp ---CCHHHHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccchhHHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 23344444432 2222 357889999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=365.35 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=208.5
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.+|++.+.||+|+||.||+|+...++ +.||||++.... .......+.+|+.++++++||||+++++++ ......+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~ 97 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQ---QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-EDSSSFY 97 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTC---CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCC---CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-EcCCEEE
Confidence 46999999999999999999986554 789999985321 112246788999999999999999999995 4566779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---CCCcEEEcccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD---DKLRIQITDNA 377 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld---~~~~~kl~DfG 377 (499)
+|+||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 98 lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR--------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEcCCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 999999999999998763 3589999999999999999999999999999999999995 45679999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-C--
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-N-- 454 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~-- 454 (499)
+++...... ......||+.|+|||++.+ .++.++|||||||++|||++ |++||.+.+..++...+..+... .
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGKYAFDLP 244 (486)
T ss_dssp CTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCCSCSG
T ss_pred cCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 998664432 2235578999999999875 59999999999999999999 89999998888887777665322 1
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+++++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 12357899999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=341.70 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=206.4
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
....+|++.+.||+|+||.||+|....++ +.||+|.+..... .+.+.+|+.+++.++||||+++++++.. ...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETG---QIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFK-NTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTC---CEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCC---CEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEe-CCE
Confidence 34568999999999999999999986544 6899999975432 3568899999999999999999998654 566
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+++|+|.+++... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLR-------NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHH-------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEeecCCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 79999999999999999742 24689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL--NQP 456 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~ 456 (499)
++....... ......|+..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+...... ..+
T Consensus 172 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T 3com_A 172 AGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE-GKPPYADIHPMRAIFMIPTNPPPTFRKP 248 (314)
T ss_dssp CEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred chhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHhcCCCcccCCc
Confidence 976543221 2234568899999999999999999999999999999999 89999888776655554443322 234
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+++.+||+.||++|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 467899999999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=337.65 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=210.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--------cHHHHHHHHHHHHHHhcCC-CCcceeEEeE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--------SAVQVSLLLQEGMAMYGLS-HKNILTVLGV 291 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~ 291 (499)
..+|++.+.||+|+||.||+|....++ +.||||++.... .....+.+.+|+.++++++ ||||++++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTC---KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcC---ceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 357889999999999999999986554 789999986432 1233567889999999995 9999999998
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
+ ......++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+
T Consensus 93 ~-~~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 93 Y-ETNTFFFLVFDLMKKGELFDYLTEK--------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp E-ECSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred e-ccCCeEEEEEeccCCCcHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcE
Confidence 6 5566789999999999999999862 368999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV------HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~ 445 (499)
||+|||+++....... .....++..|+|||.+. ...++.++||||||+++|||++ |+.||...+..+...
T Consensus 164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~ 239 (298)
T 1phk_A 164 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLR 239 (298)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHH
T ss_pred EEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH-CCCCCcCccHHHHHH
Confidence 9999999987654322 23456889999999985 4568999999999999999999 889998888777766
Q ss_pred HHHcCCC-CCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 446 SLQDGYR-LNQP--VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 446 ~i~~~~~-~~~~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+.. ...+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 6655422 2222 357899999999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=361.98 Aligned_cols=249 Identities=18% Similarity=0.239 Sum_probs=195.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-------cHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-------SAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
..+|++.+.||+|+||.||+|....++ +.||||++.... .......+.+|+.++++++||||+++++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~- 209 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTC---KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF- 209 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCC---cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-
Confidence 467999999999999999999987654 789999986431 122233588999999999999999999985
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---Cc
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LR 370 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~---~~ 370 (499)
+. ...++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+++|+||||||+|||++.+ +.
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSS--------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCC
T ss_pred ec-CceEEEEEcCCCCcHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcce
Confidence 43 346999999999999988865 2468999999999999999999999999999999999999754 45
Q ss_pred EEEcccccccccCCCCccccCCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH---KTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAAS 446 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~ 446 (499)
+||+|||+|+...... ......||+.|+|||++.+ ..++.++|||||||++|||+| |++||..... ..+...
T Consensus 281 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~ 356 (419)
T 3i6u_A 281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVSLKDQ 356 (419)
T ss_dssp EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH-SSCSSCCCSSSCCHHHH
T ss_pred EEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCcchHHHHHH
Confidence 9999999998764322 2235678999999999863 678899999999999999999 8999976533 233444
Q ss_pred HHcCCCCCC---CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 447 LQDGYRLNQ---PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 447 i~~~~~~~~---~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+..+..... ...+++++.+++.+||+.||++|||+.|+++
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 444322221 2367899999999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=355.00 Aligned_cols=257 Identities=17% Similarity=0.236 Sum_probs=206.6
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---cHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---SAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIE 294 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~ 294 (499)
+...+|++.+.||+|+||.||+|+........+.||||++.... .....+.+.+|+.+++++ +||||+++++++ .
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~ 129 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-Q 129 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-E
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE-e
Confidence 34468999999999999999999985322233789999986431 112234567899999999 699999999985 4
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
.....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR--------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEES
T ss_pred eCceEEEEeecCCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEe
Confidence 456779999999999999999863 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHH
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYAEI----DPFEMAASLQ 448 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~----~~~~~~~~i~ 448 (499)
|||+++........ ......||..|+|||++.+ ..++.++|||||||++|||+| |+.||... ...++...+.
T Consensus 202 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 202 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHHHHHHH
T ss_pred eCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH-CCCCCccCCccchHHHHHHHHh
Confidence 99999865432221 2234568999999999985 457899999999999999999 88898743 2334444444
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q psy1789 449 DGYRLNQPVNCPDELFSVMAYCWAMNPEGRP-----TFPQLHSC 487 (499)
Q Consensus 449 ~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~~ 487 (499)
.. .+..+..++..+.+++.+||+.||++|| ++.|+++.
T Consensus 280 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 280 KS-EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cc-CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 33 4556678899999999999999999999 88888754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.32 Aligned_cols=249 Identities=18% Similarity=0.190 Sum_probs=203.5
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC------CCCcceeEEeEE
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL------SHKNILTVLGVS 292 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~g~~ 292 (499)
....+|++++.||+|+||.||+|....++ +.||||++... ....+.+.+|+.+++.+ +|+||+++++++
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~---~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVH---QHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTT---EEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCC---cEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 34568999999999999999999986654 78999999754 33345677788777665 678999999985
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc--
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR-- 370 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~-- 370 (499)
......++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 169 -~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 169 -TFRNHICMTFELLS-MNLYELIKKNK------FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp -EETTEEEEEECCCC-CBHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCC
T ss_pred -ccCCeEEEEEeccC-CCHHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcc
Confidence 44567799999997 79999998733 235899999999999999999999999999999999999999887
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
+||+|||+|+..... .....||..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+....+...
T Consensus 241 vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-G~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT-GYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred eEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHH
Confidence 999999999765322 224568899999999999999999999999999999999 89999988766554433211
Q ss_pred CCC----------------------------------------------------------CCCCCCcHHHHHHHHHhhh
Q psy1789 451 YRL----------------------------------------------------------NQPVNCPDELFSVMAYCWA 472 (499)
Q Consensus 451 ~~~----------------------------------------------------------~~~~~~~~~~~~l~~~C~~ 472 (499)
... ..+...++++.+|+.+||+
T Consensus 315 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~ 394 (429)
T 3kvw_A 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394 (429)
T ss_dssp HCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTC
T ss_pred cCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCC
Confidence 000 0011236789999999999
Q ss_pred cCCCCCCCHHHHHH
Q psy1789 473 MNPEGRPTFPQLHS 486 (499)
Q Consensus 473 ~~P~~RPt~~~v~~ 486 (499)
.||++|||+.|+++
T Consensus 395 ~dP~~Rpta~e~L~ 408 (429)
T 3kvw_A 395 WDPAVRMTPGQALR 408 (429)
T ss_dssp SSTTTSCCHHHHHT
T ss_pred CChhhCCCHHHHhC
Confidence 99999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=365.86 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=212.0
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
...+|++.+.||+|+||.||+|+...++ +.||||++.... .....+.+.+|+.++++++||||+++++++ ....
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~ 99 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITG---QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-EDKG 99 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCC---CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-EeCC
Confidence 3457999999999999999999986554 789999985431 122346789999999999999999999995 4566
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---cCCCcEEEc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV---DDKLRIQIT 374 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll---d~~~~~kl~ 374 (499)
..++|+||+.+|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 171 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISR--------KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 171 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTC--------SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEE
Confidence 789999999999999999762 358999999999999999999999999999999999999 467899999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-L 453 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-~ 453 (499)
|||+++........ ....||+.|+|||++.+ .++.++|||||||++|||++ |++||.+.+..++...+..+.. .
T Consensus 172 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~ 246 (484)
T 3nyv_A 172 DFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKVEKGKYTF 246 (484)
T ss_dssp CTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred eeeeeEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876543321 23468999999999866 69999999999999999999 9999999988888877766532 2
Q ss_pred CCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 NQP--VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ~~~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 222 367899999999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.60 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=203.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..++....+||+|+||.||+|....++ +.||+|.+..... ...+.+.+|+.+++.++||||+++++++. .....+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 95 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQ---VRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFS-ENGFIK 95 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTC---CEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCC---eEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEE-eCCcEE
Confidence 333344469999999999999986554 6899999876533 33467899999999999999999999864 456779
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCcEEEcccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRIQITDNALA 379 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-~~~~kl~DfGla 379 (499)
+|+||+++++|.+++.... ....+++..+..++.|++.||.|||+++|+||||||+||+++. ++.+||+|||++
T Consensus 96 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKW-----GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTS 170 (295)
T ss_dssp EEEECCSEEEHHHHHHHTT-----CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred EEEEeCCCCCHHHHHHhhc-----cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccc
Confidence 9999999999999998632 1235679999999999999999999999999999999999997 899999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKT--FSTASDVWAFGVLLWELTTLAQQPYAEIDPFE--MAASLQDGYRLNQ 455 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~--~~~~i~~~~~~~~ 455 (499)
+....... ......|+..|+|||.+.+.. ++.++||||||+++|||++ |+.||....... ..........+..
T Consensus 171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (295)
T 2clq_A 171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELGEPQAAMFKVGMFKVHPEI 247 (295)
T ss_dssp EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH-TSCTTGGGSSHHHHHHHHHHHCCCCCC
T ss_pred cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH-CCCCccCCCchhHHHHhhccccccccc
Confidence 86643221 223556899999999997654 8999999999999999999 888987643322 2222233445566
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+..+++++.+++.+||+.||++||++.|+++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 7788999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.37 Aligned_cols=258 Identities=17% Similarity=0.308 Sum_probs=206.1
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCC--CCcceeEEe
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLS--HKNILTVLG 290 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g 290 (499)
+....+...+|++++.||+|+||.||++...++ +.+|||++... ......+.+.+|+.++.+++ |+||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKK----QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTC----CEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCC----cEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 455677788999999999999999999987442 67999998643 34556688999999999997 599999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~ 370 (499)
++.. ....++||| +.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+++ +.
T Consensus 96 ~~~~-~~~~~lv~e-~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~ 164 (313)
T 3cek_A 96 YEIT-DQYIYMVME-CGNIDLNSWLKKK--------KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM 164 (313)
T ss_dssp EEEC-SSEEEEEEC-CCSEEHHHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE
T ss_pred Eeec-CCEEEEEEe-cCCCcHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce
Confidence 8654 556799999 6679999999862 36899999999999999999999999999999999999975 89
Q ss_pred EEEcccccccccCCCCccccCCCCCCcccccccccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-----------KTFSTASDVWAFGVLLWELTTLAQQPYAEID 439 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~ 439 (499)
+||+|||+++...............|+..|+|||.+.+ ..++.++||||||+++|||++ |+.||....
T Consensus 165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~ 243 (313)
T 3cek_A 165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQII 243 (313)
T ss_dssp EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH-SSCTTTTCC
T ss_pred EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh-CCCchhhHH
Confidence 99999999987654433323345568999999999875 478899999999999999999 888987653
Q ss_pred -HHHH-HHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 440 -PFEM-AASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 440 -~~~~-~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.... ...+........+...++++.+++.+||+.||++||++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 244 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 2233 33333344555666778999999999999999999999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.91 Aligned_cols=254 Identities=17% Similarity=0.240 Sum_probs=203.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---- 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---- 295 (499)
..+|++++.||+|+||.||+|+...++ +.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTG---QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTC---CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCC---CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 357999999999999999999986554 689999885432 222235678999999999999999999987553
Q ss_pred ---CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 296 ---HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 296 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
....++||||++ |+|.+.+... ...+++.++..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~k 164 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCE-HDLAGLLSNV-------LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164 (351)
T ss_dssp ----CEEEEEEECCS-EEHHHHHHCT-------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred ccCCceEEEEEeccC-CCHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEE
Confidence 345799999999 5888887652 23589999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCc--cccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 373 ITDNALARDLFPSDY--HCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 373 l~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
|+|||+|+....... ........||+.|+|||++.+ ..++.++|||||||++|||+| |++||.+.+..+....+..
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Confidence 999999987643221 112234568999999999976 558999999999999999999 8999998877665554432
Q ss_pred C---CCCCCCCC----------------------------CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 G---YRLNQPVN----------------------------CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 ~---~~~~~~~~----------------------------~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ........ .++++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1 11111000 2567999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.90 Aligned_cols=252 Identities=17% Similarity=0.208 Sum_probs=201.7
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC--
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-- 295 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-- 295 (499)
.....+|++++.||+|+||.||+|+...++ +.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~---~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESG---KRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTC---CEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCC---CEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCc
Confidence 345678999999999999999999986554 7899999865422 234799999999999999999986432
Q ss_pred -----------------------------------CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHH
Q psy1789 296 -----------------------------------HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQ 340 (499)
Q Consensus 296 -----------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~ 340 (499)
....++||||++ |+|.+.+..... ....+++..+..++.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR----SGRSIPMNLISIYIYQ 149 (383)
T ss_dssp -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHH----TTCCCCHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh----cCCCCCHHHHHHHHHH
Confidence 223789999999 688888764221 1246899999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCceEEc-CCCcEEEcccccccccCCCCccccCCCCCCccccccccccccC-CCCCchhHH
Q psy1789 341 IIMGVQYLHKKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVW 418 (499)
Q Consensus 341 va~~L~yLH~~~iiHrDlk~~NIlld-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Dvw 418 (499)
++.||+|||+++|+||||||+|||++ .++.+||+|||+|+....... .....+|..|+|||.+.+. .++.++|||
T Consensus 150 i~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 99999999999999999999999998 689999999999987644332 2345678899999998875 499999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCCCCcHHHHHHHHHh
Q psy1789 419 AFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY----------------------------RLNQPVNCPDELFSVMAYC 470 (499)
Q Consensus 419 S~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~~~~l~~~C 470 (499)
||||++|||++ |++||.+.+..+....+.... +...+..+++++.+++.+|
T Consensus 227 slG~il~ell~-g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 227 SIGCVFGELIL-GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred hHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 99999999999 899999887766544432200 0012345788999999999
Q ss_pred hhcCCCCCCCHHHHHH
Q psy1789 471 WAMNPEGRPTFPQLHS 486 (499)
Q Consensus 471 ~~~~P~~RPt~~~v~~ 486 (499)
|+.||++|||+.|+++
T Consensus 306 L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCSSGGGSCCHHHHHT
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=340.97 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=199.7
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-----
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE----- 294 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~----- 294 (499)
...+|++++.||+|+||.||+|.....+ +.||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCD---KRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTT---EEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCC---eEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 4578999999999999999999987654 78999998754 44556789999999999999999999998532
Q ss_pred --------CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q psy1789 295 --------DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD 366 (499)
Q Consensus 295 --------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld 366 (499)
.....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---------GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---------CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---------CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 2356799999998 799999964 3589999999999999999999999999999999999997
Q ss_pred -CCCcEEEcccccccccCCCCcc-ccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy1789 367 -DKLRIQITDNALARDLFPSDYH-CLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443 (499)
Q Consensus 367 -~~~~~kl~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~ 443 (499)
+++.+||+|||+++........ .......++..|+|||.+.+ ..++.++||||||+++|||+| |+.||...+..+.
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKTLFAGAHELEQ 233 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHH
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHh-CCCCCCCCCHHHH
Confidence 5679999999999876432111 11223346788999998876 779999999999999999999 8999998776655
Q ss_pred HHHHHcCCC------------------------CC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 444 AASLQDGYR------------------------LN-----QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 444 ~~~i~~~~~------------------------~~-----~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+..... .. .+..+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 444332111 00 11357899999999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.18 Aligned_cols=251 Identities=21% Similarity=0.220 Sum_probs=205.6
Q ss_pred cceEEe-eeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCc
Q psy1789 222 CRVRLF-SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 222 ~~~~~~-~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~ 298 (499)
.+|.+. +.||+|+||.||+|....++ +.||+|++..... ......+.+|+.++..+ +||||+++++++ .....
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-~~~~~ 103 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTG---QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-ENTSE 103 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-ECSSE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCC---CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-EeCCe
Confidence 356666 89999999999999986554 7899999865321 22246788999999998 569999999985 55667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEEEcc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQITD 375 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~kl~D 375 (499)
.++||||+++|+|.+++... ....+++.++..++.|++.||+|||+++|+||||||+|||++. ++.+||+|
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE------LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC------C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEEEEEecCCCcHHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 89999999999999988542 1246899999999999999999999999999999999999997 78999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---C
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---R 452 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---~ 452 (499)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+.... .
T Consensus 178 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 178 FGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT-HTSPFVGEDNQETYLNISQVNVDYS 253 (327)
T ss_dssp GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHhcccccC
Confidence 99998764322 1234578999999999999999999999999999999999 899999888777665554432 2
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
......+++++.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 2333468899999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.59 Aligned_cols=247 Identities=19% Similarity=0.267 Sum_probs=188.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---- 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---- 295 (499)
..+|++++.||+|+||.||+|....++ +.||||++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTG---LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTT---EEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCC---CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 468999999999999999999876554 78999999653 3455567889999999999999999999986432
Q ss_pred -CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 296 -HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 296 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
....++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~ 174 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKC---------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174 (367)
T ss_dssp GCCCCEEEEECC-CEECC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCeEEEEeccc-CCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEe
Confidence 24569999999 5899998874 358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR- 452 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~- 452 (499)
|||+++..... .....+|..|+|||.+.+ ..++.++|||||||++|||++ |++||.+.+..+....+.....
T Consensus 175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~l~~i~~~~g~ 248 (367)
T 2fst_X 175 DFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRLVGT 248 (367)
T ss_dssp C--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999865322 234568899999999987 779999999999999999999 8999998776554443322100
Q ss_pred ---------------------CCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 ---------------------LNQ--------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 ---------------------~~~--------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ....++++.+|+.+||+.||++|||+.|+++
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000 1246788999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=356.07 Aligned_cols=248 Identities=15% Similarity=0.156 Sum_probs=185.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHH---HHHhcCCCCcceeEE------
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEG---MAMYGLSHKNILTVL------ 289 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~---~~l~~l~H~nIv~l~------ 289 (499)
...|++.+.||+|+||.||+|++..++ +.||||++.... .....+.+.+|+ ..|+. +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERL---EDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCC
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCC---ceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEee
Confidence 345889999999999999999986554 789999997653 344556778885 45555 799988754
Q ss_pred -eEEEcCC----------------CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHH------HHHHHHHHHHHH
Q psy1789 290 -GVSIEDH----------------TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEV------VDMCLQIIMGVQ 346 (499)
Q Consensus 290 -g~~~~~~----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~------~~i~~~va~~L~ 346 (499)
+++...+ ...++||||++ |+|.+++.... ..+.+..+ ..++.|++.||+
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~~~~~~~~~~~~vk~~i~~qi~~aL~ 208 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-------FVYVFRGDEGILALHILTAQLIRLAA 208 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-------HSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-------cccchhhhhhhhhHHHHHHHHHHHHH
Confidence 3322211 23699999999 99999998642 23455556 788899999999
Q ss_pred HHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCcccccccccccc--CCCCCchhHHHHHHHH
Q psy1789 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLL 424 (499)
Q Consensus 347 yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl 424 (499)
|||+++|+||||||+|||++.++.+||+|||+|+....... ...+|+.|+|||++.+ ..++.++|||||||++
T Consensus 209 ~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 209 NLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp HHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred HHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 99999999999999999999999999999999986532211 2345589999999987 7799999999999999
Q ss_pred HHHHcCCCCCCCCCCHHHHHHH-----H---HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 425 WELTTLAQQPYAEIDPFEMAAS-----L---QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 425 ~el~t~g~~p~~~~~~~~~~~~-----i---~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
|||+| |+.||....+...... . ........+..+++++.+++.+||+.||++|||+.|+++
T Consensus 284 ~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 284 YRVWC-LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHH-SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHh-CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999 8999987643211000 0 001112222478999999999999999999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=337.51 Aligned_cols=245 Identities=17% Similarity=0.285 Sum_probs=199.3
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcC-CC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIED-HT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~-~~ 297 (499)
...+|++++.||+|+||.||+|....++ +.||+|++.... .+.+.+|+.++++++ ||||+++++++... ..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNN---EKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCC---cEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 3578999999999999999999976554 789999997543 256889999999997 99999999986553 45
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cEEEccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDN 376 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~kl~Df 376 (499)
..++||||+++++|.+++.. +++.++..++.|++.||+|||+++|+||||||+|||++.++ .+||+||
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Df 175 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT-----------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDW 175 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG-----------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ceEEEEeccCchhHHHHHHh-----------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeC
Confidence 67999999999999999853 88999999999999999999999999999999999999776 8999999
Q ss_pred ccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH---------
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAE-IDPFEMAA--------- 445 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~-~~~~~~~~--------- 445 (499)
|+|+....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.. .+..+...
T Consensus 176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p~~~~~~~~~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRIAKVLGTE 251 (330)
T ss_dssp TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh-CCCCcccCCchHHHHHHHHHhcCCc
Confidence 99987644332 234568889999999987 679999999999999999999 7777743 33222111
Q ss_pred ----HHHcCC-----------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 446 ----SLQDGY-----------------------RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 446 ----~i~~~~-----------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+.... ....+..+++++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111110 00111226889999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=333.49 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=208.1
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|++.+.||+|+||.||+|+...++ +.||+|++.... .....+.+.+|+.++++++||||+++++++. .....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 96 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQ---QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-DSSSF 96 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCC---cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-CCCeE
Confidence 357999999999999999999986544 689999986432 2223467889999999999999999999864 45667
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC---CcEEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK---LRIQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~---~~~kl~Df 376 (499)
++|+||+++++|.+++... ..+++.++..++.|++.||.|||+++|+||||||+||+++.+ +.+||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR--------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999998763 358999999999999999999999999999999999999754 47999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC-CC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-NQ 455 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-~~ 455 (499)
|+++....... .....++..|+|||.+.+ .++.++||||||+++|||++ |+.||...+..++...+..+... ..
T Consensus 169 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 169 GLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS-GTPPFYGKNEYDILKRVETGKYAFDL 243 (287)
T ss_dssp TGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred CcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 99986643321 123347788999998865 48999999999999999999 89999988887777776655322 11
Q ss_pred --CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 456 --PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 456 --~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+++++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 2467899999999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.97 Aligned_cols=249 Identities=18% Similarity=0.225 Sum_probs=199.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-------cHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-------SAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
..+|++.+.||+|+||.||+|....++ +.||||++.... .......+.+|+.++++++||||+++++++.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTC---KKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCC---cEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 357999999999999999999986654 789999986432 1122345889999999999999999999854
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc---
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR--- 370 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~--- 370 (499)
. + ..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~-~-~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~ 155 (322)
T 2ycf_A 86 A-E-DYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 155 (322)
T ss_dssp S-S-SEEEEEECCTTEETHHHHST--------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCC
T ss_pred C-C-ceEEEEecCCCCcHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCe
Confidence 3 3 36999999999999999875 236899999999999999999999999999999999999987654
Q ss_pred EEEcccccccccCCCCccccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH
Q psy1789 371 IQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF-EMAAS 446 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~-~~~~~ 446 (499)
+||+|||+++....... .....||..|+|||++. ...++.++|||||||++|||++ |+.||...... .+...
T Consensus 156 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~ 231 (322)
T 2ycf_A 156 IKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRTQVSLKDQ 231 (322)
T ss_dssp EEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH-SSCSSCSTTCSSCHHHH
T ss_pred EEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCCcccchHHHHHHH
Confidence 99999999987643221 11335788999999974 5678999999999999999999 88898764332 33344
Q ss_pred HHcCCCCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 447 LQDGYRLN---QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 447 i~~~~~~~---~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+..+.... .+..+++++.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 44332221 12467899999999999999999999999974
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=334.10 Aligned_cols=249 Identities=18% Similarity=0.291 Sum_probs=197.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC------
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED------ 295 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~------ 295 (499)
.+|++++.||+|+||.||+|+...++ +.||+|++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDS---RYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccchhhheeccCCcEEEEEEEEcCCC---eEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 47899999999999999999976544 78999998643 44557899999999999999999999986542
Q ss_pred ------CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 296 ------HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 296 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSEN-------LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSC-------GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccc-------cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC
Confidence 345789999999999999998622 3578899999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCc------------cccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy1789 370 RIQITDNALARDLFPSDY------------HCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYA 436 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~ 436 (499)
.+||+|||+++....... ........|+..|+|||.+.+. .++.++|||||||++|||++ ||.
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~----p~~ 229 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY----PFS 229 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS----CCS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh----ccC
Confidence 999999999986542210 1112345688899999999864 78999999999999999998 554
Q ss_pred CC-CHHHHHHHHHcC---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 437 EI-DPFEMAASLQDG---YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 437 ~~-~~~~~~~~i~~~---~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. +..+....+... .....+...++.+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp SHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 32 333444444432 122334567788999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=355.17 Aligned_cols=250 Identities=19% Similarity=0.215 Sum_probs=198.2
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
...+|++.+.||+|+||.||+|++..++ +.||||++.... ..+.+|++++++++||||+++++++....
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSG---ELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCC---cEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 3457999999999999999999986554 789999986542 12347999999999999999999865421
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC-CcEEE
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK-LRIQI 373 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~-~~~kl 373 (499)
...++||||+++ +|.+.+..... ....+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl 198 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 198 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEE
T ss_pred cceeEEeehhcccc-cHHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEe
Confidence 235789999994 67666653211 12468999999999999999999999999999999999999955 67899
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC--
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-- 450 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-- 450 (499)
+|||+|+....... .....+|..|+|||++.+. .++.++|||||||++|||++ |++||.+.+..+....+...
T Consensus 199 ~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 199 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp CCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHC
T ss_pred ccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhC
Confidence 99999987643321 2345678999999999765 79999999999999999999 89999987765543332210
Q ss_pred --------------CCCC------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 --------------YRLN------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 --------------~~~~------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... .+...++++.+|+.+||+.||++|||+.|+++
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0001 12356789999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=346.02 Aligned_cols=246 Identities=17% Similarity=0.275 Sum_probs=201.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC--
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT-- 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-- 297 (499)
..+|++.+.||+|+||.||+|....++ +.||||++... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSG---EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCC---CEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 468999999999999999999986654 78999999754 345556788999999999999999999998644332
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 298 ---SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 298 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
..++||||+. ++|.+++.. .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~ 186 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMGM----------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 186 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTTS----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred cceeEEEEEcccc-ccHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEE
Confidence 1399999999 789888743 48999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR- 452 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~- 452 (499)
|||+++..... .....+|..|+|||.+.+ ..++.++|||||||++|||+| |+.||.+.+..+....+.....
T Consensus 187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~ 260 (371)
T 4exu_A 187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQILKVTGV 260 (371)
T ss_dssp STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Confidence 99999865322 234567899999999987 789999999999999999999 8999998776655443322100
Q ss_pred -----------------------C------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 -----------------------L------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 -----------------------~------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 011256889999999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=350.14 Aligned_cols=250 Identities=17% Similarity=0.210 Sum_probs=197.5
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC-
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT- 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~- 297 (499)
....+|++.+.||+|+||.||+|+...+ ..+|+|++..... ...+|+.+++.++||||+++++++.....
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~----~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVES----DEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTT----EEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCC----CeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 3456899999999999999999997654 4588888754321 12379999999999999999998754332
Q ss_pred ----ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-CCCcEE
Q psy1789 298 ----SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD-DKLRIQ 372 (499)
Q Consensus 298 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld-~~~~~k 372 (499)
..++||||++++.+....+... ....+++..+..++.|++.||+|||+++|+||||||+|||++ .++.+|
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~k 182 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAK-----LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLK 182 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHH-----TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEE
T ss_pred CCceEEEEEeeccCccHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEE
Confidence 2689999999654444333211 124689999999999999999999999999999999999999 799999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
|+|||+|+....... .....+|..|+|||.+.+. .++.++|||||||++|||++ |++||.+.+..+....+....
T Consensus 183 L~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 183 LIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp ECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHH
T ss_pred EeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHh
Confidence 999999987644322 2345678999999999765 59999999999999999999 899999887665443332210
Q ss_pred ----------------CC------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ----------------RL------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ----------------~~------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. ..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00 012247889999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=341.80 Aligned_cols=260 Identities=16% Similarity=0.289 Sum_probs=187.4
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHH-HHhcCCCCcceeEEeEEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGM-AMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~H~nIv~l~g~~~ 293 (499)
..+.+...+|++.+.||+|+||.||+|....++ +.||||++...........+..|+. +++.++||||+++++++.
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSG---QIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTT---EEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCC---CEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 345566788999999999999999999986544 7899999976655555556666666 777889999999999965
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~k 372 (499)
. .+..++||||++ |+|.+++...... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+|
T Consensus 92 ~-~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 92 R-EGDCWICMELMS-TSFDKFYKYVYSV---LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp C-SSEEEEEECCCS-EEHHHHHHHHHHT---TCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred e-CCceEEEEeecC-CChHHHHHHHHhh---hcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence 4 566799999999 5888887642211 124689999999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCcccccccccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESL----VHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF-EMAASL 447 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~-~~~~~i 447 (499)
|+|||+++...... ......||..|+|||.+ .+..++.++||||||+++|||++ |+.||...... +....+
T Consensus 167 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~ 242 (327)
T 3aln_A 167 LCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT-GRFPYPKWNSVFDQLTQV 242 (327)
T ss_dssp ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHH-SCCCSSCC-------CCC
T ss_pred EccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH-CCCCCCCcchHHHHHHHH
Confidence 99999998664322 12234688999999999 56679999999999999999999 88998764322 222222
Q ss_pred HcCCCCCC----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 QDGYRLNQ----PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ~~~~~~~~----~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+..+.. ...+++++.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 22222222 2357899999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.97 Aligned_cols=253 Identities=19% Similarity=0.219 Sum_probs=205.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc------ceeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN------ILTVL 289 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~ 289 (499)
...+...+|++.+.||+|+||.||+|.....++ +.||||++... ....+.+.+|+.+++.++|+| +++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGG--RHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTT--EEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCC--cEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 345567799999999999999999998733222 78999999754 344567889999988876654 99999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC--
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-- 367 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-- 367 (499)
+++ ......++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 84 ~~~-~~~~~~~lv~e~~-~~~l~~~l~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 84 EWF-EHHGHICIVFELL-GLSTYDFIKENG------FLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp EEE-EETTEEEEEEECC-CCBHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCC
T ss_pred ccc-ccCCcEEEEEcCC-CCCHHHHHHhcC------CCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccc
Confidence 985 4466789999999 799999998632 235899999999999999999999999999999999999987
Q ss_pred -----------------CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcC
Q psy1789 368 -----------------KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTL 430 (499)
Q Consensus 368 -----------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~ 430 (499)
++.+||+|||+++..... .....||..|+|||.+.+..++.++|||||||++|||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~- 229 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL- 229 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH-
T ss_pred cccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh-
Confidence 668999999999864322 234568999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHcCCC-------------------------------------------CCCCCCCcHHHHHHH
Q psy1789 431 AQQPYAEIDPFEMAASLQDGYR-------------------------------------------LNQPVNCPDELFSVM 467 (499)
Q Consensus 431 g~~p~~~~~~~~~~~~i~~~~~-------------------------------------------~~~~~~~~~~~~~l~ 467 (499)
|+.||...+..+....+..... ...+...++++.+++
T Consensus 230 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 309 (339)
T 1z57_A 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309 (339)
T ss_dssp SSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHH
Confidence 8999988776654433321100 001122357799999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q psy1789 468 AYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 468 ~~C~~~~P~~RPt~~~v~~ 486 (499)
.+||+.||++|||+.|+++
T Consensus 310 ~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 310 QKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHTCSSTTTSCCHHHHTT
T ss_pred HHHhCcCcccccCHHHHhc
Confidence 9999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=338.92 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=203.5
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhcC---CCCcceeEEeEEEc-
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYGL---SHKNILTVLGVSIE- 294 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~- 294 (499)
...+|++.+.||+|+||.||+|+....++ +.||+|++..... ......+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGG--RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTT--EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCC--EEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 34689999999999999999999843222 7899999864321 11112455677666554 89999999998752
Q ss_pred ---CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 295 ---DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 295 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
.....++|+||++ |+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVP------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSC------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCE
Confidence 3456799999999 79999998632 2348999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++...... ......+|..|+|||.+.+..++.++|||||||++|||++ |++||...+..+....+....
T Consensus 160 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (326)
T 1blx_A 160 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVI 235 (326)
T ss_dssp EECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHH
T ss_pred EEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHHc
Confidence 999999998653221 2335678899999999999999999999999999999999 899999887766554443210
Q ss_pred C--------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 R--------------------------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~--------------------------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ......+++++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0112357889999999999999999999999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=345.42 Aligned_cols=261 Identities=19% Similarity=0.261 Sum_probs=203.6
Q ss_pred HHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc----------cHHHHHHHHHHHHHHhc
Q psy1789 210 LHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA----------SAVQVSLLLQEGMAMYG 279 (499)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~E~~~l~~ 279 (499)
..+.+.+......+|++.+.||+|+||.||+|....+ +.||||++.... .....+.+.+|+.++++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 85 (362)
T 3pg1_A 10 MRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG----IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85 (362)
T ss_dssp HHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTS----CEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCC----CeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh
Confidence 3444555666778999999999999999999986542 789999885421 23345789999999999
Q ss_pred CCCCcceeEEeEEEcC----CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy1789 280 LSHKNILTVLGVSIED----HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLH 355 (499)
Q Consensus 280 l~H~nIv~l~g~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiH 355 (499)
++||||+++++++... ....++||||++ |+|.+++... ...+++..+..++.|++.||.|||+++|+|
T Consensus 86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 157 (362)
T 3pg1_A 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-------RIVISPQHIQYFMYHILLGLHVLHEAGVVH 157 (362)
T ss_dssp CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHHCcCEe
Confidence 9999999999986542 235799999999 7899988752 236899999999999999999999999999
Q ss_pred cCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCC
Q psy1789 356 KDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQP 434 (499)
Q Consensus 356 rDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p 434 (499)
|||||+|||++.++.+||+|||+++...... ......+|..|+|||.+.+ ..++.++|||||||++|||++ |+.|
T Consensus 158 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~p 233 (362)
T 3pg1_A 158 RDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN-RKAL 233 (362)
T ss_dssp CCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH-SSCS
T ss_pred cCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh-CCCC
Confidence 9999999999999999999999998543322 2234568889999999987 779999999999999999999 8999
Q ss_pred CCCCCHHHHHHHHHcCC-----------------------CCC--------CCCCCcHHHHHHHHHhhhcCCCCCCCHHH
Q psy1789 435 YAEIDPFEMAASLQDGY-----------------------RLN--------QPVNCPDELFSVMAYCWAMNPEGRPTFPQ 483 (499)
Q Consensus 435 ~~~~~~~~~~~~i~~~~-----------------------~~~--------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~ 483 (499)
|.+.+..+....+.... ... .+...++.+.+++.+||+.||++|||+.|
T Consensus 234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 98877655544332100 000 11255788999999999999999999999
Q ss_pred HHH
Q psy1789 484 LHS 486 (499)
Q Consensus 484 v~~ 486 (499)
+++
T Consensus 314 ll~ 316 (362)
T 3pg1_A 314 ALR 316 (362)
T ss_dssp HHT
T ss_pred HHc
Confidence 975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=347.12 Aligned_cols=259 Identities=14% Similarity=0.231 Sum_probs=210.4
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH----------------HHHHHHHHHHHHHhc
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA----------------VQVSLLLQEGMAMYG 279 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~E~~~l~~ 279 (499)
.......+|++++.||+|+||.||+|.. + + +.||+|++...... ...+.+.+|+.++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 99 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK-D-N---KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE-T-T---EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc-C-C---ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence 3445567899999999999999999998 2 2 78999998643110 011678999999999
Q ss_pred CCCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCC
Q psy1789 280 LSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDL 358 (499)
Q Consensus 280 l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDl 358 (499)
++||||+++++++.. ....++||||+++|+|.+++.............+++..+..++.|++.||.|||+ ++|+||||
T Consensus 100 l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl 178 (348)
T 2pml_X 100 IKNEYCLTCEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178 (348)
T ss_dssp CCCTTBCCCSEEEES-SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCC
T ss_pred CCCCCcceEEEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCC
Confidence 999999999999644 5677999999999999998432111111123579999999999999999999999 99999999
Q ss_pred CCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccC-CCCC-chhHHHHHHHHHHHHcCCCCCCC
Q psy1789 359 ATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFST-ASDVWAFGVLLWELTTLAQQPYA 436 (499)
Q Consensus 359 k~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DvwS~Gvvl~el~t~g~~p~~ 436 (499)
||+||+++.++.+||+|||+++..... ......++..|+|||.+.+. .++. ++||||||+++|||++ |+.||.
T Consensus 179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 253 (348)
T 2pml_X 179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY-NVVPFS 253 (348)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH-SSCSSC
T ss_pred ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh-CCCCCC
Confidence 999999999999999999999865432 22356688999999999887 6766 9999999999999999 889998
Q ss_pred CCCH-HHHHHHHHcCCCCCCC-------------------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 437 EIDP-FEMAASLQDGYRLNQP-------------------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 437 ~~~~-~~~~~~i~~~~~~~~~-------------------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... .+....+..+. ...+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 254 LKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CSSCSHHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCcHHHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 7665 66666665542 2233 467899999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=338.64 Aligned_cols=246 Identities=17% Similarity=0.281 Sum_probs=200.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC--
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT-- 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~-- 297 (499)
..+|.+.+.||+|+||.||+|....++ +.||||++... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSG---EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCC---CEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 457999999999999999999986554 78999999654 345556788999999999999999999998644322
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 298 ---SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 298 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
..++||||++ |+|.+++.. .+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~~----------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 168 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMGL----------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 168 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTTS----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred cceeEEEEecccc-CCHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEe
Confidence 3499999998 688776642 48999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--- 450 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~--- 450 (499)
|||+++..... .....+|..|+|||.+.+ ..++.++|||||||++|||++ |+.||.+.+..+....+...
T Consensus 169 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~ 242 (353)
T 3coi_A 169 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT-GKTLFKGKDYLDQLTQILKVTGV 242 (353)
T ss_dssp STTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH-SSCSSBSSCHHHHHHHHHHHHCB
T ss_pred ecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999865322 224567899999999987 678999999999999999999 89999887765544333210
Q ss_pred ------------------------CC---CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 ------------------------YR---LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 ------------------------~~---~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+ ......+++++.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 1122367899999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=331.57 Aligned_cols=255 Identities=18% Similarity=0.335 Sum_probs=190.3
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHH-HHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQV-SLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
.+...-.+|++++.||+|+||.||+|....++ +.||||++......... +.+.++..+++.++||||+++++++..
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTG---HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTC---CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCC---eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 34555678999999999999999999986544 68999999765444333 344455567888999999999999654
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEE
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQI 373 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl 373 (499)
....++||||+ ++.+..+.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||
T Consensus 96 -~~~~~lv~e~~-~~~~~~l~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl 166 (318)
T 2dyl_A 96 -NTDVFIAMELM-GTCAEKLKKRM-------QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKL 166 (318)
T ss_dssp -SSEEEEEECCC-SEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEE
T ss_pred -CCcEEEEEecc-CCcHHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEE
Confidence 56779999999 45666665432 13589999999999999999999995 9999999999999999999999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHH
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEI-DPFEMAASL 447 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~-~~~~~~~~i 447 (499)
+|||+++...... ......++..|+|||.+. ...++.++||||||+++|||++ |+.||... ...+....+
T Consensus 167 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~ 242 (318)
T 2dyl_A 167 CDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT-GQFPYKNCKTDFEVLTKV 242 (318)
T ss_dssp CCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH-SSCTTTTCCSHHHHHHHH
T ss_pred EECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh-CCCCCCCCCccHHHHHHH
Confidence 9999997654322 123456888999999994 5678999999999999999999 88899863 445555555
Q ss_pred HcCCCCCCC--CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 QDGYRLNQP--VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 ~~~~~~~~~--~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
........+ ..+++++.+++.+||+.||.+||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 243 LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 554443333 357899999999999999999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=346.06 Aligned_cols=251 Identities=16% Similarity=0.223 Sum_probs=199.4
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC--------CCcceeEE
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS--------HKNILTVL 289 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~ 289 (499)
.+...+|++.+.||+|+||.||+|+...++ +.||||++... ....+.+.+|+.+++.++ |+||++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGK---KFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCC---eEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 344678999999999999999999876554 78999999754 344567889999998885 88899999
Q ss_pred eEEEc---CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEE
Q psy1789 290 GVSIE---DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVV 365 (499)
Q Consensus 290 g~~~~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIll 365 (499)
+++.. .....++||||+ +++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~------~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll 180 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSN------YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTT------TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence 98642 345679999999 467777766521 24589999999999999999999998 99999999999999
Q ss_pred cCCC-------------------------------------------------cEEEcccccccccCCCCccccCCCCCC
Q psy1789 366 DDKL-------------------------------------------------RIQITDNALARDLFPSDYHCLGDNENR 396 (499)
Q Consensus 366 d~~~-------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~g 396 (499)
+.++ .+||+|||+|+..... .....|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g 255 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ 255 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence 9775 7999999999865432 234568
Q ss_pred ccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHc--CC-----------------
Q psy1789 397 PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP------FEMAASLQD--GY----------------- 451 (499)
Q Consensus 397 t~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~------~~~~~~i~~--~~----------------- 451 (499)
|..|+|||++.+..++.++|||||||++|||+| |+.||...+. .+....+.. +.
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 334 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELAT-GDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT 334 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH-SSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBC
T ss_pred CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhh-CCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccC
Confidence 999999999999999999999999999999999 8899976432 111111110 00
Q ss_pred ----------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ----------------------RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ----------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+...++++.+|+.+||+.||++|||+.|+++
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00112233567899999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.54 Aligned_cols=252 Identities=17% Similarity=0.186 Sum_probs=188.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT--- 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~--- 297 (499)
..+|++.+.||+|+||.||+|+...++ +.||||++..... ....+.+|+..++.++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTG---MSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HTTEEEC----------CEEEEETTTC---CEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 357889999999999999999986554 6899998854321 12345677888888999999999999754322
Q ss_pred ---ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEEcC-CCcE
Q psy1789 298 ---SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH--KKKLLHKDLATRNCVVDD-KLRI 371 (499)
Q Consensus 298 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH--~~~iiHrDlk~~NIlld~-~~~~ 371 (499)
..++||||+++ +|...+.... .....+++..+..++.|++.||.||| +++|+||||||+|||++. ++.+
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYY----RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHH----TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHh----hcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 26899999995 5555544311 11346889999999999999999999 999999999999999997 8999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
||+|||+++....... .....||..|+|||++.+.. ++.++|||||||++|||+| |+.||...+..+....+...
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~-g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHh-CCCCcCCCChHHHHHHHHHH
Confidence 9999999987654332 23456899999999997654 8999999999999999999 89999988776654443221
Q ss_pred C-------------------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 Y-------------------------------RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 ~-------------------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
. ....+...++++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 01122236789999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=335.88 Aligned_cols=250 Identities=17% Similarity=0.183 Sum_probs=201.4
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc------ceeEEeEE
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN------ILTVLGVS 292 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~g~~ 292 (499)
....+|++.+.||+|+||.||+|.....++ +.||+|++... ....+.+.+|+.+++.++|+| ++.+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHARGK--SQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTT--EEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecCCCc--eEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 446789999999999999999999764432 67999999754 334567888999999887766 88888874
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-------
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV------- 365 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll------- 365 (499)
......++||||+ +++|.+++.... ...+++.++..++.|++.||+|||+++|+||||||+|||+
T Consensus 92 -~~~~~~~lv~e~~-~~~l~~~l~~~~------~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 92 -NFHGHMCIAFELL-GKNTFEFLKENN------FQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp -EETTEEEEEEECC-CCBHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred -eeCCeEEEEEecc-CCChHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 4566789999999 577878877532 2358999999999999999999999999999999999999
Q ss_pred ------------cCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q psy1789 366 ------------DDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQ 433 (499)
Q Consensus 366 ------------d~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~ 433 (499)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||+| |+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~ 237 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR-GFT 237 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSC
T ss_pred cccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh-CCC
Confidence 67889999999999864322 234578999999999999999999999999999999999 899
Q ss_pred CCCCCCHHHHHHHHHcCCCC-------------------------------------------CCCCCCcHHHHHHHHHh
Q psy1789 434 PYAEIDPFEMAASLQDGYRL-------------------------------------------NQPVNCPDELFSVMAYC 470 (499)
Q Consensus 434 p~~~~~~~~~~~~i~~~~~~-------------------------------------------~~~~~~~~~~~~l~~~C 470 (499)
||...+..+....+...... ......+.++.+++.+|
T Consensus 238 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 238 LFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 99887765544333221000 00112245789999999
Q ss_pred hhcCCCCCCCHHHHHH
Q psy1789 471 WAMNPEGRPTFPQLHS 486 (499)
Q Consensus 471 ~~~~P~~RPt~~~v~~ 486 (499)
|+.||++|||+.|+++
T Consensus 318 L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 318 LEFDPAQRITLAEALL 333 (355)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred hcCChhhCcCHHHHhc
Confidence 9999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.00 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=184.2
Q ss_pred cceEE-eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-CCCce
Q psy1789 222 CRVRL-FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-DHTSP 299 (499)
Q Consensus 222 ~~~~~-~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-~~~~~ 299 (499)
..|++ +++||+|+||.||+|+..+.. ..+.||+|++...... ..+.+|+.++++++||||+++++++.. .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSS-CCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCC-CCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34555 468999999999999976421 1267999999755332 357799999999999999999998653 45668
Q ss_pred EEEEEeCCCCCHHHHHHhcccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----cCCCcEEEc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCP-EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVV----DDKLRIQIT 374 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIll----d~~~~~kl~ 374 (499)
++||||++ |+|.+++....... ......+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.+||+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99999998 68888886432111 1112359999999999999999999999999999999999999 778999999
Q ss_pred ccccccccCCCCc-cccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH---------HH
Q psy1789 375 DNALARDLFPSDY-HCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPF---------EM 443 (499)
Q Consensus 375 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~---------~~ 443 (499)
|||+|+....... ........||+.|+|||++.+. .++.++|||||||++|||+| |++||...... +.
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH-SSCTTCCCC------CCCCHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh-CCCCCCCccccccccccchHHH
Confidence 9999987643211 1223356789999999999874 59999999999999999999 88999754321 22
Q ss_pred HHHHHcCCCCC-------------------------------------CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 444 AASLQDGYRLN-------------------------------------QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 444 ~~~i~~~~~~~-------------------------------------~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+....... .....++++.+|+.+||+.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 22111100000 01122567899999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=340.30 Aligned_cols=250 Identities=16% Similarity=0.168 Sum_probs=200.5
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CC-----cceeEEeE
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HK-----NILTVLGV 291 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~g~ 291 (499)
.....+|++.+.||+|+||.||+|....++ +.||||++... ......+..|+.+++.++ |+ +|++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQ---EWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTT---EEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCC---cEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 344578999999999999999999986554 78999999754 334466778888887774 44 49999998
Q ss_pred EEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEEc--C
Q psy1789 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH--KKKLLHKDLATRNCVVD--D 367 (499)
Q Consensus 292 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH--~~~iiHrDlk~~NIlld--~ 367 (499)
+. .....++||||++ |+|.+++.... ...+++..+..++.|++.||.||| +.+|+||||||+|||++ .
T Consensus 125 ~~-~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 125 FM-FRNHLCLVFEMLS-YNLYDLLRNTN------FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp EE-ETTEEEEEEECCC-CBHHHHHHHTT------TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred ec-cCCceEEEEecCC-CCHHHHHhhcC------cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence 54 4567899999997 69999998632 235899999999999999999999 46899999999999995 5
Q ss_pred CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i 447 (499)
++.+||+|||+|+..... .....+|..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+....+
T Consensus 197 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~pf~~~~~~~~~~~i 270 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT-GEPLFSGANEVDQMNKI 270 (382)
T ss_dssp SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHH
T ss_pred CCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Confidence 788999999999876432 234568899999999999999999999999999999999 89999988776655444
Q ss_pred HcCCCCC-----------------------------------CCC----------------------------CCcHHHH
Q psy1789 448 QDGYRLN-----------------------------------QPV----------------------------NCPDELF 464 (499)
Q Consensus 448 ~~~~~~~-----------------------------------~~~----------------------------~~~~~~~ 464 (499)
....... .+. ...+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (382)
T 2vx3_A 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350 (382)
T ss_dssp HHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHH
T ss_pred HHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHH
Confidence 3210000 000 0014789
Q ss_pred HHHHHhhhcCCCCCCCHHHHHH
Q psy1789 465 SVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 465 ~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+|+.+||+.||++|||+.|+++
T Consensus 351 dli~~mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 351 DLILRMLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHhcCCChhhCCCHHHHhc
Confidence 9999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=339.00 Aligned_cols=246 Identities=18% Similarity=0.305 Sum_probs=202.3
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-----HHHHHHHHHHHHHhcCC--CCcceeEE
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-----VQVSLLLQEGMAMYGLS--HKNILTVL 289 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--H~nIv~l~ 289 (499)
......+|++.+.||+|+||.||+|+...++ +.||||++...... ...+.+.+|+.++++++ |+||++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~ 114 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTT---EEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCC---cEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEE
Confidence 3445678999999999999999999976554 78999998643211 11245678999999986 59999999
Q ss_pred eEEEcCCCceEEEEEeCCC-CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-C
Q psy1789 290 GVSIEDHTSPFLIYPYQDY-TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD-D 367 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld-~ 367 (499)
+++. .....++|+||+.+ ++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++ +
T Consensus 115 ~~~~-~~~~~~lv~e~~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 115 DWFE-RPDSFVLILERPEPVQDLFDFITER--------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEE-CSSEEEEEEECCSSEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred EEEe-cCCcEEEEEEcCCCCccHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC
Confidence 9964 45667999999986 9999999862 3589999999999999999999999999999999999999 7
Q ss_pred CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
++.+||+|||+++...... .....||..|+|||++.+..+ +.++||||||+++|||+| |+.||...+ +
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~-g~~pf~~~~--~---- 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHDE--E---- 254 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSHH--H----
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH-CCCCCCChh--h----
Confidence 8999999999998764332 234568999999999987776 688999999999999999 888987532 1
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 447 LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+... ....+..+++++.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 IIRG-QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHC-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhcc-cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 23345678999999999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=335.76 Aligned_cols=246 Identities=16% Similarity=0.228 Sum_probs=172.9
Q ss_pred cceEEe-eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC---CC
Q psy1789 222 CRVRLF-SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---HT 297 (499)
Q Consensus 222 ~~~~~~-~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---~~ 297 (499)
.+|++. ++||+|+||.||+|....++ +.||||++.... ...+ +....++.++||||+++++++... ..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~---~~vavK~~~~~~--~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTG---QKCALKLLYDSP--KARQ---EVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEESSH--HHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCC---CEEEEEEecCcH--HHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 457774 57999999999999987554 789999996542 2112 222335667999999999986431 33
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEEEc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQIT 374 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~kl~ 374 (499)
..++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+++|+||||||+|||++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERG------DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-------CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 4789999999999999998632 246899999999999999999999999999999999999986 4559999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA----SLQDG 450 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~----~i~~~ 450 (499)
|||+++...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......... .+...
T Consensus 174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 248 (336)
T 3fhr_A 174 DFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GFPPFYSNTGQAISPGMKRRIRLG 248 (336)
T ss_dssp CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHH-SSCCC-------------------
T ss_pred ccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH-CCCCCCCccchhhhhhHHHhhhcc
Confidence 999998654322 234567899999999999999999999999999999999 889987655443321 11111
Q ss_pred ---CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 ---YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 ---~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
........+++++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111222468999999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=339.68 Aligned_cols=252 Identities=17% Similarity=0.250 Sum_probs=198.9
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-----------CCcc
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-----------HKNI 285 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nI 285 (499)
..+...+|++.+.||+|+||.||+|+...++ +.||||++... ....+.+.+|+.++++++ |+||
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNN---THVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEecCCC---cEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 3445678999999999999999999976554 78999999753 334467888999988876 8999
Q ss_pred eeEEeEEEcCC---CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCC
Q psy1789 286 LTVLGVSIEDH---TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATR 361 (499)
Q Consensus 286 v~l~g~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~ 361 (499)
+++++++.... ...++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~ 161 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE------HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPE 161 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT------TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGG
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh------ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChH
Confidence 99999865432 2578999999 799999998632 23589999999999999999999998 9999999999
Q ss_pred ceEEc------CCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy1789 362 NCVVD------DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435 (499)
Q Consensus 362 NIlld------~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~ 435 (499)
|||++ ..+.+||+|||+++..... .....||..|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 162 NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-g~~pf 235 (373)
T 1q8y_A 162 NVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLF 235 (373)
T ss_dssp GEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC
T ss_pred HeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh-CCCCC
Confidence 99994 4458999999999865322 234568999999999999999999999999999999999 88999
Q ss_pred CCCCH------HHHHHHHHc--C---------------------------------------CCCCCCCCCcHHHHHHHH
Q psy1789 436 AEIDP------FEMAASLQD--G---------------------------------------YRLNQPVNCPDELFSVMA 468 (499)
Q Consensus 436 ~~~~~------~~~~~~i~~--~---------------------------------------~~~~~~~~~~~~~~~l~~ 468 (499)
...+. .+....+.. + .....+..+++++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 86542 111111110 0 001122344678999999
Q ss_pred HhhhcCCCCCCCHHHHHH
Q psy1789 469 YCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 469 ~C~~~~P~~RPt~~~v~~ 486 (499)
+||+.||++|||+.|+++
T Consensus 316 ~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp GGGCSSTTTCBCHHHHHT
T ss_pred HHhccCccccCCHHHHhh
Confidence 999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=332.48 Aligned_cols=244 Identities=17% Similarity=0.285 Sum_probs=195.5
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-----HHHHHHHHHHHHHhcC----CCCcceeEE
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-----VQVSLLLQEGMAMYGL----SHKNILTVL 289 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~H~nIv~l~ 289 (499)
....+|++.+.||+|+||.||+|....++ +.||+|++...... .....+.+|+.++.++ +|+||++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDR---LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTC---CEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCC---eEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34567999999999999999999875544 78999999654221 1233466788888887 899999999
Q ss_pred eEEEcCCCceEEEEEe-CCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-C
Q psy1789 290 GVSIEDHTSPFLIYPY-QDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD-D 367 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld-~ 367 (499)
+++. .....++|+|| +.+++|.+++... ..+++..+..++.|++.||+|||+++|+||||||+||+++ +
T Consensus 105 ~~~~-~~~~~~~v~e~~~~~~~L~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 105 DWFE-TQEGFMLVLERPLPAQDLFDYITEK--------GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175 (312)
T ss_dssp EEC------CEEEEECCSSEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETT
T ss_pred EEEe-cCCeEEEEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCC
Confidence 9854 45567999999 7899999999862 3589999999999999999999999999999999999999 8
Q ss_pred CCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFS-TASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
++.+||+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++ |+.||.... + .
T Consensus 176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~--~---~ 245 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC-GDIPFERDQ--E---I 245 (312)
T ss_dssp TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSHH--H---H
T ss_pred CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH-CCCCCCChH--H---H
Confidence 8999999999998765432 2345688899999999877765 58999999999999999 888987532 1 1
Q ss_pred HHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 447 LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 447 i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. .....+..+++++.+++.+||+.||++|||+.|+++
T Consensus 246 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LE--AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HH--TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hh--hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 134456678999999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.47 Aligned_cols=256 Identities=16% Similarity=0.202 Sum_probs=189.7
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
.....+...+|++.++||+|+||+||.....++ +.||||++..... ..+.+|+.+++.+ +||||+++++++
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~----~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDN----RDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSS----SEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCC----eEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEE
Confidence 445666777899999999999998654332222 6799999865422 2356899999998 899999999985
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-----
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD----- 367 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~----- 367 (499)
.+....++||||++ |+|.+++.... ..+.+..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 88 -~~~~~~~lv~E~~~-g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~ 158 (432)
T 3p23_A 88 -KDRQFQYIAIELCA-ATLQEYVEQKD-------FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158 (432)
T ss_dssp -EETTEEEEEEECCS-EEHHHHHHSSS-------CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTT
T ss_pred -ecCCEEEEEEECCC-CCHHHHHHhcC-------CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCC
Confidence 55667799999997 79999998632 12344456799999999999999999999999999999943
Q ss_pred CCcEEEcccccccccCCCCc-cccCCCCCCccccccccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDY-HCLGDNENRPVKWLAIESLV---HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~ 443 (499)
...+||+|||+|+....... ........||+.|+|||++. ...++.++|||||||++|||+|+|..||........
T Consensus 159 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~ 238 (432)
T 3p23_A 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238 (432)
T ss_dssp BCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH
T ss_pred ceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH
Confidence 34688999999987653321 12233567899999999998 467888999999999999999988899976544443
Q ss_pred HHHHHcCCCC--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 444 AASLQDGYRL--NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 444 ~~~i~~~~~~--~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+...... ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 3322221111 111223456889999999999999999999983
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.42 Aligned_cols=253 Identities=19% Similarity=0.242 Sum_probs=184.9
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~~ 300 (499)
..|.+.+.||+|+||+||.+...++ +.||||++.... .+.+.+|+.++.++ +||||+++++++ ......+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g----~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~-~~~~~~~ 85 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQG----RPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSE-TTDRFLY 85 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSS----SEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEE-ECSSEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECC----eEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEE-ecCCeEE
Confidence 3456669999999999976543322 689999986542 24567899999875 899999999985 5566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC------------
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK------------ 368 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~------------ 368 (499)
+||||++ |+|.+++......... ....++..++.++.|++.||+|||+++|+||||||+|||++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDEN-LKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp EEECCCS-EEHHHHHHTC-------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EEEecCC-CCHHHHHhccCCCchh-hhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCC
Confidence 9999996 7999999864321110 0112344567899999999999999999999999999999754
Q ss_pred -CcEEEcccccccccCCCCcc--ccCCCCCCcccccccccccc-------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q psy1789 369 -LRIQITDNALARDLFPSDYH--CLGDNENRPVKWLAIESLVH-------KTFSTASDVWAFGVLLWELTTLAQQPYAEI 438 (499)
Q Consensus 369 -~~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~ 438 (499)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+|+|+.||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 48999999999876543221 11234578999999999976 678999999999999999999889999765
Q ss_pred CHHHHHHHHHcCCCCCCC-----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 439 DPFEMAASLQDGYRLNQP-----VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 439 ~~~~~~~~i~~~~~~~~~-----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+ ...+......... ..+++++.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 244 YSRE-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTHH-HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhH-HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 4333 2222222221111 124578999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=321.41 Aligned_cols=231 Identities=13% Similarity=0.076 Sum_probs=188.8
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+...+|++.+.||+|+||.||+|.....+ +.||||++.... .....+.|.+|+..+++++||||+++++++. ..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~ 103 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALD---RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-TR 103 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTT---EEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ET
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCC---ceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-EC
Confidence 55678999999999999999999986544 789999997542 3556678999999999999999999999864 45
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
+..++||||+++++|.+++.. .....+..+|+.|++.||+|||+++|+||||||+|||+++++.+||+++
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~~----------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVADT----------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHTT----------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred CcEEEEEEecCCCCHHHHHhc----------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec
Confidence 678999999999999999964 1355678999999999999999999999999999999999999999854
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA----SLQDGYR 452 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~----~i~~~~~ 452 (499)
| |++ .++.++|||||||++|||+| |+.||.+.+..+... .+.....
T Consensus 174 ~----------------------~~~-------~~~~~~Di~slG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T 3uqc_A 174 A----------------------TMP-------DANPQDDIRGIGASLYALLV-NRWPLPEAGVRSGLAPAERDTAGQPI 223 (286)
T ss_dssp C----------------------CCT-------TCCHHHHHHHHHHHHHHHHH-SEECSCCCSBCCCSEECCBCTTSCBC
T ss_pred c----------------------ccC-------CCCchhHHHHHHHHHHHHHH-CCCCCCcCCcchhhHHHHHHhccCCC
Confidence 3 333 36899999999999999999 899998765432110 0111100
Q ss_pred C--CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 453 L--NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 453 ~--~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
. .....+++++.+++.+||+.||++| |+.|+++.|+++...
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0 1124688999999999999999999 999999999987643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=360.48 Aligned_cols=250 Identities=16% Similarity=0.205 Sum_probs=200.3
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
...+...+|++.+.||+|+||.||+|.+...++ +.||||++...........+.+|+.++++++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNG--RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTT--EEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCC--cEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 344566899999999999999999999864222 789999997666666677899999999999999999999997654
Q ss_pred CCc----eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 296 HTS----PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 296 ~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
+.. .+|||||+++++|.+++.. .+++.+++.++.|++.||.|||+++|+||||||+|||++.+ .+
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~ 220 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QL 220 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C----------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cE
Confidence 432 5999999999999887653 58999999999999999999999999999999999999986 89
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+++..... ....||+.|+|||++.+.. +.++|||||||++|||++ +.+||...... ..
T Consensus 221 kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~-g~~~~~~~~~~--------~~ 284 (681)
T 2pzi_A 221 KLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTL-DLPTRNGRYVD--------GL 284 (681)
T ss_dssp EECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHS-CCCEETTEECS--------SC
T ss_pred EEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHh-CCCCCcccccc--------cc
Confidence 99999999876432 3456899999999987754 899999999999999999 77776642110 00
Q ss_pred CCCC-CCCCcHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHHHHHH
Q psy1789 452 RLNQ-PVNCPDELFSVMAYCWAMNPEGRPT-FPQLHSCLQEFHAQ 494 (499)
Q Consensus 452 ~~~~-~~~~~~~~~~l~~~C~~~~P~~RPt-~~~v~~~L~~~~~~ 494 (499)
.... ....++++.+++.+||+.||++||+ ++++.+.|..+.++
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 0000 0123568999999999999999995 66677777766543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=337.74 Aligned_cols=250 Identities=17% Similarity=0.119 Sum_probs=187.3
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCCC-Cccee---------
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLSH-KNILT--------- 287 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H-~nIv~--------- 287 (499)
....+++.++||+|+||.||+|++..++ +.||||++..... ....+.|.+|+.+++.++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g---~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CceeEEEecccccCCCEEEEEEEecCCC---CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3445888899999999999999986554 6899999874322 2235678999999999987 32211
Q ss_pred ------E------EeEEEcC----CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy1789 288 ------V------LGVSIED----HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351 (499)
Q Consensus 288 ------l------~g~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~ 351 (499)
+ ..+.... ....+++|+++ +++|.+++....... .....+++..++.++.|++.||+|||++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS-STHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT-TTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 1 0110010 12345666654 599999986432111 1134688999999999999999999999
Q ss_pred CccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCcccccccccc----------ccCCCCCchhHHHHH
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESL----------VHKTFSTASDVWAFG 421 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DvwS~G 421 (499)
+|+||||||+|||++.++.+||+|||+++..... .....| ..|+|||++ .+..++.++||||||
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 9999999999999999999999999999864322 234556 899999999 555688999999999
Q ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 422 VLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 422 vvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
|++|||+| |+.||...+..+....+.. ....+++++.+++.+||+.||++||++.|+++
T Consensus 305 vil~ellt-g~~Pf~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 305 LAIYWIWC-ADLPNTDDAALGGSEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHH-SSCCCCTTGGGSCSGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHH-CCCCCCCcchhhhHHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999 8999987654443333222 12367899999999999999999999988864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=314.09 Aligned_cols=224 Identities=17% Similarity=0.274 Sum_probs=178.2
Q ss_pred ceEEe-eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHH-hcCCCCcceeEEeEEEc---CCC
Q psy1789 223 RVRLF-SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM-YGLSHKNILTVLGVSIE---DHT 297 (499)
Q Consensus 223 ~~~~~-~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~g~~~~---~~~ 297 (499)
+|.+. +.||+|+||.||+|....++ +.||+|++... ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQ---EKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCC---cEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 35555 88999999999999986554 78999999643 3456788877 55799999999998643 245
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEEEc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQIT 374 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~kl~ 374 (499)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++. ++.+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRG------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCT------TCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 6799999999999999998732 235899999999999999999999999999999999999998 7899999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-- 452 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-- 452 (499)
|||+++... +..++.++|||||||++|||+| |+.||...+..+....+.....
T Consensus 163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~t-g~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHH-SSCSCCC-------CCSCCSSCTT
T ss_pred ccccccccc------------------------cccCCchhhHHHHHHHHHHHHH-CCCCCCCCcchhhhHHHHHHHhhc
Confidence 999987542 2346789999999999999999 8999977654443222211111
Q ss_pred -CCCC----CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 -LNQP----VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 -~~~~----~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+ ..+++++.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112 367899999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=348.75 Aligned_cols=252 Identities=22% Similarity=0.274 Sum_probs=198.3
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-----CC
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-----DH 296 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~~ 296 (499)
.+|++.+.||+|+||.||+|....++ +.||||++.........+.+.+|+.++++++||||+++++++.. .+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg---~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTG---EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTT---CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCC---cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 46888899999999999999875544 67999999876667777889999999999999999999998532 25
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCc---EEE
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLR---IQI 373 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~---~kl 373 (499)
...++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+|+||||||+||+++.++. +||
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~-----~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFE-----NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSS-----CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred CeEEEEEEeCCCCCHHHHHHhcc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 56799999999999999998632 1235889999999999999999999999999999999999997664 999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HH-------
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM-AA------- 445 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~-~~------- 445 (499)
+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||+| |+.||........ ..
T Consensus 166 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt-G~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 166 IDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT-GFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp CSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS-SCSSCCSSCHHHHSSTTCC----
T ss_pred ccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH-CCCCCCcccchhhhhhhhhcccc
Confidence 9999998764432 2235678999999999999999999999999999999999 8888875432211 00
Q ss_pred -HHH--c---C-----CCCC----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHH
Q psy1789 446 -SLQ--D---G-----YRLN----QPVNCPDELFSVMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 446 -~i~--~---~-----~~~~----~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~ 485 (499)
... . + .... ....+++++.+++.+||+.||++|||+.|++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000 0 0 0001 1113568899999999999999999998843
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=311.49 Aligned_cols=238 Identities=11% Similarity=0.069 Sum_probs=180.4
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-------cHHHHHHHHHHHHHHhcCC---------CC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-------SAVQVSLLLQEGMAMYGLS---------HK 283 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------H~ 283 (499)
...+|++++.||+|+||+||+|+.. + +.||||++.... .....+.+.+|+.+++.++ ||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~--~---~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIAD--H---TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEET--T---EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred ccccchheeeecccCceEEEEEEeC--C---ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 3456788899999999999999872 2 789999997542 1222356778888887775 88
Q ss_pred cceeEEeEEEc-----------------------------CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHH
Q psy1789 284 NILTVLGVSIE-----------------------------DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEV 334 (499)
Q Consensus 284 nIv~l~g~~~~-----------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~ 334 (499)
||+++.+++.. +....++||||+++|++.+.+.+ ..+++.++
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---------~~~~~~~~ 163 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---------KLSSLATA 163 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---------TCCCHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---------cCCCHHHH
Confidence 88888776431 25678999999999976665542 35899999
Q ss_pred HHHHHHHHHHHHHHH-hCCccccCCCCCceEEcCCC--------------------cEEEcccccccccCCCCccccCCC
Q psy1789 335 VDMCLQIIMGVQYLH-KKKLLHKDLATRNCVVDDKL--------------------RIQITDNALARDLFPSDYHCLGDN 393 (499)
Q Consensus 335 ~~i~~~va~~L~yLH-~~~iiHrDlk~~NIlld~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~ 393 (499)
..++.|++.||+||| +++|+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 164 ~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~ 236 (336)
T 2vuw_A 164 KSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------I 236 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------E
T ss_pred HHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------c
Confidence 999999999999999 89999999999999999887 9999999999865322 3
Q ss_pred CCCccccccccccccCCCCCchhHHHHHHH-HHHHHcCCCCCCCCCCH-HHHHHHHHcCCCC--CCC----CCCcHHHHH
Q psy1789 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVL-LWELTTLAQQPYAEIDP-FEMAASLQDGYRL--NQP----VNCPDELFS 465 (499)
Q Consensus 394 ~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvv-l~el~t~g~~p~~~~~~-~~~~~~i~~~~~~--~~~----~~~~~~~~~ 465 (499)
..||..|||||++.+.. +.++||||||++ .+++++ +..||..... ......+...... ..+ ..+++++.+
T Consensus 237 ~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 237 VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG-EYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT-SCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred EEEeecccChhhhcCCC-ccceehhhhhCCCCccccc-ccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence 36888999999998766 999999998777 666777 7778753211 1122233221111 111 146778999
Q ss_pred HHHHhhhcCCCCCCCHHHHH
Q psy1789 466 VMAYCWAMNPEGRPTFPQLH 485 (499)
Q Consensus 466 l~~~C~~~~P~~RPt~~~v~ 485 (499)
++.+||+.| |+.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=282.25 Aligned_cols=182 Identities=15% Similarity=0.018 Sum_probs=123.6
Q ss_pred eeeecceEEEEEEEeCCCceeEEEEEEEecCc---------ccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCCce
Q psy1789 230 NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN---------ASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 230 lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~~~ 299 (499)
.+.|++|.+..++....+ ..+++|.+... ..+...++|.+|+++|+++ .|+||++++++ .+++...
T Consensus 242 ~~~~~~~~h~~~rr~~fg---~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-~ed~~~~ 317 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFG---EDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-GENAQSG 317 (569)
T ss_dssp -C--------CCEEEEEC---SSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-EECSSEE
T ss_pred cccCCccccccccccccc---ceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-EEECCEE
Confidence 445666555443322111 45888888543 1344457899999999999 79999999998 5667788
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
||||||++||+|.++|... ..++.. +|+.||+.||+|+|++|||||||||+||||++++.+||+|||+|
T Consensus 318 yLVMEyv~G~~L~d~i~~~--------~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlA 386 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAG--------EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSI 386 (569)
T ss_dssp EEEEECCCSEEHHHHHHTT--------CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred EEEEecCCCCcHHHHHHhC--------CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccC
Confidence 9999999999999999862 345553 58999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHc
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTT 429 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t 429 (499)
+....... ......||++|||||++.+ .+..++|+||+|++++++.+
T Consensus 387 r~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 387 VTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp ESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred eeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 87643321 1234568999999999875 46788999999999887765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-28 Score=260.14 Aligned_cols=185 Identities=16% Similarity=0.172 Sum_probs=141.4
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-------cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-------SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
.+.||+|+||.||+|...+ ..+++|+..... .....+.|.+|+.++++++||||+++..++.. ....
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~ 414 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLD-----FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNK 414 (540)
T ss_dssp -------CCEEEEEEECSS-----CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTT
T ss_pred CCEEeeCCCEEEEEEEECC-----CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCcc
Confidence 3799999999999996543 467777754321 11224568999999999999999965555444 3445
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++.. +..++.|+++||+|||+++|+||||||+|||+++ .+||+|||+|
T Consensus 415 ~lVmE~~~ggsL~~~l~~----------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla 476 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED----------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLG 476 (540)
T ss_dssp EEEEECCCSEEHHHHSTT----------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHH----------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccC
Confidence 999999999999999863 4689999999999999999999999999999999 9999999999
Q ss_pred cccCCCCccc-----cCCCCCCcccccccccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q psy1789 380 RDLFPSDYHC-----LGDNENRPVKWLAIESLVH--KTFSTASDVWAFGVLLWELTTLAQQPYA 436 (499)
Q Consensus 380 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~DvwS~Gvvl~el~t~g~~p~~ 436 (499)
+......... ......||+.|||||++.. ..|+..+|+||...-.++-+. .+.+|.
T Consensus 477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~-~r~rY~ 539 (540)
T 3en9_A 477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE-RRARYV 539 (540)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH-TCSCCC
T ss_pred EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH-hccccC
Confidence 9775432111 1124568999999999987 678889999999998888887 555554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-24 Score=208.21 Aligned_cols=159 Identities=19% Similarity=0.122 Sum_probs=122.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH-----------------HHHHHHHHHHHHHhcCCCC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA-----------------VQVSLLLQEGMAMYGLSHK 283 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~H~ 283 (499)
...|.+++.||+|+||.||+|.. .++ +.||+|++...... .....+.+|+.++++++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g---~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKF---GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTT---EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCC---CEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 45677889999999999999998 333 78999999643211 23567899999999998
Q ss_pred cceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy1789 284 NILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNC 363 (499)
Q Consensus 284 nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NI 363 (499)
| +++.+++ +. +..++||||+++|+|.+ +.. .....++.|++.||.|||+.+|+||||||+||
T Consensus 163 ~-~~v~~~~-~~-~~~~lvmE~~~g~~L~~-l~~--------------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NI 224 (282)
T 1zar_A 163 G-LAVPKVY-AW-EGNAVLMELIDAKELYR-VRV--------------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNV 224 (282)
T ss_dssp T-SSSCCEE-EE-ETTEEEEECCCCEEGGG-CCC--------------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred C-CCcCeEE-ec-cceEEEEEecCCCcHHH-cch--------------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHE
Confidence 4 5555543 32 34599999999999987 421 12457999999999999999999999999999
Q ss_pred EEcCCCcEEEcccccccccCCCCccccCCCCCCcccccccccccc----------CCCCCchhHHH
Q psy1789 364 VVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH----------KTFSTASDVWA 419 (499)
Q Consensus 364 lld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~s~~~DvwS 419 (499)
|++ ++.+||+|||+|+.. ..++|||++.. .+|...+|+|.
T Consensus 225 Ll~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVEV---------------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEE-TTEEEECCCTTCEET---------------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEE-CCcEEEEECCCCeEC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999 999999999998742 23789998853 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=180.49 Aligned_cols=140 Identities=16% Similarity=0.118 Sum_probs=107.4
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEE--EEEEEecCccc-----------------------HHHHHHHHHHHHH
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEE--VLVKTVTDNAS-----------------------AVQVSLLLQEGMA 276 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~--vavK~~~~~~~-----------------------~~~~~~~~~E~~~ 276 (499)
.-|++.+.||+|+||.||+|....++ +. ||||++..... ......+.+|+..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDG---KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETT---EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCC---cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 34678899999999999999983333 56 99998754311 1112367889999
Q ss_pred HhcCCCCcc--eeEEeEEEcCCCceEEEEEeCCC-C----CHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy1789 277 MYGLSHKNI--LTVLGVSIEDHTSPFLIYPYQDY-T----NLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349 (499)
Q Consensus 277 l~~l~H~nI--v~l~g~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH 349 (499)
+.+++|+++ +..+++ ...+|||||+.+ | +|.++... .++.....++.|++.||.|||
T Consensus 124 l~~l~~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~-----------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE-----------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG-----------GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc-----------cChHHHHHHHHHHHHHHHHHH
Confidence 999988864 444443 134899999952 4 77776432 224467889999999999999
Q ss_pred -hCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 350 -KKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 350 -~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
+.+|+||||||+|||+++ .++|+|||+|...
T Consensus 188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.4e-16 Score=158.82 Aligned_cols=137 Identities=12% Similarity=0.058 Sum_probs=96.3
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc----------------H-HH--HH--HHHHHHHHHhcCC
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS----------------A-VQ--VS--LLLQEGMAMYGLS 281 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~----------------~-~~--~~--~~~~E~~~l~~l~ 281 (499)
-|++++.||+|+||.||+|...++ +.||||+++.... . .. .. ...+|...|.++.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G----~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKG----KQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTC----CEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECCCC----CEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999986443 6899998753210 0 00 00 1134555566664
Q ss_pred CCcce--eEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy1789 282 HKNIL--TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLA 359 (499)
Q Consensus 282 H~nIv--~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk 359 (499)
+.++. ..+++ . ..+|||||+++++|.++.. ......++.|++.+|.|||+.||||||||
T Consensus 172 ~~gv~vp~p~~~--~---~~~LVME~i~G~~L~~l~~--------------~~~~~~l~~qll~~l~~lH~~gIVHrDLK 232 (397)
T 4gyi_A 172 EEGFPVPEPIAQ--S---RHTIVMSLVDALPMRQVSS--------------VPDPASLYADLIALILRLAKHGLIHGDFN 232 (397)
T ss_dssp HTTCSCCCEEEE--E---TTEEEEECCSCEEGGGCCC--------------CSCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred hcCCCCCeeeec--c---CceEEEEecCCccHhhhcc--------------cHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 44432 22222 1 1279999999888754321 11345788999999999999999999999
Q ss_pred CCceEEcCCC----------cEEEccccccccc
Q psy1789 360 TRNCVVDDKL----------RIQITDNALARDL 382 (499)
Q Consensus 360 ~~NIlld~~~----------~~kl~DfGla~~~ 382 (499)
|.|||+++++ .+.|.||+-+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999999877 4899999977543
|
| >2ygo_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2ygp_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=6.4e-12 Score=109.50 Aligned_cols=93 Identities=18% Similarity=0.323 Sum_probs=81.1
Q ss_pred cccceeEEeecCCccceEEEEE---ecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEE-EecCC
Q psy1789 6 CSDNLEFGTRPLGHLPYSISVE---STNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINV-TLSRN 81 (499)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~-~~~~~ 81 (499)
=+++|.|||++++.++|.+.++ +++..+|..|++||+.+|+||.+++.|++.|.|+|..++++.+...+.+ +....
T Consensus 52 ~I~~l~FTW~s~~~~~Y~y~f~~L~s~D~~iL~~P~lnIs~~G~VP~~~~~Fsv~L~CsG~~sG~~~v~v~l~~~~~~~~ 131 (188)
T 2ygo_A 52 NIHSMNFTWQAAGQAEYFYEFLSLRSLDXGIMADPTVNVPLLGTVPHXASVVQVGFPCLGXQDGVAAFEVDVIVMNSEGN 131 (188)
T ss_dssp TCSEEEEEEEECSSSCCEEEEEEEEESCTTTBCCCEESSCSEEECCSSCEEEEEECCBCSSCCEEEEEEEEEEEECTTSC
T ss_pred ccceEEEEEecCCcccEEEEEEEeccCChhhccCcccccccccccCCccEEEEEEeEecCCcCceEEEEEEEEEecccCc
Confidence 3789999999999999999999 8999999999999999999999999999999999999999999888833 22222
Q ss_pred CCCceEEEEeeeceeec
Q psy1789 82 SNNVTSLNFKRKKICLR 98 (499)
Q Consensus 82 ~~~~~~~~~~~~~~~~~ 98 (499)
..+.+.+.|.+.+.|..
T Consensus 132 ~~n~T~L~~k~~K~C~~ 148 (188)
T 2ygo_A 132 TILXTPQNAIFFKTCQQ 148 (188)
T ss_dssp EEEECCTTCCEEEEECC
T ss_pred cCcCcceeEeecccccC
Confidence 34578889999999965
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=3.6e-11 Score=114.52 Aligned_cols=137 Identities=15% Similarity=0.045 Sum_probs=103.5
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEE
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv 302 (499)
|++...++.|+.+.||+....+ ..+++|+...... .....+.+|..+++.+. |.++.++++++. ..+..++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~-----~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~~~~lv 88 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGEN-----ENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFER-HDGWSNLL 88 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSS-----CEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEE
T ss_pred ceeEeeccCCCCCeEEEEECCC-----CcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-cCCceEEE
Confidence 5666788888889999986432 5789999864211 11235778999888874 677888998854 45667999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-------------------------------- 350 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-------------------------------- 350 (499)
|||+++.+|.+.+.. ......++.+++++|..||+
T Consensus 89 ~e~i~G~~l~~~~~~-------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 89 MSEADGVLCSEEYED-------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EECCSSEEHHHHCCT-------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred EEecCCeehhhccCC-------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 999999999876311 11235788899999999998
Q ss_pred ---------------------------CCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 351 ---------------------------KKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 351 ---------------------------~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
..++|+|+++.||+++++..+.|.||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999887667799999764
|
| >2ygn_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: MLY PCF NAG; 1.85A {Homo sapiens} PDB: 2d3j_A | Back alignment and structure |
|---|
Probab=99.13 E-value=1.6e-10 Score=97.10 Aligned_cols=73 Identities=15% Similarity=0.413 Sum_probs=67.6
Q ss_pred cccceeEEeecCCccceEEEEE---ecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec
Q psy1789 6 CSDNLEFGTRPLGHLPYSISVE---STNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS 79 (499)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~ 79 (499)
=+++|.|||++++.++|.+.++ .++..++..|.+||+.+|+||.+.+.|++.|.|+|...+++.+...+ +..+
T Consensus 52 ~I~~l~FTW~s~~~~~Y~y~~~~L~s~D~~iL~~P~lnIs~~G~VP~~~~~FsV~LpCtG~~sG~a~f~v~L-~i~~ 127 (156)
T 2ygn_A 52 NIHSMNFTWQAAGQAEYFYEFLSLRSLDXGIMADPTVNVPLLGTVPHXASVVQVGFPCLGXQDGVAAFEVDV-IVMN 127 (156)
T ss_dssp TCSEEEEEEEECSSSCEEEEEEEEEESCTTTBCCCEESSCSEEECCSSCEEEEEECCBCSSSCEEEEEEEEE-EEEE
T ss_pred ccceEEEEEecCCCccEEEEEEEeecCChhhccCcccccccccccCCCcEEEEEEEEecCCcCceeEEEEEE-EEEC
Confidence 4789999999998999999999 89999999999999999999999999999999999999999888888 5444
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.4e-10 Score=115.75 Aligned_cols=141 Identities=10% Similarity=0.085 Sum_probs=102.1
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEec--CcccHHHHHHHHHHHHHHhcCC--CCcceeEEeEEEcCC--CceE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVT--DNASAVQVSLLLQEGMAMYGLS--HKNILTVLGVSIEDH--TSPF 300 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~--~~~~ 300 (499)
++.++.|.++.||+....+ ..+++|+.. ..........+.+|..+++.++ +.++.++++++.+.. +..+
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-----~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-----QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-----CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred EEEcCCcccceEEEEEECC-----ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4778899999999987543 457788775 3322222356788999998886 456788898864432 3479
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK------------------------------ 350 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~------------------------------ 350 (499)
+||||+++..+.+. ....++..++..++.++++.|..||+
T Consensus 118 ~vme~v~G~~l~~~----------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ----------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp EEEECCCCBCCCCT----------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCC----------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 99999998766321 11247788899999999999999996
Q ss_pred ----------------------------CCccccCCCCCceEEcCCCc--EEEccccccccc
Q psy1789 351 ----------------------------KKLLHKDLATRNCVVDDKLR--IQITDNALARDL 382 (499)
Q Consensus 351 ----------------------------~~iiHrDlk~~NIlld~~~~--~kl~DfGla~~~ 382 (499)
..++|+|+++.|||++.++. +.|.||+.+...
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 25899999999999997753 689999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=1.4e-10 Score=109.89 Aligned_cols=125 Identities=18% Similarity=0.140 Sum_probs=88.1
Q ss_pred eeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc--ceeEEeEEEcCCCceEEEEEeCCC
Q psy1789 231 MEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN--ILTVLGVSIEDHTSPFLIYPYQDY 308 (499)
Q Consensus 231 G~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~~~~~~~~~lv~e~~~~ 308 (499)
+.|..+.||+....++ ..+++|...... ...+.+|..+++.+++.+ +.+++++. ...+..++||||+++
T Consensus 29 ~gg~~~~v~~~~~~~g----~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~-~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGR----PVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVV-TEAGRDWLLLGEVPG 99 (264)
T ss_dssp CTTSSCEEEEEECTTS----CCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEE-ECSSCEEEEEECCSS
T ss_pred cCCCCceEEEEecCCC----CeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEec-cCCCCCEEEEEecCC
Confidence 3456699999864322 458889876431 235678888888886545 45688874 444567999999998
Q ss_pred CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q psy1789 309 TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK------------------------------------ 352 (499)
Q Consensus 309 gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~------------------------------------ 352 (499)
.+|. ... .+ ...++.++++.|..||+..
T Consensus 100 ~~l~--~~~-----------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 100 QDLL--SSH-----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EETT--TSC-----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred cccC--cCc-----------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 8874 110 11 2255666777777777532
Q ss_pred ----------------------ccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 353 ----------------------LLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 353 ----------------------iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
++|+|++|.||+++++..+.|.||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999987777899999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=8.1e-10 Score=107.62 Aligned_cols=184 Identities=14% Similarity=0.128 Sum_probs=116.8
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCc--ceeEEeEEEcCC--CceEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKN--ILTVLGVSIEDH--TSPFLI 302 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~n--Iv~l~g~~~~~~--~~~~lv 302 (499)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+ .+.. +.+.++.+.... ...|+|
T Consensus 26 ~~~~~G~~n~v~~v~--------~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN--------RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST--------TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC--------CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 568889999999863 23778876432 3346788999998877 3333 345555432222 234899
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-------------------------------- 350 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-------------------------------- 350 (499)
||++++.+|...... .++..++..++.++++.|..||+
T Consensus 95 m~~i~G~~l~~~~~~----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE 164 (304)
T ss_dssp EECCCCEECCHHHHH----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred EcccCCeECCccccc----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence 999999887653322 36677777788888888887775
Q ss_pred --------------------------CCccccCCCCCceEEcC--CCcEEEcccccccccCCCCccccCCCC---CCcc-
Q psy1789 351 --------------------------KKLLHKDLATRNCVVDD--KLRIQITDNALARDLFPSDYHCLGDNE---NRPV- 398 (499)
Q Consensus 351 --------------------------~~iiHrDlk~~NIlld~--~~~~kl~DfGla~~~~~~~~~~~~~~~---~gt~- 398 (499)
..++|+|+++.||++++ ...+.|.||+.+....+...-...... .+..
T Consensus 165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEF 244 (304)
T ss_dssp SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHH
T ss_pred CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHH
Confidence 13699999999999998 566789999998765432111000000 0100
Q ss_pred ------cc--cc-ccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q psy1789 399 ------KW--LA-IESLVHKTFSTASDVWAFGVLLWELTTLAQQPY 435 (499)
Q Consensus 399 ------~y--~a-PE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~ 435 (499)
.| .. |+.... .....+.|++|.++|++.+ |..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~-g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEY-GYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHT-TCHHH
T ss_pred HHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHc-CCHHH
Confidence 01 11 221111 1123689999999999999 55443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2e-06 Score=83.54 Aligned_cols=134 Identities=17% Similarity=0.041 Sum_probs=89.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCC---cceeEEeEEEcCCCceEEEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHK---NILTVLGVSIEDHTSPFLIYP 304 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~g~~~~~~~~~~lv~e 304 (499)
+.++.|....||+. + ..+++|+.. .......+.+|..+|..+.+. .+.+.++++....+..++|||
T Consensus 25 ~~l~~G~~n~v~~v---g-----~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---N-----GDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEECSSEEEEEE---T-----TTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eecCCCcceeEEEE---C-----CEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 56778888899987 2 246777753 233446788999999988653 356777776444556799999
Q ss_pred eCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q psy1789 305 YQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK---------------------------------- 350 (499)
Q Consensus 305 ~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~---------------------------------- 350 (499)
|+++..|....-. .++..++..++.++++.|..||+
T Consensus 94 ~i~G~~l~~~~~~----------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 94 KVQGQILGEDGMA----------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp CCCSEECHHHHHT----------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred ccCCeECchhhhh----------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 9998877653211 12333333444444444444332
Q ss_pred --------------------------CCccccCCCCCceEEcC---CCc-EEEccccccccc
Q psy1789 351 --------------------------KKLLHKDLATRNCVVDD---KLR-IQITDNALARDL 382 (499)
Q Consensus 351 --------------------------~~iiHrDlk~~NIlld~---~~~-~kl~DfGla~~~ 382 (499)
..++|+|+++.||+++. ++. +.|.||+.+...
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 14699999999999997 455 489999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=8e-06 Score=77.50 Aligned_cols=133 Identities=14% Similarity=0.105 Sum_probs=86.4
Q ss_pred eeeeecce-EEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 229 VNMEGTFG-RVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 229 ~lG~G~fG-~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
.+..|..| .||+-....++ ..+.+|+-... ....+.+|...|+.+. +--+.++++++.. .+..++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~---~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNA---PELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTC---CCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCC---eEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEee
Confidence 34446555 68986644332 45778876532 2356778888887763 3346778888644 45679999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK------------------------------------ 350 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~------------------------------------ 350 (499)
++.++.+..... ......++.+++..|.-||+
T Consensus 103 ~G~~~~~~~~~~------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (272)
T 4gkh_A 103 PGKTAFQVLEEY------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE 170 (272)
T ss_dssp CSEEHHHHHHHC------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred CCccccccccCC------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence 988877654321 01122333344444444441
Q ss_pred ---------------C-------CccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 351 ---------------K-------KLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 351 ---------------~-------~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
. .++|+|+.+.|||+++++.+-|.||+.+..
T Consensus 171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1 278999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=8.7e-06 Score=80.67 Aligned_cols=85 Identities=9% Similarity=0.048 Sum_probs=51.4
Q ss_pred eeee-eeecceEEEEEEEe--CCCc-eeEEEEEEEecCccc--HHHHHHHHHHHHHHhcCC-C--CcceeEEeEEEcCC-
Q psy1789 227 FSVN-MEGTFGRVYRGTYT--EEDG-VEEEVLVKTVTDNAS--AVQVSLLLQEGMAMYGLS-H--KNILTVLGVSIEDH- 296 (499)
Q Consensus 227 ~~~l-G~G~fG~Vy~~~~~--~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-H--~nIv~l~g~~~~~~- 296 (499)
.+.| +.|..+.+|+.... ..++ ....+++|....... ......+.+|..+++.++ + -.+.++++++....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 77888999988754 1100 125678887654320 000134567777777764 2 35677888754332
Q ss_pred -CceEEEEEeCCCCCH
Q psy1789 297 -TSPFLIYPYQDYTNL 311 (499)
Q Consensus 297 -~~~~lv~e~~~~gsL 311 (499)
+..++||||+++..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 346899999987554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.85 E-value=0.0002 Score=70.05 Aligned_cols=31 Identities=23% Similarity=0.275 Sum_probs=27.5
Q ss_pred CCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 351 KKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 351 ~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
..++|+|+.+.|||++.++.+.|.||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4799999999999998888899999997753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=4.7e-05 Score=76.61 Aligned_cols=77 Identities=12% Similarity=0.078 Sum_probs=47.1
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc---H---HHHHHHHHHHHHHhcCCC--C-cceeEEeEEEcCCC
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS---A---VQVSLLLQEGMAMYGLSH--K-NILTVLGVSIEDHT 297 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~---~---~~~~~~~~E~~~l~~l~H--~-nIv~l~g~~~~~~~ 297 (499)
.+.+|.|.++.||++....++ +.++||....... . ...+++..|.++++.+.. + .+.+++.+ + ..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~---~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d-~~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHD---RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D-TE 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E-TT
T ss_pred EEECCCCceEEEEEEEECCCC---cEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c-CC
Confidence 378899999999999754322 5688997653211 0 012345678888776632 3 34466665 2 23
Q ss_pred ceEEEEEeCCCC
Q psy1789 298 SPFLIYPYQDYT 309 (499)
Q Consensus 298 ~~~lv~e~~~~g 309 (499)
..++||||+++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 358999999863
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0022 Score=57.82 Aligned_cols=140 Identities=8% Similarity=0.055 Sum_probs=91.5
Q ss_pred CCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcCCCcEEEcccccccccCCCC
Q psy1789 308 YTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386 (499)
Q Consensus 308 ~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~ 386 (499)
.-+|.+.|.... .++++++++.++.|.+.+|.-+-. ..-..+=+.|..|+|..+|.+...+ ..+.
T Consensus 32 ~vSL~eIL~~~~-------~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------ 97 (229)
T 2yle_A 32 ALSLEEILRLYN-------QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------ 97 (229)
T ss_dssp EEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred cccHHHHHHHcC-------CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------
Confidence 357999998643 689999999999999999877622 1111233457899999999988764 1110
Q ss_pred ccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHH
Q psy1789 387 YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSV 466 (499)
Q Consensus 387 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 466 (499)
.....+.|||... ...+.+.=|||+|+++|.-+-.|-+ ...+...++++.+|
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~L 149 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQL 149 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHH
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHH
Confidence 0112366888763 4557888999999999999873322 22334556667777
Q ss_pred HHHhhhc-------------------------CCCCCCCHHHHHHHHH
Q psy1789 467 MAYCWAM-------------------------NPEGRPTFPQLHSCLQ 489 (499)
Q Consensus 467 ~~~C~~~-------------------------~P~~RPt~~~v~~~L~ 489 (499)
+..|... .+..|+++++|++.-.
T Consensus 150 L~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~ 197 (229)
T 2yle_A 150 IDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA 197 (229)
T ss_dssp HHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred HHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence 7666644 3568899999987654
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00016 Score=60.12 Aligned_cols=71 Identities=13% Similarity=0.066 Sum_probs=58.3
Q ss_pred CccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeee
Q psy1789 18 GHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 93 (499)
+--++++||+||+..+++.+++..... + ...++..++.+..+|+++.+++++.++.....|.+.+|.|+.+
T Consensus 43 sG~~~~v~I~Yd~~~~~L~V~l~~~~~---~--~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~ 113 (133)
T 1qmo_E 43 NGKIATAHISYNSVSKRLSVTSYYAGS---K--PATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSS 113 (133)
T ss_dssp TTSCEEEEEEEETTTTEEEEEEECSSS---C--CEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred CCCEEEEEEEEeCCCcEEEEEEccCCC---c--cceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEee
Confidence 345899999999999998999876542 1 3556666667899999999999999977777899999999866
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.001 Score=67.40 Aligned_cols=78 Identities=17% Similarity=0.130 Sum_probs=48.0
Q ss_pred HhCCccccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCC-CCccccccccccccCC---CCCchhHHHHHHHH
Q psy1789 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE-NRPVKWLAIESLVHKT---FSTASDVWAFGVLL 424 (499)
Q Consensus 349 H~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~---~s~~~DvwS~Gvvl 424 (499)
+...++|+|+++.|||++.++ ++|.||+.+....+.- . ..... .-...|.+|+...... -....++.+....+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 345799999999999999876 9999999887543210 0 00000 0012466666553211 11235556788888
Q ss_pred HHHHc
Q psy1789 425 WELTT 429 (499)
Q Consensus 425 ~el~t 429 (499)
|+.++
T Consensus 307 ~~~y~ 311 (420)
T 2pyw_A 307 WNLFN 311 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88776
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00077 Score=62.10 Aligned_cols=72 Identities=15% Similarity=0.125 Sum_probs=59.0
Q ss_pred CccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeeec
Q psy1789 18 GHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRKK 94 (499)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 94 (499)
+--++++||+||+..+++.+.+..... ....++..++.+..+|++++++++..++.....|.+..|.|+.+.
T Consensus 44 ~g~~~~v~I~Yd~~~~~L~V~l~~~~~-----~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~ 115 (237)
T 1nls_A 44 NGKVGTAHIIYNSVDKRLSAVVSYPNA-----DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp TTCEEEEEEEEETTTTEEEEEEECTTS-----CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred CCCEEEEEEEEeCCCCEEEEEEecCCC-----CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence 345899999999999988988876532 335566666778999999999999999777789999999998763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.006 Score=58.08 Aligned_cols=78 Identities=18% Similarity=0.194 Sum_probs=52.5
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC---CcceeEEeEEEcCCCce
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH---KNILTVLGVSIEDHTSP 299 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~g~~~~~~~~~ 299 (499)
++.-.+.+|.|..+.||+.++.++ +.+.+|+...... .....|..|...|+.|.- --+.+.+++. . .
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG----~~~~vK~~~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~-~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADG----TPLFVKALPDDAP-ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D-R 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTS----CEEEEEECCTTCC-CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T-T
T ss_pred CeEEEEecCCCCCeEEEEEEECCC----CEEEEEEeCCCCc-chhhHHHHHHHHHHHHHhhCCCCcceEEecc----C-c
Confidence 445568899999999999988654 5788998654321 112357788888877642 2345566652 1 2
Q ss_pred EEEEEeCCCCC
Q psy1789 300 FLIYPYQDYTN 310 (499)
Q Consensus 300 ~lv~e~~~~gs 310 (499)
++||||++.+.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 89999988654
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0015 Score=60.46 Aligned_cols=71 Identities=14% Similarity=0.114 Sum_probs=57.8
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+.+.+.+.....+ . ...++..++.+..+|++++++++..++.. ...|.+.+|.|+.+
T Consensus 153 g~~~~v~I~Yd~~~~~L~V~l~~~~~~---~-~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~H~IlsWsF~s~ 226 (240)
T 1ioa_A 153 GEKTDVQITYDSSNNDLRVFLHFTVSQ---V-KCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSK 226 (240)
T ss_dssp SSCEEEEEEEETTTTEEEEEEEETTTC---C-EEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCcEEEEEEecCCCC---c-cceeEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEee
Confidence 458999999999999889999765433 2 45566666668899999999999999666 67899999999865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0017 Score=62.35 Aligned_cols=30 Identities=23% Similarity=0.119 Sum_probs=25.3
Q ss_pred CccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
.++|+|+.+.||+ ..++.+.+.||..+...
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 4899999999999 56677899999987644
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0013 Score=59.92 Aligned_cols=71 Identities=15% Similarity=0.116 Sum_probs=57.7
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+.+.+.+.....+. ...++..++.+..+|+++++++++.++.. ...|.+.+|.|+.+
T Consensus 130 g~~~~v~I~Yd~~~~~L~V~l~~~~~~~----~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~ 203 (223)
T 1dhk_B 130 GQNAEVRITYNSSTKVFSVSLSNPSTGK----SNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSSK 203 (223)
T ss_dssp TSCEEEEEEEETTTTEEEEEEECTTTCC----EEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCCEEEEEEecCCCCc----cceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEEEec
Confidence 4689999999999998899997665432 34555566668899999999999999766 67899999999876
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0016 Score=60.48 Aligned_cols=76 Identities=14% Similarity=0.019 Sum_probs=60.4
Q ss_pred eecCCccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEE
Q psy1789 14 TRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNF 90 (499)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~ 90 (499)
|+-.+--++++||+||+..+++.|.|..... | ....++..++.+..+|+++.++++..++.. ...|.+.+|.|
T Consensus 158 ~~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e~h~IlsWsF 233 (251)
T 3ipv_A 158 WSLANGEAAKVLITYNSAVKLLVASLVYPSS---K-TSFILADIVDLSSVLPEWVRVGFSAATGASGGKIETHDVFSWSF 233 (251)
T ss_dssp CCCCTTCEEEEEEEEETTTTEEEEEEECTTT---C-CEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEE
T ss_pred eEecCCCEEEEEEEEeCCCCEEEEEEecCCC---C-ccceEEEEechHHhCCCcEEEEEEEecCCCccccceeEEEEEEE
Confidence 5433446789999999999999999886543 3 344567666678899999999999999766 67899999999
Q ss_pred eee
Q psy1789 91 KRK 93 (499)
Q Consensus 91 ~~~ 93 (499)
+.+
T Consensus 234 ~s~ 236 (251)
T 3ipv_A 234 ASK 236 (251)
T ss_dssp EEE
T ss_pred EEE
Confidence 865
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0013 Score=60.81 Aligned_cols=71 Identities=11% Similarity=0.012 Sum_probs=57.5
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec--CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS--RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~--~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+++.+.|..... | ....++..++.+..+|++++++++..++.. ...|.+.+|.|+.+
T Consensus 166 g~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF~s~ 238 (239)
T 1dbn_A 166 GGVAFATITYLAPNKTLIASLVYPSN---Q-TTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSFTST 238 (239)
T ss_dssp TCCEEEEEEEEGGGTEEEEEEEETTT---T-EEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCcEEEEEEccCCC---C-CcceEEEEechHHhCCccEEEEEEeccCCCccceeeEEEEEEeEec
Confidence 46899999999999988999876543 2 235566566667899999999999999766 67899999999754
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0014 Score=60.54 Aligned_cols=71 Identities=11% Similarity=0.054 Sum_probs=57.4
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+++.+.|..... | ....++..++.+..+|+++++++++.++.. ...|.+.+|.|+.+
T Consensus 161 G~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~ 234 (237)
T 1fny_A 161 GEVANVFISYEASTKSLTASLVYPSL---E-TSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESN 234 (237)
T ss_dssp TCCEEEEEEEEGGGTEEEEEEEETTT---T-EEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCcEEEEEEecCCC---C-CcceEEEEechHHhCCCcEEEEEEEeeCCCCcccceeEEEEEEEEEe
Confidence 46899999999999988999876543 2 235566566667899999999999999766 67899999999765
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0022 Score=59.08 Aligned_cols=72 Identities=13% Similarity=0.064 Sum_probs=57.7
Q ss_pred CccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 18 GHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
+--++++||+|++..+.+.+.|.....+ ....++..++.+..+|+++++++++.++.. ...|.+.+|.|+.+
T Consensus 157 ~g~~~~v~I~Yd~~~~~L~V~l~~~~~~----~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~ 231 (233)
T 1n47_A 157 YGEKANIVITYQASTKALAASLVFPVSQ----TSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp TTSCEEEEEEEETTTTEEEEEEEETTTT----EEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred CCCEEEEEEEEeCCCCEEEEEEecCCCC----CcceEEEEechHHhCCCceEEEEEeccCCCccccceeEEEEEEEEee
Confidence 3568999999999999889998765433 234566566668899999999999999766 67899999999764
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0021 Score=59.89 Aligned_cols=75 Identities=13% Similarity=-0.010 Sum_probs=59.7
Q ss_pred eecCCccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeee
Q psy1789 14 TRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 93 (499)
|.-.+--.+++||+||+..+.+.|.+.... +. ...++..++.+..+|+++.++++..++.....|.+.+|.|+.+
T Consensus 171 ~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~----~~-~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~e~h~IlsWsF~s~ 245 (261)
T 3zyr_A 171 WERREGKTLNVLVTYNPSTRTIDVVATYPD----GQ-RYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLESWSFTST 245 (261)
T ss_dssp CCCCTTCCEEEEEEEETTTTEEEEEEECTT----CC-EEEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEEEEE
T ss_pred ccccCCceEEEEEEEcCCCCEEEEEEEcCC----CC-CeEEEEEechHHhCcCcEEEEEEecCCCccceEEEEEEEEEEE
Confidence 443345679999999999999899988664 22 4456666667889999999999999976667899999999765
|
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0036 Score=58.92 Aligned_cols=76 Identities=20% Similarity=0.059 Sum_probs=60.0
Q ss_pred eecCCccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEe---cCCCCCceEEEE
Q psy1789 14 TRPLGHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTL---SRNSNNVTSLNF 90 (499)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~---~~~~~~~~~~~~ 90 (499)
|+-.+--++++||+||+..+.+.|.+..... |. ...++..++.+..+|+++.++++..++. ....|.+.+|.|
T Consensus 177 ~~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~---~~-~~~lS~~vDL~~~L~e~v~VGFSAsTG~~~~~~e~H~IlsWSF 252 (281)
T 3ujo_A 177 WDFANGENAEVLITYDSSTNLLVASLVHPSQ---KT-SFIVSERVDLTSVLPEWVSVGFSATTGLSKGYVETNEVLSWSF 252 (281)
T ss_dssp CCCCSSCCEEEEEEECTTTCEEEEEEECTTT---CC-CEEEEEECCSTTTSCSEEEEEEEEEECSSTTSCCCCEEEEEEE
T ss_pred ccccCCCEEEEEEEEeCCCCEEEEEEecCCC---CC-CceEEEEechHHhccCcEEEEEEeecCCCCcccceeEEEEEEE
Confidence 4433445789999999999999999987654 22 3456766777899999999999999974 356899999999
Q ss_pred eee
Q psy1789 91 KRK 93 (499)
Q Consensus 91 ~~~ 93 (499)
+.+
T Consensus 253 ss~ 255 (281)
T 3ujo_A 253 ASK 255 (281)
T ss_dssp EEE
T ss_pred EEE
Confidence 865
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0049 Score=59.59 Aligned_cols=146 Identities=14% Similarity=0.008 Sum_probs=75.6
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc--ceeEEeEE-----EcCCCce
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN--ILTVLGVS-----IEDHTSP 299 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~g~~-----~~~~~~~ 299 (499)
.+.|+.|....+|+....++ .+++|....... ...+..|..++..++..+ +.+++... ....+..
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-----~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-----PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEECC---EEEEEEEESSC-----CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred eeccCCCcccceEEEEeCCc-----cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 46677788899999875432 477888764211 123445666665543212 23333210 0112446
Q ss_pred EEEEEeCCCCCHH-----H---------HHHhcccC-CCCC---CCCCCHHHHHHH------------HHHHHHHHHHHH
Q psy1789 300 FLIYPYQDYTNLK-----R---------FLQKCKLC-PEGV---AHTLTTQEVVDM------------CLQIIMGVQYLH 349 (499)
Q Consensus 300 ~lv~e~~~~gsL~-----~---------~l~~~~~~-~~~~---~~~l~~~~~~~i------------~~~va~~L~yLH 349 (499)
+++++|+++..+. . -+|..... .... .....|.....- ...+...+++++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999875421 1 12321110 0000 001123321110 112444556665
Q ss_pred h-------CCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 350 K-------KKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 350 ~-------~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+ .+++|+|+.+.|||++++..+.|.||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2 268999999999999987666899999765
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0012 Score=60.45 Aligned_cols=71 Identities=15% Similarity=0.077 Sum_probs=56.7
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+++.+.+.....+. ...++..++.+..+|+++++++++.++.. ...|.+.+|.|+.+
T Consensus 151 g~~~~v~I~Yd~~~~~L~V~l~~~~~~~----~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~IlsWsF~s~ 224 (226)
T 1avb_A 151 GEKAEVRITYDSPKNDLRVSLLYPSSEE----KCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224 (226)
T ss_dssp TCEEEEEEEEEGGGTEEEEEEEETTTTE----EEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred CCeEEEEEEEeCCCcEEEEEEeecCCCc----cceEEEEechHHhCCCceEEEEEeccCCCCcccceeEEEEEEEEee
Confidence 4689999999999998899997664432 34555556667899999999999999655 66899999999764
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0022 Score=59.31 Aligned_cols=71 Identities=13% Similarity=0.029 Sum_probs=57.4
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec--CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS--RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~--~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+++.+.|..... | ....++..++.+..+|++++++++..++.. ...|.+.+|.|+.+
T Consensus 165 G~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF~s~ 237 (242)
T 1qnw_A 165 GEVADVVITYRAPTKSLTVCLSYPSD---G-TSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTSN 237 (242)
T ss_dssp TCCEEEEEEEEGGGTEEEEEEECTTT---C-CEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCcEEEEEEecCCC---C-cceeEEEeechHHhcCCceEEEEEeccCCCccceEEEEEEEEeEee
Confidence 46899999999999988998876543 3 234566556667899999999999999766 67899999999865
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0027 Score=58.69 Aligned_cols=71 Identities=14% Similarity=0.076 Sum_probs=56.7
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEe---cCCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTL---SRNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~---~~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+++.+.|..... | ....++..++.+..+|+++++++++.++. ....|.+.+|.|+.+
T Consensus 163 G~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~ 236 (239)
T 1gzc_A 163 GQVANVVIKYDAPSKILHVVLVYPSS---G-AIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQAS 236 (239)
T ss_dssp TCEEEEEEEEETTTTEEEEEEECTTT---C-CEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCcEEEEEEecCCC---C-ccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEEeEEe
Confidence 46899999999999988999876543 3 23456656666789999999999999964 366899999999765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0067 Score=59.04 Aligned_cols=33 Identities=18% Similarity=0.179 Sum_probs=28.2
Q ss_pred CCccccCCCCCceEEcCC----CcEEEcccccccccC
Q psy1789 351 KKLLHKDLATRNCVVDDK----LRIQITDNALARDLF 383 (499)
Q Consensus 351 ~~iiHrDlk~~NIlld~~----~~~kl~DfGla~~~~ 383 (499)
..++|+|+.+.||+++.+ ..+.|.||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 369999999999999875 688999999887554
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0028 Score=59.03 Aligned_cols=71 Identities=17% Similarity=0.103 Sum_probs=57.2
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
--++++||+|++..+.+.+.+..... | ....++..++.+..+|+++++++++.++.. ...|.+.+|.|+.+
T Consensus 158 G~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~ 231 (252)
T 1fat_A 158 GENAEVLITYDSSTNLLVASLVYPSQ---K-TSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASK 231 (252)
T ss_dssp TCEEEEEEEEETTTTEEEEEEEETTT---T-EEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCCEEEEEEecCCC---C-CcceEEEEechHHhCCCceEEEEEeccCCCCcccceEEEEEEEEEee
Confidence 46899999999999988998876543 3 234556556667889999999999999766 67899999999865
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0022 Score=59.35 Aligned_cols=69 Identities=10% Similarity=0.005 Sum_probs=56.6
Q ss_pred cceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEE--EecCCCCCceEEEEeee
Q psy1789 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINV--TLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~--~~~~~~~~~~~~~~~~~ 93 (499)
-++++||+||+..+++.+.|..... | ....++..++.+..+|+++.+++++.+ +.. ..|.+..|.|+.+
T Consensus 166 ~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~ 236 (242)
T 1fx5_A 166 NVANVEIIYEASSKTLTASLTYPSD---Q-TSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ-ATHEVLNWYFTST 236 (242)
T ss_dssp GCEEEEEEEETTTTEEEEEEEETTT---T-EEEEEEEECCGGGTSCSEEEEEEEEEEETTSC-EEEEEEEEEEEEE
T ss_pred eeEEEEEEEeCCCCEEEEEEecCCC---C-ccceeeEEechHHhCCccEEEEEEecccCCCc-ceeEEEEEEeEee
Confidence 7899999999999988999876543 2 235566666668899999999999999 666 7889999999765
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0025 Score=59.41 Aligned_cols=71 Identities=20% Similarity=0.138 Sum_probs=57.2
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
--++++||+|++..+++.+.+..... | ....++..++.+..+|+++++++++.++.. ...|.+.+|.|+.+
T Consensus 159 g~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~ 232 (253)
T 1g7y_A 159 GQNAEILITYNAATSLLVASLVHPSR---R-TSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASK 232 (253)
T ss_dssp TSEEEEEEEEETTTTEEEEEEEETTT---T-EEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEE
T ss_pred CCeEEEEEEEeCCCCEEEEEEecCCC---C-CcceEEEEechHHhCCCceEEEEEeCcCCCCcccceeEEEEEEEEee
Confidence 46899999999999988998876543 3 234566566667889999999999999666 67899999999865
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0023 Score=59.62 Aligned_cols=71 Identities=15% Similarity=0.105 Sum_probs=57.1
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec--CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS--RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~--~~~~~~~~~~~~~~ 93 (499)
--++++||+|++..+++.+.|..... | ....++..++.+..+|+++++++++.++.. ...|.+.+|.|+.+
T Consensus 159 G~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~H~IlsWsF~s~ 231 (253)
T 1sbf_A 159 NKVAKVLITYDASTSLLVASLVYPSQ---R-TSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASN 231 (253)
T ss_dssp TCCEEEEEEEETTTTEEEEEEEETTT---T-EEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEE
T ss_pred CCeeEEEEEEeCCCcEEEEEEecCCC---C-CcceEEEEechHHhCCCceEEEEEeccCCCccceeeEEEEEEeEee
Confidence 46899999999999988998876543 3 234556566667899999999999999766 67899999999866
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0024 Score=58.84 Aligned_cols=75 Identities=11% Similarity=0.034 Sum_probs=56.7
Q ss_pred ccceEEEEEecCccccCCCccccCCcccc-cCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSI-PTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~i-P~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 93 (499)
--++++||+|++..+++.+.|.....+.. .+....++..++.+..+|+++++++++.++-....|.+.+|.|+.+
T Consensus 157 g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~ 232 (234)
T 2bqp_A 157 GEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 232 (234)
T ss_dssp TCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEEEEEEEEEee
Confidence 46899999999998888998876543310 1234556656666889999999999999976667899999999764
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0032 Score=58.25 Aligned_cols=71 Identities=13% Similarity=0.103 Sum_probs=56.8
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEE----Eec---CCCCCceEEEEe
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINV----TLS---RNSNNVTSLNFK 91 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~----~~~---~~~~~~~~~~~~ 91 (499)
--++++||+||+..+++.+.|..... | ....++..++.+..+|+++.+++++.+ +.. ...|.+.+|.|+
T Consensus 158 G~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~~~~~~h~IlsWsF~ 233 (242)
T 1wbf_A 158 GGIANVVIKYDASTKILHVVLVFPSL---G-TIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFS 233 (242)
T ss_dssp TSCEEEEEEEETTTTEEEEEEEETTT---T-EEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEEEE
T ss_pred CCEEEEEEEEeCCCCEEEEEEccCCC---C-CcceEEEEechHHhcCCceEEEEEEeecCcCCccccccceEEEEEEEeE
Confidence 45799999999999988998876543 2 234566556667889999999999999 665 678999999998
Q ss_pred ee
Q psy1789 92 RK 93 (499)
Q Consensus 92 ~~ 93 (499)
.+
T Consensus 234 s~ 235 (242)
T 1wbf_A 234 AS 235 (242)
T ss_dssp EE
T ss_pred ec
Confidence 65
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0036 Score=57.94 Aligned_cols=71 Identities=11% Similarity=0.047 Sum_probs=56.6
Q ss_pred CccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeee
Q psy1789 18 GHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 93 (499)
+.-++++||+|++..+++.+.|..... ....++..++.+..+|+++++++++.++.....|.+.+|.|+.+
T Consensus 163 ~g~~~~v~I~Yd~~~~~L~V~l~~~~~-----~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~ 233 (240)
T 2fmd_A 163 NGKTATAHISYNSASKRLSVVSSYPNS-----SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRSS 233 (240)
T ss_dssp SSCEEEEEEEEETTTTEEEEEEECTTS-----CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCCEEEEEEEEEE
T ss_pred CCCEEEEEEEEeCCCCEEEEEEecCCC-----CceEEEEEechHHhCCCceEEEEEeccCCccccEEEEEEEeEec
Confidence 346899999999998888888876543 23345555666789999999999999976667899999999765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.03 Score=54.03 Aligned_cols=75 Identities=16% Similarity=0.143 Sum_probs=54.1
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC---CCcceeEEeEEEcCCCceEEEE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS---HKNILTVLGVSIEDHTSPFLIY 303 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~g~~~~~~~~~~lv~ 303 (499)
.+.|+.|....+|+.... + ..+++|+.... ....|..|...|+.|. ...+.+.++++.. .+..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~---~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--V---QTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEESS--S---CEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEE
T ss_pred eEEeCCccceeeeEEEEC--C---CeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEE
Confidence 367888999999998642 2 46778887543 1356788888887763 3567888887643 45679999
Q ss_pred EeCCCCCH
Q psy1789 304 PYQDYTNL 311 (499)
Q Consensus 304 e~~~~gsL 311 (499)
||+++..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998653
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0022 Score=58.98 Aligned_cols=69 Identities=12% Similarity=0.088 Sum_probs=56.5
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEE--EecCCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINV--TLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~--~~~~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+++.+.|.. .. |. ...++..++.+..+|++++++++..+ +.. ..|.+.+|.|+.+
T Consensus 156 g~~~~v~I~Yd~~~~~L~V~l~~-~~---~~-~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~ 226 (234)
T 2eig_A 156 GSLEKATIIYDSDTKILTVVMTH-QN---GQ-ITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHDIYSWSFTST 226 (234)
T ss_dssp TCCEEEEEEEETTTTEEEEEEEE-TT---SC-EEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCcEEEEEEec-CC---CC-cceEeEeechHHhcCCceEEEEEeeecCCCc-ceeEEEEEEEEec
Confidence 46899999999999988999987 32 33 35566566667899999999999999 766 7889999999865
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0029 Score=58.14 Aligned_cols=69 Identities=12% Similarity=0.059 Sum_probs=55.4
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEe--cCCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTL--SRNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~--~~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+++.+.|.. .. | ....++..++.+..+|+++.++++ .++. ....|.+.+|.|+.+
T Consensus 158 G~~~~v~I~Yd~~~~~L~V~l~~-~~---~-~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~IlsWsF~s~ 228 (232)
T 1v6i_A 158 GAVVKVTVIYDSSTKTLSVAVTN-DN---G-DITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLIRSWSFTST 228 (232)
T ss_dssp TCEEEEEEEEETTTTEEEEEEEC-TT---S-CEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCcEEEEEEec-CC---C-CcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEEEEEEEEee
Confidence 46899999999999988999987 32 3 345666666667899999999999 8865 466899999999765
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0025 Score=59.03 Aligned_cols=69 Identities=10% Similarity=0.023 Sum_probs=55.9
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 93 (499)
.-++++||+|++..+++.+.|..... ....++..++.+..+|+++++++++.++ ....|.+.+|.|+.+
T Consensus 169 g~~~~v~I~Yd~~~~~L~V~l~~~~~-----~~~~ls~~vdL~~~l~~~~~vGFSAsTG-~~~~h~IlsWsF~s~ 237 (243)
T 1gsl_A 169 SSIATAHITYDARSKILTVLLSYEHG-----RDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHFFST 237 (243)
T ss_dssp CCEEEEEEEEETTTTEEEEEEEETTS-----CEEEEEEECCHHHHSCSEEEEEEEEEEC-BSEEEEEEEEEEEEE
T ss_pred CcEEEEEEEEeCCCCEEEEEEecCCC-----CceeEEEEechHHhCCCceEEEEEeccC-CcceeEEEEEEEEee
Confidence 46899999999999988888876543 2244555556678899999999999999 777899999999765
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.003 Score=58.97 Aligned_cols=70 Identities=13% Similarity=0.015 Sum_probs=56.5
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEE-ecCCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVT-LSRNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~-~~~~~~~~~~~~~~~~ 93 (499)
.-++++||+|++..+++.+.|..... ....++..++.+..+|+++++++++.++ .....|.+.+|.|+.+
T Consensus 168 g~~~~v~I~Yd~~~~~L~V~l~~~~~-----~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~~~H~IlsWsF~s~ 238 (257)
T 1hql_A 168 GKIATARISYDGSAEILTVVLSYPDG-----SDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSN 238 (257)
T ss_dssp CSCEEEEEEEETTTTEEEEEEEETTT-----EEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEEE
T ss_pred CceEEEEEEEeCCCCEEEEEEecCCC-----CceeeEEeechHHhcCCceEEEEEeccCCCccceeEEEEEEeEec
Confidence 46899999999999988888876533 2345555566678999999999999998 6667899999999876
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.004 Score=57.50 Aligned_cols=71 Identities=14% Similarity=0.123 Sum_probs=56.5
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCc--eEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNA--EVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~--~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
--++++||+||+..+++.+.+..... | ....++..++.+..+|+ ++.+++++.++.. ...|.+.+|.|+.+
T Consensus 158 g~~~~v~I~Yd~~~~~L~V~l~~~~~---~-~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~ 233 (238)
T 1f9k_A 158 GGVANVVIKYDSPTKILNVVLAFHSV---G-TVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTSS 233 (238)
T ss_dssp TCCEEEEEEEETTTTEEEEEEEETTT---T-EEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCCEEEEEEecCCC---C-CceeEEEEechHHhCCCCceEEEEEEeCcCCCCcccceEEEEEeEeEee
Confidence 45799999999999988998876543 2 23455555666788999 9999999999666 67899999999765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.11 E-value=0.031 Score=56.48 Aligned_cols=73 Identities=16% Similarity=0.144 Sum_probs=45.9
Q ss_pred eeeeeecceEEEEEEEeCCC----ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcc-eeEEeEEEcCCCceEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEED----GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI-LTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~~lv 302 (499)
+.|+.|....+|+....+.. +....+++|+...... ...+..|..++..+...++ .++++.+ .+ .+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~-~~----g~v 150 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIF-SG----GRL 150 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEE-TT----EEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEe-CC----CEE
Confidence 66777888999999875311 0125688888744222 1234478888777643334 5677753 32 489
Q ss_pred EEeCCC
Q psy1789 303 YPYQDY 308 (499)
Q Consensus 303 ~e~~~~ 308 (499)
+||+++
T Consensus 151 ~e~l~G 156 (429)
T 1nw1_A 151 EEYIPS 156 (429)
T ss_dssp ECCCCE
T ss_pred EEEeCC
Confidence 999985
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.013 Score=58.24 Aligned_cols=144 Identities=15% Similarity=0.073 Sum_probs=79.6
Q ss_pred eeeeeecceEEEEEEEeCC----CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEE----DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv 302 (499)
+.+..|-...+|+....++ ++....+++|+..... .....+.+|..+++.+. +.--.++++++ .+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVF-PE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-TT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEc-CC----ccE
Confidence 5565688889999876421 1112568888863321 11244567888877664 22235677763 32 389
Q ss_pred EEeCCCCCHH--------------HH---HHhcccCCCCCCCCC--CHHHHHHHHHHHHH-------------------H
Q psy1789 303 YPYQDYTNLK--------------RF---LQKCKLCPEGVAHTL--TTQEVVDMCLQIIM-------------------G 344 (499)
Q Consensus 303 ~e~~~~gsL~--------------~~---l~~~~~~~~~~~~~l--~~~~~~~i~~~va~-------------------~ 344 (499)
+||+++..|. +. ||... ....... -|.++.++..++.. .
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~---~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGME---MPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCC---CSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCC---CCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 9999864432 11 12211 1111112 24555555544422 2
Q ss_pred HHHHH----hC----CccccCCCCCceEEcCC----CcEEEcccccccc
Q psy1789 345 VQYLH----KK----KLLHKDLATRNCVVDDK----LRIQITDNALARD 381 (499)
Q Consensus 345 L~yLH----~~----~iiHrDlk~~NIlld~~----~~~kl~DfGla~~ 381 (499)
+..|. .. .++|+|+.+.||+++.+ +.+.+.||..|..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33333 21 48999999999999876 7899999997753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.97 E-value=0.027 Score=54.45 Aligned_cols=29 Identities=24% Similarity=0.087 Sum_probs=25.1
Q ss_pred CccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
.++|+|+++.|||++ + .+.|.||+.+...
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 589999999999999 4 8999999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.80 E-value=0.045 Score=53.94 Aligned_cols=75 Identities=12% Similarity=0.075 Sum_probs=40.6
Q ss_pred eeeeeecceEEEEEEEeCCC-----ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc-ceeEEeEEEcCCCceEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEED-----GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN-ILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~~l 301 (499)
..++.|....+|+....+++ .....+++|+....... ......|..+++.+...+ ..++++. .. -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~-~~----~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNT-FN----GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEE-ET----TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEe-cC----CcE
Confidence 56677888999998764310 00136778876543211 111246777776664333 3466664 22 278
Q ss_pred EEEeCCCC
Q psy1789 302 IYPYQDYT 309 (499)
Q Consensus 302 v~e~~~~g 309 (499)
|+||+++.
T Consensus 112 v~e~i~G~ 119 (369)
T 3c5i_A 112 IEEWLYGD 119 (369)
T ss_dssp EEECCCSE
T ss_pred EEEEecCC
Confidence 99999864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=94.53 E-value=0.22 Score=50.60 Aligned_cols=73 Identities=12% Similarity=0.009 Sum_probs=43.6
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcc-eeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI-LTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.|+.|-...+|+....+.. ..+++|+....... .. ...+|..++..+...++ .++++.+ . + .+|+||+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~---~~~vLRi~g~~~~~-~i-dR~~E~~vl~~L~~~gl~P~ll~~~-~-~---G~v~e~I 183 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQ---AKYLIRLYGPKTDE-II-NREREKKISCILYNKNIAKKIYVFF-T-N---GRIEEFM 183 (458)
T ss_dssp EEECC--CEEEEEEEETTTT---EEEEEEEECC-CCS-CS-CHHHHHHHHHHHTTSSSBCCEEEEE-T-T---EEEEECC
T ss_pred EEcCCCeEeEEEEEEECCCC---ceEEEEECCCChhh-hc-CHHHHHHHHHHHHhcCCCCCEEEEe-C-C---eEEEEee
Confidence 56777888999998865422 46778876432110 00 11478888887765555 5677763 2 2 4699999
Q ss_pred CCCC
Q psy1789 307 DYTN 310 (499)
Q Consensus 307 ~~gs 310 (499)
++.+
T Consensus 184 ~G~~ 187 (458)
T 2qg7_A 184 DGYA 187 (458)
T ss_dssp CSEE
T ss_pred CCcc
Confidence 8633
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.23 E-value=0.078 Score=34.30 Aligned_cols=28 Identities=32% Similarity=0.394 Sum_probs=12.0
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhhhhccc
Q psy1789 123 ILAICAACVLITVVVIYSCACFVRNKKL 150 (499)
Q Consensus 123 ii~i~~~~~~~~~~~~~~~~~~~~~~~~ 150 (499)
+++.+++.++++++++++++++.|+|+.
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 3444444444444444444444444433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.74 E-value=0.12 Score=32.39 Aligned_cols=30 Identities=17% Similarity=0.036 Sum_probs=16.8
Q ss_pred ccchhHHHHHHHHHHHHHHHHHHHHhhhhh
Q psy1789 117 RLHLYNILAICAACVLITVVVIYSCACFVR 146 (499)
Q Consensus 117 ~~~~~~ii~i~~~~~~~~~~~~~~~~~~~~ 146 (499)
..+-..+.++++++++.+++++++.++++|
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHee
Confidence 344566677777766655555444444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.50 E-value=0.067 Score=34.72 Aligned_cols=26 Identities=19% Similarity=0.327 Sum_probs=10.2
Q ss_pred HHHHHHHHHHHHHHHHHHhhhhhhcc
Q psy1789 124 LAICAACVLITVVVIYSCACFVRNKK 149 (499)
Q Consensus 124 i~i~~~~~~~~~~~~~~~~~~~~~~~ 149 (499)
++.+++.++++++++++++++.|+|+
T Consensus 14 A~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 14 ATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 33333333333333344444444443
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.39 E-value=0.14 Score=33.11 Aligned_cols=28 Identities=14% Similarity=0.352 Sum_probs=12.1
Q ss_pred hHHHHHHHHHHHHHHHHHHHHhhhhhhcc
Q psy1789 121 YNILAICAACVLITVVVIYSCACFVRNKK 149 (499)
Q Consensus 121 ~~ii~i~~~~~~~~~~~~~~~~~~~~~~~ 149 (499)
..+++.+++ +++++++.+++++|.|||+
T Consensus 12 ~~Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 12 TSIISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred cchHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 334555555 3333333333344444433
|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.49 E-value=0.12 Score=49.98 Aligned_cols=60 Identities=22% Similarity=0.551 Sum_probs=51.0
Q ss_pred cccceeEEeecCCccce---EEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccC
Q psy1789 6 CSDNLEFGTRPLGHLPY---SISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMN 65 (499)
Q Consensus 6 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip 65 (499)
-++++.|+|.+.++.+| .+.++..+...+..+++++...|.+|.....+.+.++|+|.-.
T Consensus 52 ~~~~~~~tW~~~~~~~~~~~~~~l~s~d~~il~~ptlsi~~~g~v~~~~~~~~v~~pC~~~~~ 114 (324)
T 2ygq_A 52 NIHSMNFTWQAAGQAEYFYEFLSLRSLDKGIMADPTVNVPLLGTVPHKASVVQVGFPCLGKQD 114 (324)
T ss_dssp TCCEEEEEEEECSSSCCEEEEEECCBSCTTTBCCCEESSCSEEECCSSCEEEEEECCBCSSSC
T ss_pred ccceeEEEEcccCCcccceEEEEeeccCCcccCCCceEEEEeccccCCCcceeEecccCCCcc
Confidence 46789999999888777 7777777788888899999999999999999999999977543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=88.80 E-value=1 Score=45.11 Aligned_cols=76 Identities=12% Similarity=-0.029 Sum_probs=43.4
Q ss_pred eeeeeecceEEEEEEEeCCCce----eEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCc-ceeEEeEEEcCCCceEEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGV----EEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKN-ILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~g~~~~~~~~~~lv 302 (499)
+.+..|-...+|+....+..+. ...+++++.... .... -...+|..+++.+.-.+ ..++++.+ . -++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~-~----~~~I 148 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKF-YDSKVELDVFRYLSNINIAPNIIADF-P----EGRI 148 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE-T----TEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchh-cCHHHHHHHHHHHHhcCCCCCEEEEc-C----CCEE
Confidence 5565688889999887532111 256888886442 1111 11246666666653222 34566542 2 2789
Q ss_pred EEeCCCCC
Q psy1789 303 YPYQDYTN 310 (499)
Q Consensus 303 ~e~~~~gs 310 (499)
+||+++..
T Consensus 149 ~efI~G~~ 156 (424)
T 3mes_A 149 EEFIDGEP 156 (424)
T ss_dssp EECCCSEE
T ss_pred EEEeCCcc
Confidence 99999754
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=86.73 E-value=0.55 Score=31.73 Aligned_cols=41 Identities=17% Similarity=0.105 Sum_probs=34.0
Q ss_pred EEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeee
Q psy1789 53 TFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 53 ~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 93 (499)
.++..++.+..+|+++.++++..++.....|.+..|.|+.+
T Consensus 5 ~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~ 45 (52)
T 2ltn_B 5 TLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE 45 (52)
T ss_dssp EEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEE
T ss_pred eEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEee
Confidence 45555666889999999999999976767899999999765
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.47 E-value=0.044 Score=55.92 Aligned_cols=59 Identities=8% Similarity=0.039 Sum_probs=15.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEE------EEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEE
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLV------KTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVS 292 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vav------K~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~ 292 (499)
+.+| ||.||+|.+.... .+||| |+.... .+......|.+|..+++.++|+|+++.+++.
T Consensus 148 ~~lG---fG~v~~g~~~~~~---~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 148 EHVG---YTTLNREPAYKKH---MPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp TTSS---BCCC------------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccCC---chhhhcccccccC---CchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 5555 9999999986532 35777 665532 2333445788899999999999999998874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=83.78 E-value=0.74 Score=44.59 Aligned_cols=32 Identities=25% Similarity=0.169 Sum_probs=28.1
Q ss_pred CccccCCCCCceEEcCCCcEEEcccccccccC
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLF 383 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~ 383 (499)
.++|+|+.+.||++++++.+.|.||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 58999999999999988889999998876543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.60 E-value=4.1 Score=36.53 Aligned_cols=85 Identities=8% Similarity=0.035 Sum_probs=56.8
Q ss_pred CCCcceeEEeEEEcCCCceEEEEEeCCC-CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCC
Q psy1789 281 SHKNILTVLGVSIEDHTSPFLIYPYQDY-TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ-YLHKKKLLHKDL 358 (499)
Q Consensus 281 ~H~nIv~l~g~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~-yLH~~~iiHrDl 358 (499)
.||.+..-+ ...++...+.|+.-++ -++. .++ .++...+++++.+++.... +++ .-+|--|
T Consensus 48 ~~~~f~~~I---~~~eD~~~i~y~~~~~~~~f~-~i~-----------~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l 110 (219)
T 4ano_A 48 VDPCIVRDI---DVSEDEVKVVIKPPSSFLTFA-AIR-----------KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIV 110 (219)
T ss_dssp SCSSSEEEE---EECSSEEEEEEECCTTCEEHH-HHH-----------TSCHHHHHHHHHHHHHHHSSCCS--SSEECCC
T ss_pred cCCCCCeEE---EEeCCEEEEEEEcCcccCcHH-HHH-----------hcCHHHHHHHHHHHHHHHHHhhh--CceeEEE
Confidence 578872222 2344555555655433 3333 333 3788899999998887666 554 3466668
Q ss_pred CCCceEEcCCCcEEEccccccccc
Q psy1789 359 ATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 359 k~~NIlld~~~~~kl~DfGla~~~ 382 (499)
.|+||++|.++.+++.-.|+-..+
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp CGGGEEECTTCCEEESCCEETTTB
T ss_pred eCceEEEeCCCcEEEEEcCCcccC
Confidence 899999999999999988865433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 499 | ||||
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-49 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-38 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-33 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-09 |
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 4e-59
Identities = 101/297 (34%), Positives = 163/297 (54%), Gaps = 11/297 (3%)
Query: 203 LDDRNKDLHEKLSELTIQRCRVRLFSVNM--EGTFGRVYRGTYTEEDGVEEEVLVKTVTD 260
L N +L + + + I + + + G FG VY GT + DG + VK++
Sbjct: 6 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65
Query: 261 NASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKL 320
+VS L EG+ M SH N+L++LG+ + SP ++ PY + +L+ F++
Sbjct: 66 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET- 124
Query: 321 CPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380
H T ++++ LQ+ G+++L KK +H+DLA RNC++D+K +++ D LAR
Sbjct: 125 ------HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 381 DLFPSDYHCLGDNENR--PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEI 438
D++ ++ + + PVKW+A+ESL + F+T SDVW+FGVLLWEL T PY ++
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 439 DPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
+ F++ L G RL QP CPD L+ VM CW E RP+F +L S + +
Sbjct: 239 NTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-54
Identities = 76/259 (29%), Positives = 127/259 (49%), Gaps = 19/259 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG V G Y +V VK + ++A+A L E M L H N++ +LGV
Sbjct: 17 KGEFGDVMLGDYRGN-----KVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGV 68
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+E+ +++ Y +L +L+ L ++ L + ++YL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+H+DLA RN +V + +++D L ++ + PVKW A E+L K F
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKF 177
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
ST SDVW+FG+LLWE+ + + PY I ++ ++ GY+++ P CP ++ VM CW
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 237
Query: 472 AMNPEGRPTFPQLHSCLQE 490
++ RP+F QL L+
Sbjct: 238 HLDAAMRPSFLQLREQLEH 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-54
Identities = 88/283 (31%), Positives = 142/283 (50%), Gaps = 23/283 (8%)
Query: 232 EGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTV 288
G FG+V T + GV +V VK + + A + + L+ E M L SH+NI+ +
Sbjct: 47 SGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL 106
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK---------------LCPEGVAHTLTTQE 333
LG +LI+ Y Y +L +L+ + L E + LT ++
Sbjct: 107 LGA-CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 165
Query: 334 VVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDN 393
++ Q+ G+++L K +H+DLA RN +V ++I D LARD+ + + N
Sbjct: 166 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 225
Query: 394 ENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGYR 452
PVKW+A ESL ++ SDVW++G+LLWE+ +L PY I +Q+G++
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 285
Query: 453 LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
++QP +E++ +M CWA + RP+FP L S L QL
Sbjct: 286 MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG---CQL 325
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-53
Identities = 83/261 (31%), Positives = 135/261 (51%), Gaps = 15/261 (5%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ G Y +V VK++ ++ L E M L H+ ++ + V
Sbjct: 23 AGQFGEVWMGYYNGH----TKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
++ ++I Y + +L FL+ LT +++DM QI G+ ++ ++
Sbjct: 77 VTQEP--IYIITEYMENGSLVDFLKTPSGIK------LTINKLLDMAAQIAEGMAFIEER 128
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+H+DL N +V D L +I D LAR L + + + P+KW A E++ + TF
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
+ SDVW+FG+LL E+ T + PY + E+ +L+ GYR+ +P NCP+EL+ +M CW
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 472 AMNPEGRPTFPQLHSCLQEFH 492
PE RPTF L S L++F
Sbjct: 248 KERPEDRPTFDYLRSVLEDFF 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-53
Identities = 73/284 (25%), Positives = 140/284 (49%), Gaps = 12/284 (4%)
Query: 216 ELTIQRCRVRLFSVNM-EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEG 274
+L ++R + + + + G FG V +G Y + +V +K + +++E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-QIDVAIKVLKQGTEKADTEEMMREA 60
Query: 275 MAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEV 334
M+ L + I+ ++GV + L+ L +FL + + V
Sbjct: 61 QIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKR-------EEIPVSNV 111
Query: 335 VDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNE 394
++ Q+ MG++YL +K +H+DLA RN ++ ++ +I+D L++ L D + +
Sbjct: 112 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171
Query: 395 NR-PVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL 453
+ P+KW A E + + FS+ SDVW++GV +WE + Q+PY ++ E+ A ++ G R+
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231
Query: 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497
P CP EL+++M+ CW E RP F + ++ + L
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 6e-53
Identities = 87/280 (31%), Positives = 142/280 (50%), Gaps = 14/280 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
IQR R+ L EG FG V++G Y + V +KT + S LQE + M
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
H +I+ ++GV E+ ++I L+ FLQ K ++L ++
Sbjct: 64 QFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRK-------YSLDLASLILYA 114
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
Q+ + YL K+ +H+D+A RN +V +++ D L+R + S Y+ + P+
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK-LPI 173
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW+A ES+ + F++ASDVW FGV +WE+ +P+ + ++ +++G RL P N
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 233
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQ----LHSCLQEFHAQ 494
CP L+S+M CWA +P RP F + L + L+E AQ
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 7e-53
Identities = 92/299 (30%), Positives = 149/299 (49%), Gaps = 19/299 (6%)
Query: 210 LHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVE--EEVLVKTVTDNASAVQV 267
L+ KL L R + EG FGRV++ E V VK + + ASA
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 268 SLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK-------- 319
+ +E M + NI+ +LGV L++ Y Y +L FL+
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 320 --------LCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371
L+ E + + Q+ G+ YL ++K +H+DLATRNC+V + + +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179
Query: 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLA 431
+I D L+R+++ +DY+ N+ P++W+ ES+ + ++T SDVWA+GV+LWE+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 432 QQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
QPY + E+ ++DG L P NCP EL+++M CW+ P RP+F +H LQ
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 4e-52
Identities = 75/262 (28%), Positives = 132/262 (50%), Gaps = 13/262 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G FG V +G Y + V + V VK + + A LL E M L + I+ ++G
Sbjct: 17 SGNFGTVKKGYY-QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 75
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+ + L+ + L ++LQ+ + + + ++++ Q+ MG++YL +
Sbjct: 76 ICEAES--WMLVMEMAELGPLNKYLQQNR--------HVKDKNIIELVHQVSMGMKYLEE 125
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR-PVKWLAIESLVHK 409
+H+DLA RN ++ + +I+D L++ L + + + PVKW A E + +
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
FS+ SDVW+FGVL+WE + Q+PY + E+ A L+ G R+ P CP E++ +M
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245
Query: 470 CWAMNPEGRPTFPQLHSCLQEF 491
CW + E RP F + L+ +
Sbjct: 246 CWTYDVENRPGFAAVELRLRNY 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-51
Identities = 78/268 (29%), Positives = 138/268 (51%), Gaps = 10/268 (3%)
Query: 232 EGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G FG VY+G + E V+ V +K + + S +L E M + + ++ +LG
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 78
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+ + LI + L ++++ K +Q +++ C+QI G+ YL
Sbjct: 79 ICLTST--VQLITQLMPFGCLLDYVREHKDNI-------GSQYLLNWCVQIAKGMNYLED 129
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
++L+H+DLA RN +V ++ITD LA+ L + + P+KW+A+ES++H+
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYC 470
++ SDVW++GV +WEL T +PY I E+++ L+ G RL QP C +++ +M C
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 471 WAMNPEGRPTFPQLHSCLQEFHAQLTRY 498
W ++ + RP F +L + RY
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRY 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 8e-51
Identities = 82/273 (30%), Positives = 133/273 (48%), Gaps = 15/273 (5%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMY 278
I R +RL +G FG V+ GT+ V +KT+ + LQE M
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTT----RVAIKTL--KPGTMSPEAFLQEAQVMK 67
Query: 279 GLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMC 338
L H+ ++ + V E+ +++ Y +L FL+ + ++VDM
Sbjct: 68 KLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRL------PQLVDMA 119
Query: 339 LQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPV 398
QI G+ Y+ + +H+DL N +V + L ++ D LAR + ++Y P+
Sbjct: 120 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPI 178
Query: 399 KWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458
KW A E+ ++ F+ SDVW+FG+LL ELTT + PY + E+ ++ GYR+ P
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
CP+ L +M CW PE RPTF L + L+++
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-50
Identities = 96/285 (33%), Positives = 150/285 (52%), Gaps = 14/285 (4%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEED----GVEEEVLVKTVTDNASAVQVSLLLQEG 274
+ R R+ L EG FG+V D +V VK + +A+ +S L+ E
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69
Query: 275 MAMYGLS-HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAH------ 327
M + HKNI+ +LG +D ++I Y NL+ +LQ + ++
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 328 --TLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385
L+++++V Q+ G++YL KK +H+DLA RN +V + ++I D LARD+
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 386 DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA 445
DY+ N PVKW+A E+L + ++ SDVW+FGVLLWE+ TL PY + E+
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 446 SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
L++G+R+++P NC +EL+ +M CW P RPTF QL L
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 1e-49
Identities = 77/289 (26%), Positives = 139/289 (48%), Gaps = 13/289 (4%)
Query: 208 KDLHEKLSELT--IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAV 265
+D +E + E I V++ V G FG V G E V +KT+ +
Sbjct: 10 EDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK 69
Query: 266 QVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGV 325
Q L E M H N++ + GV + T +I + + +L FL++
Sbjct: 70 QRRDFLSEASIMGQFDHPNVIHLEGV-VTKSTPVMIITEFMENGSLDSFLRQND------ 122
Query: 326 AHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS 385
T ++V M I G++YL +H+DLA RN +V+ L +++D L+R L
Sbjct: 123 -GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 386 ---DYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442
+ P++W A E++ ++ F++ASDVW++G+++WE+ + ++PY ++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 443 MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
+ +++ YRL P++CP L +M CW + RP F Q+ + L +
Sbjct: 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-49
Identities = 89/277 (32%), Positives = 141/277 (50%), Gaps = 14/277 (5%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLG 290
EG FG+V + ++DG+ + +K + + AS E + L H NI+ +LG
Sbjct: 20 EGNFGQVLKARI-KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 78
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKL--------CPEGVAHTLTTQEVVDMCLQII 342
E +L Y + NL FL+K ++ A TL++Q+++ +
Sbjct: 79 A-CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 137
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLA 402
G+ YL +K+ +H+DLA RN +V + +I D L+R +G PV+W+A
Sbjct: 138 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG---RLPVRWMA 194
Query: 403 IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462
IESL + ++T SDVW++GVLLWE+ +L PY + E+ L GYRL +P+NC DE
Sbjct: 195 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 254
Query: 463 LFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRYV 499
++ +M CW P RP+F Q+ L + YV
Sbjct: 255 VYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-49
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 25/286 (8%)
Query: 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAM 277
I ++ + G+FG VY+G + + V VK + + Q+ E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 278 YGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDM 337
H NIL +G S ++ + + ++L L + +++D+
Sbjct: 59 RKTRHVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHIIE-------TKFEMIKLIDI 109
Query: 338 CLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRP 397
Q G+ YLH K ++H+DL + N + + L ++I D LA + +
Sbjct: 110 ARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 398 VKWLAIESLVHKT---FSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGYRL 453
+ W+A E + + +S SDV+AFG++L+EL T Q PY+ I+ + + + GY
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIFMVGRGYLS 228
Query: 454 ----NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495
NCP + +MA C + RP FPQ+ + ++ L
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 6e-49
Identities = 76/259 (29%), Positives = 133/259 (51%), Gaps = 15/259 (5%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V G + + +V +K + ++ ++E M LSH+ ++ + GV
Sbjct: 14 TGQFGVVKYGKWRGQ----YDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
F+I Y L +L++ + H TQ++++MC + ++YL K
Sbjct: 68 -CTKQRPIFIITEYMANGCLLNYLREMR-------HRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+ LH+DLA RNC+V+D+ ++++D L+R + +Y PV+W E L++ F
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKF 178
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
S+ SD+WAFGVL+WE+ +L + PY E A + G RL +P ++++++M CW
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 472 AMNPEGRPTFPQLHSCLQE 490
+ RPTF L S + +
Sbjct: 239 HEKADERPTFKILLSNILD 257
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-48
Identities = 80/263 (30%), Positives = 134/263 (50%), Gaps = 13/263 (4%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G+FG V RG + G V VK + + + + ++E AM+ L H+N++ +
Sbjct: 18 DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 77
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
GV + ++ +L L+K + + +Q+ G+ YL
Sbjct: 78 GVVLTPP--MKMVTELAPLGSLLDRLRKHQ-------GHFLLGTLSRYAVQVAEGMGYLE 128
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS-DYHCLGDNENRPVKWLAIESLVH 408
K+ +H+DLA RN ++ + ++I D L R L + D++ + ++ P W A ESL
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDGYRLNQPVNCPDELFSVM 467
+TFS ASD W FGV LWE+ T Q+P+ ++ + + ++G RL +P +CP ++++VM
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 248
Query: 468 AYCWAMNPEGRPTFPQLHSCLQE 490
CWA PE RPTF L L E
Sbjct: 249 VQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-48
Identities = 79/262 (30%), Positives = 134/262 (51%), Gaps = 10/262 (3%)
Query: 232 EGTFGRVYRGTYTEEDGVEE-EVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G FG VY+G G +E V +KT+ + Q L E M SH NI+ + G
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 76
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V I + +I Y + L +FL++ + ++V M I G++YL
Sbjct: 77 V-ISKYKPMMIITEYMENGALDKFLREKD-------GEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR-PVKWLAIESLVHK 409
+H+DLA RN +V+ L +++D L+R L + + P++W A E++ ++
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
F++ASDVW+FG+++WE+ T ++PY E+ E+ ++ DG+RL P++CP ++ +M
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQ 248
Query: 470 CWAMNPEGRPTFPQLHSCLQEF 491
CW RP F + S L +
Sbjct: 249 CWQQERARRPKFADIVSILDKL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-47
Identities = 91/279 (32%), Positives = 153/279 (54%), Gaps = 5/279 (1%)
Query: 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQE 273
E + R ++ + +G+FG VY G +D E V +KTV + AS + L E
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 274 GMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCK--LCPEGVAHTLTT 331
M + +++ +LGV + +I +LK +L+ + + V +
Sbjct: 74 ASVMKEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 332 QEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLG 391
+++ M +I G+ YL+ K +H+DLA RNC+V + ++I D + RD++ +DY+ G
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 392 DNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451
PV+W++ ESL F+T SDVW+FGV+LWE+ TLA+QPY + ++ + +G
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252
Query: 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
L++P NCPD LF +M CW NP+ RP+F ++ S ++E
Sbjct: 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-47
Identities = 71/259 (27%), Positives = 126/259 (48%), Gaps = 15/259 (5%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+ G + + ++V +KT+ A+ ++E M LSH ++ + GV
Sbjct: 15 SGQFGLVHLGYWLNK----DKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ L++ + ++ L +L+ + + ++ MCL + G+ YL +
Sbjct: 69 -CLEQAPICLVFEFMEHGCLSDYLRTQR-------GLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
++H+DLA RNC+V + I+++D + R + Y PVKW + E +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRY 179
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCW 471
S+ SDVW+FGVL+WE+ + + PY E+ + G+RL +P ++ +M +CW
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 472 AMNPEGRPTFPQLHSCLQE 490
PE RP F +L L E
Sbjct: 240 KERPEDRPAFSRLLRQLAE 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 2e-46
Identities = 84/276 (30%), Positives = 138/276 (50%), Gaps = 13/276 (4%)
Query: 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGM 275
+ ++R + + G +G VY G + + V VKT+ ++V L+E
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTL--KEDTMEVEEFLKEAA 65
Query: 276 AMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVV 335
M + H N++ +LGV ++I + Y NL +L++C ++ ++
Sbjct: 66 VMKEIKHPNLVQLLGV-CTREPPFYIITEFMTYGNLLDYLRECN------RQEVSAVVLL 118
Query: 336 DMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNEN 395
M QI ++YL KK +H+DLA RNC+V + +++ D L+R + Y +
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 396 RPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455
KW A ESL + FS SDVWAFGVLLWE+ T PY ID ++ L+ YR+ +
Sbjct: 179 PI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237
Query: 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
P CP++++ +M CW NP RP+F ++H +
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 4e-46
Identities = 78/296 (26%), Positives = 135/296 (45%), Gaps = 15/296 (5%)
Query: 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQ 272
+ R R+ G FG+V T + V VK + +A + L+
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 273 EGMAMYGLS-HKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLC---------- 321
E + L H NI+ +LG +I Y Y +L FL++ +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGA-CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 322 PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381
E L ++++ Q+ G+ +L K +H+DLA RN ++ +I D LARD
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441
+ + + N PVKW+A ES+ + ++ SDVW++G+ LWEL +L PY +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 442 EMAAS-LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496
+++G+R+ P + P E++ +M CW +P RPTF Q+ +++ ++ T
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-43
Identities = 75/289 (25%), Positives = 133/289 (46%), Gaps = 12/289 (4%)
Query: 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTY--TEEDGVEEEVLVKTVTDNASAVQVSLLLQ 272
S+ R R++L G FG+V ++ V VK + + A+ + L+
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 273 EGMAMYGLSHKNILTVL-GVSIEDHTSPFLIYPYQDYTNLKRFLQKCK--------LCPE 323
E + + H + L G + +I + + NL +L+ + +
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 324 GVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLF 383
LT + ++ Q+ G+++L +K +H+DLA RN ++ +K ++I D LARD++
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 384 PSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM 443
+ + P+KW+A E++ + ++ SDVW+FGVLLWE+ +L PY + E
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 444 AAS-LQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
L++G R+ P E++ M CW P RPTF +L L
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-42
Identities = 48/258 (18%), Positives = 100/258 (38%), Gaps = 18/258 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG+VY+ E K + D S ++ + E + H NI+ +L
Sbjct: 22 DGAFGKVYKAQNKETS---VLAAAKVI-DTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ +++ + + + + + LT ++ +C Q + + YLH
Sbjct: 78 -FYYENNLWILIEFCAGGAVDAVMLELE-------RPLTESQIQVVCKQTLDALNYLHDN 129
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH---CLGDNENRPVKWLAIESLVH 408
K++H+DL N + I++ D ++ + +G + + E+
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--YRLNQPVNCPDELFSV 466
+ + +DVW+ G+ L E+ + + P+ E++P + + L QP
Sbjct: 190 RPYDYKADVWSLGITLIEMAEI-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 467 MAYCWAMNPEGRPTFPQL 484
+ C N + R T QL
Sbjct: 249 LKKCLEKNVDARWTTSQL 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-42
Identities = 52/260 (20%), Positives = 113/260 (43%), Gaps = 17/260 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G++GR + + + ++ K + + + + +L+ E + L H NI+
Sbjct: 14 TGSYGRCQKIRRKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 291 VSI-EDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
I +T+ +++ Y + +L + K + L + V+ + Q+ + ++ H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ----YLDEEFVLRVMTQLTLALKECH 126
Query: 350 KK-----KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIE 404
++ +LH+DL N +D K +++ D LAR + D P +++ E
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTP-YYMSPE 184
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELF 464
+ +++ SD+W+ G LL+EL L P+ E+A +++G P DEL
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCAL-MPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243
Query: 465 SVMAYCWAMNPEGRPTFPQL 484
++ + RP+ ++
Sbjct: 244 EIITRMLNLKDYHRPSVEEI 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (360), Expect = 3e-39
Identities = 49/259 (18%), Positives = 96/259 (37%), Gaps = 25/259 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
G+FG VY E V +K + + S + +++E + L H N +
Sbjct: 25 HGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
G + +HT +L+ Y + K L E+ + + G+ YLH
Sbjct: 82 GCYLREHT-AWLVMEYCLGSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLH 132
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV-- 407
++H+D+ N ++ + +++ D A + P++ W+A E ++
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAM 186
Query: 408 -HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-LQDGYRLNQPVNCPDELFS 465
+ DVW+ G+ EL + P ++ Q+ Q + + +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245
Query: 466 VMAYCWAMNPEGRPTFPQL 484
+ C P+ RPT L
Sbjct: 246 FVDSCLQKIPQDRPTSEVL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 7e-39
Identities = 51/255 (20%), Positives = 89/255 (34%), Gaps = 20/255 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+G FG VY + + +K + A L +E L H NIL +
Sbjct: 16 KGKFGNVYLAREKQSK---FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
G D T +LI Y + R LQK E Q ++ + Y H
Sbjct: 73 GY-FHDATRVYLILEYAPLGTVYRELQKLSKFDE--------QRTATYITELANALSYCH 123
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409
K+++H+D+ N ++ ++I D + S L + +L E + +
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMIEGR 179
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
D+W+ GVL +E + P+ E + P + +++
Sbjct: 180 MHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRV-EFTFPDFVTEGARDLISR 237
Query: 470 CWAMNPEGRPTFPQL 484
NP RP ++
Sbjct: 238 LLKHNPSQRPMLREV 252
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-38
Identities = 42/255 (16%), Positives = 95/255 (37%), Gaps = 19/255 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G G VY +EV ++ + + + L++ E + M + NI+ L
Sbjct: 30 QGASGTVYTAMDVATG---QEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+++ Y +L + + E ++ +C + + +++LH
Sbjct: 86 -YLVGDELWVVMEYLAGGSLTDVVTETC-MDE--------GQIAAVCRECLQALEFLHSN 135
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+++H+D+ + N ++ +++TD + P W+A E + K +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY 193
Query: 412 STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--YRLNQPVNCPDELFSVMAY 469
D+W+ G++ E+ + PY +P + L P +
Sbjct: 194 GPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 470 CWAMNPEGRPTFPQL 484
C M+ E R + +L
Sbjct: 253 CLDMDVEKRGSAKEL 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 141 bits (356), Expect = 2e-38
Identities = 57/313 (18%), Positives = 111/313 (35%), Gaps = 32/313 (10%)
Query: 203 LDDRNKDLHEKLSELTIQRCRVRLFSVNM---------EGTFGRVYRGTYTEEDGVEEEV 253
++D +K + + Q V+ SV G FG V+R
Sbjct: 1 INDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG---RVF 57
Query: 254 LVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKR 313
+ K + + + + E M L H ++ + ED LI + L
Sbjct: 58 VAKFI-NTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-FEDKYEMVLILEFLSGGELFD 115
Query: 314 FLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD--DKLRI 371
+ + ++ EV++ Q G++++H+ ++H D+ N + + +
Sbjct: 116 RIAAED-------YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSV 168
Query: 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLA 431
+I D LA L P + ++ A E + + +D+WA GVL + L +
Sbjct: 169 KIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-G 224
Query: 432 QQPYAEIDPFEMAASLQDG---YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HS 486
P+A D E +++ + + + E + P R T H
Sbjct: 225 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 284
Query: 487 CLQEFHAQLTRYV 499
L+ H+ LT +
Sbjct: 285 WLKGDHSNLTSRI 297
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 7e-37
Identities = 52/255 (20%), Positives = 97/255 (38%), Gaps = 14/255 (5%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG +G V + E V VK V + + +E L+H+N++ G
Sbjct: 15 EGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
E + +L Y L ++ PE + Q++ GV YLH
Sbjct: 72 RREGN-IQYLFLEYCSGGELFDRIEPDIGMPE--------PDAQRFFHQLMAGVVYLHGI 122
Query: 352 KLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF 411
+ H+D+ N ++D++ ++I+D LA ++ L + + ++A E L + F
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 412 ST-ASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD-GYRLNQPVNCPDELFSVMAY 469
DVW+ G++L + D + + ++ LN +++
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 470 CWAMNPEGRPTFPQL 484
NP R T P +
Sbjct: 243 ILVENPSARITIPDI 257
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 136 bits (344), Expect = 9e-37
Identities = 49/269 (18%), Positives = 90/269 (33%), Gaps = 23/269 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+R T K V + +E M L H ++ +
Sbjct: 36 TGAFGVVHRVTERATG---NNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
ED +IY + L + + ++ E V+ Q+ G+ ++H+
Sbjct: 92 -FEDDNEMVMIYEFMSGGELFEKVADEH-------NKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 352 KLLHKDLATRNCVVDDKL--RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409
+H DL N + K +++ D L L P ++ A E K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAEGK 200
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG---YRLNQPVNCPDELFSV 466
+D+W+ GVL + L + P+ + E +++ + ++
Sbjct: 201 PVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 467 MAYCWAMNPEGRPTFPQL--HSCLQEFHA 493
+ +P R T Q H L +A
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNA 288
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 6e-36
Identities = 45/258 (17%), Positives = 98/258 (37%), Gaps = 16/258 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
EG+F V E +K + +V + +E M L H + +
Sbjct: 18 EGSFSTVVLARELATS---REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
+D + Y L ++++K E +I+ ++YLH
Sbjct: 75 FT-FQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--------TCTRFYTAEIVSALEYLH 125
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409
K ++H+DL N ++++ + IQITD A+ L P ++ ++++ E L K
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
+ +SD+WA G ++++L P+ + + + + + P + ++
Sbjct: 186 SACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKIIKL-EYDFPEKFFPKARDLVEK 243
Query: 470 CWAMNPEGRPTFPQLHSC 487
++ R ++
Sbjct: 244 LLVLDATKRLGCEEMEGY 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (325), Expect = 8e-35
Identities = 52/276 (18%), Positives = 103/276 (37%), Gaps = 28/276 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--------TDNASAVQVSLLLQEGMAMYGLSHK 283
G V R + +E VK + + L+E + +S
Sbjct: 13 RGVSSVVRRCIHKPTC---KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 284 NILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIM 343
+ L + E +T FL++ L +L + TL+ +E + ++
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--------TLSEKETRKIMRALLE 121
Query: 344 GVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYH---CLGDNENRPVKW 400
+ LHK ++H+DL N ++DD + I++TD + L P + C + P
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 401 LAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRLNQPV-- 457
+ H + D+W+ GV+++ L P+ M + G Y+ P
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEF 491
+ D + +++ + P+ R T + H Q++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-34
Identities = 51/266 (19%), Positives = 96/266 (36%), Gaps = 24/266 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G FG V+R T + + K V L+ +E + H+NIL +
Sbjct: 15 RGEFGIVHRCVETSSK---KTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
E +I+ + ++ + L +E+V Q+ +Q+LH
Sbjct: 70 -FESMEELVMIFEFISGLDIFERINTSA-------FELNEREIVSYVHQVCEALQFLHSH 121
Query: 352 KLLHKDLATRNCVVDDK--LRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409
+ H D+ N + + I+I + AR L P D L ++ A E H
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHD 178
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG---YRLNQPVNCPDELFSV 466
STA+D+W+ G L++ L + P+ ++ ++ + + E
Sbjct: 179 VVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 467 MAYCWAMNPEGRPTFPQL--HSCLQE 490
+ + R T + H L++
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQ 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-34
Identities = 61/294 (20%), Positives = 109/294 (37%), Gaps = 39/294 (13%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
+G FG V+RG + E EV VK ++ + E L H+NIL +
Sbjct: 13 KGRFGEVWRGKWRGE-----EVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 292 SIEDHTSP---FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
+D+ + +L+ Y ++ +L +L + + EG+ L + + V
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK-LALSTASGLAHLHMEIVGTQ 124
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--PVKWLAIESL 406
K + H+DL ++N +V I D LA + +R +++A E L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 407 ------VHKTFSTASDVWAFGVLLWELTT---------LAQQPYAEIDPFEMAAS----- 446
H +D++A G++ WE+ Q PY ++ P + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 447 -LQDGYRLNQP-----VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494
+ R N P + +M CW N R T ++ L + Q
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 1e-33
Identities = 39/274 (14%), Positives = 89/274 (32%), Gaps = 28/274 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G+FG +Y GT EEV +K Q L E + + +
Sbjct: 17 SGSFGDIYLGTDIAAG---EEVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGIPTIRW 70
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
+ ++ + F + + V+ + Q+I ++Y+H K
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSL--------KTVLLLADQMISRIEYIHSK 122
Query: 352 KLLHKDLATRNCVV---DDKLRIQITDNALARDLFPSDYHCLGDNENR-----PVKWLAI 403
+H+D+ N ++ + I D LA+ + H ++ +I
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 404 ESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-RLNQPV----- 457
+ + S D+ + G +L + + + +++ P+
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491
P E + + +C ++ + +P + L +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-33
Identities = 44/256 (17%), Positives = 93/256 (36%), Gaps = 21/256 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G G V++ ++ + K + + +++E ++ + I+ G
Sbjct: 16 AGNGGVVFKVSHKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH-K 350
+ + D +L + L+K PE Q + + + +I G+ YL K
Sbjct: 73 -FYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------QILGKVSIAVIKGLTYLREK 123
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPS-DYHCLGDNENRPVKWLAIESLVHK 409
K++H+D+ N +V+ + I++ D ++ L S +G +++ E L
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG-----TRSYMSPERLQGT 178
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
+S SD+W+ G+ L E+ + P D E+ P +
Sbjct: 179 HYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQ-VEGDAAETPPRPRTPGRP 236
Query: 470 CWAMNPEGRPTFPQLH 485
+ + RP
Sbjct: 237 LSSYGMDSRPPMAIFE 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-33
Identities = 58/270 (21%), Positives = 113/270 (41%), Gaps = 30/270 (11%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTD-NASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G+F VY+G TE EV + D + + +E + GL H NI+
Sbjct: 19 RGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 291 V---SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+++ L+ LK +L++ K+ + + C QI+ G+Q+
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI--------KVLRSWCRQILKGLQF 127
Query: 348 LHKKK--LLHKDLATRNCVVDDKL-RIQITDNALARDLFPSDYH-CLGDNENRPVKWLAI 403
LH + ++H+DL N + ++I D LA S +G +++A
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIG-----TPEFMAP 182
Query: 404 ESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE-IDPFEMAASLQDGYR-LNQPVNCPD 461
E + + + + DV+AFG+ + E+ T ++ PY+E + ++ + G + +
Sbjct: 183 E-MYEEKYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 462 ELFSVMAYCWAMNPEGRPTFPQL--HSCLQ 489
E+ ++ C N + R + L H+ Q
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (311), Expect = 1e-32
Identities = 39/275 (14%), Positives = 90/275 (32%), Gaps = 30/275 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG+FG ++ GT + ++V +K + A Q L E L+ + +
Sbjct: 15 EGSFGVIFEGTNLLNN---QQVAIKFEPRRSDAPQ---LRDEYRTYKLLAGCTGIPNVYY 68
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
++ L+ + + + V Q++ VQ +H+K
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSV--------KTVAMAAKQMLARVQSIHEK 120
Query: 352 KLLHKDLATRNCVVDDKLR-----IQITDNALARDL-FPSDYHCLGDNENRPV----KWL 401
L+++D+ N ++ I + D + + P + E + + +++
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 402 AIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV---- 457
+I + + + S D+ A G + + + G +
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 458 --NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490
P+E + M Y + + P + L +
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 47/255 (18%), Positives = 104/255 (40%), Gaps = 19/255 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ---VSLLLQEGMAMYGLSHKNILTV 288
+G+FG+V+ + + + + +K + + + ++++ + H + +
Sbjct: 12 KGSFGKVFLAEFKKTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
+ + F + Y + +L +Q C +II+G+Q+L
Sbjct: 69 FCT-FQTKENLFFVMEYLNGGDLMYHIQSCHKFDL--------SRATFYAAEIILGLQFL 119
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH 408
H K ++++DL N ++D I+I D + ++ D + ++A E L+
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILLG 177
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMA 468
+ ++ + D W+FGVLL+E+ Q P+ D E+ S++ P E ++
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMD-NPFYPRWLEKEAKDLLV 235
Query: 469 YCWAMNPEGRPTFPQ 483
+ PE R
Sbjct: 236 KLFVREPEKRLGVRG 250
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (306), Expect = 9e-32
Identities = 51/259 (19%), Positives = 97/259 (37%), Gaps = 22/259 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G F V + V +K + A + + E ++ + H NI+ + +
Sbjct: 19 TGAFSEVILAEDKRTQ---KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK 351
E +LI L + + E ++ + Q++ V+YLH
Sbjct: 76 -YESGGHLYLIMQLVSGGELFDRIVEKGFYTE--------RDASRLIFQVLDAVKYLHDL 126
Query: 352 KLLHKDLATRNCVV---DDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH 408
++H+DL N + D+ +I I+D L++ P ++A E L
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TACGTPGYVAPEVLAQ 183
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS-LQDGYRLNQPV--NCPDELFS 465
K +S A D W+ GV+ + L P+ + + ++ L+ Y + P + D
Sbjct: 184 KPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 466 VMAYCWAMNPEGRPTFPQL 484
+ + +PE R T Q
Sbjct: 243 FIRHLMEKDPEKRFTCEQA 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-31
Identities = 55/277 (19%), Positives = 100/277 (36%), Gaps = 30/277 (10%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-----TDNASAVQVSLLLQEGMAMYGLSHKNIL 286
G F V + + K + + V + +E + + H N++
Sbjct: 20 SGQFAVVKKCREKSTG---LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
T+ V E+ T LI L FL + + E +E + QI+ GV
Sbjct: 77 TLHEV-YENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEFLKQILNGVY 127
Query: 347 YLHKKKLLHKDLATRNCVVDD----KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLA 402
YLH ++ H DL N ++ D K RI+I D LA + + N +++A
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVA 184
Query: 403 IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG---YRLNQPVNC 459
E + ++ +D+W+ GV+ + L + P+ E A++ + N
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANVSAVNYEFEDEYFSNT 243
Query: 460 PDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFHAQ 494
+ +P+ R T H ++ Q
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-31
Identities = 43/277 (15%), Positives = 94/277 (33%), Gaps = 35/277 (12%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQ-VSLLLQEGMAMYGLSHKNILTVLG 290
G G+V + E+ +K + D A + V L + +I+ ++
Sbjct: 22 LGINGKVLQIFNKRTQ---EKFALKMLQDCPKARREVELHWRA------SQCPHIVRIVD 72
Query: 291 V---SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
V ++ D L +Q T +E ++ I +QY
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA------FTEREASEIMKSIGEAIQY 126
Query: 348 LHKKKLLHKDLATRNCVVD---DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIE 404
LH + H+D+ N + +++TD A++ + ++A E
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPE 183
Query: 405 SLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP-------V 457
L + + + D+W+ GV+++ L P+ ++ ++ R+ Q
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 458 NCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
+E+ ++ P R T + H + +
Sbjct: 243 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 2e-30
Identities = 46/276 (16%), Positives = 97/276 (35%), Gaps = 27/276 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVL 289
G V+ +V VK + + +E L+H I+ V
Sbjct: 17 FGGMSEVHLARDLRLH---RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 290 GVSIEDHTS---PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+ + P+++ Y D L+ + +T + +++ +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--------PMTPKRAIEVIADACQALN 125
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR-PVKWLAIES 405
+ H+ ++H+D+ N ++ +++ D +AR + S ++L+ E
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMA-ASLQDGYRLNQPV--NCPDE 462
+ SDV++ G +L+E+ T + P+ P +A +++ +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 463 LFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498
L +V+ A NPE R E A L R
Sbjct: 245 LDAVVLKALAKNPENRY------QTAAEMRADLVRV 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 116 bits (291), Expect = 3e-29
Identities = 42/260 (16%), Positives = 95/260 (36%), Gaps = 25/260 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLS---HKNIL 286
G FG VY + + +K + +L L E + + +S I+
Sbjct: 14 RGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 287 TVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+ I + +L L + + E ++ +II+G++
Sbjct: 71 CMSYA-FHTPDKLSFILDLMNGGDLHYHLSQHGVFSE--------ADMRFYAAEIILGLE 121
Query: 347 YLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESL 406
++H + ++++DL N ++D+ ++I+D LA D H ++A E L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVL 177
Query: 407 VH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ--DGYRLNQPVNCPDEL 463
+ +++D ++ G +L++L P+ + + + + P + EL
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236
Query: 464 FSVMAYCWAMNPEGRPTFPQ 483
S++ + R
Sbjct: 237 RSLLEGLLQRDVNRRLGCLG 256
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 3e-29
Identities = 49/254 (19%), Positives = 102/254 (40%), Gaps = 21/254 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
G+FGRV+ +K + QV E + + ++H I+ +
Sbjct: 14 TGSFGRVHLIRSRHNG---RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
G +D F+I Y + L L+K + P ++ + ++YLH
Sbjct: 71 GT-FQDAQQIFMIMDYIEGGELFSLLRKSQRFPN--------PVAKFYAAEVCLALEYLH 121
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409
K ++++DL N ++D I+ITD A+ + Y G ++A E + K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTK 176
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
++ + D W+FG+L++E+ P+ + + + + + L P +++ +++
Sbjct: 177 PYNKSIDWWSFGILIYEMLAG-YTPFYDSNTMKTYEKILNA-ELRFPPFFNEDVKDLLSR 234
Query: 470 CWAMNPEGRPTFPQ 483
+ R Q
Sbjct: 235 LITRDLSQRLGNLQ 248
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 44/259 (16%), Positives = 85/259 (32%), Gaps = 16/259 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV---TDNASAVQVSLLLQEGMAMYGLSHKNILTV 288
G +G+V+ + +K + T A E + + L
Sbjct: 34 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 93
Query: 289 LGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYL 348
L + + T LI Y + L L + + E EV +I++ +++L
Sbjct: 94 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTE--------HEVQIYVGEIVLALEHL 145
Query: 349 HKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW-LAIESLV 407
HK ++++D+ N ++D + +TD L+++ + D I
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---RLNQPVNCPDELF 464
A D W+ GVL++EL T P+ A + P
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 465 SVMAYCWAMNPEGRPTFPQ 483
++ +P+ R
Sbjct: 265 DLIQRLLMKDPKKRLGCGP 283
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 44/251 (17%), Positives = 93/251 (37%), Gaps = 18/251 (7%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
+GTFG+V +K + + +V+ + E + H + +
Sbjct: 15 KGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
+ H + Y + L L + ++ E + +I+ ++YLH
Sbjct: 72 YA-FQTHDRLCFVMEYANGGELFFHLSRERVFTE--------ERARFYGAEIVSALEYLH 122
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409
+ ++++D+ N ++D I+ITD L ++ ++LA E L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLEDN 180
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
+ A D W GV+++E+ + P+ D + + + P E S++A
Sbjct: 181 DYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAG 238
Query: 470 CWAMNPEGRPT 480
+P+ R
Sbjct: 239 LLKKDPKQRLG 249
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 2e-26
Identities = 50/272 (18%), Positives = 106/272 (38%), Gaps = 34/272 (12%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-----TDNASAVQVSLLLQEGMAMYGLS--HKN 284
G FG VY G ++ V +K V +D + + E + + +S
Sbjct: 14 SGGFGSVYSGIRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 285 ILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMG 344
++ +L + ++ + +L F+ + L + Q++
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--------ALQEELARSFFWQVLEA 122
Query: 345 VQYLHKKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPSDYHCL-GDNENRPVKWLA 402
V++ H +LH+D+ N ++D ++ +++ D L + Y G P +W+
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 403 IESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDE 462
H+ ++ VW+ G+LL+++ PFE + G ++ E
Sbjct: 183 ----YHRYHGRSAAVWSLGILLYDMVCGDI-------PFEHDEEIIRG-QVFFRQRVSSE 230
Query: 463 LFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
++ +C A+ P RPTF ++ H +Q+
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (265), Expect = 6e-26
Identities = 48/250 (19%), Positives = 102/250 (40%), Gaps = 21/250 (8%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV--TDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289
G+FGRV + E +K + Q+ L E + ++ ++ +
Sbjct: 51 TGSFGRVMLVKHKESG---NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
+D+++ +++ Y + L++ E QI++ +YLH
Sbjct: 108 FS-FKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE--------PHARFYAAQIVLTFEYLH 158
Query: 350 KKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK 409
L+++DL N ++D + IQ+TD A+ + + G + LA E ++ K
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIILSK 213
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAY 469
++ A D WA GVL++E+ P+ P ++ + G ++ P + +L ++
Sbjct: 214 GYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSG-KVRFPSHFSSDLKDLLRN 271
Query: 470 CWAMNPEGRP 479
++ R
Sbjct: 272 LLQVDLTKRF 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-25
Identities = 53/292 (18%), Positives = 93/292 (31%), Gaps = 44/292 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EGT+G V++ E E V +K V D+ S L+E + L HKNI+ +
Sbjct: 12 EGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V D + L PE V Q++ G+ + H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE---------IVKSFLFQLLKGLGFCHS 119
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
+ +LH+DL +N +++ +++ + LAR F C K
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR------------------ 452
+ST+ D+W+ G + EL + + D + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 453 ----------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
+N ++ NP R + + H +F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-24
Identities = 47/302 (15%), Positives = 87/302 (28%), Gaps = 52/302 (17%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G+FG VY+ + E V +K V + +E M L H NI+ +
Sbjct: 30 NGSFGVVYQAKLCDSG---ELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYF 81
Query: 292 -----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQ 346
+D L+ Y T + + TL V Q+ +
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLA 136
Query: 347 YLHKKKLLHKDL-ATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
Y+H + H+D+ + D +++ D A+ L + +
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELI 194
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--------------- 450
++++ DVW+ G +L EL Q + + +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 451 -------------YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFHAQL 495
+ P E ++ + P R T + HS E
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313
Query: 496 TR 497
+
Sbjct: 314 VK 315
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 5e-24
Identities = 54/299 (18%), Positives = 103/299 (34%), Gaps = 52/299 (17%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
EG +G V V +K ++ L+E + H+NI+ + +
Sbjct: 18 EGAYGMVCSAYDNVNK---VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 292 ----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+IE +L+ K L+ L+ + QI+ G++Y
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYK-LLKT---------QHLSNDHICYFLYQILRGLKY 124
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKW-LAIESL 406
+H +LH+DL N +++ ++I D LAR P H E +W A E +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 407 VHKTFST-ASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG--------------- 450
++ T + D+W+ G +L E+ + + + + +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 451 ----YRLNQP-----------VNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
Y L+ P N + ++ NP R Q H L++++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 1e-23
Identities = 48/295 (16%), Positives = 89/295 (30%), Gaps = 47/295 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV----TDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EG F VY+ + + V +K + A L+E + LSH NI+
Sbjct: 8 EGQFATVYKARDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+L ++ L++ + + + + L + G++Y
Sbjct: 65 LLDA-FGHKSNISLVFDFMETDLEVIIKDNSLVLTP--------SHIKAYMLMTLQGLEY 115
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
LH+ +LH+DL N ++D+ +++ D LA+ F S
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS-FGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD------ 461
+ + D+WA G +L EL + + + PD
Sbjct: 175 ARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 462 ---------------------ELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFHA 493
+L ++ + NP R T Q
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 98.0 bits (243), Expect = 2e-23
Identities = 51/290 (17%), Positives = 101/290 (34%), Gaps = 46/290 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EGT+G VY+ ++ E +K + + S ++E + L H NI+ +
Sbjct: 12 EGTYGVVYKA----QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V ++ +LK+ L C+ L + LQ++ G+ Y H
Sbjct: 68 VIHTKKR--LVLVFEHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHD 118
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT 410
+++LH+DL +N +++ + ++I D LAR F + K
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 411 FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD--------- 461
+ST D+W+ G + E+ + + + + N P+
Sbjct: 178 YSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 462 -------------------ELFSVMAYCWAMNPEGRPTFPQL--HSCLQE 490
+++ ++P R T Q H+ +E
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 3e-23
Identities = 54/293 (18%), Positives = 108/293 (36%), Gaps = 46/293 (15%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
EGT+G VY+ E V +K + D + S ++E + L+H NI+ +L
Sbjct: 12 EGTYGVVYKARNKLTG---EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
V I +L++ + K + + Q++ G+ + H
Sbjct: 69 V-IHTENKLYLVFEFLHQDLKKFMDASAL-------TGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH-K 409
++LH+DL +N +++ + I++ D LAR +E + + A E L+ K
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCK 178
Query: 410 TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-----------------YR 452
+STA D+W+ G + E+ T + + + + Y+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 453 LNQP-----------VNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
+ P ++ S+++ +P R + H Q+
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 5e-23
Identities = 48/292 (16%), Positives = 99/292 (33%), Gaps = 41/292 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV----TDNASAVQVSLLLQEGMAMYGLSHKNILT 287
EG +G+V++ + G V +K V + + + + H N++
Sbjct: 17 EGAYGKVFKARDLKNGG--RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQY 347
+ V T + PE + T+ + DM Q++ G+ +
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDF 131
Query: 348 LHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLV 407
LH +++H+DL +N +V +I++ D LAR + + + A E L+
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVTLWYRAPEVLL 188
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP------- 460
+++T D+W+ G + E+ + + + + D L + P
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 461 -------------------DELFSVMAYCWAMNPEGRPTFPQL--HSCLQEF 491
+ ++ C NP R + H Q+
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.7 bits (229), Expect = 2e-21
Identities = 47/298 (15%), Positives = 96/298 (32%), Gaps = 42/298 (14%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
+GTFG V++ + + ++V +K V +N L+E + L H+N++ ++
Sbjct: 20 QGTFGEVFKARHRKTG---QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK 350
+ SP+ Y V T E+ + ++ G+ Y+H+
Sbjct: 77 I-CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 351 KKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENR--PVKWLAIESLV- 407
K+LH+D+ N ++ +++ D LAR + NR + + E L+
Sbjct: 136 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 195
Query: 408 HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPD------ 461
+ + D+W G ++ E+ T A + P P+
Sbjct: 196 ERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254
Query: 462 -------------------------ELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
++ ++P R H
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 1e-20
Identities = 49/299 (16%), Positives = 99/299 (33%), Gaps = 56/299 (18%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G +G V +V +K + S + +E + + H+N++ +L
Sbjct: 28 SGAYGAVCSAVDGRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 291 V-----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
V +++D T +L+ P+ K + L + + Q++ G+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----------KLGEDRIQFLVYQMLKGL 134
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
+Y+H ++H+DL N V++ ++I D LAR +
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV----TRWYRAPEVI 190
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID---------------PFEMAASLQDG 450
L ++ D+W+ G ++ E+ T + + D P E LQ
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 451 YRLNQ---------------PVNCPDELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
N N +++ ++ E R T + H + H
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 3e-20
Identities = 53/333 (15%), Positives = 111/333 (33%), Gaps = 62/333 (18%)
Query: 197 RPSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVK 256
RP++ R ++L++ + E+ R + S G +G V T+ V VK
Sbjct: 1 RPTFYR-----QELNKTIWEVP---ERYQNLSPVGSGAYGSVCAAFDTKTG---LRVAVK 49
Query: 257 TV-TDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT----SPFLIYPYQDYTNL 311
+ S + +E + + H+N++ +L V + + + + +L
Sbjct: 50 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109
Query: 312 KRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371
++ KL V + QI+ G++Y+H ++H+DL N V++ +
Sbjct: 110 NNIVKCQKLTD---------DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLA 431
+I D LAR L ++ D+W+ G ++ EL T
Sbjct: 161 KILDFGLARHTDDEMTGY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-G 215
Query: 432 QQPYAEIDPFEMAASLQDGYRL------------------------------NQPVNCPD 461
+ + D + + N +
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 275
Query: 462 ELFSVMAYCWAMNPEGRPTFPQL--HSCLQEFH 492
++ ++ + R T Q H+ ++H
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 84.1 bits (207), Expect = 2e-18
Identities = 38/292 (13%), Positives = 93/292 (31%), Gaps = 59/292 (20%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLG 290
G + V+ + E+V+VK + V+ + +E + L NI+T+
Sbjct: 45 RGKYSEVFEAINITNN---EKVVVKIL----KPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 291 V-SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLH 349
+ +P L++ + + T+ K+ Q LT ++ +I+ + Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT-----------LTDYDIRFYMYEILKALDYCH 146
Query: 350 KKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH 408
++H+D+ N ++D + ++++ D LA P + + +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPELLVDY 204
Query: 409 KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAA----------------------- 445
+ + + D+W+ G +L + + + D ++
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 446 -------------SLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQL 484
+ E + + + R T +
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.2 bits (207), Expect = 2e-18
Identities = 47/259 (18%), Positives = 94/259 (36%), Gaps = 24/259 (9%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVT-DNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290
G G V D V +K ++ + +E + M ++HKNI+++L
Sbjct: 27 SGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 291 V-----SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGV 345
V ++E+ +L+ D + + + + + Q++ G+
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----------DHERMSYLLYQMLCGI 132
Query: 346 QYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIES 405
++LH ++H+DL N VV ++I D LAR S + A E
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAPEV 189
Query: 406 LVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465
++ + D+W+ G ++ E+ + + D + + + P +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 466 VMAYCWAMNPEGRPTFPQL 484
V Y TFP+L
Sbjct: 249 VRNYVENRPKYAGLTFPKL 267
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 61.6 bits (148), Expect = 6e-11
Identities = 29/207 (14%), Positives = 70/207 (33%), Gaps = 14/207 (6%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGV 291
G F V+ + V +K V V E + ++ + +
Sbjct: 23 WGHFSTVWLAKDMVNN---THVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 292 SIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQ-------EVVDMCLQIIMG 344
+ ++ + + L +A + V + Q+++G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 345 VQYLH-KKKLLHKDLATRNCVVD-DKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLA 402
+ Y+H + ++H D+ N +++ + +A Y N + ++ +
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 403 IESLVHKTFSTASDVWAFGVLLWELTT 429
E L+ + +D+W+ L++EL T
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.0 bits (129), Expect = 4e-09
Identities = 26/197 (13%), Positives = 61/197 (30%), Gaps = 33/197 (16%)
Query: 232 EGTFGRVYRGTYTEEDGVEEEVLVKTV-TDNASAVQVSL--------LLQEGMAMYGLSH 282
EG V+ E +VK + S +V +
Sbjct: 10 EGKESAVFNCY----SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 283 KNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQII 342
+ + + G+++ + + + K + P+ V I+
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLD------------MIL 113
Query: 343 MGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL-FPSDYHCLGDNENRPVKWL 401
V + + ++H DL+ N +V ++ I I D + ++ L + + +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 402 AIESLVHKTFSTASDVW 418
+ +T+ T D+
Sbjct: 173 S------RTYRTEKDIN 183
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 499 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.19 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 95.9 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 95.62 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 95.2 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 95.17 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.15 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 95.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.98 | |
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 94.82 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 94.79 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 94.69 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 94.68 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 94.63 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 94.49 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 94.46 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 94.39 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 94.3 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 94.17 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 93.87 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 93.84 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 93.59 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 92.79 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 92.42 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 90.89 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.82 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-60 Score=459.95 Aligned_cols=284 Identities=26% Similarity=0.491 Sum_probs=235.1
Q ss_pred CCccccccchhhHHhhcccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHH
Q psy1789 198 PSYSRLDDRNKDLHEKLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAM 277 (499)
Q Consensus 198 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l 277 (499)
++|++..+++.+|.. ++...+|++.++||+|+||+||+|++..++.....||||.+.........+.|.+|+.+|
T Consensus 7 ~t~~d~~~a~~~f~~-----~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l 81 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAK-----EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81 (299)
T ss_dssp GGSSSHHHHHHHHSC-----BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHhhhch-----hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHH
Confidence 456666666666543 356678999999999999999999987654444679999998777777788999999999
Q ss_pred hcCCCCcceeEEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy1789 278 YGLSHKNILTVLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKD 357 (499)
Q Consensus 278 ~~l~H~nIv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrD 357 (499)
++++|||||+++|+|.. ++..++||||+++|+|.+++.... ..++|.+++.++.|+|+||+|||+++|+|||
T Consensus 82 ~~l~HpnIv~l~g~~~~-~~~~~iv~Ey~~~g~L~~~~~~~~-------~~l~~~~~~~i~~qia~gl~yLH~~~iiHrD 153 (299)
T d1jpaa_ 82 GQFDHPNVIHLEGVVTK-STPVMIITEFMENGSLDSFLRQND-------GQFTVIQLVGMLRGIAAGMKYLADMNYVHRD 153 (299)
T ss_dssp TTCCCTTBCCEEEEECS-SSSCEEEEECCTTEEHHHHHHTTT-------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HhCCCCCCccEEEEEee-CCEEEEEEEecCCCcceeeecccc-------CCCCHHHHHHHHHHHHHHHHHHhhCCCccCc
Confidence 99999999999999744 566799999999999999988622 3589999999999999999999999999999
Q ss_pred CCCCceEEcCCCcEEEcccccccccCCCCccc---cCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q psy1789 358 LATRNCVVDDKLRIQITDNALARDLFPSDYHC---LGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP 434 (499)
Q Consensus 358 lk~~NIlld~~~~~kl~DfGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p 434 (499)
|||+|||||+++.+||+|||+|+......... ......||+.|||||.+.++.++.++|||||||++|||+|+|++|
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence 99999999999999999999998765432211 122345789999999999999999999999999999999988999
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 435 YAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 435 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
|.+....++...+..+.++..+.++++++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 234 YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp TTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 999999999999998888888999999999999999999999999999999999988653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-59 Score=447.02 Aligned_cols=265 Identities=32% Similarity=0.605 Sum_probs=234.4
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
.+++++.++|++++.||+|+||+||+|.+.++ ..||||++...... .+.|.+|+.++++++|||||+++|+|.+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTT----EEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCC----CEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 35778889999999999999999999998643 67999999754332 3579999999999999999999998643
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
+..++||||+++|+|.+++.... ...+++.+++.|+.|||+||.|||+++|+||||||+|||||+++.+||+
T Consensus 80 --~~~~iv~Ey~~~g~L~~~~~~~~------~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~ 151 (272)
T d1qpca_ 80 --EPIYIITEYMENGSLVDFLKTPS------GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA 151 (272)
T ss_dssp --SSCEEEEECCTTCBHHHHTTSHH------HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEEC
T ss_pred --CCeEEEEEeCCCCcHHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeec
Confidence 34699999999999999876432 2358999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+|++.+|+...+..++...+..+.++.
T Consensus 152 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 152 DFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp CCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999997754432 234456789999999999999999999999999999999998888898888888889999988888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.|..+++++.+++.+||+.||++||||.||++.|+++..+
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999999999999999999999999999998654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-58 Score=443.40 Aligned_cols=261 Identities=28% Similarity=0.584 Sum_probs=221.2
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
++.++|++++.||+|+||+||+|++.++ ..||||++...... .++|.+|+.++++++|||||+++|+|.. ++.
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~ 74 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAP 74 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTT----EEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCC----CEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceecc-CCc
Confidence 3456899999999999999999998653 57999999765332 3579999999999999999999999755 556
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|.+++... ...+++..++.++.|+|.||+|||+++|+||||||+|||+|+++.+||+|||+
T Consensus 75 ~~lv~E~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 147 (263)
T d1sm2a_ 75 ICLVFEFMEHGCLSDYLRTQ-------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147 (263)
T ss_dssp CEEEEECCTTCBHHHHHHTT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-
T ss_pred eEEEEEecCCCcHHHHhhcc-------ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccch
Confidence 79999999999999999763 24689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
|+........ ......||+.|||||++.+..|+.++|||||||++|||+|++++||...+..++...+..+.++..|..
T Consensus 148 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~ 226 (263)
T d1sm2a_ 148 TRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 226 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTT
T ss_pred heeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence 9876543322 233456889999999999999999999999999999999988899998888888889988888888999
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+++++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999999999999999998763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-58 Score=445.31 Aligned_cols=270 Identities=27% Similarity=0.519 Sum_probs=236.2
Q ss_pred ceeeccceEEeee-eeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 217 LTIQRCRVRLFSV-NMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 217 ~~~~~~~~~~~~~-lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
+-+.++++.+.+. ||+|+||+||+|.+...+. ...||||++.........+.|.+|+.+|++++|||||+++|+|..
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---C-CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCC-cEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 3456678888885 9999999999998754321 257999999877677777899999999999999999999999743
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
+..++||||+++|+|.+++...+ ..+++.+++.++.|+|.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 81 -~~~~lvmE~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~D 152 (285)
T d1u59a_ 81 -EALMLVMEMAGGGPLHKFLVGKR-------EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISD 152 (285)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCT-------TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECC
T ss_pred -CeEEEEEEeCCCCcHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeecc
Confidence 34799999999999999986522 4699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 376 NALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 376 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
||+|+.....+.. .......||+.|||||++.++.++.++|||||||++|||+|.|++||.+.+..++...+..+.++.
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred chhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999977654332 233456689999999999999999999999999999999997899999988888888999998999
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
.|..+++++.+++.+||+.||++||||.+|++.|+....++.
T Consensus 233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 999999999999999999999999999999999998876654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=439.94 Aligned_cols=268 Identities=30% Similarity=0.559 Sum_probs=227.7
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCc-eeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDG-VEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
++...+|++.++||+|+||.||+|.+..+++ ....||||++...........|.+|+.++++++|||||+++|+|.+ .
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-Y 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-C
Confidence 3555678889999999999999999876532 3467999999877677777789999999999999999999999754 5
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
...++|+||+.+|++.+++.... ..++|.+++.++.|++.||+|||+++|+||||||+|||||.++.+||+||
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-------~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-------TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEEecccCcchhhhhccc-------ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEccc
Confidence 56799999999999999887632 46999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 377 ALARDLFPSDY-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 377 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
|+|+....... ........||+.|||||++.++.++.++|||||||++|||+|++.+|+......++...+..+.++..
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~ 234 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 234 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred chhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC
Confidence 99987654322 12233456899999999999999999999999999999999988888888888889999999999999
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
+.++++++.+++.+||+.||++||||.||++.|+++.+
T Consensus 235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 235 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 99999999999999999999999999999999998865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-58 Score=443.95 Aligned_cols=264 Identities=26% Similarity=0.430 Sum_probs=218.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
+++++.++|++++.||+|+||+||+|++.+ .||||++... ......+.|.+|+.++++++|||||+++|++.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESSS------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEECC------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec
Confidence 567888999999999999999999998532 4999998643 344556789999999999999999999998643
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
+..++||||+++|+|.++++..+ ..+++.+++.++.|+|+||+|||+++||||||||+|||||+++.+||+
T Consensus 76 --~~~~lv~Ey~~~g~L~~~l~~~~-------~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~ 146 (276)
T d1uwha_ 76 --PQLAIVTQWCEGSSLYHHLHIIE-------TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIG 146 (276)
T ss_dssp --SSCEEEEECCCEEEHHHHHHTSC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEEC
T ss_pred --cEEEEEEecCCCCCHHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEc
Confidence 45699999999999999998532 359999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVH---KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE-MAASLQDG 450 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~-~~~~i~~~ 450 (499)
|||+|+...............||+.|||||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+ +...+..+
T Consensus 147 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t-g~~Pf~~~~~~~~~~~~~~~~ 225 (276)
T d1uwha_ 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT-GQLPYSNINNRDQIIFMVGRG 225 (276)
T ss_dssp CCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTTCCCHHHHHHHHHHT
T ss_pred cccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH-CCCCCCCCChHHHHHHHHhcC
Confidence 9999987654433333456779999999999964 458999999999999999999 899998876544 44444444
Q ss_pred CCC----CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 451 YRL----NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 451 ~~~----~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
... ..+.++++++.+++.+||+.||++|||+.||++.|+.+.+.+
T Consensus 226 ~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 332 245578999999999999999999999999999999987653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-58 Score=444.36 Aligned_cols=265 Identities=32% Similarity=0.659 Sum_probs=233.5
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
.++++..++|++.+.||+|+||+||+|++..++ +.||||++..... ..+.|.+|+.+|++++|||||+++|+|.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~- 83 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYS---LTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCT- 83 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGT---EEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCC---eEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEe-
Confidence 356778889999999999999999999987655 7899999975533 2367999999999999999999999964
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
+++..++||||+++|+|.+++.... ...+++..++.|+.|+|.||+|||+++|+||||||+|||||+++.+||+
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECN------RQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSC------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred eCCeeEEEeecccCcchHHHhhhcc------ccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 4566799999999999999998632 3468999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+|+........ ......|++.|||||++.+..|+.++|||||||++|||+|++.+|+...+..++...+..+.++.
T Consensus 158 DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~ 236 (287)
T d1opja_ 158 DFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236 (287)
T ss_dssp CCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCC
Confidence 99999976543322 23345578899999999999999999999999999999997778888888888888888888888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
.|..+++++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 89999999999999999999999999999999988753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=438.44 Aligned_cols=270 Identities=31% Similarity=0.564 Sum_probs=229.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
++++++++|++++.||+|+||.||+|++...+.....||||.+.........+.|.+|+.++++++|||||+++|++.
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-- 78 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 78 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 367889999999999999999999999876555557899999987667777788999999999999999999999863
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
++..++||||+++|+|.+++.... ..+++.+++.++.|+++||.|||+++|+||||||+||++++++.+||+|
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~-------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRK-------YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTT-------TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred cCeEEEEEEeccCCcHHhhhhccC-------CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEcc
Confidence 345799999999999999987632 4689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQ 455 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 455 (499)
||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+|+|.+||...+..++...+..+.++..
T Consensus 152 fG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~ 230 (273)
T d1mp8a_ 152 FGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230 (273)
T ss_dssp --------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred chhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9999876543322 334566899999999999999999999999999999999988999999999899888998888888
Q ss_pred CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 456 PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 456 ~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
|.++++++.+++.+||+.||++|||+.||++.|+++.++.
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999999987664
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-57 Score=444.91 Aligned_cols=279 Identities=32% Similarity=0.575 Sum_probs=241.3
Q ss_pred hcccceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEe
Q psy1789 213 KLSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLG 290 (499)
Q Consensus 213 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g 290 (499)
.+.++++++++|++++.||+|+||+||+|++.+. ....+.||||++.........+.|.+|+.++++++||||+++++
T Consensus 4 ~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred chhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 3556778899999999999999999999998652 22347899999987777777788999999999999999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccC----------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLC----------------PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLL 354 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~ii 354 (499)
+|.. ....++++||+++|+|.++++..... .......+++..++.|+.|+|.||+|||+++||
T Consensus 84 ~~~~-~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 84 VCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp EECS-SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eecc-CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence 9754 55679999999999999999764321 011234589999999999999999999999999
Q ss_pred ccCCCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q psy1789 355 HKDLATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQP 434 (499)
Q Consensus 355 HrDlk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p 434 (499)
||||||+|||+|.++.+||+|||+|+...........+...+++.|+|||.+.+..||.++|||||||++|||+|++.+|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998775544444445677889999999999999999999999999999999977789
Q ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 435 YAEIDPFEMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 435 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
|.+.+..++...+..+.++..|..+++++.+++.+||+.||++||||.||++.|+++.
T Consensus 243 ~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999888889999999999999999999999999999999998864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=436.89 Aligned_cols=256 Identities=30% Similarity=0.562 Sum_probs=222.0
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+.||+|+||+||+|.+...+ ..+.||||++.... .....+.|.+|+.+|++++|||||+++|+|.. + ..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-C-CEEEEEEcC
Confidence 47999999999999986543 34789999996542 33445789999999999999999999999743 3 468999999
Q ss_pred CCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccccCCCC
Q psy1789 307 DYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDLFPSD 386 (499)
Q Consensus 307 ~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~~~~~ 386 (499)
++|+|.++++.. ..+++.+++.++.|||.||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 90 ~~g~L~~~l~~~--------~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 90 ELGPLNKYLQQN--------RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp TTEEHHHHHHHC--------TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHhhc--------cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 999999999872 469999999999999999999999999999999999999999999999999999765443
Q ss_pred c-cccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCcHHHHH
Q psy1789 387 Y-HCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCPDELFS 465 (499)
Q Consensus 387 ~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 465 (499)
. ........||+.|||||.+.+..++.++|||||||++|||+|.|++||.+.+..++...+..+.++..|..+++++.+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 241 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 241 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 2 223345678999999999999999999999999999999998789999999999998999998899999999999999
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 466 VMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 466 l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
++.+||+.||++|||+.+|++.|+.+..+
T Consensus 242 li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 242 LMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 99999999999999999999999887543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=446.16 Aligned_cols=274 Identities=32% Similarity=0.554 Sum_probs=229.0
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
.+++++++|++++.||+|+||+||+|++...+ .....||||.+...........|.+|+.++.++ +|||||+++|++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 46788899999999999999999999986542 345689999997665556667899999999998 899999999996
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCP---------------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKD 357 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrD 357 (499)
...+..++||||+++|+|.++|+..+... ......+++..++.++.|++.||+|||+++|||||
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 111 -TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred -eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 45667799999999999999998643210 01124689999999999999999999999999999
Q ss_pred CCCCceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q psy1789 358 LATRNCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAE 437 (499)
Q Consensus 358 lk~~NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~ 437 (499)
|||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+|+|++||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765544333344566799999999999999999999999999999999878999988
Q ss_pred CCHH-HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 438 IDPF-EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 438 ~~~~-~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
.+.. .+...+..+.++..|..+++++.+|+.+||+.||++|||++||++.|..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 6544 4556677788888899999999999999999999999999999999853
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=438.08 Aligned_cols=281 Identities=27% Similarity=0.489 Sum_probs=231.9
Q ss_pred cccceeeccceEEeeeeeeecceEEEEEEEeCCC--ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEe
Q psy1789 214 LSELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED--GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLG 290 (499)
Q Consensus 214 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g 290 (499)
..++++++++|++++.||+|+||.||+|++...+ ...+.||||++.........+.+.+|...+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3567788999999999999999999999986532 345789999998766666677888888888776 7999999999
Q ss_pred EEEcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 291 VSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 291 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
++.+.+...++||||+++|+|.++++..+... ......+++.+++.++.|+++||+|||+++||||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 98777777899999999999999998643210 0123458999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-H
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP-F 441 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~ 441 (499)
|||++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+|++.+||...+. .
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999999766554444455678999999999999999999999999999999999977889987654 4
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 442 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
.+...+..+.++..|..+++++.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 45667778888888889999999999999999999999999999999998654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=429.45 Aligned_cols=258 Identities=30% Similarity=0.611 Sum_probs=224.3
Q ss_pred ceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 217 LTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 217 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
|++..++|++++.||+|+||.||+|++.+ ..||||++++... .+.|.+|+.++++++||||++++|+|.++.
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~vAvK~i~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRG-----NKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEK 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETT-----EEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECC-----eEEEEEEECcHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEecC
Confidence 56778899999999999999999999853 6799999976533 357899999999999999999999987766
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
+..++||||+++|+|.+++++.. ...++|..+++|+.||+.||.|||+.+|+||||||+|||++.++.+||+||
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 74 GGLYIVTEYMAKGSLVDYLRSRG------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHH------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CcEEEEEeccCCCCHHHHHHhcC------CCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccc
Confidence 66799999999999999997632 235899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP 456 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~ 456 (499)
|+++..... .....+|..|+|||++.+..++.++|||||||++|||+|+|++||...+..++...+..+.+++.+
T Consensus 148 g~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~ 222 (262)
T d1byga_ 148 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 222 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCC
T ss_pred ccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999865432 223457889999999999999999999999999999999889999998888999999999999999
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
..+++++.+++.+||+.||++|||+.||++.|++++.
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=441.26 Aligned_cols=268 Identities=29% Similarity=0.585 Sum_probs=228.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCC-ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEED-GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
..+|+++++||+|+||+||+|++..++ ....+||+|++....+....+.|.+|+.++++++|||||+++|+|.+. ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Ce
Confidence 356999999999999999999986543 234579999997665555567899999999999999999999997653 45
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++++||+.+|+|.+++... ...+++..++.++.|||.||+|||+++||||||||+|||++.++.+||+|||+|
T Consensus 86 ~~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH-------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT-------SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred eEEEEeccCCccccccccc-------ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccc
Confidence 8899999999999998863 246899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+...............||+.|||||++.++.|+.++|||||||++|||+|+|++||.+.+..++...+..+.++..|..+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~ 238 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 238 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTB
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 98765544434445668999999999999999999999999999999999899999998888888889888888899999
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhh
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTR 497 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~ 497 (499)
++++.+++.+||+.||++|||+.||++.|+++.....+
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~ 276 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChHh
Confidence 99999999999999999999999999999988655433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-56 Score=434.96 Aligned_cols=276 Identities=36% Similarity=0.713 Sum_probs=231.3
Q ss_pred hhcccceeeccce--EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEE
Q psy1789 212 EKLSELTIQRCRV--RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVL 289 (499)
Q Consensus 212 ~~~~~~~~~~~~~--~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~ 289 (499)
+++....+..... .+.++||+|+||+||+|++.++++....||||++.........++|.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~ 94 (311)
T d1r0pa_ 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94 (311)
T ss_dssp HHHGGGBCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred HHhhceEeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEe
Confidence 3344444444433 44689999999999999987665544679999998766777788999999999999999999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
|+|.+.+...++||||+++|+|.++++.. ...+++..+++++.|+|.||.|||+.+|+||||||+|||||+++
T Consensus 95 g~~~~~~~~~~lv~E~~~~g~l~~~~~~~-------~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~ 167 (311)
T d1r0pa_ 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF 167 (311)
T ss_dssp EEEEETTTEEEEEEECCTTCBHHHHHHCT-------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred EEEEecCCceEEEEEEeecCchhhhhccc-------cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC
Confidence 99887777789999999999999998852 24578899999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcc--ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q psy1789 370 RIQITDNALARDLFPSDYH--CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL 447 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i 447 (499)
.+||+|||+++........ .......||..|+|||.+.+..++.++||||||+++|||+|++.+|+...+..++...+
T Consensus 168 ~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i 247 (311)
T d1r0pa_ 168 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247 (311)
T ss_dssp CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH
T ss_pred CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 9999999999976543322 12334568999999999999999999999999999999999777777777777778888
Q ss_pred HcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 448 QDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
..+.++..|..+++++.+++.+||+.||++||+|.||++.|+++.+.
T Consensus 248 ~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 248 LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 88888889999999999999999999999999999999999998765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=425.50 Aligned_cols=255 Identities=30% Similarity=0.608 Sum_probs=227.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.++|++++.||+|+||+||+|+++++ +.||||++...... .+.|.+|+.++++++||||++++|+|. ++...+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~-~~~~~~ 75 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQ----YDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT-KQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTT----EEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEEC-CSSSEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCC----CEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEe-eCCceE
Confidence 45778889999999999999998643 78999999765332 357999999999999999999999965 456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|..++.... ..+++..+.+++.|+|+||+|||+++|+||||||+|||+++++.+||+|||+|+
T Consensus 76 iv~Ey~~~g~l~~~~~~~~-------~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLREMR-------HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EEEECCTTEEHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred EEEEccCCCcHHHhhhccc-------cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhe
Confidence 9999999999999987532 468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCc
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNCP 460 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 460 (499)
........ ......+|+.|+|||.+.+..++.++|||||||++|||+|+|+.||...+..++...+..+.++..|..++
T Consensus 149 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~ 227 (258)
T d1k2pa_ 149 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227 (258)
T ss_dssp BCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred eccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCccccc
Confidence 76544333 23356789999999999999999999999999999999997899999999999999999998989999999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q psy1789 461 DELFSVMAYCWAMNPEGRPTFPQLHSCLQE 490 (499)
Q Consensus 461 ~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~ 490 (499)
+++.+++.+||+.||++|||+.++++.|.+
T Consensus 228 ~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 228 EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 999999999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=431.12 Aligned_cols=263 Identities=31% Similarity=0.566 Sum_probs=224.6
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE 294 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~ 294 (499)
++++++.++|++++.||+|+||+||+|++.++ ..||||++...... .+.|.+|+.++++++|||||+++|+| .
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~----~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~-~ 82 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV-S 82 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT----EEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC----CEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEE-e
Confidence 35667788999999999999999999998654 57999999755332 36799999999999999999999997 4
Q ss_pred CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 295 DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 295 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
++ ..++||||+++|+|..++.... ...++|.+++.++.|||.||+|||+++|+||||||+|||||+++.+||+
T Consensus 83 ~~-~~~lv~Ey~~~g~l~~~~~~~~------~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~ 155 (285)
T d1fmka3 83 EE-PIYIVTEYMSKGSLLDFLKGET------GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 155 (285)
T ss_dssp SS-SCEEEECCCTTCBHHHHHSHHH------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred cC-CeEEEEEecCCCchhhhhhhcc------cccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEc
Confidence 33 4699999999999999987532 2359999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+|++++|+......++...+..+.+..
T Consensus 156 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 156 DFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp CCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999987644332 233456789999999999999999999999999999999998888888888888888888888888
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFH 492 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~ 492 (499)
.+..+++++.+++.+||+.||++||++.+|+++|+++.
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 88999999999999999999999999999999888653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=429.60 Aligned_cols=278 Identities=35% Similarity=0.569 Sum_probs=239.2
Q ss_pred ccceeeccceEEeeeeeeecceEEEEEEEeCCC----ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEE
Q psy1789 215 SELTIQRCRVRLFSVNMEGTFGRVYRGTYTEED----GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVL 289 (499)
Q Consensus 215 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~ 289 (499)
.+++++.++|++++.||+|+||.||+|+....+ .....||||++..........++.+|...+.++ +|||||+++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 457889999999999999999999999876542 233689999998877777778899999999887 899999999
Q ss_pred eEEEcCCCceEEEEEeCCCCCHHHHHHhcccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy1789 290 GVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCP--------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATR 361 (499)
Q Consensus 290 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~ 361 (499)
|+|.+ +...++||||+++|+|.+++....... ......+++.+++.++.|+|.||+|||+++||||||||+
T Consensus 86 ~~~~~-~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 86 GACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEECS-SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccc-CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99754 566799999999999999998643211 122356999999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHH
Q psy1789 362 NCVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPF 441 (499)
Q Consensus 362 NIlld~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~ 441 (499)
|||++.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||+|+|++||.+.+..
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~ 244 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 244 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence 99999999999999999997765544444556778999999999999999999999999999999999889999999998
Q ss_pred HHHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q psy1789 442 EMAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHA 493 (499)
Q Consensus 442 ~~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~ 493 (499)
++...+..+.++..|..+++++.+++.+||+.||++|||+.||++.|+++.+
T Consensus 245 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 8888999998999999999999999999999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=426.06 Aligned_cols=255 Identities=20% Similarity=0.335 Sum_probs=212.0
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-CCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-HTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-~~~~ 299 (499)
++|++++.||+|+||+||+|+...++ +.||||.+... ......+.|.+|++++++++|||||++++++.+. +...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 56899999999999999999987654 68999998654 3556677899999999999999999999987643 4567
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEEcCCCcEEEc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK-----LLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~-----iiHrDlk~~NIlld~~~~~kl~ 374 (499)
++||||+++|+|.+++..... ....+++.+++.++.|++.||.|||+++ |+||||||+|||+++++.+||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~----~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTK----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHH----HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHHhccc----cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 999999999999999975321 1246999999999999999999999865 9999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN 454 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 454 (499)
|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..+....
T Consensus 157 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~t-g~~Pf~~~~~~~~~~~i~~~~~~~ 233 (269)
T d2java1 157 DFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-LMPPFTAFSQKELAGKIREGKFRR 233 (269)
T ss_dssp CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred eccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999997654322 2335678999999999999999999999999999999999 899999999888888888776667
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.|..+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 77889999999999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=420.56 Aligned_cols=247 Identities=20% Similarity=0.270 Sum_probs=217.3
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
++|++++.||+|+||+||+|+...++ +.||+|++.... .....+.+.+|+.++++++|||||++++++ .+++..
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSK---FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-HDATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCC---cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-EECCEE
Confidence 46999999999999999999987654 789999986432 112246788999999999999999999985 556678
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+|
T Consensus 82 ~ivmEy~~~g~L~~~l~~~--------~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a 153 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL--------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 153 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred EEEEeecCCCcHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeeccccee
Confidence 9999999999999999863 36999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+...... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+... ....|..+
T Consensus 154 ~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 227 (263)
T d2j4za1 154 VHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRV-EFTFPDFV 227 (263)
T ss_dssp SCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHTT-CCCCCTTS
T ss_pred eecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc-CCCCCCCCCHHHHHHHHHcC-CCCCCccC
Confidence 8664332 224579999999999999999999999999999999999 89999998888888777665 45667789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++++.+++.+||+.||++|||+.|+++
T Consensus 228 s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-55 Score=428.02 Aligned_cols=275 Identities=33% Similarity=0.606 Sum_probs=241.1
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSI 293 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~ 293 (499)
+++++.++|++++.||+|+||.||+|.+... ......||||++...........|.+|+.++++++||||++++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 4778889999999999999999999988532 22347899999987767777788999999999999999999999975
Q ss_pred cCCCceEEEEEeCCCCCHHHHHHhcccC--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcE
Q psy1789 294 EDHTSPFLIYPYQDYTNLKRFLQKCKLC--PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRI 371 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~ 371 (499)
. +...++||||+++|+|.++++..+.. .......+++..+.+++.|+|+||.|||+++|+||||||+|||+|+++.+
T Consensus 94 ~-~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 94 Q-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp S-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred c-CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 4 55679999999999999999754310 11123457999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+|+...............+|+.|+|||.+.+..++.++||||||+++|||+|++++||.+.+..++...+.++.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 99999999977555444445566789999999999999999999999999999999997789999999999999998888
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
++..|..+++++.+++.+||+.||++||||.||++.|++.
T Consensus 253 ~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 8888899999999999999999999999999999998775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=431.28 Aligned_cols=275 Identities=31% Similarity=0.572 Sum_probs=232.0
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~~~~~~ 297 (499)
++-++|++.++||+|+||.||+|++.+++ ....||||++.........+.|.+|+++|+++ +|||||+++|+|.+ ++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCC-eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CC
Confidence 34567888999999999999999987643 33568899987665555667899999999998 79999999999755 56
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccC--------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLC--------PEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL 369 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~ 369 (499)
..++||||+++|+|.++|+..... .......+++..+.+++.|||.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 779999999999999999863210 012245799999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 370 RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 370 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++++.+||.+.+..++...+..
T Consensus 165 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred ceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 99999999998653221 223456889999999999999999999999999999999977889999999999999999
Q ss_pred CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhhhc
Q psy1789 450 GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLTRY 498 (499)
Q Consensus 450 ~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~~~ 498 (499)
+.++..+..+++++.+++.+||+.||++||||.||++.|+++.++.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~ 290 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCC
Confidence 8899999999999999999999999999999999999999998765443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=421.87 Aligned_cols=264 Identities=32% Similarity=0.569 Sum_probs=219.5
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH 296 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~ 296 (499)
+...+|++.+.||+|+||.||+|++....+....||||++... ......+.|.+|+.++++++||||++++|+|.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4567899999999999999999998766655578999998653 233445789999999999999999999999743 3
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccc
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
..++|+||+++|+|.+++.... ..+++..++.++.|+|.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 84 -~~~lv~e~~~~~~l~~~~~~~~-------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~Df 155 (273)
T d1u46a_ 84 -PMKMVTELAPLGSLLDRLRKHQ-------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDF 155 (273)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHG-------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred -chheeeeeecCcchhhhhhccc-------CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccc
Confidence 4589999999999999887632 46999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcc-ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCC
Q psy1789 377 ALARDLFPSDYH-CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ-DGYRLN 454 (499)
Q Consensus 377 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~ 454 (499)
|+++........ .......+|..|+|||.+.+..++.++|||||||++|||+|+|++||.+.+..+....+. .+.++.
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence 999987554332 233455678899999999999999999999999999999997899999999888877764 456777
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEF 491 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~ 491 (499)
.+..+++++.+++.+||+.||++||||.||++.|++.
T Consensus 236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 7888999999999999999999999999999988875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=423.46 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=208.4
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
++|++++.||+|+||+||+|+...++ +.||||++.........+.+.+|+.++++++|||||++++++ .+++..++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-~~~~~~~i 80 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGNIQYL 80 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-EETTEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-ccCceeEE
Confidence 46899999999999999999987654 789999997654444556789999999999999999999985 55667899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
||||+++|+|.+++.. ...+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+|+.
T Consensus 81 vmEy~~gg~L~~~l~~--------~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp EEECCTTEEGGGGSBT--------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence 9999999999999865 23699999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHc-CCCCCCCCC
Q psy1789 382 LFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPF-EMAASLQD-GYRLNQPVN 458 (499)
Q Consensus 382 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~-~~~~~i~~-~~~~~~~~~ 458 (499)
....+.........||+.|||||++.+..+ +.++|||||||++|||+| |++||...... ........ .........
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA-GELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH-SSCSCSSSSTTSHHHHHHHTTCTTSTTGGG
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh-CCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 654444434456789999999999988876 578999999999999999 89999765432 22233332 222233346
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++++.+++.+||+.||++|||+.|+++
T Consensus 232 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 232 IDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7899999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=422.71 Aligned_cols=278 Identities=28% Similarity=0.488 Sum_probs=239.9
Q ss_pred cceeeccceEEeeeeeeecceEEEEEEEeCC--CceeEEEEEEEecCcccHHHHHHHHHHHHHHhcC-CCCcceeEEeEE
Q psy1789 216 ELTIQRCRVRLFSVNMEGTFGRVYRGTYTEE--DGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGL-SHKNILTVLGVS 292 (499)
Q Consensus 216 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~g~~ 292 (499)
.++++.++|+++++||+|+||.||+|++... ....+.||||++...........|.+|+.+++++ +|||||+++|+|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 4668888999999999999999999998542 3455899999998776777778899999999998 799999999997
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCP----------EGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRN 362 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~N 362 (499)
.+ ....++||||+++|+|.++++...... ......+++.++..++.||+.||+|||++++|||||||+|
T Consensus 97 ~~-~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 97 TI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp CS-SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ee-CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 44 556799999999999999998754211 1123468999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Q psy1789 363 CVVDDKLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE 442 (499)
Q Consensus 363 Illd~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~ 442 (499)
||++.++.+||+|||+++...........+...||+.|+|||++.+..++.++|||||||++|||+|+|.+|+...+..+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999987655544455667889999999999999999999999999999999998888887766544
Q ss_pred -HHHHHHcCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 443 -MAASLQDGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 443 -~~~~i~~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
+...+..+.++..+..+++++.+|+.+||+.||++||||.||+++|++...+
T Consensus 256 ~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 4556677888888888999999999999999999999999999999987665
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-55 Score=421.75 Aligned_cols=251 Identities=18% Similarity=0.289 Sum_probs=215.8
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
++|++++.||+|+||+||+|+...++ +.||||++.... .....+.+.+|+.++++++||||+++++++ .+++..
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATS---REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-QDDEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-ECSSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-EECCEE
Confidence 46999999999999999999986654 789999986431 122346789999999999999999999985 556778
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+|
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--------~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a 155 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 155 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEccCCCCHHHhhhcc--------CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccc
Confidence 9999999999999998863 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||...+..++...+..+ ....|..+
T Consensus 156 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 233 (288)
T d1uu3a_ 156 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPFRAGNEYLIFQKIIKL-EYDFPEKF 233 (288)
T ss_dssp EECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHTT-CCCCCTTC
T ss_pred eecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh-CCCCCCCcCHHHHHHHHHcC-CCCCCccC
Confidence 97754433333445679999999999999999999999999999999999 89999998888888777665 45667789
Q ss_pred cHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
++++.+++.+||+.||++|||++|+++
T Consensus 234 s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 234 FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=420.03 Aligned_cols=249 Identities=17% Similarity=0.341 Sum_probs=214.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
..+|++++.||+|+||+||+|+...++ +.||||++...... ..+.+.+|+.++++++|||||++++++ ..++..+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~---~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATG---QEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSY-LVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTC---CEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCC---CEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEE-EECCEEE
Confidence 457999999999999999999976554 78999998644222 236789999999999999999999985 4566789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++.+ ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 94 ivmEy~~gg~L~~~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTE---------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEECCTTCBHHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 99999999999998875 358999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--CCCCCCC
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY--RLNQPVN 458 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~ 458 (499)
....... ......||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+....+.... ....+..
T Consensus 165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred eeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhh-CCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 7654332 2345679999999999999999999999999999999999 899999888776655544322 3344567
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+++++.+++.+||+.||++|||+.|+++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-55 Score=422.23 Aligned_cols=251 Identities=19% Similarity=0.318 Sum_probs=214.9
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.+.|++++.||+|+||+||+|+...++ +.||||++.... ....+.|.+|+++|++++|||||++++++ .+++..+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETS---VLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAF-YYENNLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEE-EETTEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCC---eEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCeEE
Confidence 356899999999999999999987655 689999987542 33456789999999999999999999985 4466789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+++|+|.+++.... ..+++.++..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 86 lvmEy~~~g~L~~~~~~~~-------~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELE-------RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEECCTTEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhh
Confidence 9999999999999987532 369999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCccccCCCCCCccccccccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--C
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLV-----HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR--L 453 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~--~ 453 (499)
..... ........||+.|||||++. +..|+.++|||||||++|||+| |++||.+.+..+....+..+.. .
T Consensus 159 ~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt-g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (288)
T d2jfla1 159 KNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-IEPPHHELNPMRVLLKIAKSEPPTL 235 (288)
T ss_dssp ECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH-SSCTTTTSCGGGHHHHHHHSCCCCC
T ss_pred ccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh-CCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 65321 11234567999999999984 5568999999999999999999 8999999888887777665543 3
Q ss_pred CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 ~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345578999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=406.75 Aligned_cols=246 Identities=22% Similarity=0.324 Sum_probs=207.6
Q ss_pred eEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC---CCce
Q psy1789 224 VRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---HTSP 299 (499)
Q Consensus 224 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---~~~~ 299 (499)
|++.+.||+|+||+||+|+...++ +.||+|++... ......+.|.+|+++|++++|||||++++++... +...
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~---~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETT---VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCC---eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 477789999999999999987654 68999998654 3555667899999999999999999999986432 3457
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEc-CCCcEEEccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKK--LLHKDLATRNCVVD-DKLRIQITDN 376 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~--iiHrDlk~~NIlld-~~~~~kl~Df 376 (499)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++ +++.+||+||
T Consensus 88 ~ivmE~~~~g~L~~~l~~~--------~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRF--------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp EEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EEEEeCCCCCcHHHHHhcc--------ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 8999999999999999863 36899999999999999999999988 99999999999997 5789999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCCC-C
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEID-PFEMAASLQDGYRL-N 454 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~-~~~~~~~i~~~~~~-~ 454 (499)
|+|+...... .....||+.|||||++.+ .|+.++|||||||++|||+| |+.||.+.. ..++...+..+..+ .
T Consensus 160 Gla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~-g~~Pf~~~~~~~~~~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 160 GLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMAT-SEYPYSECQNAAQIYRRVTSGVKPAS 233 (270)
T ss_dssp TGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHH-SSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred CcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHH-CCCCCCCcccHHHHHHHHHcCCCCcc
Confidence 9998654332 224679999999998865 69999999999999999999 899997654 45556666665443 2
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+++++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 34467889999999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-53 Score=416.10 Aligned_cols=247 Identities=18% Similarity=0.287 Sum_probs=212.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
..+|+.++.||+|+||+||+|+...++ +.||||++.... .....+.+.+|+.+|++++|||||++++++. ++..
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~ 89 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNS---EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REHT 89 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCC---cEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-ECCE
Confidence 346899999999999999999987655 789999986542 3455678999999999999999999999864 4667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|..++.. ...+++.++..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+
T Consensus 90 ~~iv~E~~~~g~l~~~~~~--------~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVH--------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp EEEEEECCSEEHHHHHHHH--------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred EEEEEEecCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccc
Confidence 8999999999999877765 24699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCcccccccccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC-
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVH---KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLN- 454 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~- 454 (499)
|+.... .....||+.|||||++.+ ..|+.++|||||||++|||++ |+.||.+.+..+....+..+..+.
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~-g~~Pf~~~~~~~~~~~i~~~~~~~~ 234 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPAL 234 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 986532 234679999999999864 468999999999999999999 899999888777666665544433
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+++++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 34568999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-53 Score=417.07 Aligned_cols=250 Identities=20% Similarity=0.232 Sum_probs=200.3
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.++|++++.||+|+||+||+|+...++ +.||||++.........+.+.+|+.+|++++|||||++++++ .+++..+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~ 83 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQ---KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-ESGGHLY 83 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTC---CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-ECSSEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCC---CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEE
Confidence 467999999999999999999986554 789999997654444456788999999999999999999985 5667789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---CCCcEEEcccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD---DKLRIQITDNA 377 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld---~~~~~kl~DfG 377 (499)
+||||+++|+|.+++.. ...+++.++..++.|++.||+|||+++|+||||||+|||+. +++.+||+|||
T Consensus 84 lvmE~~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG 155 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVE--------KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155 (307)
T ss_dssp EEECCCCSCBHHHHHHT--------CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred EEEeccCCCcHHHhhhc--------ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccc
Confidence 99999999999999986 24699999999999999999999999999999999999995 57899999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC---C
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL---N 454 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~ 454 (499)
+|+...... ......||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..+... .
T Consensus 156 ~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 231 (307)
T d1a06a_ 156 LSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYPPFYDENDAKLFEQILKAEYEFDSP 231 (307)
T ss_dssp --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHTTCCCCCTT
T ss_pred eeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCc
Confidence 998664332 2235679999999999999999999999999999999999 99999998888887777654322 2
Q ss_pred CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 455 QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 455 ~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.+..+++++.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 23478999999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=418.85 Aligned_cols=252 Identities=19% Similarity=0.257 Sum_probs=208.9
Q ss_pred eeeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 218 TIQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 218 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
++..++|++++.||+|+||+||+|+...++ +.||+|++.........+.+.+|+.+|++++|||||++++++ .++.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~ 77 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSDG 77 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTT---EEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-ECSS
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCC---cEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECC
Confidence 355678999999999999999999986655 789999997655555567899999999999999999999986 4566
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcCCCcEEEccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKK-KLLHKDLATRNCVVDDKLRIQITDN 376 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~-~iiHrDlk~~NIlld~~~~~kl~Df 376 (499)
..++||||+++|+|.+++.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+||
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~--------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKA--------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeC
Confidence 789999999999999999863 3589999999999999999999974 9999999999999999999999999
Q ss_pred ccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------------
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEM------------- 443 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~------------- 443 (499)
|+|+..... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+..+.
T Consensus 150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHH-SSCCSSCCCTTHHHHHC---------
T ss_pred CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence 999865322 2335689999999999999999999999999999999999 8999976543221
Q ss_pred -----------------------------HHHHHcCCCCCCC-CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 444 -----------------------------AASLQDGYRLNQP-VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 444 -----------------------------~~~i~~~~~~~~~-~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+.....+..+ ...+.++.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1111111111112 135788999999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=410.14 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=219.0
Q ss_pred eccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC
Q psy1789 220 QRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT 297 (499)
Q Consensus 220 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~ 297 (499)
.-++|++++.||+|+||+||+|+...++ +.||||++.+.. .....+.+.+|+.+|++++||||+++++++ +++.
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~---~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~ 78 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATG---RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QTHD 78 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-ECSS
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-cccc
Confidence 3457999999999999999999986655 789999996432 122346788999999999999999999984 5677
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||+|||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~--------~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRE--------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccceeccCCCchhhhhhcc--------cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecc
Confidence 789999999999999999873 468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPV 457 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 457 (499)
+|+....... .....+||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..+ ....|.
T Consensus 151 ~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~-G~~pf~~~~~~~~~~~i~~~-~~~~p~ 226 (337)
T d1o6la_ 151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELILME-EIRFPR 226 (337)
T ss_dssp TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCT
T ss_pred cccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHH-CCCCCCCcCHHHHHHHHhcC-CCCCCc
Confidence 9997643322 2345679999999999999999999999999999999999 89999999988888777765 466788
Q ss_pred CCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 458 NCPDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 458 ~~~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
.+++++.+++.+||+.||++||+ +.|+++
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 89999999999999999999995 677764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=404.15 Aligned_cols=250 Identities=21% Similarity=0.204 Sum_probs=214.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-----cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-----SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
.++|++++.||+|+||+||+|+...++ +.||||++.... .....+.|.+|+.+|++++|||||++++++ .+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~---~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~ 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTG---LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-EN 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTC---CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-EC
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCC---CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EE
Confidence 357999999999999999999986554 789999985431 112346789999999999999999999985 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC----cE
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL----RI 371 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~----~~ 371 (499)
....++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++ .+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~--------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK--------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCE
T ss_pred CCEEEEEEEcCCCccccchhccc--------cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccce
Confidence 67789999999999999999863 3699999999999999999999999999999999999998776 59
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY 451 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~ 451 (499)
||+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..+....+..+.
T Consensus 157 kl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp EECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHTTC
T ss_pred EecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHc-CCCCCCCCCHHHHHHHHHhcC
Confidence 999999998764432 2335678999999999999999999999999999999999 899999988888877776653
Q ss_pred CCC---CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 RLN---QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ~~~---~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... .+..+++++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 221 22468899999999999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.2e-52 Score=411.97 Aligned_cols=249 Identities=18% Similarity=0.204 Sum_probs=214.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
++|++++.||+|+||.||+|+...++ +.||||++.... ....+.+.+|+.+|++++|||||++++++ .+++..++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g---~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATG---NNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTT---EEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEE-EETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEE
Confidence 37999999999999999999986654 789999997653 44557899999999999999999999985 55677899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--CCCcEEEcccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD--DKLRIQITDNALA 379 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld--~~~~~kl~DfGla 379 (499)
||||+++|+|.+++... ...+++.++..++.||+.||+|||+++||||||||+|||++ .++.+||+|||+|
T Consensus 101 vmE~~~gg~L~~~l~~~-------~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 101 IYEFMSGGELFEKVADE-------HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp EECCCCSCBHHHHHTCT-------TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEcCCCCCHHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchh
Confidence 99999999999999642 24699999999999999999999999999999999999996 4578999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC---CCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL---NQP 456 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~---~~~ 456 (499)
+........ ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+...... ...
T Consensus 174 ~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 174 AHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp EECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHTCCCSCCGGG
T ss_pred eeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 876544322 24568999999999999999999999999999999999 89999988888887777654321 112
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 357899999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-51 Score=397.44 Aligned_cols=260 Identities=18% Similarity=0.256 Sum_probs=213.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc--ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC-
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN--ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT- 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~- 297 (499)
.++|++.+.||+|+||+||+|+...++ +.||||++... ......+.|.+|+.+++.++||||+++++++.....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLH---RDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCC---CEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 468999999999999999999986554 78999999754 245556789999999999999999999998655332
Q ss_pred --ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 298 --SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 298 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++.++..+|+|
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~--------~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d 154 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTE--------GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 154 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECC
T ss_pred CceEEEEEECCCCCEehhhhccc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeeh
Confidence 368999999999999999863 3699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCC-ccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCC
Q psy1789 376 NALARDLFPSD-YHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG-YRL 453 (499)
Q Consensus 376 fGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~-~~~ 453 (499)
||.++...... .........||+.|||||++.+..++.++|||||||++|||+| |++||.+.+..+....+... ..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVREDPIP 233 (277)
T ss_dssp CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh-CCCCCCCcCHHHHHHHHHhcCCCC
Confidence 99987654332 2223345678999999999999999999999999999999999 89999988887766544433 222
Q ss_pred --CCCCCCcHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q psy1789 454 --NQPVNCPDELFSVMAYCWAMNPEGRP-TFPQLHSCLQEFH 492 (499)
Q Consensus 454 --~~~~~~~~~~~~l~~~C~~~~P~~RP-t~~~v~~~L~~~~ 492 (499)
.....+++++.+++.+||+.||++|| |++++++.|.+++
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 22347899999999999999999999 8999999888775
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-51 Score=405.38 Aligned_cols=246 Identities=18% Similarity=0.296 Sum_probs=216.1
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCce
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSP 299 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~ 299 (499)
++|++++.||+|+||+||+|+...++ +.||||++.... .....+.+.+|+.++++++|||||++++++ .+....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g---~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNG---RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-QDAQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-ECSSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCC---CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-eeCCee
Confidence 46899999999999999999986554 789999986432 122356789999999999999999999985 556778
Q ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccccc
Q psy1789 300 FLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALA 379 (499)
Q Consensus 300 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla 379 (499)
++||||+++|+|..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 80 ~ivmE~~~gg~l~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRK--------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp EEEECCCCSCBHHHHHHH--------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eeEeeecCCccccccccc--------cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccc
Confidence 999999999999999987 246889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVNC 459 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 459 (499)
+..... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+ ....|..+
T Consensus 152 ~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~ 224 (316)
T d1fota_ 152 KYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA-GYTPFYDSNTMKTYEKILNA-ELRFPPFF 224 (316)
T ss_dssp EECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHC-CCCCCTTS
T ss_pred eEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHh-CCCCCCCcCHHHHHHHHHcC-CCCCCCCC
Confidence 876432 235679999999999999999999999999999999999 89999999888888877765 34567788
Q ss_pred cHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 460 PDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 460 ~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
++++.+++.+||+.||++|| |++|+++
T Consensus 225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 99999999999999999996 8888875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-51 Score=410.38 Aligned_cols=249 Identities=18% Similarity=0.221 Sum_probs=215.0
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFL 301 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~l 301 (499)
++|++++.||+|+||.||+|+...++ +.||||++.... ....+.+.+|+.+|++++|||||++++++ .++...++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATG---RVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEE-ECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCC---CEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEE
Confidence 46999999999999999999986554 789999987653 33456788999999999999999999984 56777899
Q ss_pred EEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--CCCcEEEcccccc
Q psy1789 302 IYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD--DKLRIQITDNALA 379 (499)
Q Consensus 302 v~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld--~~~~~kl~DfGla 379 (499)
||||+++|+|.+++... ...+++.++..|+.||+.||.|||+++|+||||||+||||+ .++.+||+|||+|
T Consensus 104 vmE~~~gg~L~~~~~~~-------~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAE-------DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp EEECCCCCBHHHHTTCT-------TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred EEEcCCCChHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccc
Confidence 99999999999887642 23599999999999999999999999999999999999998 6789999999999
Q ss_pred cccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---CCCC
Q psy1789 380 RDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR---LNQP 456 (499)
Q Consensus 380 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~---~~~~ 456 (499)
+....... .....||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+....+..+.. ...+
T Consensus 177 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 252 (352)
T d1koba_ 177 TKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQNVKRCDWEFDEDAF 252 (352)
T ss_dssp EECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHHHHHCCCCCCSSTT
T ss_pred eecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 97755432 224568899999999999999999999999999999999 8999999888888777765432 2233
Q ss_pred CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 ~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 468999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.3e-51 Score=392.02 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=212.9
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--------cHHHHHHHHHHHHHHhcCC-CCcceeEEeEE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--------SAVQVSLLLQEGMAMYGLS-HKNILTVLGVS 292 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~ 292 (499)
++|++++.||+|+||+||+|+...++ +.+|||++.... .....+.+.+|+.++++++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~---~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTC---KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred ccCEEceEEecCcCeEEEEEEECCCC---CEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec
Confidence 57999999999999999999986554 789999986432 1223456889999999997 99999999985
Q ss_pred EcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 293 IEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 293 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
.++...++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 80 -~~~~~~~ivmE~~~~g~L~~~l~~~--------~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 80 -ETNTFFFLVFDLMKKGELFDYLTEK--------VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp -ECSSEEEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred -ccCcceEEEEEcCCCchHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeE
Confidence 5677889999999999999999862 3699999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCcccccccccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVH------KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAAS 446 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~ 446 (499)
|+|||+|+...... ......||..|+|||.+.+ ..++.++||||+||++|||+| |+.||.+.+..+....
T Consensus 151 l~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~-g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 151 LTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLMLRM 226 (277)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred EccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc-CCCCCCCCCHHHHHHH
Confidence 99999998765432 2235678999999999863 457899999999999999999 9999999888887776
Q ss_pred HHcCC-CCC--CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 447 LQDGY-RLN--QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 447 i~~~~-~~~--~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+..+. ... ....+++++.+++.+||+.||++|||+.|+++
T Consensus 227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 66542 222 22378999999999999999999999999865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=403.31 Aligned_cols=249 Identities=20% Similarity=0.348 Sum_probs=214.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHh-cCCCCcceeEEeEEEcCCCc
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMY-GLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~H~nIv~l~g~~~~~~~~ 298 (499)
++|++++.||+|+||+||+|+...++ +.||||++.... .....+.+..|..++. .++|||||++++++ .+++.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~---~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-~~~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-QTKEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-ECSSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCC---CEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-ccCCc
Confidence 46899999999999999999987655 889999996432 1122345667777665 68999999999985 55677
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++||||+++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+
T Consensus 78 ~yivmEy~~~g~L~~~i~~~--------~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC--------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH--------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred eeEEEeecCCCcHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccch
Confidence 89999999999999999873 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
|+....... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..++...+..+ .+..|..
T Consensus 150 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemlt-G~~PF~~~~~~~~~~~i~~~-~~~~p~~ 225 (320)
T d1xjda_ 150 CKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI-GQSPFHGQDEEELFHSIRMD-NPFYPRW 225 (320)
T ss_dssp CBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCTT
T ss_pred hhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-CCCCCcc
Confidence 986643322 3345679999999999999999999999999999999999 89999999988888877765 4567778
Q ss_pred CcHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRPTFP-QLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RPt~~-~v~~ 486 (499)
+++++.+++.+||+.||++||++. |+++
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 999999999999999999999995 6753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-51 Score=405.98 Aligned_cols=247 Identities=19% Similarity=0.284 Sum_probs=216.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc--cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA--SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~ 298 (499)
-++|++++.||+|+||.||+|+...++ +.||||++.... .....+.+.+|+.+|+.++|||||++++++ .....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g---~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~ 115 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESG---NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSN 115 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCC---CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-ccccc
Confidence 468999999999999999999986554 689999986431 122346788999999999999999999985 55667
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNAL 378 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGl 378 (499)
.++|+||+.+|+|..++... ..+++.++..++.||+.||.|||+++||||||||+|||++.++.+||+|||+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~--------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRI--------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccccccccccchhhhHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeecee
Confidence 79999999999999999873 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQPVN 458 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 458 (499)
|+..... .....||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..++...+..+ ....|..
T Consensus 188 a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 260 (350)
T d1rdqe_ 188 AKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFADQPIQIYEKIVSG-KVRFPSH 260 (350)
T ss_dssp CEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHC-CCCCCTT
T ss_pred eeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHh-CCCCCCCcCHHHHHHHHhcC-CCCCCcc
Confidence 9976432 234678999999999999999999999999999999999 89999998888888877765 4456778
Q ss_pred CcHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q psy1789 459 CPDELFSVMAYCWAMNPEGRP-----TFPQLHS 486 (499)
Q Consensus 459 ~~~~~~~l~~~C~~~~P~~RP-----t~~~v~~ 486 (499)
+++++.+++.+||+.||++|+ |+.|+++
T Consensus 261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 999999999999999999994 8888875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-51 Score=398.30 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=201.7
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCC---c
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHT---S 298 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~---~ 298 (499)
.+|.+.+.||+|+||.||+|++.+ +.||||++...... ...+..|+..+..++||||++++|+|.+.+. .
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g-----~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRG-----EEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT-----EEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC-----EEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 467888999999999999999743 78999999654322 2223456666678899999999999876543 4
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCceEEcCCCc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK--------KKLLHKDLATRNCVVDDKLR 370 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~--------~~iiHrDlk~~NIlld~~~~ 370 (499)
.++||||+++|+|.++|++ ..++|.++++++.|+|.||+|||+ ++|+||||||+|||||+++.
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~---------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~ 146 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNR---------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 146 (303)
T ss_dssp EEEEEECCTTCBHHHHHHH---------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred EEEEEecccCCCHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence 6899999999999999986 358999999999999999999996 48999999999999999999
Q ss_pred EEEcccccccccCCCCccc--cCCCCCCccccccccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCCC----
Q psy1789 371 IQITDNALARDLFPSDYHC--LGDNENRPVKWLAIESLVHKT------FSTASDVWAFGVLLWELTTLAQQPYAEI---- 438 (499)
Q Consensus 371 ~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~~~DvwS~Gvvl~el~t~g~~p~~~~---- 438 (499)
+||+|||+++......... ......||+.|||||++.+.. ++.++|||||||++|||+| |.+|+...
T Consensus 147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t-g~~~~~~~~~~~ 225 (303)
T d1vjya_ 147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQ 225 (303)
T ss_dssp EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH-TBCBTTBCCCCC
T ss_pred eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh-CCCCCCcccccc
Confidence 9999999998775433221 234567999999999987643 6789999999999999999 65554321
Q ss_pred -----------CHHHHHHHHH-cCCCCCCCC-----CCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHh
Q psy1789 439 -----------DPFEMAASLQ-DGYRLNQPV-----NCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQL 495 (499)
Q Consensus 439 -----------~~~~~~~~i~-~~~~~~~~~-----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l 495 (499)
...+....+. .+.++..+. +.+.++.+++.+||+.||++|||+.||++.|+++.++-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1223333332 233444333 23456999999999999999999999999999998763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.7e-50 Score=399.63 Aligned_cols=249 Identities=14% Similarity=0.167 Sum_probs=204.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-----cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-----SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~ 295 (499)
-++|+++++||+|+||.||+|+...++ +.||||++.... .........+|+.+++.++|||||++++++ ..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~---~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-~~ 78 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTG---KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-HT 78 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-EC
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCC---CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-EE
Confidence 357999999999999999999987654 789999985321 112222334457778889999999999985 55
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~--------~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~D 150 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQH--------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 150 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECC
T ss_pred CCEEEEEEEecCCCcHHHHHHhc--------ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEee
Confidence 67789999999999999999863 3588999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--HcCCC
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASL--QDGYR 452 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i--~~~~~ 452 (499)
||+|+...... .....||+.|||||++.. ..|+.++|||||||++|||+| |+.||...+..+..... .....
T Consensus 151 FGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt-G~~Pf~~~~~~~~~~~~~~~~~~~ 225 (364)
T d1omwa3 151 LGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMA 225 (364)
T ss_dssp CTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH-SSCSSCSSCSSCHHHHHHHSSSCC
T ss_pred eceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhcccCC
Confidence 99998764432 235679999999999975 568999999999999999999 89999875443322222 22234
Q ss_pred CCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 453 LNQPVNCPDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 453 ~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
...+..+++++.+++.+||+.||++||| ++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 5566789999999999999999999999 577754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=394.61 Aligned_cols=248 Identities=20% Similarity=0.243 Sum_probs=213.8
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
.++|++++.||+|+||+||+|....++ +.||||++..... ....+.+|+.+|+.++|||||++++++ +++...+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~---~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSK---KTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESF-ESMEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEE-EETTEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC---cEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEE-EECCEEE
Confidence 357999999999999999999987655 7899999976533 235688999999999999999999984 5677789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCC--CcEEEccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDK--LRIQITDNAL 378 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~--~~~kl~DfGl 378 (499)
+||||+++|+|.+++... ...+++.++..++.|++.||+|||+++|+||||||+|||++.+ ..+||+|||+
T Consensus 78 lvmE~~~gg~L~~~i~~~-------~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS-------AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred EEEecCCCCcHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccch
Confidence 999999999999999752 1358999999999999999999999999999999999999854 5899999999
Q ss_pred ccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC--
Q psy1789 379 ARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRLNQP-- 456 (499)
Q Consensus 379 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~-- 456 (499)
++........ ....+|+.|+|||.+.+..|+.++|||||||++|||++ |++||...+..++...+..+.. ..+
T Consensus 151 ~~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~~~~ 225 (321)
T d1tkia_ 151 ARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAEY-TFDEE 225 (321)
T ss_dssp CEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHHHHHHTCC-CCCHH
T ss_pred hhccccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCC-CCChh
Confidence 9876543322 23467889999999999999999999999999999999 8999999888888777765432 222
Q ss_pred --CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 457 --VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 457 --~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..+++++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 367899999999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=387.95 Aligned_cols=245 Identities=20% Similarity=0.260 Sum_probs=197.8
Q ss_pred eeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccH----HHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceEEE
Q psy1789 227 FSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASA----VQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPFLI 302 (499)
Q Consensus 227 ~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~lv 302 (499)
+++||+|+||+||+|+...++ +.||||++...... ...+.+.+|+.++++++|||||++++++ ..++..++|
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-~~~~~~~iv 78 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-GHKSNISLV 78 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCC---SEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCTTCCEEE
T ss_pred ceEeccCcCeEEEEEEECCCC---cEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-ccCCceeeh
Confidence 589999999999999976544 78999998643221 1234688999999999999999999985 556678999
Q ss_pred EEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccccc
Q psy1789 303 YPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALARDL 382 (499)
Q Consensus 303 ~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~~~ 382 (499)
|||+.++++..+... ...+++.++..++.|++.||+|||+++|+||||||+|||+++++.+||+|||+|+..
T Consensus 79 mE~~~~~~~~~~~~~--------~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDN--------SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp EECCSEEHHHHHTTC--------CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hhhhcchHHhhhhhc--------ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCcccccc
Confidence 999998877766543 246888999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--------
Q psy1789 383 FPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYRL-------- 453 (499)
Q Consensus 383 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~~-------- 453 (499)
..... ......||+.|||||++... .|+.++|||||||++|||+| |.+||.+.+..+....+......
T Consensus 151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~-g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 151 GSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred CCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHh-CcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 44322 23355789999999998754 58999999999999999999 88999988877765554321000
Q ss_pred --------------CC-----CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 454 --------------NQ-----PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 454 --------------~~-----~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. ....++++.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 0145788999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=392.92 Aligned_cols=246 Identities=16% Similarity=0.243 Sum_probs=198.6
Q ss_pred cceEEe-eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhc-CCCCcceeEEeEEEc---CC
Q psy1789 222 CRVRLF-SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYG-LSHKNILTVLGVSIE---DH 296 (499)
Q Consensus 222 ~~~~~~-~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~g~~~~---~~ 296 (499)
.+|+++ ++||+|+||+||+|+...++ +.||||++.+. ..+.+|+.++.+ .+|||||++++++.. .+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQ---EKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTC---CEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCC---CEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 367776 46999999999999986654 78999999653 346689988655 589999999998532 24
Q ss_pred CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC---CCcEEE
Q psy1789 297 TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD---KLRIQI 373 (499)
Q Consensus 297 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~---~~~~kl 373 (499)
...++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+++|+||||||+|||+++ ++.+||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~------~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG------DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS------CCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred CEEEEEEECCCCCcHHHHHHhcC------CCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccc
Confidence 56799999999999999998521 246999999999999999999999999999999999999985 567999
Q ss_pred cccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Q psy1789 374 TDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-- 451 (499)
Q Consensus 374 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-- 451 (499)
+|||+|+...... ......||+.|||||++.+..|+.++|||||||++|||+| |++||.+.+..+....+....
T Consensus 156 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt-g~~Pf~~~~~~~~~~~~~~~i~~ 231 (335)
T d2ozaa1 156 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSNHGLAISPGMKTRIRM 231 (335)
T ss_dssp CCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT-SSCSCEETTCC--------CCCS
T ss_pred cccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh-CCCCCCCCCHHHHHHHHHHHHhc
Confidence 9999998765433 2345679999999999999999999999999999999999 899998765544433332221
Q ss_pred -CCCCCC----CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 -RLNQPV----NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 -~~~~~~----~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....|. .+++++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 122222 57889999999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=379.80 Aligned_cols=252 Identities=19% Similarity=0.284 Sum_probs=202.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++++.||+|+||+||+|+...++ +.||||++.... .....+.+.+|+.++++++|||||++++++ .++...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-~~~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTG---EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCC---CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-cccccee
Confidence 47899999999999999999987655 689999996442 222356789999999999999999999985 5567789
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+||||+.+ ++..++.... ...+++.++..++.|++.||+|||+++||||||||+|||++.++.+||+|||+|+
T Consensus 78 iv~e~~~~-~~~~~~~~~~------~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 78 LVFEFLHQ-DLKKFMDASA------LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp EEEECCSE-EHHHHHHHTT------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred EEEeecCC-chhhhhhhhc------ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcce
Confidence 99999985 5555554321 2469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-------- 451 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 451 (499)
....... ......||+.|+|||.+.... ++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 151 ~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 151 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhh-CCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 7644322 334567899999999987765 5899999999999999999 899999887766544332100
Q ss_pred ---------CCCC-----------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 ---------RLNQ-----------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 ---------~~~~-----------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
.... ...+++++.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 01456789999999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=380.00 Aligned_cols=242 Identities=19% Similarity=0.320 Sum_probs=200.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-----cHHHHHHHHHHHHHHhcCC--CCcceeEEeEEE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-----SAVQVSLLLQEGMAMYGLS--HKNILTVLGVSI 293 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~ 293 (499)
.++|++++.||+|+||+||+|+...++ +.||||++.... .......+.+|+.++++++ |||||++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~- 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF- 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCC---CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE-
Confidence 357999999999999999999986654 789999986431 1111234678999999886 99999999985
Q ss_pred cCCCceEEEEEeCCC-CCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-CCcE
Q psy1789 294 EDHTSPFLIYPYQDY-TNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-KLRI 371 (499)
Q Consensus 294 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-~~~~ 371 (499)
.+.+..++||||+.+ +++.+++... ..+++.++..++.|++.||+|||+++|+||||||+|||++. ++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~--------~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITER--------GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH--------CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred eeCCeEEEEEEeccCcchHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeE
Confidence 556678999999975 6888888762 46999999999999999999999999999999999999985 5799
Q ss_pred EEcccccccccCCCCccccCCCCCCccccccccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Q psy1789 372 QITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTF-STASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG 450 (499)
Q Consensus 372 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~ 450 (499)
||+|||+|+..... ..+...||+.|||||++.+..+ +.++|||||||++|||+| |+.||...+ .+..+
T Consensus 151 kl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~-g~~Pf~~~~------~i~~~ 219 (273)
T d1xwsa_ 151 KLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC-GDIPFEHDE------EIIRG 219 (273)
T ss_dssp EECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH-SSCSCCSHH------HHHHC
T ss_pred EECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh-CCCCCCCch------HHhhc
Confidence 99999999865432 2235679999999999988775 577999999999999999 899997532 12222
Q ss_pred CCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 YRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 ~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
....+..+++++.+++.+||+.||++|||++|+++
T Consensus 220 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 -QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 34456678999999999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=380.82 Aligned_cols=253 Identities=18% Similarity=0.248 Sum_probs=202.6
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-HHHHHHHHHHHHHHhc---CCCCcceeEEeEEEc--
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-AVQVSLLLQEGMAMYG---LSHKNILTVLGVSIE-- 294 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~---l~H~nIv~l~g~~~~-- 294 (499)
.++|++++.||+|+||+||+|+...+++ +.||||++..... ......+.+|+.+++. .+||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGG--RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTT--EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCC--EEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 4689999999999999999999854432 6799999854321 1112345567766655 489999999998643
Q ss_pred --CCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 295 --DHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 295 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
.....++++||+++|++....... ...+++..+..++.|++.||+|||+++|+||||||+|||+++++.+|
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVP-------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSC-------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred cccCceEEEEEEeccCCchhhhhhcc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCee
Confidence 234578999999988776555431 24689999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Q psy1789 373 ITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR 452 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~ 452 (499)
|+|||+++...... ......||+.|||||++.+..|+.++||||+||++|||+| |++||.+.+..+....+.....
T Consensus 157 l~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 157 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLGKILDVIG 232 (305)
T ss_dssp ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHC
T ss_pred ecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHH-CCCCCCCCCHHHHHHHHHHhhC
Confidence 99999998653322 3446789999999999999999999999999999999999 8999998887776554422100
Q ss_pred --------------------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 --------------------------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 --------------------------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
...+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0122356789999999999999999999999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-48 Score=375.40 Aligned_cols=259 Identities=17% Similarity=0.252 Sum_probs=207.2
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
+++|++++.||+|+||.||+|++..++ +.||||++...... ..+..|+++++.++|+|++..++.|.......+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAG---EEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTT---EEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCC---CEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 357999999999999999999986554 78999998654322 357789999999998888887777777777889
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---CCCcEEEcccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVD---DKLRIQITDNA 377 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld---~~~~~kl~DfG 377 (499)
+||||++ |+|...+... ...+++.++..++.|++.||+|||+++|+||||||+|||++ .+..+||+|||
T Consensus 80 ivme~~~-~~l~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 80 MVMELLG-PSLEDLFNFC-------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEECCC-CBHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEcC-Cchhhhhhhc-------cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccC
Confidence 9999996 6676666542 24689999999999999999999999999999999999986 45679999999
Q ss_pred cccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----
Q psy1789 378 LARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQ---- 448 (499)
Q Consensus 378 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~---- 448 (499)
+|+........ .......||+.|||||.+.+..++.++|||||||++|||+| |+.||......+....+.
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t-g~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL-GSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH-SSCTTCCCC-------HHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh-CCCcccccchHHHHHHHHHhhc
Confidence 99976543221 12345679999999999999999999999999999999999 899998765433222111
Q ss_pred ---cCCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q psy1789 449 ---DGYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQ 494 (499)
Q Consensus 449 ---~~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~ 494 (499)
..........+++++.+++..||+.+|++||++.++.+.|+++..+
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1111122347899999999999999999999999999999887554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6e-48 Score=374.34 Aligned_cols=249 Identities=19% Similarity=0.241 Sum_probs=201.2
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++++.||+|+||+||+|+.+++ +.||||++.... .....+.+.+|+.+|++++||||+++++++ ..++..+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKKRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTS----CEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-ECSSCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCC----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-ccCCcee
Confidence 4899999999999999999987543 689999996542 222346789999999999999999999986 4566679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+++||+.++.+..+... ...+++.++..++.|++.||+|||+.+||||||||+|||++.++.+||+|||+|.
T Consensus 77 i~~e~~~~~~~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVC--------EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp EEEECCSEEHHHHHHTS--------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred EEEEeehhhhHHHHHhh--------cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccce
Confidence 99999997777766653 2469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-------- 451 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 451 (499)
....... ......+++.|+|||.+.+. .++.++|||||||++|||++ |+.||.+.+..+....+....
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 225 (286)
T d1ob3a_ 149 AFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRILGTPNSKNW 225 (286)
T ss_dssp HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH-CCCCCCCCCHHHHHHHHHHhhCCCChhhc
Confidence 7644322 22344578899999999764 56999999999999999999 899999887666544432100
Q ss_pred -------C-------------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 -------R-------------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 -------~-------------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
+ .......++++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0112356789999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=376.48 Aligned_cols=253 Identities=18% Similarity=0.254 Sum_probs=202.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---C
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH---T 297 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~---~ 297 (499)
..+|++++.||+|+||+||+|+...++ +.||||++.........+.+.+|+.+|+.++||||+++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNK---VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTC---SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCC---cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 357999999999999999999976554 6899999986656666778999999999999999999999965432 1
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++||||||||+|||+++++.+||+|||
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~---------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG 154 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT---------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFG 154 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEeecCCchhhhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccC
Confidence 23556677789999999975 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcc-ccCCCCCCccccccccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc------
Q psy1789 378 LARDLFPSDYH-CLGDNENRPVKWLAIESLV-HKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD------ 449 (499)
Q Consensus 378 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~------ 449 (499)
+|+........ .......||+.|+|||.+. ...++.++||||+||++|||++ |+.||...+..+.......
T Consensus 155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~-g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh-CCCCCCCCCHHHHHHHHhhhccCCC
Confidence 99876543222 1234567899999999985 5567999999999999999999 8999987765443322211
Q ss_pred -------------------CCCCC-----CCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 -------------------GYRLN-----QPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 -------------------~~~~~-----~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
..... .....+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 01256678999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-46 Score=365.25 Aligned_cols=262 Identities=16% Similarity=0.238 Sum_probs=211.0
Q ss_pred eeccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCC-CcceeEEeEEEcCCC
Q psy1789 219 IQRCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSH-KNILTVLGVSIEDHT 297 (499)
Q Consensus 219 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~ 297 (499)
+.+.+|++++.||+|+||+||+|+...++ +.||||++...... ..+.+|++.++.++| +|++.++++. ..+.
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~~ 74 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNN---QQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFG-QEGL 74 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTT---EEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEE-EETT
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEe-ecCC
Confidence 45678999999999999999999987654 78999998654322 346678888888865 8999999885 4566
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC-----CCcEE
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD-----KLRIQ 372 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~-----~~~~k 372 (499)
..++||||+ +|+|.+++.... ..+++.++..++.|++.||+|||+++|+||||||+|||++. ++.+|
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~-------~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCG-------RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred ccEEEEEec-CCCHHHHHHhhc-------cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceE
Confidence 679999998 599999987632 35899999999999999999999999999999999999974 57899
Q ss_pred EcccccccccCCCCcc-----ccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH
Q psy1789 373 ITDNALARDLFPSDYH-----CLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP---FEMA 444 (499)
Q Consensus 373 l~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~---~~~~ 444 (499)
|+|||+|+........ .......||+.|||||.+.+..++.++|||||||++|||+| |+.||.+... .+..
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ellt-g~~Pf~~~~~~~~~~~~ 225 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQGLKAATNKQKY 225 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH-SSCTTSSCCSCCHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHh-CCCcCCCccchhHHHHH
Confidence 9999999876432211 12335679999999999999999999999999999999999 8999975432 2222
Q ss_pred HHHHc----CCCCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHhh
Q psy1789 445 ASLQD----GYRLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSCLQEFHAQLT 496 (499)
Q Consensus 445 ~~i~~----~~~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~L~~~~~~l~ 496 (499)
..+.. .........+|+++.+++..||+.+|++||+++.+.+.|+++.++++
T Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 22221 11112234688999999999999999999999999999998877653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=374.09 Aligned_cols=248 Identities=19% Similarity=0.291 Sum_probs=200.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCC---
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDH--- 296 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~--- 296 (499)
..+|++++.||+|+||+||+|....++ +.||||++... .+....+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTG---AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC---CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCC---CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 568999999999999999999986554 78999999754 35556678999999999999999999999865432
Q ss_pred --CceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEc
Q psy1789 297 --TSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQIT 374 (499)
Q Consensus 297 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~ 374 (499)
...++||||+ +++|..+.+. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+|++
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~ 163 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH---------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKIL 163 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH---------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred ccceEEEEEecc-cccHHHHHHh---------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccc
Confidence 2469999999 4788888765 359999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Q psy1789 375 DNALARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-- 451 (499)
Q Consensus 375 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-- 451 (499)
|||+|+..... .+...||..|+|||.+.+. .++.++||||+||++|||++ |++||.+.+..+....+....
T Consensus 164 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 164 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHH-CcCCCCCCChHHHHHHHHhccCC
Confidence 99999876432 2356789999999999864 57899999999999999999 899998876655433221100
Q ss_pred ----------------------C------CCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q psy1789 452 ----------------------R------LNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHSC 487 (499)
Q Consensus 452 ----------------------~------~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~~ 487 (499)
. .......++++.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 01123567899999999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=370.38 Aligned_cols=254 Identities=16% Similarity=0.202 Sum_probs=199.4
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc-cHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA-SAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---- 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---- 295 (499)
-++|++++.||+|+||+||+|+...++ +.||||++.... .......+.+|+.+|++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTG---QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCC---CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 368999999999999999999986554 789999985432 222345688999999999999999999986442
Q ss_pred ---CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEE
Q psy1789 296 ---HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQ 372 (499)
Q Consensus 296 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~k 372 (499)
....++||||++++.+..+... ...++...+..++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~--------~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~k 157 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNV--------LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 157 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCT--------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred cccCceEEEEEeccCCCccchhhhc--------ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEE
Confidence 3457899999998777655433 24688999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCccc--cCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Q psy1789 373 ITDNALARDLFPSDYHC--LGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQD 449 (499)
Q Consensus 373 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~ 449 (499)
|+|||+++......... ......||+.|+|||.+.+. .++.++|||||||++|||++ |++||.+.+..+....+..
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~-g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHH
T ss_pred eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh-CCCCCCCCCHHHHHHHHHH
Confidence 99999998765433221 22345689999999999865 68999999999999999999 8999998777665544322
Q ss_pred CC---CCCCCC----------------------------CCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 450 GY---RLNQPV----------------------------NCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 450 ~~---~~~~~~----------------------------~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.. ...... ...+++.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11 100000 12456789999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=361.74 Aligned_cols=251 Identities=20% Similarity=0.231 Sum_probs=205.6
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcCCCceE
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIEDHTSPF 300 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~~~~~~ 300 (499)
++|++++.||+|+||+||+|+...++ +.||||++... ........+.+|+.+++.++||||+++++++ ......+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETH---EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC---CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCC---cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-cccccee
Confidence 47999999999999999999987655 78999998643 2334567899999999999999999999986 4456679
Q ss_pred EEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 301 LIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 301 lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
+|+|++.+++|..++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||.|+
T Consensus 78 iv~~~~~~~~l~~~~~~--------~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSC--------NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp EEEECCSEEHHHHHHHT--------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeeecccccccccccc--------ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhh
Confidence 99999999999888875 2468899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--------
Q psy1789 381 DLFPSDYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY-------- 451 (499)
Q Consensus 381 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 451 (499)
....... ......++..|+|||.+.... ++.++|||||||++|||++|+.++|...+..+....+....
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 150 AFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred cccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 7654332 233455678899999988665 69999999999999999995555566666655544432210
Q ss_pred --------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 --------------------RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 --------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
........+.++.+|+.+||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122356778999999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=374.29 Aligned_cols=247 Identities=19% Similarity=0.205 Sum_probs=197.4
Q ss_pred ceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC-----CC
Q psy1789 223 RVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED-----HT 297 (499)
Q Consensus 223 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~-----~~ 297 (499)
+|+.+++||+|+||+||+|+...++ +.||||++..... .+.+|+.+|++++||||+++++++... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSG---ELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTC---CEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCC---CEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 6788899999999999999987655 7899999975432 234799999999999999999986432 33
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cEEEccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDN 376 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~kl~Df 376 (499)
+.+|||||+++|.+....+... ....+++.++..++.|++.||+|||+++|+||||||+|||++.++ .+||+||
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~-----~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSR-----AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHH-----TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred EEEEEEeccCCccHHHHHhhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecc
Confidence 4689999999665444443211 124699999999999999999999999999999999999999775 8999999
Q ss_pred ccccccCCCCccccCCCCCCcccccccccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-----
Q psy1789 377 ALARDLFPSDYHCLGDNENRPVKWLAIESLVH-KTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDG----- 450 (499)
Q Consensus 377 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~----- 450 (499)
|+|+....... .....||..|+|||.+.+ ..++.++||||+||++|||++ |++||...+..+....+...
T Consensus 168 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~-g~~pf~~~~~~~~l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 168 GSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGTPT 243 (350)
T ss_dssp TTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH-TSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhh-CCCCCCCCCHHHHHHHHHHHhCCCh
Confidence 99987654432 234578899999998875 578999999999999999999 89999887765544333210
Q ss_pred -----------CCC------------CCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 451 -----------YRL------------NQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 451 -----------~~~------------~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ......++++.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 011246789999999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=372.11 Aligned_cols=253 Identities=17% Similarity=0.229 Sum_probs=204.5
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcc---cHHHHHHHHHHHHHHhcCCC-CcceeEEeEEEcCCC
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNA---SAVQVSLLLQEGMAMYGLSH-KNILTVLGVSIEDHT 297 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~H-~nIv~l~g~~~~~~~ 297 (499)
++|++++.||+|+||+||+|+........+.||||++.... .....+.+.+|+.++++++| |||+++++++ ++..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-~~~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-QTET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-EETT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-ccCC
Confidence 56999999999999999999875443334789999986431 11223567899999999976 8999999984 5566
Q ss_pred ceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcccc
Q psy1789 298 SPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITDNA 377 (499)
Q Consensus 298 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~DfG 377 (499)
..++++||+.+|+|.+++... ..++......++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~--------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR--------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceeeeeecccccHHHHHHHhc--------ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeecc
Confidence 789999999999999999873 357888999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcCC
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHK--TFSTASDVWAFGVLLWELTTLAQQPYAEIDPFE----MAASLQDGY 451 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~----~~~~i~~~~ 451 (499)
+|+........ ......|++.|+|||.+.+. .++.++|||||||+||||+| |+.||...+..+ +..... ..
T Consensus 175 ~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt-G~~PF~~~~~~~~~~~i~~~~~-~~ 251 (322)
T d1vzoa_ 175 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT-GASPFTVDGEKNSQAEISRRIL-KS 251 (322)
T ss_dssp EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH-SSCTTSCTTSCCCHHHHHHHHH-HC
T ss_pred chhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcc-cC
Confidence 99866433222 23345688899999999765 47889999999999999999 899997754333 222222 22
Q ss_pred CCCCCCCCcHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q psy1789 452 RLNQPVNCPDELFSVMAYCWAMNPEGRPT-----FPQLHS 486 (499)
Q Consensus 452 ~~~~~~~~~~~~~~l~~~C~~~~P~~RPt-----~~~v~~ 486 (499)
.+..|..+++++.+++.+||+.||++||| ++|+++
T Consensus 252 ~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 45566789999999999999999999995 677764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=366.67 Aligned_cols=247 Identities=19% Similarity=0.245 Sum_probs=191.9
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEc-----C
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIE-----D 295 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~-----~ 295 (499)
++|++++.||+|+||+||+|.+..++ +.||||++... .+....+.+.+|+.++++++||||+++++++.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~---~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLD---RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTT---EEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCC---CEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 57999999999999999999987554 78999999754 345566789999999999999999999998643 2
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....++||||+.++ +.+.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+|++|
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~----------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~d 162 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ----------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC
T ss_pred CceeEEEEeccchH-HHHhhh----------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeec
Confidence 35679999999855 444443 2589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC----
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGY---- 451 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~---- 451 (499)
||+++...... ......+|..|+|||++.+..++.++||||+||++|||++ |++||.+.+.......+....
T Consensus 163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~-g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred hhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhh-CCCCCCCCCHHHHHHHHHHhccCCC
Confidence 99988654332 2345568899999999999999999999999999999999 899998876555433321100
Q ss_pred ------------------CCCC-------------C------CCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 452 ------------------RLNQ-------------P------VNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 452 ------------------~~~~-------------~------~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
.... + ...++++.+|+.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0 012457899999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-44 Score=358.08 Aligned_cols=244 Identities=17% Similarity=0.273 Sum_probs=196.0
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEc-CCCc
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIE-DHTS 298 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~-~~~~ 298 (499)
.++|++++.||+|+||+||+|+...++ +.||||++.... .+.+.+|+++|+.++ ||||+++++++.. ....
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~---~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNN---EKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCC---CEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 458999999999999999999986655 889999997543 256789999999985 9999999998643 3456
Q ss_pred eEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCC-cEEEcccc
Q psy1789 299 PFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKL-RIQITDNA 377 (499)
Q Consensus 299 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~-~~kl~DfG 377 (499)
.++||||+++|+|..+. ..+++.++..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||
T Consensus 107 ~~~v~e~~~~~~L~~~~-----------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY-----------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp EEEEEECCCSCBGGGTT-----------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred eeEEEeecCCCcHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccc
Confidence 89999999999987653 2589999999999999999999999999999999999999654 69999999
Q ss_pred cccccCCCCccccCCCCCCccccccccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH--------
Q psy1789 378 LARDLFPSDYHCLGDNENRPVKWLAIESLVHK-TFSTASDVWAFGVLLWELTTLAQQPYAEIDP-FEMAASL-------- 447 (499)
Q Consensus 378 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~-~~~~~~i-------- 447 (499)
+|+...... ......+|..|+|||.+.+. .++.++||||+||++|||++ |+.||..... .+....+
T Consensus 176 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~-g~~pf~~~~~~~~~~~~i~~~~g~~~ 251 (328)
T d3bqca1 176 LAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF-RKEPFFHGHDNYDQLVRIAKVLGTED 251 (328)
T ss_dssp GCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH-TCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred cceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc-CCCCCCCCchhHHHHHHHHHHHCCch
Confidence 998765433 23456788999999998865 47999999999999999999 7788765432 2211111
Q ss_pred -----HcC-C----------------------CCCCCCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 448 -----QDG-Y----------------------RLNQPVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 448 -----~~~-~----------------------~~~~~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... . .......+++++.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0 00011246788999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=364.08 Aligned_cols=248 Identities=19% Similarity=0.238 Sum_probs=200.5
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCc-ccHHHHHHHHHHHHHHhcCCCCcceeEEeEEEcC----
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN-ASAVQVSLLLQEGMAMYGLSHKNILTVLGVSIED---- 295 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~l~g~~~~~---- 295 (499)
.++|++++.||+|+||+||+|+...++ +.||||++... .+....+.+.+|+.+|++++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTG---LRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTT---EEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCC---CEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 357999999999999999999976555 88999999754 3455567889999999999999999999985321
Q ss_pred CCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcCCCcEEEcc
Q psy1789 296 HTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDDKLRIQITD 375 (499)
Q Consensus 296 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~~~~~kl~D 375 (499)
....+++++|+.+|+|.+++.. ..+++.++..++.|++.||+|||+++|+||||||+|||++.++.+|++|
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~---------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~d 164 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC---------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 164 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cCceEEEEEeecCCchhhhccc---------ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccc
Confidence 2234667788899999999964 3599999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccCCCCCCccccccccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--
Q psy1789 376 NALARDLFPSDYHCLGDNENRPVKWLAIESLVHKT-FSTASDVWAFGVLLWELTTLAQQPYAEIDPFEMAASLQDGYR-- 452 (499)
Q Consensus 376 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~~~~~~~i~~~~~-- 452 (499)
||+|..... ......|+..|+|||...+.. ++.++|||||||++|||++ |++||.+.+.......+.....
T Consensus 165 fg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~-g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 165 FGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT-GRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp C----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH-SSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh-CCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999975432 233567889999999877654 6899999999999999999 8999988776554443322100
Q ss_pred --------------------CCC--------CCCCcHHHHHHHHHhhhcCCCCCCCHHHHHH
Q psy1789 453 --------------------LNQ--------PVNCPDELFSVMAYCWAMNPEGRPTFPQLHS 486 (499)
Q Consensus 453 --------------------~~~--------~~~~~~~~~~l~~~C~~~~P~~RPt~~~v~~ 486 (499)
... ...+++++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 1256788999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-39 Score=325.64 Aligned_cols=249 Identities=17% Similarity=0.234 Sum_probs=186.7
Q ss_pred ccceEEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-----------CCcceeEE
Q psy1789 221 RCRVRLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-----------HKNILTVL 289 (499)
Q Consensus 221 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~ 289 (499)
..||++++.||+|+||+||+|+...++ +.||||++.... ...+.+.+|+.+++.++ |+||++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g---~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNN---THVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTT---EEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCC---CEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 357999999999999999999986655 789999997542 33466788888887765 57899999
Q ss_pred eEEEc-CCCceEEEEEeCCCCC-HHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEc
Q psy1789 290 GVSIE-DHTSPFLIYPYQDYTN-LKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHK-KKLLHKDLATRNCVVD 366 (499)
Q Consensus 290 g~~~~-~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~-~~iiHrDlk~~NIlld 366 (499)
+++.. .....+++++++..+. ........ ....+++..+..++.|++.||+|||+ .+|+||||||+|||++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKY------EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHT------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred EEeeeccccceeeeeeecccccccccccccc------cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 88643 3344567777766544 33333321 13568899999999999999999998 7899999999999998
Q ss_pred CCC------cEEEcccccccccCCCCccccCCCCCCccccccccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCH
Q psy1789 367 DKL------RIQITDNALARDLFPSDYHCLGDNENRPVKWLAIESLVHKTFSTASDVWAFGVLLWELTTLAQQPYAEIDP 440 (499)
Q Consensus 367 ~~~------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DvwS~Gvvl~el~t~g~~p~~~~~~ 440 (499)
.++ .++++|||.|+.... ......||+.|+|||.+....++.++||||+||+++||++ |+.||...+.
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~-g~~pF~~~~~ 234 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPDEG 234 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH-SSCCC-----
T ss_pred ccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHH-CCCCCCCCcc
Confidence 665 499999999986532 2235678999999999999999999999999999999999 8889875432
Q ss_pred H------HH-HHH--HH---------cC-----------C------------------CCCCCCCCcHHHHHHHHHhhhc
Q psy1789 441 F------EM-AAS--LQ---------DG-----------Y------------------RLNQPVNCPDELFSVMAYCWAM 473 (499)
Q Consensus 441 ~------~~-~~~--i~---------~~-----------~------------------~~~~~~~~~~~~~~l~~~C~~~ 473 (499)
. +. ... +. .. . ....+...++++.+|+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~ 314 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314 (362)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence 1 11 100 00 00 0 0011112356799999999999
Q ss_pred CCCCCCCHHHHHH
Q psy1789 474 NPEGRPTFPQLHS 486 (499)
Q Consensus 474 ~P~~RPt~~~v~~ 486 (499)
||.+|||++|+++
T Consensus 315 dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 315 DPRKRADAGGLVN 327 (362)
T ss_dssp STTTCBCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=2.1e-24 Score=194.90 Aligned_cols=166 Identities=16% Similarity=0.122 Sum_probs=120.5
Q ss_pred EEeeeeeeecceEEEEEEEeCCCceeEEEEEEEecCccc-----------------HHHHHHHHHHHHHHhcCCCCccee
Q psy1789 225 RLFSVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNAS-----------------AVQVSLLLQEGMAMYGLSHKNILT 287 (499)
Q Consensus 225 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~H~nIv~ 287 (499)
.+++.||+|+||.||+|+..++ +.||||++..... ........+|...+.+++|.+++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g----~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~ 78 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTT----EEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred hhCCEeeeCcceEEEEEECCCC----CEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcce
Confidence 4679999999999999987543 7899998753210 111234557888899999999999
Q ss_pred EEeEEEcCCCceEEEEEeCCCCCHHHHHHhcccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcC
Q psy1789 288 VLGVSIEDHTSPFLIYPYQDYTNLKRFLQKCKLCPEGVAHTLTTQEVVDMCLQIIMGVQYLHKKKLLHKDLATRNCVVDD 367 (499)
Q Consensus 288 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~l~~~~~~~i~~~va~~L~yLH~~~iiHrDlk~~NIlld~ 367 (499)
.+++. . .+++|||+++..+. .++......++.|++.+|.|||+++|+||||||+|||+++
T Consensus 79 ~~~~~-~----~~lvme~~~~~~~~---------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~ 138 (191)
T d1zara2 79 VYAWE-G----NAVLMELIDAKELY---------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138 (191)
T ss_dssp EEEEE-T----TEEEEECCCCEEGG---------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET
T ss_pred EEEec-C----CEEEEEeecccccc---------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC
Confidence 88762 2 28999999975442 2344456789999999999999999999999999999997
Q ss_pred CCcEEEcccccccccCCCCccccCCCCCCccccccc--c---ccccCCCCCchhHHHHHHHHH
Q psy1789 368 KLRIQITDNALARDLFPSDYHCLGDNENRPVKWLAI--E---SLVHKTFSTASDVWAFGVLLW 425 (499)
Q Consensus 368 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~s~~~DvwS~Gvvl~ 425 (499)
++ ++|+|||+|+........ .|... + ....+.|+.++|+||..--++
T Consensus 139 ~~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 139 EG-IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TE-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CC-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 64 899999999765322111 12111 1 012467889999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.91 E-value=1.1e-05 Score=73.89 Aligned_cols=80 Identities=14% Similarity=0.012 Sum_probs=47.7
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC-CCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS-HKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+..+-++.+.||+....+ ..+.+|+....... ....+.+|...+..+. +--+.++++++ +.++..++||+++
T Consensus 20 ~~~~G~s~~~v~rv~~~~-----~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~-~~~~~~~lv~~~l 92 (263)
T d1j7la_ 20 KDTEGMSPAKVYKLVGEN-----ENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFE-RHDGWSNLLMSEA 92 (263)
T ss_dssp ECSCCCSSSEEEEEECSS-----CEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEE-EETTEEEEEEECC
T ss_pred EcCCCCCCCcEEEEEeCC-----CeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEE-ecCCceEEEEEec
Confidence 433334446899875322 45677877543211 1223566777766553 43456777774 4456679999999
Q ss_pred CCCCHHHH
Q psy1789 307 DYTNLKRF 314 (499)
Q Consensus 307 ~~gsL~~~ 314 (499)
++.++.+.
T Consensus 93 ~G~~~~~~ 100 (263)
T d1j7la_ 93 DGVLCSEE 100 (263)
T ss_dssp SSEEHHHH
T ss_pred cccccccc
Confidence 98776543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.52 E-value=0.00011 Score=71.33 Aligned_cols=77 Identities=10% Similarity=0.050 Sum_probs=45.1
Q ss_pred eeeeeecceEEEEEEEeCCCceeEEEEEEEecCc------ccHHHHHHHHHHHHHHhcC---CCCcceeEEeEEEcCCCc
Q psy1789 228 SVNMEGTFGRVYRGTYTEEDGVEEEVLVKTVTDN------ASAVQVSLLLQEGMAMYGL---SHKNILTVLGVSIEDHTS 298 (499)
Q Consensus 228 ~~lG~G~fG~Vy~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l---~H~nIv~l~g~~~~~~~~ 298 (499)
+.||.|....||+....+++ +.++||.-... ......++...|.+.|+.+ -...+.++++++ ...
T Consensus 32 ~eig~G~~N~vfrV~~~~~~---~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d---~~~ 105 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHD---RALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEM 105 (392)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTT
T ss_pred EEeCCCceEeEEEEEeCCCC---eEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc---CCC
Confidence 56899999999998754433 56888864321 0111122344566666544 234567777763 233
Q ss_pred eEEEEEeCCCCC
Q psy1789 299 PFLIYPYQDYTN 310 (499)
Q Consensus 299 ~~lv~e~~~~gs 310 (499)
.++|||++++..
T Consensus 106 ~~lvmE~L~~~~ 117 (392)
T d2pula1 106 AVTVMEDLSHLK 117 (392)
T ss_dssp TEEEECCCTTSE
T ss_pred CEEEEeccCCcc
Confidence 489999998643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.19 E-value=0.0003 Score=63.44 Aligned_cols=142 Identities=15% Similarity=0.094 Sum_probs=76.0
Q ss_pred eeeecc-eEEEEEEEeCCCceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCC--CCcceeEEeEEEcCCCceEEEEEeC
Q psy1789 230 NMEGTF-GRVYRGTYTEEDGVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLS--HKNILTVLGVSIEDHTSPFLIYPYQ 306 (499)
Q Consensus 230 lG~G~f-G~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~g~~~~~~~~~~lv~e~~ 306 (499)
+..|.. ..||+....+. ..+.+|....... ..+..|...++.+. .-.+.++++++. +++..++||+++
T Consensus 18 ~~~G~s~~~v~r~~~~~~----~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~-~~~~~~~v~~~i 88 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGR----PVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVT-EAGRDWLLLGEV 88 (255)
T ss_dssp CSCTTSSCEEEEEECTTS----CCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEE-CSSCEEEEEECC
T ss_pred cCCcccCCeEEEEEeCCC----CEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecc-cccceEEEEEee
Confidence 344543 57898875333 3467787654321 23456666666543 333566777754 455679999999
Q ss_pred CCCCHH--------------HHHHhcccCC-CCCCCCCCHHHHHHHH--------------------HHHHHHHHHHHhC
Q psy1789 307 DYTNLK--------------RFLQKCKLCP-EGVAHTLTTQEVVDMC--------------------LQIIMGVQYLHKK 351 (499)
Q Consensus 307 ~~gsL~--------------~~l~~~~~~~-~~~~~~l~~~~~~~i~--------------------~~va~~L~yLH~~ 351 (499)
++.++. +.+.+.-... ......-.+.....-. ......+..+.+.
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 864432 1221110000 0000000111110000 0122233444332
Q ss_pred -------CccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 352 -------KLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 352 -------~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
.++|+|+.|.|||++++..+-|.||+.+.
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999988777899999765
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=95.90 E-value=0.0039 Score=55.44 Aligned_cols=71 Identities=13% Similarity=0.032 Sum_probs=55.9
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec--CCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS--RNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~--~~~~~~~~~~~~~~ 93 (499)
--.+++||+||+..+.+.+.+..... +.-..++..++.+..+|++++++++..++-. .+.|.+..|.|+.+
T Consensus 163 G~~~~v~I~Yd~~~~~L~V~l~~~~~----~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~h~I~sWsF~s~ 235 (237)
T d1qnwa_ 163 GEVADVVITYRAPTKSLTVCLSYPSD----GTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTSN 235 (237)
T ss_dssp TCCEEEEEEEEGGGTEEEEEEECTTT----CCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEEE
T ss_pred CcEEEEEEEEcCCCcEEEEEEecCCC----CccceEEEEEChHHhCCCcEEEEEEeECCCCCCccEeEEEEeEeEEe
Confidence 34689999999999988888865543 3446677677778899999999999999433 34789999999865
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=95.62 E-value=0.01 Score=52.25 Aligned_cols=71 Identities=14% Similarity=0.117 Sum_probs=54.9
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecC---CCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSR---NSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~---~~~~~~~~~~~~~ 93 (499)
--++.+||+||+....+.+.+..... +.-..++..++.+..+|+++++++++.++-.. ..|.+.+|.|+.+
T Consensus 153 g~~~~v~I~Yd~~~~~l~V~l~~~~~----~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~h~I~sWsFss~ 226 (228)
T d1ioaa_ 153 GEKTDVQITYDSSNNDLRVFLHFTVS----QVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSK 226 (228)
T ss_dssp SSCEEEEEEEETTTTEEEEEEEETTT----CCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred CcEEEEEEEEcCCCCEEEEEEEeCCC----CceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceEEEEEEEEeEEe
Confidence 46789999999999888888865542 33445676677788899999999999995332 2589999999854
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=95.20 E-value=0.011 Score=52.57 Aligned_cols=70 Identities=10% Similarity=0.049 Sum_probs=54.9
Q ss_pred cceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec-CCCCCceEEEEeee
Q psy1789 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS-RNSNNVTSLNFKRK 93 (499)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~-~~~~~~~~~~~~~~ 93 (499)
-.+.+||+||+..+++.+.+..+. .+....++..++.+..+|+++.++++..++.. ...|.+..|.|+.+
T Consensus 166 ~~~~v~I~Yd~~~~~L~V~l~~~~----~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H~I~sWsFsst 236 (240)
T d1fx5a_ 166 NVANVEIIYEASSKTLTASLTYPS----DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATHEVLNWYFTST 236 (240)
T ss_dssp GCEEEEEEEETTTTEEEEEEEETT----TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEEEEEEEEEEEE
T ss_pred CeEEEEEEEcCCCCEEEEEEecCC----CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceEEEEEEEeEEe
Confidence 468999999999998888876544 23345667666678899999999999999743 34789999999865
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=95.17 E-value=0.013 Score=51.95 Aligned_cols=71 Identities=15% Similarity=0.098 Sum_probs=55.3
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecC---CCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSR---NSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~---~~~~~~~~~~~~~ 93 (499)
--.+++||+||+..+.+.+.+..... +....++..++.+..+|++++++++..++... ..|.+.+|.|+.+
T Consensus 163 G~~~~v~I~Yd~~~~~L~V~l~~~~~----~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~V~sWsF~s~ 236 (239)
T d1gzca_ 163 GQVANVVIKYDAPSKILHVVLVYPSS----GAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDVYSWSFQAS 236 (239)
T ss_dssp TCEEEEEEEEETTTTEEEEEEECTTT----CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCCcEEEEEEecCCC----CcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCceeeEEEEEEeEee
Confidence 35788999999999988888765443 34556776666688899999999999996433 3688999999865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.15 E-value=0.028 Score=53.71 Aligned_cols=79 Identities=16% Similarity=0.170 Sum_probs=49.3
Q ss_pred cceEEeeeeeeecceEEEEEEEeCCC----ceeEEEEEEEecCcccHHHHHHHHHHHHHHhcCCCCcc-eeEEeEEEcCC
Q psy1789 222 CRVRLFSVNMEGTFGRVYRGTYTEED----GVEEEVLVKTVTDNASAVQVSLLLQEGMAMYGLSHKNI-LTVLGVSIEDH 296 (499)
Q Consensus 222 ~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~g~~~~~~ 296 (499)
..+++ +.|+-|-...+|+....+.. ...+.+.+++....... ....+|..+++.+.-.++ .++++++ .+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~-~~- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE---SHLVAESVIFTLLSERHLGPKLYGIF-SG- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH---HHHHHHHHHHHHHHHTTSSSCEEEEE-TT-
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh---hHHHHHHHHHHHHHhCCCCCeEEEEc-CC-
Confidence 44554 56777888999999876432 12245777776533332 234478888777643344 4778874 32
Q ss_pred CceEEEEEeCCCC
Q psy1789 297 TSPFLIYPYQDYT 309 (499)
Q Consensus 297 ~~~~lv~e~~~~g 309 (499)
.+|+||+++.
T Consensus 117 ---g~I~efi~g~ 126 (395)
T d1nw1a_ 117 ---GRLEEYIPSR 126 (395)
T ss_dssp ---EEEECCCCEE
T ss_pred ---ceEEEEeccc
Confidence 7899999864
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=95.01 E-value=0.02 Score=50.44 Aligned_cols=71 Identities=13% Similarity=0.095 Sum_probs=54.2
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecC---CCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSR---NSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~---~~~~~~~~~~~~~ 93 (499)
--++++||+|++..+.+.+.+..... +....++..++.+..+|+++++++++.++... ..|.+.+|.|+.+
T Consensus 158 g~~~~v~I~Y~~~~~~l~v~l~~~~~----~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H~I~sWsFss~ 231 (233)
T d1n47a_ 158 GEKANIVITYQASTKALAASLVFPVS----QTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231 (233)
T ss_dssp TSCEEEEEEEETTTTEEEEEEEETTT----TEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred CCEEEEEEEEcCCCeEEEEEEEeCCC----CccEEEEEEechHHhcCCcEEEEEEEecCCCCCcccccEEEEEEeEEE
Confidence 45789999999998887777765432 33445665666688899999999999996432 3688999999865
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.98 E-value=0.016 Score=53.82 Aligned_cols=28 Identities=29% Similarity=0.191 Sum_probs=23.3
Q ss_pred CccccCCCCCceEEcCCCcEEEcccccccc
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALARD 381 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~~ 381 (499)
++||+|+.+.|||++++ ..+.||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 58999999999999754 45789998764
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=94.82 E-value=0.012 Score=52.02 Aligned_cols=69 Identities=12% Similarity=0.036 Sum_probs=52.8
Q ss_pred cceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec-CCCCCceEEEEeee
Q psy1789 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS-RNSNNVTSLNFKRK 93 (499)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~-~~~~~~~~~~~~~~ 93 (499)
-.+++||+||+..+++.+.+.... |. ...++..++.+..+|+++.++++..++-+ ...|.+.+|.|..+
T Consensus 166 ~~~~v~I~Yd~~~~~L~V~l~~~~----~~-~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~h~I~sWsF~s~ 235 (236)
T d1hqla_ 166 KIATARISYDGSAEILTVVLSYPD----GS-DYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYILSWRFSSN 235 (236)
T ss_dssp SCEEEEEEEETTTTEEEEEEEETT----TE-EEEEEEECCGGGTSCSEEEEEEEEECCSCCCEEEEEEEEEEEEE
T ss_pred CEEEEEEEEeCCCcEEEEEEecCC----CC-CeeEEEEeCHHHhCCCcEEEEEEeECCCCCceEEEEEEeEeEec
Confidence 468999999999998888887543 22 23456555668899999999999999643 33578999999754
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=94.79 E-value=0.017 Score=51.21 Aligned_cols=71 Identities=13% Similarity=0.036 Sum_probs=56.0
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeeec
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRKK 94 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 94 (499)
.-.+.+||+||+..+.+.+.+..+. |.. ..++..++.+..+|+++++++++.++-..+.|.+..|.|+.+-
T Consensus 167 g~~~~v~I~Yd~~~~~L~v~~~~~~----~~~-~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~H~IlsWsFss~l 237 (241)
T d1ukga_ 167 GQSLNVLVTFNPSTRNLDVVATYSD----GTR-YEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTLESWSFTSTL 237 (241)
T ss_dssp TCCEEEEEEEETTTTEEEEEEEETT----CCE-EEEEEECCGGGTSCSEEEEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred CcEEEEEEEEeCCCcEEEEEEccCC----CCc-eEEEEEEehHHhCCCcEEEEEEEecCCCCceeEEEEeEEEEEe
Confidence 4678899999999988888887654 222 3455555667889999999999999666678999999998764
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=94.69 E-value=0.023 Score=49.98 Aligned_cols=72 Identities=15% Similarity=0.130 Sum_probs=56.9
Q ss_pred CccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeeec
Q psy1789 18 GHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRKK 94 (499)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 94 (499)
.--.+.+||+||+..+++.+.+.... | ....++..++.+..+|++++++++..++-..+.|.+..|.|..+-
T Consensus 44 ~G~~~~v~I~Yd~~~~~L~V~~~~~~----~-~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~ 115 (237)
T d1nlsa_ 44 NGKVGTAHIIYNSVDKRLSAVVSYPN----A-DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp TTCEEEEEEEEETTTTEEEEEEECTT----S-CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred CCCEEEEEEEEecCCcEEEEEEecCC----C-CCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeec
Confidence 35678999999999998887776443 2 234566666668889999999999999777789999999997653
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=94.63 E-value=0.013 Score=52.13 Aligned_cols=68 Identities=10% Similarity=0.052 Sum_probs=53.4
Q ss_pred cceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecCCCCCceEEEEeee
Q psy1789 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSRNSNNVTSLNFKRK 93 (499)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 93 (499)
=.+++||+||+..+++.+.+.... | ....++..++.+..+|++++++++..++.. ..|.+..|.|+..
T Consensus 170 ~~~~v~I~Yd~~~~~L~V~l~~~~----~-~~p~ls~~idL~~~l~~~vyvGFSAsTG~~-~~h~I~sWsF~s~ 237 (243)
T d1leda_ 170 SIATAHITYDARSKILTVLLSYEH----G-RDYILSHVVDLAKVLPQKVRIGFSAGVGYD-EVTYILSWHFFST 237 (243)
T ss_dssp CEEEEEEEEETTTTEEEEEEEETT----S-CEEEEEEECCHHHHSCSEEEEEEEEEECBS-EEEEEEEEEEEEE
T ss_pred ceeEEEEEEECCCCEEEEEEeeCC----C-CCceEEEecCHHHhcCCcEEEEEEcccCCc-ceeeEEEEEEEee
Confidence 357899999999998888887653 2 234566666667789999999999999754 6788999999754
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=94.49 E-value=0.023 Score=50.72 Aligned_cols=70 Identities=16% Similarity=0.112 Sum_probs=53.1
Q ss_pred cceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec--CCCCCceEEEEeee
Q psy1789 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS--RNSNNVTSLNFKRK 93 (499)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~--~~~~~~~~~~~~~~ 93 (499)
-.+++||+||+..+++.+.+.... .+....++..++.+..+|+++++++++.++-. ...|.+..|.|+.+
T Consensus 160 ~~~~v~I~Yd~~~~~L~v~l~~~~----~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~h~I~sWsF~s~ 231 (251)
T d1g9fa_ 160 KVAKVLITYDASTSLLVASLVYPS----QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVLSWSFASN 231 (251)
T ss_dssp CCEEEEEEEETTTTEEEEEEEEGG----GTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCCEEEEEEEEEEEE
T ss_pred CEEEEEEEEECCccEEEEEEecCC----CCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCceeEEEEeEeECC
Confidence 468999999999988887775433 33445666566668889999999999999533 24689999999866
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=94.46 E-value=0.023 Score=50.24 Aligned_cols=71 Identities=13% Similarity=0.097 Sum_probs=54.3
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec-------CCCCCceEEEEe
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS-------RNSNNVTSLNFK 91 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~-------~~~~~~~~~~~~ 91 (499)
--.+++||+||+..+.+.+.+..... +....++..++.+..+|+++++++++.++-. ...|.+.+|.|+
T Consensus 157 G~~~~v~I~Yd~~~~~L~V~l~~~~~----~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~~~e~h~I~sWsFs 232 (237)
T d2d3sa1 157 GGIANVVIKYDASTKILHVVLVFPSL----GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATETHDILSWSFS 232 (237)
T ss_dssp TCEEEEEEEEETTTTEEEEEEEETTT----TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTTCCCCCEEEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEEcCCC----CcccceeeEechHHhCCCcEEEEEEeECCCCccCccccceeeEEEEeEeE
Confidence 35689999999999988888865543 2334566566668888999999999999532 236789999997
Q ss_pred ee
Q psy1789 92 RK 93 (499)
Q Consensus 92 ~~ 93 (499)
.+
T Consensus 233 s~ 234 (237)
T d2d3sa1 233 AS 234 (237)
T ss_dssp EE
T ss_pred ee
Confidence 65
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=94.39 E-value=0.02 Score=51.16 Aligned_cols=70 Identities=20% Similarity=0.157 Sum_probs=52.4
Q ss_pred cceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec---CCCCCceEEEEeee
Q psy1789 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS---RNSNNVTSLNFKRK 93 (499)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~---~~~~~~~~~~~~~~ 93 (499)
-++++||+|++..+.+.+.+.-.. .+.-..++..++.+..+|+++++++++.++-. ...|.+.+|.|..+
T Consensus 160 ~~~~v~I~Yd~~~~~L~v~l~~~~----~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~H~IlsWsF~s~ 232 (253)
T d1g7ya_ 160 QNAEILITYNAATSLLVASLVHPS----RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSFASK 232 (253)
T ss_dssp SEEEEEEEEETTTTEEEEEEEETT----TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCCEEEEEEEEEE
T ss_pred CEEEEEEEEeCCcEEEEEEEecCC----CCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccccEEEEEEeEEe
Confidence 477899999999988777764332 34445566556667789999999999999632 24688999999754
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=94.30 E-value=0.029 Score=48.24 Aligned_cols=70 Identities=13% Similarity=0.079 Sum_probs=52.5
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEE-ec--CCCCCceEEEEee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVT-LS--RNSNNVTSLNFKR 92 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~-~~--~~~~~~~~~~~~~ 92 (499)
.-++.+||+||+....+.+.+..... |. -..|+-.++.+..+|+++++++++.++ +. ...|.+.+|.|+.
T Consensus 130 g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~-~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsWsFss 202 (204)
T d1dhkb_ 130 GQNAEVRITYNSSTKVFSVSLSNPST---GK-SNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFSS 202 (204)
T ss_dssp TSCEEEEEEEETTTTEEEEEEECTTT---CC-EEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEEEEE
T ss_pred CCEEEEEEEEcCCCEEEEEEEecCCC---CC-ceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEEEEEe
Confidence 46789999999999988888876553 22 234544455578899999999999994 43 2458899999974
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=94.17 E-value=0.026 Score=49.74 Aligned_cols=72 Identities=17% Similarity=0.198 Sum_probs=54.1
Q ss_pred CccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccC--ceEEEEEEEEEEecCC---CCCceEEEEee
Q psy1789 18 GHLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMN--AEVIVLISINVTLSRN---SNNVTSLNFKR 92 (499)
Q Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip--~~~~~~~~l~~~~~~~---~~~~~~~~~~~ 92 (499)
.--.+++||+||+..+++.+.+.....+ ....++-.++.+..+| +.++++++..++...+ .|.+..|.|+.
T Consensus 157 ~G~~~~v~I~Yd~~~~~l~V~l~~~~~~----~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~~~~~h~I~sWsF~s 232 (234)
T d1f9ka_ 157 NGGVANVVIKYDSPTKILNVVLAFHSVG----TVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNAVETHEIISWSFTS 232 (234)
T ss_dssp TTCCEEEEEEEETTTTEEEEEEEETTTT----EEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTCCCEEEEEEEEEEE
T ss_pred CCCEEEEEEEEcCCCcEEEEEEEeCCCC----ccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCCceeeeEEEEEEeEE
Confidence 3467899999999999888888765533 3445675566677777 4599999999964433 57899999975
Q ss_pred e
Q psy1789 93 K 93 (499)
Q Consensus 93 ~ 93 (499)
+
T Consensus 233 ~ 233 (234)
T d1f9ka_ 233 S 233 (234)
T ss_dssp E
T ss_pred e
Confidence 4
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=93.87 E-value=0.033 Score=49.15 Aligned_cols=71 Identities=11% Similarity=0.078 Sum_probs=53.8
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecC---CCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSR---NSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~---~~~~~~~~~~~~~ 93 (499)
--.+++||+|++..+.+.+.+..... +....++..++.+..+|+++++++++.++-.. ..|.+.+|.|+.+
T Consensus 161 g~~~~v~I~Y~~~~~~l~v~l~~~~~----~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~H~I~sWsF~s~ 234 (237)
T d1fnya_ 161 GEVANVFISYEASTKSLTASLVYPSL----ETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWSFESN 234 (237)
T ss_dssp TCCEEEEEEEEGGGTEEEEEEEETTT----TEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred CcEEEEEEEEeCCccEEEEEEEeCCC----CcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccccEEEEeEeEEe
Confidence 46788999999998888887755442 23445565566677899999999999995322 3688999999875
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=93.84 E-value=0.036 Score=48.77 Aligned_cols=71 Identities=17% Similarity=0.136 Sum_probs=53.5
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEecC---CCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLSR---NSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~~---~~~~~~~~~~~~~ 93 (499)
--.+.+||+||+....+.+.+.... .+....++..++.+..+|+++++++++.++-.. ..|.+.+|.|+.+
T Consensus 158 g~~~~~~I~yd~~~~~l~v~l~~~~----~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h~I~sWsFss~ 231 (233)
T d1g8wa_ 158 GENAEVLITYDSSTNLLVASLVYPS----QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASK 231 (233)
T ss_dssp TCCEEEEEEEETTTTEEEEEEEETT----TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCCEEEEEEEEEE
T ss_pred CcEEEEEEEEeCCCcEEEEEEEeCC----CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceeeEEEEEEEEEE
Confidence 4567899999999888777776554 334445665666678899999999999995322 3589999999754
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=93.59 E-value=0.025 Score=49.78 Aligned_cols=70 Identities=13% Similarity=0.106 Sum_probs=53.2
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEe-cCCCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTL-SRNSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~-~~~~~~~~~~~~~~~ 93 (499)
--.+++||+||+..+.+.+.+.... |. ...++..++.+..+|+.+++++++.++- ....|.+.+|.|+.+
T Consensus 158 g~~~~v~I~Yd~~~~~L~V~~~~~~----~~-~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~sWsFss~ 228 (232)
T d1v6ia_ 158 GAVVKVTVIYDSSTKTLSVAVTNDN----GD-ITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTST 228 (232)
T ss_dssp TCEEEEEEEEETTTTEEEEEEECTT----SC-EEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEEEEEEEE
T ss_pred CCEEEEEEEEeCCceEEEEEEecCC----CC-cceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEEeEeEEe
Confidence 4678999999999887777766443 22 3345555555778899999999999964 446789999999865
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=92.79 E-value=0.037 Score=48.44 Aligned_cols=71 Identities=15% Similarity=0.083 Sum_probs=53.3
Q ss_pred ccceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEE-ecC--CCCCceEEEEeee
Q psy1789 19 HLPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVT-LSR--NSNNVTSLNFKRK 93 (499)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~-~~~--~~~~~~~~~~~~~ 93 (499)
.-.+.+||+|++..+.+.+.+..... +....++..++.+..+|+++++++++.++ .+. +.|.+.+|.|+.+
T Consensus 151 g~~~~v~I~Yd~~~~~L~V~l~~~~~----~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~IlsWsF~s~ 224 (226)
T d1avba_ 151 GEKAEVRITYDSPKNDLRVSLLYPSS----EEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVLSWSFSSN 224 (226)
T ss_dssp TCEEEEEEEEEGGGTEEEEEEEETTT----TEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred CeEEEEEEEEcCCCcEEEEEEEeCCC----CccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEEEEEeEEe
Confidence 46679999999998888887766542 33445555555577899999999999994 332 3688999999865
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=92.42 E-value=0.076 Score=46.74 Aligned_cols=70 Identities=11% Similarity=0.029 Sum_probs=53.7
Q ss_pred cceEEEEEecCccccCCCccccCCcccccCceeEEEEEeeeccccCceEEEEEEEEEEec--CCCCCceEEEEeee
Q psy1789 20 LPYSISVESTNKDALINPHLNISSIGSIPTSIQTFSINLPCTGTMNAEVIVLISINVTLS--RNSNNVTSLNFKRK 93 (499)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~G~iP~~~~~l~l~l~~sg~ip~~~~~~~~l~~~~~--~~~~~~~~~~~~~~ 93 (499)
-.+.+||+|++....+.+.+.... .+....|+..++.+..+|+++++++++.++-. .+.|.+.+|.|+.+
T Consensus 167 ~~~~~~i~y~~~~~~l~v~l~~~~----~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~H~I~sWsFss~ 238 (239)
T d1dbna_ 167 GVAFATITYLAPNKTLIASLVYPS----NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSFTST 238 (239)
T ss_dssp CCEEEEEEEEGGGTEEEEEEEETT----TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred ceeEEEEEEcCCCCEEEEEEEecC----CCccEEEEEecchHHhcCCcEEEEEEEeCCCCCCcceeEEEEEEeEEe
Confidence 457899999998887777775544 34455677667778889999999999999532 34799999999754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.82 E-value=0.074 Score=48.68 Aligned_cols=29 Identities=21% Similarity=0.138 Sum_probs=26.5
Q ss_pred CccccCCCCCceEEcCCCcEEEccccccc
Q psy1789 352 KLLHKDLATRNCVVDDKLRIQITDNALAR 380 (499)
Q Consensus 352 ~iiHrDlk~~NIlld~~~~~kl~DfGla~ 380 (499)
++||+|+.++||+++.+...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 79999999999999998877899999775
|